{
    "5e6157cb1af46fc13000000e_1": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.92578125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.623046875,
            "text": "Ret",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": -1.701171875,
            "end_logit": 7.92578125,
            "text": "syndrome",
            "probability": 6.455183029174805e-05
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 7.92578125,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.8984375,
            "text": "Rett",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.92578125,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.92578125,
            "text": "CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -8.046875,
            "text": "Rett syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -1.623046875,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -1.623046875,
            "text": "CpG-binding protein-2 gene (MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -1.701171875,
            "end_logit": -8.046875,
            "text": "syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -6.8984375,
            "text": "t",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -6.8984375,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Rett",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -6.8984375,
            "text": "CpG-binding protein-2 gene (MECP2) are commonly associated with Rett",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -8.046875,
            "text": "t syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -7.67578125,
            "text": "methyl-CpG-binding protein-",
            "probability": 0.0
        },
        {
            "start_logit": -7.2890625,
            "end_logit": -8.046875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -7.75,
            "text": "methyl-CpG-",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -7.828125,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -7.84765625,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_2": [
        {
            "start_logit": 7.9375,
            "end_logit": 7.90234375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -1.6708984375,
            "text": "Ret",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": 7.90234375,
            "text": "syndrome",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.984375,
            "text": "Rett",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 7.90234375,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.57421875,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.6953125,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.72265625,
            "text": "Rett syndrome (RS) is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.76953125,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.7734375,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.8203125,
            "text": "Rett syndrome (RS) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.8203125,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.8828125,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.8828125,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.890625,
            "text": "Rett syndrome (RS) is a debilitating neurological",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.90625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.91015625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": -7.57421875,
            "text": "syndrome (RS) is a debilitating neurological disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": -7.6953125,
            "text": "syndrome (RS) is a debilitating neurological disorder affecting",
            "probability": 0.0
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": -7.72265625,
            "text": "syndrome (RS) is a",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_3": [
        {
            "start_logit": 7.890625,
            "end_logit": 7.90625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.833984375,
            "end_logit": 7.90625,
            "text": "syndrome",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.9345703125,
            "text": "Ret",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 7.90625,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 7.90625,
            "text": "neurodevelopmental disorder Rett syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.2734375,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.89453125,
            "text": "Rett syndrome (RTT).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.95703125,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 7.90625,
            "text": "disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.90625,
            "text": "MECP2 gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.90625,
            "text": "gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": -1.9345703125,
            "text": "neurodevelopmental disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -1.833984375,
            "end_logit": -7.89453125,
            "text": "syndrome (RTT).",
            "probability": 0.0
        },
        {
            "start_logit": -1.833984375,
            "end_logit": -7.95703125,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -7.98828125,
            "end_logit": -1.9345703125,
            "text": "disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -1.9345703125,
            "text": "MECP2 gene cause the neurodevelopmental disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -1.9345703125,
            "text": "gene cause the neurodevelopmental disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": -7.2734375,
            "text": "t",
            "probability": 0.0
        },
        {
            "start_logit": -6.984375,
            "end_logit": -7.2734375,
            "text": "neurodevelopmental disorder Rett",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": -7.89453125,
            "text": "t syndrome (RTT).",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_4": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.9140625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.6552734375,
            "text": "Ret",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -1.751953125,
            "end_logit": 7.9140625,
            "text": "syndrome",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": -6.671875,
            "end_logit": 7.9140625,
            "text": "t syndrome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.953125,
            "text": "Rett",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.4296875,
            "text": "Rett syndrome is a severe neurodevelopmental disorder",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.46484375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.58984375,
            "text": "Rett syndrome is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.6328125,
            "text": "Rett syndrome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.65234375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator MeCP2.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.8515625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.85546875,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.859375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.92578125,
            "text": "Rett syndrome is a severe neurodevelopmental",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.96484375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.9765625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.9921875,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator MeCP2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.751953125,
            "end_logit": -7.4296875,
            "text": "syndrome is a severe neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.751953125,
            "end_logit": -7.46484375,
            "text": "syndrome is a severe neurodevelopmental disorder mainly",
            "probability": 0.0
        },
        {
            "start_logit": -1.751953125,
            "end_logit": -7.58984375,
            "text": "syndrome is a",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_5": [
        {
            "start_logit": 7.90234375,
            "end_logit": 7.890625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": 7.890625,
            "text": "syndrome",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.9189453125,
            "text": "Ret",
            "probability": 5.4776668548583984e-05
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 7.890625,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.140625,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.51171875,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.54296875,
            "text": "Rett syndrome, a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.546875,
            "text": "Rett syndrome,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.81640625,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.86328125,
            "text": "Rett syndrome, a progressive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.91796875,
            "text": "Rett syndrome, a progressive neurodevelopmental",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.890625,
            "text": "MeCP2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.890625,
            "text": "gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.890625,
            "text": "in the MeCP2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.890625,
            "text": "P2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.51171875,
            "text": "syndrome, a progressive neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.54296875,
            "text": "syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.546875,
            "text": "syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.81640625,
            "text": "syndrome, a progressive neurodevelopmental disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.86328125,
            "text": "syndrome, a progressive",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_6": [
        {
            "start_logit": 7.9140625,
            "end_logit": 7.8984375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.7880859375,
            "text": "Ret",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": -1.814453125,
            "end_logit": 7.8984375,
            "text": "syndrome",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": -6.765625,
            "end_logit": 7.8984375,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.10546875,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.1875,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.6015625,
            "text": "Rett syndrome (RTT) is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.6171875,
            "text": "Rett syndrome (RTT) is a debilitating neurological",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.7734375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.85546875,
            "text": "Rett syndrome (RTT) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.86328125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (MECP2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.87109375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.93359375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.93359375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (MEC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.93359375,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.9765625,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.98046875,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.814453125,
            "end_logit": -7.10546875,
            "text": "syndrome (RTT) is a debilitating neurological disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.814453125,
            "end_logit": -7.5859375,
            "text": "syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (MECP2).",
            "probability": 0.0
        },
        {
            "start_logit": -1.814453125,
            "end_logit": -7.6015625,
            "text": "syndrome (RTT) is a",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_7": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.9140625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.7373046875,
            "text": "Ret",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": 7.9140625,
            "text": "syndrome",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 7.9140625,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.24609375,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.83203125,
            "text": "Rett syndrome (RTT) is associated with mutations in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.85546875,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.92578125,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeCP2.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.9375,
            "text": "Rett syndrome (RTT) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.9765625,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.0,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.03125,
            "text": "Rett syndrome (RTT) is associated with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.078125,
            "text": "Rett syndrome (RTT) is associated with mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.1015625,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeCP2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.1328125,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.1484375,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": -7.83203125,
            "text": "syndrome (RTT) is associated with mutations in the",
            "probability": 0.0
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": -7.85546875,
            "text": "syndrome (RTT) is associated with mutations in the transcriptional repressor",
            "probability": 0.0
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": -7.92578125,
            "text": "syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeCP2.",
            "probability": 0.0
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": -7.9375,
            "text": "syndrome (RTT) is",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_8": [
        {
            "start_logit": 7.90234375,
            "end_logit": 7.890625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": 7.890625,
            "text": "syndrome",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.9189453125,
            "text": "Ret",
            "probability": 5.4776668548583984e-05
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 7.890625,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.140625,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.51171875,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.54296875,
            "text": "Rett syndrome, a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.546875,
            "text": "Rett syndrome,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.81640625,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.86328125,
            "text": "Rett syndrome, a progressive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.91796875,
            "text": "Rett syndrome, a progressive neurodevelopmental",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.890625,
            "text": "MeCP2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.890625,
            "text": "gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.890625,
            "text": "in the MeCP2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.890625,
            "text": "P2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.51171875,
            "text": "syndrome, a progressive neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.54296875,
            "text": "syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.546875,
            "text": "syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.81640625,
            "text": "syndrome, a progressive neurodevelopmental disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.86328125,
            "text": "syndrome, a progressive",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_9": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.9296875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.576171875,
            "text": "Ret",
            "probability": 7.426738739013672e-05
        },
        {
            "start_logit": -1.6943359375,
            "end_logit": 7.9296875,
            "text": "syndrome",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": -6.703125,
            "end_logit": 7.9296875,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.89453125,
            "text": "Rett",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 7.9296875,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.9296875,
            "text": "CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.9296875,
            "text": "(MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.9296875,
            "text": "-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -1.576171875,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -1.576171875,
            "text": "CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -1.576171875,
            "text": "(MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -1.576171875,
            "text": "-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -6.703125,
            "end_logit": -6.89453125,
            "text": "t",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -6.89453125,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -6.89453125,
            "text": "CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -6.89453125,
            "text": "(MECP2) mutation type is associated with disease severity in Rett",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -6.89453125,
            "text": "-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -7.76171875,
            "text": "Methyl-CpG-",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -7.78515625,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_10": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.8984375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.7197265625,
            "text": "Ret",
            "probability": 6.657838821411133e-05
        },
        {
            "start_logit": -1.7958984375,
            "end_logit": 7.8984375,
            "text": "syndrome",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.92578125,
            "text": "Rett",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.8984375,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.1875,
            "text": "Rett syndrome (RTT), the second",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.43359375,
            "text": "Rett syndrome (RTT), the second most common cause of mental retardation in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.4609375,
            "text": "Rett syndrome (RTT), the second most common cause of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.48046875,
            "text": "Rett syndrome (RTT), the second most common",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.5,
            "text": "Rett syndrome (RTT), the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.5625,
            "text": "Rett syndrome (RTT), the second most common cause of mental retardation in females",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.58984375,
            "text": "Rett syndrome (RTT),",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.65625,
            "text": "Rett syndrome (RTT), the second most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.71484375,
            "text": "Rett syndrome (RTT), the second most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.75,
            "text": "Rett syndrome (RT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.75390625,
            "text": "Rett syndrome (RTT)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.75390625,
            "text": "Rett syndrome (RTT), the second most common cause of mental retardation in females,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.7958984375,
            "end_logit": -7.1875,
            "text": "syndrome (RTT), the second",
            "probability": 0.0
        },
        {
            "start_logit": -1.7958984375,
            "end_logit": -7.43359375,
            "text": "syndrome (RTT), the second most common cause of mental retardation in",
            "probability": 0.0
        },
        {
            "start_logit": -1.7958984375,
            "end_logit": -7.4609375,
            "text": "syndrome (RTT), the second most common cause of",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_11": [
        {
            "start_logit": 7.90234375,
            "end_logit": 7.890625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.869140625,
            "text": "Ret",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": 7.890625,
            "text": "syndrome",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 7.890625,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.29296875,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.296875,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.453125,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2),",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.57421875,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.7421875,
            "text": "Rett syndrome (RTT) is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.74609375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.83984375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.8515625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.87890625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MEC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.87890625,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.88671875,
            "text": "Rett syndrome (RTT) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": -7.29296875,
            "text": "syndrome (RTT) is a severe neurodevelopmental disease",
            "probability": 0.0
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": -7.453125,
            "text": "syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2),",
            "probability": 0.0
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": -7.57421875,
            "text": "syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-",
            "probability": 0.0
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": -7.7421875,
            "text": "syndrome (RTT) is a",
            "probability": 0.0
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": -7.74609375,
            "text": "syndrome (RTT) is a severe neurodevelopmental",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_12": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.91015625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.724609375,
            "text": "Ret",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": -1.7802734375,
            "end_logit": 7.91015625,
            "text": "syndrome",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 7.91015625,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.15234375,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.80078125,
            "text": "Rett syndrome (RTT) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.90234375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.91015625,
            "text": "Rett syndrome (RTT) is caused by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.921875,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.93359375,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.96484375,
            "text": "Rett syndrome (RTT) is caused",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.97265625,
            "text": "Rett syndrome (RTT) is caused by mutations in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.97265625,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.9921875,
            "text": "Rett syndrome (RTT) is caused by mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.9921875,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.015625,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MEC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.0234375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.0234375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7802734375,
            "end_logit": -7.80078125,
            "text": "syndrome (RTT) is",
            "probability": 0.0
        },
        {
            "start_logit": -1.7802734375,
            "end_logit": -7.90234375,
            "text": "syndrome (RTT) is caused by mutations in the transcriptional repressor",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_13": [
        {
            "start_logit": 7.87890625,
            "end_logit": 7.90234375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.83203125,
            "end_logit": 7.90234375,
            "text": "syndrome",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -2.013671875,
            "text": "Ret",
            "probability": 4.947185516357422e-05
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 7.90234375,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 7.90234375,
            "text": "neurodevelopmental disorder Rett syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.2734375,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.90234375,
            "text": "Rett syndrome (RTT).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.90234375,
            "text": "disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -8.0078125,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.90234375,
            "text": "in MECP2 cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -8.140625,
            "text": "Rett syndrome (RT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -8.15625,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -2.013671875,
            "text": "neurodevelopmental disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -1.83203125,
            "end_logit": -7.90234375,
            "text": "syndrome (RTT).",
            "probability": 0.0
        },
        {
            "start_logit": -1.83203125,
            "end_logit": -8.0078125,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -1.83203125,
            "end_logit": -8.140625,
            "text": "syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -2.013671875,
            "text": "disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -1.83203125,
            "end_logit": -8.15625,
            "text": "syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -2.013671875,
            "text": "in MECP2 cause the neurodevelopmental disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -6.76953125,
            "end_logit": -7.2734375,
            "text": "t",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_14": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.91796875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.681640625,
            "text": "Ret",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": -1.751953125,
            "end_logit": 7.91796875,
            "text": "syndrome",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.79296875,
            "text": "Rett",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 7.91796875,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.296875,
            "text": "Rett syndrome , an autism spectrum disorder",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.3828125,
            "text": "Rett syndrome , an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.4140625,
            "text": "Rett syndrome , an autism spectrum disorder mainly",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.47265625,
            "text": "Rett syndrome ,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.55078125,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.65625,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting young",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.7421875,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting young females",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.82421875,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting young females .",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.91796875,
            "text": "methyl-CpG-binding protein MECP2 are the major cause of Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.751953125,
            "end_logit": -7.296875,
            "text": "syndrome , an autism spectrum disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.751953125,
            "end_logit": -7.3828125,
            "text": "syndrome , an",
            "probability": 0.0
        },
        {
            "start_logit": -1.751953125,
            "end_logit": -7.4140625,
            "text": "syndrome , an autism spectrum disorder mainly",
            "probability": 0.0
        },
        {
            "start_logit": -1.751953125,
            "end_logit": -7.47265625,
            "text": "syndrome ,",
            "probability": 0.0
        },
        {
            "start_logit": -1.751953125,
            "end_logit": -7.55078125,
            "text": "syndrome , an autism spectrum disorder mainly affecting",
            "probability": 0.0
        },
        {
            "start_logit": -1.751953125,
            "end_logit": -7.65625,
            "text": "syndrome , an autism spectrum disorder mainly affecting young",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_15": [
        {
            "start_logit": 7.91796875,
            "end_logit": 7.90234375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -1.7841796875,
            "text": "Ret",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": -1.810546875,
            "end_logit": 7.90234375,
            "text": "syndrome",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 7.90234375,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.14453125,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.296875,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.48046875,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.59375,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.6171875,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.7578125,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.84375,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the gene encoding the transcriptional repressor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.86328125,
            "text": "Rett syndrome ( RTT ) is a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.93359375,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.9375,
            "text": "Rett syndrome ( RTT )",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.94140625,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.96484375,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.810546875,
            "end_logit": -7.296875,
            "text": "syndrome ( RTT ) is a severe neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.810546875,
            "end_logit": -7.48046875,
            "text": "syndrome ( RTT ) is a severe neurodevelopmental disorder with",
            "probability": 0.0
        },
        {
            "start_logit": -1.810546875,
            "end_logit": -7.59375,
            "text": "syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that",
            "probability": 0.0
        },
        {
            "start_logit": -1.810546875,
            "end_logit": -7.6171875,
            "text": "syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_16": [
        {
            "start_logit": 7.921875,
            "end_logit": 7.90234375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.921875,
            "end_logit": -1.7734375,
            "text": "Ret",
            "probability": 6.252527236938477e-05
        },
        {
            "start_logit": -1.8017578125,
            "end_logit": 7.90234375,
            "text": "syndrome",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 7.90234375,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.21484375,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.21875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.4296875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription factor MeCP2.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.7734375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.90234375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.91796875,
            "text": "Rett syndrome (RTT) is an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.921875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.97265625,
            "text": "Rett syndrome (RTT) is an X",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.0390625,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.1015625,
            "text": "Rett syndrome (RTT) is an X-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.109375,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.1171875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription factor MeCP2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.1171875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8017578125,
            "end_logit": -7.21875,
            "text": "syndrome (RTT) is an X-linked neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.8017578125,
            "end_logit": -7.4296875,
            "text": "syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription factor MeCP2.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8017578125,
            "end_logit": -7.7734375,
            "text": "syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_17": [
        {
            "start_logit": 7.89453125,
            "end_logit": 7.8984375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": 7.8984375,
            "text": "syndrome",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -1.9228515625,
            "text": "Ret",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": -6.96875,
            "end_logit": 7.8984375,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.23046875,
            "text": "Rett syndrome (RTT).",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.28125,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.8984375,
            "text": "methyl-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.5078125,
            "text": "Rett syndrome (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.8984375,
            "text": "neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 7.8984375,
            "text": "CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.8828125,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.9921875,
            "text": "Rett syndrome (RT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 7.8984375,
            "text": "onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.8984375,
            "text": "2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.8984375,
            "text": "protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.8984375,
            "text": "as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.8984375,
            "text": "factor methyl-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.8984375,
            "text": "-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.8984375,
            "text": "(MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.8984375,
            "text": "in the transcription factor methyl-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e6157cb1af46fc13000000e_18": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.9140625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.740234375,
            "text": "Ret",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": 7.9140625,
            "text": "syndrome",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 7.9140625,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.96484375,
            "text": "Rett",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.3515625,
            "text": "Rett syndrome is a neurodevelopmental disorder",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.4765625,
            "text": "Rett syndrome is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.578125,
            "text": "Rett syndrome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.6875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.69140625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.74609375,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.80078125,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.828125,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.859375,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.88671875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": -7.3515625,
            "text": "syndrome is a neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": -7.4765625,
            "text": "syndrome is a",
            "probability": 0.0
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": -7.578125,
            "text": "syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": -7.6875,
            "text": "syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-",
            "probability": 0.0
        },
        {
            "start_logit": -1.7646484375,
            "end_logit": -7.69140625,
            "text": "syndrome is a neurodevelopmental disorder caused",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_19": [
        {
            "start_logit": 7.953125,
            "end_logit": 7.9296875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 7.953125,
            "end_logit": -1.568359375,
            "text": "Ret",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -1.685546875,
            "end_logit": 7.9296875,
            "text": "syndrome",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 7.9296875,
            "text": "t syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.79296875,
            "text": "Rett",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.48046875,
            "text": "Rett syndrome is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.609375,
            "text": "Rett syndrome is a monogenic disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.609375,
            "text": "Rett syndrome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.7109375,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.72265625,
            "text": "Rett syndrome is a monogenic disease due to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.75,
            "text": "Rett syndrome is a monogenic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.76171875,
            "text": "Rett syndrome is a monogenic disease due",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.78125,
            "text": "Rett syndrome is a monogenic disease due to de novo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.86328125,
            "text": "Rett syndrome is a monogenic disease due to de",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.88671875,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or CDKL5",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.921875,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.92578125,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.9296875,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.953125,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or CDKL5 genes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.96484375,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58b6bd2622d300530900000c_1": [
        {
            "start_logit": 4.28515625,
            "end_logit": 2.134765625,
            "text": "apolipoprotein E2",
            "probability": 0.62158203125
        },
        {
            "start_logit": 4.28515625,
            "end_logit": 1.615234375,
            "text": "apolipoprotein E2 (apoE2)",
            "probability": 0.367919921875
        },
        {
            "start_logit": 4.28515625,
            "end_logit": -1.9755859375,
            "text": "apolipoprotein E2 (apoE2",
            "probability": 0.010162353515625
        },
        {
            "start_logit": 4.28515625,
            "end_logit": -6.58984375,
            "text": "apolipoprotein E2 (apoE2), an isoform of apoE",
            "probability": 0.00010079145431518555
        },
        {
            "start_logit": 4.28515625,
            "end_logit": -6.76171875,
            "text": "apolipoprotein E2 (apoE",
            "probability": 8.487701416015625e-05
        },
        {
            "start_logit": 4.28515625,
            "end_logit": -6.7890625,
            "text": "apolipoprotein",
            "probability": 8.291006088256836e-05
        },
        {
            "start_logit": 4.28515625,
            "end_logit": -6.80078125,
            "text": "apolipoprotein E2 (apoE2), an isoform",
            "probability": 8.159875869750977e-05
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 2.134765625,
            "text": "E2",
            "probability": 1.4543533325195312e-05
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 1.615234375,
            "text": "E2 (apoE2)",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 1.615234375,
            "text": "(apoE2)",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 2.134765625,
            "text": "of apolipoprotein E2",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 2.134765625,
            "text": "type III HLP is the presence of apolipoprotein E2",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -7.640625,
            "end_logit": 2.134765625,
            "text": ". The primary genetic defect in patients with type III HLP is the presence of apolipoprotein E2",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 1.615234375,
            "text": ")",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 2.134765625,
            "text": "characterized by the accumulation of remnant lipoproteins in the plasma. The primary genetic defect in patients with type III HLP is the presence of apolipoprotein E2",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -4.48046875,
            "end_logit": -1.189453125,
            "text": "Type III",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 2.134765625,
            "text": "remnant lipoproteins in the plasma. The primary genetic defect in patients with type III HLP is the presence of apolipoprotein E2",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 1.615234375,
            "text": "of apolipoprotein E2 (apoE2)",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 1.615234375,
            "text": "type III HLP is the presence of apolipoprotein E2 (apoE2)",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.609375,
            "end_logit": 1.615234375,
            "text": "apoE2)",
            "probability": 2.5033950805664062e-06
        }
    ],
    "58b6bd2622d300530900000c_2": [
        {
            "start_logit": 7.765625,
            "end_logit": 7.91796875,
            "text": "apoE2 isoform",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": 7.91796875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 0.000766754150390625
        },
        {
            "start_logit": -1.5966796875,
            "end_logit": 7.91796875,
            "text": "isoform",
            "probability": 8.541345596313477e-05
        },
        {
            "start_logit": 7.765625,
            "end_logit": -2.072265625,
            "text": "apoE",
            "probability": 4.571676254272461e-05
        },
        {
            "start_logit": -5.68359375,
            "end_logit": 7.91796875,
            "text": "2 isoform",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -6.140625,
            "end_logit": 7.91796875,
            "text": "common apoE2 isoform",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.53515625,
            "text": "apoE2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.7421875,
            "text": "apoE2 isoform is encoded by the R158C allele.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.92578125,
            "text": "apoE2 isoform is encoded by the R158C allele",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.91796875,
            "text": "type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.91796875,
            "text": "the common apoE2 isoform",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.4921875,
            "text": "apoE2 isoform is encoded by the R1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.703125,
            "text": "apoE2 isoform is encoded by the R158",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.75,
            "text": "apoE2 isoform is encoded by the R158C",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.80859375,
            "text": "apoE2 isoform is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 7.91796875,
            "text": "and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -2.072265625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -3.48046875,
            "text": "ApoE2",
            "probability": 0.0
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -5.87890625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III",
            "probability": 0.0
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -6.01171875,
            "text": "ApoE2 polymorphism",
            "probability": 0.0
        }
    ],
    "58b6bd2622d300530900000c_3": [
        {
            "start_logit": 1.7890625,
            "end_logit": 5.16796875,
            "text": "apo E2 isoform",
            "probability": 0.97998046875
        },
        {
            "start_logit": -2.169921875,
            "end_logit": 5.16796875,
            "text": "E2 isoform",
            "probability": 0.018707275390625
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 5.16796875,
            "text": "isoform",
            "probability": 0.0008759498596191406
        },
        {
            "start_logit": 1.7890625,
            "end_logit": -2.91796875,
            "text": "apo E2",
            "probability": 0.00030159950256347656
        },
        {
            "start_logit": -1.9521484375,
            "end_logit": -0.429443359375,
            "text": "apo E4",
            "probability": 8.64267349243164e-05
        },
        {
            "start_logit": -7.78125,
            "end_logit": 5.16796875,
            "text": "the apo E2 isoform",
            "probability": 6.836652755737305e-05
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 5.16796875,
            "text": "association of the apo E2 isoform",
            "probability": 6.175041198730469e-05
        },
        {
            "start_logit": -3.705078125,
            "end_logit": 0.49072265625,
            "text": "apo E2",
            "probability": 3.743171691894531e-05
        },
        {
            "start_logit": -3.705078125,
            "end_logit": -0.429443359375,
            "text": "apo E2 and the phenomenon of apo E4",
            "probability": 1.4901161193847656e-05
        },
        {
            "start_logit": -3.767578125,
            "end_logit": -0.429443359375,
            "text": "E4",
            "probability": 1.4007091522216797e-05
        },
        {
            "start_logit": -4.76171875,
            "end_logit": 0.49072265625,
            "text": "E2",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": 1.7890625,
            "end_logit": -6.7421875,
            "text": "apo E2 isoform with primary dysbetalipoproteinemia and hyperlipoproteinemia type III",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 1.7890625,
            "end_logit": -6.8671875,
            "text": "apo E2 isoform with primary dysbetalipoproteinemia and hyperlipoproteinemia type III is well established, the plasma- and LDL-cholesterol",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -2.169921875,
            "end_logit": -2.91796875,
            "text": "E2",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": -4.76171875,
            "end_logit": -0.429443359375,
            "text": "E2 and the phenomenon of apo E4",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 1.7890625,
            "end_logit": -7.01953125,
            "text": "apo E2 isoform with primary dysbeta",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 1.7890625,
            "end_logit": -7.1875,
            "text": "apo",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 1.7890625,
            "end_logit": -7.27734375,
            "text": "apo E2 isoform with primary dysbetalipoproteinemia and hyperlipoproteinemia type III is well established, the plasma- and LDL-cholesterol lowering",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 1.7890625,
            "end_logit": -7.36328125,
            "text": "apo E2 isoform with",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 1.7890625,
            "end_logit": -7.55078125,
            "text": "apo E2 isoform with primary",
            "probability": 2.9206275939941406e-06
        }
    ],
    "58b6bd2622d300530900000c_4": [
        {
            "start_logit": 6.3046875,
            "end_logit": 4.61328125,
            "text": "apolipoprotein E2",
            "probability": 0.93115234375
        },
        {
            "start_logit": 6.3046875,
            "end_logit": 2.009765625,
            "text": "apolipoprotein E2 (apoE2)",
            "probability": 0.06854248046875
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.1171875,
            "text": "apolipoprotein",
            "probability": 5.507469177246094e-05
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.40625,
            "text": "apolipoprotein E2 (apoE2",
            "probability": 4.13060188293457e-05
        },
        {
            "start_logit": -5.234375,
            "end_logit": 4.61328125,
            "text": "E2",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -7.078125,
            "text": "apolipoprotein E2 (apoE",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -7.08984375,
            "text": "apolipoprotein E2 (apoE2), an isoform",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -7.125,
            "text": "apolipoprotein E2 (apoE2), an isoform of apoE, and accumulation of remnant lipoproteins in the plasma has been thought to be attributable to the presence of",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -7.26953125,
            "text": "apolipoprotein E2 (apoE2), an",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -7.41796875,
            "text": "apolipoprotein E2 (apoE2), an isoform of apoE",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -7.4296875,
            "text": "apolipoprotein E2 (apoE2), an isoform of",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 4.61328125,
            "text": "type III HLP is the presence of apolipoprotein E2",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.46875,
            "end_logit": 4.61328125,
            "text": "HLP is the presence of apolipoprotein E2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.234375,
            "end_logit": 2.009765625,
            "text": "E2 (apoE2)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 2.009765625,
            "text": "(apoE2)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 2.009765625,
            "text": "type III HLP is the presence of apolipoprotein E2 (apoE2)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 2.009765625,
            "text": ")",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 2.009765625,
            "text": "apoE2)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 2.009765625,
            "text": "HLP is the presence of apolipoprotein E2 (apoE2)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.234375,
            "end_logit": -5.40625,
            "text": "E2 (apoE2",
            "probability": 0.0
        }
    ],
    "58b6bd2622d300530900000c_5": [
        {
            "start_logit": 7.765625,
            "end_logit": 7.91796875,
            "text": "apoE2 isoform",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": 7.91796875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 0.000766754150390625
        },
        {
            "start_logit": -1.5966796875,
            "end_logit": 7.91796875,
            "text": "isoform",
            "probability": 8.541345596313477e-05
        },
        {
            "start_logit": 7.765625,
            "end_logit": -2.072265625,
            "text": "apoE",
            "probability": 4.571676254272461e-05
        },
        {
            "start_logit": -5.68359375,
            "end_logit": 7.91796875,
            "text": "2 isoform",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -6.140625,
            "end_logit": 7.91796875,
            "text": "common apoE2 isoform",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.53515625,
            "text": "apoE2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.7421875,
            "text": "apoE2 isoform is encoded by the R158C allele.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.92578125,
            "text": "apoE2 isoform is encoded by the R158C allele",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.91796875,
            "text": "type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.91796875,
            "text": "the common apoE2 isoform",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.4921875,
            "text": "apoE2 isoform is encoded by the R1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.703125,
            "text": "apoE2 isoform is encoded by the R158",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.75,
            "text": "apoE2 isoform is encoded by the R158C",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.80859375,
            "text": "apoE2 isoform is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 7.91796875,
            "text": "and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -2.072265625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -3.48046875,
            "text": "ApoE2",
            "probability": 0.0
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -5.87890625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III",
            "probability": 0.0
        },
        {
            "start_logit": 0.5947265625,
            "end_logit": -6.01171875,
            "text": "ApoE2 polymorphism",
            "probability": 0.0
        }
    ],
    "58b6bd2622d300530900000c_6": [
        {
            "start_logit": 7.1953125,
            "end_logit": 7.4140625,
            "text": "apolipoprotein E2",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -0.1990966796875,
            "text": "apolipoprotein E2 are predisposed to type III",
            "probability": 0.0004935264587402344
        },
        {
            "start_logit": -2.642578125,
            "end_logit": 7.4140625,
            "text": "E2",
            "probability": 5.340576171875e-05
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -3.68359375,
            "text": "apolipoprotein",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -6.4609375,
            "text": "apolipoprotein E2 are predisposed to type III hyperlipoproteinemia, and apoE2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -6.625,
            "text": "apolipoprotein E2 are predisposed to type III hyperlipoproteinemia, and apoE2 may be protective against AD.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.07421875,
            "text": "apolipoprotein E2 are",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.50390625,
            "text": "apolipoprotein E2 are predisposed to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.57421875,
            "text": "apolipoprotein E2 are predisposed to type III hyperlipoproteinemia,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.59765625,
            "text": "apolipoprotein E2 are predisposed",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.67578125,
            "text": "apolipoprotein E2 are predisposed to type",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.73046875,
            "text": "apolipoprotein E2 are predisposed to type III hyperlipoproteinemia, and apoE2 may be protective against AD",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.77734375,
            "text": "apolipoprotein E2 are predisposed to type III hyperlipoproteinemia, and apoE",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 7.4140625,
            "text": "Patients homozygous for apolipoprotein E2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 7.4140625,
            "text": "for apolipoprotein E2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.828125,
            "text": "apolipoprotein E2 are predisposed to type III hyperlipoproteinemia, and apoE2 may be protective against",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.83203125,
            "text": "apolipoprotein E2 are predisposed to type III hyperlipoproteinemia, and apoE2 may",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.8359375,
            "text": "apolipoprotein E2 are predisposed to type III hyperlipoproteinemia, and apoE2 may be protective",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.84375,
            "text": "apolipoprotein E2 are predisposed to type III hyperlip",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.90234375,
            "text": "apolipoprotein E2 are predisposed to type III hyperlipoprotein",
            "probability": 2.384185791015625e-07
        }
    ],
    "54db62a3034aea571d000001_1": [
        {
            "start_logit": 2.173828125,
            "end_logit": 0.87744140625,
            "text": "SERCA",
            "probability": 0.52392578125
        },
        {
            "start_logit": 2.173828125,
            "end_logit": 0.779296875,
            "text": "SERCA)",
            "probability": 0.47509765625
        },
        {
            "start_logit": -5.19140625,
            "end_logit": 0.87744140625,
            "text": "sarcoplasmic reticulum (SR) calcium pump (SERCA",
            "probability": 0.0003323554992675781
        },
        {
            "start_logit": -5.19140625,
            "end_logit": 0.779296875,
            "text": "sarcoplasmic reticulum (SR) calcium pump (SERCA)",
            "probability": 0.0003001689910888672
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 0.87744140625,
            "text": "(SERCA",
            "probability": 4.655122756958008e-05
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 0.779296875,
            "text": "(SERCA)",
            "probability": 4.178285598754883e-05
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 0.87744140625,
            "text": "SR) calcium pump (SERCA",
            "probability": 2.6524066925048828e-05
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 0.87744140625,
            "text": ") calcium pump (SERCA",
            "probability": 2.574920654296875e-05
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 0.779296875,
            "text": "SR) calcium pump (SERCA)",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 0.87744140625,
            "text": "pump (SERCA",
            "probability": 2.3603439331054688e-05
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 0.779296875,
            "text": ") calcium pump (SERCA)",
            "probability": 2.3066997528076172e-05
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 0.779296875,
            "text": ")",
            "probability": 2.2709369659423828e-05
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 0.87744140625,
            "text": "calcium pump (SERCA",
            "probability": 2.199411392211914e-05
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 0.779296875,
            "text": "pump (SERCA)",
            "probability": 2.1338462829589844e-05
        },
        {
            "start_logit": -8.0,
            "end_logit": 0.87744140625,
            "text": "reticulum (SR) calcium pump (SERCA",
            "probability": 2.002716064453125e-05
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 0.779296875,
            "text": "calcium pump (SERCA)",
            "probability": 1.9729137420654297e-05
        },
        {
            "start_logit": -8.0,
            "end_logit": 0.779296875,
            "text": "reticulum (SR) calcium pump (SERCA)",
            "probability": 1.823902130126953e-05
        },
        {
            "start_logit": -5.19140625,
            "end_logit": -7.875,
            "text": "sarcoplasmic reticulum (SR) calcium pump",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.19140625,
            "end_logit": -7.88671875,
            "text": "sarcoplasmic reticulum",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.19140625,
            "end_logit": -8.1015625,
            "text": "sarcoplasmic reticulum (",
            "probability": 5.960464477539063e-08
        }
    ],
    "54db62a3034aea571d000001_2": [
        {
            "start_logit": -1.2294921875,
            "end_logit": 5.734375,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.78662109375
        },
        {
            "start_logit": -2.72265625,
            "end_logit": 5.734375,
            "text": "ATPase",
            "probability": 0.1768798828125
        },
        {
            "start_logit": -5.546875,
            "end_logit": 5.734375,
            "text": "the sarco/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.010498046875
        },
        {
            "start_logit": -6.4375,
            "end_logit": 5.734375,
            "text": ")-ATPase",
            "probability": 0.004306793212890625
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 5.734375,
            "text": "-ATPase",
            "probability": 0.0038318634033203125
        },
        {
            "start_logit": -6.640625,
            "end_logit": 5.734375,
            "text": "Ca(2+)-ATPase",
            "probability": 0.00351715087890625
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 5.734375,
            "text": "/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.0031642913818359375
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 5.734375,
            "text": "endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.0028820037841796875
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 5.734375,
            "text": "+)-ATPase",
            "probability": 0.001934051513671875
        },
        {
            "start_logit": -7.3125,
            "end_logit": 5.734375,
            "text": "o/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.0017957687377929688
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 5.734375,
            "text": "2+)-ATPase",
            "probability": 0.0015058517456054688
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 5.734375,
            "text": "reticulum Ca(2+)-ATPase",
            "probability": 0.00135040283203125
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 5.734375,
            "text": "(2+)-ATPase",
            "probability": 0.0013246536254882812
        },
        {
            "start_logit": -1.2294921875,
            "end_logit": -1.859375,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 0.0003960132598876953
        },
        {
            "start_logit": -2.72265625,
            "end_logit": -1.859375,
            "text": "ATPase (SERCA)",
            "probability": 8.90493392944336e-05
        },
        {
            "start_logit": -1.2294921875,
            "end_logit": -3.7109375,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA",
            "probability": 6.216764450073242e-05
        },
        {
            "start_logit": -2.72265625,
            "end_logit": -3.7109375,
            "text": "ATPase (SERCA",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": -5.546875,
            "end_logit": -1.859375,
            "text": "the sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -6.02734375,
            "end_logit": -1.859375,
            "text": "SERCA)",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -1.2294921875,
            "end_logit": -6.92578125,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (",
            "probability": 2.5033950805664062e-06
        }
    ],
    "54db62a3034aea571d000001_3": [
        {
            "start_logit": 6.46484375,
            "end_logit": 6.0546875,
            "text": "SERCA",
            "probability": 1.0
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -2.890625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.",
            "probability": 0.00013136863708496094
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -6.7265625,
            "text": "SERCA,",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -6.76171875,
            "text": "SERCA, an",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -6.8984375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.0390625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.53125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.609375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.65234375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.6640625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.7265625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump,",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.734375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.74609375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.83984375,
            "text": "SERCA, an endoplasmic reticulum (",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.83984375,
            "text": "SERCA, an endoplasmic reticulum",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.84375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.9375,
            "text": "SERCA, an endoplasmic reticulum (ER)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.9609375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -2.890625,
            "text": "into the ER lumen.",
            "probability": 0.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": -2.890625,
            "text": "is solely responsible for transporting cytosolic calcium into the ER lumen.",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_4": [
        {
            "start_logit": 0.73388671875,
            "end_logit": 2.6015625,
            "text": "ATPase (SERCA)",
            "probability": 0.9208984375
        },
        {
            "start_logit": -2.29296875,
            "end_logit": 2.6015625,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 0.044586181640625
        },
        {
            "start_logit": 0.73388671875,
            "end_logit": -1.3115234375,
            "text": "ATPase",
            "probability": 0.01837158203125
        },
        {
            "start_logit": -4.14453125,
            "end_logit": 2.6015625,
            "text": "SERCA)",
            "probability": 0.0070037841796875
        },
        {
            "start_logit": 0.73388671875,
            "end_logit": -2.982421875,
            "text": "ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.",
            "probability": 0.003452301025390625
        },
        {
            "start_logit": -5.390625,
            "end_logit": 2.6015625,
            "text": "Ca(2+)-ATPase (SERCA)",
            "probability": 0.00201416015625
        },
        {
            "start_logit": -2.29296875,
            "end_logit": -1.3115234375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.0008907318115234375
        },
        {
            "start_logit": -6.3125,
            "end_logit": 2.6015625,
            "text": "-ATPase (SERCA)",
            "probability": 0.0008015632629394531
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 2.6015625,
            "text": ")",
            "probability": 0.00047469139099121094
        },
        {
            "start_logit": -7.015625,
            "end_logit": 2.6015625,
            "text": ")-ATPase (SERCA)",
            "probability": 0.000396728515625
        },
        {
            "start_logit": -7.375,
            "end_logit": 2.6015625,
            "text": "(2+)-ATPase (SERCA)",
            "probability": 0.00027680397033691406
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 2.6015625,
            "text": "+)-ATPase (SERCA)",
            "probability": 0.00024068355560302734
        },
        {
            "start_logit": -7.515625,
            "end_logit": 2.6015625,
            "text": "2+)-ATPase (SERCA)",
            "probability": 0.00024068355560302734
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 2.6015625,
            "text": "reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 0.00020587444305419922
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 2.6015625,
            "text": "(SERCA)",
            "probability": 0.00017595291137695312
        },
        {
            "start_logit": 0.73388671875,
            "end_logit": -6.71875,
            "text": "ATPase (SERCA) is the",
            "probability": 8.249282836914062e-05
        },
        {
            "start_logit": 0.73388671875,
            "end_logit": -7.125,
            "text": "ATPase (SERCA) is the pump crucial",
            "probability": 5.4955482482910156e-05
        },
        {
            "start_logit": 0.73388671875,
            "end_logit": -7.13671875,
            "text": "ATPase (SERCA) is the pump crucial for calcium homeostasis and its",
            "probability": 5.447864532470703e-05
        },
        {
            "start_logit": 0.73388671875,
            "end_logit": -7.21875,
            "text": "ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such",
            "probability": 5.0067901611328125e-05
        },
        {
            "start_logit": 0.73388671875,
            "end_logit": -7.28125,
            "text": "ATPase (SERCA) is the pump crucial for calcium homeostasis",
            "probability": 4.696846008300781e-05
        }
    ],
    "54db62a3034aea571d000001_5": [
        {
            "start_logit": 5.33203125,
            "end_logit": 7.26953125,
            "text": "SERCA2a",
            "probability": 1.0
        },
        {
            "start_logit": -2.82421875,
            "end_logit": 7.26953125,
            "text": "2a",
            "probability": 0.0002868175506591797
        },
        {
            "start_logit": -4.62890625,
            "end_logit": 7.26953125,
            "text": "Sarcoplasmic reticulum calcium ATPase (SERCA2a",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -5.33984375,
            "text": "SERCA",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -5.359375,
            "text": "SERCA2a)",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.26953125,
            "text": "(SERCA2a",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -5.7734375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key factor in the alteration of calcium cycling.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.26953125,
            "text": "ATPase (SERCA2a",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.26953125,
            "text": "calcium ATPase (SERCA2a",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.26953125,
            "text": "reticulum calcium ATPase (SERCA2a",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.453125,
            "text": "SERCA2a), the",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.46484375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key factor in the alteration of calcium cycling",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.6015625,
            "text": "SERCA2a),",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.734375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.75,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.765625,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key factor in the alteration of calcium",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.78515625,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.8125,
            "text": "SERCA2a), the sarcoplasmic reticulum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.8359375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key factor in the alteration of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.84375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to",
            "probability": 2.980232238769531e-07
        }
    ],
    "54db62a3034aea571d000001_6": [
        {
            "start_logit": 5.33203125,
            "end_logit": 7.26953125,
            "text": "SERCA2a",
            "probability": 1.0
        },
        {
            "start_logit": -2.82421875,
            "end_logit": 7.26953125,
            "text": "2a",
            "probability": 0.0002868175506591797
        },
        {
            "start_logit": -4.62890625,
            "end_logit": 7.26953125,
            "text": "Sarcoplasmic reticulum calcium ATPase (SERCA2a",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -5.33984375,
            "text": "SERCA",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -5.359375,
            "text": "SERCA2a)",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.26953125,
            "text": "(SERCA2a",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -5.7734375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key factor in the alteration of calcium cycling.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.26953125,
            "text": "ATPase (SERCA2a",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.26953125,
            "text": "calcium ATPase (SERCA2a",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.26953125,
            "text": "reticulum calcium ATPase (SERCA2a",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.453125,
            "text": "SERCA2a), the",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.46484375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key factor in the alteration of calcium cycling",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.6015625,
            "text": "SERCA2a),",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.734375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.75,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.765625,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key factor in the alteration of calcium",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.78515625,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.8125,
            "text": "SERCA2a), the sarcoplasmic reticulum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.8359375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to be a key factor in the alteration of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -7.84375,
            "text": "SERCA2a), the sarcoplasmic reticulum calcium pump, was found to",
            "probability": 2.980232238769531e-07
        }
    ],
    "54db62a3034aea571d000001_7": [
        {
            "start_logit": 6.37890625,
            "end_logit": 6.953125,
            "text": "SERCA2a",
            "probability": 1.0
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -2.21484375,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows decreased expression in heart failure (HF).",
            "probability": 0.00010472536087036133
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -2.458984375,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": -3.1484375,
            "end_logit": 6.953125,
            "text": "2a",
            "probability": 7.31348991394043e-05
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -3.890625,
            "text": "SERCA",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -6.94921875,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -6.96875,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a)",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.0625,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.07421875,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.10546875,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.953125,
            "text": "The calcium pump SERCA2a",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.1640625,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.1875,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows decreased expression in heart failure",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.26953125,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows decreased expression in heart failure (HF",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.33203125,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction,",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.953125,
            "text": "pump SERCA2a",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.421875,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows decreased",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.4453125,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a),",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.48046875,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.6328125,
            "text": "SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role",
            "probability": 4.76837158203125e-07
        }
    ],
    "54db62a3034aea571d000001_8": [
        {
            "start_logit": 0.90478515625,
            "end_logit": 3.22265625,
            "text": "SERCA enzymes).",
            "probability": 0.91943359375
        },
        {
            "start_logit": -1.97265625,
            "end_logit": 3.22265625,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0516357421875
        },
        {
            "start_logit": 0.90478515625,
            "end_logit": -0.87255859375,
            "text": "SERCA",
            "probability": 0.0152740478515625
        },
        {
            "start_logit": -3.93359375,
            "end_logit": 3.22265625,
            "text": ".",
            "probability": 0.00727081298828125
        },
        {
            "start_logit": -5.12109375,
            "end_logit": 3.22265625,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0022182464599609375
        },
        {
            "start_logit": 0.90478515625,
            "end_logit": -3.51953125,
            "text": "SERCA enzymes)",
            "probability": 0.0010843276977539062
        },
        {
            "start_logit": -1.97265625,
            "end_logit": -0.87255859375,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 0.000858306884765625
        },
        {
            "start_logit": 0.90478515625,
            "end_logit": -4.18359375,
            "text": "SERCA enzymes",
            "probability": 0.0005583763122558594
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 3.22265625,
            "text": "in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.00030350685119628906
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 3.22265625,
            "text": "ATPases (SERCA enzymes).",
            "probability": 0.0002722740173339844
        },
        {
            "start_logit": -7.25,
            "end_logit": 3.22265625,
            "text": "(SERCA enzymes).",
            "probability": 0.0002636909484863281
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 3.22265625,
            "text": "by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0001856088638305664
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 3.22265625,
            "text": "transport ATPases (SERCA enzymes).",
            "probability": 0.00018405914306640625
        },
        {
            "start_logit": -7.75,
            "end_logit": 3.22265625,
            "text": "Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.00015997886657714844
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 3.22265625,
            "text": "o/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.000152587890625
        },
        {
            "start_logit": -7.828125,
            "end_logit": 3.22265625,
            "text": "/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.00014793872833251953
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 3.22265625,
            "text": "Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.00013899803161621094
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 3.22265625,
            "text": ").",
            "probability": 0.00013577938079833984
        },
        {
            "start_logit": -7.921875,
            "end_logit": 3.22265625,
            "text": "endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0001347064971923828
        },
        {
            "start_logit": -1.97265625,
            "end_logit": -3.51953125,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes)",
            "probability": 6.0677528381347656e-05
        }
    ],
    "54db62a3034aea571d000001_9": [
        {
            "start_logit": 4.8359375,
            "end_logit": 2.375,
            "text": "sarco(endo)plasmic reticulum calcium pump (SERCA)",
            "probability": 0.97314453125
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": 2.375,
            "text": "SERCA)",
            "probability": 0.018646240234375
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -2.71484375,
            "text": "sarco(endo)plasmic reticulum calcium pump (SERCA",
            "probability": 0.0059967041015625
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -5.10546875,
            "text": "sarc",
            "probability": 0.00054931640625
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -5.43359375,
            "text": "sarco(endo)plasm",
            "probability": 0.0003955364227294922
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -5.5859375,
            "text": "sarco(",
            "probability": 0.000339508056640625
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -6.22265625,
            "text": "sarco(endo",
            "probability": 0.00018036365509033203
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -6.52734375,
            "text": "sarco",
            "probability": 0.00013196468353271484
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -2.71484375,
            "text": "SERCA",
            "probability": 0.00011461973190307617
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -6.92578125,
            "text": "sarco(endo)plasmic",
            "probability": 8.928775787353516e-05
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -7.6015625,
            "text": "sarco(endo)",
            "probability": 4.5239925384521484e-05
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -7.8203125,
            "text": "sarco(endo)plasmic reticulum",
            "probability": 3.635883331298828e-05
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -7.96484375,
            "text": "sarco(endo)plasmic reticulum calcium pump",
            "probability": 3.135204315185547e-05
        },
        {
            "start_logit": 4.8359375,
            "end_logit": -8.15625,
            "text": "sarco(endo)plasmic reticulum calcium",
            "probability": 2.5987625122070312e-05
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 2.375,
            "text": "(SERCA)",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -7.234375,
            "end_logit": 2.375,
            "text": ")",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 2.375,
            "text": "plasmic reticulum calcium pump (SERCA)",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 2.375,
            "text": "pump (SERCA)",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 2.375,
            "text": "o(endo)plasmic reticulum calcium pump (SERCA)",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 2.375,
            "text": ")plasmic reticulum calcium pump (SERCA)",
            "probability": 3.337860107421875e-06
        }
    ],
    "54db62a3034aea571d000001_10": [
        {
            "start_logit": 6.82421875,
            "end_logit": 5.66015625,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.",
            "probability": 0.513671875
        },
        {
            "start_logit": 6.82421875,
            "end_logit": 5.60546875,
            "text": "SERCA",
            "probability": 0.486328125
        },
        {
            "start_logit": -2.482421875,
            "end_logit": 5.66015625,
            "text": ".",
            "probability": 4.673004150390625e-05
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -4.6171875,
            "text": "SERCA is a membrane protein that belongs to the family of P",
            "probability": 1.7583370208740234e-05
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -4.78515625,
            "text": "SERCA is",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -5.73828125,
            "text": "SERCA is a",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -5.76171875,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -5.99609375,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -6.08984375,
            "text": "SERCA is a membrane protein that belongs to the family of P-",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -6.26953125,
            "text": "SERCA is a membrane protein that belongs to the family of P-type",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -6.40625,
            "text": "SERCA is a membrane",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -6.46484375,
            "text": "SERCA is a membrane protein that belongs to the family of",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -6.546875,
            "text": "SERCA is a membrane protein that belongs to the family",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -6.64453125,
            "text": "SERCA is a membrane protein that",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -6.7578125,
            "text": "SERCA is a membrane protein",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -6.90234375,
            "text": "SERCA is a membrane protein that belongs to the",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -7.00390625,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -7.0703125,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.82421875,
            "end_logit": -7.07421875,
            "text": "SERCA is a membrane protein that belongs",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 5.66015625,
            "text": "free cytosolic calcium into intracellular stores.",
            "probability": 2.980232238769531e-07
        }
    ],
    "54db62a3034aea571d000001_11": [
        {
            "start_logit": 7.65234375,
            "end_logit": 7.60546875,
            "text": "SERCA2a",
            "probability": 0.7431640625
        },
        {
            "start_logit": 6.5859375,
            "end_logit": 7.60546875,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 0.2548828125
        },
        {
            "start_logit": 6.5859375,
            "end_logit": 1.9765625,
            "text": "SERCA1",
            "probability": 0.000919342041015625
        },
        {
            "start_logit": 0.027435302734375,
            "end_logit": 7.60546875,
            "text": "SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 0.00036263465881347656
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -0.6845703125,
            "text": "SERCA",
            "probability": 0.00018668174743652344
        },
        {
            "start_logit": -0.86962890625,
            "end_logit": 7.60546875,
            "text": "2a",
            "probability": 0.00014770030975341797
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -0.6845703125,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -1.748046875,
            "end_logit": 7.60546875,
            "text": "SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -0.810546875,
            "text": "SERCA1, SERCA",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -1.0712890625,
            "text": "SERCA",
            "probability": 4.369020462036133e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -1.33203125,
            "text": "SERCA1, SERCA2, and SERCA",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -2.365234375,
            "end_logit": 7.60546875,
            "text": "SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -2.50390625,
            "end_logit": 7.60546875,
            "text": "SERCA is mainly represented by the SERCA2a",
            "probability": 2.8908252716064453e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -1.8291015625,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -3.583984375,
            "text": "SERCA2a isoform in the heart.",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -3.146484375,
            "text": "SERCA1, SERCA2",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -3.583984375,
            "text": "SERCA1, SERCA2, and SERCA3.",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -3.583984375,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a isoform in the heart.",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -4.79296875,
            "text": "SERCA2a isoform in the heart",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 0.027435302734375,
            "end_logit": 1.9765625,
            "text": "SERCA genes were identified-SERCA1",
            "probability": 1.3113021850585938e-06
        }
    ],
    "54db62a3034aea571d000001_12": [
        {
            "start_logit": 7.65234375,
            "end_logit": 7.60546875,
            "text": "SERCA2a",
            "probability": 0.7431640625
        },
        {
            "start_logit": 6.5859375,
            "end_logit": 7.60546875,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 0.2548828125
        },
        {
            "start_logit": 6.5859375,
            "end_logit": 1.9765625,
            "text": "SERCA1",
            "probability": 0.000919342041015625
        },
        {
            "start_logit": 0.027435302734375,
            "end_logit": 7.60546875,
            "text": "SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 0.00036263465881347656
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -0.6845703125,
            "text": "SERCA",
            "probability": 0.00018668174743652344
        },
        {
            "start_logit": -0.86962890625,
            "end_logit": 7.60546875,
            "text": "2a",
            "probability": 0.00014770030975341797
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -0.6845703125,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -1.748046875,
            "end_logit": 7.60546875,
            "text": "SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -0.810546875,
            "text": "SERCA1, SERCA",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -1.0712890625,
            "text": "SERCA",
            "probability": 4.369020462036133e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -1.33203125,
            "text": "SERCA1, SERCA2, and SERCA",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -2.365234375,
            "end_logit": 7.60546875,
            "text": "SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -2.50390625,
            "end_logit": 7.60546875,
            "text": "SERCA is mainly represented by the SERCA2a",
            "probability": 2.8908252716064453e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -1.8291015625,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -3.583984375,
            "text": "SERCA2a isoform in the heart.",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -3.146484375,
            "text": "SERCA1, SERCA2",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -3.583984375,
            "text": "SERCA1, SERCA2, and SERCA3.",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -3.583984375,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a isoform in the heart.",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -4.79296875,
            "text": "SERCA2a isoform in the heart",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 0.027435302734375,
            "end_logit": 1.9765625,
            "text": "SERCA genes were identified-SERCA1",
            "probability": 1.3113021850585938e-06
        }
    ],
    "54db62a3034aea571d000001_13": [
        {
            "start_logit": 5.87890625,
            "end_logit": -1.0908203125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA)",
            "probability": 0.81591796875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -3.771484375,
            "text": "The",
            "probability": 0.055816650390625
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -4.08203125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA",
            "probability": 0.040924072265625
        },
        {
            "start_logit": -3.583984375,
            "end_logit": 4.6875,
            "text": ".",
            "probability": 0.0204620361328125
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -4.94921875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase",
            "probability": 0.0172119140625
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -5.765625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte",
            "probability": 0.007602691650390625
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -5.76953125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher",
            "probability": 0.00757598876953125
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.1171875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a",
            "probability": 0.005352020263671875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.2734375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane",
            "probability": 0.004573822021484375
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.5546875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the",
            "probability": 0.0034542083740234375
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.57421875,
            "text": "The sarcoplasmic reticulum Ca",
            "probability": 0.0033855438232421875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.6875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is",
            "probability": 0.0030231475830078125
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.70703125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-",
            "probability": 0.0029659271240234375
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.7421875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump",
            "probability": 0.0028629302978515625
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.859375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz",
            "probability": 0.0025463104248046875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.9140625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the",
            "probability": 0.002410888671875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.94140625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to",
            "probability": 0.002346038818359375
        },
        {
            "start_logit": -7.171875,
            "end_logit": 4.6875,
            "text": "SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 0.0005660057067871094
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 4.6875,
            "text": "utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 0.0004878044128417969
        },
        {
            "start_logit": -7.359375,
            "end_logit": 4.6875,
            "text": "(SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 0.000469207763671875
        }
    ],
    "54db62a3034aea571d000001_14": [
        {
            "start_logit": 5.87890625,
            "end_logit": -1.0908203125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA)",
            "probability": 0.81591796875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -3.771484375,
            "text": "The",
            "probability": 0.055816650390625
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -4.08203125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA",
            "probability": 0.040924072265625
        },
        {
            "start_logit": -3.583984375,
            "end_logit": 4.6875,
            "text": ".",
            "probability": 0.0204620361328125
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -4.94921875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase",
            "probability": 0.0172119140625
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -5.765625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte",
            "probability": 0.007602691650390625
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -5.76953125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher",
            "probability": 0.00757598876953125
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.1171875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a",
            "probability": 0.005352020263671875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.2734375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane",
            "probability": 0.004573822021484375
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.5546875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the",
            "probability": 0.0034542083740234375
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.57421875,
            "text": "The sarcoplasmic reticulum Ca",
            "probability": 0.0033855438232421875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.6875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is",
            "probability": 0.0030231475830078125
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.70703125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-",
            "probability": 0.0029659271240234375
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.7421875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump",
            "probability": 0.0028629302978515625
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.859375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz",
            "probability": 0.0025463104248046875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.9140625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the",
            "probability": 0.002410888671875
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -6.94140625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to",
            "probability": 0.002346038818359375
        },
        {
            "start_logit": -7.171875,
            "end_logit": 4.6875,
            "text": "SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 0.0005660057067871094
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 4.6875,
            "text": "utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 0.0004878044128417969
        },
        {
            "start_logit": -7.359375,
            "end_logit": 4.6875,
            "text": "(SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 0.000469207763671875
        }
    ],
    "550739cf3b8a5dc045000002_1": [
        {
            "start_logit": 6.953125,
            "end_logit": 1.521484375,
            "text": "AAUAAA",
            "probability": 0.5849609375
        },
        {
            "start_logit": 6.953125,
            "end_logit": 1.173828125,
            "text": "AAUAAA hexamer",
            "probability": 0.41162109375
        },
        {
            "start_logit": 6.953125,
            "end_logit": -3.9296875,
            "text": "AA",
            "probability": 0.002506256103515625
        },
        {
            "start_logit": 6.953125,
            "end_logit": -5.08203125,
            "text": "AAUAAA hexa",
            "probability": 0.0007920265197753906
        },
        {
            "start_logit": 6.953125,
            "end_logit": -7.3984375,
            "text": "AAUA",
            "probability": 7.808208465576172e-05
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 1.521484375,
            "text": "UAAA",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 1.173828125,
            "text": "UAAA hexamer",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 1.521484375,
            "text": "AA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 1.521484375,
            "text": "canonical AAUAAA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 1.173828125,
            "text": "AA hexamer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 1.521484375,
            "text": "most canonical AAUAAA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 1.173828125,
            "text": "canonical AAUAAA hexamer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 1.521484375,
            "text": "The most canonical AAUAAA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 1.173828125,
            "text": "mer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 1.173828125,
            "text": "hexamer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 1.173828125,
            "text": "most canonical AAUAAA hexamer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 1.173828125,
            "text": "The most canonical AAUAAA hexamer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.2421875,
            "end_logit": -5.08203125,
            "text": "UAAA hexa",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -3.9296875,
            "text": "canonical AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.8125,
            "end_logit": -3.9296875,
            "text": "most canonical AA",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_2": [
        {
            "start_logit": 6.5,
            "end_logit": 7.421875,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": -2.9921875,
            "end_logit": 7.421875,
            "text": "AA",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": 6.5,
            "end_logit": -4.65625,
            "text": "AA",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 7.421875,
            "text": "UAAA",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.421875,
            "text": "polyadenylation signal AAUAAA",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.421875,
            "text": "signal AAUAAA",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 7.421875,
            "text": "ylation signal AAUAAA",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.1953125,
            "text": "AAUA",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -4.65625,
            "text": "polyadenylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -4.65625,
            "text": "signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -4.65625,
            "text": "ylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -7.1953125,
            "text": "UA",
            "probability": 0.0
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -7.1953125,
            "text": "polyadenylation signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -7.1953125,
            "text": "signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -7.1953125,
            "text": "ylation signal AAUA",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_3": [
        {
            "start_logit": 6.5,
            "end_logit": 7.421875,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": -2.9921875,
            "end_logit": 7.421875,
            "text": "AA",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": 6.5,
            "end_logit": -4.65625,
            "text": "AA",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 7.421875,
            "text": "UAAA",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.421875,
            "text": "polyadenylation signal AAUAAA",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.421875,
            "text": "signal AAUAAA",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 7.421875,
            "text": "ylation signal AAUAAA",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.1953125,
            "text": "AAUA",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -4.65625,
            "text": "polyadenylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -4.65625,
            "text": "signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -4.65625,
            "text": "ylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -7.1953125,
            "text": "UA",
            "probability": 0.0
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -7.1953125,
            "text": "polyadenylation signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -7.1953125,
            "text": "signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -7.1953125,
            "text": "ylation signal AAUA",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_4": [
        {
            "start_logit": 7.82421875,
            "end_logit": 7.6484375,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -2.275390625,
            "text": "AA",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": -2.478515625,
            "end_logit": 7.6484375,
            "text": "AA",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -4.9140625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A) synthesis.",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -5.58203125,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 7.6484375,
            "text": "UAAA",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.76953125,
            "text": "AAUAAA) nearby the 3",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.85546875,
            "text": "AAUAAA)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.875,
            "text": "AAUAAA) nearby the 3' end of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.90234375,
            "text": "AAUAAA) nearby the",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.1015625,
            "text": "AAUA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.1953125,
            "text": "AAUAAA) nearby the 3' end of pre",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.359375,
            "text": "AAUAAA) nearby the 3'",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.375,
            "text": "AAUAAA) nearby",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.40625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.546875,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.56640625,
            "text": "AAUAAA) nearby the 3' end",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.58984375,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A) synthesis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.67578125,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 7.6484375,
            "text": "(AAUAAA",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e764647c6a8763d23000016_1": [
        {
            "start_logit": -1.8994140625,
            "end_logit": 6.8359375,
            "text": "The oral live cholera vaccine CVD 103-HgR",
            "probability": 0.68994140625
        },
        {
            "start_logit": -3.849609375,
            "end_logit": 6.8359375,
            "text": "R",
            "probability": 0.0980224609375
        },
        {
            "start_logit": -3.943359375,
            "end_logit": 6.8359375,
            "text": "CVD 103-HgR",
            "probability": 0.08929443359375
        },
        {
            "start_logit": -4.125,
            "end_logit": 6.8359375,
            "text": "103-HgR",
            "probability": 0.074462890625
        },
        {
            "start_logit": -5.08203125,
            "end_logit": 6.8359375,
            "text": "HgR",
            "probability": 0.028594970703125
        },
        {
            "start_logit": -6.234375,
            "end_logit": 6.8359375,
            "text": "cholera vaccine CVD 103-HgR",
            "probability": 0.009033203125
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 6.8359375,
            "text": "-HgR",
            "probability": 0.00800323486328125
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 6.8359375,
            "text": "live cholera vaccine CVD 103-HgR",
            "probability": 0.0027866363525390625
        },
        {
            "start_logit": -1.8994140625,
            "end_logit": -4.640625,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol, Mutachol)",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -1.8994140625,
            "end_logit": -6.2421875,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol, Mutachol), the first",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -3.849609375,
            "end_logit": -4.640625,
            "text": "R (Orochol, Mutachol)",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -1.8994140625,
            "end_logit": -6.66796875,
            "text": "The oral live cholera",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -3.943359375,
            "end_logit": -4.640625,
            "text": "CVD 103-HgR (Orochol, Mutachol)",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -1.8994140625,
            "end_logit": -6.72265625,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol, Mutachol",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -4.125,
            "end_logit": -4.640625,
            "text": "103-HgR (Orochol, Mutachol)",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.8994140625,
            "end_logit": -7.0078125,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.8994140625,
            "end_logit": -7.21875,
            "text": "The oral live cholera vaccine",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.8994140625,
            "end_logit": -7.34375,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol, Mut",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.08203125,
            "end_logit": -4.640625,
            "text": "HgR (Orochol, Mutachol)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.849609375,
            "end_logit": -6.2421875,
            "text": "R (Orochol, Mutachol), the first",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e499e266d0a27794100000c_1": [
        {
            "start_logit": 7.77734375,
            "end_logit": 7.70703125,
            "text": "Viagra",
            "probability": 1.0
        },
        {
            "start_logit": -2.119140625,
            "end_logit": 7.70703125,
            "text": "a",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -2.427734375,
            "text": "Via",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": -4.14453125,
            "end_logit": 7.70703125,
            "text": "Sildenafil citrate, sold as the trade name of Viagra",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 7.70703125,
            "text": "gra",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -6.43359375,
            "text": "Viagra\u00ae",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 7.70703125,
            "text": "citrate, sold as the trade name of Viagra",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -6.984375,
            "text": "Viagra\u00ae can be considered as a prime and important treatment.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.265625,
            "text": "Viagr",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.70703125,
            "text": "which Sildenafil citrate, sold as the trade name of Viagra",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 7.70703125,
            "text": "sold as the trade name of Viagra",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.70703125,
            "text": "counter or non-prescription medications, out of which Sildenafil citrate, sold as the trade name of Viagra",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 7.70703125,
            "text": "of Viagra",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 7.70703125,
            "text": "over-the-counter or non-prescription medications, out of which Sildenafil citrate, sold as the trade name of Viagra",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 7.70703125,
            "text": "medications, out of which Sildenafil citrate, sold as the trade name of Viagra",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 7.70703125,
            "text": "d as the trade name of Viagra",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.70703125,
            "text": "name of Viagra",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.14453125,
            "end_logit": 0.2366943359375,
            "text": "Sildenafil citrate",
            "probability": 0.0
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 0.2366943359375,
            "text": "citrate",
            "probability": 0.0
        },
        {
            "start_logit": -4.14453125,
            "end_logit": -2.427734375,
            "text": "Sildenafil citrate, sold as the trade name of Via",
            "probability": 0.0
        }
    ],
    "5319a7d2b166e2b806000029_1": [
        {
            "start_logit": 7.04296875,
            "end_logit": 6.32421875,
            "text": "hsc70-interacting protein (CHIP)",
            "probability": 1.0
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -2.54296875,
            "text": "hsc70-interacting protein (CHIP) can",
            "probability": 0.00014090538024902344
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -3.576171875,
            "text": "hsc",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": -3.859375,
            "end_logit": 6.32421875,
            "text": ")",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -5.62890625,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -5.08203125,
            "end_logit": 6.32421875,
            "text": "interacting protein (CHIP)",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -5.87890625,
            "text": "hsc70",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -5.2890625,
            "end_logit": 6.32421875,
            "text": "Carboxyl terminus of hsc70-interacting protein (CHIP)",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -5.5625,
            "end_logit": 6.32421875,
            "text": "protein (CHIP)",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.94140625,
            "end_logit": 6.32421875,
            "text": "CHIP)",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.67578125,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR)",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.68359375,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -6.0390625,
            "end_logit": 6.32421875,
            "text": "of hsc70-interacting protein (CHIP)",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.890625,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 6.32421875,
            "text": "-interacting protein (CHIP)",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.30859375,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.7265625,
            "text": "hsc70-interacting protein (CHIP) can remodel mature",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.8203125,
            "text": "hsc70-interacting protein (CHIP",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.8203125,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.8515625,
            "text": "hsc70-interacting",
            "probability": 7.152557373046875e-07
        }
    ],
    "5313058de3eabad02100000e_1": [
        {
            "start_logit": 7.0078125,
            "end_logit": 6.9765625,
            "text": "lumbosacral transitional vertebrae",
            "probability": 1.0
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -2.341796875,
            "text": "lumbosacral",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": -3.3046875,
            "end_logit": 6.9765625,
            "text": "vertebrae",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -5.0234375,
            "end_logit": 6.9765625,
            "text": "transitional vertebrae",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 6.9765625,
            "text": "lumbago in lumbosacral transitional vertebrae",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -6.51171875,
            "text": "lumbosacral transitional",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -6.9453125,
            "text": "lumbosacral transitional vertebrae,",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 6.9765625,
            "text": "form of lumbago in lumbosacral transitional vertebrae",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.40625,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in young patients.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.5859375,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in young",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 6.9765625,
            "text": "in lumbosacral transitional vertebrae",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.62109375,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.64453125,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.66015625,
            "text": "lumbosacral transitional vertebrae, is an important",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.9765625,
            "text": "bago in lumbosacral transitional vertebrae",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.78515625,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.79296875,
            "text": "lumbosacral transitional vertebrae, is an important cause of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 6.9765625,
            "text": ", a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.9765625,
            "text": "Bertolotti's syndrome (BS), a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.2578125,
            "end_logit": -2.341796875,
            "text": "lumbago in lumbosacral",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_2": [
        {
            "start_logit": 6.33984375,
            "end_logit": 6.6875,
            "text": "lumbosacral",
            "probability": 1.0
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.546875,
            "text": "lumbosacral anomalies and often have severe sciatica",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.6875,
            "text": "characteristic lumbosacral",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.67578125,
            "text": "lumbosacral anomalies and often have severe sciatica.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.68359375,
            "text": "lumbosacral anomalies",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.6875,
            "text": "Bertolotti's syndrome have characteristic lumbosacral",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.73828125,
            "text": "lumbosacral anomalies and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 6.6875,
            "text": "tolotti's syndrome have characteristic lumbosacral",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 6.6875,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.6875,
            "text": "syndrome have characteristic lumbosacral",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.87109375,
            "text": "lumbosacral anomalies and often have severe sciatic",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.546875,
            "text": "sciatica",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.67578125,
            "text": "sciatica.",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -7.546875,
            "text": "a",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.67578125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.87109375,
            "text": "sciatic",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -7.67578125,
            "text": "a.",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.546875,
            "text": "characteristic lumbosacral anomalies and often have severe sciatica",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.67578125,
            "text": "characteristic lumbosacral anomalies and often have severe sciatica.",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.68359375,
            "text": "characteristic lumbosacral anomalies",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_3": [
        {
            "start_logit": 7.828125,
            "end_logit": 7.73828125,
            "text": "lumbosacral junction",
            "probability": 1.0
        },
        {
            "start_logit": 7.828125,
            "end_logit": -1.810546875,
            "text": "lumbosacral",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -2.064453125,
            "end_logit": 7.73828125,
            "text": "junction",
            "probability": 5.066394805908203e-05
        },
        {
            "start_logit": 7.828125,
            "end_logit": -5.78515625,
            "text": "lumbosacral junction pseudarticulation",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.828125,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome): a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.8671875,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome): a case report",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.88671875,
            "text": "lumbosacral junction pseudarticulation (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.9453125,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome): a case",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -8.03125,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome):",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -8.0390625,
            "text": "lumbosacral junction pseudarticulation (Bertolotti",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.73828125,
            "text": "unilateral lumbosacral junction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.73828125,
            "text": "Radiofrequency sensory ablation as a treatment for symptomatic unilateral lumbosacral junction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.73828125,
            "text": "sensory ablation as a treatment for symptomatic unilateral lumbosacral junction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.064453125,
            "end_logit": -5.78515625,
            "text": "junction pseudarticulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -1.810546875,
            "text": "unilateral lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -2.064453125,
            "end_logit": -7.828125,
            "text": "junction pseudarticulation (Bertolotti's syndrome): a",
            "probability": 0.0
        },
        {
            "start_logit": -2.064453125,
            "end_logit": -7.8671875,
            "text": "junction pseudarticulation (Bertolotti's syndrome): a case report",
            "probability": 0.0
        },
        {
            "start_logit": -2.064453125,
            "end_logit": -7.88671875,
            "text": "junction pseudarticulation (",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -1.810546875,
            "text": "Radiofrequency sensory ablation as a treatment for symptomatic unilateral lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -2.064453125,
            "end_logit": -7.9453125,
            "text": "junction pseudarticulation (Bertolotti's syndrome): a case",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_4": [
        {
            "start_logit": 5.39453125,
            "end_logit": 7.046875,
            "text": "spine",
            "probability": 1.0
        },
        {
            "start_logit": -3.54296875,
            "end_logit": 7.046875,
            "text": "lumbar spine",
            "probability": 0.00013136863708496094
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 7.046875,
            "text": "the lumbar spine",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 7.046875,
            "text": "sacrum or ilium. The association of that variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 7.046875,
            "text": "with the sacrum or ilium. The association of that variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.046875,
            "text": ". The association of that variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.046875,
            "text": "of the lumbar spine",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 5.39453125,
            "end_logit": -6.515625,
            "text": "spine is called Bertolotti's syndrome.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 5.39453125,
            "end_logit": -7.7265625,
            "text": "spine is called Bertolotti",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.650390625,
            "end_logit": -2.5390625,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -2.5390625,
            "text": "fifth lumbar vertebra",
            "probability": 0.0
        },
        {
            "start_logit": -3.650390625,
            "end_logit": -3.462890625,
            "text": "Lumbosacral transitional vertebra",
            "probability": 0.0
        },
        {
            "start_logit": -4.61328125,
            "end_logit": -2.5390625,
            "text": "transitional vertebra is an anatomical variation of the fifth lumbar vertebra",
            "probability": 0.0
        },
        {
            "start_logit": -5.48828125,
            "end_logit": -2.5390625,
            "text": "the fifth lumbar vertebra",
            "probability": 0.0
        },
        {
            "start_logit": -4.61328125,
            "end_logit": -3.462890625,
            "text": "transitional vertebra",
            "probability": 0.0
        },
        {
            "start_logit": -3.650390625,
            "end_logit": -4.96875,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar",
            "probability": 0.0
        },
        {
            "start_logit": -6.7421875,
            "end_logit": -2.5390625,
            "text": "lumbar vertebra",
            "probability": 0.0
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -2.5390625,
            "text": "vertebra",
            "probability": 0.0
        },
        {
            "start_logit": -3.650390625,
            "end_logit": -5.76171875,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra in which an enlarged transverse process can form a joint or fusion with the sacr",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -4.96875,
            "text": "fifth lumbar",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_5": [
        {
            "start_logit": 4.4609375,
            "end_logit": 6.69140625,
            "text": "lumbosacral vertebrae",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.728515625,
            "end_logit": 6.69140625,
            "text": "vertebrae",
            "probability": 0.0007491111755371094
        },
        {
            "start_logit": -5.34765625,
            "end_logit": 6.69140625,
            "text": "Transitional lumbosacral vertebrae",
            "probability": 5.4717063903808594e-05
        },
        {
            "start_logit": 4.4609375,
            "end_logit": -4.8984375,
            "text": "lumbosacral",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": 4.4609375,
            "end_logit": -7.58984375,
            "text": "lumbosacral vertebrae and low back",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 4.4609375,
            "end_logit": -7.62109375,
            "text": "lumbosacral vertebrae and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.4609375,
            "end_logit": -7.7265625,
            "text": "lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 4.4609375,
            "end_logit": -7.8984375,
            "text": "lumbosacral vertebrae and low back pain",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.4609375,
            "end_logit": -7.90234375,
            "text": "lumbosacral vertebrae and low back pain:",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.4609375,
            "end_logit": -8.0078125,
            "text": "lumbosacral vertebrae and low back pain: diagnostic pitfalls and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.4609375,
            "end_logit": -8.03125,
            "text": "lumbosacral vertebrae and low back pain: diagnostic pitfalls",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.34765625,
            "end_logit": -4.8984375,
            "text": "Transitional lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -2.728515625,
            "end_logit": -7.58984375,
            "text": "vertebrae and low back",
            "probability": 0.0
        },
        {
            "start_logit": -2.728515625,
            "end_logit": -7.62109375,
            "text": "vertebrae and",
            "probability": 0.0
        },
        {
            "start_logit": -2.728515625,
            "end_logit": -7.7265625,
            "text": "vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -2.728515625,
            "end_logit": -7.8984375,
            "text": "vertebrae and low back pain",
            "probability": 0.0
        },
        {
            "start_logit": -2.728515625,
            "end_logit": -7.90234375,
            "text": "vertebrae and low back pain:",
            "probability": 0.0
        },
        {
            "start_logit": -2.728515625,
            "end_logit": -8.0078125,
            "text": "vertebrae and low back pain: diagnostic pitfalls and",
            "probability": 0.0
        },
        {
            "start_logit": -2.728515625,
            "end_logit": -8.03125,
            "text": "vertebrae and low back pain: diagnostic pitfalls",
            "probability": 0.0
        },
        {
            "start_logit": -5.34765625,
            "end_logit": -7.58984375,
            "text": "Transitional lumbosacral vertebrae and low back",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_6": [
        {
            "start_logit": 7.43359375,
            "end_logit": 7.4921875,
            "text": "facet joint",
            "probability": 0.95263671875
        },
        {
            "start_logit": 7.43359375,
            "end_logit": 4.48046875,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral",
            "probability": 0.04705810546875
        },
        {
            "start_logit": 1.9521484375,
            "end_logit": 4.48046875,
            "text": "lumbosacral",
            "probability": 0.00019693374633789062
        },
        {
            "start_logit": -2.6484375,
            "end_logit": 7.4921875,
            "text": "joint",
            "probability": 3.999471664428711e-05
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -3.068359375,
            "text": "facet",
            "probability": 2.47955322265625e-05
        },
        {
            "start_logit": -2.6484375,
            "end_logit": 4.48046875,
            "text": "joint contralateral to a unilateral anomalous lumbosacral",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.4921875,
            "text": "the facet joint",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.50390625,
            "text": "facet joint contralateral to a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.5546875,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.56640625,
            "text": "facet joint contralateral",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.4921875,
            "text": "from the facet joint",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.4921875,
            "text": "low back pain from the facet joint",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.765625,
            "text": "facet joint contralateral to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.83984375,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation (Bertolotti's syndrome).",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 7.4921875,
            "text": "pain from the facet joint",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.8984375,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 7.4921875,
            "text": "back pain from the facet joint",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 4.48046875,
            "text": "anomalous lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 4.48046875,
            "text": "the facet joint contralateral to a unilateral anomalous lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 4.48046875,
            "text": "unilateral anomalous lumbosacral",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_7": [
        {
            "start_logit": 7.69921875,
            "end_logit": 7.21484375,
            "text": "L6-S1 facet joint",
            "probability": 0.88720703125
        },
        {
            "start_logit": 5.63671875,
            "end_logit": 7.21484375,
            "text": "facet joint",
            "probability": 0.11273193359375
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -1.49609375,
            "text": "L6",
            "probability": 0.0001461505889892578
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -2.4296875,
            "text": "L6-S1",
            "probability": 5.7697296142578125e-05
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -3.3203125,
            "text": "L6-S1 facet joint contralateral to an anomalous lumbosacral",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": -3.091796875,
            "end_logit": 7.21484375,
            "text": "joint",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": -4.09765625,
            "end_logit": 7.21484375,
            "text": "S1 facet joint",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -5.328125,
            "text": "L6-S1 facet",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 5.63671875,
            "end_logit": -3.3203125,
            "text": "facet joint contralateral to an anomalous lumbosacral",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -6.90234375,
            "text": "L6-S1 facet joint contralateral",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.63671875,
            "end_logit": -5.328125,
            "text": "facet",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 7.21484375,
            "text": "-S1 facet joint",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.58203125,
            "text": "L6-S1 facet joint contralateral to an anomalous lumbosacral articulation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.59765625,
            "text": "L6-S1 facet joint contralateral to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.70703125,
            "text": "L6-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.75390625,
            "text": "L6-S1 facet joint contralateral to an anomalous lumbosacral articulation.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.89453125,
            "text": "L6-S1 facet joint contralateral to an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.21484375,
            "text": "symptomatic L6-S1 facet joint",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.21484375,
            "text": "fluoroscopically guided injections implicated a symptomatic L6-S1 facet joint",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -8.109375,
            "text": "L6-S1 facet joint contralateral to an anomalous",
            "probability": 2.384185791015625e-07
        }
    ],
    "5313058de3eabad02100000e_8": [
        {
            "start_logit": 6.8046875,
            "end_logit": 7.26171875,
            "text": "lumbosacral transitional vertebrae",
            "probability": 1.0
        },
        {
            "start_logit": -2.9609375,
            "end_logit": 7.26171875,
            "text": "vertebrae",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -2.865234375,
            "text": "lumbosacral",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 7.26171875,
            "text": "transitional vertebrae",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.26171875,
            "text": "back pain with lumbosacral transitional vertebrae",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -7.09375,
            "text": "lumbosacral transitional",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 7.26171875,
            "text": "with lumbosacral transitional vertebrae",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 7.26171875,
            "text": "association of back pain with lumbosacral transitional vertebrae",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.26171875,
            "text": "tolotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.26171875,
            "text": "syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.26171875,
            "text": "Bertolotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.26171875,
            "text": "lotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.26171875,
            "text": "ti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.26171875,
            "text": "pain with lumbosacral transitional vertebrae",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -7.70703125,
            "text": "lumbosacral transitional vertebrae.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -2.865234375,
            "text": "back pain with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -2.865234375,
            "text": "with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -2.9609375,
            "end_logit": -7.70703125,
            "text": "vertebrae.",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -2.865234375,
            "text": "association of back pain with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -2.865234375,
            "text": "tolotti's syndrome refers to the association of back pain with lumbosacral",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_1": [
        {
            "start_logit": 7.96484375,
            "end_logit": 7.921875,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -1.5439453125,
            "text": "mpM",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -1.7392578125,
            "end_logit": 7.921875,
            "text": "DB",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 7.921875,
            "text": "oRFsDB",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.015625,
            "end_logit": 7.921875,
            "text": "FsDB",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.5703125,
            "text": "mpMoRFs",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.4765625,
            "text": "mpMoR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.640625,
            "text": "mpMoRFsDB: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.85546875,
            "text": "mpMoRFsDB:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.8828125,
            "text": "mpMoRFsDB: a database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -8.0,
            "text": "mpMoRFsDB: a database of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7392578125,
            "end_logit": -7.640625,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.7392578125,
            "end_logit": -7.85546875,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -1.7392578125,
            "end_logit": -7.8828125,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -1.7392578125,
            "end_logit": -8.0,
            "text": "DB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -6.5703125,
            "text": "oRFs",
            "probability": 0.0
        },
        {
            "start_logit": -6.015625,
            "end_logit": -6.5703125,
            "text": "Fs",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -7.4765625,
            "text": "oR",
            "probability": 0.0
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -7.640625,
            "text": "oRFsDB: a",
            "probability": 0.0
        },
        {
            "start_logit": -6.015625,
            "end_logit": -7.640625,
            "text": "FsDB: a",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_2": [
        {
            "start_logit": 7.95703125,
            "end_logit": 7.953125,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -1.513671875,
            "text": "mpM",
            "probability": 7.784366607666016e-05
        },
        {
            "start_logit": -1.6318359375,
            "end_logit": 7.953125,
            "text": "DB",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 7.953125,
            "text": "oRFsDB",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.96875,
            "end_logit": 7.953125,
            "text": "FsDB",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.81640625,
            "text": "mpMoRFs",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.671875,
            "text": "mpMoR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -8.0234375,
            "text": "mpMoRFsDB provides",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -8.125,
            "text": "mpMoRFsDB provides valuable",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -8.1796875,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6318359375,
            "end_logit": -8.0234375,
            "text": "DB provides",
            "probability": 0.0
        },
        {
            "start_logit": -1.6318359375,
            "end_logit": -8.125,
            "text": "DB provides valuable",
            "probability": 0.0
        },
        {
            "start_logit": -1.6318359375,
            "end_logit": -8.1796875,
            "text": "DB provides valuable information related to disorder-based protein-protein",
            "probability": 0.0
        },
        {
            "start_logit": -5.87109375,
            "end_logit": -6.81640625,
            "text": "oRFs",
            "probability": 0.0
        },
        {
            "start_logit": -5.96875,
            "end_logit": -6.81640625,
            "text": "Fs",
            "probability": 0.0
        },
        {
            "start_logit": -5.87109375,
            "end_logit": -7.671875,
            "text": "oR",
            "probability": 0.0
        },
        {
            "start_logit": -5.87109375,
            "end_logit": -8.0234375,
            "text": "oRFsDB provides",
            "probability": 0.0
        },
        {
            "start_logit": -5.96875,
            "end_logit": -8.0234375,
            "text": "FsDB provides",
            "probability": 0.0
        },
        {
            "start_logit": -5.87109375,
            "end_logit": -8.125,
            "text": "oRFsDB provides valuable",
            "probability": 0.0
        },
        {
            "start_logit": -5.87109375,
            "end_logit": -8.1796875,
            "text": "oRFsDB provides valuable information related to disorder-based protein-protein",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_3": [
        {
            "start_logit": 7.96484375,
            "end_logit": 7.9296875,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -1.5419921875,
            "text": "mpM",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -1.7373046875,
            "end_logit": 7.9296875,
            "text": "DB",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 7.9296875,
            "text": "FsDB",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.0625,
            "end_logit": 7.9296875,
            "text": "oRFsDB",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.53125,
            "text": "mpMoRFs",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.42578125,
            "text": "mpMoR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.67578125,
            "text": "mpMoRFsDB: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.7734375,
            "text": "mpMoRFsDB:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.9296875,
            "text": "mpMoRFsDB: a database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.95703125,
            "text": "mpMoRFsDB: a database of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -8.015625,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7373046875,
            "end_logit": -7.67578125,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.7373046875,
            "end_logit": -7.7734375,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -1.7373046875,
            "end_logit": -7.9296875,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -1.7373046875,
            "end_logit": -7.95703125,
            "text": "DB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": -1.7373046875,
            "end_logit": -8.015625,
            "text": "DB: a database of molecular recognition features in membrane proteins.",
            "probability": 0.0
        },
        {
            "start_logit": -6.03515625,
            "end_logit": -6.53125,
            "text": "Fs",
            "probability": 0.0
        },
        {
            "start_logit": -6.0625,
            "end_logit": -6.53125,
            "text": "oRFs",
            "probability": 0.0
        },
        {
            "start_logit": -6.0625,
            "end_logit": -7.42578125,
            "text": "oR",
            "probability": 0.0
        }
    ],
    "5c632542e842deac6700000d_1": [
        {
            "start_logit": 7.75390625,
            "end_logit": 8.03125,
            "text": "magnetic resonance imaging",
            "probability": 1.0
        },
        {
            "start_logit": -1.44140625,
            "end_logit": 8.03125,
            "text": "imaging",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -2.3984375,
            "text": "magnetic",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -6.03125,
            "end_logit": 8.03125,
            "text": "novel approach of magnetic resonance imaging",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -6.1640625,
            "text": "magnetic resonance",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 8.03125,
            "text": "resonance imaging",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -6.41796875,
            "text": "magnetic resonance imaging and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 8.03125,
            "text": "of magnetic resonance imaging",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 8.03125,
            "text": "the novel approach of magnetic resonance imaging",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -7.171875,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of this syndrome.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -7.2109375,
            "text": "magnetic resonance imaging and we",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.03125,
            "text": "patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.03125,
            "text": "using the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.03125,
            "text": "CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.03125,
            "text": "approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 8.03125,
            "text": ". Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -7.625,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.44140625,
            "end_logit": -6.41796875,
            "text": "imaging and",
            "probability": 0.0
        },
        {
            "start_logit": -6.03125,
            "end_logit": -2.3984375,
            "text": "novel approach of magnetic",
            "probability": 0.0
        },
        {
            "start_logit": -1.44140625,
            "end_logit": -7.171875,
            "text": "imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of this syndrome.",
            "probability": 0.0
        }
    ],
    "5c632542e842deac6700000d_2": [
        {
            "start_logit": 7.515625,
            "end_logit": 7.97265625,
            "text": "magnetic resonance imaging",
            "probability": 1.0
        },
        {
            "start_logit": -1.720703125,
            "end_logit": 7.97265625,
            "text": "imaging",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": 7.515625,
            "end_logit": -3.04296875,
            "text": "magnetic",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 7.97265625,
            "text": "resonance imaging",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 7.97265625,
            "text": "novel approach of magnetic resonance imaging",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.515625,
            "end_logit": -6.6328125,
            "text": "magnetic resonance",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.97265625,
            "text": "the novel approach of magnetic resonance imaging",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.515625,
            "end_logit": -7.140625,
            "text": "magnetic resonance imaging and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.97265625,
            "text": "of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.97265625,
            "text": "patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 7.97265625,
            "text": "using the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.515625,
            "end_logit": -7.6796875,
            "text": "magnetic resonance imaging and we",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.515625,
            "end_logit": -7.7109375,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of this syndrome.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.515625,
            "end_logit": -7.91796875,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.515625,
            "end_logit": -7.984375,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.720703125,
            "end_logit": -7.140625,
            "text": "imaging and",
            "probability": 0.0
        },
        {
            "start_logit": -1.720703125,
            "end_logit": -7.6796875,
            "text": "imaging and we",
            "probability": 0.0
        },
        {
            "start_logit": -1.720703125,
            "end_logit": -7.7109375,
            "text": "imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of this syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -1.720703125,
            "end_logit": -7.91796875,
            "text": "imaging and we conduct a systematic review of all patients reported in the last 60",
            "probability": 0.0
        },
        {
            "start_logit": -1.720703125,
            "end_logit": -7.984375,
            "text": "imaging and we conduct a systematic review of all patients reported in the last 60 years,",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_1": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.890625,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.5751953125,
            "text": "tra",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -1.845703125,
            "end_logit": 7.890625,
            "text": "R",
            "probability": 5.561113357543945e-05
        },
        {
            "start_logit": -5.96484375,
            "end_logit": 7.890625,
            "text": "seR",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.37109375,
            "text": "trase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.8359375,
            "text": "traseR:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.90234375,
            "text": "traseR: an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.91796875,
            "text": "traseR: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.9765625,
            "text": "traseR: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.9921875,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.0,
            "text": "traseR: an R package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.2890625,
            "text": "traseR: an R package for performing trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.3046875,
            "text": "traseR: an R package for performing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.3046875,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.3203125,
            "text": "traseR: an R package for performing trait-associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.359375,
            "text": "traseR: an R package for performing trait",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.845703125,
            "end_logit": -7.8359375,
            "text": "R:",
            "probability": 0.0
        },
        {
            "start_logit": -1.845703125,
            "end_logit": -7.90234375,
            "text": "R: an",
            "probability": 0.0
        },
        {
            "start_logit": -1.845703125,
            "end_logit": -7.91796875,
            "text": "R: an R",
            "probability": 0.0
        },
        {
            "start_logit": -1.845703125,
            "end_logit": -7.9765625,
            "text": "R: an R package for",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_2": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.86328125,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.7470703125,
            "text": "tra",
            "probability": 6.711483001708984e-05
        },
        {
            "start_logit": -1.9423828125,
            "end_logit": 7.86328125,
            "text": "R",
            "probability": 5.1856040954589844e-05
        },
        {
            "start_logit": -6.203125,
            "end_logit": 7.86328125,
            "text": "seR",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.31640625,
            "text": "trase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.86328125,
            "text": "present traseR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.86328125,
            "text": "traseR,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.0703125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.0859375,
            "text": "traseR, an easy-to-use",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.125,
            "text": "traseR, an easy-to-use R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.171875,
            "text": "traseR, an easy-to-use R Bioconductor package that",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.1953125,
            "text": "traseR, an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.203125,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.2109375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.21875,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.2890625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -1.7470703125,
            "text": "present tra",
            "probability": 0.0
        },
        {
            "start_logit": -1.9423828125,
            "end_logit": -7.86328125,
            "text": "R,",
            "probability": 0.0
        },
        {
            "start_logit": -1.9423828125,
            "end_logit": -8.0703125,
            "text": "R, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 0.0
        },
        {
            "start_logit": -1.9423828125,
            "end_logit": -8.0859375,
            "text": "R, an easy-to-use",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_3": [
        {
            "start_logit": 7.9140625,
            "end_logit": 7.85546875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.80859375,
            "text": "tra",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -1.9794921875,
            "end_logit": 7.85546875,
            "text": "R",
            "probability": 5.066394805908203e-05
        },
        {
            "start_logit": -6.21875,
            "end_logit": 7.85546875,
            "text": "seR",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.33984375,
            "text": "trase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.85546875,
            "text": "present traseR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.97265625,
            "text": "traseR,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.0625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.078125,
            "text": "traseR, an easy-to-use R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.078125,
            "text": "traseR, an easy-to-use",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.1015625,
            "text": "traseR, an easy-to-use R Bioconductor package that",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.1171875,
            "text": "traseR, an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.1640625,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.1875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.2109375,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.2265625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.28125,
            "text": "traseR, an easy-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -1.80859375,
            "text": "present tra",
            "probability": 0.0
        },
        {
            "start_logit": -1.9794921875,
            "end_logit": -7.97265625,
            "text": "R,",
            "probability": 0.0
        },
        {
            "start_logit": -1.9794921875,
            "end_logit": -8.0625,
            "text": "R, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_4": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.708984375,
            "text": "tra",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": -1.9072265625,
            "end_logit": 7.875,
            "text": "R",
            "probability": 5.346536636352539e-05
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 7.875,
            "text": "seR",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.234375,
            "text": "trase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.875,
            "text": "present traseR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.8671875,
            "text": "traseR,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.984375,
            "text": "traseR, an easy-to-use",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.0546875,
            "text": "traseR, an easy-to-use R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.0625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.0859375,
            "text": "traseR, an easy-to-use R Bioconductor package that",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.109375,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.140625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.1484375,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.1484375,
            "text": "traseR, an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.25,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.265625,
            "text": "traseR, an easy-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -1.708984375,
            "text": "present tra",
            "probability": 0.0
        },
        {
            "start_logit": -1.9072265625,
            "end_logit": -7.8671875,
            "text": "R,",
            "probability": 0.0
        },
        {
            "start_logit": -1.9072265625,
            "end_logit": -7.984375,
            "text": "R, an easy-to-use",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_5": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.90234375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.5234375,
            "text": "tra",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": 7.90234375,
            "text": "R",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": -5.9375,
            "end_logit": 7.90234375,
            "text": "seR",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.3046875,
            "text": "trase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.79296875,
            "text": "traseR:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.87109375,
            "text": "traseR: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.91015625,
            "text": "traseR: an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.9296875,
            "text": "traseR: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.98828125,
            "text": "traseR: an R package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.1640625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.1640625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.2109375,
            "text": "traseR: an R package for performing trait",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.21875,
            "text": "traseR: an R package for performing trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.234375,
            "text": "traseR: an R package for performing trait-associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.234375,
            "text": "traseR: an R package for performing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": -7.79296875,
            "text": "R:",
            "probability": 0.0
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": -7.87109375,
            "text": "R: an R",
            "probability": 0.0
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": -7.91015625,
            "text": "R: an",
            "probability": 0.0
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": -7.9296875,
            "text": "R: an R package for",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_6": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.90234375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.5234375,
            "text": "tra",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": 7.90234375,
            "text": "R",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": -5.9375,
            "end_logit": 7.90234375,
            "text": "seR",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.3046875,
            "text": "trase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.79296875,
            "text": "traseR:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.87109375,
            "text": "traseR: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.91015625,
            "text": "traseR: an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.9296875,
            "text": "traseR: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.98828125,
            "text": "traseR: an R package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.1640625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.1640625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.2109375,
            "text": "traseR: an R package for performing trait",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.21875,
            "text": "traseR: an R package for performing trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.234375,
            "text": "traseR: an R package for performing trait-associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -8.234375,
            "text": "traseR: an R package for performing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": -7.79296875,
            "text": "R:",
            "probability": 0.0
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": -7.87109375,
            "text": "R: an R",
            "probability": 0.0
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": -7.91015625,
            "text": "R: an",
            "probability": 0.0
        },
        {
            "start_logit": -1.8115234375,
            "end_logit": -7.9296875,
            "text": "R: an R package for",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_7": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.708984375,
            "text": "tra",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": -1.9072265625,
            "end_logit": 7.875,
            "text": "R",
            "probability": 5.346536636352539e-05
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 7.875,
            "text": "seR",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.234375,
            "text": "trase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.875,
            "text": "present traseR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.8671875,
            "text": "traseR,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.984375,
            "text": "traseR, an easy-to-use",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.0546875,
            "text": "traseR, an easy-to-use R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.0625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.0859375,
            "text": "traseR, an easy-to-use R Bioconductor package that",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.109375,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.140625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.1484375,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.1484375,
            "text": "traseR, an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.25,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.265625,
            "text": "traseR, an easy-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -1.708984375,
            "text": "present tra",
            "probability": 0.0
        },
        {
            "start_logit": -1.9072265625,
            "end_logit": -7.8671875,
            "text": "R,",
            "probability": 0.0
        },
        {
            "start_logit": -1.9072265625,
            "end_logit": -7.984375,
            "text": "R, an easy-to-use",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_8": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.84765625,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -1.5849609375,
            "text": "tra",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -1.9091796875,
            "end_logit": 7.84765625,
            "text": "R",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": -5.59375,
            "end_logit": 7.84765625,
            "text": "seR",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.09765625,
            "text": "traseR R package",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.3828125,
            "text": "trase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.84765625,
            "text": "The traseR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.78515625,
            "text": "traseR R package preload",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.0390625,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.1015625,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in Bioconductor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.109375,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.109375,
            "text": "traseR R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.2578125,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in Bioconductor zhaohui",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.265625,
            "text": "traseR R package preloaded with up-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.3515625,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in Bioconductor zhaohu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.375,
            "text": "traseR R package preloaded with up-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -1.5849609375,
            "text": "The tra",
            "probability": 0.0
        },
        {
            "start_logit": -1.9091796875,
            "end_logit": -7.09765625,
            "text": "R R package",
            "probability": 0.0
        },
        {
            "start_logit": -1.9091796875,
            "end_logit": -7.78515625,
            "text": "R R package preload",
            "probability": 0.0
        },
        {
            "start_logit": -1.9091796875,
            "end_logit": -8.0390625,
            "text": "R R package preloaded with up-to-date collection of trait-associated SNPs are freely available in",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_1": [
        {
            "start_logit": 7.91796875,
            "end_logit": 7.9140625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -1.7607421875,
            "text": "GBs",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": -1.8330078125,
            "end_logit": 7.9140625,
            "text": "e",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": -5.98046875,
            "end_logit": 7.9140625,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.24609375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.61328125,
            "text": "GBshape: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.75390625,
            "text": "GBshape:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -8.03125,
            "text": "GBshape: a genome browser database for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -8.09375,
            "text": "GBshape: a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -8.09375,
            "text": "GBshape: a genome browser database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -8.1640625,
            "text": "GBshape: a genome browser database for DNA shape annotations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8330078125,
            "end_logit": -7.61328125,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.8330078125,
            "end_logit": -7.75390625,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -1.8330078125,
            "end_logit": -8.03125,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -1.8330078125,
            "end_logit": -8.09375,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -1.8330078125,
            "end_logit": -8.09375,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -1.8330078125,
            "end_logit": -8.1640625,
            "text": "e: a genome browser database for DNA shape annotations",
            "probability": 0.0
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -7.24609375,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -7.61328125,
            "text": "hape: a",
            "probability": 0.0
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -7.75390625,
            "text": "hape:",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_2": [
        {
            "start_logit": 7.91796875,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.175537109375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.1728515625
        },
        {
            "start_logit": 7.890625,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.170166015625
        },
        {
            "start_logit": 7.890625,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.1689453125
        },
        {
            "start_logit": 7.81640625,
            "end_logit": 8.046875,
            "text": "GBshape framework. GBshape",
            "probability": 0.1573486328125
        },
        {
            "start_logit": 7.81640625,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.1549072265625
        },
        {
            "start_logit": -0.66162109375,
            "end_logit": 8.046875,
            "text": "e framework. GBshape",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": -0.66162109375,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 3.254413604736328e-05
        },
        {
            "start_logit": -0.6796875,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -0.76171875,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -0.85791015625,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.6941299438476562e-05
        },
        {
            "start_logit": -0.85791015625,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.676248550415039e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.76220703125,
            "text": "GBs",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -0.76220703125,
            "text": "GBshape framework. GBs",
            "probability": 2.3603439331054688e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.9013671875,
            "text": "GBs",
            "probability": 2.2709369659423828e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -0.9013671875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.199411392211914e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.220703125,
            "text": "GBs",
            "probability": 1.609325408935547e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -1.453125,
            "text": "GBs",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": -3.171875,
            "end_logit": 8.046875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -3.693359375,
            "end_logit": 8.046875,
            "text": "hape framework. GBshape",
            "probability": 1.6093254089355469e-06
        }
    ],
    "587e1bfdfc7e8dd84f000002_3": [
        {
            "start_logit": 7.91796875,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.175537109375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.1728515625
        },
        {
            "start_logit": 7.890625,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.170166015625
        },
        {
            "start_logit": 7.890625,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.1689453125
        },
        {
            "start_logit": 7.81640625,
            "end_logit": 8.046875,
            "text": "GBshape framework. GBshape",
            "probability": 0.1573486328125
        },
        {
            "start_logit": 7.81640625,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.1549072265625
        },
        {
            "start_logit": -0.66162109375,
            "end_logit": 8.046875,
            "text": "e framework. GBshape",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": -0.66162109375,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 3.254413604736328e-05
        },
        {
            "start_logit": -0.6796875,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -0.76171875,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -0.85791015625,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.6941299438476562e-05
        },
        {
            "start_logit": -0.85791015625,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.676248550415039e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.76220703125,
            "text": "GBs",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -0.76220703125,
            "text": "GBshape framework. GBs",
            "probability": 2.3603439331054688e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.9013671875,
            "text": "GBs",
            "probability": 2.2709369659423828e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -0.9013671875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.199411392211914e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.220703125,
            "text": "GBs",
            "probability": 1.609325408935547e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -1.453125,
            "text": "GBs",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": -3.171875,
            "end_logit": 8.046875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -3.693359375,
            "end_logit": 8.046875,
            "text": "hape framework. GBshape",
            "probability": 1.6093254089355469e-06
        }
    ],
    "587e1bfdfc7e8dd84f000002_4": [
        {
            "start_logit": 7.91796875,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.175537109375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.1728515625
        },
        {
            "start_logit": 7.890625,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.170166015625
        },
        {
            "start_logit": 7.890625,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.1689453125
        },
        {
            "start_logit": 7.81640625,
            "end_logit": 8.046875,
            "text": "GBshape framework. GBshape",
            "probability": 0.1573486328125
        },
        {
            "start_logit": 7.81640625,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.1549072265625
        },
        {
            "start_logit": -0.66162109375,
            "end_logit": 8.046875,
            "text": "e framework. GBshape",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": -0.66162109375,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 3.254413604736328e-05
        },
        {
            "start_logit": -0.6796875,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -0.76171875,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -0.85791015625,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.6941299438476562e-05
        },
        {
            "start_logit": -0.85791015625,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.676248550415039e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.76220703125,
            "text": "GBs",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -0.76220703125,
            "text": "GBshape framework. GBs",
            "probability": 2.3603439331054688e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.9013671875,
            "text": "GBs",
            "probability": 2.2709369659423828e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -0.9013671875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.199411392211914e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.220703125,
            "text": "GBs",
            "probability": 1.609325408935547e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -1.453125,
            "text": "GBs",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": -3.171875,
            "end_logit": 8.046875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -3.693359375,
            "end_logit": 8.046875,
            "text": "hape framework. GBshape",
            "probability": 1.6093254089355469e-06
        }
    ],
    "587e1bfdfc7e8dd84f000002_5": [
        {
            "start_logit": 7.91796875,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.175537109375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.1728515625
        },
        {
            "start_logit": 7.890625,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.170166015625
        },
        {
            "start_logit": 7.890625,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.1689453125
        },
        {
            "start_logit": 7.81640625,
            "end_logit": 8.046875,
            "text": "GBshape framework. GBshape",
            "probability": 0.1573486328125
        },
        {
            "start_logit": 7.81640625,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.1549072265625
        },
        {
            "start_logit": -0.66162109375,
            "end_logit": 8.046875,
            "text": "e framework. GBshape",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": -0.66162109375,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 3.254413604736328e-05
        },
        {
            "start_logit": -0.6796875,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -0.76171875,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -0.85791015625,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.6941299438476562e-05
        },
        {
            "start_logit": -0.85791015625,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.676248550415039e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.76220703125,
            "text": "GBs",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -0.76220703125,
            "text": "GBshape framework. GBs",
            "probability": 2.3603439331054688e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.9013671875,
            "text": "GBs",
            "probability": 2.2709369659423828e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -0.9013671875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.199411392211914e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.220703125,
            "text": "GBs",
            "probability": 1.609325408935547e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -1.453125,
            "text": "GBs",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": -3.171875,
            "end_logit": 8.046875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -3.693359375,
            "end_logit": 8.046875,
            "text": "hape framework. GBshape",
            "probability": 1.6093254089355469e-06
        }
    ],
    "587e1bfdfc7e8dd84f000002_6": [
        {
            "start_logit": 7.9140625,
            "end_logit": 7.91015625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.759765625,
            "text": "GBs",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": -1.865234375,
            "end_logit": 7.91015625,
            "text": "e",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": -5.828125,
            "end_logit": 7.91015625,
            "text": "hape",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.24609375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.5390625,
            "text": "GBshape: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.7578125,
            "text": "GBshape:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.0078125,
            "text": "GBshape: a genome browser database for DNA shape annotations.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.0234375,
            "text": "GBshape: a genome browser database for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.09375,
            "text": "GBshape: a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.1015625,
            "text": "GBshape: a genome browser database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -7.5390625,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -7.7578125,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -8.0078125,
            "text": "e: a genome browser database for DNA shape annotations.",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -8.0234375,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -8.09375,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -8.1015625,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": -7.24609375,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": -7.5390625,
            "text": "hape: a",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": -7.7578125,
            "text": "hape:",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_7": [
        {
            "start_logit": 7.9375,
            "end_logit": 7.95703125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -1.5400390625,
            "text": "GBs",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": 7.95703125,
            "text": "e",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 7.95703125,
            "text": "hape",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.953125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.015625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1171875,
            "text": "GBshape can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1640625,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1796875,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -7.953125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.015625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1171875,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1640625,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1796875,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -7.375,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -7.953125,
            "text": "hape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -6.23046875,
            "end_logit": -7.32421875,
            "text": "format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution.",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_8": [
        {
            "start_logit": 7.92578125,
            "end_logit": 8.015625,
            "text": "GBshape",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0234375,
            "text": "GBshape",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.015625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.91748046875,
            "text": "GBs",
            "probability": 4.4286251068115234e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.91748046875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 4.392862319946289e-05
        },
        {
            "start_logit": -1.0625,
            "end_logit": 8.015625,
            "text": "e",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.0234375,
            "text": "e",
            "probability": 3.814697265625e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.015625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.7550926208496094e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.2802734375,
            "text": "GBs",
            "probability": 3.039836883544922e-05
        },
        {
            "start_logit": -4.44921875,
            "end_logit": 8.0234375,
            "text": "hape",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.44921875,
            "end_logit": 8.015625,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.84375,
            "end_logit": 8.015625,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.0078125,
            "end_logit": 8.0234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 8.0234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.05859375,
            "end_logit": 8.015625,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 8.015625,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.3125,
            "text": "GBshape;",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 8.015625,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 8.015625,
            "text": "hslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.0,
            "text": "GBshape/",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_9": [
        {
            "start_logit": 7.92578125,
            "end_logit": 8.015625,
            "text": "GBshape",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0234375,
            "text": "GBshape",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.015625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.91748046875,
            "text": "GBs",
            "probability": 4.4286251068115234e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.91748046875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 4.392862319946289e-05
        },
        {
            "start_logit": -1.0625,
            "end_logit": 8.015625,
            "text": "e",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.0234375,
            "text": "e",
            "probability": 3.814697265625e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.015625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.7550926208496094e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.2802734375,
            "text": "GBs",
            "probability": 3.039836883544922e-05
        },
        {
            "start_logit": -4.44921875,
            "end_logit": 8.0234375,
            "text": "hape",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.44921875,
            "end_logit": 8.015625,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.84375,
            "end_logit": 8.015625,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.0078125,
            "end_logit": 8.0234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 8.0234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.05859375,
            "end_logit": 8.015625,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 8.015625,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.3125,
            "text": "GBshape;",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 8.015625,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 8.015625,
            "text": "hslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.0,
            "text": "GBshape/",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_10": [
        {
            "start_logit": 7.9375,
            "end_logit": 7.95703125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -1.5400390625,
            "text": "GBs",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": 7.95703125,
            "text": "e",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 7.95703125,
            "text": "hape",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.953125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.015625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1171875,
            "text": "GBshape can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1640625,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1796875,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -7.953125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.015625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1171875,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1640625,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1796875,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -7.375,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -7.953125,
            "text": "hape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -6.23046875,
            "end_logit": -7.32421875,
            "text": "format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution.",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_11": [
        {
            "start_logit": 7.9375,
            "end_logit": 7.95703125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -1.5400390625,
            "text": "GBs",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": 7.95703125,
            "text": "e",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 7.95703125,
            "text": "hape",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.953125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.015625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1171875,
            "text": "GBshape can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1640625,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1796875,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.1875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -7.953125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.015625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1171875,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1640625,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1796875,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -1.6162109375,
            "end_logit": -8.1875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -7.375,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -7.953125,
            "text": "hape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -6.23046875,
            "end_logit": -7.32421875,
            "text": "format, and to download quantitative values of DNA shape features as a function of genomic position at nucleotide resolution.",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_12": [
        {
            "start_logit": 7.9140625,
            "end_logit": 7.91015625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.759765625,
            "text": "GBs",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": -1.865234375,
            "end_logit": 7.91015625,
            "text": "e",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": -5.828125,
            "end_logit": 7.91015625,
            "text": "hape",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.24609375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.5390625,
            "text": "GBshape: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.7578125,
            "text": "GBshape:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.0078125,
            "text": "GBshape: a genome browser database for DNA shape annotations.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.0234375,
            "text": "GBshape: a genome browser database for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.09375,
            "text": "GBshape: a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.1015625,
            "text": "GBshape: a genome browser database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -7.5390625,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -7.7578125,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -8.0078125,
            "text": "e: a genome browser database for DNA shape annotations.",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -8.0234375,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -8.09375,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -8.1015625,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": -7.24609375,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": -7.5390625,
            "text": "hape: a",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": -7.7578125,
            "text": "hape:",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_13": [
        {
            "start_logit": 7.92578125,
            "end_logit": 8.015625,
            "text": "GBshape",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0234375,
            "text": "GBshape",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.015625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.91748046875,
            "text": "GBs",
            "probability": 4.4286251068115234e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.91748046875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 4.392862319946289e-05
        },
        {
            "start_logit": -1.0625,
            "end_logit": 8.015625,
            "text": "e",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.0234375,
            "text": "e",
            "probability": 3.814697265625e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.015625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.7550926208496094e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.2802734375,
            "text": "GBs",
            "probability": 3.039836883544922e-05
        },
        {
            "start_logit": -4.44921875,
            "end_logit": 8.0234375,
            "text": "hape",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.44921875,
            "end_logit": 8.015625,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.84375,
            "end_logit": 8.015625,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.0078125,
            "end_logit": 8.0234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 8.0234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.05859375,
            "end_logit": 8.015625,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 8.015625,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.3125,
            "text": "GBshape;",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 8.015625,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 8.015625,
            "text": "hslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.0,
            "text": "GBshape/",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_14": [
        {
            "start_logit": 7.92578125,
            "end_logit": 8.015625,
            "text": "GBshape",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0234375,
            "text": "GBshape",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.015625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.91748046875,
            "text": "GBs",
            "probability": 4.4286251068115234e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.91748046875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 4.392862319946289e-05
        },
        {
            "start_logit": -1.0625,
            "end_logit": 8.015625,
            "text": "e",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.0234375,
            "text": "e",
            "probability": 3.814697265625e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.015625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.7550926208496094e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.2802734375,
            "text": "GBs",
            "probability": 3.039836883544922e-05
        },
        {
            "start_logit": -4.44921875,
            "end_logit": 8.0234375,
            "text": "hape",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.44921875,
            "end_logit": 8.015625,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.84375,
            "end_logit": 8.015625,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.0078125,
            "end_logit": 8.0234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 8.0234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.05859375,
            "end_logit": 8.015625,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 8.015625,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.3125,
            "text": "GBshape;",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 8.015625,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 8.015625,
            "text": "hslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.0,
            "text": "GBshape/",
            "probability": 1.1920928955078125e-07
        }
    ],
    "53262cdcd6d3ac6a34000003_1": [
        {
            "start_logit": 0.6005859375,
            "end_logit": 0.18701171875,
            "text": "epidural blood patch.",
            "probability": 0.71484375
        },
        {
            "start_logit": 0.6005859375,
            "end_logit": -0.763671875,
            "text": "epidural blood patch",
            "probability": 0.2763671875
        },
        {
            "start_logit": -4.984375,
            "end_logit": 0.18701171875,
            "text": "CSF leak using an epidural blood patch.",
            "probability": 0.002681732177734375
        },
        {
            "start_logit": 0.6005859375,
            "end_logit": -6.0,
            "text": "epidural blood",
            "probability": 0.001468658447265625
        },
        {
            "start_logit": -4.984375,
            "end_logit": -0.763671875,
            "text": "CSF leak using an epidural blood patch",
            "probability": 0.001033782958984375
        },
        {
            "start_logit": -5.984375,
            "end_logit": 0.18701171875,
            "text": ".",
            "probability": 0.0009870529174804688
        },
        {
            "start_logit": 0.6005859375,
            "end_logit": -6.80859375,
            "text": "epidural",
            "probability": 0.0006546974182128906
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 0.18701171875,
            "text": "treated for CSF leak using an epidural blood patch.",
            "probability": 0.0003190040588378906
        },
        {
            "start_logit": -7.296875,
            "end_logit": 0.18701171875,
            "text": "she was treated for CSF leak using an epidural blood patch.",
            "probability": 0.00026535987854003906
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 0.18701171875,
            "text": "blood patch.",
            "probability": 0.00020503997802734375
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 0.18701171875,
            "text": "was treated for CSF leak using an epidural blood patch.",
            "probability": 0.0001882314682006836
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 0.18701171875,
            "text": "an epidural blood patch.",
            "probability": 0.00014209747314453125
        },
        {
            "start_logit": -7.9375,
            "end_logit": 0.18701171875,
            "text": "patch.",
            "probability": 0.0001398324966430664
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -0.763671875,
            "text": "treated for CSF leak using an epidural blood patch",
            "probability": 0.00012350082397460938
        },
        {
            "start_logit": -7.296875,
            "end_logit": -0.763671875,
            "text": "she was treated for CSF leak using an epidural blood patch",
            "probability": 0.0001024007797241211
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -0.763671875,
            "text": "blood patch",
            "probability": 7.909536361694336e-05
        },
        {
            "start_logit": -4.984375,
            "end_logit": -3.416015625,
            "text": "CSF leak",
            "probability": 7.31348991394043e-05
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -0.763671875,
            "text": "was treated for CSF leak using an epidural blood patch",
            "probability": 7.259845733642578e-05
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -0.763671875,
            "text": "an epidural blood patch",
            "probability": 5.4836273193359375e-05
        },
        {
            "start_logit": -7.9375,
            "end_logit": -0.763671875,
            "text": "patch",
            "probability": 5.3942203521728516e-05
        }
    ],
    "53262cdcd6d3ac6a34000003_2": [
        {
            "start_logit": 6.31640625,
            "end_logit": -1.8193359375,
            "text": "Epidural blood patch",
            "probability": 0.50244140625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -2.3046875,
            "text": "Epidural",
            "probability": 0.3095703125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -3.341796875,
            "text": "Epidural blood patching",
            "probability": 0.1097412109375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -4.80078125,
            "text": "Epidural blood patching may be necessary to seal the leak - CT fluoroscopy may be helpful in delivering the patch directly to the site of the leak",
            "probability": 0.0255126953125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -5.62890625,
            "text": "Epidural blood patching may be necessary to seal the leak",
            "probability": 0.01114654541015625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -5.65625,
            "text": "Epidural blood",
            "probability": 0.01084136962890625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -5.8359375,
            "text": "Epidural blood patching may be necessary to seal the leak - CT fluoroscopy may be helpful in delivering the patch",
            "probability": 0.009063720703125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.59375,
            "text": "Epidural blood patching may be necessary to seal the leak - CT fluoroscopy",
            "probability": 0.004245758056640625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.03125,
            "text": "Epidural blood patching may",
            "probability": 0.0027408599853515625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.08203125,
            "text": "Epidural blood patching may be necessary to seal the leak - CT fluoroscopy may be helpful in delivering the patch directly to the site of the",
            "probability": 0.0026073455810546875
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.4453125,
            "text": "Epidural blood patching may be necessary to seal the leak - CT fluoroscopy may be helpful in delivering the patch directly to the",
            "probability": 0.001811981201171875
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.46484375,
            "text": "Epidural blood patching may be necessary to seal the leak - CT",
            "probability": 0.0017766952514648438
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.5,
            "text": "Epidural blood patching may be necessary to seal the leak - CT fluoroscopy may be helpful in delivering the",
            "probability": 0.0017156600952148438
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.71875,
            "text": "Epidural blood patching may be necessary to seal the leak -",
            "probability": 0.0013790130615234375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.765625,
            "text": "Epidural blood patching may be necessary to seal the leak - CT fluoroscopy may be helpful in delivering the patch directly to the site of",
            "probability": 0.001316070556640625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.7734375,
            "text": "Epidural blood patching may be necessary to seal the",
            "probability": 0.0013055801391601562
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.7734375,
            "text": "Epidural blood patching may be necessary",
            "probability": 0.0013055801391601562
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.81640625,
            "text": "Epidural blood patching may be necessary to seal",
            "probability": 0.0012502670288085938
        },
        {
            "start_logit": -6.93359375,
            "end_logit": -1.8193359375,
            "text": "patch",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.2734375,
            "end_logit": -4.80078125,
            "text": "CT fluoroscopy may be helpful in delivering the patch directly to the site of the leak",
            "probability": 2.384185791015625e-07
        }
    ],
    "53262cdcd6d3ac6a34000003_3": [
        {
            "start_logit": 5.046875,
            "end_logit": 5.69921875,
            "text": "epidural blood patch",
            "probability": 0.9990234375
        },
        {
            "start_logit": -3.25,
            "end_logit": 5.69921875,
            "text": "invasive measures with epidural blood patch",
            "probability": 0.0002491474151611328
        },
        {
            "start_logit": 5.046875,
            "end_logit": -3.1015625,
            "text": "epidural",
            "probability": 0.0001499652862548828
        },
        {
            "start_logit": -4.6171875,
            "end_logit": 5.69921875,
            "text": "patch",
            "probability": 6.29425048828125e-05
        },
        {
            "start_logit": 5.046875,
            "end_logit": -4.671875,
            "text": "epidural blood patch providing the cornerstone of the invasive measures",
            "probability": 3.1113624572753906e-05
        },
        {
            "start_logit": 5.046875,
            "end_logit": -5.88671875,
            "text": "epidural blood patch providing the cornerstone of the invasive",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": 5.046875,
            "end_logit": -6.01953125,
            "text": "epidural blood",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 5.69921875,
            "text": "blood patch",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 5.69921875,
            "text": "measures with epidural blood patch",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 5.046875,
            "end_logit": -7.1171875,
            "text": "epidural blood patch providing",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 5.69921875,
            "text": "with epidural blood patch",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 5.046875,
            "end_logit": -7.671875,
            "text": "epidural blood patch providing the cornerstone",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 5.046875,
            "end_logit": -7.7109375,
            "text": "epidural blood patch providing the",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 5.046875,
            "end_logit": -8.0625,
            "text": "epidural blood patch providing the cornerstone of the",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.046875,
            "end_logit": -8.1484375,
            "text": "epidural blood patch providing the cornerstone of",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -3.25,
            "end_logit": -3.1015625,
            "text": "invasive measures with epidural",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.25,
            "end_logit": -3.408203125,
            "text": "invasive measures",
            "probability": 0.0
        },
        {
            "start_logit": -3.25,
            "end_logit": -4.671875,
            "text": "invasive measures with epidural blood patch providing the cornerstone of the invasive measures",
            "probability": 0.0
        },
        {
            "start_logit": -3.25,
            "end_logit": -5.78125,
            "text": "invasive",
            "probability": 0.0
        },
        {
            "start_logit": -3.25,
            "end_logit": -5.88671875,
            "text": "invasive measures with epidural blood patch providing the cornerstone of the invasive",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_4": [
        {
            "start_logit": 6.58203125,
            "end_logit": 2.037109375,
            "text": "epidural blood patch",
            "probability": 0.93017578125
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -0.6103515625,
            "text": "epidural",
            "probability": 0.06610107421875
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -3.482421875,
            "text": "epidural blood",
            "probability": 0.003742218017578125
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.59765625,
            "text": "epidural blood patch should be performed",
            "probability": 6.097555160522461e-05
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 2.037109375,
            "text": "needle puncture, epidural blood patch",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.125,
            "end_logit": 2.037109375,
            "text": "gauge needle puncture, epidural blood patch",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.265625,
            "end_logit": 2.037109375,
            "text": ", epidural blood patch",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 2.037109375,
            "text": "patch",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 2.037109375,
            "text": "blood patch",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 2.037109375,
            "text": "-gauge needle puncture, epidural blood patch",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -0.6103515625,
            "text": "needle puncture, epidural",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": -0.6103515625,
            "text": "gauge needle puncture, epidural",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.265625,
            "end_logit": -0.6103515625,
            "text": ", epidural",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -0.6103515625,
            "text": "-gauge needle puncture, epidural",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -3.482421875,
            "text": "needle puncture, epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.125,
            "end_logit": -3.482421875,
            "text": "gauge needle puncture, epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -3.482421875,
            "text": ", epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -3.482421875,
            "text": "blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -3.482421875,
            "text": "-gauge needle puncture, epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -6.46484375,
            "text": "needle puncture",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_5": [
        {
            "start_logit": 7.0,
            "end_logit": 5.84765625,
            "text": "acupuncture",
            "probability": 1.0
        },
        {
            "start_logit": 7.0,
            "end_logit": -6.08203125,
            "text": "acupuncture rather than an epidural blood patch.",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 7.0,
            "end_logit": -6.7890625,
            "text": "acupuncture rather than",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 7.0,
            "end_logit": -7.2578125,
            "text": "acupuncture rather than an epidural",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 7.0,
            "end_logit": -7.54296875,
            "text": "acupuncture rather than an",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.0,
            "end_logit": -7.55078125,
            "text": "acupuncture rather than an epidural blood patch",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.0,
            "end_logit": -7.61328125,
            "text": "acupuncture rather",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 7.0,
            "end_logit": -7.76171875,
            "text": "acupuncture rather than an epidural blood",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 5.84765625,
            "text": "parturients were successfully managed using acupuncture",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 5.84765625,
            "text": "Both parturients were successfully managed using acupuncture",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 5.84765625,
            "text": "using acupuncture",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 5.84765625,
            "text": "urients were successfully managed using acupuncture",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 5.84765625,
            "text": "managed using acupuncture",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 5.84765625,
            "text": "successfully managed using acupuncture",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 5.84765625,
            "text": "ients were successfully managed using acupuncture",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -6.08203125,
            "text": "parturients were successfully managed using acupuncture rather than an epidural blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.08203125,
            "text": "epidural blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.08203125,
            "text": "Both parturients were successfully managed using acupuncture rather than an epidural blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -6.08203125,
            "text": "blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -6.08203125,
            "text": "using acupuncture rather than an epidural blood patch.",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_6": [
        {
            "start_logit": 1.0263671875,
            "end_logit": 0.72265625,
            "text": "epidural blood patch",
            "probability": 0.97705078125
        },
        {
            "start_logit": -3.095703125,
            "end_logit": 0.72265625,
            "text": "shunt placement alleviated by an epidural blood patch",
            "probability": 0.0158538818359375
        },
        {
            "start_logit": -3.095703125,
            "end_logit": -1.3486328125,
            "text": "shunt placement",
            "probability": 0.0019931793212890625
        },
        {
            "start_logit": 1.0263671875,
            "end_logit": -5.90625,
            "text": "epidural blood patch.",
            "probability": 0.0012912750244140625
        },
        {
            "start_logit": 1.0263671875,
            "end_logit": -6.5625,
            "text": "epidural blood",
            "probability": 0.0006699562072753906
        },
        {
            "start_logit": -6.265625,
            "end_logit": 0.72265625,
            "text": "LP shunt placement alleviated by an epidural blood patch",
            "probability": 0.0006647109985351562
        },
        {
            "start_logit": 1.0263671875,
            "end_logit": -6.578125,
            "text": "epidural",
            "probability": 0.000659942626953125
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 0.72265625,
            "text": "blood patch",
            "probability": 0.00044798851013183594
        },
        {
            "start_logit": -7.296875,
            "end_logit": 0.72265625,
            "text": "after LP shunt placement alleviated by an epidural blood patch",
            "probability": 0.00023794174194335938
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 0.72265625,
            "text": "an epidural blood patch",
            "probability": 0.00018095970153808594
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 0.72265625,
            "text": "patch",
            "probability": 0.00013887882232666016
        },
        {
            "start_logit": -3.095703125,
            "end_logit": -4.0390625,
            "text": "shunt",
            "probability": 0.00013554096221923828
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 0.72265625,
            "text": "headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 0.00013136863708496094
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 0.72265625,
            "text": "by an epidural blood patch",
            "probability": 0.0001283884048461914
        },
        {
            "start_logit": -8.0625,
            "end_logit": 0.72265625,
            "text": "girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 0.000110626220703125
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 0.72265625,
            "text": "low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 0.00010639429092407227
        },
        {
            "start_logit": -6.265625,
            "end_logit": -1.3486328125,
            "text": "LP shunt placement",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": -7.296875,
            "end_logit": -1.3486328125,
            "text": "after LP shunt placement",
            "probability": 2.9742717742919922e-05
        },
        {
            "start_logit": -3.095703125,
            "end_logit": -5.90625,
            "text": "shunt placement alleviated by an epidural blood patch.",
            "probability": 2.09808349609375e-05
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -1.3486328125,
            "text": "headache after LP shunt placement",
            "probability": 1.6570091247558594e-05
        }
    ],
    "53262cdcd6d3ac6a34000003_7": [
        {
            "start_logit": 7.36328125,
            "end_logit": 4.41015625,
            "text": "epidural blood patch",
            "probability": 0.98193359375
        },
        {
            "start_logit": 7.36328125,
            "end_logit": 0.4091796875,
            "text": "epidural",
            "probability": 0.017974853515625
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -5.1171875,
            "text": "epidural blood",
            "probability": 7.12275505065918e-05
        },
        {
            "start_logit": -6.140625,
            "end_logit": 4.41015625,
            "text": "patch",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.59375,
            "end_logit": 4.41015625,
            "text": "needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 4.41015625,
            "text": "dural puncture) epidural blood patch",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 4.41015625,
            "text": "blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 4.41015625,
            "text": "gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 4.41015625,
            "text": "48 h of dural puncture) epidural blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 0.4091796875,
            "text": "needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 0.4091796875,
            "text": "dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 0.4091796875,
            "text": "gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 0.4091796875,
            "text": "48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -5.1171875,
            "text": "needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -5.1171875,
            "text": "dural puncture) epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -5.1171875,
            "text": "blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -5.1171875,
            "text": "gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -5.1171875,
            "text": "48 h of dural puncture) epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -6.65625,
            "text": "needle puncture), patients should be offered early (within 24-48 h of dural",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -6.65625,
            "text": "dural",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_8": [
        {
            "start_logit": 2.2265625,
            "end_logit": 2.033203125,
            "text": "dural puncture and a blood patch",
            "probability": 0.9970703125
        },
        {
            "start_logit": 2.2265625,
            "end_logit": -5.0078125,
            "text": "dural puncture and",
            "probability": 0.0008745193481445312
        },
        {
            "start_logit": 2.2265625,
            "end_logit": -5.15234375,
            "text": "dural puncture",
            "probability": 0.0007567405700683594
        },
        {
            "start_logit": -5.46875,
            "end_logit": 2.033203125,
            "text": "blood patch",
            "probability": 0.0004534721374511719
        },
        {
            "start_logit": 2.2265625,
            "end_logit": -6.390625,
            "text": "dural puncture and a blood",
            "probability": 0.00021946430206298828
        },
        {
            "start_logit": 2.2265625,
            "end_logit": -6.64453125,
            "text": "dural",
            "probability": 0.00017082691192626953
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 2.033203125,
            "text": "following dural puncture and a blood patch",
            "probability": 7.82012939453125e-05
        },
        {
            "start_logit": 2.2265625,
            "end_logit": -7.61328125,
            "text": "dural puncture and a",
            "probability": 6.4849853515625e-05
        },
        {
            "start_logit": -7.421875,
            "end_logit": 2.033203125,
            "text": "puncture and a blood patch",
            "probability": 6.437301635742188e-05
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 2.033203125,
            "text": "patch",
            "probability": 5.501508712768555e-05
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 2.033203125,
            "text": "MRI in a patient with presumed low-pressure headache following dural puncture and a blood patch",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 2.033203125,
            "text": "intracranial pachymeninges, revealed by MRI in a patient with presumed low-pressure headache following dural puncture and a blood patch",
            "probability": 4.780292510986328e-05
        },
        {
            "start_logit": -7.921875,
            "end_logit": 2.033203125,
            "text": "headache following dural puncture and a blood patch",
            "probability": 3.904104232788086e-05
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 2.033203125,
            "text": "a blood patch",
            "probability": 3.522634506225586e-05
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 2.033203125,
            "text": "low-pressure headache following dural puncture and a blood patch",
            "probability": 3.361701965332031e-05
        },
        {
            "start_logit": -5.46875,
            "end_logit": -6.390625,
            "text": "blood",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -5.0078125,
            "text": "following dural puncture and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -5.15234375,
            "text": "following dural puncture",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": -5.0078125,
            "text": "puncture and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": -5.15234375,
            "text": "puncture",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5b268986df2b9174000019_1": [
        {
            "start_logit": 7.80078125,
            "end_logit": 7.74609375,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -2.130859375,
            "text": "DSM",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": -2.185546875,
            "end_logit": 7.74609375,
            "text": "NC",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.359375,
            "text": "DSMNC: a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.57421875,
            "text": "DSMNC: a database of somatic mutations in normal cells.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.78515625,
            "text": "DSMNC:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.8203125,
            "text": "DSMNC: a database",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.953125,
            "text": "DSMNC: a database of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -8.0390625,
            "text": "DSMNC: a database of somatic mutations in normal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -8.0703125,
            "text": "DSMNC: a database of somatic mutations in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -8.1171875,
            "text": "DSMNC: a database of somatic mutations in normal cells",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -7.359375,
            "text": "NC: a",
            "probability": 0.0
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -7.57421875,
            "text": "NC: a database of somatic mutations in normal cells.",
            "probability": 0.0
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -7.78515625,
            "text": "NC:",
            "probability": 0.0
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -7.8203125,
            "text": "NC: a database",
            "probability": 0.0
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -7.953125,
            "text": "NC: a database of",
            "probability": 0.0
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -8.0390625,
            "text": "NC: a database of somatic mutations in normal",
            "probability": 0.0
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -8.0703125,
            "text": "NC: a database of somatic mutations in",
            "probability": 0.0
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -8.1171875,
            "text": "NC: a database of somatic mutations in normal cells",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -7.57421875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_2": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.91015625,
            "text": "DSMNC",
            "probability": 0.228515625
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 7.8984375,
            "text": "DSMNC",
            "probability": 0.2232666015625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 7.89453125,
            "text": "DSMNC",
            "probability": 0.2232666015625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 7.828125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.2081298828125
        },
        {
            "start_logit": 7.33203125,
            "end_logit": 7.828125,
            "text": "dsmnc",
            "probability": 0.1158447265625
        },
        {
            "start_logit": -0.0947265625,
            "end_logit": 7.89453125,
            "text": "established DSMNC",
            "probability": 7.432699203491211e-05
        },
        {
            "start_logit": -0.0947265625,
            "end_logit": 7.828125,
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 6.92605972290039e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.93310546875,
            "text": "DSM",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.9521484375,
            "text": "DSM",
            "probability": 3.248453140258789e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.111328125,
            "text": "DSM",
            "probability": 2.7358531951904297e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.2099609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -1.2333984375,
            "end_logit": 7.91015625,
            "text": "NC",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 7.828125,
            "text": "nc",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": -1.2490234375,
            "end_logit": 7.8984375,
            "text": "NC",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": 7.89453125,
            "text": "NC",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": 7.828125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 7.33203125,
            "end_logit": -1.2099609375,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -2.63671875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": 7.33203125,
            "end_logit": -2.63671875,
            "text": "dsm",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.3515625,
            "end_logit": 7.8984375,
            "text": ", DSMNC",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5c5b268986df2b9174000019_3": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.91015625,
            "text": "DSMNC",
            "probability": 0.228515625
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 7.8984375,
            "text": "DSMNC",
            "probability": 0.2232666015625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 7.89453125,
            "text": "DSMNC",
            "probability": 0.2232666015625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 7.828125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.2081298828125
        },
        {
            "start_logit": 7.33203125,
            "end_logit": 7.828125,
            "text": "dsmnc",
            "probability": 0.1158447265625
        },
        {
            "start_logit": -0.0947265625,
            "end_logit": 7.89453125,
            "text": "established DSMNC",
            "probability": 7.432699203491211e-05
        },
        {
            "start_logit": -0.0947265625,
            "end_logit": 7.828125,
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 6.92605972290039e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.93310546875,
            "text": "DSM",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.9521484375,
            "text": "DSM",
            "probability": 3.248453140258789e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.111328125,
            "text": "DSM",
            "probability": 2.7358531951904297e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.2099609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -1.2333984375,
            "end_logit": 7.91015625,
            "text": "NC",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 7.828125,
            "text": "nc",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": -1.2490234375,
            "end_logit": 7.8984375,
            "text": "NC",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": 7.89453125,
            "text": "NC",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": 7.828125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 7.33203125,
            "end_logit": -1.2099609375,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -2.63671875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": 7.33203125,
            "end_logit": -2.63671875,
            "text": "dsm",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.3515625,
            "end_logit": 7.8984375,
            "text": ", DSMNC",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5c5b268986df2b9174000019_4": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.91015625,
            "text": "DSMNC",
            "probability": 0.228515625
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 7.8984375,
            "text": "DSMNC",
            "probability": 0.2232666015625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 7.89453125,
            "text": "DSMNC",
            "probability": 0.2232666015625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 7.828125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.2081298828125
        },
        {
            "start_logit": 7.33203125,
            "end_logit": 7.828125,
            "text": "dsmnc",
            "probability": 0.1158447265625
        },
        {
            "start_logit": -0.0947265625,
            "end_logit": 7.89453125,
            "text": "established DSMNC",
            "probability": 7.432699203491211e-05
        },
        {
            "start_logit": -0.0947265625,
            "end_logit": 7.828125,
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 6.92605972290039e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.93310546875,
            "text": "DSM",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.9521484375,
            "text": "DSM",
            "probability": 3.248453140258789e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.111328125,
            "text": "DSM",
            "probability": 2.7358531951904297e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.2099609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -1.2333984375,
            "end_logit": 7.91015625,
            "text": "NC",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 7.828125,
            "text": "nc",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": -1.2490234375,
            "end_logit": 7.8984375,
            "text": "NC",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": 7.89453125,
            "text": "NC",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": 7.828125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 7.33203125,
            "end_logit": -1.2099609375,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -2.63671875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": 7.33203125,
            "end_logit": -2.63671875,
            "text": "dsm",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.3515625,
            "end_logit": 7.8984375,
            "text": ", DSMNC",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5c5b268986df2b9174000019_5": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.91015625,
            "text": "DSMNC",
            "probability": 0.228515625
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 7.8984375,
            "text": "DSMNC",
            "probability": 0.2232666015625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 7.89453125,
            "text": "DSMNC",
            "probability": 0.2232666015625
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 7.828125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.2081298828125
        },
        {
            "start_logit": 7.33203125,
            "end_logit": 7.828125,
            "text": "dsmnc",
            "probability": 0.1158447265625
        },
        {
            "start_logit": -0.0947265625,
            "end_logit": 7.89453125,
            "text": "established DSMNC",
            "probability": 7.432699203491211e-05
        },
        {
            "start_logit": -0.0947265625,
            "end_logit": 7.828125,
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 6.92605972290039e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.93310546875,
            "text": "DSM",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.9521484375,
            "text": "DSM",
            "probability": 3.248453140258789e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.111328125,
            "text": "DSM",
            "probability": 2.7358531951904297e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.2099609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -1.2333984375,
            "end_logit": 7.91015625,
            "text": "NC",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 7.828125,
            "text": "nc",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": -1.2490234375,
            "end_logit": 7.8984375,
            "text": "NC",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": 7.89453125,
            "text": "NC",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": -1.3466796875,
            "end_logit": 7.828125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 7.33203125,
            "end_logit": -1.2099609375,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -2.63671875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": 7.33203125,
            "end_logit": -2.63671875,
            "text": "dsm",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.3515625,
            "end_logit": 7.8984375,
            "text": ", DSMNC",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5c5b268986df2b9174000019_6": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.8125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.3359375
        },
        {
            "start_logit": 7.84375,
            "end_logit": 7.8046875,
            "text": "DSMNC",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.828125,
            "end_logit": 7.8125,
            "text": "dsmnc",
            "probability": 0.330810546875
        },
        {
            "start_logit": -1.3515625,
            "end_logit": 7.8125,
            "text": "nc",
            "probability": 3.409385681152344e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.4931640625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": 7.828125,
            "end_logit": -1.4931640625,
            "text": "dsm",
            "probability": 3.0100345611572266e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.724609375,
            "text": "DSM",
            "probability": 2.4199485778808594e-05
        },
        {
            "start_logit": -1.9443359375,
            "end_logit": 7.8125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": -1.9443359375,
            "end_logit": 7.8046875,
            "text": "NC",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -6.40234375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -6.40234375,
            "text": "dsmnc.big.ac.cn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 7.8125,
            "text": "http://dsmnc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.8125,
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.8046875,
            "text": "established DSMNC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.12109375,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.32421875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.31640625,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.32421875,
            "text": "dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.8125,
            "text": "/dsmnc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.8125,
            "text": "://dsmnc",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5b268986df2b9174000019_7": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.8125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.3359375
        },
        {
            "start_logit": 7.84375,
            "end_logit": 7.8046875,
            "text": "DSMNC",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.828125,
            "end_logit": 7.8125,
            "text": "dsmnc",
            "probability": 0.330810546875
        },
        {
            "start_logit": -1.3515625,
            "end_logit": 7.8125,
            "text": "nc",
            "probability": 3.409385681152344e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.4931640625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": 7.828125,
            "end_logit": -1.4931640625,
            "text": "dsm",
            "probability": 3.0100345611572266e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.724609375,
            "text": "DSM",
            "probability": 2.4199485778808594e-05
        },
        {
            "start_logit": -1.9443359375,
            "end_logit": 7.8125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": -1.9443359375,
            "end_logit": 7.8046875,
            "text": "NC",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -6.40234375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -6.40234375,
            "text": "dsmnc.big.ac.cn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 7.8125,
            "text": "http://dsmnc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.8125,
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.8046875,
            "text": "established DSMNC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.12109375,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.32421875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.31640625,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.32421875,
            "text": "dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.8125,
            "text": "/dsmnc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.8125,
            "text": "://dsmnc",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5b268986df2b9174000019_8": [
        {
            "start_logit": 7.78515625,
            "end_logit": 7.75,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -2.150390625,
            "text": "DSM",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": -2.1328125,
            "end_logit": 7.75,
            "text": "NC",
            "probability": 4.947185516357422e-05
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.03515625,
            "text": "DSMNC: a database of somatic mutations in normal cells.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.28125,
            "text": "DSMNC: a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.44921875,
            "text": "DSMNC:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.5703125,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.58984375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.6328125,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.64453125,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.6640625,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.6796875,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.734375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.734375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.1328125,
            "end_logit": -7.03515625,
            "text": "NC: a database of somatic mutations in normal cells.",
            "probability": 0.0
        },
        {
            "start_logit": -2.1328125,
            "end_logit": -7.28125,
            "text": "NC: a",
            "probability": 0.0
        },
        {
            "start_logit": -2.1328125,
            "end_logit": -7.44921875,
            "text": "NC:",
            "probability": 0.0
        },
        {
            "start_logit": -2.1328125,
            "end_logit": -7.5703125,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line",
            "probability": 0.0
        },
        {
            "start_logit": -2.1328125,
            "end_logit": -7.58984375,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin,",
            "probability": 0.0
        },
        {
            "start_logit": -2.1328125,
            "end_logit": -7.6328125,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations,",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_9": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.8125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.3359375
        },
        {
            "start_logit": 7.84375,
            "end_logit": 7.8046875,
            "text": "DSMNC",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.828125,
            "end_logit": 7.8125,
            "text": "dsmnc",
            "probability": 0.330810546875
        },
        {
            "start_logit": -1.3515625,
            "end_logit": 7.8125,
            "text": "nc",
            "probability": 3.409385681152344e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.4931640625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": 7.828125,
            "end_logit": -1.4931640625,
            "text": "dsm",
            "probability": 3.0100345611572266e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.724609375,
            "text": "DSM",
            "probability": 2.4199485778808594e-05
        },
        {
            "start_logit": -1.9443359375,
            "end_logit": 7.8125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": -1.9443359375,
            "end_logit": 7.8046875,
            "text": "NC",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -6.40234375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -6.40234375,
            "text": "dsmnc.big.ac.cn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 7.8125,
            "text": "http://dsmnc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.8125,
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.8046875,
            "text": "established DSMNC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.12109375,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.32421875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.31640625,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.32421875,
            "text": "dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.8125,
            "text": "/dsmnc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.8125,
            "text": "://dsmnc",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5b268986df2b9174000019_10": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.8125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.3359375
        },
        {
            "start_logit": 7.84375,
            "end_logit": 7.8046875,
            "text": "DSMNC",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.828125,
            "end_logit": 7.8125,
            "text": "dsmnc",
            "probability": 0.330810546875
        },
        {
            "start_logit": -1.3515625,
            "end_logit": 7.8125,
            "text": "nc",
            "probability": 3.409385681152344e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.4931640625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": 7.828125,
            "end_logit": -1.4931640625,
            "text": "dsm",
            "probability": 3.0100345611572266e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.724609375,
            "text": "DSM",
            "probability": 2.4199485778808594e-05
        },
        {
            "start_logit": -1.9443359375,
            "end_logit": 7.8125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": -1.9443359375,
            "end_logit": 7.8046875,
            "text": "NC",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -6.40234375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -6.40234375,
            "text": "dsmnc.big.ac.cn",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 7.8125,
            "text": "http://dsmnc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.8125,
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.8046875,
            "text": "established DSMNC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.12109375,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.32421875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.31640625,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.32421875,
            "text": "dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.8125,
            "text": "/dsmnc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.8125,
            "text": "://dsmnc",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e5b8b4e752ebcdc7a000001_1": [
        {
            "start_logit": -0.791015625,
            "end_logit": -1.2158203125,
            "text": "heterotopic ossification",
            "probability": 0.658203125
        },
        {
            "start_logit": -1.490234375,
            "end_logit": -1.2158203125,
            "text": "congenital heterotopic ossification",
            "probability": 0.3271484375
        },
        {
            "start_logit": -0.791015625,
            "end_logit": -7.36328125,
            "text": "heterotopic ossification (HO) syndrome",
            "probability": 0.0014057159423828125
        },
        {
            "start_logit": -1.490234375,
            "end_logit": -6.7421875,
            "text": "congenital",
            "probability": 0.001300811767578125
        },
        {
            "start_logit": -0.791015625,
            "end_logit": -7.62109375,
            "text": "heterotopic ossification (",
            "probability": 0.0010862350463867188
        },
        {
            "start_logit": -0.791015625,
            "end_logit": -7.63671875,
            "text": "heterotopic ossification (HO) syndrome caused by gain-of-function mutations of bone morphogenetic protein (BMP) type I receptor ACVR1",
            "probability": 0.0010700225830078125
        },
        {
            "start_logit": -0.791015625,
            "end_logit": -7.63671875,
            "text": "heterotopic ossification (HO) syndrome caused by gain-of-function mutations of bone morphogenetic protein (BMP",
            "probability": 0.0010700225830078125
        },
        {
            "start_logit": -0.791015625,
            "end_logit": -7.734375,
            "text": "heterotopic ossification (HO",
            "probability": 0.0009741783142089844
        },
        {
            "start_logit": -0.791015625,
            "end_logit": -7.78515625,
            "text": "heterotopic ossification (HO)",
            "probability": 0.0009217262268066406
        },
        {
            "start_logit": -0.791015625,
            "end_logit": -7.82421875,
            "text": "heterotopic ossification (HO) syndrome caused by gain-of-function mutations of bone morphogenetic protein (BMP) type I",
            "probability": 0.0008869171142578125
        },
        {
            "start_logit": -0.791015625,
            "end_logit": -7.8359375,
            "text": "heterotopic ossification (HO) syndrome caused by gain-of-function mutations of bone morphogenetic protein (BMP) type I receptor ACVR",
            "probability": 0.0008797645568847656
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -1.2158203125,
            "text": "a congenital heterotopic ossification",
            "probability": 0.0008077621459960938
        },
        {
            "start_logit": -1.490234375,
            "end_logit": -7.36328125,
            "text": "congenital heterotopic ossification (HO) syndrome",
            "probability": 0.000701904296875
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -1.2158203125,
            "text": "), a congenital heterotopic ossification",
            "probability": 0.0006093978881835938
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -1.2158203125,
            "text": "FOP), a congenital heterotopic ossification",
            "probability": 0.0005726814270019531
        },
        {
            "start_logit": -1.490234375,
            "end_logit": -7.62109375,
            "text": "congenital heterotopic ossification (",
            "probability": 0.0005421638488769531
        },
        {
            "start_logit": -1.490234375,
            "end_logit": -7.63671875,
            "text": "congenital heterotopic ossification (HO) syndrome caused by gain-of-function mutations of bone morphogenetic protein (BMP) type I receptor ACVR1",
            "probability": 0.0005335807800292969
        },
        {
            "start_logit": -1.490234375,
            "end_logit": -7.63671875,
            "text": "congenital heterotopic ossification (HO) syndrome caused by gain-of-function mutations of bone morphogenetic protein (BMP",
            "probability": 0.0005335807800292969
        },
        {
            "start_logit": -7.921875,
            "end_logit": -1.2158203125,
            "text": "(FOP), a congenital heterotopic ossification",
            "probability": 0.0005254745483398438
        },
        {
            "start_logit": -1.490234375,
            "end_logit": -7.734375,
            "text": "congenital heterotopic ossification (HO",
            "probability": 0.00048232078552246094
        }
    ],
    "5a690487b750ff445500001f_1": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.76171875,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.62109375,
            "text": "Epstein",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": -2.3203125,
            "end_logit": 7.76171875,
            "text": "virus",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -5.1171875,
            "text": "Epstein-Barr virus (EBV",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -5.22265625,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 7.76171875,
            "text": "Barr virus",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.26953125,
            "text": "Epstein-Barr",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.546875,
            "text": "Epstein-Barr virus (EBV) is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 7.76171875,
            "text": "-Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.5546875,
            "end_logit": -1.7490234375,
            "text": "EBV",
            "probability": 0.0
        },
        {
            "start_logit": -1.5546875,
            "end_logit": -3.271484375,
            "text": "EBV infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.5546875,
            "end_logit": -5.7421875,
            "text": "EBV infection.",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -5.1171875,
            "text": "virus (EBV",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -5.22265625,
            "text": "virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -6.1484375,
            "end_logit": -1.7490234375,
            "text": "during EBV",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -6.546875,
            "text": "virus (EBV) is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -1.7490234375,
            "text": "which detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -1.7490234375,
            "text": "detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV",
            "probability": 0.0
        },
        {
            "start_logit": -6.1484375,
            "end_logit": -3.271484375,
            "text": "during EBV infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.703125,
            "end_logit": -1.7490234375,
            "text": "cell antibodies produced as part of a polyclonal antibody response occurring during EBV",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_2": [
        {
            "start_logit": 6.8125,
            "end_logit": 6.2265625,
            "text": "cytomegalovirus",
            "probability": 0.9697265625
        },
        {
            "start_logit": 2.22265625,
            "end_logit": 6.43359375,
            "text": "Epstein-Barr virus",
            "probability": 0.01210784912109375
        },
        {
            "start_logit": 2.22265625,
            "end_logit": 6.2265625,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 0.0098876953125
        },
        {
            "start_logit": 2.22265625,
            "end_logit": 5.45703125,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 0.0045623779296875
        },
        {
            "start_logit": 0.63818359375,
            "end_logit": 6.2265625,
            "text": "Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 0.0020160675048828125
        },
        {
            "start_logit": 0.63818359375,
            "end_logit": 5.45703125,
            "text": "Epstein-Barr virus",
            "probability": 0.0009341239929199219
        },
        {
            "start_logit": 6.8125,
            "end_logit": -1.107421875,
            "text": "cytomegalovirus (CMV) IgM and IgG were positive, suggesting that her mononucleosis-like syndrome was due to acute CMV infection",
            "probability": 0.0006322860717773438
        },
        {
            "start_logit": -3.984375,
            "end_logit": 6.43359375,
            "text": "virus",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -3.984375,
            "end_logit": 6.2265625,
            "text": "virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -4.4765625,
            "end_logit": 6.43359375,
            "text": "Barr virus",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -4.4765625,
            "end_logit": 6.2265625,
            "text": "Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 1.2159347534179688e-05
        },
        {
            "start_logit": -3.984375,
            "end_logit": 5.45703125,
            "text": "virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 6.2265625,
            "text": "virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -5.21875,
            "end_logit": 6.2265625,
            "text": "Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -4.4765625,
            "end_logit": 5.45703125,
            "text": "Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 6.8125,
            "end_logit": -6.01171875,
            "text": "cytomegalovirus (CMV) IgM and IgG were positive",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 5.45703125,
            "text": "virus",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.8125,
            "end_logit": -6.375,
            "text": "cytomegalovirus (CMV)",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 6.8125,
            "end_logit": -6.44140625,
            "text": "cytomegalovirus (CMV",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -5.21875,
            "end_logit": 5.45703125,
            "text": "Barr virus",
            "probability": 2.682209014892578e-06
        }
    ],
    "5a690487b750ff445500001f_3": [
        {
            "start_logit": 6.8125,
            "end_logit": 6.2265625,
            "text": "cytomegalovirus",
            "probability": 0.9697265625
        },
        {
            "start_logit": 2.22265625,
            "end_logit": 6.43359375,
            "text": "Epstein-Barr virus",
            "probability": 0.01210784912109375
        },
        {
            "start_logit": 2.22265625,
            "end_logit": 6.2265625,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 0.0098876953125
        },
        {
            "start_logit": 2.22265625,
            "end_logit": 5.45703125,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 0.0045623779296875
        },
        {
            "start_logit": 0.63818359375,
            "end_logit": 6.2265625,
            "text": "Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 0.0020160675048828125
        },
        {
            "start_logit": 0.63818359375,
            "end_logit": 5.45703125,
            "text": "Epstein-Barr virus",
            "probability": 0.0009341239929199219
        },
        {
            "start_logit": 6.8125,
            "end_logit": -1.107421875,
            "text": "cytomegalovirus (CMV) IgM and IgG were positive, suggesting that her mononucleosis-like syndrome was due to acute CMV infection",
            "probability": 0.0006322860717773438
        },
        {
            "start_logit": -3.984375,
            "end_logit": 6.43359375,
            "text": "virus",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -3.984375,
            "end_logit": 6.2265625,
            "text": "virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -4.4765625,
            "end_logit": 6.43359375,
            "text": "Barr virus",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -4.4765625,
            "end_logit": 6.2265625,
            "text": "Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 1.2159347534179688e-05
        },
        {
            "start_logit": -3.984375,
            "end_logit": 5.45703125,
            "text": "virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 6.2265625,
            "text": "virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -5.21875,
            "end_logit": 6.2265625,
            "text": "Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -4.4765625,
            "end_logit": 5.45703125,
            "text": "Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 6.8125,
            "end_logit": -6.01171875,
            "text": "cytomegalovirus (CMV) IgM and IgG were positive",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 5.45703125,
            "text": "virus",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.8125,
            "end_logit": -6.375,
            "text": "cytomegalovirus (CMV)",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 6.8125,
            "end_logit": -6.44140625,
            "text": "cytomegalovirus (CMV",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -5.21875,
            "end_logit": 5.45703125,
            "text": "Barr virus",
            "probability": 2.682209014892578e-06
        }
    ],
    "5a690487b750ff445500001f_4": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.71875,
            "text": "Epstein-Barr virus infection",
            "probability": 0.83544921875
        },
        {
            "start_logit": 7.94921875,
            "end_logit": 6.09375,
            "text": "Epstein-Barr virus",
            "probability": 0.1644287109375
        },
        {
            "start_logit": -1.3076171875,
            "end_logit": 7.71875,
            "text": "infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.7490234375,
            "text": "Epstein",
            "probability": 6.449222564697266e-05
        },
        {
            "start_logit": -1.984375,
            "end_logit": 7.71875,
            "text": "infection",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": -1.3076171875,
            "end_logit": 6.09375,
            "text": "infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 1.5556812286376953e-05
        },
        {
            "start_logit": -4.140625,
            "end_logit": 7.71875,
            "text": "virus infection",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -5.05078125,
            "end_logit": 7.71875,
            "text": "Barr virus infection",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -5.94921875,
            "text": "Epstein-Barr",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.140625,
            "end_logit": 6.09375,
            "text": "virus",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 7.71875,
            "text": "mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 7.71875,
            "text": ". The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 7.71875,
            "text": "-Barr virus infection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.8671875,
            "text": "Epstein-Barr virus infection.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.05078125,
            "end_logit": 6.09375,
            "text": "Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 7.71875,
            "text": "to Epstein-Barr virus infection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.71875,
            "text": "secondary to Epstein-Barr virus infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.3076171875,
            "end_logit": 1.3779296875,
            "text": "infectious mononucleosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 6.09375,
            "text": "mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 6.09375,
            "text": ". The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a690487b750ff445500001f_5": [
        {
            "start_logit": 7.91015625,
            "end_logit": 7.56640625,
            "text": "Epstein-Barr virus",
            "probability": 0.9951171875
        },
        {
            "start_logit": 4.61328125,
            "end_logit": 5.40234375,
            "text": "infectious mononucleosis",
            "probability": 0.004230499267578125
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -1.9296875,
            "text": "Epstein",
            "probability": 7.450580596923828e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -2.3125,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 5.120038986206055e-05
        },
        {
            "start_logit": -2.767578125,
            "end_logit": 7.56640625,
            "text": "virus",
            "probability": 2.288818359375e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -5.59375,
            "text": "Epstein-Barr",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -5.96484375,
            "text": "Epstein-Barr virus (EBV",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.9609375,
            "end_logit": 7.56640625,
            "text": "Barr virus",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.21875,
            "text": "Epstein-Barr virus (EBV) is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 7.56640625,
            "text": "-Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.44140625,
            "text": "Epstein-Barr virus (EBV) is almost ubiquitous in humans and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.49609375,
            "text": "Epstein-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 7.56640625,
            "text": "Infection with Epstein-Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19140625,
            "end_logit": 5.40234375,
            "text": "osis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 5.40234375,
            "text": "mononucleosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.61328125,
            "end_logit": -6.30859375,
            "text": "infectious mononucleosis (IM) in ~25% cases. The determinants of whether the infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.61328125,
            "end_logit": -6.33984375,
            "text": "infectious",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.61328125,
            "end_logit": -6.9375,
            "text": "infectious mononucle",
            "probability": 0.0
        },
        {
            "start_logit": 4.61328125,
            "end_logit": -7.07421875,
            "text": "infectious mononucleosis (IM) in ~25%",
            "probability": 0.0
        },
        {
            "start_logit": 4.61328125,
            "end_logit": -7.19921875,
            "text": "infectious mononucleosis (IM) in",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_6": [
        {
            "start_logit": 7.9921875,
            "end_logit": 7.9375,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -1.3564453125,
            "text": "Epstein",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": -1.6953125,
            "end_logit": 7.9375,
            "text": "virus",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": -5.375,
            "end_logit": 7.9375,
            "text": "Barr virus",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -5.6328125,
            "text": "Epstein-Barr virus viral load (EBV",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.3046875,
            "end_logit": 7.9375,
            "text": "-Barr virus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -6.48828125,
            "text": "Epstein-Barr",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -6.703125,
            "text": "Epstein-Barr virus viral",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 7.9375,
            "text": "time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.27734375,
            "text": "Epstein-Barr virus viral load (EBV-VL",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.9375,
            "text": "real-time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.41015625,
            "text": "Epstein-Barr virus viral load",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.9375,
            "text": "of Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.7265625,
            "text": "Epstein-Barr virus viral load (EBV-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.80078125,
            "text": "Epstein-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.9375,
            "text": "(RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.9375,
            "text": "measurement of Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 7.9375,
            "text": "-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 7.9375,
            "text": "assays [measurement of Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6953125,
            "end_logit": -5.6328125,
            "text": "virus viral load (EBV",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_7": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.890625,
            "text": "Epstein-Barr virus",
            "probability": 0.607421875
        },
        {
            "start_logit": 7.9296875,
            "end_logit": 7.453125,
            "text": "Epstein-Barr virus-related infectious mononucleosis",
            "probability": 0.39208984375
        },
        {
            "start_logit": 0.51025390625,
            "end_logit": 7.453125,
            "text": "infectious mononucleosis",
            "probability": 0.00023543834686279297
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.818359375,
            "text": "Epstein",
            "probability": 3.6835670471191406e-05
        },
        {
            "start_logit": -1.916015625,
            "end_logit": 7.890625,
            "text": "virus",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -1.916015625,
            "end_logit": 7.453125,
            "text": "virus-related infectious mononucleosis",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -2.671875,
            "end_logit": 7.453125,
            "text": "osis",
            "probability": 9.715557098388672e-06
        },
        {
            "start_logit": -5.3046875,
            "end_logit": 7.890625,
            "text": "Barr virus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -5.3046875,
            "end_logit": 7.453125,
            "text": "Barr virus-related infectious mononucleosis",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -5.7890625,
            "text": "Epstein-Barr",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.484375,
            "end_logit": 7.453125,
            "text": "mononucleosis",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.328125,
            "end_logit": 7.890625,
            "text": "-Barr virus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 7.890625,
            "text": ". Epstein-Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 7.890625,
            "text": ". The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.328125,
            "end_logit": 7.453125,
            "text": "-Barr virus-related infectious mononucleosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 7.453125,
            "text": "related infectious mononucleosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 7.453125,
            "text": ". Epstein-Barr virus-related infectious mononucleosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 7.453125,
            "text": ". The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus-related infectious mononucleosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.890625,
            "text": "positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.421875,
            "text": "Epstein-Barr virus-related infectious mononucleosis was considered the most likely diagnosis for our patient.",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a690487b750ff445500001f_8": [
        {
            "start_logit": 7.76171875,
            "end_logit": 7.01171875,
            "text": "Epstein-Barr virus",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.76171875,
            "end_logit": 0.2344970703125,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis",
            "probability": 0.0011386871337890625
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -2.38671875,
            "text": "Epstein",
            "probability": 8.279085159301758e-05
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -2.77734375,
            "text": "Epstein-Barr virus (EBV",
            "probability": 5.602836608886719e-05
        },
        {
            "start_logit": -3.55859375,
            "end_logit": 7.01171875,
            "text": "virus",
            "probability": 1.2099742889404297e-05
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -4.59375,
            "text": "Epstein-Barr",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -4.86328125,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -5.73828125,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and tested for anti-CMV",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -5.453125,
            "end_logit": 7.01171875,
            "text": "Barr virus",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -6.4140625,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 7.01171875,
            "text": "Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.8125,
            "end_logit": 7.01171875,
            "text": "against Epstein-Barr virus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 7.01171875,
            "text": "-Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.01171875,
            "text": "Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.55859375,
            "end_logit": 0.2344970703125,
            "text": "virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis",
            "probability": 0.0
        },
        {
            "start_logit": -4.0625,
            "end_logit": 0.2344970703125,
            "text": "infectious mononucleosis",
            "probability": 0.0
        },
        {
            "start_logit": 0.040008544921875,
            "end_logit": -4.62109375,
            "text": "Cytomegalovirus (CMV) infection",
            "probability": 0.0
        },
        {
            "start_logit": 0.040008544921875,
            "end_logit": -4.890625,
            "text": "Cytomegalovirus (CMV",
            "probability": 0.0
        },
        {
            "start_logit": 0.040008544921875,
            "end_logit": -4.89453125,
            "text": "Cytomegalovirus (CMV) infection.",
            "probability": 0.0
        },
        {
            "start_logit": 0.040008544921875,
            "end_logit": -5.0703125,
            "text": "Cytomegalovirus",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_9": [
        {
            "start_logit": 7.9921875,
            "end_logit": 7.87109375,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -1.5126953125,
            "text": "Epstein",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -1.9931640625,
            "end_logit": 7.87109375,
            "text": "virus",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": -5.203125,
            "end_logit": 7.87109375,
            "text": "Barr virus",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 7.87109375,
            "text": "-Barr virus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.046875,
            "text": "Epstein-Barr",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.60546875,
            "text": "Epstein-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.6796875,
            "text": "Epstein-Barr virus.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.87109375,
            "text": "screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.87109375,
            "text": "His septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 7.87109375,
            "text": "positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.87109375,
            "text": "negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.87109375,
            "text": "for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.87109375,
            "text": "he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.87109375,
            "text": "Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 7.87109375,
            "text": ", but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 7.87109375,
            "text": "pot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.87109375,
            "text": "septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.87109375,
            "text": "test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": -1.5126953125,
            "text": "screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein",
            "probability": 0.0
        }
    ],
    "5c89623bf9c2ba6b28000004_1": [
        {
            "start_logit": -5.5546875,
            "end_logit": -2.478515625,
            "text": "Val7Met",
            "probability": 0.1925048828125
        },
        {
            "start_logit": -5.703125,
            "end_logit": -2.478515625,
            "text": "(c.19G>A, p.Val7Met",
            "probability": 0.1658935546875
        },
        {
            "start_logit": -5.9140625,
            "end_logit": -2.478515625,
            "text": "p.Val7Met",
            "probability": 0.1343994140625
        },
        {
            "start_logit": -6.265625,
            "end_logit": -2.478515625,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.09454345703125
        },
        {
            "start_logit": -6.66015625,
            "end_logit": -2.478515625,
            "text": "novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0634765625
        },
        {
            "start_logit": -6.69140625,
            "end_logit": -2.478515625,
            "text": "missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0615234375
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -2.478515625,
            "text": "mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0560302734375
        },
        {
            "start_logit": -6.90625,
            "end_logit": -2.478515625,
            "text": "homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0498046875
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -2.478515625,
            "text": ".Val7Met",
            "probability": 0.03851318359375
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -2.478515625,
            "text": "c.19G>A, p.Val7Met",
            "probability": 0.032928466796875
        },
        {
            "start_logit": -7.53125,
            "end_logit": -2.478515625,
            "text": "in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.02667236328125
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -2.478515625,
            "text": "gene and a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0252532958984375
        },
        {
            "start_logit": -7.609375,
            "end_logit": -2.478515625,
            "text": "exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0246734619140625
        },
        {
            "start_logit": -5.703125,
            "end_logit": -5.58203125,
            "text": "(c.19",
            "probability": 0.007465362548828125
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -5.890625,
            "text": "Val7",
            "probability": 0.0063323974609375
        },
        {
            "start_logit": -5.703125,
            "end_logit": -5.890625,
            "text": "(c.19G>A, p.Val7",
            "probability": 0.005458831787109375
        },
        {
            "start_logit": -5.9140625,
            "end_logit": -5.890625,
            "text": "p.Val7",
            "probability": 0.004425048828125
        },
        {
            "start_logit": -6.265625,
            "end_logit": -5.58203125,
            "text": "a novel homozygous missense mutation in exon 2 (c.19",
            "probability": 0.004253387451171875
        },
        {
            "start_logit": -6.265625,
            "end_logit": -5.890625,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7",
            "probability": 0.0031108856201171875
        },
        {
            "start_logit": -6.66015625,
            "end_logit": -5.58203125,
            "text": "novel homozygous missense mutation in exon 2 (c.19",
            "probability": 0.0028553009033203125
        }
    ],
    "56c85ed65795f9a73e000012_1": [
        {
            "start_logit": -3.60546875,
            "end_logit": -1.8701171875,
            "text": "inhibits",
            "probability": 0.697265625
        },
        {
            "start_logit": -5.1015625,
            "end_logit": -1.8701171875,
            "text": "dasatinib inhibits",
            "probability": 0.1561279296875
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -1.8701171875,
            "text": "that dasatinib inhibits",
            "probability": 0.028106689453125
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -1.8701171875,
            "text": "atinib inhibits",
            "probability": 0.0240325927734375
        },
        {
            "start_logit": -7.078125,
            "end_logit": -1.8701171875,
            "text": "Herein, we show that dasatinib inhibits",
            "probability": 0.0217132568359375
        },
        {
            "start_logit": -7.390625,
            "end_logit": -1.8701171875,
            "text": ", we show that dasatinib inhibits",
            "probability": 0.0158843994140625
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -1.8701171875,
            "text": "show that dasatinib inhibits",
            "probability": 0.01528167724609375
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -1.8701171875,
            "text": "we show that dasatinib inhibits",
            "probability": 0.01247406005859375
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -6.5546875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.006473541259765625
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -6.953125,
            "text": "inhibits TCR",
            "probability": 0.00431060791015625
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.45703125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine",
            "probability": 0.002613067626953125
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.6796875,
            "text": "inhibits TCR-mediated signal transduction",
            "probability": 0.0020999908447265625
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.71875,
            "text": "inhibits TCR-mediated signal transduction,",
            "probability": 0.0020046234130859375
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.73046875,
            "text": "inhibits TCR-mediated",
            "probability": 0.0019893646240234375
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.80859375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo",
            "probability": 0.00183868408203125
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.8515625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production",
            "probability": 0.0017681121826171875
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.9296875,
            "text": "inhibits TCR-mediated signal transduction, cellular",
            "probability": 0.0016355514526367188
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.9453125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production,",
            "probability": 0.00160980224609375
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.98828125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell",
            "probability": 0.001537322998046875
        },
        {
            "start_logit": -3.60546875,
            "end_logit": -7.9921875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T",
            "probability": 0.001537322998046875
        }
    ],
    "56c85ed65795f9a73e000012_2": [
        {
            "start_logit": -3.275390625,
            "end_logit": -0.88134765625,
            "text": "inhibits",
            "probability": 0.83447265625
        },
        {
            "start_logit": -5.9453125,
            "end_logit": -0.88134765625,
            "text": "dasatinib inhibits",
            "probability": 0.057708740234375
        },
        {
            "start_logit": -6.8671875,
            "end_logit": -0.88134765625,
            "text": "that dasatinib inhibits",
            "probability": 0.02294921875
        },
        {
            "start_logit": -7.09765625,
            "end_logit": -0.88134765625,
            "text": "Herein, we show that dasatinib inhibits",
            "probability": 0.018218994140625
        },
        {
            "start_logit": -7.1953125,
            "end_logit": -0.88134765625,
            "text": "atinib inhibits",
            "probability": 0.0165252685546875
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -0.88134765625,
            "text": ", we show that dasatinib inhibits",
            "probability": 0.014251708984375
        },
        {
            "start_logit": -7.375,
            "end_logit": -0.88134765625,
            "text": "show that dasatinib inhibits",
            "probability": 0.01380157470703125
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -0.88134765625,
            "text": "we show that dasatinib inhibits",
            "probability": 0.01126861572265625
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.1328125,
            "text": "inhibits TCR",
            "probability": 0.0016107559204101562
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.609375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine",
            "probability": 0.0010004043579101562
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.63671875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses",
            "probability": 0.0009694099426269531
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.75390625,
            "text": "inhibits TCR-mediated signal transduction",
            "probability": 0.00086212158203125
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.7578125,
            "text": "inhibits TCR-mediated signal transduction,",
            "probability": 0.00086212158203125
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.7890625,
            "text": "inhibits TCR-mediated",
            "probability": 0.0008358955383300781
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.88671875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell",
            "probability": 0.0007548332214355469
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.90234375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo",
            "probability": 0.0007433891296386719
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.9375,
            "text": "inhibits TCR-mediated signal transduction, cellular",
            "probability": 0.0007205009460449219
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.9765625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production",
            "probability": 0.0006928443908691406
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.984375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and",
            "probability": 0.0006875991821289062
        },
        {
            "start_logit": -3.275390625,
            "end_logit": -7.99609375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T",
            "probability": 0.0006771087646484375
        }
    ],
    "56c85ed65795f9a73e000012_3": [
        {
            "start_logit": 7.8359375,
            "end_logit": 7.10546875,
            "text": "tyrosine kinase inhibitor",
            "probability": 1.0
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -0.890625,
            "text": "tyrosine kinase",
            "probability": 0.0003380775451660156
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -2.263671875,
            "text": "tyrosine",
            "probability": 8.547306060791016e-05
        },
        {
            "start_logit": -3.2890625,
            "end_logit": 7.10546875,
            "text": "inhibitor",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -3.853515625,
            "end_logit": 7.10546875,
            "text": "molecule protein tyrosine kinase inhibitor",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 7.10546875,
            "text": "protein tyrosine kinase inhibitor",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.10546875,
            "text": "kinase inhibitor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 7.10546875,
            "text": "small-molecule protein tyrosine kinase inhibitor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 7.10546875,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.8359375,
            "text": "tyrosine kinase inhibitor, inhibits T-cell activation and proliferation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -8.09375,
            "text": "tyrosine kinase inhibitor, inhibits",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.10546875,
            "text": "atinib, a small-molecule protein tyrosine kinase inhibitor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 7.10546875,
            "text": "-molecule protein tyrosine kinase inhibitor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.10546875,
            "text": "a small-molecule protein tyrosine kinase inhibitor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.10546875,
            "text": ", a small-molecule protein tyrosine kinase inhibitor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.853515625,
            "end_logit": -0.890625,
            "text": "molecule protein tyrosine kinase",
            "probability": 0.0
        },
        {
            "start_logit": -3.853515625,
            "end_logit": -2.263671875,
            "text": "molecule protein tyrosine",
            "probability": 0.0
        },
        {
            "start_logit": -6.08984375,
            "end_logit": -0.890625,
            "text": "protein tyrosine kinase",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -0.890625,
            "text": "kinase",
            "probability": 0.0
        },
        {
            "start_logit": -6.4296875,
            "end_logit": -0.890625,
            "text": "small-molecule protein tyrosine kinase",
            "probability": 0.0
        }
    ],
    "56c85ed65795f9a73e000012_4": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.66796875,
            "text": "tyrosine kinase inhibitor",
            "probability": 1.0
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.822265625,
            "text": "tyrosine kinase",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -2.240234375,
            "text": "tyrosine",
            "probability": 4.947185516357422e-05
        },
        {
            "start_logit": -2.373046875,
            "end_logit": 7.66796875,
            "text": "inhibitor",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -3.1484375,
            "text": "tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": -3.982421875,
            "end_logit": 7.66796875,
            "text": "molecule protein tyrosine kinase inhibitor",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -5.84375,
            "end_logit": 7.66796875,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.3046875,
            "end_logit": 7.66796875,
            "text": "kinase inhibitor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 7.66796875,
            "text": "small-molecule protein tyrosine kinase inhibitor",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 7.66796875,
            "text": "protein tyrosine kinase inhibitor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.51171875,
            "text": "tyrosine kinase inhibitor, inhibits",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.66796875,
            "text": "atinib, a small-molecule protein tyrosine kinase inhibitor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.9765625,
            "text": "tyrosine kinase inhibitor, inhibits T-cell activation and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.66796875,
            "text": ", a small-molecule protein tyrosine kinase inhibitor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -8.0625,
            "text": "tyrosine kinase inhibitor, inhibits T-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 7.66796875,
            "text": "-molecule protein tyrosine kinase inhibitor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -8.1484375,
            "text": "tyrosine kinase inhibitor, inhibits T-cell",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -8.1640625,
            "text": "tyrosine kinase inhibitor, inhibits T-cell activation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.373046875,
            "end_logit": -3.1484375,
            "text": "inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.0
        },
        {
            "start_logit": -3.982421875,
            "end_logit": -1.822265625,
            "text": "molecule protein tyrosine kinase",
            "probability": 0.0
        }
    ],
    "56c85ed65795f9a73e000012_5": [
        {
            "start_logit": -2.638671875,
            "end_logit": -0.200439453125,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.",
            "probability": 0.403076171875
        },
        {
            "start_logit": -2.9609375,
            "end_logit": -0.200439453125,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T cells.",
            "probability": 0.292236328125
        },
        {
            "start_logit": -3.46875,
            "end_logit": -0.200439453125,
            "text": "CD4+CD25+ regulatory T cells.",
            "probability": 0.17578125
        },
        {
            "start_logit": -5.16796875,
            "end_logit": -0.200439453125,
            "text": ".",
            "probability": 0.032196044921875
        },
        {
            "start_logit": -2.638671875,
            "end_logit": -2.986328125,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells",
            "probability": 0.024871826171875
        },
        {
            "start_logit": -2.9609375,
            "end_logit": -2.986328125,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T cells",
            "probability": 0.01806640625
        },
        {
            "start_logit": -3.46875,
            "end_logit": -2.986328125,
            "text": "CD4+CD25+ regulatory T cells",
            "probability": 0.01087188720703125
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -0.200439453125,
            "text": "+CD25+ regulatory T cells.",
            "probability": 0.006389617919921875
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -0.200439453125,
            "text": "atinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.",
            "probability": 0.0052947998046875
        },
        {
            "start_logit": -7.0078125,
            "end_logit": -0.200439453125,
            "text": "+ regulatory T cells.",
            "probability": 0.005115509033203125
        },
        {
            "start_logit": -7.03515625,
            "end_logit": -0.200439453125,
            "text": "T cells.",
            "probability": 0.004978179931640625
        },
        {
            "start_logit": -7.265625,
            "end_logit": -0.200439453125,
            "text": "of CD4+CD25+ regulatory T cells.",
            "probability": 0.0039520263671875
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -0.200439453125,
            "text": "CD25+ regulatory T cells.",
            "probability": 0.0034084320068359375
        },
        {
            "start_logit": -7.46875,
            "end_logit": -0.200439453125,
            "text": "function of CD4+CD25+ regulatory T cells.",
            "probability": 0.00322723388671875
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -0.200439453125,
            "text": "regulatory T cells.",
            "probability": 0.0032024383544921875
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -0.200439453125,
            "text": "proliferation and function of CD4+CD25+ regulatory T cells.",
            "probability": 0.0031890869140625
        },
        {
            "start_logit": -2.638671875,
            "end_logit": -5.796875,
            "text": "Dasatinib inhibits",
            "probability": 0.0014944076538085938
        },
        {
            "start_logit": -2.9609375,
            "end_logit": -5.796875,
            "text": "inhibits",
            "probability": 0.0010852813720703125
        },
        {
            "start_logit": -2.638671875,
            "end_logit": -6.66796875,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25",
            "probability": 0.0006279945373535156
        },
        {
            "start_logit": -2.638671875,
            "end_logit": -6.69921875,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory",
            "probability": 0.0006084442138671875
        }
    ],
    "58f4b25e70f9fc6f0f000011_1": [
        {
            "start_logit": 6.484375,
            "end_logit": 6.52734375,
            "text": "Liver",
            "probability": 1.0
        },
        {
            "start_logit": 6.484375,
            "end_logit": -6.33203125,
            "text": "Liver Injury",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 6.52734375,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.484375,
            "end_logit": -7.0703125,
            "text": "Liver Injury Network.",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.484375,
            "end_logit": -7.2265625,
            "text": "Liver Injury Network",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.40625,
            "end_logit": 6.52734375,
            "text": "10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.52734375,
            "text": "Induced Liver",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.52734375,
            "text": "need for transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.52734375,
            "text": "of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.52734375,
            "text": "been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.52734375,
            "text": "Drug-Induced Liver",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -6.33203125,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -6.33203125,
            "text": "10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -6.90234375,
            "text": "transplant",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -6.33203125,
            "text": "Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -7.2265625,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury Network",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -7.2421875,
            "text": "transplant of 10% or higher",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -7.3359375,
            "text": "transplant of 10%",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -7.3515625,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S.",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": -6.33203125,
            "text": "of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_2": [
        {
            "start_logit": 6.49609375,
            "end_logit": 6.60546875,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -6.609375,
            "text": "liver injury",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.4453125,
            "text": "liver injury patterns",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.5703125,
            "text": "liver injury patterns were found to affect",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.62890625,
            "text": "liver injury patterns were found to affect potential severity as measured by Hy's Law criteria.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.67578125,
            "text": "liver injury patterns were found to affect potential",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.73046875,
            "text": "liver injury patterns were found to",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.74609375,
            "text": "liver injury patterns were found to affect potential severity as",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.81640625,
            "text": "liver injury patterns were found to affect potential severity",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.9296875,
            "text": "liver injury patterns were found to affect potential severity as measured by Hy's Law",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.9453125,
            "text": "liver injury patterns were found to affect potential severity as measured",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -6.609375,
            "text": "injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -7.62890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -7.4453125,
            "text": "injury patterns",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -7.5703125,
            "text": "found to affect",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -7.62890625,
            "text": "found to affect potential severity as measured by Hy's Law criteria.",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -7.5703125,
            "text": "injury patterns were found to affect",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -7.67578125,
            "text": "found to affect potential",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -7.62890625,
            "text": "injury patterns were found to affect potential severity as measured by Hy's Law criteria.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -7.73046875,
            "text": "found to",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_3": [
        {
            "start_logit": 6.53125,
            "end_logit": 6.56640625,
            "text": "liver",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.51953125,
            "end_logit": 6.57421875,
            "text": "liver",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.51953125,
            "end_logit": 6.56640625,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.1171875,
            "text": "liver aminotransferase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 6.57421875,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.3359375,
            "text": "liver disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.3359375,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.4921875,
            "text": "liver aminotransferase levels above the upper limit of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.57421875,
            "text": "liver aminotransferase levels above the upper",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.578125,
            "text": "liver aminotransferase levels above the upper limit of normal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.57421875,
            "text": "DILI from 2004 through 2010, liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.56640625,
            "text": "DILI from 2004 through 2010, liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.56640625,
            "text": "existing liver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 6.57421875,
            "text": "2010, liver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 6.56640625,
            "text": "2010, liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.2421875,
            "text": "DILI",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.26953125,
            "text": "DILI based on levels of alanine aminotransferase",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.3046875,
            "text": "DILI based on levels of alanine aminotransferase or aspartate aminotransferase",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.34375,
            "text": "DILI based on levels of alanine aminotransferase or aspartate aminotransferase and total bilirubin, and",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.36328125,
            "text": "DILI based on levels of alanine aminotransferase or aspartate aminotransferase and total bilirubin, and validated the model in a separate sample.We",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_4": [
        {
            "start_logit": 6.53125,
            "end_logit": 6.56640625,
            "text": "liver",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.51953125,
            "end_logit": 6.57421875,
            "text": "liver",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.51953125,
            "end_logit": 6.56640625,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.1171875,
            "text": "liver aminotransferase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 6.57421875,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.3359375,
            "text": "liver disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.3359375,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.4921875,
            "text": "liver aminotransferase levels above the upper limit of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.57421875,
            "text": "liver aminotransferase levels above the upper",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.578125,
            "text": "liver aminotransferase levels above the upper limit of normal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.57421875,
            "text": "DILI from 2004 through 2010, liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.56640625,
            "text": "DILI from 2004 through 2010, liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.56640625,
            "text": "existing liver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 6.57421875,
            "text": "2010, liver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 6.56640625,
            "text": "2010, liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.2421875,
            "text": "DILI",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.26953125,
            "text": "DILI based on levels of alanine aminotransferase",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.3046875,
            "text": "DILI based on levels of alanine aminotransferase or aspartate aminotransferase",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.34375,
            "text": "DILI based on levels of alanine aminotransferase or aspartate aminotransferase and total bilirubin, and",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.36328125,
            "text": "DILI based on levels of alanine aminotransferase or aspartate aminotransferase and total bilirubin, and validated the model in a separate sample.We",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_5": [
        {
            "start_logit": 6.5,
            "end_logit": 6.5859375,
            "text": "Liver",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.50390625,
            "end_logit": 6.5703125,
            "text": "Liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.5,
            "end_logit": 6.5703125,
            "text": "Liver Failure in Patients With Drug-Induced Liver",
            "probability": 0.330810546875
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -6.546875,
            "text": "Liver Injury",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -6.546875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.32421875,
            "text": "Liver Injury:",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.32421875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury:",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.58984375,
            "text": "Liver Failure in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.60546875,
            "text": "Liver Failure in Patients With Drug-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.63671875,
            "text": "Liver Failure",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.65625,
            "text": "Liver Failure in Patients",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.6796875,
            "text": "Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.6796875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.73828125,
            "text": "Liver Injury: Evaluation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.73828125,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.75,
            "text": "Liver Failure in Patients With",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.75390625,
            "text": "Liver Failure in Patients With Drug",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.796875,
            "text": "Liver Injury: Evaluation of Hy's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.80078125,
            "text": "Liver Injury: Evaluation of Hy's Law",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.796875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_6": [
        {
            "start_logit": 6.5,
            "end_logit": 6.5859375,
            "text": "Liver",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.50390625,
            "end_logit": 6.5703125,
            "text": "Liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.5,
            "end_logit": 6.5703125,
            "text": "Liver Failure in Patients With Drug-Induced Liver",
            "probability": 0.330810546875
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -6.546875,
            "text": "Liver Injury",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -6.546875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.32421875,
            "text": "Liver Injury:",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.32421875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury:",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.58984375,
            "text": "Liver Failure in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.60546875,
            "text": "Liver Failure in Patients With Drug-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.63671875,
            "text": "Liver Failure",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.65625,
            "text": "Liver Failure in Patients",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.6796875,
            "text": "Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.6796875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.73828125,
            "text": "Liver Injury: Evaluation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.73828125,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.75,
            "text": "Liver Failure in Patients With",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.75390625,
            "text": "Liver Failure in Patients With Drug",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.796875,
            "text": "Liver Injury: Evaluation of Hy's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.80078125,
            "text": "Liver Injury: Evaluation of Hy's Law",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.796875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_7": [
        {
            "start_logit": 6.5390625,
            "end_logit": 6.484375,
            "text": "liver",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.52734375,
            "end_logit": 6.484375,
            "text": "liver",
            "probability": 0.33251953125
        },
        {
            "start_logit": 6.52734375,
            "end_logit": 6.484375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 0.33251953125
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -5.89453125,
            "text": "liver injury",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.1015625,
            "text": "liver failure (ALF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.1015625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.46484375,
            "text": "liver injury (DILI) with jaundice",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.4921875,
            "text": "liver failure (ALF).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.4921875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.484375,
            "text": "acute liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.6484375,
            "text": "liver injury (DILI) with jaundice indicates a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.67578125,
            "text": "liver injury (DILI) with jaundice indicates a serious",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.7265625,
            "text": "liver injury (DIL",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.484375,
            "text": "states that hepatocellular drug-induced liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.484375,
            "text": "states that hepatocellular drug-induced liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.796875,
            "text": "liver injury (DILI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.84765625,
            "text": "liver failure",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.8359375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.84765625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.85546875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_8": [
        {
            "start_logit": 6.5390625,
            "end_logit": 6.484375,
            "text": "liver",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.52734375,
            "end_logit": 6.484375,
            "text": "liver",
            "probability": 0.33251953125
        },
        {
            "start_logit": 6.52734375,
            "end_logit": 6.484375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 0.33251953125
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -5.89453125,
            "text": "liver injury",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.1015625,
            "text": "liver failure (ALF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.1015625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.46484375,
            "text": "liver injury (DILI) with jaundice",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.4921875,
            "text": "liver failure (ALF).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.4921875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.484375,
            "text": "acute liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.6484375,
            "text": "liver injury (DILI) with jaundice indicates a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.67578125,
            "text": "liver injury (DILI) with jaundice indicates a serious",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.7265625,
            "text": "liver injury (DIL",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.484375,
            "text": "states that hepatocellular drug-induced liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.484375,
            "text": "states that hepatocellular drug-induced liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.796875,
            "text": "liver injury (DILI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.84765625,
            "text": "liver failure",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.8359375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.84765625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.85546875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_9": [
        {
            "start_logit": 6.48828125,
            "end_logit": 6.58984375,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.30859375,
            "text": "liver injury",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.828125,
            "text": "liver injury (DILI)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.9140625,
            "text": "liver injury (DILI",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.9765625,
            "text": "liver injury (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -8.015625,
            "text": "liver injury (DIL",
            "probability": 4.76837158203125e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_10": [
        {
            "start_logit": 6.4921875,
            "end_logit": 6.63671875,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.484375,
            "text": "liver injury",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.7265625,
            "text": "liver injury is",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.74609375,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.7578125,
            "text": "liver injury is identified in",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.76953125,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2 \u00d7 ULN, and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.77734375,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.77734375,
            "text": "liver injury is identified in clinical trials",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.83984375,
            "text": "liver injury is identified in clinical trials by",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.83984375,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2 \u00d7 ULN",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.8515625,
            "text": "liver injury is identified in clinical",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.86328125,
            "text": "liver injury is identified in clinical trials by ALT>",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.86328125,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.875,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.87890625,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.88671875,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.88671875,
            "text": "liver injury is identified",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.88671875,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>",
            "probability": 4.76837158203125e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_11": [
        {
            "start_logit": 6.50390625,
            "end_logit": 6.609375,
            "text": "liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.49609375,
            "end_logit": 6.6171875,
            "text": "liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.49609375,
            "end_logit": 6.609375,
            "text": "liver injury is identified by the liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.53515625,
            "text": "liver injury",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.58203125,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.58984375,
            "text": "liver chemistry",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.58203125,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.58984375,
            "text": "liver injury is identified by the liver chemistry",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.6875,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.6953125,
            "text": "liver chemistry threshold of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.6875,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.6953125,
            "text": "liver injury is identified by the liver chemistry threshold of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.71484375,
            "text": "liver chemistry threshold of alanine aminotransferase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.71484375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.7421875,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2\u00d7 ULN",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.74609375,
            "text": "liver chemistry threshold",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.75,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.75390625,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.74609375,
            "text": "liver injury is identified by the liver chemistry threshold",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.75,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN)",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_12": [
        {
            "start_logit": 6.50390625,
            "end_logit": 6.609375,
            "text": "liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.49609375,
            "end_logit": 6.6171875,
            "text": "liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.49609375,
            "end_logit": 6.609375,
            "text": "liver injury is identified by the liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.53515625,
            "text": "liver injury",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.58203125,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.58984375,
            "text": "liver chemistry",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.58203125,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.58984375,
            "text": "liver injury is identified by the liver chemistry",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.6875,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.6953125,
            "text": "liver chemistry threshold of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.6875,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.6953125,
            "text": "liver injury is identified by the liver chemistry threshold of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.71484375,
            "text": "liver chemistry threshold of alanine aminotransferase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.71484375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.7421875,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2\u00d7 ULN",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.74609375,
            "text": "liver chemistry threshold",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.75,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.75390625,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.74609375,
            "text": "liver injury is identified by the liver chemistry threshold",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.75,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN)",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5a7237672dc08e987e000008_1": [
        {
            "start_logit": 6.52734375,
            "end_logit": 6.73046875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": 6.73046875,
            "text": "DOACs i.e., dabigatran",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 6.73046875,
            "text": "ACs i.e., dabigatran",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.73046875,
            "text": ", dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.73046875,
            "text": "reversal agent has been approved by the Food and Drug Administration (FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.73046875,
            "text": "agent has been approved by the Food and Drug Administration (FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.73046875,
            "text": "(FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 6.73046875,
            "text": "the DOACs i.e., dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.73046875,
            "text": "of the DOACs i.e., dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.953125,
            "text": "dabigatran.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -3.88671875,
            "text": "DOACs",
            "probability": 0.0
        },
        {
            "start_logit": -6.6640625,
            "end_logit": -3.88671875,
            "text": "ACs",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -7.640625,
            "text": "DO",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -7.6640625,
            "text": "DOACs i",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -7.8359375,
            "text": "DOACs i.e",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -3.88671875,
            "text": "reversal agent has been approved by the Food and Drug Administration (FDA), idarucizumab for one of the DOACs",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -3.88671875,
            "text": "agent has been approved by the Food and Drug Administration (FDA), idarucizumab for one of the DOACs",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -3.88671875,
            "text": "far only one reversal agent has been approved by the Food and Drug Administration (FDA), idarucizumab for one of the DOACs",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -7.953125,
            "text": "DOACs i.e., dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -3.962890625,
            "end_logit": -7.9765625,
            "text": "DOACs i.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_2": [
        {
            "start_logit": 6.60546875,
            "end_logit": 6.515625,
            "text": "anticoagulants",
            "probability": 0.73291015625
        },
        {
            "start_logit": 6.60546875,
            "end_logit": 5.31640625,
            "text": "anticoagulants such as apixa",
            "probability": 0.2200927734375
        },
        {
            "start_logit": 4.3046875,
            "end_logit": 5.31640625,
            "text": "xa",
            "probability": 0.0221405029296875
        },
        {
            "start_logit": 6.60546875,
            "end_logit": 2.994140625,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 0.0216217041015625
        },
        {
            "start_logit": 4.3046875,
            "end_logit": 2.994140625,
            "text": "xaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 0.0021572113037109375
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -0.377197265625,
            "text": "anticoagulants such as apixaban, rivaroxaban",
            "probability": 0.0007395744323730469
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -0.377197265625,
            "text": "xaban, rivaroxaban",
            "probability": 7.43865966796875e-05
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -3.375,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran",
            "probability": 3.713369369506836e-05
        },
        {
            "start_logit": -1.2958984375,
            "end_logit": 2.994140625,
            "text": "rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -4.95703125,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -1.962890625,
            "end_logit": 2.994140625,
            "text": "vitamin K antagonists",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -3.375,
            "text": "xaban, rivaroxaban, or dabigatran",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.65625,
            "text": "anticoagulants such as apixaban",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.81640625,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -3.453125,
            "end_logit": 2.994140625,
            "text": "dabigatran may be preferred to vitamin K antagonists",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 6.515625,
            "text": "oral anticoagulants",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -4.95703125,
            "text": "xaban, rivaroxaban, or dabigatran may be preferred to vitamin K",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -7.5546875,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -7.62109375,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists in",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -7.6484375,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists in patients without",
            "probability": 5.364418029785156e-07
        }
    ],
    "5a7237672dc08e987e000008_3": [
        {
            "start_logit": 6.578125,
            "end_logit": 6.58203125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.578125,
            "end_logit": -4.0546875,
            "text": "dabigatran-mediated anticoagulation",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": 6.578125,
            "end_logit": -7.21484375,
            "text": "dabigatran-mediated anticoagulation.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.578125,
            "end_logit": -7.8125,
            "text": "dabigatran-mediated",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.58203125,
            "text": ": Idarucizumab is an antibody fragment that specifically reverses dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.58203125,
            "text": "OBJECTIVES: Idarucizumab is an antibody fragment that specifically reverses dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.58203125,
            "text": "BACKGROUND AND OBJECTIVES: Idarucizumab is an antibody fragment that specifically reverses dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.578125,
            "end_logit": -8.0546875,
            "text": "dabigatran-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.58203125,
            "text": "s dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.58203125,
            "text": "AND OBJECTIVES: Idarucizumab is an antibody fragment that specifically reverses dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 6.58203125,
            "text": "reverses dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -4.0546875,
            "text": "anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -4.0546875,
            "text": ": Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -4.0546875,
            "text": "OBJECTIVES: Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -4.0546875,
            "text": "mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -4.0546875,
            "text": "BACKGROUND AND OBJECTIVES: Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -4.0546875,
            "text": "s dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -4.0546875,
            "text": "AND OBJECTIVES: Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -4.0546875,
            "text": "reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -4.0546875,
            "text": "-mediated anticoagulation",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_4": [
        {
            "start_logit": 6.52734375,
            "end_logit": 6.71875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.71875,
            "text": "dabigatran anticoagulant",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.78125,
            "text": "dabigatran anticoagulant activity, and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.71875,
            "text": "complete and sustained reversal of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.828125,
            "text": "dabigatran anticoagulant activity",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.86328125,
            "text": "dabigatran anticoagulant activity, and was",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.88671875,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.91015625,
            "text": "dabigatran anticoagulant activity,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.91015625,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.9140625,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and renally impaired",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.91796875,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and renal",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.94140625,
            "text": "dabigatran anticoagulant activity, and was safe and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.9453125,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -7.71875,
            "text": "complete and sustained reversal of dabigatran anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -7.78125,
            "text": "complete and sustained reversal of dabigatran anticoagulant activity, and",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -7.828125,
            "text": "complete and sustained reversal of dabigatran anticoagulant activity",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -7.86328125,
            "text": "complete and sustained reversal of dabigatran anticoagulant activity, and was",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -7.88671875,
            "text": "complete and sustained reversal of dabigatran anticoagulant activity, and was safe and well tolerated in",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -7.91015625,
            "text": "complete and sustained reversal of dabigatran anticoagulant activity,",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -7.91015625,
            "text": "complete and sustained reversal of dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_5": [
        {
            "start_logit": 6.51953125,
            "end_logit": 6.73046875,
            "text": "Dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.56640625,
            "text": "Dabigatran Anticoagulant",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.67578125,
            "text": "Dabigatran Anticoagulant Activity in",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.8125,
            "text": "Dabigatran Anticoagulant Activity in a",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.8125,
            "text": "Dabigatran Anticoagulant Activity",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.984375,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 6.73046875,
            "text": "Reversal of Dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.98828125,
            "text": "Dabigatran Anticoagulant Activity in a Randomized,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.73046875,
            "text": "Mediated Reversal of Dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.56640625,
            "text": "Reversal of Dabigatran Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": -7.56640625,
            "text": "Mediated Reversal of Dabigatran Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.67578125,
            "text": "Reversal of Dabigatran Anticoagulant Activity in",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": -7.67578125,
            "text": "Mediated Reversal of Dabigatran Anticoagulant Activity in",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": -7.984375,
            "text": "Crossover Phase Ib Study",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.8125,
            "text": "Reversal of Dabigatran Anticoagulant Activity in a",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.8125,
            "text": "Reversal of Dabigatran Anticoagulant Activity",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": -7.8125,
            "text": "Mediated Reversal of Dabigatran Anticoagulant Activity in a",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": -7.8125,
            "text": "Mediated Reversal of Dabigatran Anticoagulant Activity",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.984375,
            "text": "Phase Ib Study",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.97265625,
            "text": "Reversal of",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_6": [
        {
            "start_logit": 6.4765625,
            "end_logit": 6.78515625,
            "text": "rivaroxaban, apixaban, and edoxaban",
            "probability": 0.1142578125
        },
        {
            "start_logit": 6.4921875,
            "end_logit": 6.765625,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban, apixa",
            "probability": 0.1134033203125
        },
        {
            "start_logit": 6.47265625,
            "end_logit": 6.78515625,
            "text": "xaban, and edoxaban",
            "probability": 0.1134033203125
        },
        {
            "start_logit": 6.4765625,
            "end_logit": 6.765625,
            "text": "rivaroxaban, apixa",
            "probability": 0.11163330078125
        },
        {
            "start_logit": 6.4921875,
            "end_logit": 6.7421875,
            "text": "dabigatran",
            "probability": 0.11077880859375
        },
        {
            "start_logit": 6.4921875,
            "end_logit": 6.73828125,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban",
            "probability": 0.11077880859375
        },
        {
            "start_logit": 6.47265625,
            "end_logit": 6.765625,
            "text": "xa",
            "probability": 0.11077880859375
        },
        {
            "start_logit": 6.4765625,
            "end_logit": 6.73828125,
            "text": "rivaroxaban",
            "probability": 0.10906982421875
        },
        {
            "start_logit": 6.40625,
            "end_logit": 6.78515625,
            "text": "oxaban",
            "probability": 0.105712890625
        },
        {
            "start_logit": -0.22412109375,
            "end_logit": 6.78515625,
            "text": "aban",
            "probability": 0.00014030933380126953
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -0.140869140625,
            "text": "rivaroxaban, apixaban, and edox",
            "probability": 0.00011181831359863281
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -0.140869140625,
            "text": "xaban, and edox",
            "probability": 0.00011140108108520508
        },
        {
            "start_logit": 6.40625,
            "end_logit": -0.140869140625,
            "text": "ox",
            "probability": 0.00010418891906738281
        },
        {
            "start_logit": -6.78125,
            "end_logit": 6.78515625,
            "text": "edoxaban",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -6.78515625,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban, apixaban",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -6.78515625,
            "text": "rivaroxaban, apixaban",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -6.78515625,
            "text": "xaban",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 6.78515625,
            "text": "exanet and ciraparantag, currently under development for the reversal of rivaroxaban, apixaban, and edoxaban",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 6.765625,
            "text": "exanet and ciraparantag, currently under development for the reversal of rivaroxaban, apixa",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 6.73828125,
            "text": "exanet and ciraparantag, currently under development for the reversal of rivaroxaban",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a7237672dc08e987e000008_7": [
        {
            "start_logit": 6.51171875,
            "end_logit": 6.7421875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.7421875,
            "text": "anticoagulant effects of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.80078125,
            "text": "dabigatran.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.7421875,
            "text": "reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.80078125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -7.80078125,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -7.91796875,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.80078125,
            "text": "reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -7.984375,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -8.03125,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.90234375,
            "text": "reversal agent that is approved for the urgent reversal of",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.90625,
            "text": "reversal agent that is approved for the urgent",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.91796875,
            "text": "reversal agent that is approved for the urgent reversal of the anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.93359375,
            "text": "reversal agent that is approved for",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.9765625,
            "text": "reversal agent that is",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.984375,
            "text": "reversal agent that is approved for the urgent reversal of the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.984375,
            "text": "reversal agent that is approved for the",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -8.0234375,
            "text": "reversal agent that is approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -8.03125,
            "text": "reversal agent that is approved for the urgent reversal of the anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -8.0390625,
            "text": "reversal agent",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_8": [
        {
            "start_logit": 6.54296875,
            "end_logit": 6.70703125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.70703125,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.70703125,
            "text": "CONCLUSIONS: The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7265625,
            "text": "dabigatran.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.70703125,
            "text": "with dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.70703125,
            "text": "associated with dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.70703125,
            "text": "bleeding associated with dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.7265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.7265625,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.8828125,
            "text": ": The initial data suggest a definite role for idarucizumab in",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.88671875,
            "text": ": The initial data suggest a definite role",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.89453125,
            "text": ": The initial data",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.90625,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.91015625,
            "text": ": The initial data suggest a definite",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.95703125,
            "text": ": The initial data suggest a definite role for idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.96875,
            "text": ": The initial data suggest",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.9765625,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.9765625,
            "text": ": The initial data suggest a definite role for",
            "probability": 0.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": -7.7265625,
            "text": "CONCLUSIONS: The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -8.0,
            "text": ": The",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_9": [
        {
            "start_logit": 6.51953125,
            "end_logit": 6.73046875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 6.73046875,
            "text": "completely reversed the anticoagulant activity of dabigatran",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 6.73046875,
            "text": "anticoagulant activity of dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.73046875,
            "text": "5 g of intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.55859375,
            "text": "dabigatran as assessed by routine and specific coagulation",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.56640625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.56640625,
            "text": "dabigatran as",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.6328125,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.69921875,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin time from 92",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 6.73046875,
            "text": "reversed the anticoagulant activity of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.796875,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.73046875,
            "text": "intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.87109375,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.875,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.8828125,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.8828125,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -6.98046875,
            "text": "completely reversed the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -6.98046875,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.71875,
            "end_logit": -7.86328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -6.98046875,
            "text": "5 g of intravenous idarucizumab promptly and completely reversed the anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_10": [
        {
            "start_logit": 6.515625,
            "end_logit": 6.73046875,
            "text": "dabigatran",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.51171875,
            "end_logit": 6.734375,
            "text": "dabigatran",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.51171875,
            "end_logit": 6.73046875,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.49609375,
            "text": "dabigatran.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.49609375,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.56640625,
            "text": "dabigatran with high affinity, is in development as a specific antidote",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.5703125,
            "text": "dabigatran with high",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.64453125,
            "text": "dabigatran with high affinity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.6875,
            "text": "dabigatran with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.8046875,
            "text": "dabigatran with high affinity, is in development",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.8203125,
            "text": "dabigatran with high affinity, is in development as a specific antidote for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.73046875,
            "text": "antidote for dabigatran",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.87109375,
            "text": "dabigatran with high affinity, is in development as a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.87890625,
            "text": "dabigatran with high affinity, is in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.8984375,
            "text": "dabigatran with high affinity,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -7.49609375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.49609375,
            "text": "antidote for dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.56640625,
            "text": "antidote",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.8203125,
            "text": "antidote for",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_11": [
        {
            "start_logit": 6.515625,
            "end_logit": 6.73046875,
            "text": "dabigatran",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.51171875,
            "end_logit": 6.734375,
            "text": "dabigatran",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.51171875,
            "end_logit": 6.73046875,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.49609375,
            "text": "dabigatran.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.49609375,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.56640625,
            "text": "dabigatran with high affinity, is in development as a specific antidote",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.5703125,
            "text": "dabigatran with high",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.64453125,
            "text": "dabigatran with high affinity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.6875,
            "text": "dabigatran with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.8046875,
            "text": "dabigatran with high affinity, is in development",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.8203125,
            "text": "dabigatran with high affinity, is in development as a specific antidote for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.73046875,
            "text": "antidote for dabigatran",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.87109375,
            "text": "dabigatran with high affinity, is in development as a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.87890625,
            "text": "dabigatran with high affinity, is in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.8984375,
            "text": "dabigatran with high affinity,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -7.49609375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.49609375,
            "text": "antidote for dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.56640625,
            "text": "antidote",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.8203125,
            "text": "antidote for",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_12": [
        {
            "start_logit": 6.52734375,
            "end_logit": 6.7265625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -8.0,
            "end_logit": 6.7265625,
            "text": "antidote to dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.84765625,
            "text": "dabigatran.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.7265625,
            "text": "ote to dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": -7.84765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -7.84765625,
            "text": "antidote to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -7.90625,
            "text": "antidote",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.84765625,
            "text": "ote to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.90625,
            "text": "ote",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_13": [
        {
            "start_logit": 6.5078125,
            "end_logit": 6.7421875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.7421875,
            "text": "anticoagulant activity of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.39453125,
            "text": "dabigatran and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.68359375,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of this agent.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.71875,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of this",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -7.1015625,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -7.39453125,
            "text": "anticoagulant activity of dabigatran and",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -7.65625,
            "text": "anticoagulant activity of",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -7.66015625,
            "text": "anticoagulant activity",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -7.68359375,
            "text": "anticoagulant activity of dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of this agent.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -7.71875,
            "text": "anticoagulant activity of dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of this",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -7.68359375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.68359375,
            "text": ", and safety of this agent.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.68359375,
            "text": "review the pharmacology, pharmacokinetic properties, efficacy, and safety of this agent.",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.71875,
            "text": ", and safety of this",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.71875,
            "text": "review the pharmacology, pharmacokinetic properties, efficacy, and safety of this",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.68359375,
            "text": "of this agent.",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -7.68359375,
            "text": "the pharmacology, pharmacokinetic properties, efficacy, and safety of this agent.",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.71875,
            "text": "of this",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -7.71875,
            "text": "the pharmacology, pharmacokinetic properties, efficacy, and safety of this",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_14": [
        {
            "start_logit": 8.2421875,
            "end_logit": 7.05078125,
            "text": "Dabigatran etexilate",
            "probability": 0.998046875
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 0.7998046875,
            "text": "Dabigatran",
            "probability": 0.001911163330078125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -3.837890625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor",
            "probability": 1.8596649169921875e-05
        },
        {
            "start_logit": -3.724609375,
            "end_logit": 7.05078125,
            "text": "te",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.203125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab.",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -5.73828125,
            "end_logit": 7.05078125,
            "text": "etexilate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.046875,
            "end_logit": 7.05078125,
            "text": "exilate",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.390625,
            "text": "Dabigatran etexila",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.30078125,
            "end_logit": 7.05078125,
            "text": "ilate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.65234375,
            "text": "Dabigatran etexilate is an oral",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.80078125,
            "text": "Dabigatran etexilate is an",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.8125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.83984375,
            "text": "Dabigatran etex",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.87109375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.9140625,
            "text": "Dabigatran et",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.9765625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.984375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.99609375,
            "text": "Dabigatran etexilate is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.03125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab",
            "probability": 2.980232238769531e-07
        }
    ],
    "5a7237672dc08e987e000008_15": [
        {
            "start_logit": 6.50390625,
            "end_logit": 6.7265625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -6.6796875,
            "text": "dabigatran, anticoagulation",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.4609375,
            "text": "dabigatran, anticoagulation can be rapidly",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.7265625,
            "text": "ICH related to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.7578125,
            "text": "dabigatran, anticoagulation can be rapidly reversed with idarucizumab.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 6.7265625,
            "text": "In ICH related to dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.7265625,
            "text": "to dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.92578125,
            "text": "dabigatran,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.9453125,
            "text": "dabigatran, anticoagulation can be rapidly reversed",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.98046875,
            "text": "dabigatran, anticoagulation can be rapidly reversed with",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.99609375,
            "text": "dabigatran, anticoagulation can be rapidly reversed with idarucizumab",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -8.0,
            "text": "dabigatran, anticoagulation can be rapidly reversed with ida",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -8.0078125,
            "text": "dabigatran, anticoagulation can be rapidly reversed with idaruc",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -8.03125,
            "text": "dabigatran, anticoagulation can be",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -8.09375,
            "text": "dabigatran, anticoagulation can",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -6.6796875,
            "text": "ICH related to dabigatran, anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -6.6796875,
            "text": "anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -6.6796875,
            "text": "In ICH related to dabigatran, anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -6.6796875,
            "text": "to dabigatran, anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.7578125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_16": [
        {
            "start_logit": 7.671875,
            "end_logit": 4.80078125,
            "text": "dabigatran etexilate",
            "probability": 0.59619140625
        },
        {
            "start_logit": 7.671875,
            "end_logit": 4.40234375,
            "text": "dabigatran",
            "probability": 0.403564453125
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.5078125,
            "text": "dabigatran etexila",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.73828125,
            "text": "dabigatran etexilate.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.87890625,
            "text": "dabigatran etex",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.99609375,
            "text": "dabigatran et",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -5.8671875,
            "end_logit": 4.80078125,
            "text": "etexilate",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.9296875,
            "end_logit": 4.80078125,
            "text": "exilate",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 4.80078125,
            "text": "te",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 4.80078125,
            "text": "ilate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.8671875,
            "end_logit": -7.5078125,
            "text": "etexila",
            "probability": 0.0
        },
        {
            "start_logit": -5.9296875,
            "end_logit": -7.5078125,
            "text": "exila",
            "probability": 0.0
        },
        {
            "start_logit": -5.8671875,
            "end_logit": -7.73828125,
            "text": "etexilate.",
            "probability": 0.0
        },
        {
            "start_logit": -5.9296875,
            "end_logit": -7.73828125,
            "text": "exilate.",
            "probability": 0.0
        },
        {
            "start_logit": -5.8671875,
            "end_logit": -7.87890625,
            "text": "etex",
            "probability": 0.0
        },
        {
            "start_logit": -5.9296875,
            "end_logit": -7.87890625,
            "text": "ex",
            "probability": 0.0
        },
        {
            "start_logit": -6.08984375,
            "end_logit": -7.73828125,
            "text": "te.",
            "probability": 0.0
        },
        {
            "start_logit": -5.8671875,
            "end_logit": -7.99609375,
            "text": "et",
            "probability": 0.0
        },
        {
            "start_logit": -6.59765625,
            "end_logit": -7.5078125,
            "text": "ila",
            "probability": 0.0
        },
        {
            "start_logit": -6.59765625,
            "end_logit": -7.73828125,
            "text": "ilate.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_17": [
        {
            "start_logit": 6.51953125,
            "end_logit": 6.72265625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.6875,
            "text": "dabigatran within minutes.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.7421875,
            "text": "dabigatran within",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.72265625,
            "text": "anticoagulant effect of dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.72265625,
            "text": "completely reversed the anticoagulant effect of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.72265625,
            "text": "reversed the anticoagulant effect of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.90234375,
            "text": "dabigatran within minutes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -7.6875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.6875,
            "text": "anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.69140625,
            "text": "anticoagulant effect of",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.6875,
            "text": "completely reversed the anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.69140625,
            "text": "completely reversed the anticoagulant effect of",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.7421875,
            "text": "anticoagulant effect of dabigatran within",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.7421875,
            "text": "completely reversed the anticoagulant effect of dabigatran within",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.8046875,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.6875,
            "text": "reversed the anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.69140625,
            "text": "reversed the anticoagulant effect of",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.8046875,
            "text": "completely reversed the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.7421875,
            "text": "reversed the anticoagulant effect of dabigatran within",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.87109375,
            "text": "anticoagulant effect",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_18": [
        {
            "start_logit": 8.2421875,
            "end_logit": 7.05078125,
            "text": "Dabigatran etexilate",
            "probability": 0.998046875
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 0.7998046875,
            "text": "Dabigatran",
            "probability": 0.001911163330078125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -3.837890625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor",
            "probability": 1.8596649169921875e-05
        },
        {
            "start_logit": -3.724609375,
            "end_logit": 7.05078125,
            "text": "te",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.203125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab.",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -5.73828125,
            "end_logit": 7.05078125,
            "text": "etexilate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.046875,
            "end_logit": 7.05078125,
            "text": "exilate",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.390625,
            "text": "Dabigatran etexila",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.30078125,
            "end_logit": 7.05078125,
            "text": "ilate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.65234375,
            "text": "Dabigatran etexilate is an oral",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.80078125,
            "text": "Dabigatran etexilate is an",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.8125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.83984375,
            "text": "Dabigatran etex",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.87109375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.9140625,
            "text": "Dabigatran et",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.9765625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.984375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.99609375,
            "text": "Dabigatran etexilate is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.03125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab",
            "probability": 2.980232238769531e-07
        }
    ],
    "5a7237672dc08e987e000008_19": [
        {
            "start_logit": 7.09375,
            "end_logit": 5.828125,
            "text": "dabigatran",
            "probability": 0.94970703125
        },
        {
            "start_logit": 7.09375,
            "end_logit": 2.88671875,
            "text": "dabigatran etexilate",
            "probability": 0.05035400390625
        },
        {
            "start_logit": 7.09375,
            "end_logit": -7.31640625,
            "text": "dabigatran etexila",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.09375,
            "end_logit": -7.6875,
            "text": "dabigatran etex",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.09375,
            "end_logit": -7.6875,
            "text": "dabigatran etexilate.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.09375,
            "end_logit": -7.984375,
            "text": "dabigatran et",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 5.828125,
            "text": "INTRODUCTION Idarucizumab is a reversal agent for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.078125,
            "end_logit": 2.88671875,
            "text": "etexilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.1875,
            "end_logit": 2.88671875,
            "text": "exilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 2.88671875,
            "text": "ilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 2.88671875,
            "text": "te",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 2.88671875,
            "text": "INTRODUCTION Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -6.078125,
            "end_logit": -7.31640625,
            "text": "etexila",
            "probability": 0.0
        },
        {
            "start_logit": -6.1875,
            "end_logit": -7.31640625,
            "text": "exila",
            "probability": 0.0
        },
        {
            "start_logit": -6.078125,
            "end_logit": -7.6875,
            "text": "etex",
            "probability": 0.0
        },
        {
            "start_logit": -6.078125,
            "end_logit": -7.6875,
            "text": "etexilate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.1875,
            "end_logit": -7.6875,
            "text": "ex",
            "probability": 0.0
        },
        {
            "start_logit": -6.1875,
            "end_logit": -7.6875,
            "text": "exilate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -7.31640625,
            "text": "ila",
            "probability": 0.0
        },
        {
            "start_logit": -6.078125,
            "end_logit": -7.984375,
            "text": "et",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_20": [
        {
            "start_logit": 6.52734375,
            "end_logit": 6.71484375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.57421875,
            "text": "dabigatran.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.71484375,
            "text": "anticoagulant effects of dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -7.57421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.57421875,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.609375,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.8046875,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.8203125,
            "text": "anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_21": [
        {
            "start_logit": 6.5390625,
            "end_logit": 6.71484375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.71484375,
            "text": "to dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.984375,
            "text": "dabigatran.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": -7.984375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.984375,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -8.1796875,
            "text": "to",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_22": [
        {
            "start_logit": 6.5390625,
            "end_logit": 6.71484375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.71484375,
            "text": "to dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.984375,
            "text": "dabigatran.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": -7.984375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.984375,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -8.1796875,
            "text": "to",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_23": [
        {
            "start_logit": 6.5859375,
            "end_logit": 6.57421875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -2.96875,
            "text": "dabigatran-mediated anticoagulation",
            "probability": 7.200241088867188e-05
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -7.0546875,
            "text": "dabigatran-mediated anticoagulation.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.57421875,
            "text": "OBJECTIVES Idarucizumab is an antibody fragment that specifically reverses dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -7.875,
            "text": "dabigatran-mediated",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.57421875,
            "text": "AND OBJECTIVES Idarucizumab is an antibody fragment that specifically reverses dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -7.90234375,
            "text": "dabigatran-",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.57421875,
            "text": "BACKGROUND AND OBJECTIVES Idarucizumab is an antibody fragment that specifically reverses dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.57421875,
            "text": "s dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.57421875,
            "text": "reverses dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -2.96875,
            "text": "anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -2.96875,
            "text": "OBJECTIVES Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -2.96875,
            "text": "AND OBJECTIVES Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -2.96875,
            "text": "mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -2.96875,
            "text": "BACKGROUND AND OBJECTIVES Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -2.96875,
            "text": "s dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -2.96875,
            "text": "reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -7.0546875,
            "text": "anticoagulation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -7.0546875,
            "text": "OBJECTIVES Idarucizumab is an antibody fragment that specifically reverses dabigatran-mediated anticoagulation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.0546875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_24": [
        {
            "start_logit": 8.21875,
            "end_logit": 7.7578125,
            "text": "dabigatran etexilate",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.21875,
            "end_logit": 0.361572265625,
            "text": "dabigatran",
            "probability": 0.0006117820739746094
        },
        {
            "start_logit": -2.3828125,
            "end_logit": 7.7578125,
            "text": "te",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": -5.51953125,
            "end_logit": 7.7578125,
            "text": "etexilate",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -5.52734375,
            "end_logit": 7.7578125,
            "text": "exilate",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 7.7578125,
            "text": "ilate",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.40625,
            "text": "dabigatran etexila",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.69140625,
            "text": "dabigatran etexilate and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.90234375,
            "text": "dabigatran etexilate and neutralizes its",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.9296875,
            "text": "dabigatran etex",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.93359375,
            "text": "dabigatran et",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.984375,
            "text": "dabigatran etexilate and neutralizes its activity.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.0390625,
            "text": "dabigatran etexilate and neutral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.1171875,
            "text": "dabigatran etexilate and neutralizes its activity",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 7.7578125,
            "text": "binds dabigatran etexilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 0.361572265625,
            "text": "binds dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -2.3828125,
            "end_logit": -7.69140625,
            "text": "te and",
            "probability": 0.0
        },
        {
            "start_logit": -2.3828125,
            "end_logit": -7.90234375,
            "text": "te and neutralizes its",
            "probability": 0.0
        },
        {
            "start_logit": -2.3828125,
            "end_logit": -7.984375,
            "text": "te and neutralizes its activity.",
            "probability": 0.0
        },
        {
            "start_logit": -2.3828125,
            "end_logit": -8.0390625,
            "text": "te and neutral",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_25": [
        {
            "start_logit": 6.52734375,
            "end_logit": 6.73046875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.578125,
            "text": "dabigatran with high",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.70703125,
            "text": "dabigatran with high affinity",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.7578125,
            "text": "dabigatran with",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.81640625,
            "text": "dabigatran with high affinity.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 6.73046875,
            "text": "binds dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -7.81640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.578125,
            "text": "binds dabigatran with high",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.70703125,
            "text": "binds dabigatran with high affinity",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.7578125,
            "text": "binds dabigatran with",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.81640625,
            "text": "binds dabigatran with high affinity.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_26": [
        {
            "start_logit": 7.1796875,
            "end_logit": 7.6328125,
            "text": "dabigatran etexilate",
            "probability": 0.88427734375
        },
        {
            "start_logit": 7.1796875,
            "end_logit": 5.59765625,
            "text": "dabigatran",
            "probability": 0.11602783203125
        },
        {
            "start_logit": -2.724609375,
            "end_logit": 7.6328125,
            "text": "te",
            "probability": 4.410743713378906e-05
        },
        {
            "start_logit": -4.75390625,
            "end_logit": 7.6328125,
            "text": "etexilate",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -5.0546875,
            "end_logit": 7.6328125,
            "text": "exilate",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -5.703125,
            "end_logit": 7.6328125,
            "text": "ilate",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -6.62890625,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.1953125,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 7.6328125,
            "text": "CONCLUSION Reversal of dabigatran etexilate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.87109375,
            "text": "dabigatran etexilate using idarucizumab was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.87890625,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.91015625,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator interactions",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.9375,
            "text": "dabigatran etexilate using idarucizumab was safe and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.9375,
            "text": "dabigatran etexilate using",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.94921875,
            "text": "dabigatran etexila",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.97265625,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -8.0234375,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator interactions.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -8.0546875,
            "text": "dabigatran etexilate using idarucizumab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -8.0625,
            "text": "dabigatran etexilate using idarucizumab was safe and successful",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -8.078125,
            "text": "dabigatran etexilate using idaruc",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5a7237672dc08e987e000008_27": [
        {
            "start_logit": 6.5390625,
            "end_logit": 6.70703125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.30078125,
            "text": "dabigatran.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.70703125,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 6.70703125,
            "text": "to dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.70703125,
            "text": "novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 6.70703125,
            "text": "represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -7.30078125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.30078125,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.98828125,
            "end_logit": -7.30078125,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.30078125,
            "text": "novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.30078125,
            "text": "represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.58203125,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.64453125,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.58203125,
            "text": "novel treatment option as it is the",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.64453125,
            "text": "novel treatment option as it is the only",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.58203125,
            "text": "represents a novel treatment option as it is the",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.796875,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.80078125,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.64453125,
            "text": "represents a novel treatment option as it is the only",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.859375,
            "text": "RESULTS Idarucizumab represents a",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_28": [
        {
            "start_logit": 6.51953125,
            "end_logit": 6.73046875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": 6.73046875,
            "text": "anticoagulant effects of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.890625,
            "text": "dabigatran.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.8515625,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.890625,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.94140625,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.953125,
            "text": "anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_29": [
        {
            "start_logit": 6.55078125,
            "end_logit": 6.66796875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -1.5966796875,
            "end_logit": 6.66796875,
            "text": "direct thrombin inhibitor, dabigatran",
            "probability": 0.0002892017364501953
        },
        {
            "start_logit": -5.11328125,
            "end_logit": 6.66796875,
            "text": "thrombin inhibitor, dabigatran",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -1.5966796875,
            "end_logit": 1.3798828125,
            "text": "direct thrombin inhibitor",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.15625,
            "end_logit": 6.66796875,
            "text": "inhibitor, dabigatran",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.54296875,
            "text": "dabigatran, which was recently approved for use in the USA.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.890625,
            "text": "dabigatran, which was recently approved for",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9140625,
            "text": "dabigatran, which was recently approved for use in the",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.94140625,
            "text": "dabigatran, which was recently approved for use in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.97265625,
            "text": "dabigatran, which was recently approved for use in the USA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 6.66796875,
            "text": "antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.66796875,
            "text": "the direct thrombin inhibitor, dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.11328125,
            "end_logit": 1.3798828125,
            "text": "thrombin inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15625,
            "end_logit": 1.3798828125,
            "text": "inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": 1.3798828125,
            "text": "antidote targeted to reverse the direct thrombin inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 1.3798828125,
            "text": "the direct thrombin inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -1.5966796875,
            "end_logit": -7.53125,
            "text": "direct thrombin",
            "probability": 0.0
        },
        {
            "start_logit": -1.5966796875,
            "end_logit": -7.54296875,
            "text": "direct thrombin inhibitor, dabigatran, which was recently approved for use in the USA.",
            "probability": 0.0
        },
        {
            "start_logit": -1.5966796875,
            "end_logit": -7.72265625,
            "text": "direct",
            "probability": 0.0
        },
        {
            "start_logit": -1.5966796875,
            "end_logit": -7.890625,
            "text": "direct thrombin inhibitor, dabigatran, which was recently approved for",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_30": [
        {
            "start_logit": 6.52734375,
            "end_logit": 6.73046875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -4.21875,
            "text": "dabigatran, is the first specific antidote for a NOAC",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.38671875,
            "text": "dabigatran, is the first specific antidote for a NOAC to",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.4453125,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world experience is limited.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.7109375,
            "text": "dabigatran, is the",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.73828125,
            "text": "dabigatran, is the first specific antidote for",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.75,
            "text": "dabigatran, is the first specific antidote for a NOAC to be",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.765625,
            "text": "dabigatran, is the first",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.765625,
            "text": "dabigatran, is the first specific antidote",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.80078125,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.80859375,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.828125,
            "text": "dabigatran, is",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.828125,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world experience is limited",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.83203125,
            "text": "dabigatran,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.84375,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 6.73046875,
            "text": "targeting dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.66015625,
            "end_logit": -4.21875,
            "text": "NOAC",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": -4.21875,
            "text": "AC",
            "probability": 0.0
        },
        {
            "start_logit": -4.66015625,
            "end_logit": -7.38671875,
            "text": "NOAC to",
            "probability": 0.0
        },
        {
            "start_logit": -4.66015625,
            "end_logit": -7.4453125,
            "text": "NOAC to be approved, but real-world experience is limited.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_31": [
        {
            "start_logit": 6.54296875,
            "end_logit": 6.6953125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.0546875,
            "text": "dabigatran, and reversed the effects of the drug on coagulation variables.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.46484375,
            "text": "dabigatran, and reversed the effects of the drug",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.62890625,
            "text": "dabigatran, and reversed the effects of the drug on coagulation",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7890625,
            "text": "dabigatran,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.828125,
            "text": "dabigatran, and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.85546875,
            "text": "dabigatran, and reversed the effects of the drug on",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.6953125,
            "text": "neutralised plasma concentrations of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.8828125,
            "text": "dabigatran, and reversed the effects of the",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.921875,
            "text": "dabigatran, and reversed the effects of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -7.0546875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -7.0546875,
            "text": "coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -7.0546875,
            "text": "effects of the drug on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.0546875,
            "text": "neutralised plasma concentrations of dabigatran, and reversed the effects of the drug on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.0546875,
            "text": "variables.",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.0546875,
            "text": "reversed the effects of the drug on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.0546875,
            "text": "the effects of the drug on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -7.46484375,
            "text": "effects of the drug",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.46484375,
            "text": "neutralised plasma concentrations of dabigatran, and reversed the effects of the drug",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -7.62890625,
            "text": "coagulation",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_32": [
        {
            "start_logit": 6.58984375,
            "end_logit": 6.57421875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -3.400390625,
            "text": "dabigatran-mediated anticoagulation",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.72265625,
            "text": "dabigatran-mediated anticoagulation.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.65234375,
            "text": "dabigatran-mediated",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 6.57421875,
            "text": "s dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.9609375,
            "text": "dabigatran-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 6.57421875,
            "text": "reverses dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.57421875,
            "text": "specifically reverses dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": -3.400390625,
            "text": "anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -3.400390625,
            "text": "mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -3.400390625,
            "text": "s dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -3.400390625,
            "text": "reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -3.400390625,
            "text": "specifically reverses dabigatran-mediated anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -6.72265625,
            "text": "anticoagulation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -6.72265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -6.72265625,
            "text": "mediated anticoagulation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -6.72265625,
            "text": "s dabigatran-mediated anticoagulation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -6.72265625,
            "text": "reverses dabigatran-mediated anticoagulation.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -6.72265625,
            "text": "specifically reverses dabigatran-mediated anticoagulation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.65234375,
            "text": "mediated",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_33": [
        {
            "start_logit": 6.51953125,
            "end_logit": 6.72265625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.4921875,
            "text": "dabigatran.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.72265625,
            "text": "anticoagulant effects of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -7.4921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.4921875,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.53125,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.7421875,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.90234375,
            "text": "anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_34": [
        {
            "start_logit": 6.53125,
            "end_logit": 6.69140625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.53125,
            "end_logit": -6.99609375,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin generation.",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.16015625,
            "text": "dabigatran and, unlike PCC",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.30859375,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.37890625,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin generation",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.484375,
            "text": "dabigatran and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.64453125,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.734375,
            "text": "dabigatran and, unlike PCCs, was not associated with over-",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.75,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.8203125,
            "text": "dabigatran and, unlike PCCs, was not associated with",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.83984375,
            "text": "dabigatran and, unlike PCCs",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.85546875,
            "text": "dabigatran and, unlike PCCs, was not",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.8671875,
            "text": "dabigatran and, unlike",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.69140625,
            "text": "reversed the effects of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.8828125,
            "text": "dabigatran and, unlike PCCs, was",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 6.69140625,
            "text": "effects of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.9296875,
            "text": "dabigatran and, unlike PCCs, was not associated with over",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": -6.99609375,
            "text": "thrombin generation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -6.99609375,
            "text": "PCCs, was not associated with over-correction of thrombin generation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.0234375,
            "end_logit": -7.30859375,
            "text": "thrombin",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_35": [
        {
            "start_logit": 6.64453125,
            "end_logit": 6.56640625,
            "text": "Dabigatran",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -0.9326171875,
            "text": "Dabigatran etexilate",
            "probability": 0.0005526542663574219
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.01953125,
            "text": "Dabigatran etexila",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.42578125,
            "text": "Dabigatran etexilate (DE) dose-dependently",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.5703125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed by idarucizumab.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.671875,
            "text": "Dabigatran etexilate (DE",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.6796875,
            "text": "Dabigatran etexilate (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.7265625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.7421875,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.7421875,
            "text": "Dabigatran etexilate (DE)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.75,
            "text": "Dabigatran etexilate (DE) dose",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.765625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.81640625,
            "text": "Dabigatran etexilate (DE) dose-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.8359375,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.84375,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed by idarucizumab",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.84765625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.90625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.90625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed by",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.96484375,
            "end_logit": -0.9326171875,
            "text": "etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -6.01953125,
            "end_logit": -0.9326171875,
            "text": "exilate",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_36": [
        {
            "start_logit": 6.515625,
            "end_logit": 6.74609375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.74609375,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.77734375,
            "text": "dabigatran.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.77734375,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.83203125,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety,",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.90234375,
            "text": "In this article,",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.90234375,
            "text": "In this article, we discuss the evidence",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.9375,
            "text": "In this article, we discuss the evidence addressing",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.94921875,
            "text": "In this article, we",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.9609375,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.96875,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.9765625,
            "text": "In this article",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.9921875,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.9921875,
            "text": "In this",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.99609375,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -8.0,
            "text": "In this article, we discuss the",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -8.015625,
            "text": "In this article, we discuss the evidence addressing idaruc",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -8.015625,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -8.015625,
            "text": "In this article, we discuss the evidence addressing idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -8.046875,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_37": [
        {
            "start_logit": 6.53125,
            "end_logit": 6.73046875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.73046875,
            "text": "recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.83203125,
            "text": "dabigatran.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 6.73046875,
            "text": "and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 6.73046875,
            "text": "The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 6.73046875,
            "text": "Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 6.73046875,
            "text": "potential reversal agent for dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": -7.83203125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.73828125,
            "text": "recent The Food and Drug Administration approval of",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.83203125,
            "text": "recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.83984375,
            "text": "recent The Food and Drug Administration approval",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.8515625,
            "text": "recent The Food and Drug Administration approval of idarucizumab, a",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.875,
            "text": "recent The Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.91796875,
            "text": "recent The Food and Drug Administration approval of idarucizumab,",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.93359375,
            "text": "recent The Food and Drug Administration approval of idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.9765625,
            "text": "recent The Food and Drug Administration approval of idaruc",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -7.73828125,
            "text": "and Drug Administration approval of",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -7.73828125,
            "text": "The Food and Drug Administration approval of",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -8.0,
            "text": "recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.73828125,
            "text": "Food and Drug Administration approval of",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_38": [
        {
            "start_logit": 6.53515625,
            "end_logit": 6.6328125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -6.92578125,
            "text": "dabigatran-induced anticoagulation",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.09765625,
            "text": "dabigatran-induced",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.6328125,
            "text": "completely reversed dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.6328125,
            "text": "reversed dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": -7.19921875,
            "text": "5 g plus 2\u00b75 g idarucizumab (99% reduction).",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.0546875,
            "text": "idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -6.83203125,
            "end_logit": -6.90234375,
            "text": "idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -7.0546875,
            "text": "4 g idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -6.08984375,
            "text": "placebo",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.19921875,
            "text": "idarucizumab (98% reduction), and 0\u00b701 with 5 g plus 2\u00b75 g idarucizumab (99% reduction).",
            "probability": 0.0
        },
        {
            "start_logit": -6.83203125,
            "end_logit": -7.0546875,
            "text": "idarucizumab (94% reduction), 0\u00b702 with 4 g idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -6.90234375,
            "text": "rucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.375,
            "text": "idarucizumab (98%",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -7.0546875,
            "text": "rucizumab (94% reduction), 0\u00b702 with 4 g idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -7.0546875,
            "text": "rucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.46875,
            "text": "idarucizumab (98",
            "probability": 0.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -7.375,
            "text": "4 g idarucizumab (98%",
            "probability": 0.0
        },
        {
            "start_logit": -6.83203125,
            "end_logit": -7.375,
            "text": "idarucizumab (94% reduction), 0\u00b702 with 4 g idarucizumab (98%",
            "probability": 0.0
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -7.19921875,
            "text": "rucizumab (98% reduction), and 0\u00b701 with 5 g plus 2\u00b75 g idarucizumab (99% reduction).",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_39": [
        {
            "start_logit": 6.96484375,
            "end_logit": 5.98828125,
            "text": "Dabigatran",
            "probability": 0.9853515625
        },
        {
            "start_logit": 6.96484375,
            "end_logit": 1.7294921875,
            "text": "Dabigatran-Induced Anticoagulation",
            "probability": 0.013946533203125
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.53515625,
            "text": "Dabigatran-Induced Anticoagulation: A Systematic Review",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.6328125,
            "text": "Dabigatran-Induced Anticoagulation: A Systematic Review.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.71484375,
            "text": "Dabigatran-Induced",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.8046875,
            "text": "Dabigatran-Induced Anticoagulation: A",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.890625,
            "text": "Dabigatran-Induced Anticoagulation:",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.96875,
            "text": "Dabigatran-Induced Anticoagulation: A Systematic",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 5.98828125,
            "text": "Reversing Dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 5.98828125,
            "text": "Idarucizumab for Reversing Dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 5.98828125,
            "text": "rucizumab for Reversing Dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 5.98828125,
            "text": "izumab for Reversing Dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.7265625,
            "end_logit": 1.7294921875,
            "text": "Induced Anticoagulation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 1.7294921875,
            "text": "Anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": 1.7294921875,
            "text": "-Induced Anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 1.7294921875,
            "text": "Reversing Dabigatran-Induced Anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 1.7294921875,
            "text": "Idarucizumab for Reversing Dabigatran-Induced Anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": 1.7294921875,
            "text": "rucizumab for Reversing Dabigatran-Induced Anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 1.7294921875,
            "text": "izumab for Reversing Dabigatran-Induced Anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -5.7265625,
            "end_logit": -7.53515625,
            "text": "Induced Anticoagulation: A Systematic Review",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_1": [
        {
            "start_logit": 7.96875,
            "end_logit": 7.9296875,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 7.96875,
            "end_logit": -1.0478515625,
            "text": "lectin",
            "probability": 0.00012636184692382812
        },
        {
            "start_logit": -1.8740234375,
            "end_logit": 7.9296875,
            "text": "pathway",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": -3.939453125,
            "end_logit": 7.9296875,
            "text": "complement pathway",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -6.9140625,
            "text": "lectin complement pathway and SLE.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.24609375,
            "text": "lectin complement pathway and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.9296875,
            "text": "part of the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.9296875,
            "text": "the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.9296875,
            "text": "ficolins that are part of the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.9296875,
            "text": "of the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.9296875,
            "text": "are part of the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.9296875,
            "text": "olins that are part of the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.87109375,
            "text": "lectin complement",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.97265625,
            "text": "lectin complement pathway and SLE",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.9296875,
            "text": "between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.9296875,
            "text": "s that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.9296875,
            "text": "This study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.9296875,
            "text": "investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -1.0478515625,
            "text": "part of the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -1.0478515625,
            "text": "the lectin",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_2": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.890625,
            "text": "Lectin pathway",
            "probability": 1.0
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.1494140625,
            "text": "Lectin",
            "probability": 0.00011962652206420898
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": 7.890625,
            "text": "pathway",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.6953125,
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine serum albumin (acBS",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.2265625,
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine serum albumin (acBSA) and measured as Fic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.39453125,
            "text": "Lectin pathway activity via",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.43359375,
            "text": "Lectin pathway activity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.49609375,
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine serum albumin (acBSA) and measured as Ficolin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.51953125,
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine serum albumin (acBSA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.53125,
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.5390625,
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine serum albumin (acBSA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.5546875,
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.56640625,
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine serum albumin (acBSA) and measured as Ficolin-3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.56640625,
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.87744140625,
            "end_logit": -0.8505859375,
            "text": "complement",
            "probability": 0.0
        },
        {
            "start_logit": -6.21875,
            "end_logit": -0.8505859375,
            "text": "terminal complement",
            "probability": 0.0
        },
        {
            "start_logit": -6.890625,
            "end_logit": -0.8505859375,
            "text": "of C4, C3 and the terminal complement",
            "probability": 0.0
        },
        {
            "start_logit": -0.87744140625,
            "end_logit": -7.140625,
            "text": "complement complex (TCC",
            "probability": 0.0
        },
        {
            "start_logit": -0.87744140625,
            "end_logit": -7.3046875,
            "text": "complement complex (TCC).",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -0.8505859375,
            "text": "Ficolin-3 binding and deposition of C4, C3 and the terminal complement",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_3": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.83203125,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.54296875,
            "text": "lectin",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -2.125,
            "end_logit": 7.83203125,
            "text": "pathway",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 7.83203125,
            "text": "complement pathway",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.3828125,
            "text": "lectin complement",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.6171875,
            "text": "lectin complement pathway (LCP), in subarachnoid",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.62890625,
            "text": "lectin complement pathway (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.6484375,
            "text": "lectin complement pathway (LCP), in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.73828125,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH) pathology and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 7.83203125,
            "text": "the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.8515625,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.85546875,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH) pathology and outcome.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.86328125,
            "text": "lectin complement pathway (LCP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.87109375,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.9140625,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH) pathology",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 7.83203125,
            "text": "of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 7.83203125,
            "text": "OBJECTIVES: To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 7.83203125,
            "text": "initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 7.83203125,
            "text": ": To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": -1.54296875,
            "text": "the lectin",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_4": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.94921875,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.416015625,
            "text": "lectin",
            "probability": 8.547306060791016e-05
        },
        {
            "start_logit": -1.7138671875,
            "end_logit": 7.94921875,
            "text": "pathway",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": -4.66796875,
            "end_logit": 7.94921875,
            "text": "complement pathway",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.35546875,
            "text": "lectin complement pathway activation in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.30078125,
            "text": "lectin complement pathway activation in patients with subarachnoid",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.38671875,
            "text": "lectin complement",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.94921875,
            "text": "mediated lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.515625,
            "text": "lectin complement pathway activation in patients with subarachnoid hemorrhage.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.6640625,
            "text": "lectin complement pathway activation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.71875,
            "text": "lectin complement pathway activation in patients with subarachnoid hemorrhage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 7.94921875,
            "text": "Ficolin-3-mediated lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 7.94921875,
            "text": "3-mediated lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.078125,
            "text": "lectin complement pathway activation in patients with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7138671875,
            "end_logit": -6.35546875,
            "text": "pathway activation in",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -1.416015625,
            "text": "mediated lectin",
            "probability": 0.0
        },
        {
            "start_logit": -1.7138671875,
            "end_logit": -7.30078125,
            "text": "pathway activation in patients with subarachnoid",
            "probability": 0.0
        },
        {
            "start_logit": -1.7138671875,
            "end_logit": -7.515625,
            "text": "pathway activation in patients with subarachnoid hemorrhage.",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -1.416015625,
            "text": "Ficolin-3-mediated lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -1.416015625,
            "text": "3-mediated lectin",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_5": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.96484375,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -0.436767578125,
            "text": "lectin",
            "probability": 0.00022351741790771484
        },
        {
            "start_logit": -1.5927734375,
            "end_logit": 7.96484375,
            "text": "pathway",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -2.73046875,
            "end_logit": 7.96484375,
            "text": "complement pathway",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -2.94921875,
            "end_logit": 7.96484375,
            "text": "complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -5.5859375,
            "text": "lectin complement pathway initiators.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 7.96484375,
            "text": "among the lectin complement pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 7.96484375,
            "text": "Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.96484375,
            "text": "the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.96484375,
            "text": ", Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.4453125,
            "text": "lectin complement pathway initiator",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.5078125,
            "text": "lectin complement",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 7.96484375,
            "text": "is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 7.96484375,
            "text": "Moreover, Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 7.96484375,
            "text": "high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 7.96484375,
            "text": "has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.94921875,
            "end_logit": -0.436767578125,
            "text": "complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -2.94921875,
            "end_logit": -3.56640625,
            "text": "complement",
            "probability": 0.0
        },
        {
            "start_logit": -1.5927734375,
            "end_logit": -5.5859375,
            "text": "pathway initiators.",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -0.436767578125,
            "text": "among the lectin",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_6": [
        {
            "start_logit": 7.65625,
            "end_logit": 7.87109375,
            "text": "lectin pathway",
            "probability": 0.998046875
        },
        {
            "start_logit": 1.4091796875,
            "end_logit": 7.87109375,
            "text": "complement activation through the lectin pathway",
            "probability": 0.001926422119140625
        },
        {
            "start_logit": -1.83984375,
            "end_logit": 7.87109375,
            "text": "pathway",
            "probability": 7.474422454833984e-05
        },
        {
            "start_logit": 7.65625,
            "end_logit": -2.4453125,
            "text": "lectin",
            "probability": 3.2901763916015625e-05
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 7.87109375,
            "text": "LCP activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -5.93359375,
            "end_logit": 7.87109375,
            "text": "MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.34375,
            "end_logit": 7.87109375,
            "text": "mediated complement activation through the lectin pathway",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 7.87109375,
            "text": "through the lectin pathway",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 7.87109375,
            "text": "molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 7.87109375,
            "text": "Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 7.87109375,
            "text": "P activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 7.87109375,
            "text": "activation through the lectin pathway",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 7.87109375,
            "text": "appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.87109375,
            "text": "the lectin pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.87109375,
            "text": "olin-3 mediated complement activation through the lectin pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.65625,
            "end_logit": -7.4609375,
            "text": "lectin pathway.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.4091796875,
            "end_logit": -1.5,
            "text": "complement",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.4091796875,
            "end_logit": -2.4453125,
            "text": "complement activation through the lectin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.4091796875,
            "end_logit": -7.4609375,
            "text": "complement activation through the lectin pathway.",
            "probability": 0.0
        },
        {
            "start_logit": -5.140625,
            "end_logit": -1.5,
            "text": "MASP-3 among the LCP activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_7": [
        {
            "start_logit": 6.97265625,
            "end_logit": 7.640625,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": -2.560546875,
            "end_logit": 7.640625,
            "text": "pathway",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -3.154296875,
            "end_logit": 7.640625,
            "text": "complement pathway",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -2.81640625,
            "text": "lectin",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -5.40625,
            "end_logit": 7.640625,
            "text": "Ficolin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 7.640625,
            "text": "the lectin complement pathway",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 7.640625,
            "text": "ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 7.640625,
            "text": "in the lectin complement pathway",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -6.1640625,
            "text": "lectin complement pathway.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.640625,
            "text": "molecule in the lectin complement pathway",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.640625,
            "text": "Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 7.640625,
            "text": "3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 7.640625,
            "text": "-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.640625,
            "text": "is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 7.640625,
            "text": "H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 7.640625,
            "text": "antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 7.640625,
            "text": ") is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -7.63671875,
            "text": "lectin complement",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.40625,
            "end_logit": -2.81640625,
            "text": "Ficolin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -2.560546875,
            "end_logit": -6.1640625,
            "text": "pathway.",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_8": [
        {
            "start_logit": 7.3984375,
            "end_logit": 6.734375,
            "text": "lectin pathway",
            "probability": 1.0
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -2.9609375,
            "text": "lectin",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": -3.775390625,
            "end_logit": 6.734375,
            "text": "pathway",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -4.58984375,
            "text": "lectin pathway of the complement system",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.94921875,
            "text": "lectin pathway of the complement",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -6.53515625,
            "text": "lectin pathway of the complement system.",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 6.734375,
            "text": "Ficolin-3, encoded by the FCN3 gene and expressed in the lung and liver, is a recognition molecule in the lectin pathway",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.42578125,
            "text": "lectin pathway of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 6.734375,
            "text": "the lectin pathway",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.734375,
            "text": "in the lectin pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.734375,
            "text": "FCN3 gene and expressed in the lung and liver, is a recognition molecule in the lectin pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.734375,
            "text": "molecule in the lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.734375,
            "text": "is a recognition molecule in the lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.75,
            "end_logit": -4.58984375,
            "text": "complement system",
            "probability": 0.0
        },
        {
            "start_logit": -3.775390625,
            "end_logit": -4.58984375,
            "text": "pathway of the complement system",
            "probability": 0.0
        },
        {
            "start_logit": -6.65234375,
            "end_logit": -2.9609375,
            "text": "Ficolin-3, encoded by the FCN3 gene and expressed in the lung and liver, is a recognition molecule in the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -3.75,
            "end_logit": -5.94921875,
            "text": "complement",
            "probability": 0.0
        },
        {
            "start_logit": -3.775390625,
            "end_logit": -5.94921875,
            "text": "pathway of the complement",
            "probability": 0.0
        },
        {
            "start_logit": -6.875,
            "end_logit": -2.9609375,
            "text": "the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -3.75,
            "end_logit": -6.53515625,
            "text": "complement system.",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_9": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.94921875,
            "text": "lectin complement pathway",
            "probability": 0.98828125
        },
        {
            "start_logit": 3.384765625,
            "end_logit": 7.94921875,
            "text": "complement pathway",
            "probability": 0.01141357421875
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.4072265625,
            "text": "lectin",
            "probability": 8.511543273925781e-05
        },
        {
            "start_logit": -1.7060546875,
            "end_logit": 7.94921875,
            "text": "pathway",
            "probability": 7.003545761108398e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -6.65234375,
            "text": "lectin complement pathway and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -6.71875,
            "text": "lectin complement",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 7.94921875,
            "text": "Ficolin-1, -2 and -3 are recognition molecules in the lectin complement pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.94921875,
            "text": "the lectin complement pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 7.94921875,
            "text": "2 and -3 are recognition molecules in the lectin complement pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.94921875,
            "text": "in the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.3671875,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.54296875,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.546875,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.55078125,
            "text": "lectin complement pathway and form complexes with serine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.1287841796875,
            "end_logit": 0.4072265625,
            "text": "lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.625,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and -3 and two nonenzymatic proteins.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.625,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and -3 and two nonenzymatic proteins. MAS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.625,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.6328125,
            "text": "lectin complement pathway and form complexes with serine proteases named MAS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.63671875,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and -3 and two",
            "probability": 1.7881393432617188e-07
        }
    ],
    "56c1d856ef6e394741000032_10": [
        {
            "start_logit": 7.96875,
            "end_logit": 7.8359375,
            "text": "lectin pathway",
            "probability": 1.0
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.98388671875,
            "text": "lectin",
            "probability": 0.00014770030975341797
        },
        {
            "start_logit": -1.7548828125,
            "end_logit": 7.8359375,
            "text": "pathway",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -4.55078125,
            "text": "lectin pathway activator in vitro.",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 7.8359375,
            "text": "ficolins, Ficolin-3 has the highest concentration in serum and is the most potent lectin pathway",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.8359375,
            "text": "human ficolins, Ficolin-3 has the highest concentration in serum and is the most potent lectin pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 7.8359375,
            "text": "potent lectin pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.26953125,
            "text": "lectin pathway activator in vitro",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.8359375,
            "text": ". Amongst human ficolins, Ficolin-3 has the highest concentration in serum and is the most potent lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.8359375,
            "text": "Ficolin-3 has the highest concentration in serum and is the most potent lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.8359375,
            "text": "olins, Ficolin-3 has the highest concentration in serum and is the most potent lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.7548828125,
            "end_logit": -4.55078125,
            "text": "pathway activator in vitro.",
            "probability": 0.0
        },
        {
            "start_logit": -3.7890625,
            "end_logit": -3.41015625,
            "text": "complement",
            "probability": 0.0
        },
        {
            "start_logit": -6.2890625,
            "end_logit": -0.98388671875,
            "text": "ficolins, Ficolin-3 has the highest concentration in serum and is the most potent lectin",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -0.98388671875,
            "text": "human ficolins, Ficolin-3 has the highest concentration in serum and is the most potent lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -0.98388671875,
            "text": "potent lectin",
            "probability": 0.0
        },
        {
            "start_logit": -3.7890625,
            "end_logit": -4.55078125,
            "text": "complement-activating pattern recognition molecule, possessing a fibrinogen-like domain involved in carbohydrate binding.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -0.98388671875,
            "text": ". Amongst human ficolins, Ficolin-3 has the highest concentration in serum and is the most potent lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -0.98388671875,
            "text": "Ficolin-3 has the highest concentration in serum and is the most potent lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -0.98388671875,
            "text": "olins, Ficolin-3 has the highest concentration in serum and is the most potent lectin",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_11": [
        {
            "start_logit": 7.65625,
            "end_logit": 7.87109375,
            "text": "lectin pathway",
            "probability": 0.998046875
        },
        {
            "start_logit": 1.4091796875,
            "end_logit": 7.87109375,
            "text": "complement activation through the lectin pathway",
            "probability": 0.001926422119140625
        },
        {
            "start_logit": -1.83984375,
            "end_logit": 7.87109375,
            "text": "pathway",
            "probability": 7.474422454833984e-05
        },
        {
            "start_logit": 7.65625,
            "end_logit": -2.4453125,
            "text": "lectin",
            "probability": 3.2901763916015625e-05
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 7.87109375,
            "text": "LCP activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -5.93359375,
            "end_logit": 7.87109375,
            "text": "MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.34375,
            "end_logit": 7.87109375,
            "text": "mediated complement activation through the lectin pathway",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 7.87109375,
            "text": "through the lectin pathway",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 7.87109375,
            "text": "molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 7.87109375,
            "text": "Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 7.87109375,
            "text": "P activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 7.87109375,
            "text": "activation through the lectin pathway",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 7.87109375,
            "text": "appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.87109375,
            "text": "the lectin pathway",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.87109375,
            "text": "olin-3 mediated complement activation through the lectin pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.65625,
            "end_logit": -7.4609375,
            "text": "lectin pathway.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.4091796875,
            "end_logit": -1.5,
            "text": "complement",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.4091796875,
            "end_logit": -2.4453125,
            "text": "complement activation through the lectin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.4091796875,
            "end_logit": -7.4609375,
            "text": "complement activation through the lectin pathway.",
            "probability": 0.0
        },
        {
            "start_logit": -5.140625,
            "end_logit": -1.5,
            "text": "MASP-3 among the LCP activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_12": [
        {
            "start_logit": 7.76953125,
            "end_logit": 7.73828125,
            "text": "lectin pathway",
            "probability": 1.0
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -1.9931640625,
            "text": "lectin pathway of complement",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -2.203125,
            "text": "lectin",
            "probability": 4.83393669128418e-05
        },
        {
            "start_logit": -2.263671875,
            "end_logit": 7.73828125,
            "text": "pathway",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 7.73828125,
            "text": "LPS/ficolin-3 complexes activated the lectin pathway",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 7.73828125,
            "text": "activated the lectin pathway",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -6.96875,
            "text": "lectin pathway of complement in a C4",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.0078125,
            "text": "lectin pathway of complement in",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.06640625,
            "text": "lectin pathway of complement in a C4b-deposition assay in a calcium- and magnesium-dependent way.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.11328125,
            "text": "lectin pathway of complement in a C4b",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 7.73828125,
            "text": "these LPS/ficolin-3 complexes activated the lectin pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.73828125,
            "text": "complexes activated the lectin pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.5,
            "text": "lectin pathway of complement in a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.6640625,
            "text": "lectin pathway of complement in a C4b-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.73828125,
            "text": ", these LPS/ficolin-3 complexes activated the lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.73828125,
            "text": "ficolin-3 complexes activated the lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.75,
            "text": "lectin pathway of complement in a C4b-deposition",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.73828125,
            "text": "Moreover, these LPS/ficolin-3 complexes activated the lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 7.73828125,
            "text": "/ficolin-3 complexes activated the lectin pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.8515625,
            "text": "lectin pathway of complement in a C4b-deposition assay in a",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5a7639419e632bc066000005_1": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.9453125,
            "text": "DeepLoc",
            "probability": 1.0
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.6171875,
            "text": "Deep",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": -1.71484375,
            "end_logit": 7.9453125,
            "text": "c",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -6.24609375,
            "end_logit": 7.9453125,
            "text": "Loc",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.91796875,
            "text": "DeepLo",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.61328125,
            "text": "DeepLoc:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.99609375,
            "text": "DeepLoc: prediction of protein subcellular localization using",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.0625,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.0859375,
            "text": "DeepLoc: prediction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.125,
            "text": "DeepLoc: prediction of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.1328125,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.1875,
            "text": "DeepLoc: prediction of protein subcellular localization using deep",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.2421875,
            "text": "DeepLoc: prediction of protein subcellular",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.2578125,
            "text": "DeepLoc: prediction of protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -7.61328125,
            "text": "c:",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -7.99609375,
            "text": "c: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -8.0625,
            "text": "c: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -8.0859375,
            "text": "c: prediction",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -8.125,
            "text": "c: prediction of",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -8.1328125,
            "text": "c: prediction of protein subcellular localization using deep learning.",
            "probability": 0.0
        }
    ],
    "5a7639419e632bc066000005_2": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.9453125,
            "text": "DeepLoc",
            "probability": 1.0
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.6171875,
            "text": "Deep",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": -1.71484375,
            "end_logit": 7.9453125,
            "text": "c",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -6.24609375,
            "end_logit": 7.9453125,
            "text": "Loc",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.91796875,
            "text": "DeepLo",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.61328125,
            "text": "DeepLoc:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.99609375,
            "text": "DeepLoc: prediction of protein subcellular localization using",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.0625,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.0859375,
            "text": "DeepLoc: prediction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.125,
            "text": "DeepLoc: prediction of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.1328125,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.1875,
            "text": "DeepLoc: prediction of protein subcellular localization using deep",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.2421875,
            "text": "DeepLoc: prediction of protein subcellular",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.2578125,
            "text": "DeepLoc: prediction of protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -7.61328125,
            "text": "c:",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -7.99609375,
            "text": "c: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -8.0625,
            "text": "c: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -8.0859375,
            "text": "c: prediction",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -8.125,
            "text": "c: prediction of",
            "probability": 0.0
        },
        {
            "start_logit": -1.71484375,
            "end_logit": -8.1328125,
            "text": "c: prediction of protein subcellular localization using deep learning.",
            "probability": 0.0
        }
    ],
    "53442023aeec6fbd07000007_1": [
        {
            "start_logit": 1.4453125,
            "end_logit": 4.30078125,
            "text": "aspin phosphorylates histone H3",
            "probability": 0.9091796875
        },
        {
            "start_logit": -0.8876953125,
            "end_logit": 4.30078125,
            "text": "histone H3",
            "probability": 0.08831787109375
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 4.30078125,
            "text": "H3",
            "probability": 0.0007405281066894531
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 4.30078125,
            "text": "in phosphorylates histone H3",
            "probability": 0.0004703998565673828
        },
        {
            "start_logit": -6.24609375,
            "end_logit": 4.30078125,
            "text": "phosphorylates histone H3",
            "probability": 0.0004153251647949219
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -4.94140625,
            "text": "aspin phosphorylates histone H3 at",
            "probability": 8.809566497802734e-05
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 4.30078125,
            "text": "ates histone H3",
            "probability": 8.344650268554688e-05
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -6.1796875,
            "text": "aspin phosphorylates histone H3 at Thr3",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -6.55859375,
            "text": "aspin phosphorylates",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -6.78125,
            "text": "aspin phosphorylates histone H3 at Thr3 (H3T3ph)",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -6.7890625,
            "text": "aspin phosphorylates histone H3 at Thr",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -6.80078125,
            "text": "aspin phosphorylates histone H3 at Thr3 (H3T3ph",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -7.25390625,
            "text": "asp",
            "probability": 8.702278137207031e-06
        },
        {
            "start_logit": -0.8876953125,
            "end_logit": -4.94140625,
            "text": "histone H3 at",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -7.44140625,
            "text": "aspin phosphorylates histone H3 at Thr3 (H3T3",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -7.4453125,
            "text": "aspin phosphorylates histone H3 at Thr3 (H3",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -7.45703125,
            "text": "aspin phosphoryl",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -7.73828125,
            "text": "aspin",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 1.4453125,
            "end_logit": -7.984375,
            "text": "aspin phosphorylates histone H3 at Thr3 (",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -0.8876953125,
            "end_logit": -6.1796875,
            "text": "histone H3 at Thr3",
            "probability": 2.5033950805664062e-06
        }
    ],
    "53442023aeec6fbd07000007_2": [
        {
            "start_logit": 5.046875,
            "end_logit": -2.48046875,
            "text": "phosphorylation of histone H3",
            "probability": 0.62841796875
        },
        {
            "start_logit": 5.046875,
            "end_logit": -3.810546875,
            "text": "phosphorylation of histone H3 at Thr3 residue (H3T3ph",
            "probability": 0.166259765625
        },
        {
            "start_logit": 5.046875,
            "end_logit": -3.904296875,
            "text": "phosphorylation of",
            "probability": 0.1513671875
        },
        {
            "start_logit": 5.046875,
            "end_logit": -5.57421875,
            "text": "phosphorylation",
            "probability": 0.0284881591796875
        },
        {
            "start_logit": 5.046875,
            "end_logit": -6.95703125,
            "text": "phosphorylation of histone H3 at",
            "probability": 0.007152557373046875
        },
        {
            "start_logit": 5.046875,
            "end_logit": -7.37109375,
            "text": "phosphorylation of histone H3 at Thr3",
            "probability": 0.00472259521484375
        },
        {
            "start_logit": 5.046875,
            "end_logit": -7.49609375,
            "text": "phosphorylation of histone H3 at Thr3 residue (H3T3",
            "probability": 0.004169464111328125
        },
        {
            "start_logit": 5.046875,
            "end_logit": -7.515625,
            "text": "phosphorylation of histone H3 at Thr3 residue",
            "probability": 0.00408935546875
        },
        {
            "start_logit": 5.046875,
            "end_logit": -7.98828125,
            "text": "phosphorylation of histone H3 at Thr3 residue (H3T3ph)",
            "probability": 0.0025482177734375
        },
        {
            "start_logit": 5.046875,
            "end_logit": -8.046875,
            "text": "phosphorylation of histone H3 at Thr3 residue (H3",
            "probability": 0.00240325927734375
        },
        {
            "start_logit": -3.998046875,
            "end_logit": -2.48046875,
            "text": "histone H3",
            "probability": 7.402896881103516e-05
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -2.48046875,
            "text": "Haspin is a protein kinase the only known target of which is phosphorylation of histone H3",
            "probability": 4.4226646423339844e-05
        },
        {
            "start_logit": -3.998046875,
            "end_logit": -3.810546875,
            "text": "histone H3 at Thr3 residue (H3T3ph",
            "probability": 1.9609928131103516e-05
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -3.810546875,
            "text": "Haspin is a protein kinase the only known target of which is phosphorylation of histone H3 at Thr3 residue (H3T3ph",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -3.904296875,
            "text": "Haspin is a protein kinase the only known target of which is phosphorylation of",
            "probability": 1.0669231414794922e-05
        },
        {
            "start_logit": -5.50390625,
            "end_logit": -3.810546875,
            "text": "H3T3ph",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.5625,
            "end_logit": -2.48046875,
            "text": "pin is a protein kinase the only known target of which is phosphorylation of histone H3",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -5.57421875,
            "text": "Haspin is a protein kinase the only known target of which is phosphorylation",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.734375,
            "end_logit": -2.48046875,
            "text": "of histone H3",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -2.48046875,
            "text": "H3",
            "probability": 1.7881393432617188e-06
        }
    ],
    "54e0d7471388e8454a000015_1": [
        {
            "start_logit": 7.95703125,
            "end_logit": 7.98046875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -1.5810546875,
            "text": "interleukin",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": 7.98046875,
            "text": "17A",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.98046875,
            "text": "-17A",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.33984375,
            "text": "interleukin-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.98046875,
            "text": "-interleukin-17A",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -8.0234375,
            "text": "interleukin-17A monoclonal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -8.0234375,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": -1.5810546875,
            "text": "-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": -8.0234375,
            "text": "17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": -8.0234375,
            "text": "17A monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -7.33984375,
            "text": "-",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -8.0234375,
            "text": "-17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -8.0234375,
            "text": "-17A monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.33984375,
            "text": "-interleukin-",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -8.0234375,
            "text": "-interleukin-17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -8.0234375,
            "text": "-interleukin-17A monoclonal antibody",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_2": [
        {
            "start_logit": 7.9609375,
            "end_logit": 7.98828125,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.5419921875,
            "end_logit": 7.98828125,
            "text": "17A",
            "probability": 7.426738739013672e-05
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -1.5380859375,
            "text": "interleukin",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 7.98828125,
            "text": "-17A",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.23828125,
            "text": "interleukin-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.98828125,
            "text": "-interleukin-17A",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 7.98828125,
            "text": "fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.95703125,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.9609375,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.96484375,
            "text": "interleukin-17A monoclonal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.96875,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.98046875,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -8.0,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -8.0,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -8.0,
            "text": "interleukin-17A monoclonal antibody, demonstrated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -8.03125,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -8.0703125,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -8.0703125,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -8.0703125,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -1.5380859375,
            "text": "-interleukin",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_3": [
        {
            "start_logit": 7.95703125,
            "end_logit": 7.99609375,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.5546875,
            "end_logit": 7.99609375,
            "text": "17A",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -1.5615234375,
            "text": "interleukin",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": -6.453125,
            "end_logit": 7.99609375,
            "text": "-17A",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.23046875,
            "text": "interleukin-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.99609375,
            "text": "-interleukin-17A",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.73046875,
            "text": "interleukin-17A monoclonal antibody, in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.7890625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.85546875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.91015625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.93359375,
            "text": "interleukin-17A monoclonal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.94921875,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.953125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.9765625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -8.0,
            "text": "interleukin-17A monoclonal antibody, in patients",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.99609375,
            "text": "fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -1.5615234375,
            "text": "-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -1.5546875,
            "end_logit": -7.73046875,
            "text": "17A monoclonal antibody, in",
            "probability": 0.0
        },
        {
            "start_logit": -1.5546875,
            "end_logit": -7.7890625,
            "text": "17A monoclonal antibody, in patients with moderate-to",
            "probability": 0.0
        },
        {
            "start_logit": -1.5546875,
            "end_logit": -7.85546875,
            "text": "17A monoclonal antibody, in patients with moderate-to-",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_4": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.97265625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.673828125,
            "end_logit": 7.97265625,
            "text": "17A",
            "probability": 6.711483001708984e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.73828125,
            "text": "interleukin",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 7.97265625,
            "text": "-17A",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.890625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.46875,
            "text": "interleukin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.58203125,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.765625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.7890625,
            "text": "interleukin-17A monoclonal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.7890625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.80859375,
            "text": "interleukin-17A monoclonal antibody secukinumab in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.8359375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.84375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.84765625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.85546875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 7.97265625,
            "text": "-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.90234375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.91796875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.94140625,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.9765625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54e0d7471388e8454a000015_5": [
        {
            "start_logit": 7.95703125,
            "end_logit": 7.98046875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -1.546875,
            "text": "interleukin",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -1.5712890625,
            "end_logit": 7.98046875,
            "text": "17A",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -6.328125,
            "end_logit": 7.98046875,
            "text": "-17A",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.4296875,
            "text": "interleukin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.59765625,
            "text": "interleukin-17A monoclonal antibody, in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.61328125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.6328125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 7.98046875,
            "text": "-interleukin-17A",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.69921875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.69921875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.70703125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.70703125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.73046875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.765625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.7734375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.81640625,
            "text": "interleukin-17A monoclonal antibody, in patients with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.98046875,
            "text": "fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.98046875,
            "text": "human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.98046875,
            "text": "anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54e0d7471388e8454a000015_6": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.98046875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.615234375,
            "end_logit": 7.98046875,
            "text": "17A",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.6640625,
            "text": "interleukin",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": -6.59375,
            "end_logit": 7.98046875,
            "text": "-17A",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.34375,
            "text": "interleukin-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.65234375,
            "text": "interleukin-17A blockade, in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.90625,
            "text": "interleukin-17A blockade",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 7.98046875,
            "text": "targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.98046875,
            "text": "fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.92578125,
            "text": "interleukin-17A blockade, in patients with noninfectious",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.9609375,
            "text": "interleukin-17A blockade, in patients with nonin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 7.98046875,
            "text": "PURPOSE: To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -7.65234375,
            "text": "17A blockade, in",
            "probability": 0.0
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -7.90625,
            "text": "17A blockade",
            "probability": 0.0
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -7.92578125,
            "text": "17A blockade, in patients with noninfectious",
            "probability": 0.0
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -7.9609375,
            "text": "17A blockade, in patients with nonin",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -1.6640625,
            "text": "targeted interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -1.6640625,
            "text": "fully human monoclonal antibody for targeted interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -1.6640625,
            "text": "PURPOSE: To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -6.59375,
            "end_logit": -7.34375,
            "text": "-",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_7": [
        {
            "start_logit": 7.89453125,
            "end_logit": 7.96484375,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.6767578125,
            "end_logit": 7.96484375,
            "text": "17A",
            "probability": 6.979703903198242e-05
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -1.8876953125,
            "text": "interleukin",
            "probability": 5.269050598144531e-05
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 7.96484375,
            "text": "-17A",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.4453125,
            "text": "interleukin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.640625,
            "text": "interleukin-17A-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.76953125,
            "text": "interleukin-17A-blocking antibody secukinumab does",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.7734375,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.77734375,
            "text": "interleukin-17A-blocking",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.79296875,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.8125,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.82421875,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.82421875,
            "text": "interleukin-17A-blocking antibody secukinumab does not",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.8359375,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.8671875,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.8828125,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.89453125,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.8984375,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.90234375,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6767578125,
            "end_logit": -7.640625,
            "text": "17A-",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_8": [
        {
            "start_logit": 7.96875,
            "end_logit": 7.97265625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": 7.96875,
            "end_logit": -1.3115234375,
            "text": "interleukin",
            "probability": 9.316205978393555e-05
        },
        {
            "start_logit": -1.5859375,
            "end_logit": 7.97265625,
            "text": "17A",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.4375,
            "text": "interleukin-17A (IL-17A",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 7.97265625,
            "text": "-17A",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.43359375,
            "text": "interleukin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.71875,
            "text": "interleukin-17A (IL-17A)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.73828125,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.97265625,
            "text": "-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5859375,
            "end_logit": -5.4375,
            "text": "17A (IL-17A",
            "probability": 0.0
        },
        {
            "start_logit": -1.5859375,
            "end_logit": -7.71875,
            "text": "17A (IL-17A)",
            "probability": 0.0
        },
        {
            "start_logit": -1.5859375,
            "end_logit": -7.73828125,
            "text": "17A (IL-17A) monoclonal antibody (",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -1.3115234375,
            "text": "-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -5.4375,
            "text": "-17A (IL-17A",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -5.4375,
            "text": "IL-17A",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -5.4375,
            "text": "17A",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -5.4375,
            "text": "-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -5.4375,
            "text": "-interleukin-17A (IL-17A",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -7.43359375,
            "text": "-",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -7.71875,
            "text": "-17A (IL-17A)",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_1": [
        {
            "start_logit": 1.6337890625,
            "end_logit": 7.83984375,
            "text": "APP.V717I",
            "probability": 0.9267578125
        },
        {
            "start_logit": -1.7421875,
            "end_logit": 7.83984375,
            "text": "amyloid precursor protein (APP.V717I",
            "probability": 0.031585693359375
        },
        {
            "start_logit": -2.1015625,
            "end_logit": 7.83984375,
            "text": "I",
            "probability": 0.0220489501953125
        },
        {
            "start_logit": -3.1171875,
            "end_logit": 7.83984375,
            "text": ".V717I",
            "probability": 0.00798797607421875
        },
        {
            "start_logit": -3.6015625,
            "end_logit": 7.83984375,
            "text": "human amyloid precursor protein (APP.V717I",
            "probability": 0.00492095947265625
        },
        {
            "start_logit": -3.623046875,
            "end_logit": 7.83984375,
            "text": "V717I",
            "probability": 0.004825592041015625
        },
        {
            "start_logit": -6.1640625,
            "end_logit": 7.83984375,
            "text": "717I",
            "probability": 0.00037932395935058594
        },
        {
            "start_logit": -6.41015625,
            "end_logit": 7.83984375,
            "text": "the human amyloid precursor protein (APP.V717I",
            "probability": 0.0002968311309814453
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 7.83984375,
            "text": "precursor protein (APP.V717I",
            "probability": 0.00029206275939941406
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 7.83984375,
            "text": "(APP.V717I",
            "probability": 0.00023114681243896484
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 7.83984375,
            "text": "harboring London mutation of the human amyloid precursor protein (APP.V717I",
            "probability": 0.0002071857452392578
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.83984375,
            "text": "mice harboring London mutation of the human amyloid precursor protein (APP.V717I",
            "probability": 0.00018274784088134766
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 7.83984375,
            "text": "7I",
            "probability": 0.00017571449279785156
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 7.83984375,
            "text": "transgenic mice harboring London mutation of the human amyloid precursor protein (APP.V717I",
            "probability": 0.00015151500701904297
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.83984375,
            "text": "of the human amyloid precursor protein (APP.V717I",
            "probability": 9.47713851928711e-05
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.83984375,
            "text": "protein (APP.V717I",
            "probability": 8.767843246459961e-05
        },
        {
            "start_logit": 1.6337890625,
            "end_logit": -5.19140625,
            "text": "APP.V717I)",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 1.6337890625,
            "end_logit": -5.5234375,
            "text": "APP.V717",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 1.6337890625,
            "end_logit": -5.9296875,
            "text": "APP",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -1.7421875,
            "end_logit": -2.814453125,
            "text": "amyloid precursor protein",
            "probability": 7.748603820800781e-07
        }
    ],
    "58b6978822d300530900000a_2": [
        {
            "start_logit": 8.015625,
            "end_logit": 7.97265625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.015625,
            "end_logit": -1.384765625,
            "text": "Alzheimer",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": -1.56640625,
            "end_logit": 7.97265625,
            "text": "disease",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 7.97265625,
            "text": "s disease",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.97265625,
            "text": "'s disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -6.97265625,
            "text": "Alzheimer'",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.17578125,
            "text": "Alzheimer's",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 7.97265625,
            "text": "the Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 7.97265625,
            "text": "new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.97265625,
            "text": "of the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.97265625,
            "text": "into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.97265625,
            "text": "insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.97265625,
            "text": "in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.97265625,
            "text": "study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.97265625,
            "text": "The novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.97265625,
            "text": "paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 7.97265625,
            "text": "dysfunctions of the Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.84375,
            "text": "Alzheimer's disease mouse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.2265625,
            "text": "Alzheimer's disease mouse model.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.3203125,
            "text": "Alzheimer's disease mouse model",
            "probability": 5.960464477539063e-08
        }
    ],
    "58b6978822d300530900000a_3": [
        {
            "start_logit": 7.890625,
            "end_logit": 6.390625,
            "text": "Alzheimer's disease (AD)",
            "probability": 0.57177734375
        },
        {
            "start_logit": 7.890625,
            "end_logit": 6.1015625,
            "text": "Alzheimer's disease",
            "probability": 0.42822265625
        },
        {
            "start_logit": 7.890625,
            "end_logit": -2.009765625,
            "text": "Alzheimer",
            "probability": 0.00012874603271484375
        },
        {
            "start_logit": -3.849609375,
            "end_logit": 6.390625,
            "text": "disease (AD)",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": -4.0234375,
            "end_logit": 6.390625,
            "text": ")",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -3.849609375,
            "end_logit": 6.1015625,
            "text": "disease",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -4.4453125,
            "end_logit": 6.390625,
            "text": "AD)",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 7.890625,
            "end_logit": -6.2578125,
            "text": "Alzheimer'",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.890625,
            "end_logit": -6.5859375,
            "text": "Alzheimer's disease (AD) is the massive loss of synapses that occurs at an early clinical stage of the disease",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.890625,
            "end_logit": -6.60546875,
            "text": "Alzheimer's",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.890625,
            "end_logit": -6.67578125,
            "text": "Alzheimer's disease (AD",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 6.390625,
            "text": "s disease (AD)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 6.390625,
            "text": "of Alzheimer's disease (AD)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 6.1015625,
            "text": "s disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 6.1015625,
            "text": "of Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.265625,
            "end_logit": -4.734375,
            "text": "the Swedish",
            "probability": 0.0
        },
        {
            "start_logit": 1.265625,
            "end_logit": -6.24609375,
            "text": "the Swedish mutation",
            "probability": 0.0
        },
        {
            "start_logit": 1.265625,
            "end_logit": -6.41015625,
            "text": "the Swedish mutation, compared with wild-type littermates. A similar reduction of 42",
            "probability": 0.0
        },
        {
            "start_logit": 1.265625,
            "end_logit": -6.5078125,
            "text": "the Swedish mutation, compared with wild-type littermates. A similar reduction of 42%",
            "probability": 0.0
        },
        {
            "start_logit": 1.265625,
            "end_logit": -6.53515625,
            "text": "the Swedish mutation, compared with wild-type",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_4": [
        {
            "start_logit": 7.91015625,
            "end_logit": 7.95703125,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": 7.95703125,
            "text": "disease",
            "probability": 6.252527236938477e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -1.9501953125,
            "text": "Alzheimer",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -3.599609375,
            "end_logit": 7.95703125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 7.95703125,
            "text": "s disease",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.421875,
            "end_logit": 7.95703125,
            "text": "717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.625,
            "end_logit": 7.95703125,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 7.95703125,
            "text": "'s disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -6.80859375,
            "text": "Alzheimer'",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.95703125,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 7.95703125,
            "text": "7Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -6.98828125,
            "text": "Alzheimer's",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.95703125,
            "text": "onset Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.95703125,
            "text": "mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.95703125,
            "text": "London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 7.95703125,
            "text": "with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.77734375,
            "text": "Alzheimer's disease.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.95703125,
            "text": "early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.599609375,
            "end_logit": -1.31640625,
            "text": "Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -3.599609375,
            "end_logit": -1.9501953125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_5": [
        {
            "start_logit": 6.48828125,
            "end_logit": 6.640625,
            "text": "AD",
            "probability": 0.5
        },
        {
            "start_logit": 6.48046875,
            "end_logit": 6.6484375,
            "text": "AD",
            "probability": 0.5
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 6.640625,
            "text": ". Two subjects of the other family with AD",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.27734375,
            "text": "AD in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.640625,
            "text": "with AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.6484375,
            "text": "mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.640625,
            "text": "family with AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.6484375,
            "text": "this mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.6484375,
            "text": ", this mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.6484375,
            "text": "In 1 family, this mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.6484375,
            "text": "responsible for AD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.640625,
            "text": "subjects of the other family with AD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.73046875,
            "text": "AD diagnosis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.76171875,
            "text": "AD in 3 out of 7",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.8125,
            "text": "AD in 3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.81640625,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.83984375,
            "text": "AD diagnosis were carriers of the same",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.85546875,
            "text": "AD diagnosis were carriers of the same mutation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.88671875,
            "text": "AD in 3 out of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.90234375,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only",
            "probability": 2.384185791015625e-07
        }
    ],
    "58b6978822d300530900000a_6": [
        {
            "start_logit": 6.48828125,
            "end_logit": 6.640625,
            "text": "AD",
            "probability": 0.5
        },
        {
            "start_logit": 6.48046875,
            "end_logit": 6.6484375,
            "text": "AD",
            "probability": 0.5
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 6.640625,
            "text": ". Two subjects of the other family with AD",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.27734375,
            "text": "AD in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.640625,
            "text": "with AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.6484375,
            "text": "mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.640625,
            "text": "family with AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.6484375,
            "text": "this mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.6484375,
            "text": ", this mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.6484375,
            "text": "In 1 family, this mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.6484375,
            "text": "responsible for AD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.640625,
            "text": "subjects of the other family with AD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.73046875,
            "text": "AD diagnosis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.76171875,
            "text": "AD in 3 out of 7",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.8125,
            "text": "AD in 3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.81640625,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.83984375,
            "text": "AD diagnosis were carriers of the same",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48828125,
            "end_logit": -7.85546875,
            "text": "AD diagnosis were carriers of the same mutation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.88671875,
            "text": "AD in 3 out of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.90234375,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only",
            "probability": 2.384185791015625e-07
        }
    ],
    "58b6978822d300530900000a_7": [
        {
            "start_logit": 6.29296875,
            "end_logit": 6.62109375,
            "text": "AD",
            "probability": 0.26025390625
        },
        {
            "start_logit": 6.3046875,
            "end_logit": 6.58984375,
            "text": "AD",
            "probability": 0.254150390625
        },
        {
            "start_logit": 6.29296875,
            "end_logit": 6.58984375,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 0.252197265625
        },
        {
            "start_logit": 6.2578125,
            "end_logit": 6.546875,
            "text": "AD",
            "probability": 0.2332763671875
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 6.62109375,
            "text": "of AD",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 6.58984375,
            "text": "of AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -4.3046875,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -5.171875,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 6.62109375,
            "text": "amyloid precursor protein (APP). Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.265625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.359375,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.5546875,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.828125,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW))",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 6.62109375,
            "text": "of amyloid precursor protein (APP). Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.390625,
            "end_logit": 6.62109375,
            "text": "form (<60 years old) of AD",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.390625,
            "end_logit": 6.58984375,
            "text": "form (<60 years old) of AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -6.16796875,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -6.22265625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -6.39453125,
            "text": "AD.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.39453125,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD.",
            "probability": 5.960464477539062e-07
        }
    ],
    "58b6978822d300530900000a_8": [
        {
            "start_logit": 6.29296875,
            "end_logit": 6.62109375,
            "text": "AD",
            "probability": 0.26025390625
        },
        {
            "start_logit": 6.3046875,
            "end_logit": 6.58984375,
            "text": "AD",
            "probability": 0.254150390625
        },
        {
            "start_logit": 6.29296875,
            "end_logit": 6.58984375,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 0.252197265625
        },
        {
            "start_logit": 6.2578125,
            "end_logit": 6.546875,
            "text": "AD",
            "probability": 0.2332763671875
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 6.62109375,
            "text": "of AD",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 6.58984375,
            "text": "of AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -4.3046875,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -5.171875,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 6.62109375,
            "text": "amyloid precursor protein (APP). Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.265625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.359375,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.5546875,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.828125,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW))",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 6.62109375,
            "text": "of amyloid precursor protein (APP). Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.390625,
            "end_logit": 6.62109375,
            "text": "form (<60 years old) of AD",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.390625,
            "end_logit": 6.58984375,
            "text": "form (<60 years old) of AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -6.16796875,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -6.22265625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -6.39453125,
            "text": "AD.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.39453125,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD.",
            "probability": 5.960464477539062e-07
        }
    ],
    "58b6978822d300530900000a_9": [
        {
            "start_logit": 6.29296875,
            "end_logit": 6.62109375,
            "text": "AD",
            "probability": 0.26025390625
        },
        {
            "start_logit": 6.3046875,
            "end_logit": 6.58984375,
            "text": "AD",
            "probability": 0.254150390625
        },
        {
            "start_logit": 6.29296875,
            "end_logit": 6.58984375,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 0.252197265625
        },
        {
            "start_logit": 6.2578125,
            "end_logit": 6.546875,
            "text": "AD",
            "probability": 0.2332763671875
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 6.62109375,
            "text": "of AD",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 6.58984375,
            "text": "of AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -4.3046875,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -5.171875,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 6.62109375,
            "text": "amyloid precursor protein (APP). Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.265625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.359375,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.5546875,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -5.828125,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW))",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 6.62109375,
            "text": "of amyloid precursor protein (APP). Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.390625,
            "end_logit": 6.62109375,
            "text": "form (<60 years old) of AD",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.390625,
            "end_logit": 6.58984375,
            "text": "form (<60 years old) of AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -6.16796875,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -6.22265625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -6.39453125,
            "text": "AD.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.39453125,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD.",
            "probability": 5.960464477539062e-07
        }
    ],
    "58b6978822d300530900000a_10": [
        {
            "start_logit": 6.32421875,
            "end_logit": 6.6484375,
            "text": "AD",
            "probability": 1.0
        },
        {
            "start_logit": -3.81640625,
            "end_logit": 6.6484375,
            "text": "APP(SW) and APP(LON) in AD",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": -5.87890625,
            "end_logit": 6.6484375,
            "text": "APP(LON) in AD",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 6.6484375,
            "text": "of APP(SW) and APP(LON) in AD",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.578125,
            "end_logit": 6.6484375,
            "text": "and APP(LON) in AD",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -6.32421875,
            "text": "AD development.",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 6.6484375,
            "text": "in AD",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 6.6484375,
            "text": "investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.03125,
            "end_logit": 6.6484375,
            "text": ") in AD",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 6.6484375,
            "text": ") and APP(LON) in AD",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 6.6484375,
            "text": "the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -1.515625,
            "end_logit": -2.75,
            "text": "APP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.515625,
            "end_logit": -3.76953125,
            "text": "APP(SW) and APP",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -4.2265625,
            "text": "APP(SW)",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -5.59375,
            "text": "APP(",
            "probability": 0.0
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -3.875,
            "text": "APP",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -6.203125,
            "text": "APP(SW) and APP(LON) as",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -6.58984375,
            "text": "APP(SW",
            "probability": 0.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": -6.63671875,
            "text": "APP(SW) and APP(LON",
            "probability": 0.0
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -4.39453125,
            "text": "APP(SW) and APP",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_11": [
        {
            "start_logit": 7.63671875,
            "end_logit": 7.97265625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": 7.97265625,
            "text": "disease",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -2.796875,
            "text": "Alzheimer",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -5.4296875,
            "end_logit": 7.97265625,
            "text": "familial Alzheimer's disease",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 7.97265625,
            "text": "amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.07421875,
            "end_logit": 7.97265625,
            "text": "s disease",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 7.97265625,
            "text": "type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 7.97265625,
            "text": "'s disease",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -6.48046875,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant and wild-type allelic",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -6.87890625,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant and wild-type",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 7.97265625,
            "text": "variants related to familial Alzheimer's disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.05859375,
            "text": "Alzheimer's disease using",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.18359375,
            "text": "Alzheimer'",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.97265625,
            "text": "precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.27734375,
            "text": "Alzheimer's disease using two reporter alleles encoding the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.97265625,
            "text": "to familial Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.328125,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.515625,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.5625,
            "text": "Alzheimer's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.6484375,
            "text": "Alzheimer's disease using two reporter alleles encoding the Phot",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58b6978822d300530900000a_12": [
        {
            "start_logit": 6.48046875,
            "end_logit": 7.94921875,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 7.94921875,
            "text": "disease",
            "probability": 0.0002493858337402344
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -1.7275390625,
            "text": "Alzheimer's disease (V642I",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -4.55859375,
            "text": "Alzheimer",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 7.94921875,
            "text": "s disease",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -6.6875,
            "end_logit": 7.94921875,
            "text": "'s disease",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 7.94921875,
            "text": "amyloid precursor protein (APP, 695 isoform) bearing a mutation associated with Alzheimer's disease",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.140625,
            "end_logit": 7.94921875,
            "text": "bearing a mutation associated with Alzheimer's disease",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.94921875,
            "text": "associated with Alzheimer's disease",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.94921875,
            "text": "form of the human amyloid precursor protein (APP, 695 isoform) bearing a mutation associated with Alzheimer's disease",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 7.94921875,
            "text": "mutation associated with Alzheimer's disease",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -6.84375,
            "text": "Alzheimer's disease (V642I,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -6.96484375,
            "text": "Alzheimer's disease (V642I, so",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -6.9765625,
            "text": "Alzheimer'",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.1640625,
            "text": "Alzheimer's",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.23828125,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2) and wild-type",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.23828125,
            "text": "Alzheimer's disease (V64",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.25,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2) and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.265625,
            "text": "Alzheimer's disease (V642I, so-called London mutation,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.33984375,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter",
            "probability": 2.384185791015625e-07
        }
    ],
    "58b6978822d300530900000a_13": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.99609375,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.5830078125,
            "end_logit": 7.99609375,
            "text": "disease",
            "probability": 7.31348991394043e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.7802734375,
            "text": "Alzheimer",
            "probability": 5.692243576049805e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -4.66015625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -5.9375,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.265625,
            "end_logit": 7.99609375,
            "text": "s disease",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.7109375,
            "text": "Alzheimer's",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 7.99609375,
            "text": "'s disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.81640625,
            "text": "Alzheimer'",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 7.99609375,
            "text": "of Alzheimer's disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.09375,
            "text": "Alzheimer's disease genes: the amyloid",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.1328125,
            "text": "Alzheimer's disease genes: the amyloid precursor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 7.99609375,
            "text": "Allele-specific silencing of Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.3515625,
            "text": "Alzheimer's disease genes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.4375,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.78125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.80859375,
            "text": "Alzheimer's disease genes:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.8203125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58b6978822d300530900000a_14": [
        {
            "start_logit": 7.3828125,
            "end_logit": 5.0390625,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -3.21484375,
            "text": "Alzheimer",
            "probability": 0.0002613067626953125
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -4.26953125,
            "text": "Alzheimers disease (AD",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -5.99609375,
            "text": "Alzheimers",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -6.43359375,
            "text": "Alzheimers disease (AD)",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.03125,
            "text": "Alzheimers disease (AD).We",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.11328125,
            "text": "Alzheimers disease (AD).",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 5.0390625,
            "text": "disease",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 5.0390625,
            "text": "amyloid precursor protein gene were the first to be recognized as a cause of Alzheimers disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 5.0390625,
            "text": "s disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 5.0390625,
            "text": "cause of Alzheimers disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 5.0390625,
            "text": "precursor protein gene were the first to be recognized as a cause of Alzheimers disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.25,
            "end_logit": -2.482421875,
            "text": "Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -7.0234375,
            "end_logit": -2.482421875,
            "text": "(Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -6.07421875,
            "end_logit": -3.4609375,
            "text": "AD",
            "probability": 0.0
        },
        {
            "start_logit": -6.25,
            "end_logit": -3.4609375,
            "text": "Val717Ile), known as London mutation.In 1 family, this mutation was responsible for AD",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -2.482421875,
            "text": "AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -5.6015625,
            "end_logit": -4.26953125,
            "text": "disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -2.482421875,
            "text": "amyloid precursor protein gene on chromosome 21 (Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -2.482421875,
            "text": "717Ile",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_15": [
        {
            "start_logit": 7.3828125,
            "end_logit": 5.0390625,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -3.21484375,
            "text": "Alzheimer",
            "probability": 0.0002613067626953125
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -4.26953125,
            "text": "Alzheimers disease (AD",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -5.99609375,
            "text": "Alzheimers",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -6.43359375,
            "text": "Alzheimers disease (AD)",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.03125,
            "text": "Alzheimers disease (AD).We",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.11328125,
            "text": "Alzheimers disease (AD).",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 5.0390625,
            "text": "disease",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 5.0390625,
            "text": "amyloid precursor protein gene were the first to be recognized as a cause of Alzheimers disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 5.0390625,
            "text": "s disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 5.0390625,
            "text": "cause of Alzheimers disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 5.0390625,
            "text": "precursor protein gene were the first to be recognized as a cause of Alzheimers disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.25,
            "end_logit": -2.482421875,
            "text": "Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -7.0234375,
            "end_logit": -2.482421875,
            "text": "(Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -6.07421875,
            "end_logit": -3.4609375,
            "text": "AD",
            "probability": 0.0
        },
        {
            "start_logit": -6.25,
            "end_logit": -3.4609375,
            "text": "Val717Ile), known as London mutation.In 1 family, this mutation was responsible for AD",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -2.482421875,
            "text": "AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -5.6015625,
            "end_logit": -4.26953125,
            "text": "disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -2.482421875,
            "text": "amyloid precursor protein gene on chromosome 21 (Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -2.482421875,
            "text": "717Ile",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_16": [
        {
            "start_logit": 7.79296875,
            "end_logit": 7.6328125,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -2.322265625,
            "text": "Alzheimer",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": -2.548828125,
            "end_logit": 7.6328125,
            "text": "disease",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": -4.359375,
            "end_logit": 7.6328125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -6.4453125,
            "text": "Alzheimers",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 7.6328125,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 7.6328125,
            "text": "717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 7.6328125,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 7.6328125,
            "text": "s disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.6328125,
            "text": "7Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.6328125,
            "text": "mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 7.6328125,
            "text": "London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 7.6328125,
            "text": "onset Alzheimers disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 7.6328125,
            "text": "with early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.359375,
            "end_logit": -0.96044921875,
            "text": "Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -4.359375,
            "end_logit": -2.322265625,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -6.29296875,
            "end_logit": -0.96044921875,
            "text": "(Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -6.65625,
            "end_logit": -0.96044921875,
            "text": "717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -0.96044921875,
            "text": "APP mutation (Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -0.96044921875,
            "text": "7Ile",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_17": [
        {
            "start_logit": 6.0,
            "end_logit": 7.37109375,
            "text": "V642I-AbetaPP",
            "probability": 0.34326171875
        },
        {
            "start_logit": 5.6640625,
            "end_logit": 7.64453125,
            "text": "AbetaPP",
            "probability": 0.322265625
        },
        {
            "start_logit": 5.6640625,
            "end_logit": 7.37109375,
            "text": "AbetaPP mutant, V642I-AbetaPP",
            "probability": 0.2432861328125
        },
        {
            "start_logit": 4.6796875,
            "end_logit": 7.37109375,
            "text": "AbetaPP",
            "probability": 0.09088134765625
        },
        {
            "start_logit": -2.10546875,
            "end_logit": 7.64453125,
            "text": "PP",
            "probability": 0.00013566017150878906
        },
        {
            "start_logit": 6.0,
            "end_logit": -0.67333984375,
            "text": "V642I",
            "probability": 0.00010985136032104492
        },
        {
            "start_logit": -2.10546875,
            "end_logit": 7.37109375,
            "text": "PP mutant, V642I-AbetaPP",
            "probability": 0.00010317564010620117
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -0.67333984375,
            "text": "AbetaPP mutant, V642I",
            "probability": 7.849931716918945e-05
        },
        {
            "start_logit": -2.685546875,
            "end_logit": 7.37109375,
            "text": "PP",
            "probability": 5.78761100769043e-05
        },
        {
            "start_logit": -4.62109375,
            "end_logit": 7.64453125,
            "text": "type AbetaPP",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": -4.62109375,
            "end_logit": 7.37109375,
            "text": "type AbetaPP mutant, V642I-AbetaPP",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.7890625,
            "text": "V",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -4.7890625,
            "text": "AbetaPP mutant, V",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -4.8125,
            "text": "Abeta",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -5.53515625,
            "text": "V642I-Abeta",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 7.37109375,
            "text": "-AbetaPP",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 7.37109375,
            "text": "642I-AbetaPP",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -5.53515625,
            "text": "AbetaPP mutant, V642I-Abeta",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 7.37109375,
            "text": "2I-AbetaPP",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.64453125,
            "text": "-type AbetaPP",
            "probability": 5.364418029785156e-07
        }
    ],
    "58b6978822d300530900000a_18": [
        {
            "start_logit": 6.47265625,
            "end_logit": 5.62109375,
            "text": "PS1 mutations have additive effects on the increased secretion of betaA4(1-42)",
            "probability": 0.427490234375
        },
        {
            "start_logit": 6.47265625,
            "end_logit": 5.578125,
            "text": "PS1",
            "probability": 0.40771484375
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 5.62109375,
            "text": "betaA4(1-42)",
            "probability": 0.1597900390625
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 1.4990234375,
            "text": "betaA4(1-42) relative to betaA4(1-40), indicating that both mutations operate independently.",
            "probability": 0.00260162353515625
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -1.048828125,
            "text": "PS1 mutations have additive effects on the increased secretion of betaA4(1-42) relative to betaA4",
            "probability": 0.0005412101745605469
        },
        {
            "start_logit": -0.4423828125,
            "end_logit": 5.62109375,
            "text": "APP-London and PS1 mutations have additive effects on the increased secretion of betaA4(1-42)",
            "probability": 0.0004246234893798828
        },
        {
            "start_logit": -0.4423828125,
            "end_logit": 5.578125,
            "text": "APP-London and PS1",
            "probability": 0.0004067420959472656
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -2.009765625,
            "text": "PS1 mutations have additive effects on the increased secretion of betaA4",
            "probability": 0.00020694732666015625
        },
        {
            "start_logit": 5.4921875,
            "end_logit": -1.048828125,
            "text": "betaA4(1-42) relative to betaA4",
            "probability": 0.00020384788513183594
        },
        {
            "start_logit": 2.76953125,
            "end_logit": 1.4990234375,
            "text": "betaA4(1-40), indicating that both mutations operate independently.",
            "probability": 0.00017082691192626953
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -2.65625,
            "text": "PS",
            "probability": 0.00010824203491210938
        },
        {
            "start_logit": 5.4921875,
            "end_logit": -2.009765625,
            "text": "betaA4",
            "probability": 7.796287536621094e-05
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -3.208984375,
            "text": "PS1 mutations have additive effects on the increased secretion of betaA4(1-42) relative to betaA4(1-40)",
            "probability": 6.258487701416016e-05
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -3.80078125,
            "text": "PS1 mutations have additive effects on the increased secretion of beta",
            "probability": 3.457069396972656e-05
        },
        {
            "start_logit": 5.4921875,
            "end_logit": -3.208984375,
            "text": "betaA4(1-42) relative to betaA4(1-40)",
            "probability": 2.3424625396728516e-05
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -4.5078125,
            "text": "PS1 mutations have additive effects on the increased secretion of betaA4(",
            "probability": 1.710653305053711e-05
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -4.54296875,
            "text": "PS1 mutations have additive effects on the increased secretion of betaA4(1-42",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": 5.4921875,
            "end_logit": -3.76171875,
            "text": "betaA4(1-42) relative to betaA4(1-40), indicating that both",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": 2.76953125,
            "end_logit": -1.048828125,
            "text": "betaA4",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": 5.4921875,
            "end_logit": -3.80078125,
            "text": "beta",
            "probability": 1.2934207916259766e-05
        }
    ],
    "58b6978822d300530900000a_19": [
        {
            "start_logit": -1.7939453125,
            "end_logit": 3.85546875,
            "text": "mutations in APP at codon 717 (APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.474609375
        },
        {
            "start_logit": -1.7939453125,
            "end_logit": 2.587890625,
            "text": "mutations in APP at codon 717",
            "probability": 0.1334228515625
        },
        {
            "start_logit": -3.388671875,
            "end_logit": 3.85546875,
            "text": "Pathogenic mutations in APP at codon 717 (APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.09619140625
        },
        {
            "start_logit": -3.4296875,
            "end_logit": 3.85546875,
            "text": ".",
            "probability": 0.09234619140625
        },
        {
            "start_logit": -3.623046875,
            "end_logit": 3.85546875,
            "text": "APP at codon 717 (APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.07611083984375
        },
        {
            "start_logit": -3.388671875,
            "end_logit": 2.587890625,
            "text": "Pathogenic mutations in APP at codon 717",
            "probability": 0.0270843505859375
        },
        {
            "start_logit": -4.66796875,
            "end_logit": 3.85546875,
            "text": "APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.0267791748046875
        },
        {
            "start_logit": -3.623046875,
            "end_logit": 2.587890625,
            "text": "APP at codon 717",
            "probability": 0.0214385986328125
        },
        {
            "start_logit": -5.078125,
            "end_logit": 3.85546875,
            "text": "Abeta 1-42 being produced and secreted.",
            "probability": 0.01776123046875
        },
        {
            "start_logit": -5.453125,
            "end_logit": 3.85546875,
            "text": "717 (APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.01220703125
        },
        {
            "start_logit": -5.453125,
            "end_logit": 2.587890625,
            "text": "717",
            "probability": 0.003429412841796875
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 3.85546875,
            "text": "London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.0031108856201171875
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 3.85546875,
            "text": "of Abeta 1-42 being produced and secreted.",
            "probability": 0.0027027130126953125
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 3.85546875,
            "text": "7 (APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.0025005340576171875
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 3.85546875,
            "text": "in APP at codon 717 (APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.0024623870849609375
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 3.85546875,
            "text": "(APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.0020961761474609375
        },
        {
            "start_logit": -7.46875,
            "end_logit": 3.85546875,
            "text": "increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.0016260147094726562
        },
        {
            "start_logit": -7.59375,
            "end_logit": 3.85546875,
            "text": "codon 717 (APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.0014352798461914062
        },
        {
            "start_logit": -7.640625,
            "end_logit": 3.85546875,
            "text": "at codon 717 (APP \"London\") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.001369476318359375
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 3.85546875,
            "text": ") lead to an increased proportion of Abeta 1-42 being produced and secreted.",
            "probability": 0.0013647079467773438
        }
    ],
    "58b6978822d300530900000a_20": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.99609375,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.5830078125,
            "end_logit": 7.99609375,
            "text": "disease",
            "probability": 7.31348991394043e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.7802734375,
            "text": "Alzheimer",
            "probability": 5.692243576049805e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -4.66015625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -5.9375,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.265625,
            "end_logit": 7.99609375,
            "text": "s disease",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.7109375,
            "text": "Alzheimer's",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 7.99609375,
            "text": "'s disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.81640625,
            "text": "Alzheimer'",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 7.99609375,
            "text": "of Alzheimer's disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.09375,
            "text": "Alzheimer's disease genes: the amyloid",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.1328125,
            "text": "Alzheimer's disease genes: the amyloid precursor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 7.99609375,
            "text": "Allele-specific silencing of Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.3515625,
            "text": "Alzheimer's disease genes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.4375,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.78125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.80859375,
            "text": "Alzheimer's disease genes:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.8203125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58b6978822d300530900000a_21": [
        {
            "start_logit": 7.91015625,
            "end_logit": 7.95703125,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": 7.95703125,
            "text": "disease",
            "probability": 6.252527236938477e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -1.9501953125,
            "text": "Alzheimer",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -3.599609375,
            "end_logit": 7.95703125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 7.95703125,
            "text": "s disease",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.421875,
            "end_logit": 7.95703125,
            "text": "717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.625,
            "end_logit": 7.95703125,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 7.95703125,
            "text": "'s disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -6.80859375,
            "text": "Alzheimer'",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.95703125,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 7.95703125,
            "text": "7Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -6.98828125,
            "text": "Alzheimer's",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.95703125,
            "text": "onset Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.95703125,
            "text": "mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.95703125,
            "text": "London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 7.95703125,
            "text": "with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.77734375,
            "text": "Alzheimer's disease.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.95703125,
            "text": "early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.599609375,
            "end_logit": -1.31640625,
            "text": "Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -3.599609375,
            "end_logit": -1.9501953125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_1": [
        {
            "start_logit": -3.908203125,
            "end_logit": -1.55078125,
            "text": "multiple origins.",
            "probability": 0.468017578125
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -1.55078125,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.126953125
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -1.55078125,
            "text": "Bacteria and some archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.1024169921875
        },
        {
            "start_logit": -5.91796875,
            "end_logit": -1.55078125,
            "text": "from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.0628662109375
        },
        {
            "start_logit": -6.37890625,
            "end_logit": -1.55078125,
            "text": "archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.039642333984375
        },
        {
            "start_logit": -6.39453125,
            "end_logit": -1.55078125,
            "text": "origins.",
            "probability": 0.039031982421875
        },
        {
            "start_logit": -6.6328125,
            "end_logit": -1.55078125,
            "text": "replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.0306243896484375
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -1.55078125,
            "text": "origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.0264129638671875
        },
        {
            "start_logit": -7.3125,
            "end_logit": -1.55078125,
            "text": ".",
            "probability": 0.0156402587890625
        },
        {
            "start_logit": -7.375,
            "end_logit": -1.55078125,
            "text": "replicate using multiple origins.",
            "probability": 0.0146942138671875
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -1.55078125,
            "text": "whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.012664794921875
        },
        {
            "start_logit": -7.578125,
            "end_logit": -1.55078125,
            "text": "using multiple origins.",
            "probability": 0.01200103759765625
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -1.55078125,
            "text": "archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.011810302734375
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -1.55078125,
            "text": "eukaryotes replicate using multiple origins.",
            "probability": 0.00978851318359375
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -4.640625,
            "text": "single origins",
            "probability": 0.005756378173828125
        },
        {
            "start_logit": -3.908203125,
            "end_logit": -6.02734375,
            "text": "multiple origins",
            "probability": 0.0053253173828125
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -4.828125,
            "text": "single",
            "probability": 0.004772186279296875
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -4.640625,
            "text": "Bacteria and some archaea replicate from single origins",
            "probability": 0.004657745361328125
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -4.828125,
            "text": "Bacteria and some archaea replicate from single",
            "probability": 0.003864288330078125
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -5.01953125,
            "text": "Bacteria",
            "probability": 0.003177642822265625
        }
    ],
    "52fe58f82059c6d71c00007a_2": [
        {
            "start_logit": 7.3515625,
            "end_logit": 2.955078125,
            "text": "multiple",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -4.74609375,
            "text": "multiple DNA replication origins",
            "probability": 0.0004527568817138672
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -5.46484375,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and some Archaea",
            "probability": 0.00021982192993164062
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -6.421875,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes",
            "probability": 8.475780487060547e-05
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -6.83984375,
            "text": "multiple DNA replication origins are",
            "probability": 5.555152893066406e-05
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -7.2734375,
            "text": "multiple DNA replication origins are a",
            "probability": 3.612041473388672e-05
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -7.46875,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -7.65234375,
            "text": "multiple DNA replication origins are a hallmark of",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -7.66796875,
            "text": "multiple DNA replication origins are a hallmark",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -7.91015625,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and some",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 7.3515625,
            "end_logit": -7.9453125,
            "text": "multiple DNA replication",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -4.74609375,
            "text": "DNA replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -5.46484375,
            "text": "DNA replication origins are a hallmark of Eukaryotes and some Archaea",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -6.421875,
            "text": "DNA replication origins are a hallmark of Eukaryotes",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -6.83984375,
            "text": "DNA replication origins are",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -4.74609375,
            "text": "replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -7.2734375,
            "text": "DNA replication origins are a",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -7.46875,
            "text": "DNA replication origins are a hallmark of Eukaryotes and",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -4.74609375,
            "text": "origins",
            "probability": 0.0
        },
        {
            "start_logit": -5.1796875,
            "end_logit": -7.65234375,
            "text": "DNA replication origins are a hallmark of",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_3": [
        {
            "start_logit": 4.09765625,
            "end_logit": -3.29296875,
            "text": "Multiple",
            "probability": 0.4375
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -3.81640625,
            "text": "Multiple orc/cdc6-associated replication origins were",
            "probability": 0.25927734375
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -5.1796875,
            "text": "Multiple orc/cdc6",
            "probability": 0.06634521484375
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -5.31640625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaeal genome",
            "probability": 0.057861328125
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -5.73828125,
            "text": "Multiple orc/cdc6-associated replication origins",
            "probability": 0.037933349609375
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -6.3515625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted",
            "probability": 0.0205535888671875
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -6.453125,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all",
            "probability": 0.0185699462890625
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -6.6640625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed",
            "probability": 0.01503753662109375
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -6.80078125,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaeal",
            "probability": 0.01311492919921875
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -6.9609375,
            "text": "Multiple orc/cdc",
            "probability": 0.01116943359375
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -7.0546875,
            "text": "Multiple or",
            "probability": 0.01016998291015625
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -7.1171875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed halo",
            "probability": 0.009552001953125
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -7.21875,
            "text": "Multiple orc",
            "probability": 0.008636474609375
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -7.23046875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaea",
            "probability": 0.00853729248046875
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -7.296875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarch",
            "probability": 0.00798797607421875
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -7.390625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in",
            "probability": 0.00727081298828125
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -7.6015625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the",
            "probability": 0.005886077880859375
        },
        {
            "start_logit": 4.09765625,
            "end_logit": -7.91015625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of",
            "probability": 0.004322052001953125
        },
        {
            "start_logit": -4.75390625,
            "end_logit": -3.81640625,
            "text": "orc/cdc6-associated replication origins were",
            "probability": 3.713369369506836e-05
        },
        {
            "start_logit": -4.75390625,
            "end_logit": -5.1796875,
            "text": "orc/cdc6",
            "probability": 9.47713851928711e-06
        }
    ],
    "52fe58f82059c6d71c00007a_4": [
        {
            "start_logit": -2.572265625,
            "end_logit": -5.03515625,
            "text": "multiple replication origins serve purposes other than simply shortening the time required for replication",
            "probability": 0.44091796875
        },
        {
            "start_logit": -2.572265625,
            "end_logit": -5.92578125,
            "text": "multiple",
            "probability": 0.1810302734375
        },
        {
            "start_logit": -2.572265625,
            "end_logit": -7.03515625,
            "text": "multiple replication origins serve",
            "probability": 0.0596923828125
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -5.03515625,
            "text": "Sulfolobus chromosome implies that the multiple replication origins serve purposes other than simply shortening the time required for replication",
            "probability": 0.05517578125
        },
        {
            "start_logit": -2.572265625,
            "end_logit": -7.3984375,
            "text": "multiple replication origins serve purposes other than",
            "probability": 0.041656494140625
        },
        {
            "start_logit": -2.572265625,
            "end_logit": -7.4765625,
            "text": "multiple replication origins serve purposes other than simply",
            "probability": 0.038543701171875
        },
        {
            "start_logit": -2.572265625,
            "end_logit": -7.55859375,
            "text": "multiple replication",
            "probability": 0.035369873046875
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -5.92578125,
            "text": "Sulfolobus chromosome implies that the multiple",
            "probability": 0.02264404296875
        },
        {
            "start_logit": -5.84375,
            "end_logit": -5.03515625,
            "text": "The strong replication-biased structuring of the Sulfolobus chromosome implies that the multiple replication origins serve purposes other than simply shortening the time required for replication",
            "probability": 0.0168304443359375
        },
        {
            "start_logit": -5.84375,
            "end_logit": -5.1328125,
            "text": "The strong",
            "probability": 0.01520538330078125
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -6.37109375,
            "text": "Sulfolobus",
            "probability": 0.0145111083984375
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -6.55859375,
            "text": "Sulfolobus chromosome",
            "probability": 0.01203155517578125
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -6.640625,
            "text": "Sulfolobus chromosome implies",
            "probability": 0.01103973388671875
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -5.03515625,
            "text": "the Sulfolobus chromosome implies that the multiple replication origins serve purposes other than simply shortening the time required for replication",
            "probability": 0.01053619384765625
        },
        {
            "start_logit": -5.84375,
            "end_logit": -5.62890625,
            "text": "The strong replication-biased",
            "probability": 0.00930023193359375
        },
        {
            "start_logit": -6.6328125,
            "end_logit": -5.03515625,
            "text": "bus chromosome implies that the multiple replication origins serve purposes other than simply shortening the time required for replication",
            "probability": 0.00759124755859375
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -7.03515625,
            "text": "Sulfolobus chromosome implies that the multiple replication origins serve",
            "probability": 0.00746917724609375
        },
        {
            "start_logit": -5.84375,
            "end_logit": -5.92578125,
            "text": "The strong replication-biased structuring of the Sulfolobus chromosome implies that the multiple",
            "probability": 0.0069122314453125
        },
        {
            "start_logit": -6.74609375,
            "end_logit": -5.03515625,
            "text": "replication origins serve purposes other than simply shortening the time required for replication",
            "probability": 0.006801605224609375
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -7.140625,
            "text": "Sulfolobus chromosome implies that the",
            "probability": 0.006694793701171875
        }
    ],
    "52fe58f82059c6d71c00007a_5": [
        {
            "start_logit": -2.447265625,
            "end_logit": -4.375,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain of life",
            "probability": 0.374755859375
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -5.7890625,
            "text": "multiple replication origin",
            "probability": 0.09112548828125
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -5.921875,
            "text": "multiple",
            "probability": 0.07977294921875
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -5.9921875,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal",
            "probability": 0.07440185546875
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -6.09375,
            "text": "multiple replication origin paradigm",
            "probability": 0.06719970703125
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -6.52734375,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain",
            "probability": 0.04339599609375
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -6.53515625,
            "text": "multiple replication",
            "probability": 0.043060302734375
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -6.5703125,
            "text": "multiple replication origin paradigm has also been demonstrated within the",
            "probability": 0.041717529296875
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -4.375,
            "text": "the multiple replication origin paradigm has also been demonstrated within the archaeal domain of life",
            "probability": 0.041717529296875
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -7.23828125,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain of",
            "probability": 0.0213165283203125
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -7.29296875,
            "text": "multiple replication origin paradigm has also been",
            "probability": 0.020172119140625
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -7.34375,
            "text": "multiple replication origin paradigm has also been demonstrated",
            "probability": 0.019256591796875
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -7.3828125,
            "text": "multiple replication origin paradigm has also",
            "probability": 0.018524169921875
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -7.7265625,
            "text": "multiple replication origin paradigm has",
            "probability": 0.01313018798828125
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -7.9140625,
            "text": "multiple replication origin paradigm has also been demonstrated within",
            "probability": 0.01088714599609375
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -5.7890625,
            "text": "the multiple replication origin",
            "probability": 0.01006317138671875
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -5.921875,
            "text": "the multiple",
            "probability": 0.008880615234375
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -5.9921875,
            "text": "the multiple replication origin paradigm has also been demonstrated within the archaeal",
            "probability": 0.00821685791015625
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -6.09375,
            "text": "the multiple replication origin paradigm",
            "probability": 0.007480621337890625
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -6.52734375,
            "text": "the multiple replication origin paradigm has also been demonstrated within the archaeal domain",
            "probability": 0.00482940673828125
        }
    ],
    "52fe58f82059c6d71c00007a_6": [
        {
            "start_logit": 2.5078125,
            "end_logit": -1.9150390625,
            "text": "multiple",
            "probability": 0.91259765625
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -5.9609375,
            "text": "multiple chromosome replication origins",
            "probability": 0.0159454345703125
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -6.203125,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic trait to the archaea",
            "probability": 0.01251983642578125
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -6.3046875,
            "text": "multiple chromosome",
            "probability": 0.0113067626953125
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -6.62890625,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic",
            "probability": 0.0081787109375
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -6.96484375,
            "text": "multiple chromosome replication",
            "probability": 0.0058441162109375
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -7.171875,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another",
            "probability": 0.00475311279296875
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -7.265625,
            "text": "multiple chromosome replication origins in",
            "probability": 0.00432586669921875
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -7.29296875,
            "text": "multiple chromosome replication origins in Sulfolobu",
            "probability": 0.004207611083984375
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -7.3359375,
            "text": "multiple chromosome replication origins in Sulfolobus",
            "probability": 0.004032135009765625
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -7.5390625,
            "text": "multiple chromosome replication origins in Sulfolobus species",
            "probability": 0.003292083740234375
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -7.5703125,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet",
            "probability": 0.0031909942626953125
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -7.6171875,
            "text": "multiple chromosome replication origins in Sulfo",
            "probability": 0.00304412841796875
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -7.7578125,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic trait",
            "probability": 0.002643585205078125
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -7.9609375,
            "text": "multiple chromosome replication origins in Sulfolobus species has",
            "probability": 0.00215911865234375
        },
        {
            "start_logit": 2.5078125,
            "end_logit": -8.0078125,
            "text": "multiple chromosome replication origins in Sulfolo",
            "probability": 0.0020599365234375
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -5.9609375,
            "text": "chromosome replication origins",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -6.203125,
            "text": "chromosome replication origins in Sulfolobus species has added yet another eukaryotic trait to the archaea",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -6.3046875,
            "text": "chromosome",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -6.62890625,
            "text": "chromosome replication origins in Sulfolobus species has added yet another eukaryotic",
            "probability": 1.1920928955078125e-06
        }
    ],
    "52fe58f82059c6d71c00007a_7": [
        {
            "start_logit": -0.47119140625,
            "end_logit": 0.1923828125,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.92919921875
        },
        {
            "start_logit": -3.47265625,
            "end_logit": 0.1923828125,
            "text": "Sulfolobus solfataricus",
            "probability": 0.046173095703125
        },
        {
            "start_logit": -5.671875,
            "end_logit": 0.1923828125,
            "text": "bus solfataricus",
            "probability": 0.0051116943359375
        },
        {
            "start_logit": -0.47119140625,
            "end_logit": -5.55078125,
            "text": "multiple replication origins",
            "probability": 0.00296783447265625
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 0.1923828125,
            "text": "lobus solfataricus",
            "probability": 0.0026416778564453125
        },
        {
            "start_logit": -0.47119140625,
            "end_logit": -5.89453125,
            "text": "multiple",
            "probability": 0.002105712890625
        },
        {
            "start_logit": -6.6875,
            "end_logit": 0.1923828125,
            "text": "replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.001850128173828125
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 0.1923828125,
            "text": "potential multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.0010833740234375
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 0.1923828125,
            "text": "archaeon Sulfolobus solfataricus",
            "probability": 0.0010423660278320312
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 0.1923828125,
            "text": "s solfataricus",
            "probability": 0.0009946823120117188
        },
        {
            "start_logit": -7.4375,
            "end_logit": 0.1923828125,
            "text": "the potential multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.0008740425109863281
        },
        {
            "start_logit": -7.53125,
            "end_logit": 0.1923828125,
            "text": "solfataricus",
            "probability": 0.0007958412170410156
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 0.1923828125,
            "text": "fataricus",
            "probability": 0.0007777214050292969
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 0.1923828125,
            "text": "ricus",
            "probability": 0.0007190704345703125
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 0.1923828125,
            "text": "the archaeon Sulfolobus solfataricus",
            "probability": 0.0007166862487792969
        },
        {
            "start_logit": -7.6875,
            "end_logit": 0.1923828125,
            "text": "In addition, the potential multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.0006809234619140625
        },
        {
            "start_logit": -0.47119140625,
            "end_logit": -7.18359375,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z curve method",
            "probability": 0.000579833984375
        },
        {
            "start_logit": -0.47119140625,
            "end_logit": -7.25390625,
            "text": "multiple replication origins of",
            "probability": 0.0005407333374023438
        },
        {
            "start_logit": -0.47119140625,
            "end_logit": -7.2890625,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z",
            "probability": 0.0005221366882324219
        },
        {
            "start_logit": -0.47119140625,
            "end_logit": -7.4609375,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are",
            "probability": 0.00043964385986328125
        }
    ],
    "52fe58f82059c6d71c00007a_8": [
        {
            "start_logit": 1.2900390625,
            "end_logit": -3.357421875,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes.",
            "probability": 0.49658203125
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -4.375,
            "text": "multiple replication origins",
            "probability": 0.17919921875
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -4.4609375,
            "text": "multiple",
            "probability": 0.1644287109375
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -6.38671875,
            "text": "multiple replication origins have been",
            "probability": 0.023956298828125
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -6.58203125,
            "text": "multiple replication origins have",
            "probability": 0.01971435546875
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -6.78515625,
            "text": "multiple replication origins have been observed in archaea",
            "probability": 0.0160980224609375
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -6.84765625,
            "text": "multiple replication origins have been observed",
            "probability": 0.01511383056640625
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -6.92578125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known",
            "probability": 0.01397705078125
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -6.9921875,
            "text": "multiple replication origins have been observed in archaea,",
            "probability": 0.0130767822265625
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -7.05859375,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their",
            "probability": 0.012237548828125
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -7.3984375,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary",
            "probability": 0.0087127685546875
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -7.48828125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about",
            "probability": 0.007965087890625
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -7.51953125,
            "text": "multiple replication origins have been observed in",
            "probability": 0.007717132568359375
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -7.5859375,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes",
            "probability": 0.00722503662109375
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -7.60546875,
            "text": "multiple replication origins have been observed in archaea, considerably",
            "probability": 0.007083892822265625
        },
        {
            "start_logit": 1.2900390625,
            "end_logit": -7.72265625,
            "text": "multiple replication",
            "probability": 0.0063018798828125
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -3.357421875,
            "text": "While multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes.",
            "probability": 0.0002453327178955078
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -3.357421875,
            "text": "replication origins have been observed in archaea, considerably less is known about their evolutionary processes.",
            "probability": 0.0001277923583984375
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -4.375,
            "text": "While multiple replication origins",
            "probability": 8.916854858398438e-05
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -4.4609375,
            "text": "While multiple",
            "probability": 8.118152618408203e-05
        }
    ],
    "52fe58f82059c6d71c00007a_9": [
        {
            "start_logit": 3.791015625,
            "end_logit": -0.84814453125,
            "text": "multiple",
            "probability": 0.931640625
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -4.3359375,
            "text": "multiple orc/cdc6-associated replication origins in",
            "probability": 0.0284576416015625
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -4.9921875,
            "text": "multiple orc/cdc6",
            "probability": 0.0147705078125
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -6.02734375,
            "text": "multiple orc/cdc6-associated replication origins",
            "probability": 0.005245208740234375
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -6.65234375,
            "text": "multiple orc/cdc",
            "probability": 0.0028076171875
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -6.703125,
            "text": "multiple or",
            "probability": 0.0026683807373046875
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -6.828125,
            "text": "multiple orc/cdc6-associated replication origins in halo",
            "probability": 0.0023555755615234375
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -6.94921875,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaeal genomes",
            "probability": 0.002086639404296875
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -7.11328125,
            "text": "multiple orc/cdc6-",
            "probability": 0.0017709732055664062
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -7.15234375,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaeal",
            "probability": 0.0017032623291015625
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -7.1796875,
            "text": "multiple orc",
            "probability": 0.0016574859619140625
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -7.234375,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaea",
            "probability": 0.0015687942504882812
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -7.39453125,
            "text": "multiple orc/cdc6-associated replication origins in haloarch",
            "probability": 0.0013360977172851562
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -7.82421875,
            "text": "multiple orc/cdc6-associated",
            "probability": 0.0008697509765625
        },
        {
            "start_logit": 3.791015625,
            "end_logit": -7.98828125,
            "text": "multiple orc/",
            "probability": 0.0007381439208984375
        },
        {
            "start_logit": -5.76953125,
            "end_logit": -4.3359375,
            "text": "orc/cdc6-associated replication origins in",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -5.76953125,
            "end_logit": -4.9921875,
            "text": "orc/cdc6",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -4.3359375,
            "text": "c/cdc6-associated replication origins in",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -4.9921875,
            "text": "c/cdc6",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -4.3359375,
            "text": "/cdc6-associated replication origins in",
            "probability": 4.172325134277344e-07
        }
    ],
    "5fe31317a43ad31278000044_1": [
        {
            "start_logit": 2.185546875,
            "end_logit": 4.50390625,
            "text": "IL-1\u03b2",
            "probability": 0.46630859375
        },
        {
            "start_logit": 1.552734375,
            "end_logit": 4.50390625,
            "text": "pro-inflammatory cytokines (IL-1\u03b2",
            "probability": 0.2476806640625
        },
        {
            "start_logit": 1.552734375,
            "end_logit": 4.4453125,
            "text": "pro-inflammatory cytokines",
            "probability": 0.2344970703125
        },
        {
            "start_logit": -0.716796875,
            "end_logit": 4.50390625,
            "text": "cytokines (IL-1\u03b2",
            "probability": 0.0256500244140625
        },
        {
            "start_logit": -0.716796875,
            "end_logit": 4.4453125,
            "text": "cytokines",
            "probability": 0.0241851806640625
        },
        {
            "start_logit": -4.875,
            "end_logit": 4.50390625,
            "text": "1\u03b2",
            "probability": 0.0004010200500488281
        },
        {
            "start_logit": -4.91796875,
            "end_logit": 4.50390625,
            "text": "inflammatory cytokines (IL-1\u03b2",
            "probability": 0.00038433074951171875
        },
        {
            "start_logit": -4.91796875,
            "end_logit": 4.4453125,
            "text": "inflammatory cytokines",
            "probability": 0.00036215782165527344
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 4.50390625,
            "text": "of pro-inflammatory cytokines (IL-1\u03b2",
            "probability": 6.41942024230957e-05
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 4.4453125,
            "text": "of pro-inflammatory cytokines",
            "probability": 6.031990051269531e-05
        },
        {
            "start_logit": -6.859375,
            "end_logit": 4.50390625,
            "text": "adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines (IL-1\u03b2",
            "probability": 5.4895877838134766e-05
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 4.50390625,
            "text": "(IL-1\u03b2",
            "probability": 5.364418029785156e-05
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 4.50390625,
            "text": "-1\u03b2",
            "probability": 5.2809715270996094e-05
        },
        {
            "start_logit": -6.859375,
            "end_logit": 4.4453125,
            "text": "adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 5.1975250244140625e-05
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 4.50390625,
            "text": "human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines (IL-1\u03b2",
            "probability": 4.696846008300781e-05
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 4.4453125,
            "text": "human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 4.410743713378906e-05
        },
        {
            "start_logit": -7.203125,
            "end_logit": 4.50390625,
            "text": "obesity and expression of pro-inflammatory cytokines (IL-1\u03b2",
            "probability": 3.892183303833008e-05
        },
        {
            "start_logit": -7.203125,
            "end_logit": 4.4453125,
            "text": "obesity and expression of pro-inflammatory cytokines",
            "probability": 3.6835670471191406e-05
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 4.50390625,
            "text": "-inflammatory cytokines (IL-1\u03b2",
            "probability": 3.629922866821289e-05
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 4.4453125,
            "text": "-inflammatory cytokines",
            "probability": 3.4332275390625e-05
        }
    ],
    "5fe31317a43ad31278000044_2": [
        {
            "start_logit": 8.0,
            "end_logit": 7.98828125,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 8.0,
            "end_logit": -1.125,
            "text": "IL",
            "probability": 0.000110626220703125
        },
        {
            "start_logit": -1.2216796875,
            "end_logit": 7.98828125,
            "text": "1\u03b2",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": -2.681640625,
            "end_logit": 7.98828125,
            "text": "adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": 8.0,
            "end_logit": -5.53125,
            "text": "IL-1\u03b2 and its responsive cytokines IL",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 7.98828125,
            "text": "-1\u03b2",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.0,
            "end_logit": -6.3984375,
            "text": "IL-1\u03b2 and its responsive cytokines",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 7.98828125,
            "text": "tissue inflammation, specifically for IL-1\u03b2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -6.890625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-8",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.05078125,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.0625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.1796875,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-8, but does not seem to have systemic effects on insulin resistance.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.98828125,
            "text": "local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 7.98828125,
            "text": "MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.98828125,
            "text": "mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.681640625,
            "end_logit": 3.22265625,
            "text": "adipose tissue",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.98828125,
            "text": "that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.65625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.66796875,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-8, but",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.76171875,
            "text": "IL-",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5fe31317a43ad31278000044_3": [
        {
            "start_logit": -2.904296875,
            "end_logit": 4.03515625,
            "text": "TNF\u03b1, IL-1\u03b2",
            "probability": 0.390625
        },
        {
            "start_logit": -3.33984375,
            "end_logit": 4.03515625,
            "text": "production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.252685546875
        },
        {
            "start_logit": -3.41796875,
            "end_logit": 4.03515625,
            "text": "IL-1\u03b2",
            "probability": 0.233642578125
        },
        {
            "start_logit": -5.546875,
            "end_logit": 4.03515625,
            "text": "1\u03b2",
            "probability": 0.0277862548828125
        },
        {
            "start_logit": -5.765625,
            "end_logit": 4.03515625,
            "text": ", IL-1\u03b2",
            "probability": 0.0223388671875
        },
        {
            "start_logit": -6.265625,
            "end_logit": 4.03515625,
            "text": "of TNF\u03b1, IL-1\u03b2",
            "probability": 0.0135498046875
        },
        {
            "start_logit": -6.3828125,
            "end_logit": 4.03515625,
            "text": "-1\u03b2",
            "probability": 0.01204681396484375
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 4.03515625,
            "text": "known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.0101470947265625
        },
        {
            "start_logit": -6.703125,
            "end_logit": 4.03515625,
            "text": "3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.00875091552734375
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 4.03515625,
            "text": ") is a potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.00799560546875
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 4.03515625,
            "text": "also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.007568359375
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 4.03515625,
            "text": "potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.006561279296875
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -1.0634765625,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.0023784637451171875
        },
        {
            "start_logit": -3.33984375,
            "end_logit": -1.0634765625,
            "text": "production of TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.0015468597412109375
        },
        {
            "start_logit": -3.41796875,
            "end_logit": -1.0634765625,
            "text": "IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.001430511474609375
        },
        {
            "start_logit": -0.60205078125,
            "end_logit": -5.78515625,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 0.00021266937255859375
        },
        {
            "start_logit": -5.49609375,
            "end_logit": -1.0634765625,
            "text": ".",
            "probability": 0.00017905235290527344
        },
        {
            "start_logit": -5.546875,
            "end_logit": -1.0634765625,
            "text": "1\u03b2, and IFN\u03b3.",
            "probability": 0.00016951560974121094
        },
        {
            "start_logit": -5.765625,
            "end_logit": -1.0634765625,
            "text": ", IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.00013625621795654297
        },
        {
            "start_logit": -6.265625,
            "end_logit": -1.0634765625,
            "text": "of TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 8.26120376586914e-05
        }
    ],
    "5fe31317a43ad31278000044_4": [
        {
            "start_logit": -2.56640625,
            "end_logit": 2.84375,
            "text": "production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.546875
        },
        {
            "start_logit": -3.921875,
            "end_logit": 2.84375,
            "text": "TNF\u03b1, IL-1\u03b2",
            "probability": 0.1409912109375
        },
        {
            "start_logit": -4.4453125,
            "end_logit": 2.84375,
            "text": "IL-1\u03b2",
            "probability": 0.08355712890625
        },
        {
            "start_logit": -2.56640625,
            "end_logit": 0.7880859375,
            "text": "production of TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.07012939453125
        },
        {
            "start_logit": -5.76953125,
            "end_logit": 2.84375,
            "text": ", IL-1\u03b2",
            "probability": 0.0222320556640625
        },
        {
            "start_logit": -3.921875,
            "end_logit": 0.7880859375,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.0180816650390625
        },
        {
            "start_logit": -6.10546875,
            "end_logit": 2.84375,
            "text": "of TNF\u03b1, IL-1\u03b2",
            "probability": 0.0158843994140625
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 2.84375,
            "text": "1\u03b2",
            "probability": 0.012176513671875
        },
        {
            "start_logit": -4.4453125,
            "end_logit": 0.7880859375,
            "text": "IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.010711669921875
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 2.84375,
            "text": "known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.01026153564453125
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 2.84375,
            "text": "3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.00948333740234375
        },
        {
            "start_logit": -4.67578125,
            "end_logit": 0.7880859375,
            "text": ".",
            "probability": 0.0084991455078125
        },
        {
            "start_logit": -6.78125,
            "end_logit": 2.84375,
            "text": ") is a potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.008087158203125
        },
        {
            "start_logit": -6.78125,
            "end_logit": 2.84375,
            "text": "the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.008087158203125
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 2.84375,
            "text": "-1\u03b2",
            "probability": 0.00792694091796875
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 2.84375,
            "text": "is a potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.00768280029296875
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 2.84375,
            "text": "also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.00738525390625
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 2.84375,
            "text": "drives the production of TNF\u03b1, IL-1\u03b2",
            "probability": 0.007076263427734375
        },
        {
            "start_logit": -5.76953125,
            "end_logit": 0.7880859375,
            "text": ", IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.0028476715087890625
        },
        {
            "start_logit": -6.10546875,
            "end_logit": 0.7880859375,
            "text": "of TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.0020351409912109375
        }
    ],
    "5fe31317a43ad31278000044_5": [
        {
            "start_logit": 7.96484375,
            "end_logit": 7.97265625,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -1.22265625,
            "text": "IL",
            "probability": 0.00010150671005249023
        },
        {
            "start_logit": -1.375,
            "end_logit": 7.97265625,
            "text": "1\u03b2",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -5.49609375,
            "end_logit": 7.97265625,
            "text": "-1\u03b2",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -5.88671875,
            "end_logit": 7.97265625,
            "text": "induced IL-1\u03b2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.04296875,
            "end_logit": 7.97265625,
            "text": "tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 7.97265625,
            "text": "EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 7.97265625,
            "text": "found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.49609375,
            "text": "IL-1\u03b2 reporter",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.97265625,
            "text": "reduced AR agonist-induced IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.515625,
            "text": "IL-1\u03b2 reporter activity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 7.97265625,
            "text": "that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.69140625,
            "text": "IL-1\u03b2 reporter activity.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.84375,
            "text": "IL-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.88671875,
            "end_logit": -1.22265625,
            "text": "induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -1.22265625,
            "text": "tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -1.22265625,
            "text": "EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -6.66015625,
            "end_logit": -1.22265625,
            "text": "found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -1.22265625,
            "text": "reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -1.375,
            "end_logit": -7.49609375,
            "text": "1\u03b2 reporter",
            "probability": 0.0
        }
    ],
    "5fe31317a43ad31278000044_6": [
        {
            "start_logit": 4.390625,
            "end_logit": 5.6328125,
            "text": "IL-1\u03b2",
            "probability": 0.9580078125
        },
        {
            "start_logit": 4.390625,
            "end_logit": 2.408203125,
            "text": "IL-1\u03b2, IL-6 and IL-8",
            "probability": 0.03802490234375
        },
        {
            "start_logit": 4.390625,
            "end_logit": -0.5634765625,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 0.001953125
        },
        {
            "start_logit": 4.390625,
            "end_logit": -1.2451171875,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF",
            "probability": 0.0009860992431640625
        },
        {
            "start_logit": -0.54931640625,
            "end_logit": 2.408203125,
            "text": "IL-8",
            "probability": 0.0002727508544921875
        },
        {
            "start_logit": -4.03125,
            "end_logit": 5.6328125,
            "text": "1\u03b2",
            "probability": 0.00021076202392578125
        },
        {
            "start_logit": 4.390625,
            "end_logit": -4.51953125,
            "text": "IL",
            "probability": 3.725290298461914e-05
        },
        {
            "start_logit": 4.390625,
            "end_logit": -4.94140625,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1, in human adipose tissue were associated with higher expression",
            "probability": 2.4378299713134766e-05
        },
        {
            "start_logit": 4.390625,
            "end_logit": -5.11328125,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1, in human adipose tissue were associated with higher",
            "probability": 2.0563602447509766e-05
        },
        {
            "start_logit": -0.52880859375,
            "end_logit": -0.5634765625,
            "text": "TNF -\u03b1",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": -0.54931640625,
            "end_logit": -0.5634765625,
            "text": "IL-8, but not TNF -\u03b1",
            "probability": 1.3887882232666016e-05
        },
        {
            "start_logit": 4.390625,
            "end_logit": -5.5390625,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1, in human adipose tissue",
            "probability": 1.3470649719238281e-05
        },
        {
            "start_logit": 4.390625,
            "end_logit": -5.8046875,
            "text": "IL-1\u03b2, IL-6",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -4.03125,
            "end_logit": 2.408203125,
            "text": "1\u03b2, IL-6 and IL-8",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 4.390625,
            "end_logit": -6.11328125,
            "text": "IL-1\u03b2, IL",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 5.6328125,
            "text": ", high mRNA expression levels of IL-1\u03b2",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -0.52880859375,
            "end_logit": -1.2451171875,
            "text": "TNF",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -0.54931640625,
            "end_logit": -1.2451171875,
            "text": "IL-8, but not TNF",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -4.2734375,
            "end_logit": 2.408203125,
            "text": "8",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 4.390625,
            "end_logit": -6.3046875,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1, in human adipose tissue were",
            "probability": 6.258487701416016e-06
        }
    ],
    "5fe31317a43ad31278000044_7": [
        {
            "start_logit": 7.9921875,
            "end_logit": 7.97265625,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -1.197265625,
            "text": "IL",
            "probability": 0.00010395050048828125
        },
        {
            "start_logit": -1.1884765625,
            "end_logit": 7.97265625,
            "text": "1\u03b2",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": -4.87890625,
            "end_logit": 7.97265625,
            "text": "-1\u03b2",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -5.46484375,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -5.7421875,
            "text": "IL-1\u03b2, IL-6 and CXCL1",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -5.80859375,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to WT animals.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -5.88671875,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -6.5078125,
            "text": "IL-1\u03b2, IL-6",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 7.97265625,
            "text": "of IL-1\u03b2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -6.94921875,
            "text": "IL-1\u03b2, IL",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.03515625,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.23046875,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.28515625,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.3046875,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to WT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.3125,
            "text": "IL-1\u03b2, IL-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 7.97265625,
            "text": "expression levels of IL-1\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.97265625,
            "text": "Mice lacking MAP3K8 had similar bodyweight gain as WT mice, yet displayed lower mRNA expression levels of IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.97265625,
            "text": "MAP3K8 had similar bodyweight gain as WT mice, yet displayed lower mRNA expression levels of IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.1884765625,
            "end_logit": -5.46484375,
            "text": "1\u03b2, IL-6 and CXCL1 in adipose tissue",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_1": [
        {
            "start_logit": 4.92578125,
            "end_logit": 4.9296875,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against virus",
            "probability": 0.958984375
        },
        {
            "start_logit": 1.66015625,
            "end_logit": 4.9296875,
            "text": "against virus",
            "probability": 0.036468505859375
        },
        {
            "start_logit": 4.92578125,
            "end_logit": -0.95166015625,
            "text": "SARS-CoV",
            "probability": 0.0026721954345703125
        },
        {
            "start_logit": 4.92578125,
            "end_logit": -1.732421875,
            "text": "SARS-CoV-2.",
            "probability": 0.0012235641479492188
        },
        {
            "start_logit": -2.908203125,
            "end_logit": 4.9296875,
            "text": "antivirals against virus",
            "probability": 0.0003790855407714844
        },
        {
            "start_logit": 4.92578125,
            "end_logit": -4.328125,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antiviral",
            "probability": 9.071826934814453e-05
        },
        {
            "start_logit": 4.92578125,
            "end_logit": -4.375,
            "text": "SARS",
            "probability": 8.660554885864258e-05
        },
        {
            "start_logit": -4.703125,
            "end_logit": 4.9296875,
            "text": "virus",
            "probability": 6.288290023803711e-05
        },
        {
            "start_logit": 4.92578125,
            "end_logit": -4.8046875,
            "text": "SARS-CoV-2",
            "probability": 5.6743621826171875e-05
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 4.9296875,
            "text": "existing antivirals against virus",
            "probability": 1.4126300811767578e-05
        },
        {
            "start_logit": 4.92578125,
            "end_logit": -6.3125,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against",
            "probability": 1.245737075805664e-05
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 4.9296875,
            "text": "-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against virus",
            "probability": 1.245737075805664e-05
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 4.9296875,
            "text": "against SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against virus",
            "probability": 1.138448715209961e-05
        },
        {
            "start_logit": 4.92578125,
            "end_logit": -6.578125,
            "text": "SARS-CoV-",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 4.9296875,
            "text": "CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against virus",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 4.9296875,
            "text": ". There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against virus",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 4.9296875,
            "text": "s against virus",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 4.9296875,
            "text": "as existing antivirals against virus",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 4.92578125,
            "end_logit": -7.43359375,
            "text": "SARS-",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 4.9296875,
            "text": "Remdesivir and Favipiravir as existing antivirals against virus",
            "probability": 3.6954879760742188e-06
        }
    ],
    "621ebb733a8413c65300005c_2": [
        {
            "start_logit": 1.4765625,
            "end_logit": 6.41796875,
            "text": "COVID-19",
            "probability": 0.9873046875
        },
        {
            "start_logit": -3.390625,
            "end_logit": 6.41796875,
            "text": "19",
            "probability": 0.007598876953125
        },
        {
            "start_logit": -4.05859375,
            "end_logit": 6.41796875,
            "text": "treat COVID-19",
            "probability": 0.003894805908203125
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 6.41796875,
            "text": "to treat COVID-19",
            "probability": 0.0003752708435058594
        },
        {
            "start_logit": -7.0625,
            "end_logit": 6.41796875,
            "text": "ID-19",
            "probability": 0.00019311904907226562
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 6.41796875,
            "text": "key repurposed drugs advocated to treat COVID-19",
            "probability": 0.000164031982421875
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.41796875,
            "text": "repurposed drugs advocated to treat COVID-19",
            "probability": 0.00015163421630859375
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 6.41796875,
            "text": "advocated to treat COVID-19",
            "probability": 0.00012969970703125
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 6.41796875,
            "text": "-19",
            "probability": 0.00012576580047607422
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 6.41796875,
            "text": "sed drugs advocated to treat COVID-19",
            "probability": 0.00011992454528808594
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.41796875,
            "text": "posed drugs advocated to treat COVID-19",
            "probability": 0.00011813640594482422
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.41796875,
            "text": "urposed drugs advocated to treat COVID-19",
            "probability": 0.00010585784912109375
        },
        {
            "start_logit": 1.4765625,
            "end_logit": -5.38671875,
            "text": "COVID",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": 1.4765625,
            "end_logit": -6.296875,
            "text": "COVID-",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 1.4765625,
            "end_logit": -6.65234375,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin, remdesivir and favipiravir)",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 1.4765625,
            "end_logit": -6.99609375,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin, remdesivir and favipiravir),",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 1.4765625,
            "end_logit": -7.0625,
            "text": "COVID-19 (",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 1.4765625,
            "end_logit": -7.30078125,
            "text": "COVID-19 (lopinavir",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 1.4765625,
            "end_logit": -7.3828125,
            "text": "COV",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 1.4765625,
            "end_logit": -7.46875,
            "text": "COVID-19 (lopinavir, ritonavir",
            "probability": 9.5367431640625e-07
        }
    ],
    "621ebb733a8413c65300005c_3": [
        {
            "start_logit": 7.86328125,
            "end_logit": 8.109375,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -1.2255859375,
            "end_logit": 8.109375,
            "text": "19",
            "probability": 0.00011324882507324219
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -1.998046875,
            "text": "COV",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": -6.421875,
            "end_logit": 8.109375,
            "text": "ID-19",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.515625,
            "end_logit": 8.109375,
            "text": "-19",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.3515625,
            "text": "COVID",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 8.109375,
            "text": "treat COVID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.51171875,
            "text": "COVID-19 patients",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.21484375,
            "text": "COVID-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.109375,
            "text": ": To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.109375,
            "text": ") to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 8.109375,
            "text": "to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 8.109375,
            "text": "vir (Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 8.109375,
            "text": "compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 8.109375,
            "text": "idol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.2255859375,
            "end_logit": -6.51171875,
            "text": "19 patients",
            "probability": 0.0
        },
        {
            "start_logit": -6.71875,
            "end_logit": -1.998046875,
            "text": "treat COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -1.998046875,
            "text": ": To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -1.998046875,
            "text": ") to treat COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -1.998046875,
            "text": "to treat COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_4": [
        {
            "start_logit": 7.765625,
            "end_logit": 8.1640625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -0.7587890625,
            "end_logit": 8.1640625,
            "text": "19",
            "probability": 0.00019872188568115234
        },
        {
            "start_logit": 7.765625,
            "end_logit": -1.9755859375,
            "text": "COV",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": -3.7265625,
            "end_logit": 8.1640625,
            "text": "possible COVID-19",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 8.1640625,
            "text": "ID-19",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 8.1640625,
            "text": "-19",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.07421875,
            "text": "COVID",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.5859375,
            "text": "COVID-19 treatments",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 8.1640625,
            "text": ") and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -6.9296875,
            "text": "COVID-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.1640625,
            "text": "Favipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.1640625,
            "text": "considered possible COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.1640625,
            "text": ") are considered possible COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.1640625,
            "text": "V) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.1640625,
            "text": "are considered possible COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 8.1640625,
            "text": "ipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.1640625,
            "text": "FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.1640625,
            "text": "hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 8.1640625,
            "text": "Q) are considered possible COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.7265625,
            "end_logit": -1.9755859375,
            "text": "possible COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_5": [
        {
            "start_logit": 3.115234375,
            "end_logit": 5.546875,
            "text": "COVID-19",
            "probability": 0.9990234375
        },
        {
            "start_logit": -4.42578125,
            "end_logit": 5.546875,
            "text": "19",
            "probability": 0.0005292892456054688
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 5.546875,
            "text": "ID-19",
            "probability": 8.475780487060547e-05
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 5.546875,
            "text": "of COVID-19",
            "probability": 5.2988529205322266e-05
        },
        {
            "start_logit": -7.171875,
            "end_logit": 5.546875,
            "text": "Favipiravir (FVP) has been used for treatment of COVID-19",
            "probability": 3.3915042877197266e-05
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 5.546875,
            "text": "-19",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 5.546875,
            "text": "treatment of COVID-19",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -7.734375,
            "end_logit": 5.546875,
            "text": "been used for treatment of COVID-19",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 5.546875,
            "text": ") has been used for treatment of COVID-19",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 5.546875,
            "text": "has been used for treatment of COVID-19",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 5.546875,
            "text": "FVP) has been used for treatment of COVID-19",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 5.546875,
            "text": "used for treatment of COVID-19",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": 3.115234375,
            "end_logit": -5.81640625,
            "text": "COVID",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 3.115234375,
            "end_logit": -6.0546875,
            "text": "COVID-19 in many countries.",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": 3.115234375,
            "end_logit": -6.22265625,
            "text": "COV",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 3.115234375,
            "end_logit": -7.19921875,
            "text": "COVID-19 in",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 3.115234375,
            "end_logit": -7.3515625,
            "text": "COVID-",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 3.115234375,
            "end_logit": -7.92578125,
            "text": "COVID-19 in many",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 3.115234375,
            "end_logit": -7.96484375,
            "text": "COVID-19 in many countries",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -4.42578125,
            "end_logit": -6.0546875,
            "text": "19 in many countries.",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_6": [
        {
            "start_logit": 6.51953125,
            "end_logit": 8.0390625,
            "text": "severe COVID-19 infection",
            "probability": 0.994140625
        },
        {
            "start_logit": 1.35546875,
            "end_logit": 8.0390625,
            "text": "COVID-19 infection",
            "probability": 0.00563812255859375
        },
        {
            "start_logit": -1.46875,
            "end_logit": 8.0390625,
            "text": "infection",
            "probability": 0.0003361701965332031
        },
        {
            "start_logit": -3.974609375,
            "end_logit": 8.0390625,
            "text": "ID-19 infection",
            "probability": 2.7358531951904297e-05
        },
        {
            "start_logit": -4.55078125,
            "end_logit": 8.0390625,
            "text": "19 infection",
            "probability": 1.531839370727539e-05
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -3.888671875,
            "text": "severe",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 8.0390625,
            "text": "-19 infection",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.0390625,
            "text": "patients with severe COVID-19 infection",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -6.21875,
            "text": "severe COVID-19 infection.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.0390625,
            "text": "treating patients with severe COVID-19 infection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -6.359375,
            "text": "severe COVID-19",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 8.0390625,
            "text": "with severe COVID-19 infection",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 8.0390625,
            "text": "standard therapy in treating patients with severe COVID-19 infection",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 8.0390625,
            "text": "therapy in treating patients with severe COVID-19 infection",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.6640625,
            "text": "severe COV",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.83984375,
            "text": "severe COVID",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.35546875,
            "end_logit": -6.21875,
            "text": "COVID-19 infection.",
            "probability": 0.0
        },
        {
            "start_logit": 1.35546875,
            "end_logit": -6.359375,
            "text": "COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": 1.35546875,
            "end_logit": -7.6640625,
            "text": "COV",
            "probability": 0.0
        },
        {
            "start_logit": 1.35546875,
            "end_logit": -7.83984375,
            "text": "COVID",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_7": [
        {
            "start_logit": -1.2578125,
            "end_logit": 6.234375,
            "text": "severe COVID-19 infections",
            "probability": 0.53857421875
        },
        {
            "start_logit": -1.85546875,
            "end_logit": 6.234375,
            "text": "COVID-19 infections",
            "probability": 0.29638671875
        },
        {
            "start_logit": -3.208984375,
            "end_logit": 6.234375,
            "text": "19 infections",
            "probability": 0.07647705078125
        },
        {
            "start_logit": -3.595703125,
            "end_logit": 6.234375,
            "text": "ID-19 infections",
            "probability": 0.051971435546875
        },
        {
            "start_logit": -4.3828125,
            "end_logit": 6.234375,
            "text": "infections",
            "probability": 0.0236663818359375
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 6.234375,
            "text": "-19 infections",
            "probability": 0.0033168792724609375
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 6.234375,
            "text": "patients with severe COVID-19 infections",
            "probability": 0.0021228790283203125
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 6.234375,
            "text": "with severe COVID-19 infections",
            "probability": 0.00113677978515625
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.234375,
            "text": "in patients with severe COVID-19 infections",
            "probability": 0.000995635986328125
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.234375,
            "text": "Favipiravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.0009388923645019531
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.234375,
            "text": "standard of care in patients with severe COVID-19 infections",
            "probability": 0.0009207725524902344
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 6.234375,
            "text": "ipiravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.000835418701171875
        },
        {
            "start_logit": -7.859375,
            "end_logit": 6.234375,
            "text": "iravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.0007309913635253906
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.234375,
            "text": "vir versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.0006709098815917969
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.234375,
            "text": "versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.0006608963012695312
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.234375,
            "text": "care in patients with severe COVID-19 infections",
            "probability": 0.0006375312805175781
        },
        {
            "start_logit": -1.2578125,
            "end_logit": -6.44140625,
            "text": "severe COVID-19",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -1.85546875,
            "end_logit": -6.44140625,
            "text": "COVID-19",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -1.2578125,
            "end_logit": -7.265625,
            "text": "severe",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.2578125,
            "end_logit": -7.37109375,
            "text": "severe COVID",
            "probability": 6.556510925292969e-07
        }
    ],
    "621ebb733a8413c65300005c_8": [
        {
            "start_logit": 4.3671875,
            "end_logit": 6.09765625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -3.927734375,
            "end_logit": 6.09765625,
            "text": "19",
            "probability": 0.0002493858337402344
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 6.09765625,
            "text": "ID-19",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 6.09765625,
            "text": "of COVID-19",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -6.90625,
            "end_logit": 6.09765625,
            "text": "-19",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -7.3125,
            "end_logit": 6.09765625,
            "text": "treatment of COVID-19",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 4.3671875,
            "end_logit": -6.05859375,
            "text": "COV",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.09765625,
            "text": "nupiravir/Favipiravir in the treatment of COVID-19",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.09765625,
            "text": "Molnupiravir/Favipiravir in the treatment of COVID-19",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 4.3671875,
            "end_logit": -6.50390625,
            "text": "COVID",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 4.3671875,
            "end_logit": -6.953125,
            "text": "COVID-19.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 4.3671875,
            "end_logit": -7.734375,
            "text": "COVID-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -3.927734375,
            "end_logit": -6.953125,
            "text": "19.",
            "probability": 0.0
        },
        {
            "start_logit": -6.51953125,
            "end_logit": -6.05859375,
            "text": "of COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.34765625,
            "end_logit": -6.50390625,
            "text": "ID",
            "probability": 0.0
        },
        {
            "start_logit": -6.51953125,
            "end_logit": -6.50390625,
            "text": "of COVID",
            "probability": 0.0
        },
        {
            "start_logit": -6.34765625,
            "end_logit": -6.953125,
            "text": "ID-19.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -6.05859375,
            "text": "treatment of COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.51953125,
            "end_logit": -6.953125,
            "text": "of COVID-19.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -6.50390625,
            "text": "treatment of COVID",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_9": [
        {
            "start_logit": 7.4765625,
            "end_logit": 7.61328125,
            "text": "influenza infections",
            "probability": 1.0
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -1.814453125,
            "text": "influenza",
            "probability": 8.028745651245117e-05
        },
        {
            "start_logit": -2.08984375,
            "end_logit": 7.61328125,
            "text": "infections",
            "probability": 6.979703903198242e-05
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -2.216796875,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not yet fully validated.",
            "probability": 5.346536636352539e-05
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -4.640625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -5.3671875,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2,",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -5.57421875,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 7.61328125,
            "text": "of new and re-emerging influenza infections",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -6.4453125,
            "text": "influenza infections, has been suggested to be effective against SARS",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -6.53515625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 7.61328125,
            "text": "emerging influenza infections",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 7.61328125,
            "text": "treatment of new and re-emerging influenza infections",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.61328125,
            "text": "Favipiravir, indicated for the treatment of new and re-emerging influenza infections",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.61328125,
            "text": "re-emerging influenza infections",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.61328125,
            "text": "the treatment of new and re-emerging influenza infections",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -7.4921875,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.61328125,
            "text": "new and re-emerging influenza infections",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -7.63671875,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -7.69140625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.4765625,
            "end_logit": -7.79296875,
            "text": "influenza infections,",
            "probability": 1.7881393432617188e-07
        }
    ],
    "621ebb733a8413c65300005c_10": [
        {
            "start_logit": 6.64453125,
            "end_logit": 7.171875,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.416015625,
            "end_logit": 7.171875,
            "text": "19",
            "probability": 0.00011682510375976562
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -2.15234375,
            "text": "COVID-19 patients",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -3.95703125,
            "text": "COV",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -5.3828125,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -5.5078125,
            "text": "COVID",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -6.0625,
            "end_logit": 7.171875,
            "text": "ID-19",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 7.171875,
            "text": "-19",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -6.27734375,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 7.171875,
            "text": "mild/moderate COVID-19",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 7.171875,
            "text": "moderate COVID-19",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -6.484375,
            "text": "COVID-19 patients treated with hydroxychloroquine",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -6.609375,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychlor",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -6.625,
            "text": "COVID-",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 7.171875,
            "text": "ICU admission rates of mild/moderate COVID-19",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.171875,
            "text": "Comparing ICU admission rates of mild/moderate COVID-19",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.0390625,
            "text": "COVID-19 patients treated with hydroxychlor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.12890625,
            "text": "COVID-19 patients treated with hydroxychloroquine,",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -7.203125,
            "text": "COVID-19 patients treated",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.171875,
            "text": "/moderate COVID-19",
            "probability": 5.960464477539062e-07
        }
    ],
    "621ebb733a8413c65300005c_11": [
        {
            "start_logit": 6.83203125,
            "end_logit": -0.76513671875,
            "text": "influenza A/California/04/2009 (H1N1) virus",
            "probability": 0.771484375
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -2.951171875,
            "text": "influenza A",
            "probability": 0.08673095703125
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -3.107421875,
            "text": "influenza",
            "probability": 0.07415771484375
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -4.2578125,
            "text": "influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 0.0234832763671875
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -4.40625,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in mice.",
            "probability": 0.020233154296875
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -4.75390625,
            "text": "influenza A/California/04/2009 (H1N1",
            "probability": 0.0142974853515625
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -6.45703125,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in mice",
            "probability": 0.0026035308837890625
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -6.63671875,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in",
            "probability": 0.0021762847900390625
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -6.90625,
            "text": "influenza A/California/04/2009",
            "probability": 0.0016613006591796875
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.37890625,
            "text": "influenza A/California",
            "probability": 0.0010366439819335938
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.40234375,
            "text": "influenza A/California/04",
            "probability": 0.0010118484497070312
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.84375,
            "text": "influenza A/",
            "probability": 0.0006508827209472656
        },
        {
            "start_logit": -3.75390625,
            "end_logit": -0.76513671875,
            "text": "pandemic influenza A/California/04/2009 (H1N1) virus",
            "probability": 1.9490718841552734e-05
        },
        {
            "start_logit": -5.40234375,
            "end_logit": -0.76513671875,
            "text": "2009 (H1N1) virus",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -3.75390625,
            "end_logit": -2.951171875,
            "text": "pandemic influenza A",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -3.75390625,
            "end_logit": -3.107421875,
            "text": "pandemic influenza",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.390625,
            "end_logit": -0.76513671875,
            "text": ") virus",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -0.76513671875,
            "text": "H1N1) virus",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -0.76513671875,
            "text": "/2009 (H1N1) virus",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": -0.76513671875,
            "text": "virus",
            "probability": 8.940696716308594e-07
        }
    ],
    "621ebb733a8413c65300005c_12": [
        {
            "start_logit": 3.421875,
            "end_logit": 4.109375,
            "text": "COVID-19",
            "probability": 0.9990234375
        },
        {
            "start_logit": -4.91015625,
            "end_logit": 4.109375,
            "text": "19",
            "probability": 0.00024139881134033203
        },
        {
            "start_logit": -5.65234375,
            "end_logit": 4.109375,
            "text": "ID-19",
            "probability": 0.00011402368545532227
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 4.109375,
            "text": "with COVID-19",
            "probability": 5.555152893066406e-05
        },
        {
            "start_logit": 3.421875,
            "end_logit": -6.30078125,
            "text": "COVID",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 3.421875,
            "end_logit": -6.34375,
            "text": "COV",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -7.1875,
            "end_logit": 4.109375,
            "text": "-19",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 3.421875,
            "end_logit": -6.5625,
            "text": "COVID-19.",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 4.109375,
            "text": "patients with COVID-19",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 4.109375,
            "text": "treating patients with COVID-19",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 3.421875,
            "end_logit": -6.94140625,
            "text": "COVID-",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 4.109375,
            "text": ": Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": -7.8125,
            "end_logit": 4.109375,
            "text": "BACKGROUND: Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 4.109375,
            "text": "Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -8.03125,
            "end_logit": 4.109375,
            "text": "possesses high utility for treating patients with COVID-19",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": -8.0625,
            "end_logit": 4.109375,
            "text": "high utility for treating patients with COVID-19",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -8.078125,
            "end_logit": 4.109375,
            "text": "iravir possesses high utility for treating patients with COVID-19",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": -4.91015625,
            "end_logit": -6.5625,
            "text": "19.",
            "probability": 0.0
        },
        {
            "start_logit": -5.65234375,
            "end_logit": -6.30078125,
            "text": "ID",
            "probability": 0.0
        },
        {
            "start_logit": -5.65234375,
            "end_logit": -6.5625,
            "text": "ID-19.",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_13": [
        {
            "start_logit": 3.046875,
            "end_logit": 5.2421875,
            "text": "influenza viruses",
            "probability": 0.9853515625
        },
        {
            "start_logit": 3.046875,
            "end_logit": 0.9228515625,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9) avian virus.",
            "probability": 0.0131072998046875
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 5.2421875,
            "text": "viruses",
            "probability": 0.0003437995910644531
        },
        {
            "start_logit": 3.046875,
            "end_logit": -2.810546875,
            "text": "influenza viruses, including A(H1N1)pdm09",
            "probability": 0.00031304359436035156
        },
        {
            "start_logit": -6.28515625,
            "end_logit": 5.2421875,
            "text": "Favipiravir is active against a broad range of influenza viruses",
            "probability": 8.755922317504883e-05
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 5.2421875,
            "text": "of influenza viruses",
            "probability": 6.461143493652344e-05
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 5.2421875,
            "text": "against a broad range of influenza viruses",
            "probability": 4.583597183227539e-05
        },
        {
            "start_logit": 3.046875,
            "end_logit": -5.4765625,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9) avian virus",
            "probability": 2.181529998779297e-05
        },
        {
            "start_logit": 3.046875,
            "end_logit": -5.4921875,
            "text": "influenza viruses, including A(H1N1)pd",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 3.046875,
            "end_logit": -5.8125,
            "text": "influenza viruses, including A(H1N1",
            "probability": 1.5556812286376953e-05
        },
        {
            "start_logit": 3.046875,
            "end_logit": -5.92578125,
            "text": "influenza viruses,",
            "probability": 1.3887882232666016e-05
        },
        {
            "start_logit": 3.046875,
            "end_logit": -5.92578125,
            "text": "influenza",
            "probability": 1.3887882232666016e-05
        },
        {
            "start_logit": 3.046875,
            "end_logit": -6.28515625,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1",
            "probability": 9.715557098388672e-06
        },
        {
            "start_logit": 3.046875,
            "end_logit": -6.53125,
            "text": "influenza viruses, including A",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": 3.046875,
            "end_logit": -6.54296875,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9) avian",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 3.046875,
            "end_logit": -7.01171875,
            "text": "influenza viruses, including A(H1N1)pdm09, A",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 3.046875,
            "end_logit": -7.02734375,
            "text": "influenza viruses, including A(H1N1)pdm",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 0.9228515625,
            "text": "viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9) avian virus.",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 3.046875,
            "end_logit": -7.10546875,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 3.046875,
            "end_logit": -7.3359375,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9",
            "probability": 3.3974647521972656e-06
        }
    ],
    "621ebb733a8413c65300005c_14": [
        {
            "start_logit": 7.7890625,
            "end_logit": 7.81640625,
            "text": "influenza virus infections",
            "probability": 1.0
        },
        {
            "start_logit": -1.8984375,
            "end_logit": 7.81640625,
            "text": "infections",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -2.263671875,
            "text": "influenza",
            "probability": 4.166364669799805e-05
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -3.580078125,
            "text": "influenza virus",
            "probability": 1.1205673217773438e-05
        },
        {
            "start_logit": -6.453125,
            "end_logit": 7.81640625,
            "text": "virus infections",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -6.7578125,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -6.96484375,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient mouse model.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.0,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.81640625,
            "text": "treatment of influenza virus infections",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.34375,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCH",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.39453125,
            "text": "influenza virus infections and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.5234375,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.81640625,
            "text": "of influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.81640625,
            "text": "Favipiravir is approved in Japan for the treatment of influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 7.81640625,
            "text": "the treatment of influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.87109375,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -8.0703125,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -8.09375,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -8.1015625,
            "text": "influenza virus infections and has shown promise against other highly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -8.1015625,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_15": [
        {
            "start_logit": 7.828125,
            "end_logit": 7.8046875,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": 7.828125,
            "end_logit": -1.865234375,
            "text": "COV",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": -1.9443359375,
            "end_logit": 7.8046875,
            "text": "19",
            "probability": 5.692243576049805e-05
        },
        {
            "start_logit": 7.828125,
            "end_logit": -5.54296875,
            "text": "COVID",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 7.828125,
            "end_logit": -6.1875,
            "text": "COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 7.8046875,
            "text": "antiviral drug, is being used for COVID-19",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 7.8046875,
            "text": "ID-19",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -6.66015625,
            "text": "COVID-",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 7.8046875,
            "text": "-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.58984375,
            "text": "COVID-19 treatment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.8046875,
            "text": "Favipiravir, an antiviral drug, is being used for COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.76953125,
            "text": "COVID-19 treatment,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.77734375,
            "text": "COVID-19 treatment, and we",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 7.8046875,
            "text": ", is being used for COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 7.8046875,
            "text": "an antiviral drug, is being used for COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.98828125,
            "text": "COVID-19 treatment, and we currently have limited information regarding its efficacy and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -8.0,
            "text": "COVID-19 treatment, and we currently have limited",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -8.0,
            "text": "COVID-19 treatment, and we currently have limited information regarding its",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -8.015625,
            "text": "COVID-19 treatment, and we currently have limited information regarding",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.8046875,
            "text": "is being used for COVID-19",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_16": [
        {
            "start_logit": 7.80078125,
            "end_logit": 0.9140625,
            "text": "severe acute respiratory syndrome",
            "probability": 0.81787109375
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -0.90869140625,
            "text": "severe acute respiratory syndrome coronavirus",
            "probability": 0.1314697265625
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -2.322265625,
            "text": "severe",
            "probability": 0.031982421875
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -3.0,
            "text": "severe acute respiratory",
            "probability": 0.016265869140625
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -5.75,
            "text": "severe acute",
            "probability": 0.0010395050048828125
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -6.2421875,
            "text": "severe acute respiratory syndrome coronavirus-2.",
            "probability": 0.0006351470947265625
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -6.71484375,
            "text": "severe acute respiratory syndrome coronavirus-",
            "probability": 0.0003960132598876953
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.57421875,
            "text": "severe acute respiratory syndrome coronavirus-2",
            "probability": 0.00016772747039794922
        },
        {
            "start_logit": -4.44140625,
            "end_logit": 0.9140625,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -4.44140625,
            "end_logit": -0.90869140625,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 0.9140625,
            "text": "against severe acute respiratory syndrome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 0.9140625,
            "text": "acute respiratory syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 0.9140625,
            "text": "drug that was approved for new and reemerging pandemic influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 0.9140625,
            "text": "oral drug that was approved for new and reemerging pandemic influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 0.9140625,
            "text": "reemerging pandemic influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 0.9140625,
            "text": "pandemic influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 0.9140625,
            "text": "merging pandemic influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 0.9140625,
            "text": "syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.44140625,
            "end_logit": -2.322265625,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 0.9140625,
            "text": "was approved for new and reemerging pandemic influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_17": [
        {
            "start_logit": 0.10693359375,
            "end_logit": 1.671875,
            "text": "influenza",
            "probability": 0.9453125
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -2.115234375,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19.",
            "probability": 0.02142333984375
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -2.640625,
            "text": "influenza and Ebola",
            "probability": 0.012664794921875
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -3.2109375,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19",
            "probability": 0.00716400146484375
        },
        {
            "start_logit": -1.4609375,
            "end_logit": -2.115234375,
            "text": "COVID-19.",
            "probability": 0.004467010498046875
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -4.1328125,
            "text": "influenza and Ebola,",
            "probability": 0.002849578857421875
        },
        {
            "start_logit": -1.4609375,
            "end_logit": -3.2109375,
            "text": "COVID-19",
            "probability": 0.0014896392822265625
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 1.671875,
            "text": "antiviral previously indicated for influenza",
            "probability": 0.0009322166442871094
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 1.671875,
            "text": "Favipiravir is an antiviral previously indicated for influenza",
            "probability": 0.0008420944213867188
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -5.625,
            "text": "influenza and",
            "probability": 0.000640869140625
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 1.671875,
            "text": "an antiviral previously indicated for influenza",
            "probability": 0.0002956390380859375
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 1.671875,
            "text": "previously indicated for influenza",
            "probability": 0.0002777576446533203
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 1.671875,
            "text": "for influenza",
            "probability": 0.0002777576446533203
        },
        {
            "start_logit": -8.03125,
            "end_logit": 1.671875,
            "text": "indicated for influenza",
            "probability": 0.0002753734588623047
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -6.70703125,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID",
            "probability": 0.0002162456512451172
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -7.1796875,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of",
            "probability": 0.0001354217529296875
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -7.421875,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-",
            "probability": 0.0001062154769897461
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -7.53125,
            "text": "influenza and Ebola, which",
            "probability": 9.524822235107422e-05
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -7.640625,
            "text": "influenza and Ebola, which has shown some",
            "probability": 8.535385131835938e-05
        },
        {
            "start_logit": 0.10693359375,
            "end_logit": -7.6953125,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment",
            "probability": 8.082389831542969e-05
        }
    ],
    "621ebb733a8413c65300005c_18": [
        {
            "start_logit": 7.328125,
            "end_logit": 7.91796875,
            "text": "Ebola virus infection",
            "probability": 1.0
        },
        {
            "start_logit": -1.8291015625,
            "end_logit": 7.91796875,
            "text": "infection",
            "probability": 0.0001055598258972168
        },
        {
            "start_logit": 7.328125,
            "end_logit": -3.12109375,
            "text": "Ebola",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -4.90234375,
            "end_logit": 7.91796875,
            "text": "influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 7.91796875,
            "text": "virus infection",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 7.91796875,
            "text": "treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 7.91796875,
            "text": "treating Ebola virus infection",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.91796875,
            "text": "been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.328125,
            "end_logit": -7.171875,
            "text": "Ebola virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.91796875,
            "text": "of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 7.91796875,
            "text": "antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.91796875,
            "text": "which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 7.91796875,
            "text": "has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 7.91796875,
            "text": "demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 7.91796875,
            "text": "drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 7.91796875,
            "text": "novel antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 7.91796875,
            "text": "was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.328125,
            "end_logit": -7.92578125,
            "text": "Ebola virus infection.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.328125,
            "end_logit": -8.0546875,
            "text": "Ebola virus infection. I",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.90234375,
            "end_logit": -0.28369140625,
            "text": "influenza",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_19": [
        {
            "start_logit": 4.421875,
            "end_logit": 7.0234375,
            "text": "influenza virus",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.92578125,
            "end_logit": 7.0234375,
            "text": "infections with the influenza virus",
            "probability": 0.0006437301635742188
        },
        {
            "start_logit": -3.2890625,
            "end_logit": 7.0234375,
            "text": "virus",
            "probability": 0.0004475116729736328
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 7.0234375,
            "text": "the influenza virus",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.0234375,
            "text": "treatment of infections with the influenza virus",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.0234375,
            "text": "with the influenza virus",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.0234375,
            "text": "the treatment of infections with the influenza virus",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 7.0234375,
            "text": "demonstrate that Favipiravir [T-705, a drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.0234375,
            "text": "clinical development for the treatment of infections with the influenza virus",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.0234375,
            "text": "for the treatment of infections with the influenza virus",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 4.421875,
            "end_logit": -5.78515625,
            "text": "influenza virus]",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 4.421875,
            "end_logit": -6.0078125,
            "text": "influenza",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 4.421875,
            "end_logit": -7.02734375,
            "text": "influenza virus] inhibits in vitro murine norovirus",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 4.421875,
            "end_logit": -7.58984375,
            "text": "influenza virus] inhibits in vitro murine norovirus replication",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.421875,
            "end_logit": -7.73046875,
            "text": "influenza virus] inhibits in vitro murine norovirus replication.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.421875,
            "end_logit": -7.88671875,
            "text": "influenza virus] inhibits",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.92578125,
            "end_logit": -5.78515625,
            "text": "infections with the influenza virus]",
            "probability": 0.0
        },
        {
            "start_logit": -2.92578125,
            "end_logit": -6.0078125,
            "text": "infections with the influenza",
            "probability": 0.0
        },
        {
            "start_logit": -3.2890625,
            "end_logit": -5.78515625,
            "text": "virus]",
            "probability": 0.0
        },
        {
            "start_logit": -2.92578125,
            "end_logit": -6.92578125,
            "text": "infections with",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_20": [
        {
            "start_logit": 4.0546875,
            "end_logit": 6.921875,
            "text": "COVID-19",
            "probability": 0.998046875
        },
        {
            "start_logit": -2.60546875,
            "end_logit": 6.921875,
            "text": "19",
            "probability": 0.001277923583984375
        },
        {
            "start_logit": -5.25,
            "end_logit": 6.921875,
            "text": "with COVID-19",
            "probability": 9.083747863769531e-05
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 6.921875,
            "text": "ID-19",
            "probability": 8.869171142578125e-05
        },
        {
            "start_logit": -6.328125,
            "end_logit": 6.921875,
            "text": "-19",
            "probability": 3.0875205993652344e-05
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 6.921875,
            "text": "Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 2.3126602172851562e-05
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 6.921875,
            "text": "pinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.921875,
            "text": "patients with COVID-19",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.921875,
            "text": "The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.921875,
            "text": "treatment option for patients with COVID-19",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.921875,
            "text": "combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.921875,
            "text": "of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.921875,
            "text": "Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.921875,
            "text": "avir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 4.0546875,
            "end_logit": -6.203125,
            "text": "COV",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 4.0546875,
            "end_logit": -6.79296875,
            "text": "COVID",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 4.0546875,
            "end_logit": -7.33984375,
            "text": "COVID-",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.25,
            "end_logit": -6.203125,
            "text": "with COV",
            "probability": 0.0
        },
        {
            "start_logit": -5.25,
            "end_logit": -6.79296875,
            "text": "with COVID",
            "probability": 0.0
        },
        {
            "start_logit": -5.2734375,
            "end_logit": -6.79296875,
            "text": "ID",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_21": [
        {
            "start_logit": 4.328125,
            "end_logit": 5.1328125,
            "text": "COVID-19",
            "probability": 0.9990234375
        },
        {
            "start_logit": -4.3671875,
            "end_logit": 5.1328125,
            "text": "19",
            "probability": 0.0001672506332397461
        },
        {
            "start_logit": 4.328125,
            "end_logit": -3.728515625,
            "text": "COVID-19.",
            "probability": 0.00014197826385498047
        },
        {
            "start_logit": -5.515625,
            "end_logit": 5.1328125,
            "text": "ID-19",
            "probability": 5.2988529205322266e-05
        },
        {
            "start_logit": -5.74609375,
            "end_logit": 5.1328125,
            "text": "for COVID-19",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": 4.328125,
            "end_logit": -5.078125,
            "text": "COV",
            "probability": 3.6716461181640625e-05
        },
        {
            "start_logit": 4.328125,
            "end_logit": -5.4296875,
            "text": "COVID",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -6.390625,
            "end_logit": 5.1328125,
            "text": "Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -6.578125,
            "end_logit": 5.1328125,
            "text": "vir, Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": -7.140625,
            "end_logit": 5.1328125,
            "text": "Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 5.1328125,
            "text": "-19",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": -7.25,
            "end_logit": 5.1328125,
            "text": "and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 5.1328125,
            "text": "option for COVID-19",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": -7.6875,
            "end_logit": 5.1328125,
            "text": "iravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 4.328125,
            "end_logit": -6.90625,
            "text": "COVID-19. Recent",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 5.1328125,
            "text": "ipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 5.1328125,
            "text": "be a safer therapeutic option for COVID-19",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 5.1328125,
            "text": ", Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 4.328125,
            "end_logit": -7.109375,
            "text": "COVID-",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -4.3671875,
            "end_logit": -3.728515625,
            "text": "19.",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_22": [
        {
            "start_logit": 3.63671875,
            "end_logit": 6.98828125,
            "text": "Covid-19",
            "probability": 0.9990234375
        },
        {
            "start_logit": -3.12890625,
            "end_logit": 6.98828125,
            "text": "19",
            "probability": 0.00115203857421875
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 6.98828125,
            "text": "id-19",
            "probability": 4.678964614868164e-05
        },
        {
            "start_logit": -6.453125,
            "end_logit": 6.98828125,
            "text": "of Covid-19",
            "probability": 4.13060188293457e-05
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 6.98828125,
            "text": "-19",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 6.98828125,
            "text": "Hydroxychloroquine for Management of Covid-19",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 6.98828125,
            "text": "Management of Covid-19",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 6.98828125,
            "text": "loroquine for Management of Covid-19",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.98828125,
            "text": "Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -6.3203125,
            "text": "Cov",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -6.54296875,
            "text": "Covid-19: A Retrospective Study.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -6.8359375,
            "text": "Covid",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -7.1796875,
            "text": "Covid-19:",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -7.42578125,
            "text": "Covid-",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -7.5390625,
            "text": "Covid-19: A",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -7.6953125,
            "text": "Covid-19: A Retrospective",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -7.76953125,
            "text": "Covid-19: A Retrospective Study",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -3.12890625,
            "end_logit": -6.54296875,
            "text": "19: A Retrospective Study.",
            "probability": 0.0
        },
        {
            "start_logit": -3.12890625,
            "end_logit": -7.1796875,
            "text": "19:",
            "probability": 0.0
        },
        {
            "start_logit": -3.12890625,
            "end_logit": -7.5390625,
            "text": "19: A",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_23": [
        {
            "start_logit": 0.287841796875,
            "end_logit": 6.2890625,
            "text": "influenza",
            "probability": 0.99609375
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.2890625,
            "text": "treatment of influenza",
            "probability": 0.00044274330139160156
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.2890625,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 0.00039076805114746094
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 6.2890625,
            "text": "AIM: Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 0.0002949237823486328
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.2890625,
            "text": "antiviral compounds used for the treatment of influenza",
            "probability": 0.0002791881561279297
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.2890625,
            "text": "eltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 0.00027680397033691406
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.2890625,
            "text": "of influenza",
            "probability": 0.0002727508544921875
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 6.2890625,
            "text": "for the treatment of influenza",
            "probability": 0.00026869773864746094
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 6.2890625,
            "text": "vir are antiviral compounds used for the treatment of influenza",
            "probability": 0.0002522468566894531
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.2890625,
            "text": "used for the treatment of influenza",
            "probability": 0.00024628639221191406
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.2890625,
            "text": "the treatment of influenza",
            "probability": 0.0002332925796508789
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.2890625,
            "text": "oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 0.0002313852310180664
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 6.2890625,
            "text": "are antiviral compounds used for the treatment of influenza",
            "probability": 0.0002295970916748047
        },
        {
            "start_logit": 0.287841796875,
            "end_logit": -3.751953125,
            "text": "influenza inf",
            "probability": 4.315376281738281e-05
        },
        {
            "start_logit": 0.287841796875,
            "end_logit": -7.0390625,
            "text": "influenza infec",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -3.751953125,
            "text": "treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -3.751953125,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -3.751953125,
            "text": "AIM: Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -3.751953125,
            "text": "antiviral compounds used for the treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -3.751953125,
            "text": "eltamivir are antiviral compounds used for the treatment of influenza inf",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_24": [
        {
            "start_logit": 7.390625,
            "end_logit": 7.3984375,
            "text": "coronavirus disease",
            "probability": 0.94970703125
        },
        {
            "start_logit": 7.390625,
            "end_logit": 4.44921875,
            "text": "coronavirus disease 2019",
            "probability": 0.049957275390625
        },
        {
            "start_logit": -2.892578125,
            "end_logit": 7.3984375,
            "text": "disease",
            "probability": 3.254413604736328e-05
        },
        {
            "start_logit": 7.390625,
            "end_logit": -2.94921875,
            "text": "coronavirus",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": -2.892578125,
            "end_logit": 4.44921875,
            "text": "disease 2019",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.5,
            "end_logit": 7.3984375,
            "text": "managing coronavirus disease",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.3984375,
            "text": "treatment candidate for managing coronavirus disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 7.3984375,
            "text": "OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.390625,
            "end_logit": -7.8203125,
            "text": "coronavirus disease 2019 (COVID",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.3984375,
            "text": "is a promising treatment candidate for managing coronavirus disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 7.3984375,
            "text": ": Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.3984375,
            "text": "for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.390625,
            "end_logit": -8.03125,
            "text": "coronavirus disease 2019 (COVID-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.3984375,
            "text": "a promising treatment candidate for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.3984375,
            "text": "Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.3984375,
            "text": "promising treatment candidate for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.828125,
            "end_logit": 4.44921875,
            "text": "2019",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.5,
            "end_logit": 4.44921875,
            "text": "managing coronavirus disease 2019",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.765625,
            "end_logit": 4.44921875,
            "text": "treatment candidate for managing coronavirus disease 2019",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 4.44921875,
            "text": "OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_25": [
        {
            "start_logit": 0.325439453125,
            "end_logit": 2.962890625,
            "text": "RNA virus infections",
            "probability": 0.615234375
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": 2.962890625,
            "text": "severe influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 0.319091796875
        },
        {
            "start_logit": 0.325439453125,
            "end_logit": -0.5400390625,
            "text": "RNA virus infections for which standard treatments are not available.",
            "probability": 0.0185089111328125
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": -0.314697265625,
            "text": "severe influenza",
            "probability": 0.01204681396484375
        },
        {
            "start_logit": -3.673828125,
            "end_logit": 2.962890625,
            "text": "influenza strain, and other severe RNA virus infections",
            "probability": 0.01126861572265625
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": -0.5400390625,
            "text": "severe influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.0095977783203125
        },
        {
            "start_logit": -4.5078125,
            "end_logit": 2.962890625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 0.004886627197265625
        },
        {
            "start_logit": -4.5546875,
            "end_logit": 2.962890625,
            "text": "severe RNA virus infections",
            "probability": 0.00466156005859375
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 2.962890625,
            "text": "virus infections",
            "probability": 0.001636505126953125
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 2.962890625,
            "text": "infections",
            "probability": 0.0008764266967773438
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": -3.78515625,
            "text": "severe influenza,",
            "probability": 0.00037384033203125
        },
        {
            "start_logit": -3.673828125,
            "end_logit": -0.5400390625,
            "text": "influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.0003390312194824219
        },
        {
            "start_logit": -7.1875,
            "end_logit": 2.962890625,
            "text": "Favipiravir is expected to be an important therapeutic agent for severe influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 0.0003352165222167969
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": -4.14453125,
            "text": "severe influenza, the next pandemic influenza",
            "probability": 0.00026106834411621094
        },
        {
            "start_logit": -4.5078125,
            "end_logit": -0.314697265625,
            "text": "influenza",
            "probability": 0.0001850128173828125
        },
        {
            "start_logit": -7.90625,
            "end_logit": 2.962890625,
            "text": "other severe RNA virus infections",
            "probability": 0.0001633167266845703
        },
        {
            "start_logit": -4.5078125,
            "end_logit": -0.5400390625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.0001475811004638672
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -0.5400390625,
            "text": "severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.00014078617095947266
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 2.962890625,
            "text": "iravir is expected to be an important therapeutic agent for severe influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 0.00013434886932373047
        },
        {
            "start_logit": 0.325439453125,
            "end_logit": -5.47265625,
            "text": "RNA virus",
            "probability": 0.00013327598571777344
        }
    ],
    "621ebb733a8413c65300005c_26": [
        {
            "start_logit": 0.325439453125,
            "end_logit": 2.962890625,
            "text": "RNA virus infections",
            "probability": 0.615234375
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": 2.962890625,
            "text": "severe influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 0.319091796875
        },
        {
            "start_logit": 0.325439453125,
            "end_logit": -0.5400390625,
            "text": "RNA virus infections for which standard treatments are not available.",
            "probability": 0.0185089111328125
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": -0.314697265625,
            "text": "severe influenza",
            "probability": 0.01204681396484375
        },
        {
            "start_logit": -3.673828125,
            "end_logit": 2.962890625,
            "text": "influenza strain, and other severe RNA virus infections",
            "probability": 0.01126861572265625
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": -0.5400390625,
            "text": "severe influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.0095977783203125
        },
        {
            "start_logit": -4.5078125,
            "end_logit": 2.962890625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 0.004886627197265625
        },
        {
            "start_logit": -4.5546875,
            "end_logit": 2.962890625,
            "text": "severe RNA virus infections",
            "probability": 0.00466156005859375
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 2.962890625,
            "text": "virus infections",
            "probability": 0.001636505126953125
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 2.962890625,
            "text": "infections",
            "probability": 0.0008764266967773438
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": -3.78515625,
            "text": "severe influenza,",
            "probability": 0.00037384033203125
        },
        {
            "start_logit": -3.673828125,
            "end_logit": -0.5400390625,
            "text": "influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.0003390312194824219
        },
        {
            "start_logit": -7.1875,
            "end_logit": 2.962890625,
            "text": "Favipiravir is expected to be an important therapeutic agent for severe influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 0.0003352165222167969
        },
        {
            "start_logit": -0.3310546875,
            "end_logit": -4.14453125,
            "text": "severe influenza, the next pandemic influenza",
            "probability": 0.00026106834411621094
        },
        {
            "start_logit": -4.5078125,
            "end_logit": -0.314697265625,
            "text": "influenza",
            "probability": 0.0001850128173828125
        },
        {
            "start_logit": -7.90625,
            "end_logit": 2.962890625,
            "text": "other severe RNA virus infections",
            "probability": 0.0001633167266845703
        },
        {
            "start_logit": -4.5078125,
            "end_logit": -0.5400390625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.0001475811004638672
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -0.5400390625,
            "text": "severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.00014078617095947266
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 2.962890625,
            "text": "iravir is expected to be an important therapeutic agent for severe influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 0.00013434886932373047
        },
        {
            "start_logit": 0.325439453125,
            "end_logit": -5.47265625,
            "text": "RNA virus",
            "probability": 0.00013327598571777344
        }
    ],
    "621ebb733a8413c65300005c_27": [
        {
            "start_logit": 7.81640625,
            "end_logit": 7.76171875,
            "text": "influenza virus infections",
            "probability": 1.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": 7.76171875,
            "text": "infections",
            "probability": 4.5418739318847656e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -2.25,
            "text": "influenza",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -3.728515625,
            "text": "influenza virus",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": -4.69140625,
            "end_logit": 7.76171875,
            "text": "treat pandemic influenza virus infections",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 7.76171875,
            "text": "pandemic influenza virus infections",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 7.76171875,
            "text": "virus infections",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.30078125,
            "text": "influenza virus infections.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.76171875,
            "text": "antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 7.76171875,
            "text": "has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 7.76171875,
            "text": "been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 7.76171875,
            "text": "to treat pandemic influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 7.76171875,
            "text": "drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.76171875,
            "text": "is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.76171875,
            "text": "that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 7.76171875,
            "text": "approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 7.76171875,
            "text": "an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.76171875,
            "text": "2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.69140625,
            "end_logit": -2.25,
            "text": "treat pandemic influenza",
            "probability": 0.0
        },
        {
            "start_logit": -5.83203125,
            "end_logit": -2.25,
            "text": "pandemic influenza",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_28": [
        {
            "start_logit": 6.62890625,
            "end_logit": 4.9609375,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 6.62890625,
            "end_logit": -3.669921875,
            "text": "influenza strains",
            "probability": 0.00017821788787841797
        },
        {
            "start_logit": 6.62890625,
            "end_logit": -6.4765625,
            "text": "influenza strains;",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 6.62890625,
            "end_logit": -6.87109375,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United States and Europe.",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": 6.62890625,
            "end_logit": -7.765625,
            "text": "influenza strains; and",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 6.62890625,
            "end_logit": -7.9609375,
            "text": "influenza strains; and several phase 2 and 3",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 4.9609375,
            "text": "emerging influenza",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 4.9609375,
            "text": "antiviral approved for use in Japan against emerging influenza",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 4.9609375,
            "text": "purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 4.9609375,
            "text": "analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 4.9609375,
            "text": "is a purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 4.9609375,
            "text": "use in Japan against emerging influenza",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 4.9609375,
            "text": "a purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": -3.669921875,
            "text": "emerging influenza strains",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -3.669921875,
            "text": "antiviral approved for use in Japan against emerging influenza strains",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -3.669921875,
            "text": "purine analogue antiviral approved for use in Japan against emerging influenza strains",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -3.669921875,
            "text": "analogue antiviral approved for use in Japan against emerging influenza strains",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -3.669921875,
            "text": "is a purine analogue antiviral approved for use in Japan against emerging influenza strains",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -3.669921875,
            "text": "use in Japan against emerging influenza strains",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -3.669921875,
            "text": "a purine analogue antiviral approved for use in Japan against emerging influenza strains",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_29": [
        {
            "start_logit": 3.19921875,
            "end_logit": 5.8359375,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -3.099609375,
            "text": "influenza and many other RNA viral diseases",
            "probability": 0.00013244152069091797
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -3.30859375,
            "text": "influenza and many other RNA viral diseases for which there are no approved therapies.",
            "probability": 0.00010722875595092773
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 5.8359375,
            "text": "antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 5.8359375,
            "text": ", favipiravir is a promising drug candidate for influenza",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 5.8359375,
            "text": "for influenza",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 5.8359375,
            "text": "of antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": -7.859375,
            "end_logit": 5.8359375,
            "text": "favipiravir is a promising drug candidate for influenza",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 5.8359375,
            "text": "is a promising drug candidate for influenza",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -8.0625,
            "end_logit": 5.8359375,
            "text": "its unique mechanism of action and broad range of antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -5.5078125,
            "text": "influenza and",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -5.71484375,
            "text": "influenza and many other RNA viral",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -6.8828125,
            "text": "influenza and many other RNA viral diseases for which there are no approved",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -6.90234375,
            "text": "influenza and many other RNA",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -7.15234375,
            "text": "influenza and many other RNA viral diseases for which there are",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -7.24609375,
            "text": "influenza and many other RNA viral diseases for which there are no",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -7.37890625,
            "text": "influenza and many other RNA viral diseases for which there",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -7.40234375,
            "text": "influenza and many",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -7.625,
            "text": "influenza and many other RNA viral diseases for which there are no approved therapies",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 3.19921875,
            "end_logit": -7.828125,
            "text": "influenza and many other RNA viral diseases for which",
            "probability": 1.1920928955078125e-06
        }
    ],
    "621ebb733a8413c65300005c_30": [
        {
            "start_logit": 7.43359375,
            "end_logit": 7.625,
            "text": "anti-influenza drug and licensed as an anti-influenza",
            "probability": 0.525390625
        },
        {
            "start_logit": 7.43359375,
            "end_logit": 7.18359375,
            "text": "anti-influenza",
            "probability": 0.336669921875
        },
        {
            "start_logit": 6.09375,
            "end_logit": 7.625,
            "text": "anti-influenza",
            "probability": 0.1370849609375
        },
        {
            "start_logit": 0.2021484375,
            "end_logit": 7.625,
            "text": "influenza",
            "probability": 0.0003790855407714844
        },
        {
            "start_logit": 0.073486328125,
            "end_logit": 7.625,
            "text": "influenza drug and licensed as an anti-influenza",
            "probability": 0.0003333091735839844
        },
        {
            "start_logit": 0.073486328125,
            "end_logit": 7.18359375,
            "text": "influenza",
            "probability": 0.0002143383026123047
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -1.46484375,
            "text": "anti",
            "probability": 5.900859832763672e-05
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -2.875,
            "text": "anti-influenza drug and licensed as an anti",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": 6.09375,
            "end_logit": -2.875,
            "text": "anti",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -4.296875,
            "text": "anti-influenza drug",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -5.609375,
            "text": "anti-influenza drug and licensed as an anti-influenza drug in Japan.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -5.8125,
            "text": "anti-influenza drug and licensed as an anti-influenza drug",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -6.9375,
            "text": "anti-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.09375,
            "end_logit": -5.609375,
            "text": "anti-influenza drug in Japan.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.0625,
            "text": "anti-influenza drug and licensed as an anti-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.625,
            "text": "-influenza",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 7.625,
            "text": "-influenza drug and licensed as an anti-influenza",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.09375,
            "end_logit": -5.8125,
            "text": "anti-influenza drug",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.3671875,
            "text": "anti-influenza drug and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.42578125,
            "text": "anti-influenza drug and licensed as an anti-influenza drug in Japan",
            "probability": 1.7881393432617188e-07
        }
    ],
    "621ebb733a8413c65300005c_31": [
        {
            "start_logit": 7.43359375,
            "end_logit": 7.625,
            "text": "anti-influenza drug and licensed as an anti-influenza",
            "probability": 0.525390625
        },
        {
            "start_logit": 7.43359375,
            "end_logit": 7.18359375,
            "text": "anti-influenza",
            "probability": 0.336669921875
        },
        {
            "start_logit": 6.09375,
            "end_logit": 7.625,
            "text": "anti-influenza",
            "probability": 0.1370849609375
        },
        {
            "start_logit": 0.2021484375,
            "end_logit": 7.625,
            "text": "influenza",
            "probability": 0.0003790855407714844
        },
        {
            "start_logit": 0.073486328125,
            "end_logit": 7.625,
            "text": "influenza drug and licensed as an anti-influenza",
            "probability": 0.0003333091735839844
        },
        {
            "start_logit": 0.073486328125,
            "end_logit": 7.18359375,
            "text": "influenza",
            "probability": 0.0002143383026123047
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -1.46484375,
            "text": "anti",
            "probability": 5.900859832763672e-05
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -2.875,
            "text": "anti-influenza drug and licensed as an anti",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": 6.09375,
            "end_logit": -2.875,
            "text": "anti",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -4.296875,
            "text": "anti-influenza drug",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -5.609375,
            "text": "anti-influenza drug and licensed as an anti-influenza drug in Japan.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -5.8125,
            "text": "anti-influenza drug and licensed as an anti-influenza drug",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -6.9375,
            "text": "anti-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.09375,
            "end_logit": -5.609375,
            "text": "anti-influenza drug in Japan.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.0625,
            "text": "anti-influenza drug and licensed as an anti-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 7.625,
            "text": "-influenza",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 7.625,
            "text": "-influenza drug and licensed as an anti-influenza",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.09375,
            "end_logit": -5.8125,
            "text": "anti-influenza drug",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.3671875,
            "text": "anti-influenza drug and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.42578125,
            "text": "anti-influenza drug and licensed as an anti-influenza drug in Japan",
            "probability": 1.7881393432617188e-07
        }
    ],
    "621ebb733a8413c65300005c_32": [
        {
            "start_logit": 1.6044921875,
            "end_logit": 7.44140625,
            "text": "life-threatening RNA virus infections",
            "probability": 0.94287109375
        },
        {
            "start_logit": -2.015625,
            "end_logit": 7.44140625,
            "text": "RNA virus infections",
            "probability": 0.0252227783203125
        },
        {
            "start_logit": -2.966796875,
            "end_logit": 7.44140625,
            "text": "infections",
            "probability": 0.009765625
        },
        {
            "start_logit": 1.6044921875,
            "end_logit": 2.701171875,
            "text": "life-threatening RNA virus infections.",
            "probability": 0.0082244873046875
        },
        {
            "start_logit": -3.58203125,
            "end_logit": 7.44140625,
            "text": "influenza drug against life-threatening RNA virus infections",
            "probability": 0.0052642822265625
        },
        {
            "start_logit": -3.888671875,
            "end_logit": 7.44140625,
            "text": "anti-influenza drug against life-threatening RNA virus infections",
            "probability": 0.0038852691650390625
        },
        {
            "start_logit": -4.0390625,
            "end_logit": 7.44140625,
            "text": "threatening RNA virus infections",
            "probability": 0.00333404541015625
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 7.44140625,
            "text": "virus infections",
            "probability": 0.00024819374084472656
        },
        {
            "start_logit": -6.65625,
            "end_logit": 7.44140625,
            "text": "-threatening RNA virus infections",
            "probability": 0.00024259090423583984
        },
        {
            "start_logit": -2.015625,
            "end_logit": 2.701171875,
            "text": "RNA virus infections.",
            "probability": 0.00022089481353759766
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 7.44140625,
            "text": "against life-threatening RNA virus infections",
            "probability": 0.0001666545867919922
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.44140625,
            "text": "-influenza drug against life-threatening RNA virus infections",
            "probability": 0.0001360177993774414
        },
        {
            "start_logit": -2.966796875,
            "end_logit": 2.701171875,
            "text": "infections.",
            "probability": 8.51750373840332e-05
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 7.44140625,
            "text": "Favipiravir, an anti-influenza drug against life-threatening RNA virus infections",
            "probability": 6.788969039916992e-05
        },
        {
            "start_logit": -3.58203125,
            "end_logit": 2.701171875,
            "text": "influenza drug against life-threatening RNA virus infections.",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": -3.888671875,
            "end_logit": 2.701171875,
            "text": "anti-influenza drug against life-threatening RNA virus infections.",
            "probability": 3.3915042877197266e-05
        },
        {
            "start_logit": -4.0390625,
            "end_logit": 2.701171875,
            "text": "threatening RNA virus infections.",
            "probability": 2.9146671295166016e-05
        },
        {
            "start_logit": -4.4375,
            "end_logit": 2.701171875,
            "text": ".",
            "probability": 1.9609928131103516e-05
        },
        {
            "start_logit": 1.6044921875,
            "end_logit": -4.734375,
            "text": "life-threatening RNA virus",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 2.701171875,
            "text": "virus infections.",
            "probability": 2.205371856689453e-06
        }
    ],
    "5e48bf5ed14c9f295d000019_1": [
        {
            "start_logit": 7.8046875,
            "end_logit": 7.76953125,
            "text": "Nonconvulsive Status Epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": 7.76953125,
            "text": "Epilepticus",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -2.421875,
            "text": "Noncon",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": -3.515625,
            "end_logit": 7.76953125,
            "text": "Status Epilepticus",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": -6.40625,
            "end_logit": 7.76953125,
            "text": "ulsive Status Epilepticus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 7.76953125,
            "text": "vulsive Status Epilepticus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.46484375,
            "text": "Nonconvulsive Status Epilepticus by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.5,
            "text": "Nonconvulsive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.76953125,
            "text": "Patients With Nonconvulsive Status Epilepticus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.6015625,
            "text": "Nonconv",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.76953125,
            "text": "With Nonconvulsive Status Epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.76953125,
            "text": "Critically Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.80078125,
            "text": "Nonconvulsive Status",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.94140625,
            "text": "Nonconvulsive Status Epilepticus by Using Salzburg Consensus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.94140625,
            "text": "Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -7.46484375,
            "text": "Epilepticus by",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -2.421875,
            "text": "Patients With Noncon",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -2.421875,
            "text": "With Noncon",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -2.421875,
            "text": "Critically Ill Patients With Noncon",
            "probability": 0.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -7.94140625,
            "text": "Epilepticus by Using Salzburg Consensus",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_2": [
        {
            "start_logit": 7.56640625,
            "end_logit": 7.7890625,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": -2.185546875,
            "end_logit": 7.7890625,
            "text": "epilepticus",
            "probability": 5.7816505432128906e-05
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -2.9609375,
            "text": "noncon",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 7.7890625,
            "text": "status epilepticus",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 7.7890625,
            "text": "vulsive status epilepticus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 7.7890625,
            "text": "ulsive status epilepticus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.7890625,
            "text": "with nonconvulsive status epilepticus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.4453125,
            "text": "nonconvulsive status",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.48046875,
            "text": "nonconvulsive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.5859375,
            "text": "nonconv",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.7890625,
            "text": "patients with nonconvulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.80859375,
            "text": "nonconvulsive status epilepticus (NCSE).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.7890625,
            "text": "critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -7.80859375,
            "text": "epilepticus (NCSE).",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -2.9609375,
            "text": "with noncon",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -2.9609375,
            "text": "patients with noncon",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -2.9609375,
            "text": "OBJECTIVE: We aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with noncon",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -2.9609375,
            "text": ": We aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with noncon",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -2.9609375,
            "text": "critically ill patients with noncon",
            "probability": 0.0
        },
        {
            "start_logit": -5.19921875,
            "end_logit": -7.4453125,
            "text": "status",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_3": [
        {
            "start_logit": 7.86328125,
            "end_logit": 7.8203125,
            "text": "status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -1.8515625,
            "text": "status",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": -1.9755859375,
            "end_logit": 7.8203125,
            "text": "epilepticus",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": -4.859375,
            "end_logit": 7.8203125,
            "text": "convulsive status epilepticus",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.8203125,
            "text": "ulsive status epilepticus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.8203125,
            "text": "non-convulsive status epilepticus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.56640625,
            "text": "status epilepticus:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.73046875,
            "text": "status epilepticus: a retrospective",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.80859375,
            "text": "status epilepticus: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.828125,
            "text": "status epilepticus: a retrospective study",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.99609375,
            "text": "status epilepticus: a retrospective study.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.8203125,
            "text": "-convulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.8203125,
            "text": "EEG criteria for non-convulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.8203125,
            "text": "Salzburg EEG criteria for non-convulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.8203125,
            "text": "zburg EEG criteria for non-convulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.8203125,
            "text": "criteria for non-convulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 7.8203125,
            "text": "burg EEG criteria for non-convulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.234375,
            "end_logit": 7.8203125,
            "text": "Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.859375,
            "end_logit": -1.8515625,
            "text": "convulsive status",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -1.8515625,
            "text": "ulsive status",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_4": [
        {
            "start_logit": 7.90234375,
            "end_logit": 7.8828125,
            "text": "status epilepticus",
            "probability": 0.5
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 7.8828125,
            "text": "Status Epilepticus",
            "probability": 0.5
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.2177734375,
            "text": "Status",
            "probability": 5.614757537841797e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.2900390625,
            "text": "status",
            "probability": 5.1975250244140625e-05
        },
        {
            "start_logit": -1.52734375,
            "end_logit": 7.8828125,
            "text": "Epilepticus",
            "probability": 4.0471553802490234e-05
        },
        {
            "start_logit": -1.564453125,
            "end_logit": 7.8828125,
            "text": "epilepticus",
            "probability": 3.892183303833008e-05
        },
        {
            "start_logit": -4.2109375,
            "end_logit": 7.8828125,
            "text": "convulsive status epilepticus",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.8828125,
            "text": "ulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 7.8828125,
            "text": "non-convulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.8828125,
            "text": "on Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.44140625,
            "text": "Status Epilepticus in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.640625,
            "text": "Status Epilepticus in Salzburg, 2013",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.66796875,
            "text": "status epilepticus (NCSE), but none have been clinically validated. We",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.7109375,
            "text": "status epilepticus (NCSE), but none have been clinically validated. We aimed to assess the diagnostic accuracy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.74609375,
            "text": "status epilepticus (NCSE), but none have been clinically validated. We aimed to assess the diagnostic accuracy of the EEG criteria proposed by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.75390625,
            "text": "status epilepticus (NCSE), but none have been clinically validated. We aimed to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.76171875,
            "text": "Status Epilepticus in Salzburg, 2013 (henceforth called the Salz",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.76171875,
            "text": "Status Epilepticus in Salzburg, 2013 (henceforth called the Salzburg",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.76953125,
            "text": "Status Epilepticus in Salzburg, 2013 (henceforth called the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.7734375,
            "text": "status epilepticus (NCSE), but none",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e48bf5ed14c9f295d000019_5": [
        {
            "start_logit": 7.90234375,
            "end_logit": 7.8828125,
            "text": "status epilepticus",
            "probability": 0.5
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 7.8828125,
            "text": "Status Epilepticus",
            "probability": 0.5
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.2177734375,
            "text": "Status",
            "probability": 5.614757537841797e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.2900390625,
            "text": "status",
            "probability": 5.1975250244140625e-05
        },
        {
            "start_logit": -1.52734375,
            "end_logit": 7.8828125,
            "text": "Epilepticus",
            "probability": 4.0471553802490234e-05
        },
        {
            "start_logit": -1.564453125,
            "end_logit": 7.8828125,
            "text": "epilepticus",
            "probability": 3.892183303833008e-05
        },
        {
            "start_logit": -4.2109375,
            "end_logit": 7.8828125,
            "text": "convulsive status epilepticus",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.8828125,
            "text": "ulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 7.8828125,
            "text": "non-convulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.8828125,
            "text": "on Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.44140625,
            "text": "Status Epilepticus in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.640625,
            "text": "Status Epilepticus in Salzburg, 2013",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.66796875,
            "text": "status epilepticus (NCSE), but none have been clinically validated. We",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.7109375,
            "text": "status epilepticus (NCSE), but none have been clinically validated. We aimed to assess the diagnostic accuracy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.74609375,
            "text": "status epilepticus (NCSE), but none have been clinically validated. We aimed to assess the diagnostic accuracy of the EEG criteria proposed by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.75390625,
            "text": "status epilepticus (NCSE), but none have been clinically validated. We aimed to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.76171875,
            "text": "Status Epilepticus in Salzburg, 2013 (henceforth called the Salz",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.76171875,
            "text": "Status Epilepticus in Salzburg, 2013 (henceforth called the Salzburg",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.76953125,
            "text": "Status Epilepticus in Salzburg, 2013 (henceforth called the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.7734375,
            "text": "status epilepticus (NCSE), but none",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e48bf5ed14c9f295d000019_6": [
        {
            "start_logit": 7.8125,
            "end_logit": 7.80078125,
            "text": "Status Epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": -2.0,
            "end_logit": 7.80078125,
            "text": "Epilepticus",
            "probability": 5.4776668548583984e-05
        },
        {
            "start_logit": 7.8125,
            "end_logit": -2.064453125,
            "text": "Status",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": -2.7578125,
            "end_logit": 7.80078125,
            "text": "Convulsive Status Epilepticus",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -6.484375,
            "end_logit": 7.80078125,
            "text": "ulsive Status Epilepticus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 7.80078125,
            "text": "Non-Convulsive Status Epilepticus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.25390625,
            "text": "Status Epilepticus--",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.29296875,
            "text": "Status Epilepticus-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.45703125,
            "text": "Status Epilepticus--approach to clinical application.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.80078125,
            "text": "-Convulsive Status Epilepticus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.80078125,
            "text": "Consensus Criteria for Non-Convulsive Status Epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.80078125,
            "text": "Criteria for Non-Convulsive Status Epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.80078125,
            "text": "Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.80078125,
            "text": "for Non-Convulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 7.80078125,
            "text": "burg Consensus Criteria for Non-Convulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -8.15625,
            "text": "Status Epilepticus--approach to clinical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -8.2265625,
            "text": "Status Epilepticus--approach to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.7578125,
            "end_logit": -2.064453125,
            "text": "Convulsive Status",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -2.064453125,
            "text": "ulsive Status",
            "probability": 0.0
        },
        {
            "start_logit": -6.51953125,
            "end_logit": -2.064453125,
            "text": "Non-Convulsive Status",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_7": [
        {
            "start_logit": 7.890625,
            "end_logit": 7.8828125,
            "text": "Status Epilepticus",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.890625,
            "end_logit": 7.87890625,
            "text": "Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 0.33251953125
        },
        {
            "start_logit": 7.890625,
            "end_logit": 7.87890625,
            "text": "status epilepticus",
            "probability": 0.33251953125
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.28515625,
            "text": "Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.28515625,
            "text": "status",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.35546875,
            "text": "Status",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -1.5654296875,
            "end_logit": 7.87890625,
            "text": "epilepticus",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": -1.5693359375,
            "end_logit": 7.8828125,
            "text": "Epilepticus",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": -1.5693359375,
            "end_logit": 7.87890625,
            "text": "Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -4.625,
            "end_logit": 7.8828125,
            "text": "Convulsive Status Epilepticus",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -4.625,
            "end_logit": 7.87890625,
            "text": "Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 7.87890625,
            "text": "on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 7.8828125,
            "text": "ulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 7.87890625,
            "text": "ulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 7.8828125,
            "text": "Non-Convulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 7.87890625,
            "text": "Non-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.8828125,
            "text": "-Convulsive Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.87890625,
            "text": "-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.87890625,
            "text": "C) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.87890625,
            "text": ") were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e48bf5ed14c9f295d000019_8": [
        {
            "start_logit": 7.890625,
            "end_logit": 7.8828125,
            "text": "Status Epilepticus",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.890625,
            "end_logit": 7.87890625,
            "text": "Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 0.33251953125
        },
        {
            "start_logit": 7.890625,
            "end_logit": 7.87890625,
            "text": "status epilepticus",
            "probability": 0.33251953125
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.28515625,
            "text": "Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.28515625,
            "text": "status",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.35546875,
            "text": "Status",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -1.5654296875,
            "end_logit": 7.87890625,
            "text": "epilepticus",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": -1.5693359375,
            "end_logit": 7.8828125,
            "text": "Epilepticus",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": -1.5693359375,
            "end_logit": 7.87890625,
            "text": "Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -4.625,
            "end_logit": 7.8828125,
            "text": "Convulsive Status Epilepticus",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -4.625,
            "end_logit": 7.87890625,
            "text": "Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 7.87890625,
            "text": "on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 7.8828125,
            "text": "ulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 7.87890625,
            "text": "ulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 7.8828125,
            "text": "Non-Convulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 7.87890625,
            "text": "Non-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.8828125,
            "text": "-Convulsive Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.87890625,
            "text": "-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.87890625,
            "text": "C) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.87890625,
            "text": ") were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e48bf5ed14c9f295d000019_9": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.74609375,
            "text": "Nonconvulsive Status Epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.994140625,
            "text": "Noncon",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": -2.349609375,
            "end_logit": 7.74609375,
            "text": "Epilepticus",
            "probability": 3.451108932495117e-05
        },
        {
            "start_logit": -5.875,
            "end_logit": 7.74609375,
            "text": "Status Epilepticus",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.8359375,
            "text": "Nonconvulsive Status",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 7.74609375,
            "text": "ulsive Status Epilepticus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 7.74609375,
            "text": "vulsive Status Epilepticus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.296875,
            "text": "Nonconv",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.51171875,
            "text": "Nonconvulsive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.625,
            "text": "Nonconvulsive Status Epilepticus:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.80859375,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.87109375,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.8984375,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.03125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.0546875,
            "text": "Nonconvulsive Status Epilepticus: Validating the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.15625,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.1640625,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.25,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.349609375,
            "end_logit": -7.625,
            "text": "Epilepticus:",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_10": [
        {
            "start_logit": 7.9921875,
            "end_logit": 7.8046875,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -1.642578125,
            "text": "noncon",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -2.146484375,
            "end_logit": 7.8046875,
            "text": "epilepticus",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": -5.53125,
            "end_logit": 7.8046875,
            "text": "status epilepticus",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.2734375,
            "end_logit": 7.8046875,
            "text": "ulsive status epilepticus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.578125,
            "end_logit": 7.8046875,
            "text": "vulsive status epilepticus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.00390625,
            "text": "nonconvulsive status",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.06640625,
            "text": "nonconv",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.2109375,
            "text": "nonconvulsive",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.45703125,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.671875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.6953125,
            "text": "nonconvulsive status epilepticus (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.85546875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.8671875,
            "text": "nonconvulsive status epilepticus (NCS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.90625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.9609375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.9609375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.98046875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.8046875,
            "text": "electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.8046875,
            "text": "improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e48bf5ed14c9f295d000019_11": [
        {
            "start_logit": 7.89453125,
            "end_logit": 7.890625,
            "text": "Status Epilepticus",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.89453125,
            "end_logit": 7.8828125,
            "text": "Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.89453125,
            "end_logit": 7.8828125,
            "text": "status epilepticus",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -1.259765625,
            "text": "Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status",
            "probability": 3.546476364135742e-05
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -1.259765625,
            "text": "status",
            "probability": 3.546476364135742e-05
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -1.32421875,
            "text": "Status",
            "probability": 3.331899642944336e-05
        },
        {
            "start_logit": -1.548828125,
            "end_logit": 7.890625,
            "text": "Epilepticus",
            "probability": 2.658367156982422e-05
        },
        {
            "start_logit": -1.548828125,
            "end_logit": 7.8828125,
            "text": "Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 2.6345252990722656e-05
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": 7.8828125,
            "text": "epilepticus",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": -4.41796875,
            "end_logit": 7.890625,
            "text": "Convulsive Status Epilepticus",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -4.41796875,
            "end_logit": 7.8828125,
            "text": "Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 7.890625,
            "text": "ulsive Status Epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 7.8828125,
            "text": "ulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 7.8828125,
            "text": "on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.890625,
            "text": "Non-Convulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.8828125,
            "text": "Non-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.890625,
            "text": "-Convulsive Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.8828125,
            "text": "-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.890625,
            "text": "Criteria for diagnosis of Non-Convulsive Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.8828125,
            "text": "C) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e48bf5ed14c9f295d000019_12": [
        {
            "start_logit": 7.89453125,
            "end_logit": 7.890625,
            "text": "Status Epilepticus",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.89453125,
            "end_logit": 7.8828125,
            "text": "Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.89453125,
            "end_logit": 7.8828125,
            "text": "status epilepticus",
            "probability": 0.333251953125
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -1.259765625,
            "text": "Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status",
            "probability": 3.546476364135742e-05
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -1.259765625,
            "text": "status",
            "probability": 3.546476364135742e-05
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -1.32421875,
            "text": "Status",
            "probability": 3.331899642944336e-05
        },
        {
            "start_logit": -1.548828125,
            "end_logit": 7.890625,
            "text": "Epilepticus",
            "probability": 2.658367156982422e-05
        },
        {
            "start_logit": -1.548828125,
            "end_logit": 7.8828125,
            "text": "Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 2.6345252990722656e-05
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": 7.8828125,
            "text": "epilepticus",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": -4.41796875,
            "end_logit": 7.890625,
            "text": "Convulsive Status Epilepticus",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -4.41796875,
            "end_logit": 7.8828125,
            "text": "Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 7.890625,
            "text": "ulsive Status Epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 7.8828125,
            "text": "ulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 7.8828125,
            "text": "on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.890625,
            "text": "Non-Convulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.8828125,
            "text": "Non-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.890625,
            "text": "-Convulsive Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.8828125,
            "text": "-Convulsive Status Epilepticus (SCNC) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.890625,
            "text": "Criteria for diagnosis of Non-Convulsive Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.8828125,
            "text": "C) were proposed at the 4th London-Innsbruck Colloquium on status epilepticus",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e48bf5ed14c9f295d000019_13": [
        {
            "start_logit": 7.9921875,
            "end_logit": 7.8046875,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -1.642578125,
            "text": "noncon",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -2.146484375,
            "end_logit": 7.8046875,
            "text": "epilepticus",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": -5.53125,
            "end_logit": 7.8046875,
            "text": "status epilepticus",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.2734375,
            "end_logit": 7.8046875,
            "text": "ulsive status epilepticus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.578125,
            "end_logit": 7.8046875,
            "text": "vulsive status epilepticus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.00390625,
            "text": "nonconvulsive status",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.06640625,
            "text": "nonconv",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.2109375,
            "text": "nonconvulsive",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.45703125,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.671875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.6953125,
            "text": "nonconvulsive status epilepticus (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.85546875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.8671875,
            "text": "nonconvulsive status epilepticus (NCS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.90625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.9609375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.9609375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.98046875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.8046875,
            "text": "electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.8046875,
            "text": "improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        }
    ],
    "623e02e0f0baec9a1b000005_1": [
        {
            "start_logit": 7.1640625,
            "end_logit": 0.88037109375,
            "text": "ER retention sequence (KDEL)",
            "probability": 0.9072265625
        },
        {
            "start_logit": 7.1640625,
            "end_logit": -2.05859375,
            "text": "ER retention sequence",
            "probability": 0.047882080078125
        },
        {
            "start_logit": 7.1640625,
            "end_logit": -2.130859375,
            "text": "ER",
            "probability": 0.044464111328125
        },
        {
            "start_logit": 7.1640625,
            "end_logit": -7.1796875,
            "text": "ER retention sequence (KDEL",
            "probability": 0.00028586387634277344
        },
        {
            "start_logit": 7.1640625,
            "end_logit": -7.59765625,
            "text": "ER retention",
            "probability": 0.0001875162124633789
        },
        {
            "start_logit": 7.1640625,
            "end_logit": -7.80078125,
            "text": "ER retention sequence (KD",
            "probability": 0.00015294551849365234
        },
        {
            "start_logit": 7.1640625,
            "end_logit": -8.1640625,
            "text": "ER retention sequence (",
            "probability": 0.0001068115234375
        },
        {
            "start_logit": -4.98828125,
            "end_logit": 0.88037109375,
            "text": ")",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 0.88037109375,
            "text": "retention sequence (KDEL)",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.0625,
            "end_logit": 0.88037109375,
            "text": "KDEL)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 0.88037109375,
            "text": "(KDEL)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 0.88037109375,
            "text": "sequence (KDEL)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.7421875,
            "end_logit": -2.05859375,
            "text": "retention sequence",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -2.05859375,
            "text": "sequence",
            "probability": 0.0
        },
        {
            "start_logit": -5.7421875,
            "end_logit": -7.1796875,
            "text": "retention sequence (KDEL",
            "probability": 0.0
        },
        {
            "start_logit": -5.7421875,
            "end_logit": -7.59765625,
            "text": "retention",
            "probability": 0.0
        },
        {
            "start_logit": -5.7421875,
            "end_logit": -7.80078125,
            "text": "retention sequence (KD",
            "probability": 0.0
        },
        {
            "start_logit": -5.7421875,
            "end_logit": -8.1640625,
            "text": "retention sequence (",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": -7.1796875,
            "text": "KDEL",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.1796875,
            "text": "(KDEL",
            "probability": 0.0
        }
    ],
    "53617eeb7d100faa0900000a_1": [
        {
            "start_logit": -1.9990234375,
            "end_logit": -1.3642578125,
            "text": "Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 0.6201171875
        },
        {
            "start_logit": -1.9990234375,
            "end_logit": -2.16796875,
            "text": "Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 0.27734375
        },
        {
            "start_logit": -5.359375,
            "end_logit": -1.3642578125,
            "text": "Athletica.",
            "probability": 0.0215606689453125
        },
        {
            "start_logit": -5.765625,
            "end_logit": -1.3642578125,
            "text": "Anorexia Athletica.",
            "probability": 0.0143585205078125
        },
        {
            "start_logit": -5.359375,
            "end_logit": -2.16796875,
            "text": "Athletica",
            "probability": 0.00963592529296875
        },
        {
            "start_logit": -6.2890625,
            "end_logit": -1.3642578125,
            "text": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 0.00850677490234375
        },
        {
            "start_logit": -1.9990234375,
            "end_logit": -5.76953125,
            "text": "Rhythmic",
            "probability": 0.007564544677734375
        },
        {
            "start_logit": -5.765625,
            "end_logit": -2.16796875,
            "text": "Anorexia Athletica",
            "probability": 0.006420135498046875
        },
        {
            "start_logit": -6.86328125,
            "end_logit": -1.3642578125,
            "text": ".",
            "probability": 0.004791259765625
        },
        {
            "start_logit": -6.9453125,
            "end_logit": -1.3642578125,
            "text": "developing Anorexia Athletica.",
            "probability": 0.00439453125
        },
        {
            "start_logit": -1.9990234375,
            "end_logit": -6.35546875,
            "text": "Rhythmic Gymnasts (RGs",
            "probability": 0.0042266845703125
        },
        {
            "start_logit": -6.2890625,
            "end_logit": -2.16796875,
            "text": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 0.0038204193115234375
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -1.3642578125,
            "text": "Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 0.00270843505859375
        },
        {
            "start_logit": -1.9990234375,
            "end_logit": -6.921875,
            "text": "Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletic",
            "probability": 0.0023899078369140625
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -1.3642578125,
            "text": "a.",
            "probability": 0.0021762847900390625
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -1.3642578125,
            "text": "unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 0.0020771026611328125
        },
        {
            "start_logit": -1.9990234375,
            "end_logit": -7.08984375,
            "text": "Rhythmic Gym",
            "probability": 0.0020294189453125
        },
        {
            "start_logit": -6.9453125,
            "end_logit": -2.16796875,
            "text": "developing Anorexia Athletica",
            "probability": 0.0019817352294921875
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -1.3642578125,
            "text": ") constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 0.001804351806640625
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -1.3642578125,
            "text": "nasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 0.0017900466918945312
        }
    ],
    "53617eeb7d100faa0900000a_2": [
        {
            "start_logit": -3.203125,
            "end_logit": -1.1015625,
            "text": "anorexia athletica",
            "probability": 0.85400390625
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -1.1015625,
            "text": "athletica",
            "probability": 0.07550048828125
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -1.1015625,
            "text": "a",
            "probability": 0.0111846923828125
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -1.1015625,
            "text": "with anorexia athletica",
            "probability": 0.01050567626953125
        },
        {
            "start_logit": -3.203125,
            "end_logit": -5.61328125,
            "text": "anorexia athletica (AA",
            "probability": 0.0094146728515625
        },
        {
            "start_logit": -7.8125,
            "end_logit": -1.1015625,
            "text": "ts with anorexia athletica",
            "probability": 0.00850677490234375
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -1.1015625,
            "text": "gymnasts with anorexia athletica",
            "probability": 0.00830841064453125
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -1.1015625,
            "text": "nasts with anorexia athletica",
            "probability": 0.007564544677734375
        },
        {
            "start_logit": -7.96875,
            "end_logit": -1.1015625,
            "text": "female juvenile elite gymnasts with anorexia athletica",
            "probability": 0.00727081298828125
        },
        {
            "start_logit": -3.203125,
            "end_logit": -6.39453125,
            "text": "anorexia athletica (",
            "probability": 0.00431060791015625
        },
        {
            "start_logit": -3.203125,
            "end_logit": -7.72265625,
            "text": "anorexia athletic",
            "probability": 0.0011415481567382812
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -5.61328125,
            "text": "athletica (AA",
            "probability": 0.0008292198181152344
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -6.39453125,
            "text": "athletica (",
            "probability": 0.0003795623779296875
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -5.61328125,
            "text": "a (AA",
            "probability": 0.00012230873107910156
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -5.61328125,
            "text": "with anorexia athletica (AA",
            "probability": 0.00011485815048217773
        },
        {
            "start_logit": -5.62890625,
            "end_logit": -7.72265625,
            "text": "athletic",
            "probability": 0.00010061264038085938
        },
        {
            "start_logit": -7.8125,
            "end_logit": -5.61328125,
            "text": "ts with anorexia athletica (AA",
            "probability": 9.375810623168945e-05
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -5.61328125,
            "text": "gymnasts with anorexia athletica (AA",
            "probability": 9.083747863769531e-05
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -5.61328125,
            "text": "nasts with anorexia athletica (AA",
            "probability": 8.338689804077148e-05
        },
        {
            "start_logit": -7.96875,
            "end_logit": -5.61328125,
            "text": "female juvenile elite gymnasts with anorexia athletica (AA",
            "probability": 8.016824722290039e-05
        }
    ],
    "5c900b9eecadf2e73f000004_1": [
        {
            "start_logit": 7.953125,
            "end_logit": 7.796875,
            "text": "Alnylam Pharmaceuticals",
            "probability": 1.0
        },
        {
            "start_logit": 7.953125,
            "end_logit": -1.7548828125,
            "text": "Al",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -2.21875,
            "end_logit": 7.796875,
            "text": "Pharmaceuticals",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.34375,
            "text": "Alnylam",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.37890625,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.828125,
            "text": "Alnyl",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 7.796875,
            "text": "ylam Pharmaceuticals",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.8125,
            "end_logit": 7.796875,
            "text": "am Pharmaceuticals",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 7.796875,
            "text": "nylam Pharmaceuticals",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.140625,
            "text": "Aln",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.3828125,
            "text": "Alnylam Pharmaceuticals;",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.64453125,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.6640625,
            "text": "Alnylam Pharmaceuticals; it was recently",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.78125,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hAT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.84765625,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.87109375,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 7.796875,
            "text": "Patisiran has been developed by Alnylam Pharmaceuticals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.796875,
            "text": "has been developed by Alnylam Pharmaceuticals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.21875,
            "end_logit": -6.37890625,
            "text": "Pharmaceuticals; it was recently approved in the USA",
            "probability": 0.0
        },
        {
            "start_logit": -2.21875,
            "end_logit": -7.3828125,
            "text": "Pharmaceuticals;",
            "probability": 0.0
        }
    ],
    "58c27b7102b8c60953000021_1": [
        {
            "start_logit": 7.80078125,
            "end_logit": 7.75,
            "text": "Enhancer Sharing",
            "probability": 1.0
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -2.17578125,
            "text": "Enhancer",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": -2.240234375,
            "end_logit": 7.75,
            "text": "Sharing",
            "probability": 4.369020462036133e-05
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.66796875,
            "text": "Enhancer Sharing Promotes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -8.1796875,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -8.3203125,
            "text": "Enhancer Sharing Promotes Neighborhoods of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.240234375,
            "end_logit": -7.66796875,
            "text": "Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -2.240234375,
            "end_logit": -8.1796875,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -2.240234375,
            "end_logit": -8.3203125,
            "text": "Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -8.1796875,
            "text": "Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -8.1796875,
            "text": "Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -8.1796875,
            "text": "Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -8.3203125,
            "text": "Neighborhoods of",
            "probability": 0.0
        }
    ],
    "58c27b7102b8c60953000021_2": [
        {
            "start_logit": 7.890625,
            "end_logit": 7.6875,
            "text": "enhancer sharing",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.890625,
            "end_logit": 1.33984375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance",
            "probability": 0.0017538070678710938
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.7919921875,
            "text": "enhancer",
            "probability": 7.593631744384766e-05
        },
        {
            "start_logit": -2.28515625,
            "end_logit": 7.6875,
            "text": "sharing",
            "probability": 3.814697265625e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -6.578125,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene regulation.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -6.828125,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.28515625,
            "text": "enhancer sharing is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.5390625,
            "text": "enhancer sharing is commonplace",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.58984375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.60546875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.609375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.71484375,
            "text": "enhancer sharing is commonplace among eukaryotes,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.76171875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene regulation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.79296875,
            "text": "enhancer sharing is commonplace among eukaryotes, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.79296875,
            "text": "enhancer sharing is commonplace among",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.6875,
            "text": "that enhancer sharing",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.8515625,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.86328125,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.8671875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 7.6875,
            "text": "propose that enhancer sharing",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58c27b7102b8c60953000021_3": [
        {
            "start_logit": 7.8359375,
            "end_logit": 7.796875,
            "text": "Enhancer Sharing",
            "probability": 1.0
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -1.986328125,
            "text": "Enhancer",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": -2.091796875,
            "end_logit": 7.796875,
            "text": "Sharing",
            "probability": 4.869699478149414e-05
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.703125,
            "text": "Enhancer Sharing Promotes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.9609375,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -8.0703125,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -8.203125,
            "text": "Enhancer Sharing Promotes Neighborhoods of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -8.2578125,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.091796875,
            "end_logit": -7.703125,
            "text": "Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -2.091796875,
            "end_logit": -7.9609375,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes.",
            "probability": 0.0
        },
        {
            "start_logit": -2.091796875,
            "end_logit": -8.0703125,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -2.091796875,
            "end_logit": -8.203125,
            "text": "Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -2.091796875,
            "end_logit": -8.2578125,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 0.0
        },
        {
            "start_logit": -7.34375,
            "end_logit": -7.9609375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -7.9609375,
            "text": "Regulation Across Eukaryotes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.9609375,
            "text": "Transcriptional Regulation Across Eukaryotes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -7.9609375,
            "text": "Eukaryotes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -7.9609375,
            "text": "Neighborhoods of Transcriptional Regulation Across Eukaryotes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -8.0703125,
            "text": "Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -8.0703125,
            "text": "Transcriptional Regulation Across",
            "probability": 0.0
        }
    ],
    "5c8973f3d558e5f232000007_1": [
        {
            "start_logit": 4.90625,
            "end_logit": 7.21875,
            "text": "Alipogene tiparvovec",
            "probability": 1.0
        },
        {
            "start_logit": -3.357421875,
            "end_logit": 7.21875,
            "text": "c",
            "probability": 0.00025725364685058594
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 7.21875,
            "text": "tiparvovec",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -3.470703125,
            "end_logit": 4.765625,
            "text": "GENIALL (GENetherapy In the MAnagement of Lipoprotein Lipase Deficiency",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -5.94921875,
            "end_logit": 7.21875,
            "text": "gene tiparvovec",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 7.21875,
            "text": "vovec",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 7.21875,
            "text": "vec",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 7.21875,
            "text": "pogene tiparvovec",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 7.21875,
            "text": "arvovec",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": -4.34375,
            "end_logit": 4.765625,
            "text": "of Lipoprotein Lipase Deficiency",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -4.6640625,
            "end_logit": 4.765625,
            "text": "Lipoprotein Lipase Deficiency",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 4.90625,
            "end_logit": -5.94140625,
            "text": "Ali",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.94140625,
            "end_logit": 4.765625,
            "text": "Deficiency",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 4.90625,
            "end_logit": -6.12109375,
            "text": "Alipogene tiparvovec (Glybera",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 4.765625,
            "text": "IALL (GENetherapy In the MAnagement of Lipoprotein Lipase Deficiency",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 4.765625,
            "text": "Lipase Deficiency",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 4.765625,
            "text": "MAnagement of Lipoprotein Lipase Deficiency",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 4.765625,
            "text": "GENetherapy In the MAnagement of Lipoprotein Lipase Deficiency",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.90625,
            "end_logit": -7.46875,
            "text": "Alipogene tiparvovec (Glybera\u00ae)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.90625,
            "end_logit": -7.515625,
            "text": "Alipogene tiparvovec (Glybera\u00ae",
            "probability": 4.172325134277344e-07
        }
    ],
    "5c929094ecadf2e73f000019_1": [
        {
            "start_logit": 1.4208984375,
            "end_logit": 3.11328125,
            "text": "Senescent cells undergo dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 0.70556640625
        },
        {
            "start_logit": 0.425537109375,
            "end_logit": 3.11328125,
            "text": "activation of retrotransposons.",
            "probability": 0.2607421875
        },
        {
            "start_logit": -2.73828125,
            "end_logit": 3.11328125,
            "text": "the activation of retrotransposons.",
            "probability": 0.01100921630859375
        },
        {
            "start_logit": -3.419921875,
            "end_logit": 3.11328125,
            "text": ".",
            "probability": 0.00556182861328125
        },
        {
            "start_logit": -3.419921875,
            "end_logit": 3.11328125,
            "text": ".",
            "probability": 0.00556182861328125
        },
        {
            "start_logit": 1.4208984375,
            "end_logit": -1.875,
            "text": "Senescent cells undergo",
            "probability": 0.004810333251953125
        },
        {
            "start_logit": -4.43359375,
            "end_logit": 3.11328125,
            "text": "changes in chromatin composition that can lead to the activation of retrotransposons.",
            "probability": 0.00202178955078125
        },
        {
            "start_logit": 1.4208984375,
            "end_logit": -3.337890625,
            "text": "Senescent cells",
            "probability": 0.0011119842529296875
        },
        {
            "start_logit": 0.425537109375,
            "end_logit": -2.70703125,
            "text": "activation",
            "probability": 0.0007734298706054688
        },
        {
            "start_logit": -5.8359375,
            "end_logit": 3.11328125,
            "text": "can lead to the activation of retrotransposons.",
            "probability": 0.0004973411560058594
        },
        {
            "start_logit": 1.4208984375,
            "end_logit": -4.265625,
            "text": "Senescent cells undergo dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program. These include the loss of",
            "probability": 0.0004405975341796875
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 3.11328125,
            "text": "lead to the activation of retrotransposons.",
            "probability": 0.00034737586975097656
        },
        {
            "start_logit": 1.4208984375,
            "end_logit": -4.515625,
            "text": "Senescent cells undergo dramatic alterations",
            "probability": 0.00034308433532714844
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 3.11328125,
            "text": "dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 0.00024330615997314453
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 3.11328125,
            "text": "that can lead to the activation of retrotransposons.",
            "probability": 0.0002008676528930664
        },
        {
            "start_logit": 1.4208984375,
            "end_logit": -5.109375,
            "text": "Senescent cells undergo dramatic",
            "probability": 0.00019025802612304688
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 3.11328125,
            "text": "to the activation of retrotransposons.",
            "probability": 0.0001888275146484375
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 3.11328125,
            "text": "retrotransposons.",
            "probability": 0.00018727779388427734
        },
        {
            "start_logit": 1.4208984375,
            "end_logit": -5.63671875,
            "text": "Senescent cells undergo dramatic alterations to",
            "probability": 0.00011181831359863281
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 3.11328125,
            "text": "centromeres, and changes in chromatin composition that can lead to the activation of retrotransposons.",
            "probability": 0.00011014938354492188
        }
    ],
    "5fe3130da43ad3127800003f_1": [
        {
            "start_logit": -0.264892578125,
            "end_logit": 6.0703125,
            "text": "28 joints",
            "probability": 0.9677734375
        },
        {
            "start_logit": -4.140625,
            "end_logit": 6.0703125,
            "text": "joints",
            "probability": 0.02008056640625
        },
        {
            "start_logit": -5.37109375,
            "end_logit": 6.0703125,
            "text": "in 28 joints",
            "probability": 0.005870819091796875
        },
        {
            "start_logit": -5.52734375,
            "end_logit": 6.0703125,
            "text": "Disease activity score in 28 joints",
            "probability": 0.0050201416015625
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.0703125,
            "text": "activity score in 28 joints",
            "probability": 0.0006794929504394531
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.0703125,
            "text": "score in 28 joints",
            "probability": 0.0005764961242675781
        },
        {
            "start_logit": -0.264892578125,
            "end_logit": -7.4453125,
            "text": "28 joints (",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -0.264892578125,
            "end_logit": -7.8671875,
            "text": "28 joints (DAS28)",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -0.264892578125,
            "end_logit": -7.88671875,
            "text": "28",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -0.264892578125,
            "end_logit": -7.92578125,
            "text": "28 joints (DAS",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -0.264892578125,
            "end_logit": -8.046875,
            "text": "28 joints (DAS28",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -4.140625,
            "end_logit": -7.4453125,
            "text": "joints (",
            "probability": 0.0
        },
        {
            "start_logit": -4.140625,
            "end_logit": -7.8671875,
            "text": "joints (DAS28)",
            "probability": 0.0
        },
        {
            "start_logit": -4.140625,
            "end_logit": -7.92578125,
            "text": "joints (DAS",
            "probability": 0.0
        },
        {
            "start_logit": -4.140625,
            "end_logit": -8.046875,
            "text": "joints (DAS28",
            "probability": 0.0
        },
        {
            "start_logit": -5.37109375,
            "end_logit": -7.4453125,
            "text": "in 28 joints (",
            "probability": 0.0
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -7.4453125,
            "text": "Disease activity score in 28 joints (",
            "probability": 0.0
        },
        {
            "start_logit": -5.37109375,
            "end_logit": -7.8671875,
            "text": "in 28 joints (DAS28)",
            "probability": 0.0
        },
        {
            "start_logit": -5.37109375,
            "end_logit": -7.88671875,
            "text": "in 28",
            "probability": 0.0
        },
        {
            "start_logit": -5.37109375,
            "end_logit": -7.92578125,
            "text": "in 28 joints (DAS",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_2": [
        {
            "start_logit": -1.3349609375,
            "end_logit": 6.0703125,
            "text": "28 joints",
            "probability": 0.900390625
        },
        {
            "start_logit": -3.90234375,
            "end_logit": 6.0703125,
            "text": "joints",
            "probability": 0.06915283203125
        },
        {
            "start_logit": -5.203125,
            "end_logit": 6.0703125,
            "text": "in 28 joints",
            "probability": 0.0188446044921875
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 6.0703125,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.00225830078125
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 6.0703125,
            "text": "level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.0019321441650390625
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.0703125,
            "text": "(Disease Activity Score in 28 joints",
            "probability": 0.001407623291015625
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.0703125,
            "text": "Activity Score in 28 joints",
            "probability": 0.0013971328735351562
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.0703125,
            "text": "infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.0013866424560546875
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.0703125,
            "text": "study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.0013751983642578125
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.0703125,
            "text": "questionnaire designed specifically for the present study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.0013074874877929688
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": -6.25,
            "text": "28 joints [DAS28]) and the reasons for infliximab",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": -7.47265625,
            "text": "28 joints [",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": -7.5,
            "text": "28 joints [DAS28",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": -7.61328125,
            "text": "28 joints [DAS",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": -7.7578125,
            "text": "28 joints [DAS28]) and",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -1.3349609375,
            "end_logit": -7.7578125,
            "text": "28 joints [DAS28]",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -3.90234375,
            "end_logit": -6.25,
            "text": "joints [DAS28]) and the reasons for infliximab",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.90234375,
            "end_logit": -7.47265625,
            "text": "joints [",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.90234375,
            "end_logit": -7.5,
            "text": "joints [DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.203125,
            "end_logit": -6.25,
            "text": "in 28 joints [DAS28]) and the reasons for infliximab",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5fe3130da43ad3127800003f_3": [
        {
            "start_logit": -1.2734375,
            "end_logit": 6.80859375,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.79150390625
        },
        {
            "start_logit": -3.427734375,
            "end_logit": 6.80859375,
            "text": "Joints",
            "probability": 0.091796875
        },
        {
            "start_logit": -3.45703125,
            "end_logit": 6.80859375,
            "text": "28 Joints",
            "probability": 0.089111328125
        },
        {
            "start_logit": -4.83984375,
            "end_logit": 6.80859375,
            "text": "in 28 Joints",
            "probability": 0.022369384765625
        },
        {
            "start_logit": -7.328125,
            "end_logit": 6.80859375,
            "text": "Activity Score in 28 Joints",
            "probability": 0.0018568038940429688
        },
        {
            "start_logit": -7.359375,
            "end_logit": 6.80859375,
            "text": "Score in 28 Joints",
            "probability": 0.001800537109375
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.80859375,
            "text": ": Disease Activity Score in 28 Joints",
            "probability": 0.001613616943359375
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -2.515625,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA).",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": -3.427734375,
            "end_logit": -2.515625,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA).",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -3.45703125,
            "end_logit": -2.515625,
            "text": "28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA).",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": -4.83984375,
            "end_logit": -2.515625,
            "text": "in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA).",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.203125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.40625,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.7109375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.7109375,
            "text": "Disease Activity Score in 28 Joints (DAS",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.7421875,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.74609375,
            "text": "Disease Activity Score in 28 Joints (DAS28",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.76953125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.92578125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.9375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5fe3130da43ad3127800003f_4": [
        {
            "start_logit": -4.265625,
            "end_logit": 3.349609375,
            "text": "28 joints",
            "probability": 0.41162109375
        },
        {
            "start_logit": -4.80859375,
            "end_logit": 3.349609375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.2391357421875
        },
        {
            "start_logit": -5.33203125,
            "end_logit": 3.349609375,
            "text": "rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.1417236328125
        },
        {
            "start_logit": -6.24609375,
            "end_logit": 3.349609375,
            "text": "joints",
            "probability": 0.05682373046875
        },
        {
            "start_logit": -6.609375,
            "end_logit": 3.349609375,
            "text": "a Disease Activity Score in 28 joints",
            "probability": 0.03948974609375
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 3.349609375,
            "text": "in 28 joints",
            "probability": 0.036376953125
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 3.349609375,
            "text": "by a Disease Activity Score in 28 joints",
            "probability": 0.0193328857421875
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 3.349609375,
            "text": "Activity Score in 28 joints",
            "probability": 0.0168914794921875
        },
        {
            "start_logit": -7.578125,
            "end_logit": 3.349609375,
            "text": "Score in 28 joints",
            "probability": 0.01502227783203125
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 3.349609375,
            "text": "with active rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.0121612548828125
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 3.349609375,
            "text": "active rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.0114288330078125
        },
        {
            "start_logit": -4.265625,
            "end_logit": -5.109375,
            "text": "28 joints (",
            "probability": 8.70823860168457e-05
        },
        {
            "start_logit": -4.265625,
            "end_logit": -5.53125,
            "text": "28 joints (DAS28) score greater tha",
            "probability": 5.710124969482422e-05
        },
        {
            "start_logit": -4.80859375,
            "end_logit": -5.109375,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 5.036592483520508e-05
        },
        {
            "start_logit": -6.296875,
            "end_logit": -3.998046875,
            "text": "rheumatic",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": -4.80859375,
            "end_logit": -5.53125,
            "text": "Disease Activity Score in 28 joints (DAS28) score greater tha",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": -5.33203125,
            "end_logit": -5.109375,
            "text": "rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints (",
            "probability": 3.0100345611572266e-05
        },
        {
            "start_logit": -4.265625,
            "end_logit": -6.3671875,
            "text": "28 joints (DAS28",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": -5.33203125,
            "end_logit": -5.33984375,
            "text": "rheumatoid arthritis",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": -4.265625,
            "end_logit": -6.4609375,
            "text": "28 joints (DAS",
            "probability": 2.2530555725097656e-05
        }
    ],
    "5fe3130da43ad3127800003f_5": [
        {
            "start_logit": 3.626953125,
            "end_logit": 4.9375,
            "text": "28 joints",
            "probability": 1.0
        },
        {
            "start_logit": -5.05078125,
            "end_logit": 4.9375,
            "text": "joints",
            "probability": 0.00017130374908447266
        },
        {
            "start_logit": -5.86328125,
            "end_logit": 4.9375,
            "text": "on 28 joints",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -5.640625,
            "text": "28",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 4.9375,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 4.9375,
            "text": "based on 28 joints",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 4.9375,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 4.9375,
            "text": ": The Disease Activity Score based on 28 joints",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 4.9375,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 4.9375,
            "text": "Activity Score based on 28 joints",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": -8.015625,
            "end_logit": 4.9375,
            "text": "Score based on 28 joints",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -6.9765625,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.17578125,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arthr",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.5,
            "text": "28 joints (DAS28) has been increasingly",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.53125,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.58984375,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.6171875,
            "text": "28 joints (DAS28",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.671875,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.6875,
            "text": "28 joints (",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.7109375,
            "text": "28 joints (DAS",
            "probability": 3.2186508178710938e-06
        }
    ],
    "5fe3130da43ad3127800003f_6": [
        {
            "start_logit": 3.46484375,
            "end_logit": 5.09765625,
            "text": "28 joints",
            "probability": 1.0
        },
        {
            "start_logit": -4.9375,
            "end_logit": 5.09765625,
            "text": "joints",
            "probability": 0.00022351741790771484
        },
        {
            "start_logit": -5.87890625,
            "end_logit": 5.09765625,
            "text": "on 28 joints",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -7.390625,
            "end_logit": 5.09765625,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -5.8359375,
            "text": "28",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 5.09765625,
            "text": "based on 28 joints",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": -7.671875,
            "end_logit": 5.09765625,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 5.09765625,
            "text": ": The Disease Activity Score based on 28 joints",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 5.09765625,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 5.09765625,
            "text": "Activity Score based on 28 joints",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 5.09765625,
            "text": "Score based on 28 joints",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -6.953125,
            "text": "28 joints (DAS28) has been widely used in clinical practice and research studies of rheumatoid",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -7.1015625,
            "text": "28 joints (DAS28) has been widely used in clinical practice and research studies of rheumatoid arthr",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -7.484375,
            "text": "28 joints (DAS28) has been widely used in clinical practice and research studies of rheumatoid arth",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -7.546875,
            "text": "28 joints (DAS28) has been widely used in clinical practice",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -7.578125,
            "text": "28 joints (DAS",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -7.58203125,
            "text": "28 joints (DAS28",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -7.59765625,
            "text": "28 joints (DAS28) has been widely",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -7.59765625,
            "text": "28 joints (DAS28) has been widely used in clinical practice and research",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 3.46484375,
            "end_logit": -7.60546875,
            "text": "28 joints (",
            "probability": 3.039836883544922e-06
        }
    ],
    "5fe3130da43ad3127800003f_7": [
        {
            "start_logit": -1.6806640625,
            "end_logit": 3.25390625,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.89892578125
        },
        {
            "start_logit": -4.328125,
            "end_logit": 3.25390625,
            "text": "28 joints",
            "probability": 0.0635986328125
        },
        {
            "start_logit": -5.90234375,
            "end_logit": 3.25390625,
            "text": "in 28 joints",
            "probability": 0.01317596435546875
        },
        {
            "start_logit": -6.21484375,
            "end_logit": 3.25390625,
            "text": "joints",
            "probability": 0.0096435546875
        },
        {
            "start_logit": -6.546875,
            "end_logit": 3.25390625,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.006916046142578125
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 3.25390625,
            "text": "Activity Score in 28 joints",
            "probability": 0.00255584716796875
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 3.25390625,
            "text": "Score in 28 joints",
            "probability": 0.0024089813232421875
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 3.25390625,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.0023822784423828125
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -5.98046875,
            "text": "The Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis",
            "probability": 8.779764175415039e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -7.4765625,
            "text": "The Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA",
            "probability": 1.9729137420654297e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -7.55078125,
            "text": "The Disease Activity Score in 28 joints (DAS28",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -7.5625,
            "text": "The Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA), is a composite",
            "probability": 1.811981201171875e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -7.69921875,
            "text": "The Disease Activity Score in 28 joints (DAS",
            "probability": 1.5735626220703125e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -7.90234375,
            "text": "The Disease Activity Score in 28 joints (",
            "probability": 1.2874603271484375e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -7.92578125,
            "text": "The Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA), is a",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -7.96484375,
            "text": "The Disease Activity Score in 28 joints (DAS28),",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -7.9921875,
            "text": "The Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA), is a composite score comprising clinical",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -7.99609375,
            "text": "The Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -8.0,
            "text": "The Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": -4.328125,
            "end_logit": -5.98046875,
            "text": "28 joints (DAS28), used to assess disease activity in rheumatoid arthritis",
            "probability": 6.198883056640625e-06
        }
    ],
    "5fe3130da43ad3127800003f_8": [
        {
            "start_logit": 1.2646484375,
            "end_logit": 3.392578125,
            "text": "component Disease Activity Score in 28 joints",
            "probability": 0.9892578125
        },
        {
            "start_logit": -4.33984375,
            "end_logit": 3.392578125,
            "text": "better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.0036525726318359375
        },
        {
            "start_logit": -5.3359375,
            "end_logit": 3.392578125,
            "text": "28 joints",
            "probability": 0.0013437271118164062
        },
        {
            "start_logit": -5.37109375,
            "end_logit": 3.392578125,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.0013017654418945312
        },
        {
            "start_logit": -5.41015625,
            "end_logit": 3.392578125,
            "text": "2-component Disease Activity Score in 28 joints",
            "probability": 0.0012531280517578125
        },
        {
            "start_logit": -6.21484375,
            "end_logit": 3.392578125,
            "text": "joints",
            "probability": 0.0005598068237304688
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 3.392578125,
            "text": "the 2-component Disease Activity Score in 28 joints",
            "probability": 0.000530242919921875
        },
        {
            "start_logit": -6.53125,
            "end_logit": 3.392578125,
            "text": "in 28 joints",
            "probability": 0.0004067420959472656
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 3.392578125,
            "text": "reweighted disease activity score that better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.0003478527069091797
        },
        {
            "start_logit": -6.796875,
            "end_logit": 3.392578125,
            "text": "eighted disease activity score that better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.00031185150146484375
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 3.392578125,
            "text": "reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.00023353099822998047
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 3.392578125,
            "text": "-component Disease Activity Score in 28 joints",
            "probability": 0.00020599365234375
        },
        {
            "start_logit": 1.2646484375,
            "end_logit": -6.7734375,
            "text": "component",
            "probability": 3.808736801147461e-05
        },
        {
            "start_logit": 1.2646484375,
            "end_logit": -7.1171875,
            "text": "component Disease Activity Score in 28 joints (DAS28",
            "probability": 2.7000904083251953e-05
        },
        {
            "start_logit": 1.2646484375,
            "end_logit": -7.484375,
            "text": "component Disease Activity Score in 28 joints (DAS28) (based on swollen joint count and C-reactive protein level",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": 1.2646484375,
            "end_logit": -7.51171875,
            "text": "component Disease Activity Score in 28 joints (DAS28) (based on swollen joint count and C-reactive protein",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": 1.2646484375,
            "end_logit": -7.61328125,
            "text": "component Disease Activity Score in 28 joints (DAS",
            "probability": 1.6510486602783203e-05
        },
        {
            "start_logit": 1.2646484375,
            "end_logit": -7.6484375,
            "text": "component Disease Activity Score in 28 joints (DAS28) (based on swollen joint count and C-reactive",
            "probability": 1.5854835510253906e-05
        },
        {
            "start_logit": 1.2646484375,
            "end_logit": -7.67578125,
            "text": "component Disease Activity Score in 28 joints (DAS28) (based on swollen joint count and C-reactive protein level), produces more clinically relevant",
            "probability": 1.5497207641601562e-05
        },
        {
            "start_logit": 1.2646484375,
            "end_logit": -7.8046875,
            "text": "component Disease Activity Score in 28 joints (",
            "probability": 1.3589859008789062e-05
        }
    ],
    "5fe3130da43ad3127800003f_9": [
        {
            "start_logit": -1.4052734375,
            "end_logit": 6.125,
            "text": "28 joints",
            "probability": 0.9091796875
        },
        {
            "start_logit": -4.04296875,
            "end_logit": 6.125,
            "text": "joints",
            "probability": 0.06512451171875
        },
        {
            "start_logit": -5.79296875,
            "end_logit": 6.125,
            "text": "in 28 joints",
            "probability": 0.01131439208984375
        },
        {
            "start_logit": -6.421875,
            "end_logit": 6.125,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.006031036376953125
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 6.125,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.002227783203125
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.125,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.0018405914306640625
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.125,
            "text": "Activity Score in 28 joints",
            "probability": 0.0014390945434570312
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.125,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.0014047622680664062
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.125,
            "text": "Score in 28 joints",
            "probability": 0.0013561248779296875
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.4296875,
            "text": "28 joints (",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.44921875,
            "text": "28 joints (DAS28) is a key",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.453125,
            "text": "28 joints (DAS28) is a key measure in clinical practice",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.5,
            "text": "28 joints (DAS28) is a",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.5703125,
            "text": "28 joints (DAS28",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.57421875,
            "text": "28 joints (DAS28) is a key measure in clinical practice and",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.625,
            "text": "28 joints (DAS",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.7265625,
            "text": "28 joints (DAS28) is a key measure in clinical",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.7421875,
            "text": "28 joints (DAS28) is a key measure",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.74609375,
            "text": "28 joints (DAS28) is a key measure in",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -1.4052734375,
            "end_logit": -7.953125,
            "text": "28 joints (DAS28) is a key measure in clinical practice and clinic",
            "probability": 7.152557373046875e-07
        }
    ],
    "5fe3130da43ad3127800003f_10": [
        {
            "start_logit": -2.775390625,
            "end_logit": 7.1171875,
            "text": "28 Joints",
            "probability": 0.366455078125
        },
        {
            "start_logit": -2.9453125,
            "end_logit": 7.1171875,
            "text": "Joints",
            "probability": 0.30859375
        },
        {
            "start_logit": -3.17578125,
            "end_logit": 7.1171875,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.2451171875
        },
        {
            "start_logit": -4.51953125,
            "end_logit": 7.1171875,
            "text": "in 28 Joints",
            "probability": 0.06390380859375
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.1171875,
            "text": "Activity Score in 28 Joints",
            "probability": 0.0037670135498046875
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 7.1171875,
            "text": ": Disease Activity Score in 28 Joints",
            "probability": 0.003749847412109375
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.1171875,
            "text": "Score in 28 Joints",
            "probability": 0.0034694671630859375
        },
        {
            "start_logit": -7.9375,
            "end_logit": 7.1171875,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 0.0020961761474609375
        },
        {
            "start_logit": -2.775390625,
            "end_logit": 1.0146484375,
            "text": "28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 0.0008172988891601562
        },
        {
            "start_logit": -2.9453125,
            "end_logit": 1.0146484375,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 0.0006909370422363281
        },
        {
            "start_logit": -3.17578125,
            "end_logit": 1.0146484375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 0.0005488395690917969
        },
        {
            "start_logit": -4.51953125,
            "end_logit": 1.0146484375,
            "text": "in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 0.00014317035675048828
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 1.0146484375,
            "text": "arth",
            "probability": 3.68952751159668e-05
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 1.0146484375,
            "text": "in rheumatoid arth",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 1.0146484375,
            "text": "Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 1.0146484375,
            "text": ": Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 1.0146484375,
            "text": "Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 1.0146484375,
            "text": "evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 1.0146484375,
            "text": "system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 1.0146484375,
            "text": "is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 5.841255187988281e-06
        }
    ],
    "5fe3130da43ad3127800003f_11": [
        {
            "start_logit": -2.30859375,
            "end_logit": 2.873046875,
            "text": "28 joints",
            "probability": 0.93603515625
        },
        {
            "start_logit": -6.03125,
            "end_logit": 2.873046875,
            "text": "joints",
            "probability": 0.0226287841796875
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 2.873046875,
            "text": "in 28 joints",
            "probability": 0.017974853515625
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 2.873046875,
            "text": "Comparison of Disease Activity Score in 28 joints",
            "probability": 0.0133514404296875
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 2.873046875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.00882720947265625
        },
        {
            "start_logit": -5.12890625,
            "end_logit": -2.138671875,
            "text": "rheumatoid arthritis",
            "probability": 0.00037288665771484375
        },
        {
            "start_logit": -6.17578125,
            "end_logit": -2.138671875,
            "text": ") & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis",
            "probability": 0.0001308917999267578
        },
        {
            "start_logit": -6.50390625,
            "end_logit": -2.138671875,
            "text": "with rheumatoid arthritis",
            "probability": 9.429454803466797e-05
        },
        {
            "start_logit": -2.30859375,
            "end_logit": -6.44140625,
            "text": "28 joints with ESR",
            "probability": 8.45193862915039e-05
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -2.138671875,
            "text": "measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis",
            "probability": 6.479024887084961e-05
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -2.138671875,
            "text": "Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis",
            "probability": 4.89354133605957e-05
        },
        {
            "start_logit": -7.1953125,
            "end_logit": -2.138671875,
            "text": ") for assessing disease activity in patients with rheumatoid arthritis",
            "probability": 4.70280647277832e-05
        },
        {
            "start_logit": -2.30859375,
            "end_logit": -7.046875,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI",
            "probability": 4.595518112182617e-05
        },
        {
            "start_logit": -2.30859375,
            "end_logit": -7.2578125,
            "text": "28 joints with ESR (DAS28",
            "probability": 3.74913215637207e-05
        },
        {
            "start_logit": -2.30859375,
            "end_logit": -7.28125,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) &",
            "probability": 3.635883331298828e-05
        },
        {
            "start_logit": -2.30859375,
            "end_logit": -7.48046875,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HA",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": -2.30859375,
            "end_logit": -7.625,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire",
            "probability": 2.574920654296875e-05
        },
        {
            "start_logit": -2.30859375,
            "end_logit": -7.671875,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": -2.30859375,
            "end_logit": -7.8046875,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CD",
            "probability": 2.1696090698242188e-05
        },
        {
            "start_logit": -2.30859375,
            "end_logit": -7.80859375,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability",
            "probability": 2.1517276763916016e-05
        }
    ],
    "5fe3130da43ad3127800003f_12": [
        {
            "start_logit": -1.59765625,
            "end_logit": 4.15625,
            "text": "the Disease Activity Score in 28 joints",
            "probability": 0.818359375
        },
        {
            "start_logit": -4.4609375,
            "end_logit": 4.15625,
            "text": "28 joints",
            "probability": 0.046722412109375
        },
        {
            "start_logit": -4.953125,
            "end_logit": 4.15625,
            "text": "Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0285491943359375
        },
        {
            "start_logit": -5.26171875,
            "end_logit": 4.15625,
            "text": "Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0209808349609375
        },
        {
            "start_logit": -5.42578125,
            "end_logit": 4.15625,
            "text": "Disease Activity Index (SDAI) scores, Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.017791748046875
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 4.15625,
            "text": "joints",
            "probability": 0.016143798828125
        },
        {
            "start_logit": -5.79296875,
            "end_logit": 4.15625,
            "text": "and the Disease Activity Score in 28 joints",
            "probability": 0.01233673095703125
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 4.15625,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.010467529296875
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 4.15625,
            "text": "CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.006011962890625
        },
        {
            "start_logit": -6.671875,
            "end_logit": 4.15625,
            "text": "Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.00511932373046875
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 4.15625,
            "text": "in 28 joints",
            "probability": 0.004791259765625
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 4.15625,
            "text": "Activity Index (SDAI) scores, Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.00354766845703125
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 4.15625,
            "text": "AI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0033855438232421875
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 4.15625,
            "text": "scores, and the Disease Activity Score in 28 joints",
            "probability": 0.00286102294921875
        },
        {
            "start_logit": -7.28125,
            "end_logit": 4.15625,
            "text": ", Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0027828216552734375
        },
        {
            "start_logit": -1.59765625,
            "end_logit": -5.31640625,
            "text": "the Disease Activity Score in 28 joints (DAS28) were calculated using data from tocilizumab trials in patients with RA",
            "probability": 6.324052810668945e-05
        },
        {
            "start_logit": -1.59765625,
            "end_logit": -7.09765625,
            "text": "the Disease Activity Score in 28 joints (DAS28",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": -1.59765625,
            "end_logit": -7.23046875,
            "text": "the Disease Activity Score in 28 joints (DAS",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": -1.59765625,
            "end_logit": -7.29296875,
            "text": "the Disease Activity Score in 28 joints (DAS28) were",
            "probability": 8.702278137207031e-06
        },
        {
            "start_logit": -1.59765625,
            "end_logit": -7.30859375,
            "text": "the Disease Activity Score in 28 joints (DAS28) were calculated using data from",
            "probability": 8.52346420288086e-06
        }
    ],
    "5fe3130da43ad3127800003f_13": [
        {
            "start_logit": -2.4140625,
            "end_logit": 6.6640625,
            "text": "28 joints",
            "probability": 0.55419921875
        },
        {
            "start_logit": -3.13671875,
            "end_logit": 6.6640625,
            "text": "joints",
            "probability": 0.26904296875
        },
        {
            "start_logit": -3.81640625,
            "end_logit": 6.6640625,
            "text": "Disease activity score in 28 joints",
            "probability": 0.1363525390625
        },
        {
            "start_logit": -5.25,
            "end_logit": 6.6640625,
            "text": "in 28 joints",
            "probability": 0.032501220703125
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.6640625,
            "text": "score in 28 joints",
            "probability": 0.004116058349609375
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 6.6640625,
            "text": "activity score in 28 joints",
            "probability": 0.00403594970703125
        },
        {
            "start_logit": -2.4140625,
            "end_logit": -5.95703125,
            "text": "28 joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -5.95703125,
            "text": "joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -2.4140625,
            "end_logit": -6.93359375,
            "text": "28 joints (DAS28)-remission",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.4140625,
            "end_logit": -7.33203125,
            "text": "28 joints (DAS28)-remission has not been included among American College of Rheumatology",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -5.95703125,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -2.4140625,
            "end_logit": -7.546875,
            "text": "28 joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism definitions, because of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.4140625,
            "end_logit": -7.578125,
            "text": "28 joints (DAS28",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -6.93359375,
            "text": "joints (DAS28)-remission",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.4140625,
            "end_logit": -7.66015625,
            "text": "28 joints (DAS28)-remission has not been included among",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.4140625,
            "end_logit": -7.7578125,
            "text": "28 joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism definitions, because",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.4140625,
            "end_logit": -7.8359375,
            "text": "28 joints (DAS28)-remission has not been included among American",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -7.33203125,
            "text": "joints (DAS28)-remission has not been included among American College of Rheumatology",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -7.546875,
            "text": "joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism definitions, because of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -7.578125,
            "text": "joints (DAS28",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5fe3130da43ad3127800003f_14": [
        {
            "start_logit": -3.029296875,
            "end_logit": 1.8466796875,
            "text": "with C-reactive protein",
            "probability": 0.398193359375
        },
        {
            "start_logit": -3.4609375,
            "end_logit": 1.8466796875,
            "text": "28 joints with C-reactive protein",
            "probability": 0.258544921875
        },
        {
            "start_logit": -3.72265625,
            "end_logit": 1.8466796875,
            "text": "C-reactive protein",
            "probability": 0.1990966796875
        },
        {
            "start_logit": -4.62890625,
            "end_logit": 1.8466796875,
            "text": "joints with C-reactive protein",
            "probability": 0.08050537109375
        },
        {
            "start_logit": -6.671875,
            "end_logit": 1.8466796875,
            "text": "reactive protein",
            "probability": 0.01044464111328125
        },
        {
            "start_logit": -6.859375,
            "end_logit": 1.8466796875,
            "text": "-reactive protein",
            "probability": 0.00865936279296875
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 1.8466796875,
            "text": "disease-modifying anti-rheumatic drugs (bDMARDs) and in low or moderate Disease Activity Score of 28 joints with C-reactive protein",
            "probability": 0.00638580322265625
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 1.8466796875,
            "text": "MARDs) and in low or moderate Disease Activity Score of 28 joints with C-reactive protein",
            "probability": 0.00554656982421875
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 1.8466796875,
            "text": "biological disease-modifying anti-rheumatic drugs (bDMARDs) and in low or moderate Disease Activity Score of 28 joints with C-reactive protein",
            "probability": 0.005191802978515625
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 1.8466796875,
            "text": "Disease Activity Score of 28 joints with C-reactive protein",
            "probability": 0.005191802978515625
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 1.8466796875,
            "text": "modifying anti-rheumatic drugs (bDMARDs) and in low or moderate Disease Activity Score of 28 joints with C-reactive protein",
            "probability": 0.00514984130859375
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 1.8466796875,
            "text": "rheumatic drugs (bDMARDs) and in low or moderate Disease Activity Score of 28 joints with C-reactive protein",
            "probability": 0.004405975341796875
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 1.8466796875,
            "text": "protein",
            "probability": 0.004302978515625
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 1.8466796875,
            "text": "of 28 joints with C-reactive protein",
            "probability": 0.0037975311279296875
        },
        {
            "start_logit": -3.029296875,
            "end_logit": -3.6796875,
            "text": "with C-reactive protein (DAS)28-CRP",
            "probability": 0.0015821456909179688
        },
        {
            "start_logit": -3.4609375,
            "end_logit": -3.6796875,
            "text": "28 joints with C-reactive protein (DAS)28-CRP",
            "probability": 0.0010309219360351562
        },
        {
            "start_logit": -3.72265625,
            "end_logit": -3.6796875,
            "text": "C-reactive protein (DAS)28-CRP",
            "probability": 0.0007929801940917969
        },
        {
            "start_logit": -3.4609375,
            "end_logit": -4.1640625,
            "text": "28 joints",
            "probability": 0.0006346702575683594
        },
        {
            "start_logit": -4.62890625,
            "end_logit": -3.6796875,
            "text": "joints with C-reactive protein (DAS)28-CRP",
            "probability": 0.0003192424774169922
        },
        {
            "start_logit": -3.029296875,
            "end_logit": -5.72265625,
            "text": "with C-reactive protein (DAS)28",
            "probability": 0.00020599365234375
        }
    ],
    "5fe3130da43ad3127800003f_15": [
        {
            "start_logit": -2.740234375,
            "end_logit": 6.9140625,
            "text": "28 Joints",
            "probability": 0.37841796875
        },
        {
            "start_logit": -3.01171875,
            "end_logit": 6.9140625,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.2890625
        },
        {
            "start_logit": -3.15625,
            "end_logit": 6.9140625,
            "text": "Joints",
            "probability": 0.250244140625
        },
        {
            "start_logit": -4.546875,
            "end_logit": 6.9140625,
            "text": "in 28 Joints",
            "probability": 0.062255859375
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 6.9140625,
            "text": ": Disease Activity Score in 28 Joints",
            "probability": 0.0038890838623046875
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 6.9140625,
            "text": "Activity Score in 28 Joints",
            "probability": 0.003871917724609375
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 6.9140625,
            "text": "Score in 28 Joints",
            "probability": 0.00360870361328125
        },
        {
            "start_logit": -2.740234375,
            "end_logit": 1.8828125,
            "text": "28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 0.002471923828125
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.9140625,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 0.002162933349609375
        },
        {
            "start_logit": -3.01171875,
            "end_logit": 1.8828125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 0.0018863677978515625
        },
        {
            "start_logit": -3.15625,
            "end_logit": 1.8828125,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 0.0016336441040039062
        },
        {
            "start_logit": -4.546875,
            "end_logit": 1.8828125,
            "text": "in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 0.0004067420959472656
        },
        {
            "start_logit": -5.83984375,
            "end_logit": 1.8828125,
            "text": "rheumatoid art",
            "probability": 0.00011205673217773438
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 1.8828125,
            "text": "art",
            "probability": 9.584426879882812e-05
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 1.8828125,
            "text": "in rheumatoid art",
            "probability": 7.575750350952148e-05
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 1.8828125,
            "text": ": Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 2.5391578674316406e-05
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 1.8828125,
            "text": "Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 2.5391578674316406e-05
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 1.8828125,
            "text": "evaluate disease activity and treatment response in rheumatoid art",
            "probability": 2.3484230041503906e-05
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 1.8828125,
            "text": "Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 2.3484230041503906e-05
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 1.8828125,
            "text": "system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 2.2411346435546875e-05
        }
    ],
    "5fe3130da43ad3127800003f_16": [
        {
            "start_logit": -1.4501953125,
            "end_logit": 6.48046875,
            "text": "28 joints",
            "probability": 0.8720703125
        },
        {
            "start_logit": -3.611328125,
            "end_logit": 6.48046875,
            "text": "joints",
            "probability": 0.10040283203125
        },
        {
            "start_logit": -5.75390625,
            "end_logit": 6.48046875,
            "text": "in 28 joints",
            "probability": 0.01177978515625
        },
        {
            "start_logit": -6.32421875,
            "end_logit": 6.48046875,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.006656646728515625
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 6.48046875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.00231170654296875
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.48046875,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.001850128173828125
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.48046875,
            "text": "Activity Score in 28 joints",
            "probability": 0.0015573501586914062
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.48046875,
            "text": "Score in 28 joints",
            "probability": 0.0014514923095703125
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 6.48046875,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.00139617919921875
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.4765625,
            "text": "28 joints (",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.484375,
            "text": "28 joints (DAS28) is a",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.54296875,
            "text": "28 joints (DAS28) is a key",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.5625,
            "text": "28 joints (DAS28) is a key measure in clinical practice",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.578125,
            "text": "28 joints (DAS28",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.68359375,
            "text": "28 joints (DAS28) is a key measure in clinical practice and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.68359375,
            "text": "28 joints (DAS",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.83203125,
            "text": "28 joints (DAS28) is a key measure in clinical practice and clini",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.83984375,
            "text": "28 joints (DAS28) is a key measure in clinical",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.8828125,
            "text": "28 joints (DAS28) is a key measure in",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.4501953125,
            "end_logit": -7.8828125,
            "text": "28 joints (DAS28) is a key measure",
            "probability": 5.364418029785156e-07
        }
    ],
    "5fe3130da43ad3127800003f_17": [
        {
            "start_logit": -2.4921875,
            "end_logit": 2.52734375,
            "text": "28 joints",
            "probability": 0.86572265625
        },
        {
            "start_logit": -5.42578125,
            "end_logit": 2.52734375,
            "text": "The Disease Activity Score including 28 joints",
            "probability": 0.046051025390625
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -0.908203125,
            "text": "28 joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.027862548828125
        },
        {
            "start_logit": -6.015625,
            "end_logit": 2.52734375,
            "text": "including 28 joints",
            "probability": 0.0255279541015625
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 2.52734375,
            "text": "joints",
            "probability": 0.0179595947265625
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 2.52734375,
            "text": "Disease Activity Score including 28 joints",
            "probability": 0.0081329345703125
        },
        {
            "start_logit": -4.6953125,
            "end_logit": -0.908203125,
            "text": "rheumatoid arthritis",
            "probability": 0.003086090087890625
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -0.908203125,
            "text": "of rheumatoid arthritis",
            "probability": 0.0011529922485351562
        },
        {
            "start_logit": -5.84375,
            "end_logit": -0.908203125,
            "text": "Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.0009784698486328125
        },
        {
            "start_logit": -6.015625,
            "end_logit": -0.908203125,
            "text": "including 28 joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.000823974609375
        },
        {
            "start_logit": -6.3671875,
            "end_logit": -0.908203125,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.000579833984375
        },
        {
            "start_logit": -6.5625,
            "end_logit": -0.908203125,
            "text": "CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.000476837158203125
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -0.908203125,
            "text": "Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.00040459632873535156
        },
        {
            "start_logit": -7.09765625,
            "end_logit": -0.908203125,
            "text": "Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.0002770423889160156
        },
        {
            "start_logit": -7.203125,
            "end_logit": -0.908203125,
            "text": "order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.0002522468566894531
        },
        {
            "start_logit": -7.21875,
            "end_logit": -0.908203125,
            "text": "AI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.00024819374084472656
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -0.908203125,
            "text": "the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.00023686885833740234
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -0.908203125,
            "text": "measure of rheumatoid arthritis",
            "probability": 0.00023686885833740234
        },
        {
            "start_logit": -7.3125,
            "end_logit": -0.908203125,
            "text": "Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.00022614002227783203
        },
        {
            "start_logit": -7.328125,
            "end_logit": -0.908203125,
            "text": "and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 0.00022268295288085938
        }
    ],
    "5fe3130da43ad3127800003f_18": [
        {
            "start_logit": 3.716796875,
            "end_logit": 4.9453125,
            "text": "28 joints",
            "probability": 0.66162109375
        },
        {
            "start_logit": 3.716796875,
            "end_logit": 4.27734375,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 0.337890625
        },
        {
            "start_logit": 3.716796875,
            "end_logit": -2.44921875,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid",
            "probability": 0.0004050731658935547
        },
        {
            "start_logit": -5.09375,
            "end_logit": 4.9453125,
            "text": "joints",
            "probability": 9.846687316894531e-05
        },
        {
            "start_logit": -4.8359375,
            "end_logit": 4.27734375,
            "text": "arth",
            "probability": 6.562471389770508e-05
        },
        {
            "start_logit": -5.09375,
            "end_logit": 4.27734375,
            "text": "joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 5.030632019042969e-05
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 4.9453125,
            "text": "on 28 joints",
            "probability": 4.953145980834961e-05
        },
        {
            "start_logit": -5.671875,
            "end_logit": 4.27734375,
            "text": "rheumatoid arth",
            "probability": 2.8252601623535156e-05
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 4.27734375,
            "text": "on 28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 2.5272369384765625e-05
        },
        {
            "start_logit": 3.716796875,
            "end_logit": -5.5703125,
            "text": "28",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": -7.34375,
            "end_logit": 4.9453125,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": -6.6875,
            "end_logit": 4.27734375,
            "text": "of rheumatoid arth",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 4.9453125,
            "text": "based on 28 joints",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": 4.9453125,
            "text": ": The Disease Activity Score based on 28 joints",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 4.9453125,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -7.8125,
            "end_logit": 4.9453125,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": -7.96875,
            "end_logit": 4.9453125,
            "text": "Activity Score based on 28 joints",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 4.27734375,
            "text": "The Disease Activity Score based on 28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 4.9453125,
            "text": "Score based on 28 joints",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 4.27734375,
            "text": "based on 28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 4.470348358154297e-06
        }
    ],
    "5fe3130da43ad3127800003f_19": [
        {
            "start_logit": 0.373046875,
            "end_logit": 6.58984375,
            "text": "28 joints",
            "probability": 0.96142578125
        },
        {
            "start_logit": -3.529296875,
            "end_logit": 6.58984375,
            "text": "joints",
            "probability": 0.0194549560546875
        },
        {
            "start_logit": -3.73046875,
            "end_logit": 6.58984375,
            "text": "including 28 joints",
            "probability": 0.015899658203125
        },
        {
            "start_logit": -6.234375,
            "end_logit": 6.58984375,
            "text": "Disease Activity Score including 28 joints",
            "probability": 0.001300811767578125
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 6.58984375,
            "text": "rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints",
            "probability": 0.0007500648498535156
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 6.58984375,
            "text": "the Disease Activity Score including 28 joints",
            "probability": 0.0007128715515136719
        },
        {
            "start_logit": 0.373046875,
            "end_logit": -5.53125,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 0.373046875,
            "end_logit": -6.55859375,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 0.373046875,
            "end_logit": -7.68359375,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CD",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 0.373046875,
            "end_logit": -7.83203125,
            "text": "28 joints (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 0.373046875,
            "end_logit": -7.8515625,
            "text": "28 joints (DAS28",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 0.373046875,
            "end_logit": -7.87109375,
            "text": "28",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 0.373046875,
            "end_logit": -7.94140625,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -5.53125,
            "text": "joints (DAS28) compared with the Clinical Disease Activity Index (CDAI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.73046875,
            "end_logit": -5.53125,
            "text": "including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -6.55859375,
            "text": "joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.73046875,
            "end_logit": -6.55859375,
            "text": "including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -7.68359375,
            "text": "joints (DAS28) compared with the Clinical Disease Activity Index (CD",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -7.83203125,
            "text": "joints (",
            "probability": 0.0
        },
        {
            "start_logit": -3.529296875,
            "end_logit": -7.8515625,
            "text": "joints (DAS28",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_20": [
        {
            "start_logit": -4.23828125,
            "end_logit": 1.681640625,
            "text": "C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.30810546875
        },
        {
            "start_logit": -4.6171875,
            "end_logit": 1.681640625,
            "text": "rheumatoid arthritis",
            "probability": 0.2109375
        },
        {
            "start_logit": -5.0234375,
            "end_logit": 1.681640625,
            "text": "erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.1405029296875
        },
        {
            "start_logit": -5.98046875,
            "end_logit": 1.681640625,
            "text": "DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.0540771484375
        },
        {
            "start_logit": -5.984375,
            "end_logit": 1.681640625,
            "text": "28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.053619384765625
        },
        {
            "start_logit": -6.40625,
            "end_logit": 1.681640625,
            "text": "reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.035186767578125
        },
        {
            "start_logit": -6.671875,
            "end_logit": 1.681640625,
            "text": "with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.0269622802734375
        },
        {
            "start_logit": -6.6875,
            "end_logit": 1.681640625,
            "text": "of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.02655029296875
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 1.681640625,
            "text": "-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.0241851806640625
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 1.681640625,
            "text": "sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.0220184326171875
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 1.681640625,
            "text": "assess rheumatoid arthritis",
            "probability": 0.0218505859375
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 1.681640625,
            "text": ") is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.0195770263671875
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 1.681640625,
            "text": "instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.017822265625
        },
        {
            "start_logit": -5.75390625,
            "end_logit": -0.037933349609375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.01210784912109375
        },
        {
            "start_logit": -5.75390625,
            "end_logit": -0.037933349609375,
            "text": "28 joints",
            "probability": 0.01210784912109375
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -0.037933349609375,
            "text": "in 28 joints",
            "probability": 0.00446319580078125
        },
        {
            "start_logit": -4.23828125,
            "end_logit": -3.013671875,
            "text": "C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.00281524658203125
        },
        {
            "start_logit": -4.23828125,
            "end_logit": -3.041015625,
            "text": "C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR",
            "probability": 0.0027294158935546875
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -2.849609375,
            "text": "rheumatoid arthritis disease activity; however, values for remission and low disease activity (LDA) for DAS28-CRP",
            "probability": 0.002262115478515625
        },
        {
            "start_logit": -4.69921875,
            "end_logit": -2.849609375,
            "text": "DAS28-CRP",
            "probability": 0.0020923614501953125
        }
    ],
    "5fe3130da43ad3127800003f_21": [
        {
            "start_logit": -3.619140625,
            "end_logit": 0.07177734375,
            "text": "28 joints",
            "probability": 0.88134765625
        },
        {
            "start_logit": -6.3828125,
            "end_logit": 0.07177734375,
            "text": "in 28 joints",
            "probability": 0.055450439453125
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 0.07177734375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.036224365234375
        },
        {
            "start_logit": -7.3125,
            "end_logit": 0.07177734375,
            "text": "joints",
            "probability": 0.0218963623046875
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -6.6875,
            "text": "28 joints (DAS28) in early rheumatoid arthritis (RA) by adding the \"squeeze test\" of forefeet.",
            "probability": 0.0010232925415039062
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.1875,
            "text": "28 joints (DAS28) in early rheumatoid arthritis",
            "probability": 0.0006208419799804688
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.61328125,
            "text": "28 joints (DAS28) in early rheumatoid arthritis (RA) by",
            "probability": 0.00040411949157714844
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.66796875,
            "text": "28 joints (DAS28) in early rheumatoid arthritis (RA) by adding the \"squeeze",
            "probability": 0.0003826618194580078
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.73828125,
            "text": "28 joints (DAS28",
            "probability": 0.00035643577575683594
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.7421875,
            "text": "28 joints (DAS28) in",
            "probability": 0.00035643577575683594
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.77734375,
            "text": "28 joints (DAS28) in early rheumatoid arthritis (RA) by adding the \"squeeze test\" of forefeet",
            "probability": 0.0003428459167480469
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.8359375,
            "text": "28 joints (DAS28) in early rheumatoid arthritis (RA",
            "probability": 0.0003247261047363281
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.875,
            "text": "28 joints (DAS28) in early rheumatoid arthritis (RA) by adding the \"squeeze test",
            "probability": 0.0003123283386230469
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.93359375,
            "text": "28 joints (DAS",
            "probability": 0.0002932548522949219
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -7.94921875,
            "text": "28 joints (DAS28)",
            "probability": 0.0002887248992919922
        },
        {
            "start_logit": -5.9609375,
            "end_logit": -6.6875,
            "text": "squeeze test\" of forefeet.",
            "probability": 9.828805923461914e-05
        },
        {
            "start_logit": -6.2578125,
            "end_logit": -6.61328125,
            "text": "squeeze test is used to examine bilateral compression pain (BCP) across the metatarsophal",
            "probability": 7.832050323486328e-05
        },
        {
            "start_logit": -6.3828125,
            "end_logit": -6.6875,
            "text": "in 28 joints (DAS28) in early rheumatoid arthritis (RA) by adding the \"squeeze test\" of forefeet.",
            "probability": 6.443262100219727e-05
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -6.6875,
            "text": "eeze test\" of forefeet.",
            "probability": 5.137920379638672e-05
        },
        {
            "start_logit": -6.71484375,
            "end_logit": -6.61328125,
            "text": "metatarsophal",
            "probability": 4.976987838745117e-05
        }
    ],
    "5710a592cf1c32585100002a_1": [
        {
            "start_logit": -1.83203125,
            "end_logit": 1.294921875,
            "text": "anthrax toxins and extracellular capsular layer.",
            "probability": 0.8896484375
        },
        {
            "start_logit": -4.25,
            "end_logit": 1.294921875,
            "text": ".",
            "probability": 0.07928466796875
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 1.294921875,
            "text": "ax toxins and extracellular capsular layer.",
            "probability": 0.00452423095703125
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 1.294921875,
            "text": "the anthrax toxins and extracellular capsular layer.",
            "probability": 0.00421905517578125
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 1.294921875,
            "text": "elevated temperature (37\u00b0C) and bicarbonate/CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer.",
            "probability": 0.003780364990234375
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 1.294921875,
            "text": "CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer.",
            "probability": 0.0035800933837890625
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 1.294921875,
            "text": "of virulence factors that include the anthrax toxins and extracellular capsular layer.",
            "probability": 0.0031337738037109375
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 1.294921875,
            "text": "virulence factors that include the anthrax toxins and extracellular capsular layer.",
            "probability": 0.00292205810546875
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 1.294921875,
            "text": "include the anthrax toxins and extracellular capsular layer.",
            "probability": 0.0027446746826171875
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 1.294921875,
            "text": "increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer.",
            "probability": 0.0022220611572265625
        },
        {
            "start_logit": -1.83203125,
            "end_logit": -4.78515625,
            "text": "anthrax toxins",
            "probability": 0.0020389556884765625
        },
        {
            "start_logit": -1.83203125,
            "end_logit": -5.39453125,
            "text": "anthrax",
            "probability": 0.0011091232299804688
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -4.2421875,
            "text": "Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 0.000133514404296875
        },
        {
            "start_logit": -5.296875,
            "end_logit": -4.2421875,
            "text": ", Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 0.00010979175567626953
        },
        {
            "start_logit": -5.64453125,
            "end_logit": -4.2421875,
            "text": "Upon infection of a mammalian host, Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -4.83984375,
            "text": "Bacillus anthracis responds to host",
            "probability": 7.37309455871582e-05
        },
        {
            "start_logit": -5.64453125,
            "end_logit": -4.4140625,
            "text": "Upon infection of a mammalian host",
            "probability": 6.508827209472656e-05
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -4.984375,
            "text": "Bacillus anthracis",
            "probability": 6.407499313354492e-05
        },
        {
            "start_logit": -5.09765625,
            "end_logit": -5.00390625,
            "text": "Bacillus anthracis responds to host cues",
            "probability": 6.258487701416016e-05
        },
        {
            "start_logit": -5.296875,
            "end_logit": -4.83984375,
            "text": ", Bacillus anthracis responds to host",
            "probability": 6.020069122314453e-05
        }
    ],
    "5710a592cf1c32585100002a_2": [
        {
            "start_logit": 8.09375,
            "end_logit": 8.21875,
            "text": "CO(2) /bicarbonate",
            "probability": 0.5078125
        },
        {
            "start_logit": 8.078125,
            "end_logit": 8.203125,
            "text": "CO(2) /bicarbonate",
            "probability": 0.4921875
        },
        {
            "start_logit": -0.22607421875,
            "end_logit": 8.21875,
            "text": "bicarbonate",
            "probability": 0.00012362003326416016
        },
        {
            "start_logit": -0.6552734375,
            "end_logit": 8.21875,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate",
            "probability": 8.040666580200195e-05
        },
        {
            "start_logit": -0.6552734375,
            "end_logit": 8.203125,
            "text": "bicarbonate",
            "probability": 7.921457290649414e-05
        },
        {
            "start_logit": 8.078125,
            "end_logit": -0.7265625,
            "text": "CO",
            "probability": 6.514787673950195e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -0.876953125,
            "text": "CO",
            "probability": 5.704164505004883e-05
        },
        {
            "start_logit": 8.078125,
            "end_logit": -0.876953125,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO",
            "probability": 5.614757537841797e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -2.443359375,
            "text": "CO(2)",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 8.078125,
            "end_logit": -2.443359375,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2)",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -4.40234375,
            "text": "CO(2) /bicarbonate, suggesting that this host-associated signal enhances AtxA function by shifting the dimer/monomer equilibrium towards the dimeric state.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -5.171875,
            "end_logit": 8.21875,
            "text": "/bicarbonate",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -5.171875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -5.32421875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -5.37109375,
            "text": "CO(",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -5.37109375,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -5.46875,
            "text": "CO(2)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 8.21875,
            "text": "/bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 8.203125,
            "text": "/bicarbonate",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -5.5546875,
            "text": "CO(2) /bicarbonate, suggesting that this host-associated signal enhances AtxA",
            "probability": 5.364418029785156e-07
        }
    ],
    "5710a592cf1c32585100002a_3": [
        {
            "start_logit": 8.09375,
            "end_logit": 8.21875,
            "text": "CO(2) /bicarbonate",
            "probability": 0.5078125
        },
        {
            "start_logit": 8.078125,
            "end_logit": 8.203125,
            "text": "CO(2) /bicarbonate",
            "probability": 0.4921875
        },
        {
            "start_logit": -0.22607421875,
            "end_logit": 8.21875,
            "text": "bicarbonate",
            "probability": 0.00012362003326416016
        },
        {
            "start_logit": -0.6552734375,
            "end_logit": 8.21875,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate",
            "probability": 8.040666580200195e-05
        },
        {
            "start_logit": -0.6552734375,
            "end_logit": 8.203125,
            "text": "bicarbonate",
            "probability": 7.921457290649414e-05
        },
        {
            "start_logit": 8.078125,
            "end_logit": -0.7265625,
            "text": "CO",
            "probability": 6.514787673950195e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -0.876953125,
            "text": "CO",
            "probability": 5.704164505004883e-05
        },
        {
            "start_logit": 8.078125,
            "end_logit": -0.876953125,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO",
            "probability": 5.614757537841797e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -2.443359375,
            "text": "CO(2)",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 8.078125,
            "end_logit": -2.443359375,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2)",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -4.40234375,
            "text": "CO(2) /bicarbonate, suggesting that this host-associated signal enhances AtxA function by shifting the dimer/monomer equilibrium towards the dimeric state.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -5.171875,
            "end_logit": 8.21875,
            "text": "/bicarbonate",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -5.171875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -5.32421875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -5.37109375,
            "text": "CO(",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -5.37109375,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -5.46875,
            "text": "CO(2)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 8.21875,
            "text": "/bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 8.203125,
            "text": "/bicarbonate",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -5.5546875,
            "text": "CO(2) /bicarbonate, suggesting that this host-associated signal enhances AtxA",
            "probability": 5.364418029785156e-07
        }
    ],
    "5710a592cf1c32585100002a_4": [
        {
            "start_logit": 6.421875,
            "end_logit": 6.69140625,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.421875,
            "end_logit": -4.02734375,
            "text": "CO2, a signal mimicking the host environment.",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 6.421875,
            "end_logit": -6.61328125,
            "text": "CO2, a",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.421875,
            "end_logit": -6.64453125,
            "text": "CO2, a signal mimicking the host",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.421875,
            "end_logit": -6.703125,
            "text": "CO2,",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.078125,
            "text": "CO2, a signal mimicking the host environment",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.27734375,
            "text": "CO2, a signal",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.69140625,
            "text": "Bacillus anthracis virulence genes is triggered by CO2",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.4765625,
            "text": "CO2, a signal mimicking",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.515625,
            "text": "CO2, a signal mimicking the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.69140625,
            "text": "anthracis virulence genes is triggered by CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 6.69140625,
            "text": "by CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.69140625,
            "text": "genes is triggered by CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 6.69140625,
            "text": "Transcription of the major Bacillus anthracis virulence genes is triggered by CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.69140625,
            "text": "virulence genes is triggered by CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -4.02734375,
            "text": "Bacillus anthracis virulence genes is triggered by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -4.02734375,
            "text": "anthracis virulence genes is triggered by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -4.02734375,
            "text": "by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -4.02734375,
            "text": "genes is triggered by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.98828125,
            "end_logit": -4.02734375,
            "text": "Transcription of the major Bacillus anthracis virulence genes is triggered by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_5": [
        {
            "start_logit": 6.33203125,
            "end_logit": 6.78515625,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -4.5703125,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory network.",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.18359375,
            "text": "CO2 and in vivo",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.78515625,
            "text": "presence of CO2",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.2421875,
            "text": "CO2 and in vivo, AtxA is part of the sap",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.78515625,
            "text": ", in vitro in presence of CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.28515625,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 6.78515625,
            "text": "in presence of CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.31640625,
            "text": "CO2 and in vivo, AtxA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.78515625,
            "text": "of CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.40234375,
            "text": "CO2 and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.44140625,
            "text": "CO2 and in vivo, AtxA is part of the sap and ea",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.61328125,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.65625,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory network",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.68359375,
            "text": "CO2 and in vivo, AtxA is part of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.71484375,
            "text": "CO2 and in vivo, AtxA is part",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.765625,
            "text": "CO2 and in vivo, AtxA is part of the",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.8359375,
            "text": "CO2 and in vivo, At",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.92578125,
            "text": "CO2 and in vivo, AtxA is part of the sap and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.3203125,
            "end_logit": -4.5703125,
            "text": "eag regulatory network.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_6": [
        {
            "start_logit": 6.31640625,
            "end_logit": -0.390869140625,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis",
            "probability": 0.5927734375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -1.041015625,
            "text": "anthrax toxin activator",
            "probability": 0.308837890625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -2.873046875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 0.049530029296875
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -4.01171875,
            "text": "anthrax toxin",
            "probability": 0.0158538818359375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -4.40234375,
            "text": "anthr",
            "probability": 0.0107269287109375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -4.734375,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature",
            "probability": 0.007694244384765625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -5.78515625,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.002689361572265625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -5.90234375,
            "text": "anthrax",
            "probability": 0.0023937225341796875
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -5.9921875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthrac",
            "probability": 0.0021877288818359375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.0,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.002170562744140625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.63671875,
            "text": "anthrax toxin activator gene (atxA",
            "probability": 0.001148223876953125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.80078125,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate, affects AtxA",
            "probability": 0.0009746551513671875
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.90234375,
            "text": "anthrax toxin activator gene",
            "probability": 0.0008807182312011719
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.03515625,
            "text": "anthrax toxin activator gene (",
            "probability": 0.0007710456848144531
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.3046875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis:",
            "probability": 0.0005888938903808594
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.33984375,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate,",
            "probability": 0.000568389892578125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.54296875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate, affects AtxA synthesis",
            "probability": 0.0004639625549316406
        },
        {
            "start_logit": -3.544921875,
            "end_logit": -2.873046875,
            "text": "temperature, not CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -0.390869140625,
            "text": "Regulation of anthrax toxin activator gene (atxA) expression in Bacillus anthracis",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -6.828125,
            "end_logit": -0.390869140625,
            "text": "xA) expression in Bacillus anthracis",
            "probability": 1.1920928955078125e-06
        }
    ],
    "5710a592cf1c32585100002a_7": [
        {
            "start_logit": -2.564453125,
            "end_logit": -0.374755859375,
            "text": "CO2/bicarbonate",
            "probability": 0.72705078125
        },
        {
            "start_logit": -2.564453125,
            "end_logit": -2.25390625,
            "text": "CO2/bicarbonate and temperature.",
            "probability": 0.11090087890625
        },
        {
            "start_logit": -5.45703125,
            "end_logit": -0.374755859375,
            "text": "toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.040313720703125
        },
        {
            "start_logit": -5.953125,
            "end_logit": -0.374755859375,
            "text": "xA+ strains, expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.0245513916015625
        },
        {
            "start_logit": -6.203125,
            "end_logit": -0.374755859375,
            "text": "expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.0191192626953125
        },
        {
            "start_logit": -6.21875,
            "end_logit": -0.374755859375,
            "text": "elevated CO2/bicarbonate",
            "probability": 0.0188140869140625
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -0.374755859375,
            "text": "lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.006443023681640625
        },
        {
            "start_logit": -5.45703125,
            "end_logit": -2.25390625,
            "text": "toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate and temperature.",
            "probability": 0.0061492919921875
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -0.374755859375,
            "text": "f, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.005908966064453125
        },
        {
            "start_logit": -2.564453125,
            "end_logit": -5.29296875,
            "text": "CO2",
            "probability": 0.005298614501953125
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -0.374755859375,
            "text": ") is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.004940032958984375
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -0.374755859375,
            "text": "by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.004428863525390625
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -0.374755859375,
            "text": ", expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.004428863525390625
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -0.374755859375,
            "text": "enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.0042266845703125
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -0.374755859375,
            "text": "of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 0.003612518310546875
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -0.374755859375,
            "text": "/bicarbonate",
            "probability": 0.0035839080810546875
        },
        {
            "start_logit": -6.203125,
            "end_logit": -2.25390625,
            "text": "expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate and temperature.",
            "probability": 0.0029277801513671875
        },
        {
            "start_logit": -6.21875,
            "end_logit": -2.25390625,
            "text": "elevated CO2/bicarbonate and temperature.",
            "probability": 0.002880096435546875
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -2.25390625,
            "text": ".",
            "probability": 0.0023517608642578125
        },
        {
            "start_logit": -2.564453125,
            "end_logit": -6.34765625,
            "text": "CO2/bicarbonate and temperature",
            "probability": 0.0018453598022460938
        }
    ],
    "5710a592cf1c32585100002a_8": [
        {
            "start_logit": 8.1015625,
            "end_logit": 8.1484375,
            "text": "CO2/bicarbonate",
            "probability": 0.337890625
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 8.1328125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 0.332763671875
        },
        {
            "start_logit": 8.0859375,
            "end_logit": 8.1328125,
            "text": "CO2/bicarbonate",
            "probability": 0.32763671875
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 1.97265625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2",
            "probability": 0.0007052421569824219
        },
        {
            "start_logit": 8.0859375,
            "end_logit": 1.97265625,
            "text": "CO2",
            "probability": 0.00069427490234375
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 1.3232421875,
            "text": "CO2",
            "probability": 0.0003657341003417969
        },
        {
            "start_logit": -0.654296875,
            "end_logit": 8.1328125,
            "text": "bicarbonate",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": 8.1484375,
            "text": "bicarbonate",
            "probability": 4.2378902435302734e-05
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": 8.1328125,
            "text": "bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.172325134277344e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -5.11328125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.11328125,
            "text": "CO2/bicarbonate at 37 degrees C is five",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -5.6953125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.71875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.07421875,
            "text": "CO2/bicarbonate levels.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.07421875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than that observed in cells grown in the same conditions at 28 degrees C.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.13671875,
            "text": "CO2/bicarbonate levels. However",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.18359375,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.19140625,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.2109375,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.2109375,
            "text": "CO2/bicarbonate at",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5710a592cf1c32585100002a_9": [
        {
            "start_logit": 8.1015625,
            "end_logit": 8.1484375,
            "text": "CO2/bicarbonate",
            "probability": 0.337890625
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 8.1328125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 0.332763671875
        },
        {
            "start_logit": 8.0859375,
            "end_logit": 8.1328125,
            "text": "CO2/bicarbonate",
            "probability": 0.32763671875
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 1.97265625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2",
            "probability": 0.0007052421569824219
        },
        {
            "start_logit": 8.0859375,
            "end_logit": 1.97265625,
            "text": "CO2",
            "probability": 0.00069427490234375
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 1.3232421875,
            "text": "CO2",
            "probability": 0.0003657341003417969
        },
        {
            "start_logit": -0.654296875,
            "end_logit": 8.1328125,
            "text": "bicarbonate",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": 8.1484375,
            "text": "bicarbonate",
            "probability": 4.2378902435302734e-05
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": 8.1328125,
            "text": "bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.172325134277344e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -5.11328125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.11328125,
            "text": "CO2/bicarbonate at 37 degrees C is five",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -5.6953125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.71875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.07421875,
            "text": "CO2/bicarbonate levels.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.07421875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than that observed in cells grown in the same conditions at 28 degrees C.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.13671875,
            "text": "CO2/bicarbonate levels. However",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.18359375,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.19140625,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.2109375,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.2109375,
            "text": "CO2/bicarbonate at",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5710a592cf1c32585100002a_10": [
        {
            "start_logit": 8.1015625,
            "end_logit": 8.1484375,
            "text": "CO2/bicarbonate",
            "probability": 0.337890625
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 8.1328125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 0.332763671875
        },
        {
            "start_logit": 8.0859375,
            "end_logit": 8.1328125,
            "text": "CO2/bicarbonate",
            "probability": 0.32763671875
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 1.97265625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2",
            "probability": 0.0007052421569824219
        },
        {
            "start_logit": 8.0859375,
            "end_logit": 1.97265625,
            "text": "CO2",
            "probability": 0.00069427490234375
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 1.3232421875,
            "text": "CO2",
            "probability": 0.0003657341003417969
        },
        {
            "start_logit": -0.654296875,
            "end_logit": 8.1328125,
            "text": "bicarbonate",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": 8.1484375,
            "text": "bicarbonate",
            "probability": 4.2378902435302734e-05
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": 8.1328125,
            "text": "bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.172325134277344e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -5.11328125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.11328125,
            "text": "CO2/bicarbonate at 37 degrees C is five",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -5.6953125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.71875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.07421875,
            "text": "CO2/bicarbonate levels.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.07421875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than that observed in cells grown in the same conditions at 28 degrees C.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.13671875,
            "text": "CO2/bicarbonate levels. However",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.18359375,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.19140625,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.2109375,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.2109375,
            "text": "CO2/bicarbonate at",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5710a592cf1c32585100002a_11": [
        {
            "start_logit": 8.1015625,
            "end_logit": 8.1484375,
            "text": "CO2/bicarbonate",
            "probability": 0.337890625
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 8.1328125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 0.332763671875
        },
        {
            "start_logit": 8.0859375,
            "end_logit": 8.1328125,
            "text": "CO2/bicarbonate",
            "probability": 0.32763671875
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 1.97265625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2",
            "probability": 0.0007052421569824219
        },
        {
            "start_logit": 8.0859375,
            "end_logit": 1.97265625,
            "text": "CO2",
            "probability": 0.00069427490234375
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 1.3232421875,
            "text": "CO2",
            "probability": 0.0003657341003417969
        },
        {
            "start_logit": -0.654296875,
            "end_logit": 8.1328125,
            "text": "bicarbonate",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": 8.1484375,
            "text": "bicarbonate",
            "probability": 4.2378902435302734e-05
        },
        {
            "start_logit": -0.8818359375,
            "end_logit": 8.1328125,
            "text": "bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.172325134277344e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -5.11328125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.11328125,
            "text": "CO2/bicarbonate at 37 degrees C is five",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -5.6953125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.71875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.07421875,
            "text": "CO2/bicarbonate levels.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.07421875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than that observed in cells grown in the same conditions at 28 degrees C.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.13671875,
            "text": "CO2/bicarbonate levels. However",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.18359375,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.19140625,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.2109375,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.2109375,
            "text": "CO2/bicarbonate at",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5710a592cf1c32585100002a_12": [
        {
            "start_logit": -2.197265625,
            "end_logit": 5.984375,
            "text": "CO2",
            "probability": 0.9658203125
        },
        {
            "start_logit": -6.515625,
            "end_logit": 5.984375,
            "text": "in response to the same signal, CO2",
            "probability": 0.012847900390625
        },
        {
            "start_logit": -6.703125,
            "end_logit": 5.984375,
            "text": ", CO2",
            "probability": 0.010650634765625
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 5.984375,
            "text": "response to the same signal, CO2",
            "probability": 0.01000213623046875
        },
        {
            "start_logit": -6.515625,
            "end_logit": -6.109375,
            "text": "in response to the same signal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.515625,
            "end_logit": -6.2421875,
            "text": "in response to the same",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65625,
            "end_logit": -6.1484375,
            "text": "Bacillus anthrac",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65625,
            "end_logit": -6.18359375,
            "text": "Bacillus anthracis toxin genes, cya, lef, and pag, can be viewed as a regulon, in which transcription",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.76953125,
            "end_logit": -6.109375,
            "text": "response to the same signal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.76953125,
            "end_logit": -6.2421875,
            "text": "response to the same",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65625,
            "end_logit": -6.53125,
            "text": "Bacillus anthracis toxin genes, cya, lef, and pag, can be viewed as a regulon, in which transcription of all",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65625,
            "end_logit": -6.61328125,
            "text": "Bacillus anthracis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65625,
            "end_logit": -6.6640625,
            "text": "Bacillus anthracis toxin genes, cya",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65625,
            "end_logit": -6.75,
            "text": "Bacillus anthracis toxin genes, cya, lef, and pag, can be viewed as a regulon, in which transcription of all three",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65625,
            "end_logit": -6.87890625,
            "text": "Bacillus anthracis toxin genes, cya, lef, and pag, can be viewed as a regulon, in which transcription of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65625,
            "end_logit": -7.06640625,
            "text": "Bacillus anthracis toxin genes, cya, lef, and pag, can be viewed as a regulon, in which transcription of all three genes is",
            "probability": 0.0
        },
        {
            "start_logit": -6.65625,
            "end_logit": -7.15625,
            "text": "Bacillus anthracis toxin",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_13": [
        {
            "start_logit": 6.4296875,
            "end_logit": 6.61328125,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -2.544921875,
            "text": "CO2-enhanced toxin gene transcription is not observed in atx4",
            "probability": 0.00010472536087036133
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -3.19921875,
            "text": "CO2-enhanced toxin gene transcription is not observed in atx",
            "probability": 5.4776668548583984e-05
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -3.5,
            "text": "CO2-enhanced toxin",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -4.359375,
            "text": "CO2-enhanced toxin gene transcription is not observed in atx4-null mutants.",
            "probability": 1.710653305053711e-05
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -6.17578125,
            "text": "CO2-enhanced toxin gene transcription is not observed in atx4-null",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -6.2421875,
            "text": "CO2-enhanced toxin gene transcription is not observed in atx4-",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -6.26953125,
            "text": "CO2-enhanced toxin gene transcription is not",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -6.328125,
            "text": "CO2-enhanced toxin gene transcription is not observed in atx4-null mutants",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -6.36328125,
            "text": "CO2-enhanced toxin gene transcription",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -6.84375,
            "text": "CO2-enhanced toxin gene",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.0234375,
            "text": "CO2-",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.109375,
            "text": "CO2-enhanced",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.17578125,
            "text": "CO2-enhanced toxin gene transcription is",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.25390625,
            "text": "CO2-enhanced toxin gene transcription is not observed",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.33984375,
            "text": "CO2-enhanced toxin gene transcription is not observed in at",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.48828125,
            "text": "CO2-enhanced toxin gene transcription is not observed in",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -2.544921875,
            "text": "x4",
            "probability": 0.0
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -3.19921875,
            "text": "x",
            "probability": 0.0
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -2.544921875,
            "text": "toxin gene transcription is not observed in atx4",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_14": [
        {
            "start_logit": 5.9140625,
            "end_logit": 6.59765625,
            "text": "CO2",
            "probability": 0.9990234375
        },
        {
            "start_logit": 5.9140625,
            "end_logit": -0.666015625,
            "text": "CO2 and the toxin gene regulator, atxA.",
            "probability": 0.0006985664367675781
        },
        {
            "start_logit": -5.90625,
            "end_logit": 6.59765625,
            "text": "elevated CO2",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 5.9140625,
            "end_logit": -5.44140625,
            "text": "CO2 and the toxin",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -6.140625,
            "end_logit": 6.59765625,
            "text": "toxin proteins is influenced by growth in elevated CO2",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 6.59765625,
            "text": "indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -6.640625,
            "end_logit": 6.59765625,
            "text": "Comparison of the resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 5.9140625,
            "end_logit": -6.17578125,
            "text": "CO2 and the toxin gene regulator",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 5.9140625,
            "end_logit": -6.5,
            "text": "CO2 and the toxin gene regulator, atxA",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 6.59765625,
            "text": "non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 6.59765625,
            "text": "the resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.59765625,
            "text": "in elevated CO2",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 6.59765625,
            "text": "synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.59765625,
            "text": "resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 5.9140625,
            "end_logit": -6.98828125,
            "text": "CO2 and the toxin gene",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.59765625,
            "text": "protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 5.9140625,
            "end_logit": -7.30078125,
            "text": "CO2 and the toxin gene regulator, at",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.56640625,
            "end_logit": -0.666015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -0.666015625,
            "text": "elevated CO2 and the toxin gene regulator, atxA.",
            "probability": 0.0
        },
        {
            "start_logit": -6.06640625,
            "end_logit": -0.666015625,
            "text": "toxin gene regulator, atxA.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_15": [
        {
            "start_logit": 6.37109375,
            "end_logit": 6.703125,
            "text": "CO2",
            "probability": 0.59521484375
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 6.015625,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in 17 mutants carrying CO2",
            "probability": 0.29931640625
        },
        {
            "start_logit": 5.32421875,
            "end_logit": 6.015625,
            "text": "CO2",
            "probability": 0.1051025390625
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -2.6796875,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in 17 mutants carrying CO2- and atxA",
            "probability": 4.971027374267578e-05
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -2.6796875,
            "text": "CO2- and atxA",
            "probability": 1.7464160919189453e-05
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -4.3203125,
            "text": "CO2-enhanced atxA",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -3.53125,
            "text": "CO2- and atxA-regulated fusions revealed 10 mutants carrying independent insertions on the 185-kb toxin",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -3.595703125,
            "text": "CO2- and atxA-regulated fusions revealed 10 mutants carrying independent insertions on the 185-kb toxin plasmid pXO1 which did not map to the toxin",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 6.703125,
            "text": "Transposon-insertion libraries were screened for mutants expressing CO2",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -5.3515625,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity.",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -5.78515625,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in 17 mutants carrying CO2- and atxA-regulated",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -5.96484375,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in 17",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 6.703125,
            "text": "insertion libraries were screened for mutants expressing CO2",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.578125,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.58984375,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -5.67578125,
            "text": "CO2- and atxA-regulated fusions revealed",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.81640625,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -5.78515625,
            "text": "CO2- and atxA-regulated",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 6.015625,
            "text": ". DNA sequence analysis of transposon insertion sites in 17 mutants carrying CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -5.828125,
            "text": "CO2- and atxA-regulated fusions revealed 10 mutants carrying independent insertions on the 185",
            "probability": 7.748603820800781e-07
        }
    ],
    "5710a592cf1c32585100002a_16": [
        {
            "start_logit": 6.37109375,
            "end_logit": 6.703125,
            "text": "CO2",
            "probability": 0.59521484375
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 6.015625,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in 17 mutants carrying CO2",
            "probability": 0.29931640625
        },
        {
            "start_logit": 5.32421875,
            "end_logit": 6.015625,
            "text": "CO2",
            "probability": 0.1051025390625
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -2.6796875,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in 17 mutants carrying CO2- and atxA",
            "probability": 4.971027374267578e-05
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -2.6796875,
            "text": "CO2- and atxA",
            "probability": 1.7464160919189453e-05
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -4.3203125,
            "text": "CO2-enhanced atxA",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -3.53125,
            "text": "CO2- and atxA-regulated fusions revealed 10 mutants carrying independent insertions on the 185-kb toxin",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -3.595703125,
            "text": "CO2- and atxA-regulated fusions revealed 10 mutants carrying independent insertions on the 185-kb toxin plasmid pXO1 which did not map to the toxin",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 6.703125,
            "text": "Transposon-insertion libraries were screened for mutants expressing CO2",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -5.3515625,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity.",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -5.78515625,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in 17 mutants carrying CO2- and atxA-regulated",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -5.96484375,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in 17",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 6.703125,
            "text": "insertion libraries were screened for mutants expressing CO2",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.578125,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.58984375,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of transposon insertion sites in",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -5.67578125,
            "text": "CO2- and atxA-regulated fusions revealed",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.81640625,
            "text": "CO2-enhanced atxA-dependent beta-galactosidase activity. DNA sequence analysis of",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -5.78515625,
            "text": "CO2- and atxA-regulated",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 6.015625,
            "text": ". DNA sequence analysis of transposon insertion sites in 17 mutants carrying CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -5.828125,
            "text": "CO2- and atxA-regulated fusions revealed 10 mutants carrying independent insertions on the 185",
            "probability": 7.748603820800781e-07
        }
    ],
    "5710a592cf1c32585100002a_17": [
        {
            "start_logit": 6.7421875,
            "end_logit": 6.0546875,
            "text": "CO2",
            "probability": 0.65478515625
        },
        {
            "start_logit": 6.7421875,
            "end_logit": 5.3203125,
            "text": "CO2-enhanced gene expression in B. anthracis",
            "probability": 0.314208984375
        },
        {
            "start_logit": 6.7421875,
            "end_logit": 2.986328125,
            "text": "CO2-enhanced gene expression in B. anthracis and provide evidence that atxA regulates genes other than the structural genes for the anthrax toxin proteins.",
            "probability": 0.0303955078125
        },
        {
            "start_logit": -0.418212890625,
            "end_logit": 5.3203125,
            "text": "B. anthracis",
            "probability": 0.000244140625
        },
        {
            "start_logit": 1.6884765625,
            "end_logit": 2.986328125,
            "text": "anthrax toxin proteins.",
            "probability": 0.0001938343048095703
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -2.279296875,
            "text": "CO2-enhanced gene expression in B. anthracis and",
            "probability": 0.0001569986343383789
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -2.646484375,
            "text": "CO2-enhanced gene expression in B. anthracis and provide evidence that atxA regulates genes other than the structural genes for the anthrax toxin",
            "probability": 0.0001087188720703125
        },
        {
            "start_logit": -0.418212890625,
            "end_logit": 2.986328125,
            "text": "B. anthracis and provide evidence that atxA regulates genes other than the structural genes for the anthrax toxin proteins.",
            "probability": 2.3663043975830078e-05
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -5.21484375,
            "text": "CO2-enhanced gene expression in B. anthracis and provide evidence that atxA regulates genes other than the structural genes for the anthrax toxin proteins",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -5.63671875,
            "text": "CO2-enhanced gene expression in B. anthrac",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -6.60546875,
            "text": "CO2-enhanced gene expression",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -5.2265625,
            "end_logit": 5.3203125,
            "text": "is",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -6.65625,
            "text": "CO2-enhanced gene expression in B. anthracis and provide evidence that atxA regulates genes other than",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -6.66796875,
            "text": "CO2-",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -6.6796875,
            "text": "CO2-enhanced gene expression in B. anthracis and provide evidence that atxA regulates genes other",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -6.6875,
            "text": "CO2-enhanced gene expression in B.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -6.6953125,
            "text": "CO2-enhanced gene expression in B. anthracis and provide evidence that atxA regulates genes other than the structural genes for the anthr",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.3046875,
            "end_logit": 5.3203125,
            "text": "anthracis",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -6.859375,
            "text": "CO2-enhanced gene expression in B. anthracis and provide evidence that atxA regulates genes other than the",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -6.86328125,
            "text": "CO2-enhanced",
            "probability": 1.6093254089355469e-06
        }
    ],
    "5710a592cf1c32585100002a_18": [
        {
            "start_logit": 6.671875,
            "end_logit": 6.7109375,
            "text": "acpA",
            "probability": 0.998046875
        },
        {
            "start_logit": 6.671875,
            "end_logit": 0.308837890625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0016546249389648438
        },
        {
            "start_logit": 6.671875,
            "end_logit": -2.380859375,
            "text": "acp",
            "probability": 0.00011211633682250977
        },
        {
            "start_logit": -2.69921875,
            "end_logit": 6.7109375,
            "text": "A",
            "probability": 8.463859558105469e-05
        },
        {
            "start_logit": -3.84765625,
            "end_logit": 6.7109375,
            "text": "xA and acpA",
            "probability": 2.7060508728027344e-05
        },
        {
            "start_logit": 6.671875,
            "end_logit": -4.6953125,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": -5.33203125,
            "end_logit": 6.7109375,
            "text": "both atxA and acpA",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -5.984375,
            "text": "acpA,",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 6.7109375,
            "text": "activated by both atxA and acpA",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 6.7109375,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 6.7109375,
            "text": "P1 and P2 was activated by both atxA and acpA",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -6.97265625,
            "text": "acpA, and activation",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 6.7109375,
            "text": "from P1 and P2 was activated by both atxA and acpA",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.0,
            "text": "acpA, and activation appeared to be",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.171875,
            "text": "acpA, and activation appeared",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 6.7109375,
            "text": "atxA and acpA",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.30859375,
            "text": "acpA, and activation appeared to",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.40234375,
            "text": "acpA, and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.7109375,
            "text": "and acpA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.69921875,
            "end_logit": 0.308837890625,
            "text": "A, and activation appeared to be stimulated by bicarbonate.",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_19": [
        {
            "start_logit": 6.26953125,
            "end_logit": 6.59375,
            "text": "CO2",
            "probability": 0.966796875
        },
        {
            "start_logit": 2.677734375,
            "end_logit": 6.59375,
            "text": "anthrax toxin activator gene atxA is associated with CO2",
            "probability": 0.02679443359375
        },
        {
            "start_logit": 6.26953125,
            "end_logit": 1.5625,
            "text": "CO2-enhanced non-toxin gene expression in Bacillus anthracis.",
            "probability": 0.00634002685546875
        },
        {
            "start_logit": 2.677734375,
            "end_logit": 1.5625,
            "text": "anthrax toxin activator gene atxA is associated with CO2-enhanced non-toxin gene expression in Bacillus anthracis.",
            "probability": 0.00017499923706054688
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -3.08984375,
            "text": "CO2-enhanced non-toxin gene expression in Bacillus anthracis",
            "probability": 6.0439109802246094e-05
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 6.59375,
            "text": "The anthrax toxin activator gene atxA is associated with CO2",
            "probability": 1.3470649719238281e-05
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -5.703125,
            "text": "CO2-enhanced non-toxin gene expression in Bacillus anthrac",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 6.59375,
            "text": "ax toxin activator gene atxA is associated with CO2",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 6.59375,
            "text": "toxin activator gene atxA is associated with CO2",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -6.3515625,
            "text": "CO2-enhanced non-toxin",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -6.65234375,
            "text": "CO2-enhanced non",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 2.677734375,
            "end_logit": -3.08984375,
            "text": "anthrax toxin activator gene atxA is associated with CO2-enhanced non-toxin gene expression in Bacillus anthracis",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -6.78125,
            "text": "CO2-",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.10546875,
            "text": "CO2-enhanced non-toxin gene expression in Bacillus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.21484375,
            "text": "CO2-enhanced non-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.23828125,
            "text": "CO2-enhanced",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.24609375,
            "text": "CO2-enhanced non-toxin gene",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.59375,
            "text": "gene atxA is associated with CO2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 2.677734375,
            "end_logit": -5.4296875,
            "text": "anthrax toxin activator",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.677734375,
            "end_logit": -5.6015625,
            "text": "anthrax toxin",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_20": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.77734375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.71484375,
            "text": "CO2 through an AtxA-dependent mechanism",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.77734375,
            "text": "to CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 6.77734375,
            "text": "Bacillus anthracis genes that respond to CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 6.77734375,
            "text": "anthracis genes that respond to CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.77734375,
            "text": "respond to CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.77734375,
            "text": "analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.77734375,
            "text": "is genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.77734375,
            "text": "Transcriptome analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.77734375,
            "text": "genes that respond to CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.77734375,
            "text": "identifies Bacillus anthracis genes that respond to CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.51171875,
            "text": "CO2 through an AtxA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.80859375,
            "text": "CO2 through an At",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.80859375,
            "text": "CO2 through an",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.93359375,
            "text": "CO2 through an AtxA-dependent",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -8.0234375,
            "text": "CO2 through an AtxA-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -8.03125,
            "text": "CO2 through",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -6.71484375,
            "text": "to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -6.71484375,
            "text": "Bacillus anthracis genes that respond to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -6.71484375,
            "text": "anthracis genes that respond to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_21": [
        {
            "start_logit": 6.671875,
            "end_logit": 6.7109375,
            "text": "acpA",
            "probability": 0.998046875
        },
        {
            "start_logit": 6.671875,
            "end_logit": 0.308837890625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0016546249389648438
        },
        {
            "start_logit": 6.671875,
            "end_logit": -2.380859375,
            "text": "acp",
            "probability": 0.00011211633682250977
        },
        {
            "start_logit": -2.69921875,
            "end_logit": 6.7109375,
            "text": "A",
            "probability": 8.463859558105469e-05
        },
        {
            "start_logit": -3.84765625,
            "end_logit": 6.7109375,
            "text": "xA and acpA",
            "probability": 2.7060508728027344e-05
        },
        {
            "start_logit": 6.671875,
            "end_logit": -4.6953125,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": -5.33203125,
            "end_logit": 6.7109375,
            "text": "both atxA and acpA",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -5.984375,
            "text": "acpA,",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 6.7109375,
            "text": "activated by both atxA and acpA",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 6.7109375,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 6.7109375,
            "text": "P1 and P2 was activated by both atxA and acpA",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -6.97265625,
            "text": "acpA, and activation",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 6.7109375,
            "text": "from P1 and P2 was activated by both atxA and acpA",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.0,
            "text": "acpA, and activation appeared to be",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.171875,
            "text": "acpA, and activation appeared",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 6.7109375,
            "text": "atxA and acpA",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.30859375,
            "text": "acpA, and activation appeared to",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.40234375,
            "text": "acpA, and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.7109375,
            "text": "and acpA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.69921875,
            "end_logit": 0.308837890625,
            "text": "A, and activation appeared to be stimulated by bicarbonate.",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_22": [
        {
            "start_logit": 6.39453125,
            "end_logit": 6.73828125,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -5.5078125,
            "text": "CO2 through an AtxA-dependent mechanism.",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 6.73828125,
            "text": "to CO2",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.421875,
            "end_logit": 6.73828125,
            "text": "Bacillus anthracis genes that respond to CO2",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 6.73828125,
            "text": "anthracis genes that respond to CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.18359375,
            "text": "CO2 through an AtxA",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.28515625,
            "text": "CO2 through an AtxA-dependent mechanism",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.73828125,
            "text": "Transcriptome analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.73828125,
            "text": "respond to CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.73828125,
            "text": "is genes that respond to CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.73828125,
            "text": "identifies Bacillus anthracis genes that respond to CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.52734375,
            "text": "CO2 through an At",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 6.73828125,
            "text": "analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.65625,
            "text": "CO2 through an",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.76953125,
            "text": "CO2 through an AtxA-dependent",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.8046875,
            "text": "CO2 through an AtxA-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.8125,
            "text": "CO2 through",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -5.5078125,
            "text": "to CO2 through an AtxA-dependent mechanism.",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -5.5078125,
            "text": "Bacillus anthracis genes that respond to CO2 through an AtxA-dependent mechanism.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -5.5078125,
            "text": "anthracis genes that respond to CO2 through an AtxA-dependent mechanism.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_23": [
        {
            "start_logit": 6.3125,
            "end_logit": 6.64453125,
            "text": "CO2",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.310546875,
            "end_logit": 6.64453125,
            "text": "B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 0.0004916191101074219
        },
        {
            "start_logit": 6.3125,
            "end_logit": -1.59765625,
            "text": "CO2.",
            "probability": 0.0002651214599609375
        },
        {
            "start_logit": -5.4375,
            "end_logit": 6.64453125,
            "text": "Expression of the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -5.53125,
            "end_logit": 6.64453125,
            "text": "by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 6.64453125,
            "text": "toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -6.75,
            "end_logit": 6.64453125,
            "text": "anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.59375,
            "end_logit": 6.64453125,
            "text": "the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.64453125,
            "text": "under elevated levels of CO2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.64453125,
            "text": "enhanced during growth under elevated levels of CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.64453125,
            "text": "of CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.64453125,
            "text": "of the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.64453125,
            "text": "genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.64453125,
            "text": ". anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -1.59765625,
            "text": "B. anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -2.361328125,
            "text": "B. anthracis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -4.71875,
            "text": "B. anthrac",
            "probability": 0.0
        },
        {
            "start_logit": -5.4375,
            "end_logit": -1.59765625,
            "text": "Expression of the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -5.53125,
            "end_logit": -1.59765625,
            "text": "by B. anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -5.8359375,
            "text": "B. anthracis is",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_24": [
        {
            "start_logit": 5.16015625,
            "end_logit": 5.96484375,
            "text": "CO2",
            "probability": 0.97802734375
        },
        {
            "start_logit": 5.16015625,
            "end_logit": 1.6953125,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin",
            "probability": 0.01367950439453125
        },
        {
            "start_logit": 5.16015625,
            "end_logit": 0.56005859375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin synthesis.",
            "probability": 0.004390716552734375
        },
        {
            "start_logit": 3.505859375,
            "end_logit": 1.6953125,
            "text": "anthrax toxin",
            "probability": 0.002620697021484375
        },
        {
            "start_logit": 3.505859375,
            "end_logit": 0.56005859375,
            "text": "anthrax toxin synthesis.",
            "probability": 0.0008411407470703125
        },
        {
            "start_logit": 1.59765625,
            "end_logit": 1.6953125,
            "text": "pXO1 gene, atxA, which encodes a transactivator of anthrax toxin",
            "probability": 0.0003879070281982422
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -2.919921875,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin synthesis",
            "probability": 0.00013566017150878906
        },
        {
            "start_logit": 1.59765625,
            "end_logit": 0.56005859375,
            "text": "pXO1 gene, atxA, which encodes a transactivator of anthrax toxin synthesis.",
            "probability": 0.0001245737075805664
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -3.64453125,
            "text": "CO2 effect is observed only in the presence of another pXO1",
            "probability": 6.562471389770508e-05
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -4.4765625,
            "text": "CO2 effect is observed only in the presence of another pX",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": 3.505859375,
            "end_logit": -2.919921875,
            "text": "anthrax toxin synthesis",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -4.95703125,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 5.96484375,
            "text": "This CO2",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -6.265625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthr",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -6.3671875,
            "text": "CO2 effect is observed only in the presence of",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 1.59765625,
            "end_logit": -2.919921875,
            "text": "pXO1 gene, atxA, which encodes a transactivator of anthrax toxin synthesis",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -6.50390625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -6.5625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -6.71875,
            "text": "CO2 effect is observed only in the presence of another",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 5.16015625,
            "end_logit": -6.9296875,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which",
            "probability": 2.4437904357910156e-06
        }
    ],
    "5710a592cf1c32585100002a_25": [
        {
            "start_logit": 6.2578125,
            "end_logit": 6.85546875,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -2.73046875,
            "end_logit": 6.85546875,
            "text": "5% CO2",
            "probability": 0.00012540817260742188
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -5.39453125,
            "text": "CO2 compared with cells grown in air.",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -6.984375,
            "end_logit": 6.85546875,
            "text": "Here we show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -6.99609375,
            "text": "CO2 compared with cells grown in air",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.85546875,
            "text": "xA does not appear to differ in cells grown in 5% CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.85546875,
            "text": "show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -7.1328125,
            "text": "CO2 compared with",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 6.85546875,
            "text": "we show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -7.1796875,
            "text": "CO2 compared",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -7.39453125,
            "text": "CO2 compared with cells",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -2.73046875,
            "end_logit": -5.39453125,
            "text": "5% CO2 compared with cells grown in air.",
            "probability": 0.0
        },
        {
            "start_logit": -2.73046875,
            "end_logit": -6.125,
            "text": "5%",
            "probability": 0.0
        },
        {
            "start_logit": -2.73046875,
            "end_logit": -6.99609375,
            "text": "5% CO2 compared with cells grown in air",
            "probability": 0.0
        },
        {
            "start_logit": -2.73046875,
            "end_logit": -7.1328125,
            "text": "5% CO2 compared with",
            "probability": 0.0
        },
        {
            "start_logit": -2.73046875,
            "end_logit": -7.1796875,
            "text": "5% CO2 compared",
            "probability": 0.0
        },
        {
            "start_logit": -2.73046875,
            "end_logit": -7.39453125,
            "text": "5% CO2 compared with cells",
            "probability": 0.0
        },
        {
            "start_logit": -2.73046875,
            "end_logit": -7.484375,
            "text": "5",
            "probability": 0.0
        },
        {
            "start_logit": -6.984375,
            "end_logit": -5.39453125,
            "text": "Here we show that transcription of atxA does not appear to differ in cells grown in 5% CO2 compared with cells grown in air.",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -5.39453125,
            "text": "xA does not appear to differ in cells grown in 5% CO2 compared with cells grown in air.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_26": [
        {
            "start_logit": 6.7734375,
            "end_logit": 6.93359375,
            "text": "acpA",
            "probability": 0.60498046875
        },
        {
            "start_logit": 6.27734375,
            "end_logit": 6.9765625,
            "text": "acpA",
            "probability": 0.384521484375
        },
        {
            "start_logit": 2.12890625,
            "end_logit": 6.9765625,
            "text": "revealed that activation by both atxA and acpA",
            "probability": 0.0061187744140625
        },
        {
            "start_logit": 0.57275390625,
            "end_logit": 6.9765625,
            "text": "xA and acpA",
            "probability": 0.0012874603271484375
        },
        {
            "start_logit": 6.7734375,
            "end_logit": 0.58349609375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed",
            "probability": 0.0010585784912109375
        },
        {
            "start_logit": 6.7734375,
            "end_logit": 0.0157470703125,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0006008148193359375
        },
        {
            "start_logit": 6.27734375,
            "end_logit": 0.01629638671875,
            "text": "acpA required a DNA segment of 70 bp extending upstream of the P1 site.",
            "probability": 0.00036597251892089844
        },
        {
            "start_logit": -0.86669921875,
            "end_logit": 6.9765625,
            "text": "both atxA and acpA",
            "probability": 0.0003044605255126953
        },
        {
            "start_logit": -0.9384765625,
            "end_logit": 6.93359375,
            "text": "xA and acpA",
            "probability": 0.0002720355987548828
        },
        {
            "start_logit": -1.27734375,
            "end_logit": 6.9765625,
            "text": ". Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA",
            "probability": 0.0002028942108154297
        },
        {
            "start_logit": -1.703125,
            "end_logit": 6.9765625,
            "text": "A",
            "probability": 0.00013196468353271484
        },
        {
            "start_logit": -1.84375,
            "end_logit": 6.93359375,
            "text": "A",
            "probability": 0.00011032819747924805
        },
        {
            "start_logit": 6.7734375,
            "end_logit": -2.009765625,
            "text": "acp",
            "probability": 7.94529914855957e-05
        },
        {
            "start_logit": -2.22265625,
            "end_logit": 6.9765625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA",
            "probability": 7.826089859008789e-05
        },
        {
            "start_logit": -2.34765625,
            "end_logit": 6.9765625,
            "text": "and acpA",
            "probability": 6.902217864990234e-05
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -2.408203125,
            "text": "acp",
            "probability": 3.236532211303711e-05
        },
        {
            "start_logit": -3.44140625,
            "end_logit": 6.9765625,
            "text": "that activation by both atxA and acpA",
            "probability": 2.3126602172851562e-05
        },
        {
            "start_logit": -3.51171875,
            "end_logit": 6.9765625,
            "text": "activation by both atxA and acpA",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": 6.7734375,
            "end_logit": -3.443359375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": 6.7734375,
            "end_logit": -3.748046875,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA",
            "probability": 1.3887882232666016e-05
        }
    ],
    "5710a592cf1c32585100002a_27": [
        {
            "start_logit": 5.83984375,
            "end_logit": 6.3046875,
            "text": "acpA",
            "probability": 0.998046875
        },
        {
            "start_logit": -1.001953125,
            "end_logit": 6.3046875,
            "text": "xA and acpA",
            "probability": 0.0010728836059570312
        },
        {
            "start_logit": 5.83984375,
            "end_logit": -1.765625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.00031447410583496094
        },
        {
            "start_logit": -2.76953125,
            "end_logit": 6.3046875,
            "text": "A",
            "probability": 0.00018203258514404297
        },
        {
            "start_logit": -3.189453125,
            "end_logit": 6.3046875,
            "text": "both atxA and acpA",
            "probability": 0.00012034177780151367
        },
        {
            "start_logit": 5.83984375,
            "end_logit": -3.388671875,
            "text": "acp",
            "probability": 6.192922592163086e-05
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 6.3046875,
            "text": "and acpA",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 5.83984375,
            "end_logit": -5.84375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -6.3125,
            "end_logit": 6.3046875,
            "text": ". Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 6.3046875,
            "text": "activated by both atxA and acpA",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -6.4375,
            "end_logit": 6.3046875,
            "text": "upstream of the translation-initiation codon of capB. Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 6.3046875,
            "text": "capB. Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 6.3046875,
            "text": "atxA and acpA",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 5.83984375,
            "end_logit": -6.71875,
            "text": "acpA,",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 5.83984375,
            "end_logit": -6.72265625,
            "text": "acpA, and activation",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -1.001953125,
            "end_logit": -1.765625,
            "text": "xA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.001953125,
            "end_logit": -1.990234375,
            "text": "xA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.001953125,
            "end_logit": -3.388671875,
            "text": "xA and acp",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.72265625,
            "end_logit": -1.765625,
            "text": "bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.76953125,
            "end_logit": -1.765625,
            "text": "A, and activation appeared to be stimulated by bicarbonate",
            "probability": 5.960464477539063e-08
        }
    ],
    "5710a592cf1c32585100002a_28": [
        {
            "start_logit": 6.671875,
            "end_logit": 6.7109375,
            "text": "acpA",
            "probability": 0.998046875
        },
        {
            "start_logit": 6.671875,
            "end_logit": 0.308837890625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0016546249389648438
        },
        {
            "start_logit": 6.671875,
            "end_logit": -2.380859375,
            "text": "acp",
            "probability": 0.00011211633682250977
        },
        {
            "start_logit": -2.69921875,
            "end_logit": 6.7109375,
            "text": "A",
            "probability": 8.463859558105469e-05
        },
        {
            "start_logit": -3.84765625,
            "end_logit": 6.7109375,
            "text": "xA and acpA",
            "probability": 2.7060508728027344e-05
        },
        {
            "start_logit": 6.671875,
            "end_logit": -4.6953125,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": -5.33203125,
            "end_logit": 6.7109375,
            "text": "both atxA and acpA",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -5.984375,
            "text": "acpA,",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 6.7109375,
            "text": "activated by both atxA and acpA",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 6.7109375,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 6.7109375,
            "text": "P1 and P2 was activated by both atxA and acpA",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -6.97265625,
            "text": "acpA, and activation",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 6.7109375,
            "text": "from P1 and P2 was activated by both atxA and acpA",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.0,
            "text": "acpA, and activation appeared to be",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.171875,
            "text": "acpA, and activation appeared",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 6.7109375,
            "text": "atxA and acpA",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.30859375,
            "text": "acpA, and activation appeared to",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.671875,
            "end_logit": -7.40234375,
            "text": "acpA, and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.7109375,
            "text": "and acpA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.69921875,
            "end_logit": 0.308837890625,
            "text": "A, and activation appeared to be stimulated by bicarbonate.",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_29": [
        {
            "start_logit": 6.31640625,
            "end_logit": -0.390869140625,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis",
            "probability": 0.5927734375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -1.041015625,
            "text": "anthrax toxin activator",
            "probability": 0.308837890625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -2.873046875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 0.049530029296875
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -4.01171875,
            "text": "anthrax toxin",
            "probability": 0.0158538818359375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -4.40234375,
            "text": "anthr",
            "probability": 0.0107269287109375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -4.734375,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature",
            "probability": 0.007694244384765625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -5.78515625,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.002689361572265625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -5.90234375,
            "text": "anthrax",
            "probability": 0.0023937225341796875
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -5.9921875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthrac",
            "probability": 0.0021877288818359375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.0,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.002170562744140625
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.63671875,
            "text": "anthrax toxin activator gene (atxA",
            "probability": 0.001148223876953125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.80078125,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate, affects AtxA",
            "probability": 0.0009746551513671875
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.90234375,
            "text": "anthrax toxin activator gene",
            "probability": 0.0008807182312011719
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.03515625,
            "text": "anthrax toxin activator gene (",
            "probability": 0.0007710456848144531
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.3046875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis:",
            "probability": 0.0005888938903808594
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.33984375,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate,",
            "probability": 0.000568389892578125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.54296875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate, affects AtxA synthesis",
            "probability": 0.0004639625549316406
        },
        {
            "start_logit": -3.544921875,
            "end_logit": -2.873046875,
            "text": "temperature, not CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -0.390869140625,
            "text": "Regulation of anthrax toxin activator gene (atxA) expression in Bacillus anthracis",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -6.828125,
            "end_logit": -0.390869140625,
            "text": "xA) expression in Bacillus anthracis",
            "probability": 1.1920928955078125e-06
        }
    ],
    "5710a592cf1c32585100002a_30": [
        {
            "start_logit": 6.26953125,
            "end_logit": 6.59375,
            "text": "CO2",
            "probability": 0.966796875
        },
        {
            "start_logit": 2.677734375,
            "end_logit": 6.59375,
            "text": "anthrax toxin activator gene atxA is associated with CO2",
            "probability": 0.02679443359375
        },
        {
            "start_logit": 6.26953125,
            "end_logit": 1.5625,
            "text": "CO2-enhanced non-toxin gene expression in Bacillus anthracis.",
            "probability": 0.00634002685546875
        },
        {
            "start_logit": 2.677734375,
            "end_logit": 1.5625,
            "text": "anthrax toxin activator gene atxA is associated with CO2-enhanced non-toxin gene expression in Bacillus anthracis.",
            "probability": 0.00017499923706054688
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -3.08984375,
            "text": "CO2-enhanced non-toxin gene expression in Bacillus anthracis",
            "probability": 6.0439109802246094e-05
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 6.59375,
            "text": "The anthrax toxin activator gene atxA is associated with CO2",
            "probability": 1.3470649719238281e-05
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -5.703125,
            "text": "CO2-enhanced non-toxin gene expression in Bacillus anthrac",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 6.59375,
            "text": "ax toxin activator gene atxA is associated with CO2",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 6.59375,
            "text": "toxin activator gene atxA is associated with CO2",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -6.3515625,
            "text": "CO2-enhanced non-toxin",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -6.65234375,
            "text": "CO2-enhanced non",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 2.677734375,
            "end_logit": -3.08984375,
            "text": "anthrax toxin activator gene atxA is associated with CO2-enhanced non-toxin gene expression in Bacillus anthracis",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -6.78125,
            "text": "CO2-",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.10546875,
            "text": "CO2-enhanced non-toxin gene expression in Bacillus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.21484375,
            "text": "CO2-enhanced non-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.23828125,
            "text": "CO2-enhanced",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.24609375,
            "text": "CO2-enhanced non-toxin gene",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.59375,
            "text": "gene atxA is associated with CO2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 2.677734375,
            "end_logit": -5.4296875,
            "text": "anthrax toxin activator",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.677734375,
            "end_logit": -5.6015625,
            "text": "anthrax toxin",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a87ea1861bb38fb2400000d_1": [
        {
            "start_logit": 8.0,
            "end_logit": 7.3828125,
            "text": "circularized oligodeoxynucleotides",
            "probability": 1.0
        },
        {
            "start_logit": 8.0,
            "end_logit": -1.5654296875,
            "text": "circular",
            "probability": 0.00012934207916259766
        },
        {
            "start_logit": -3.150390625,
            "end_logit": 7.3828125,
            "text": "otides",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": 8.0,
            "end_logit": -5.66796875,
            "text": "circularized oligodeoxynucleotides (coligos)",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -5.50390625,
            "end_logit": 7.3828125,
            "text": "oligodeoxynucleotides",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.90625,
            "end_logit": 7.3828125,
            "text": "ynucleotides",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.94140625,
            "end_logit": 7.3828125,
            "text": "ized oligodeoxynucleotides",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -6.7578125,
            "text": "circularized oligodeoxynucle",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.06640625,
            "text": "circularized oligodeoxynucleotides (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.140625,
            "text": "circularized oligodeox",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.3515625,
            "text": "circularized",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.9453125,
            "text": "circularized oligodeoxynucleotides (coligo",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.9609375,
            "text": "circularized oligodeoxynucleotides (coligos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.150390625,
            "end_logit": -5.66796875,
            "text": "otides (coligos)",
            "probability": 0.0
        },
        {
            "start_logit": -3.150390625,
            "end_logit": -7.06640625,
            "text": "otides (",
            "probability": 0.0
        },
        {
            "start_logit": -3.150390625,
            "end_logit": -7.9453125,
            "text": "otides (coligo",
            "probability": 0.0
        },
        {
            "start_logit": -3.150390625,
            "end_logit": -7.9609375,
            "text": "otides (coligos",
            "probability": 0.0
        },
        {
            "start_logit": -5.50390625,
            "end_logit": -5.66796875,
            "text": "oligodeoxynucleotides (coligos)",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -5.66796875,
            "text": "ynucleotides (coligos)",
            "probability": 0.0
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -5.66796875,
            "text": "ized oligodeoxynucleotides (coligos)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_1": [
        {
            "start_logit": 7.74609375,
            "end_logit": 7.765625,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -2.23046875,
            "end_logit": 7.765625,
            "text": "cardiomyopathy",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -2.416015625,
            "text": "hypertrophic",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -6.5625,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -6.70703125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -6.7109375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -6.7421875,
            "text": "hypertrophic cardiomyopathy (30 %",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -6.8984375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %).",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.0078125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.03125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.03125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.34765625,
            "text": "hypertrophic cardiomyopathy (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.37890625,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.44921875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.55859375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.56640625,
            "text": "hypertrophic cardiomyopathy (30 %)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.57421875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.765625,
            "text": "The most common cause of death was hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.765625,
            "text": "most common cause of death was hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.23046875,
            "end_logit": -6.5625,
            "text": "cardiomyopathy (30 %), followed by coronary artery anomalies",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_2": [
        {
            "start_logit": 7.7734375,
            "end_logit": 7.7421875,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -2.216796875,
            "text": "hypertrophic",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": -2.28515625,
            "end_logit": 7.7421875,
            "text": "cardiomyopathy",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.77734375,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and is manageable.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.94140625,
            "text": "hypertrophic cardiomyopathy (HCM",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.95703125,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.2734375,
            "text": "hypertrophic cardiomyopathy (HCM)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.33984375,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.375,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.46484375,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.6015625,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.72265625,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.72265625,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -7.78125,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.7421875,
            "text": "The most common cause of this, hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.28515625,
            "end_logit": -6.77734375,
            "text": "cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and is manageable.",
            "probability": 0.0
        },
        {
            "start_logit": -2.28515625,
            "end_logit": -6.94140625,
            "text": "cardiomyopathy (HCM",
            "probability": 0.0
        },
        {
            "start_logit": -2.28515625,
            "end_logit": -6.95703125,
            "text": "cardiomyopathy (HCM), is a genetic disorder responsible for more than a third",
            "probability": 0.0
        },
        {
            "start_logit": -2.28515625,
            "end_logit": -7.2734375,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -2.28515625,
            "end_logit": -7.33984375,
            "text": "cardiomyopathy (HCM), is a genetic disorder responsible for",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_3": [
        {
            "start_logit": 7.73046875,
            "end_logit": 7.5859375,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -2.431640625,
            "text": "Hypertrophic",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": -2.71484375,
            "end_logit": 7.5859375,
            "text": "cardiomyopathy",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -5.7890625,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.5,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.5546875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.61328125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.6875,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.69140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.69140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people, including",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.73046875,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.73046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people, including trained",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.765625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.77734375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.78515625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.8046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.87109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.90625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.93359375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.71484375,
            "end_logit": -5.7890625,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_4": [
        {
            "start_logit": 7.72265625,
            "end_logit": 7.44140625,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -2.48046875,
            "text": "Hypertrophic",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": -2.98828125,
            "end_logit": 7.44140625,
            "text": "cardiomyopathy",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -5.8046875,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.390625,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.4375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.48046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.5234375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.5703125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.57421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.62109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.62109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.63671875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.67578125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including trained",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.73046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including trained athletes).",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.73828125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.75390625,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.76953125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.77734375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.98828125,
            "end_logit": -5.8046875,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_5": [
        {
            "start_logit": 7.73046875,
            "end_logit": 7.4765625,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -2.4375,
            "text": "Hypertrophic",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -2.927734375,
            "end_logit": 7.4765625,
            "text": "cardiomyopathy",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -5.140625,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.5390625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.55859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.6328125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.7265625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including trained",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.73046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.76171875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.78515625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.7890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.8046875,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.86328125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.90234375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.91015625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including trained athletes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.9296875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.94140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.927734375,
            "end_logit": -5.140625,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -2.927734375,
            "end_logit": -7.5390625,
            "text": "cardiomyopathy (HCM) is the",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_6": [
        {
            "start_logit": 7.765625,
            "end_logit": 7.75,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 7.765625,
            "end_logit": -2.21484375,
            "text": "Hypertrophic",
            "probability": 4.684925079345703e-05
        },
        {
            "start_logit": -2.251953125,
            "end_logit": 7.75,
            "text": "cardiomyopathy",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.5390625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.5546875,
            "text": "Hypertrophic cardiomyopathy is regarded as the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.6171875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.6328125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.6484375,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.6484375,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.70703125,
            "text": "Hypertrophic cardiomyopathy is regarded as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.7109375,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.74609375,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.84375,
            "text": "Hypertrophic cardiomyopathy is regarded",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.8515625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.85546875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.87890625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.8828125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.91015625,
            "text": "Hypertrophic cardiomyopathy is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -7.9140625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.251953125,
            "end_logit": -7.5390625,
            "text": "cardiomyopathy is regarded as the most common",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_7": [
        {
            "start_logit": 7.7734375,
            "end_logit": 7.7734375,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -2.1796875,
            "end_logit": 7.7734375,
            "text": "cardiomyopathy",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -2.201171875,
            "text": "hypertrophic",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": -7.984375,
            "end_logit": 7.7734375,
            "text": "The most common cause of sudden cardiac death in athletes is hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.7734375,
            "text": "most common cause of sudden cardiac death in athletes is hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -8.0625,
            "text": "hypertrophic cardiomyopathy.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.7734375,
            "text": "sudden cardiac death in athletes is hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": -2.201171875,
            "text": "The most common cause of sudden cardiac death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -2.201171875,
            "text": "most common cause of sudden cardiac death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -2.1796875,
            "end_logit": -8.0625,
            "text": "cardiomyopathy.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -2.201171875,
            "text": "sudden cardiac death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.20703125,
            "end_logit": -8.0625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.8515625,
            "text": "The most common",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.8515625,
            "text": "most common",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.95703125,
            "text": "The most common cause of",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.95703125,
            "text": "most common cause of",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -8.0078125,
            "text": "The most common cause of sudden cardiac death in athletes is",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -8.0078125,
            "text": "most common cause of sudden cardiac death in athletes is",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -8.046875,
            "text": "The most common cause of sudden cardiac death in",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -8.0625,
            "text": "The most common cause of sudden cardiac death in athletes is hypertrophic cardiomyopathy.",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_8": [
        {
            "start_logit": 7.6640625,
            "end_logit": 6.82421875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -2.70703125,
            "text": "Hypertrophic",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -3.490234375,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -3.873046875,
            "end_logit": 6.82421875,
            "text": "cardiomyopathy",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.9375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.12109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause of sudden cardiac death in young athletes.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.32421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.37109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.4140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.44140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.578125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.5859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.64453125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.66796875,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.72265625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.75,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.7734375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.77734375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.85546875,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -3.873046875,
            "end_logit": -3.490234375,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_9": [
        {
            "start_logit": 7.14453125,
            "end_logit": 7.26171875,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -3.388671875,
            "end_logit": 7.26171875,
            "text": "cardiomyopathy",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -3.919921875,
            "text": "hypertrophic",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -5.94921875,
            "text": "hypertrophic cardiomyopathy (HCM)",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -7.3046875,
            "text": "hypertrophic cardiomyopathy (HCM",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -7.48828125,
            "text": "hypertrophic cardiomyopathy (HCM).",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.26171875,
            "text": "The most common cause of sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.26171875,
            "text": "disorder hypertrophic cardiomyopathy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.388671875,
            "end_logit": -5.94921875,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -3.388671875,
            "end_logit": -7.3046875,
            "text": "cardiomyopathy (HCM",
            "probability": 0.0
        },
        {
            "start_logit": -3.388671875,
            "end_logit": -7.48828125,
            "text": "cardiomyopathy (HCM).",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -3.919921875,
            "text": "The most common cause of sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -3.919921875,
            "text": "disorder hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -5.94921875,
            "text": "HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -5.94921875,
            "text": "(HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -5.94921875,
            "text": "The most common cause of sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -5.94921875,
            "text": "disorder hypertrophic cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -7.3046875,
            "text": "HCM",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -7.48828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -7.3046875,
            "text": "(HCM",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_10": [
        {
            "start_logit": 7.73046875,
            "end_logit": 7.57421875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -2.447265625,
            "text": "Hypertrophic",
            "probability": 4.4345855712890625e-05
        },
        {
            "start_logit": -2.73828125,
            "end_logit": 7.57421875,
            "text": "cardiomyopathy",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -6.43359375,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.5625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.60546875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.609375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.7421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.796875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.82421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.828125,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.8671875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.90234375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.9140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly in young competitive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.91796875,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.91796875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.92578125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.9296875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly in young competitive athletes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.73828125,
            "end_logit": -6.43359375,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -2.73828125,
            "end_logit": -7.5625,
            "text": "cardiomyopathy (HCM) is the",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_11": [
        {
            "start_logit": 7.76953125,
            "end_logit": 7.73046875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -2.220703125,
            "text": "Hypertrophic",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": -2.296875,
            "end_logit": 7.73046875,
            "text": "cardiomyopathy",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.6328125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.67578125,
            "text": "Hypertrophic cardiomyopathy (HC)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.70703125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.75,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.77734375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.7890625,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.80078125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.83203125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.8671875,
            "text": "Hypertrophic cardiomyopathy (HC) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.87109375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.88671875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.88671875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.90625,
            "text": "Hypertrophic cardiomyopathy (HC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.91796875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a contraindication",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.296875,
            "end_logit": -7.6328125,
            "text": "cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this",
            "probability": 0.0
        },
        {
            "start_logit": -2.296875,
            "end_logit": -7.67578125,
            "text": "cardiomyopathy (HC)",
            "probability": 0.0
        },
        {
            "start_logit": -2.296875,
            "end_logit": -7.70703125,
            "text": "cardiomyopathy (HC) is probably the most common",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_1": [
        {
            "start_logit": 7.859375,
            "end_logit": 7.84765625,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.859375,
            "end_logit": -1.52734375,
            "text": "multiple",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -1.6943359375,
            "end_logit": 7.84765625,
            "text": "sclerosis",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.61328125,
            "text": "multiple sclerosis with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.79296875,
            "text": "multiple sclerosis with a simplified three",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.8515625,
            "text": "multiple sclerosis with a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.88671875,
            "text": "multiple sclerosis with a simplified three-lesion",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.9140625,
            "text": "multiple sclerosis with a simplified",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.9765625,
            "text": "multiple sclerosis with a simplified three-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -8.0078125,
            "text": "multiple sclerosis with a simplified three-lesion algorithm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.84765625,
            "text": "central vein sign for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.84765625,
            "text": "vein sign for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.84765625,
            "text": "sign for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6943359375,
            "end_logit": -7.61328125,
            "text": "sclerosis with",
            "probability": 0.0
        },
        {
            "start_logit": -1.6943359375,
            "end_logit": -7.79296875,
            "text": "sclerosis with a simplified three",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -1.52734375,
            "text": "central vein sign for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -1.6943359375,
            "end_logit": -7.8515625,
            "text": "sclerosis with a",
            "probability": 0.0
        },
        {
            "start_logit": -1.6943359375,
            "end_logit": -7.88671875,
            "text": "sclerosis with a simplified three-lesion",
            "probability": 0.0
        },
        {
            "start_logit": -1.6943359375,
            "end_logit": -7.9140625,
            "text": "sclerosis with a simplified",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -1.52734375,
            "text": "vein sign for multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_2": [
        {
            "start_logit": 7.84765625,
            "end_logit": 7.828125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -1.7763671875,
            "text": "multiple",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": 7.828125,
            "text": "sclerosis",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -6.25,
            "text": "multiple sclerosis (MS",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.55859375,
            "text": "multiple sclerosis (MS)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.9140625,
            "text": "multiple sclerosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.828125,
            "text": "magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.828125,
            "text": "central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.828125,
            "text": "vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 7.828125,
            "text": "CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 7.828125,
            "text": "imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 7.828125,
            "text": "sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 7.828125,
            "text": "for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": -6.25,
            "text": "sclerosis (MS",
            "probability": 0.0
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": -7.55859375,
            "text": "sclerosis (MS)",
            "probability": 0.0
        },
        {
            "start_logit": -1.8701171875,
            "end_logit": -7.9140625,
            "text": "sclerosis (",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -1.7763671875,
            "text": "magnetic resonance imaging (MRI) is highly specific and sensitive for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -1.7763671875,
            "text": "central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -1.7763671875,
            "text": "vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -1.7763671875,
            "text": "BACKGROUND: Detection of a \"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_3": [
        {
            "start_logit": 7.83984375,
            "end_logit": 7.8359375,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -1.7802734375,
            "text": "Multiple",
            "probability": 6.711483001708984e-05
        },
        {
            "start_logit": -1.83984375,
            "end_logit": 7.8359375,
            "text": "Sclerosis",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -6.23828125,
            "text": "Multiple Sclerosis from central nervous system inflammatory vasculopathies.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -6.44140625,
            "text": "Multiple Sclerosis from central nervous system inflammatory vascul",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -6.60546875,
            "text": "Multiple Sclerosis from central nervous system inflammatory vasculopathies",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -6.8984375,
            "text": "Multiple Sclerosis from central nervous system inflammatory",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.04296875,
            "text": "Multiple Sclerosis from central nervous system",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 7.8359375,
            "text": "differentiates Multiple Sclerosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.1796875,
            "text": "Multiple Sclerosis from central nervous",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.8359375,
            "text": "Central vein sign differentiates Multiple Sclerosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.8359375,
            "text": "vein sign differentiates Multiple Sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.6875,
            "text": "Multiple Sclerosis from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 7.8359375,
            "text": "sign differentiates Multiple Sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 7.8359375,
            "text": "s Multiple Sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.83203125,
            "text": "Multiple Sclerosis from central",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.83984375,
            "end_logit": -6.23828125,
            "text": "Sclerosis from central nervous system inflammatory vasculopathies.",
            "probability": 0.0
        },
        {
            "start_logit": -1.83984375,
            "end_logit": -6.44140625,
            "text": "Sclerosis from central nervous system inflammatory vascul",
            "probability": 0.0
        },
        {
            "start_logit": -1.83984375,
            "end_logit": -6.60546875,
            "text": "Sclerosis from central nervous system inflammatory vasculopathies",
            "probability": 0.0
        },
        {
            "start_logit": -1.83984375,
            "end_logit": -6.8984375,
            "text": "Sclerosis from central nervous system inflammatory",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_4": [
        {
            "start_logit": 7.80078125,
            "end_logit": 7.80078125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.044921875,
            "end_logit": 7.80078125,
            "text": "sclerosis",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -2.083984375,
            "text": "multiple",
            "probability": 5.1021575927734375e-05
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -2.302734375,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -6.5234375,
            "text": "multiple sclerosis (MS) and neuromyelitis optica",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 7.80078125,
            "text": "between multiple sclerosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.2265625,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.26171875,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.80078125,
            "text": "distinguish between multiple sclerosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.6328125,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NM",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.66796875,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.76953125,
            "text": "multiple sclerosis (MS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.828125,
            "text": "multiple sclerosis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 7.80078125,
            "text": "to distinguish between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.80078125,
            "text": "central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.703125,
            "end_logit": -2.302734375,
            "text": "neuromyelitis optica spectrum disorder",
            "probability": 0.0
        },
        {
            "start_logit": -2.044921875,
            "end_logit": -2.302734375,
            "text": "sclerosis (MS) and neuromyelitis optica spectrum disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.703125,
            "end_logit": -6.5234375,
            "text": "neuromyelitis optica",
            "probability": 0.0
        },
        {
            "start_logit": -2.044921875,
            "end_logit": -6.5234375,
            "text": "sclerosis (MS) and neuromyelitis optica",
            "probability": 0.0
        },
        {
            "start_logit": -6.296875,
            "end_logit": -2.302734375,
            "text": "optica spectrum disorder",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_5": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.84375,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.63671875,
            "text": "Multiple",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": -1.75,
            "end_logit": 7.84375,
            "text": "Sclerosis",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.84375,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 7.84375,
            "text": "Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.234375,
            "end_logit": 7.84375,
            "text": "Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": -1.63671875,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -1.63671875,
            "text": "Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -1.63671875,
            "text": "Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.7578125,
            "text": "Central Vein Sign as",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.7578125,
            "text": "Vein Sign as",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -7.7578125,
            "text": "Sign as",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.8671875,
            "text": "Central Vein Sign as a",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.91796875,
            "text": "Central Vein Sign as a Diagnostic",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.8671875,
            "text": "Vein Sign as a",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.93359375,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -7.8671875,
            "text": "Sign as a",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.91796875,
            "text": "Vein Sign as a Diagnostic",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.93359375,
            "text": "Vein Sign as a Diagnostic Imaging Biomarker",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.99609375,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker in",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_6": [
        {
            "start_logit": 7.8359375,
            "end_logit": 7.8203125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -1.7666015625,
            "text": "multiple",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": -1.9033203125,
            "end_logit": 7.8203125,
            "text": "sclerosis",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -6.5546875,
            "text": "multiple sclerosis (MS) and not MS",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -6.9375,
            "text": "multiple sclerosis (MS",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.02734375,
            "text": "multiple sclerosis (MS)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.45703125,
            "text": "multiple sclerosis (MS) and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.48046875,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI) studies.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.5078125,
            "text": "multiple sclerosis (MS) and not MS, mainly",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.671875,
            "text": "multiple sclerosis (MS) and not",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.6953125,
            "text": "multiple sclerosis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.765625,
            "text": "multiple sclerosis (MS) and not MS,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.8203125,
            "text": "between multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.8046875,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.8125,
            "text": "multiple sclerosis (MS) and not MS, mainly based on",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.8203125,
            "text": "distinguishing between multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.8203125,
            "text": "Importance  The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.8203125,
            "text": "central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.8203125,
            "text": "vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 7.8203125,
            "text": "imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e4601293f54159529000002_7": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.84765625,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.5634765625,
            "text": "multiple",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": -1.69140625,
            "end_logit": 7.84765625,
            "text": "sclerosis",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.84765625,
            "text": "PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 7.84765625,
            "text": "AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 7.84765625,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.84765625,
            "text": "vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.84765625,
            "text": "BACKGROUND AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.84765625,
            "text": "MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.84765625,
            "text": "sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -1.5634765625,
            "text": "PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -1.5634765625,
            "text": "AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -1.5634765625,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -1.5634765625,
            "text": "vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -1.5634765625,
            "text": "BACKGROUND AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -1.5634765625,
            "text": "MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -1.5634765625,
            "text": "sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.88671875,
            "text": "PURPOSE  The central vein sign is a promising",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.890625,
            "text": "PURPOSE  The",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.89453125,
            "text": "PURPOSE  The central vein sign is a promising MR imaging diagnostic",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_8": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.84765625,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.5634765625,
            "text": "multiple",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": -1.69140625,
            "end_logit": 7.84765625,
            "text": "sclerosis",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.84765625,
            "text": "PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 7.84765625,
            "text": "AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 7.84765625,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.84765625,
            "text": "vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.84765625,
            "text": "BACKGROUND AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.84765625,
            "text": "MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.84765625,
            "text": "sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -1.5634765625,
            "text": "PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -1.5634765625,
            "text": "AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -1.5634765625,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -1.5634765625,
            "text": "vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -1.5634765625,
            "text": "BACKGROUND AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -1.5634765625,
            "text": "MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -1.5634765625,
            "text": "sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.88671875,
            "text": "PURPOSE The central vein sign is a promising",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.890625,
            "text": "PURPOSE The",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.89453125,
            "text": "PURPOSE The central vein sign is a promising MR imaging diagnostic",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_9": [
        {
            "start_logit": 7.87109375,
            "end_logit": 7.84765625,
            "text": "multiple sclerosis",
            "probability": 0.5
        },
        {
            "start_logit": 7.8671875,
            "end_logit": 7.85546875,
            "text": "Multiple Sclerosis",
            "probability": 0.5
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.4482421875,
            "text": "Multiple",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -1.45703125,
            "text": "multiple",
            "probability": 4.553794860839844e-05
        },
        {
            "start_logit": -1.7001953125,
            "end_logit": 7.85546875,
            "text": "Sclerosis",
            "probability": 3.516674041748047e-05
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": 7.84765625,
            "text": "sclerosis",
            "probability": 3.409385681152344e-05
        },
        {
            "start_logit": -6.703125,
            "end_logit": 7.84765625,
            "text": "distinguish multiple sclerosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.78125,
            "text": "multiple sclerosis (MS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.84765625,
            "text": "white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.0859375,
            "text": "Multiple Sclerosis Lesions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.40234375,
            "text": "multiple sclerosis (MS) from its",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.43359375,
            "text": "multiple sclerosis (MS) from its mimics",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.4765625,
            "text": "multiple sclerosis (MS) from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.84765625,
            "text": "magnetic resonance imaging (MRI) studies have used white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.84765625,
            "text": "WML) central veins to distinguish multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.640625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.6484375,
            "text": "multiple sclerosis (MS)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.65625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.71484375,
            "text": "Multiple Sclerosis Lesions Is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.75390625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2*",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e4601293f54159529000002_10": [
        {
            "start_logit": 7.87109375,
            "end_logit": 7.84765625,
            "text": "multiple sclerosis",
            "probability": 0.5
        },
        {
            "start_logit": 7.8671875,
            "end_logit": 7.85546875,
            "text": "Multiple Sclerosis",
            "probability": 0.5
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.4482421875,
            "text": "Multiple",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -1.45703125,
            "text": "multiple",
            "probability": 4.553794860839844e-05
        },
        {
            "start_logit": -1.7001953125,
            "end_logit": 7.85546875,
            "text": "Sclerosis",
            "probability": 3.516674041748047e-05
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": 7.84765625,
            "text": "sclerosis",
            "probability": 3.409385681152344e-05
        },
        {
            "start_logit": -6.703125,
            "end_logit": 7.84765625,
            "text": "distinguish multiple sclerosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.78125,
            "text": "multiple sclerosis (MS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.84765625,
            "text": "white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.0859375,
            "text": "Multiple Sclerosis Lesions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.40234375,
            "text": "multiple sclerosis (MS) from its",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.43359375,
            "text": "multiple sclerosis (MS) from its mimics",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.4765625,
            "text": "multiple sclerosis (MS) from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.84765625,
            "text": "magnetic resonance imaging (MRI) studies have used white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.84765625,
            "text": "WML) central veins to distinguish multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.640625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.6484375,
            "text": "multiple sclerosis (MS)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.65625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.71484375,
            "text": "Multiple Sclerosis Lesions Is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.75390625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2*",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a9d8d691d1251d03b000020_1": [
        {
            "start_logit": -4.1015625,
            "end_logit": 2.306640625,
            "text": ".",
            "probability": 0.3076171875
        },
        {
            "start_logit": -4.7421875,
            "end_logit": 2.306640625,
            "text": "AD.",
            "probability": 0.1619873046875
        },
        {
            "start_logit": -4.76953125,
            "end_logit": 2.306640625,
            "text": "SEC22B, RAB10, and FLT1 may be potential biomarkers of AD.",
            "probability": 0.15771484375
        },
        {
            "start_logit": -5.52734375,
            "end_logit": 2.306640625,
            "text": "22B, RAB10, and FLT1 may be potential biomarkers of AD.",
            "probability": 0.07391357421875
        },
        {
            "start_logit": -5.83984375,
            "end_logit": 2.306640625,
            "text": "FLT1 may be potential biomarkers of AD.",
            "probability": 0.054046630859375
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 2.306640625,
            "text": "of AD.",
            "probability": 0.036590576171875
        },
        {
            "start_logit": -6.265625,
            "end_logit": 2.306640625,
            "text": "genes SEC22B, RAB10, and FLT1 may be potential biomarkers of AD.",
            "probability": 0.035308837890625
        },
        {
            "start_logit": -6.359375,
            "end_logit": 2.306640625,
            "text": "1 may be potential biomarkers of AD.",
            "probability": 0.0321044921875
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 2.306640625,
            "text": "The target genes SEC22B, RAB10, and FLT1 may be potential biomarkers of AD.",
            "probability": 0.0240478515625
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 2.306640625,
            "text": "potential biomarkers of AD.",
            "probability": 0.0191650390625
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 2.306640625,
            "text": "be potential biomarkers of AD.",
            "probability": 0.0184326171875
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 2.306640625,
            "text": "may be potential biomarkers of AD.",
            "probability": 0.0178680419921875
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 2.306640625,
            "text": "biomarkers of AD.",
            "probability": 0.0174560546875
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 2.306640625,
            "text": "B, RAB10, and FLT1 may be potential biomarkers of AD.",
            "probability": 0.01480865478515625
        },
        {
            "start_logit": -7.140625,
            "end_logit": 2.306640625,
            "text": "RAB10, and FLT1 may be potential biomarkers of AD.",
            "probability": 0.0146942138671875
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 2.306640625,
            "text": "and FLT1 may be potential biomarkers of AD.",
            "probability": 0.014129638671875
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -6.78515625,
            "text": "AD",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": -4.76953125,
            "end_logit": -6.78515625,
            "text": "SEC22B, RAB10, and FLT1 may be potential biomarkers of AD",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -4.76953125,
            "end_logit": -7.3828125,
            "text": "SEC22B",
            "probability": 9.775161743164062e-06
        },
        {
            "start_logit": -4.76953125,
            "end_logit": -7.50390625,
            "text": "SEC22B, RAB10,",
            "probability": 8.64267349243164e-06
        }
    ],
    "5c8fe7cb0101eac87000000c_1": [
        {
            "start_logit": 6.97265625,
            "end_logit": 2.548828125,
            "text": "Runt related factor",
            "probability": 0.8818359375
        },
        {
            "start_logit": 6.97265625,
            "end_logit": 0.4892578125,
            "text": "Runt related factor-2",
            "probability": 0.112060546875
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -2.9296875,
            "text": "Runt related factor-2 (Runx2)",
            "probability": 0.003673553466796875
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -3.68359375,
            "text": "Run",
            "probability": 0.0017290115356445312
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -6.2421875,
            "text": "Runt related",
            "probability": 0.00013327598571777344
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -6.5859375,
            "text": "Runt related factor-",
            "probability": 9.459257125854492e-05
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -6.8984375,
            "text": "Runt",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -7.55078125,
            "text": "Runt related factor-2 (Runx2",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": 6.97265625,
            "end_logit": -7.6484375,
            "text": "Runt related factor-2 (",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -6.8125,
            "end_logit": 2.548828125,
            "text": "factor",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 2.548828125,
            "text": "related factor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 2.548828125,
            "text": "t related factor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.8125,
            "end_logit": 0.4892578125,
            "text": "factor-2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 0.4892578125,
            "text": "related factor-2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 0.4892578125,
            "text": "t related factor-2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 0.4892578125,
            "text": "2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.8125,
            "end_logit": -2.9296875,
            "text": "factor-2 (Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -2.9296875,
            "text": "related factor-2 (Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -7.203125,
            "end_logit": -2.9296875,
            "text": "t related factor-2 (Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -2.9296875,
            "text": ")",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_1": [
        {
            "start_logit": 7.96875,
            "end_logit": 7.84375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.96875,
            "end_logit": -1.7294921875,
            "text": "calcitonin",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -2.095703125,
            "end_logit": 7.84375,
            "text": "receptor",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -3.248046875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -6.4453125,
            "text": "calcitonin gene-related peptide receptor occupancy",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 7.84375,
            "text": "gene-related peptide receptor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -6.6328125,
            "text": "calcitonin gene-related",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 7.84375,
            "text": "related peptide receptor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.734375,
            "end_logit": 7.84375,
            "text": "-related peptide receptor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.04296875,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 7.84375,
            "text": "peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.41015625,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.43359375,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.62890625,
            "text": "calcitonin gene-related peptide receptor occupancy by",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.69140625,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.73046875,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.75390625,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.77734375,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.79296875,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.80078125,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]",
            "probability": 1.7881393432617188e-07
        }
    ],
    "55032efde9bde69634000035_2": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.79296875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.947265625,
            "text": "calcitonin",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": -2.208984375,
            "end_logit": 7.79296875,
            "text": "peptide",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": -6.359375,
            "end_logit": 7.79296875,
            "text": "novel calcitonin gene-related peptide",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.6953125,
            "text": "calcitonin gene-related",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 7.79296875,
            "text": "related peptide",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 7.79296875,
            "text": "gene-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.05859375,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 7.79296875,
            "text": "-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.2734375,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.47265625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.57421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com/research",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.734375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.74609375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com/research/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.91015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.921875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.9453125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.97265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -8.015625,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_3": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.81640625,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.880859375,
            "text": "calcitonin",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": -2.16015625,
            "end_logit": 7.81640625,
            "text": "peptide",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.53125,
            "text": "calcitonin gene-related",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 7.81640625,
            "text": "related peptide",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 7.81640625,
            "text": "gene-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.015625,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 7.81640625,
            "text": "-related peptide",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.2734375,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.28515625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.3203125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.48046875,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.5390625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.578125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.859375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.94140625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine treatment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.94921875,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -7.28515625,
            "text": "peptide (CGRP) receptor antagonist being evaluated for acute migraine",
            "probability": 0.0
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -7.3203125,
            "text": "peptide (CGRP",
            "probability": 0.0
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -7.48046875,
            "text": "peptide (CGRP) receptor",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_4": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.8828125,
            "text": "Calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.8291015625,
            "text": "Calcitonin",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": -1.95703125,
            "end_logit": 7.8828125,
            "text": "receptor",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -2.97265625,
            "text": "Calcitonin gene-related peptide",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.3359375,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.375,
            "text": "Calcitonin gene-related",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 7.8828125,
            "text": "related peptide receptor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.625,
            "end_logit": 7.8828125,
            "text": "gene-related peptide receptor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.78125,
            "text": "Calcitonin gene",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 7.8828125,
            "text": "-related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 7.8828125,
            "text": "peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.34765625,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.46484375,
            "text": "Calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.6484375,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.66796875,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.75,
            "text": "Calcitonin gene-related peptide receptor antagonists, such",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.78125,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepan",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 7.8828125,
            "text": ": Calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.8828125,
            "text": "BACKGROUND: Calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.95703125,
            "end_logit": -5.18359375,
            "text": "receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a population for whom triptan",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_5": [
        {
            "start_logit": 7.953125,
            "end_logit": 7.82421875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.953125,
            "end_logit": -1.7880859375,
            "text": "calcitonin",
            "probability": 6.657838821411133e-05
        },
        {
            "start_logit": -2.125,
            "end_logit": 7.82421875,
            "text": "peptide",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": -6.390625,
            "end_logit": 7.82421875,
            "text": "related peptide",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.82421875,
            "text": "calcitonin gene-related",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 7.82421875,
            "text": "gene-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.87109375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.1015625,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.82421875,
            "text": "-related peptide",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.19921875,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.2421875,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.43359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-olcegepan",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.59375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.6171875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.640625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.6796875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-ol",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.71484375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-olcegepant (BIBN",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.76171875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-olcegepant (BIBN 4096",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.125,
            "end_logit": -6.87109375,
            "text": "peptide (CGRP",
            "probability": 0.0
        },
        {
            "start_logit": -2.125,
            "end_logit": -7.2421875,
            "text": "peptide (CGRP)",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_6": [
        {
            "start_logit": 7.9375,
            "end_logit": 7.82421875,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.9375,
            "end_logit": -1.9208984375,
            "text": "calcitonin",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 7.82421875,
            "text": "receptor",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 7.9375,
            "end_logit": -3.9453125,
            "text": "calcitonin gene-related peptide",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 7.82421875,
            "text": "related peptide receptor",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.56640625,
            "text": "calcitonin gene-related",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 7.82421875,
            "text": "gene-related peptide receptor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.84765625,
            "text": "calcitonin gene",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 7.82421875,
            "text": "-related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.82421875,
            "text": "peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.38671875,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.640625,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.828125,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of migraine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.8515625,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of migraine.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 7.82421875,
            "text": "a calcitonin gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -7.96875,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.0078125,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.0234375,
            "text": "calcitonin gene-related peptide receptor antagonist, is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.0234375,
            "text": "calcitonin gene-related peptide receptor antagonist, is being",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -8.03125,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_7": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.84375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.8154296875,
            "text": "calcitonin",
            "probability": 6.35385513305664e-05
        },
        {
            "start_logit": -2.04296875,
            "end_logit": 7.84375,
            "text": "receptor",
            "probability": 4.5418739318847656e-05
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -2.470703125,
            "text": "calcitonin gene-related peptide",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.4921875,
            "text": "calcitonin gene-related",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 7.84375,
            "text": "related peptide receptor",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.453125,
            "end_logit": 7.84375,
            "text": "gene-related peptide receptor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.859375,
            "text": "calcitonin gene",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.84375,
            "text": "-related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 7.84375,
            "text": "peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.25,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.84375,
            "text": "potent calcitonin gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.67578125,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.73046875,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.7421875,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.79296875,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.796875,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.8046875,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.84375,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.859375,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does",
            "probability": 1.7881393432617188e-07
        }
    ],
    "55032efde9bde69634000035_8": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.82421875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.8271484375,
            "text": "calcitonin",
            "probability": 6.455183029174805e-05
        },
        {
            "start_logit": -2.1328125,
            "end_logit": 7.82421875,
            "text": "peptide",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.33203125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 7.82421875,
            "text": "related peptide",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.73046875,
            "text": "calcitonin gene-related",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 7.82421875,
            "text": "gene-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 7.82421875,
            "text": "-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.109375,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.44140625,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.45703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.578125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.59375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.61328125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.6171875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.70703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to sublingual",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.71875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to sublingual nitroglycerin (NTG",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.73046875,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.73046875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.74609375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to",
            "probability": 1.7881393432617188e-07
        }
    ],
    "55032efde9bde69634000035_9": [
        {
            "start_logit": 7.921875,
            "end_logit": 7.859375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.921875,
            "end_logit": -1.9716796875,
            "text": "calcitonin",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": -2.05859375,
            "end_logit": 7.859375,
            "text": "receptor",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -4.09375,
            "text": "calcitonin gene-related peptide",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -6.171875,
            "end_logit": 7.859375,
            "text": "related peptide receptor",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 7.859375,
            "text": "gene-related peptide receptor",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.80078125,
            "text": "calcitonin gene-related",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.85546875,
            "text": "calcitonin gene",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 7.859375,
            "text": "-related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 7.859375,
            "text": "peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.15625,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.44921875,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.59375,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.859375,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.82421875,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.94140625,
            "text": "calcitonin gene-related peptide receptor antagonist which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.94921875,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.0,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.015625,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.859375,
            "text": "BACKGROUND: Telcagepant is an oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_10": [
        {
            "start_logit": 7.953125,
            "end_logit": 7.8125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.953125,
            "end_logit": -1.7919921875,
            "text": "calcitonin",
            "probability": 6.711483001708984e-05
        },
        {
            "start_logit": -2.14453125,
            "end_logit": 7.8125,
            "text": "peptide",
            "probability": 4.1365623474121094e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.5390625,
            "text": "calcitonin gene-related",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 7.8125,
            "text": "related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.8125,
            "end_logit": 7.8125,
            "text": "gene-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.01171875,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.12890625,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.22265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.8125,
            "text": "-related peptide",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.484375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.5625,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.68359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepan",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.6875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.72265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant are very",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.83984375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists ol",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.84375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepan",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.90234375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant are very potent",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.91015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant are",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.921875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_11": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.8359375,
            "text": "Calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.8046875,
            "text": "Calcitonin",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": -2.0859375,
            "end_logit": 7.8359375,
            "text": "peptide",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 7.8359375,
            "text": "related peptide",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 7.8359375,
            "text": "gene-related peptide",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.78515625,
            "text": "Calcitonin gene-related",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.0390625,
            "text": "Calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.0625,
            "text": "Calcitonin gene-related peptide (CGRP",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 7.8359375,
            "text": "-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.10546875,
            "text": "Calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.140625,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine. Olcegepan",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.2421875,
            "text": "Calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.515625,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.51953125,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.57421875,
            "text": "Calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -7.0625,
            "text": "peptide (CGRP",
            "probability": 0.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -7.10546875,
            "text": "peptide (CGRP) receptor",
            "probability": 0.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -7.140625,
            "text": "peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine. Olcegepan",
            "probability": 0.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -7.28515625,
            "text": "peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine. Olcegepant (BIBN409",
            "probability": 0.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -7.40234375,
            "text": "peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine. Olcegepant (BIBN4096",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_12": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.80859375,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -1.88671875,
            "text": "calcitonin",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": -2.1640625,
            "end_logit": 7.80859375,
            "text": "peptide",
            "probability": 4.1365623474121094e-05
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.80859375,
            "text": "related peptide",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -6.6953125,
            "text": "calcitonin gene-related",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -6.80078125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 7.80859375,
            "text": "gene-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.05078125,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 7.80859375,
            "text": "-related peptide",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.1875,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.27734375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.59375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.671875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.6875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.80078125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.86328125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.8671875,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.8984375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.91015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 7.80859375,
            "text": "- Telcagepant is a calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_13": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.81640625,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.9658203125,
            "text": "calcitonin",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": -2.2421875,
            "end_logit": 7.81640625,
            "text": "peptide",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -3.517578125,
            "text": "calcitonin gene-related peptide antagonist",
            "probability": 1.1920928955078125e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -5.9375,
            "text": "calcitonin gene-related",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.7265625,
            "text": "calcitonin gene",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 7.81640625,
            "text": "gene-related peptide",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 7.81640625,
            "text": "-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 7.81640625,
            "text": "related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.40234375,
            "text": "calcitonin gene-related peptide antagonist telcagepan",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.55859375,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg orally had an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.625,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg orally had an incidence of adverse events similar to placebo when",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.63671875,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.640625,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.6484375,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.2421875,
            "end_logit": -3.517578125,
            "text": "peptide antagonist",
            "probability": 0.0
        },
        {
            "start_logit": -2.2421875,
            "end_logit": -7.40234375,
            "text": "peptide antagonist telcagepan",
            "probability": 0.0
        },
        {
            "start_logit": -2.2421875,
            "end_logit": -7.453125,
            "text": "peptide antagonist telcagepant 300 mg orally had an incidence of adverse events similar to placebo when used in the acute treatment of migraine",
            "probability": 0.0
        },
        {
            "start_logit": -2.2421875,
            "end_logit": -7.55859375,
            "text": "peptide antagonist telcagepant 300 mg orally had an",
            "probability": 0.0
        },
        {
            "start_logit": -2.2421875,
            "end_logit": -7.625,
            "text": "peptide antagonist telcagepant 300 mg orally had an incidence of adverse events similar to placebo when",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_14": [
        {
            "start_logit": 7.9140625,
            "end_logit": 7.8359375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.9951171875,
            "text": "calcitonin",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": -2.068359375,
            "end_logit": 7.8359375,
            "text": "receptor",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -3.966796875,
            "text": "calcitonin gene-related peptide",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": -6.28515625,
            "end_logit": 7.8359375,
            "text": "related peptide receptor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 7.8359375,
            "text": "gene-related peptide receptor",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.8203125,
            "text": "calcitonin gene-related",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.921875,
            "text": "calcitonin gene",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.08203125,
            "text": "calcitonin gene-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.8359375,
            "text": "-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.140625,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to oral triptan",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 7.8359375,
            "text": "peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.43359375,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.8359375,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.73046875,
            "text": "calcitonin gene-related peptide receptor antagonist with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.859375,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to oral trip",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.89453125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to oral triptans",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.0,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.03125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.0625,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_15": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.82421875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -1.884765625,
            "text": "calcitonin",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": -2.125,
            "end_logit": 7.82421875,
            "text": "peptide",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -6.21875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 7.82421875,
            "text": "related peptide",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -6.75,
            "text": "calcitonin gene-related",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 7.82421875,
            "text": "gene-related peptide",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 7.82421875,
            "text": "-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.1328125,
            "text": "calcitonin gene",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.296875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.3125,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.640625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and across four",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.65234375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.65234375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and across four attacks",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.68359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.73046875,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.76171875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.80859375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.82421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.8359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for",
            "probability": 1.7881393432617188e-07
        }
    ],
    "55032efde9bde69634000035_16": [
        {
            "start_logit": 7.87890625,
            "end_logit": 7.83203125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -2.046875,
            "text": "calcitonin",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 7.83203125,
            "text": "peptide",
            "probability": 4.5418739318847656e-05
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -5.09765625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -5.4296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 7.83203125,
            "text": "related peptide",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -6.7421875,
            "text": "calcitonin gene-related",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 7.83203125,
            "text": "gene-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.0,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 7.83203125,
            "text": "-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.15625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan in the acute treatment of migraine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.25,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.27734375,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitript",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.33984375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.5234375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.671875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.83203125,
            "text": "the calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.83203125,
            "text": "post-hoc analysis of patient-level data from a previous randomized, placebo-controlled trial of the calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_17": [
        {
            "start_logit": 7.96875,
            "end_logit": 7.8125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.96875,
            "end_logit": -1.7197265625,
            "text": "calcitonin",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -2.1484375,
            "end_logit": 7.8125,
            "text": "peptide",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -6.734375,
            "text": "calcitonin gene-related",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": 7.8125,
            "text": "related peptide",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 7.8125,
            "text": "gene-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.10546875,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 7.8125,
            "text": "-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.15625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.20703125,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.23046875,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.51953125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.56640625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.69140625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.7421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.79296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.8125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.98828125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist tel",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -8.0,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepan",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -8.0,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_18": [
        {
            "start_logit": 7.96484375,
            "end_logit": 7.8515625,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -1.748046875,
            "text": "calcitonin",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -2.0703125,
            "end_logit": 7.8515625,
            "text": "receptor",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -3.978515625,
            "text": "calcitonin gene-related peptide",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -6.328125,
            "end_logit": 7.8515625,
            "text": "gene-related peptide receptor",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 7.8515625,
            "text": "related peptide receptor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.7890625,
            "text": "calcitonin gene-related",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.75,
            "end_logit": 7.8515625,
            "text": "-related peptide receptor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.8515625,
            "text": "peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.16015625,
            "text": "calcitonin gene",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.4453125,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.47265625,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.67578125,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.69140625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.69921875,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.7109375,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.73828125,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.74609375,
            "text": "calcitonin gene-related peptide receptor antagonist tel",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.75390625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-09",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.7890625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974",
            "probability": 1.7881393432617188e-07
        }
    ],
    "55032efde9bde69634000035_19": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.81640625,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.7587890625,
            "text": "calcitonin gene-related peptide",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.921875,
            "text": "calcitonin",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": -2.099609375,
            "end_logit": 7.81640625,
            "text": "receptor",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.46875,
            "text": "calcitonin gene-related",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 7.81640625,
            "text": "related peptide receptor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.5625,
            "end_logit": 7.81640625,
            "text": "gene-related peptide receptor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.72265625,
            "text": "calcitonin gene",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.984375,
            "text": "calcitonin gene-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.81640625,
            "text": "-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 7.81640625,
            "text": "peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.5,
            "text": "calcitonin gene-related peptide receptor blockers.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.70703125,
            "text": "calcitonin gene-related peptide receptor blockers",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.81640625,
            "text": "the calcitonin gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": -1.7587890625,
            "text": "related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -6.5625,
            "end_logit": -1.7587890625,
            "text": "gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -1.7587890625,
            "text": "-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -1.7587890625,
            "text": "peptide",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -1.7587890625,
            "text": "the calcitonin gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -7.5,
            "text": "receptor blockers.",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_20": [
        {
            "start_logit": 7.96484375,
            "end_logit": 7.83203125,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -1.759765625,
            "text": "calcitonin",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 7.83203125,
            "text": "receptor",
            "probability": 4.166364669799805e-05
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -4.2421875,
            "text": "calcitonin gene-related peptide",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -6.18359375,
            "end_logit": 7.83203125,
            "text": "related peptide receptor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.3125,
            "end_logit": 7.83203125,
            "text": "gene-related peptide receptor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.83203125,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 7.83203125,
            "text": "-related peptide receptor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.98046875,
            "text": "calcitonin gene-related",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.0625,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 7.83203125,
            "text": "peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.2734375,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.55078125,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.75390625,
            "text": "calcitonin gene-related peptide receptor antagonist, in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.83203125,
            "text": "an oral calcitonin gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -8.015625,
            "text": "calcitonin gene-related peptide receptor antagonist, in adults",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -1.759765625,
            "text": "oral calcitonin",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -1.759765625,
            "text": "an oral calcitonin",
            "probability": 0.0
        },
        {
            "start_logit": -2.123046875,
            "end_logit": -7.2734375,
            "text": "receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": -2.123046875,
            "end_logit": -7.75390625,
            "text": "receptor antagonist, in",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_21": [
        {
            "start_logit": 7.953125,
            "end_logit": 7.84375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 7.953125,
            "end_logit": -1.8369140625,
            "text": "calcitonin",
            "probability": 6.252527236938477e-05
        },
        {
            "start_logit": -2.083984375,
            "end_logit": 7.84375,
            "text": "receptor",
            "probability": 4.369020462036133e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -2.837890625,
            "text": "calcitonin gene-related peptide",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.6015625,
            "text": "calcitonin gene-related",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 7.84375,
            "text": "related peptide receptor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 7.84375,
            "text": "gene-related peptide receptor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.86328125,
            "text": "calcitonin gene",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.06640625,
            "text": "calcitonin gene-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 7.84375,
            "text": "-related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.84375,
            "text": "selective calcitonin gene-related peptide receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.375,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.84375,
            "text": "peptide receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.41015625,
            "text": "calcitonin gene-related peptide receptor antagonist being",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.77734375,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.78515625,
            "text": "calcitonin gene-related peptide receptor antagonist being developed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.80078125,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.8046875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without aura.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.80859375,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.828125,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for",
            "probability": 1.7881393432617188e-07
        }
    ],
    "55032efde9bde69634000035_22": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.80078125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.8115234375,
            "text": "calcitonin",
            "probability": 6.711483001708984e-05
        },
        {
            "start_logit": -2.1953125,
            "end_logit": 7.80078125,
            "text": "peptide",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.19140625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 7.80078125,
            "text": "related peptide",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.890625,
            "text": "calcitonin gene-related",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 7.80078125,
            "text": "gene-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 7.80078125,
            "text": "-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.140625,
            "text": "calcitonin gene",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.3984375,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.4296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.4609375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and to compare its coronary vasoconstrictive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.515625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.58984375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.6015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.85546875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepan",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.80078125,
            "text": "coronary arteries to explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.80078125,
            "text": "arteries to explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -6.19140625,
            "text": "peptide (CGRP",
            "probability": 0.0
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -6.93359375,
            "text": "peptide (CGRP) receptor antagonist telcagepant and to compare its coronary vasoconstrictive potential to that of zolmitriptan",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_23": [
        {
            "start_logit": 7.96484375,
            "end_logit": 7.79296875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -1.751953125,
            "text": "calcitonin",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -2.1953125,
            "end_logit": 7.79296875,
            "text": "peptide",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.6953125,
            "text": "calcitonin gene-related",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 7.79296875,
            "text": "related peptide",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.01171875,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 7.79296875,
            "text": "gene-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.79296875,
            "text": "-related peptide",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.2578125,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.34375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.58984375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.6640625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.87109375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.79296875,
            "text": "novel oral calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.953125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.9921875,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 7.79296875,
            "text": "oral calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -1.751953125,
            "text": "novel oral calcitonin",
            "probability": 0.0
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -7.34375,
            "text": "peptide (CGRP",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -1.751953125,
            "text": "oral calcitonin",
            "probability": 0.0
        }
    ],
    "5c6ab4c17c78d6947100001d_1": [
        {
            "start_logit": 4.99609375,
            "end_logit": 7.93359375,
            "text": "MATLAB environment",
            "probability": 0.96435546875
        },
        {
            "start_logit": 1.6357421875,
            "end_logit": 7.93359375,
            "text": "under the MATLAB environment",
            "probability": 0.03350830078125
        },
        {
            "start_logit": -1.361328125,
            "end_logit": 7.93359375,
            "text": "environment",
            "probability": 0.0016689300537109375
        },
        {
            "start_logit": -3.939453125,
            "end_logit": 7.93359375,
            "text": "the MATLAB environment",
            "probability": 0.00012671947479248047
        },
        {
            "start_logit": -4.25,
            "end_logit": 7.93359375,
            "text": "LAB environment",
            "probability": 9.262561798095703e-05
        },
        {
            "start_logit": -6.0703125,
            "end_logit": 7.93359375,
            "text": "simulation options.Availability and implementation: SELANSI runs under the MATLAB environment",
            "probability": 1.5139579772949219e-05
        },
        {
            "start_logit": 4.99609375,
            "end_logit": -5.015625,
            "text": "MATLAB",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 4.99609375,
            "end_logit": -6.1484375,
            "text": "MAT",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 4.99609375,
            "end_logit": -6.68359375,
            "text": "MATLAB environment,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.99609375,
            "end_logit": -6.86328125,
            "text": "MATLAB environment, and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 4.99609375,
            "end_logit": -6.890625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 4.99609375,
            "end_logit": -7.37890625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.171875,
            "end_logit": -5.63671875,
            "text": "SEmi-LAgrangian SImulation of GRNs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.6357421875,
            "end_logit": -5.015625,
            "text": "under the MATLAB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.171875,
            "end_logit": -6.8984375,
            "text": "SEmi-LAgrangian SImulation of GRNs), a software toolbox for the simulation of stochastic multidimensional gene regulatory networks",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.171875,
            "end_logit": -6.9140625,
            "text": "SEmi-LAgrangian",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.171875,
            "end_logit": -6.96875,
            "text": "SEmi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.171875,
            "end_logit": -7.52734375,
            "text": "SEmi-LAgrangian SImulation of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.6357421875,
            "end_logit": -6.1484375,
            "text": "under the MAT",
            "probability": 0.0
        },
        {
            "start_logit": 1.6357421875,
            "end_logit": -6.68359375,
            "text": "under the MATLAB environment,",
            "probability": 0.0
        }
    ],
    "5c6ab4c17c78d6947100001d_2": [
        {
            "start_logit": 6.71484375,
            "end_logit": 7.91015625,
            "text": "MATLAB environment",
            "probability": 1.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": 7.91015625,
            "text": "environment",
            "probability": 0.0002416372299194336
        },
        {
            "start_logit": -2.53515625,
            "end_logit": 7.91015625,
            "text": "under the MATLAB environment",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": -4.94921875,
            "end_logit": 7.91015625,
            "text": "LAB environment",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -4.40625,
            "text": "MAT",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -6.609375,
            "end_logit": 7.91015625,
            "text": "the MATLAB environment",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.078125,
            "end_logit": 7.91015625,
            "text": "implementation SELANSI runs under the MATLAB environment",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.91015625,
            "text": "runs under the MATLAB environment",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.91015625,
            "text": "SELANSI runs under the MATLAB environment",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -6.8828125,
            "text": "MATLAB",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -7.62890625,
            "text": "MATLAB environment, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -7.69921875,
            "text": "MATLAB environment,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -7.80078125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -7.953125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -7.9765625,
            "text": "MATLAB environment, and is available under GPLv",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -7.984375,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -8.0546875,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -8.0625,
            "text": "MATLAB environment, and is available under GPLv3 license at https:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -8.1015625,
            "text": "MATLAB environment, and is available under GP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.71484375,
            "end_logit": -8.15625,
            "text": "MATLAB environment, and is available under",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c6ab4c17c78d6947100001d_3": [
        {
            "start_logit": 5.0390625,
            "end_logit": 7.953125,
            "text": "MATLAB environment",
            "probability": 0.998046875
        },
        {
            "start_logit": -1.3544921875,
            "end_logit": 7.953125,
            "text": "environment",
            "probability": 0.0016679763793945312
        },
        {
            "start_logit": -2.919921875,
            "end_logit": 7.953125,
            "text": "under the MATLAB environment",
            "probability": 0.00034809112548828125
        },
        {
            "start_logit": -5.35546875,
            "end_logit": 7.953125,
            "text": "the MATLAB environment",
            "probability": 3.063678741455078e-05
        },
        {
            "start_logit": -5.46875,
            "end_logit": 7.953125,
            "text": "LAB environment",
            "probability": 2.7239322662353516e-05
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 7.953125,
            "text": "simulation options.<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 7.953125,
            "text": "options.<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 7.953125,
            "text": "implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -5.7421875,
            "text": "MATLAB",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -6.109375,
            "text": "MAT",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -7.796875,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -8.0625,
            "text": "MATLAB environment, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -8.0703125,
            "text": "MATLAB environment,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -8.0859375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -8.125,
            "text": "MATLAB environment, and is available under GPLv",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -8.15625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -8.1875,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.919921875,
            "end_logit": -5.7421875,
            "text": "under the MATLAB",
            "probability": 0.0
        },
        {
            "start_logit": -2.919921875,
            "end_logit": -6.109375,
            "text": "under the MAT",
            "probability": 0.0
        },
        {
            "start_logit": -1.3544921875,
            "end_logit": -7.796875,
            "text": "environment, and is available under GPLv3 licens",
            "probability": 0.0
        }
    ],
    "5c6ab4c17c78d6947100001d_4": [
        {
            "start_logit": 5.2734375,
            "end_logit": 7.69140625,
            "text": "MATLAB environment",
            "probability": 0.998046875
        },
        {
            "start_logit": -1.7919921875,
            "end_logit": 7.69140625,
            "text": "under the MATLAB environment",
            "probability": 0.0008487701416015625
        },
        {
            "start_logit": -1.8193359375,
            "end_logit": 7.69140625,
            "text": "environment",
            "probability": 0.0008254051208496094
        },
        {
            "start_logit": -4.76171875,
            "end_logit": 7.69140625,
            "text": "LAB environment",
            "probability": 4.363059997558594e-05
        },
        {
            "start_logit": -5.79296875,
            "end_logit": 7.69140625,
            "text": "the MATLAB environment",
            "probability": 1.5497207641601562e-05
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.69140625,
            "text": "SELANSI runs under the MATLAB environment",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.69140625,
            "text": "runs under the MATLAB environment",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -5.78515625,
            "text": "MAT",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -6.9375,
            "text": "MATLAB environment,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -7.32421875,
            "text": "MATLAB environment, and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -7.34765625,
            "text": "MATLAB",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -7.5703125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -7.8359375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -7.98046875,
            "text": "MATLAB environment, and is available under GPLv",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -7.9921875,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -7.99609375,
            "text": "MATLAB environment, and is available under GP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -8.0,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -8.0078125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -8.0078125,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -8.03125,
            "text": "MATLAB environment, and is available under GPLv3 license at",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a992b371d1251d03b00000a_1": [
        {
            "start_logit": 7.90625,
            "end_logit": 7.875,
            "text": "Metagenomics of the Human Intestinal Tract",
            "probability": 1.0
        },
        {
            "start_logit": -1.953125,
            "end_logit": 7.875,
            "text": "Tract",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -2.03125,
            "text": "Metagen",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -4.65234375,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human microbiome.",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -4.9609375,
            "end_logit": 7.875,
            "text": "and Metagenomics of the Human Intestinal Tract",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -4.984375,
            "end_logit": 7.875,
            "text": "Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -5.50390625,
            "end_logit": 7.875,
            "text": "the Human Intestinal Tract",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.1640625,
            "end_logit": 7.875,
            "text": "of the Human Intestinal Tract",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.18359375,
            "end_logit": 7.875,
            "text": "Human Intestinal Tract",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 7.875,
            "text": "Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.375,
            "end_logit": 7.875,
            "text": "omics of the Human Intestinal Tract",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.55078125,
            "text": "Metagenomics of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.578125,
            "end_logit": 7.875,
            "text": "Intestinal Tract",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.84375,
            "text": "Metagenomics of the Human Intestinal",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 7.875,
            "text": "consortia like the Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.91796875,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human microbiome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.9375,
            "text": "Metagenomics of the Human",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.16796875,
            "text": "Metagenomics of the Human Intestinal Tract (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.18359375,
            "text": "Metagenomics",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.875,
            "text": "tia like the Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 2.384185791015625e-07
        }
    ],
    "530c7f52970c65fa6b000010_1": [
        {
            "start_logit": -3.1328125,
            "end_logit": 5.8125,
            "text": "of periodontal pathogens",
            "probability": 0.6318359375
        },
        {
            "start_logit": -4.703125,
            "end_logit": 5.8125,
            "text": "pathogens",
            "probability": 0.13134765625
        },
        {
            "start_logit": -5.48046875,
            "end_logit": 5.8125,
            "text": "disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.060394287109375
        },
        {
            "start_logit": -5.92578125,
            "end_logit": 5.8125,
            "text": "biofilm development of periodontal pathogens",
            "probability": 0.0386962890625
        },
        {
            "start_logit": -6.0625,
            "end_logit": 5.8125,
            "text": "Oxantel disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.033721923828125
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 5.8125,
            "text": "polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.0253753662109375
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 5.8125,
            "text": "periodontal pathogens",
            "probability": 0.0207061767578125
        },
        {
            "start_logit": -6.953125,
            "end_logit": 5.8125,
            "text": "robial biofilm development of periodontal pathogens",
            "probability": 0.01385498046875
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 5.8125,
            "text": "icrobial biofilm development of periodontal pathogens",
            "probability": 0.01270294189453125
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 5.8125,
            "text": "ial biofilm development of periodontal pathogens",
            "probability": 0.00994110107421875
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 5.8125,
            "text": "development of periodontal pathogens",
            "probability": 0.00887298583984375
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 5.8125,
            "text": "el disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.006000518798828125
        },
        {
            "start_logit": -7.859375,
            "end_logit": 5.8125,
            "text": "ntel disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.005596160888671875
        },
        {
            "start_logit": -5.48046875,
            "end_logit": 0.63134765625,
            "text": "disrupts polymicrobial biofilm development",
            "probability": 0.0003399848937988281
        },
        {
            "start_logit": -5.92578125,
            "end_logit": 0.63134765625,
            "text": "biofilm development",
            "probability": 0.00021779537200927734
        },
        {
            "start_logit": -6.0625,
            "end_logit": 0.63134765625,
            "text": "Oxantel disrupts polymicrobial biofilm development",
            "probability": 0.00018990039825439453
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 0.63134765625,
            "text": "polymicrobial biofilm development",
            "probability": 0.00014340877532958984
        },
        {
            "start_logit": -6.953125,
            "end_logit": 0.63134765625,
            "text": "robial biofilm development",
            "probability": 7.796287536621094e-05
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 0.63134765625,
            "text": "icrobial biofilm development",
            "probability": 7.152557373046875e-05
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 0.63134765625,
            "text": "ial biofilm development",
            "probability": 5.614757537841797e-05
        }
    ],
    "5540fbce234c5a7c75000001_1": [
        {
            "start_logit": 6.48046875,
            "end_logit": 7.65625,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -2.455078125,
            "end_logit": 7.65625,
            "text": "autophagy",
            "probability": 0.00013136863708496094
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -4.51171875,
            "text": "Chaperone",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 7.65625,
            "text": "mediated autophagy",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -5.2734375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 7.65625,
            "text": "-mediated autophagy",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -6.3046875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -6.34375,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.05859375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.453125,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.4921875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.515625,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.56640625,
            "text": "Chaperone-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.6640625,
            "text": "Chaperone-mediated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.88671875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.90234375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.92578125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -8.03125,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -8.03125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -8.09375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5540fbce234c5a7c75000001_2": [
        {
            "start_logit": 4.53515625,
            "end_logit": 7.86328125,
            "text": "chaperone-mediated autophagy",
            "probability": 0.9970703125
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": 7.86328125,
            "text": "autophagy",
            "probability": 0.002033233642578125
        },
        {
            "start_logit": -2.328125,
            "end_logit": 7.86328125,
            "text": "mediated autophagy",
            "probability": 0.0010423660278320312
        },
        {
            "start_logit": -4.88671875,
            "end_logit": 7.86328125,
            "text": "lamp2a in the chaperone-mediated autophagy",
            "probability": 8.07046890258789e-05
        },
        {
            "start_logit": -6.4375,
            "end_logit": 7.86328125,
            "text": "-mediated autophagy",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.86328125,
            "text": "glycoprotein lamp2a in the chaperone-mediated autophagy",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.86328125,
            "text": "in the chaperone-mediated autophagy",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -5.77734375,
            "text": "chaperone",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -7.97265625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.0546875,
            "text": "chaperone-mediated autophagy of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.09375,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been described",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.1015625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been described in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.140625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.15625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -7.44921875,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described in details as well as the chaperone protein Hsc73 and other chaperones involved in this process.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -7.97265625,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -8.0390625,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described in details as well as the chaperone protein Hsc73 and other chaperones involved in this process",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -8.0546875,
            "text": "autophagy of",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -8.09375,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -8.1015625,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described in",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_3": [
        {
            "start_logit": 7.39453125,
            "end_logit": 7.6484375,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": 7.6484375,
            "text": "autophagy",
            "probability": 4.684925079345703e-05
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -3.18359375,
            "text": "chaperone",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -5.57421875,
            "end_logit": 7.6484375,
            "text": "mediated autophagy",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -6.02734375,
            "text": "chaperone-mediated autophagy, a lysosomal",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -6.50390625,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 7.6484375,
            "text": "-mediated autophagy",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -6.6484375,
            "text": "chaperone-mediated autophagy, a",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.0390625,
            "text": "chaperone-mediated autophagy,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.16015625,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.21484375,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of proteins containing a specific lysosomal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.21875,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.36328125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.46875,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.5390625,
            "text": "chaperone-mediated autophagy, a lysosomal import",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.734375,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.76953125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -6.02734375,
            "text": "autophagy, a lysosomal",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -6.50390625,
            "text": "autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -6.6484375,
            "text": "autophagy, a",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_4": [
        {
            "start_logit": 4.53515625,
            "end_logit": 7.86328125,
            "text": "chaperone-mediated autophagy",
            "probability": 0.9970703125
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": 7.86328125,
            "text": "autophagy",
            "probability": 0.002033233642578125
        },
        {
            "start_logit": -2.328125,
            "end_logit": 7.86328125,
            "text": "mediated autophagy",
            "probability": 0.0010423660278320312
        },
        {
            "start_logit": -4.88671875,
            "end_logit": 7.86328125,
            "text": "lamp2a in the chaperone-mediated autophagy",
            "probability": 8.07046890258789e-05
        },
        {
            "start_logit": -6.4375,
            "end_logit": 7.86328125,
            "text": "-mediated autophagy",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.86328125,
            "text": "glycoprotein lamp2a in the chaperone-mediated autophagy",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.86328125,
            "text": "in the chaperone-mediated autophagy",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -5.77734375,
            "text": "chaperone",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -7.97265625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.0546875,
            "text": "chaperone-mediated autophagy of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.09375,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been described",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.1015625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been described in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.140625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.53515625,
            "end_logit": -8.15625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -7.44921875,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described in details as well as the chaperone protein Hsc73 and other chaperones involved in this process.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -7.97265625,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -8.0390625,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described in details as well as the chaperone protein Hsc73 and other chaperones involved in this process",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -8.0546875,
            "text": "autophagy of",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -8.09375,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described",
            "probability": 0.0
        },
        {
            "start_logit": -1.6611328125,
            "end_logit": -8.1015625,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described in",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_5": [
        {
            "start_logit": 7.39453125,
            "end_logit": 7.6484375,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": 7.6484375,
            "text": "autophagy",
            "probability": 4.684925079345703e-05
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -3.18359375,
            "text": "chaperone",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -5.57421875,
            "end_logit": 7.6484375,
            "text": "mediated autophagy",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -6.02734375,
            "text": "chaperone-mediated autophagy, a lysosomal",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -6.50390625,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 7.6484375,
            "text": "-mediated autophagy",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -6.6484375,
            "text": "chaperone-mediated autophagy, a",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.0390625,
            "text": "chaperone-mediated autophagy,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.16015625,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.21484375,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of proteins containing a specific lysosomal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.21875,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.36328125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.46875,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.5390625,
            "text": "chaperone-mediated autophagy, a lysosomal import",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.734375,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.76953125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -6.02734375,
            "text": "autophagy, a lysosomal",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -6.50390625,
            "text": "autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -6.6484375,
            "text": "autophagy, a",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_6": [
        {
            "start_logit": 6.48046875,
            "end_logit": 7.65625,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -2.455078125,
            "end_logit": 7.65625,
            "text": "autophagy",
            "probability": 0.00013136863708496094
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -4.51171875,
            "text": "Chaperone",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 7.65625,
            "text": "mediated autophagy",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -5.2734375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 7.65625,
            "text": "-mediated autophagy",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -6.3046875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -6.34375,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.05859375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.453125,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.4921875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.515625,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.56640625,
            "text": "Chaperone-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.6640625,
            "text": "Chaperone-mediated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.88671875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.90234375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -7.92578125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -8.03125,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -8.03125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.48046875,
            "end_logit": -8.09375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5540fbce234c5a7c75000001_7": [
        {
            "start_logit": 6.76953125,
            "end_logit": 7.5625,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -2.642578125,
            "end_logit": 7.5625,
            "text": "autophagy",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -4.19140625,
            "text": "Chaperone",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -6.02734375,
            "end_logit": 7.5625,
            "text": "mediated autophagy",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -6.0703125,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 7.5625,
            "text": "-mediated autophagy",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -6.3203125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.41015625,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.4296875,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.50390625,
            "text": "Chaperone-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.5546875,
            "text": "Chaperone-mediated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.98046875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.0078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.03125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.046875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.09375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.109375,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.203125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.642578125,
            "end_logit": -6.0703125,
            "text": "autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -2.642578125,
            "end_logit": -6.3203125,
            "text": "autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_8": [
        {
            "start_logit": 5.37890625,
            "end_logit": 7.921875,
            "text": "chaperone-mediated autophagy",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.6845703125,
            "end_logit": 7.921875,
            "text": "autophagy",
            "probability": 0.0008592605590820312
        },
        {
            "start_logit": -3.640625,
            "end_logit": 7.921875,
            "text": "mediated autophagy",
            "probability": 0.00012135505676269531
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 7.921875,
            "text": "-mediated autophagy",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.921875,
            "text": "containing that chaperone-mediated autophagy",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -5.21484375,
            "text": "chaperone",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.921875,
            "text": "that chaperone-mediated autophagy",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -6.265625,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38% and individual KFERQ containing proteins [e.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -7.01171875,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -7.484375,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -7.78125,
            "text": "chaperone-mediated autophagy K",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -7.828125,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -7.96875,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38% and individual KFERQ containing proteins [",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -8.125,
            "text": "chaperone-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -8.15625,
            "text": "chaperone-mediated autophagy KFERQ",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -8.1640625,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38% and individual K",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -8.1953125,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38% and individual KFERQ containing proteins [e",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6845703125,
            "end_logit": -6.265625,
            "text": "autophagy KFERQ signal motif increased 38% and individual KFERQ containing proteins [e.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6845703125,
            "end_logit": -7.01171875,
            "text": "autophagy KFERQ signal motif increased 38%",
            "probability": 0.0
        },
        {
            "start_logit": -1.6845703125,
            "end_logit": -7.484375,
            "text": "autophagy KFERQ signal motif increased 38",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_9": [
        {
            "start_logit": 4.48828125,
            "end_logit": 7.75390625,
            "text": "mediated autophagy",
            "probability": 0.98828125
        },
        {
            "start_logit": -0.314697265625,
            "end_logit": 7.75390625,
            "text": "lysosomes with high chaperone-mediated autophagy",
            "probability": 0.0081024169921875
        },
        {
            "start_logit": -1.9345703125,
            "end_logit": 7.75390625,
            "text": "autophagy",
            "probability": 0.0016069412231445312
        },
        {
            "start_logit": -2.1015625,
            "end_logit": 7.75390625,
            "text": "chaperone-mediated autophagy",
            "probability": 0.0013580322265625
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 7.75390625,
            "text": "-mediated autophagy",
            "probability": 2.2590160369873047e-05
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 7.75390625,
            "text": "annexins I, II, IV, and VI, are enriched in lysosomes with high chaperone-mediated autophagy",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 7.75390625,
            "text": "in lysosomes with high chaperone-mediated autophagy",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.75390625,
            "text": ", and VI, are enriched in lysosomes with high chaperone-mediated autophagy",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.75390625,
            "text": ", are enriched in lysosomes with high chaperone-mediated autophagy",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.75390625,
            "text": "II, IV, and VI, are enriched in lysosomes with high chaperone-mediated autophagy",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.75390625,
            "text": "IV, and VI, are enriched in lysosomes with high chaperone-mediated autophagy",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.75390625,
            "text": "VI, are enriched in lysosomes with high chaperone-mediated autophagy",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -0.314697265625,
            "end_logit": -0.42041015625,
            "text": "lysosomes",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -6.40234375,
            "text": "mediated",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -7.16796875,
            "text": "mediated autophagy activity as expected for substrate proteins.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -7.546875,
            "text": "mediated autophagy activity as expected",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -7.8828125,
            "text": "mediated autophagy activity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -7.921875,
            "text": "mediated autophagy activity as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -7.9765625,
            "text": "mediated autophagy activity as expected for substrate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.314697265625,
            "end_logit": -6.40234375,
            "text": "lysosomes with high chaperone-mediated",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_10": [
        {
            "start_logit": -1.6953125,
            "end_logit": 0.284423828125,
            "text": "autophagy",
            "probability": 0.440185546875
        },
        {
            "start_logit": -2.099609375,
            "end_logit": 0.284423828125,
            "text": "lysosomes, only the annexins containing KFERQ-like sequences are degraded by chaperone mediated-autophagy",
            "probability": 0.2939453125
        },
        {
            "start_logit": -1.6953125,
            "end_logit": -0.94970703125,
            "text": "autophagy.",
            "probability": 0.128173828125
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -0.94970703125,
            "text": "lysosomes, only the annexins containing KFERQ-like sequences are degraded by chaperone mediated-autophagy.",
            "probability": 0.08563232421875
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -2.904296875,
            "text": "lysosomes",
            "probability": 0.01210784912109375
        },
        {
            "start_logit": -5.53125,
            "end_logit": 0.284423828125,
            "text": "degraded by chaperone mediated-autophagy",
            "probability": 0.00949859619140625
        },
        {
            "start_logit": -5.96484375,
            "end_logit": 0.284423828125,
            "text": "annexins containing KFERQ-like sequences are degraded by chaperone mediated-autophagy",
            "probability": 0.00615692138671875
        },
        {
            "start_logit": -4.99609375,
            "end_logit": -0.94970703125,
            "text": ".",
            "probability": 0.00472259521484375
        },
        {
            "start_logit": -6.671875,
            "end_logit": 0.284423828125,
            "text": "containing KFERQ-like sequences are degraded by chaperone mediated-autophagy",
            "probability": 0.0030364990234375
        },
        {
            "start_logit": -5.53125,
            "end_logit": -0.94970703125,
            "text": "degraded by chaperone mediated-autophagy.",
            "probability": 0.0027637481689453125
        },
        {
            "start_logit": -7.0625,
            "end_logit": 0.284423828125,
            "text": "mediated-autophagy",
            "probability": 0.0020542144775390625
        },
        {
            "start_logit": -5.96484375,
            "end_logit": -0.94970703125,
            "text": "annexins containing KFERQ-like sequences are degraded by chaperone mediated-autophagy.",
            "probability": 0.0017919540405273438
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 0.284423828125,
            "text": "-autophagy",
            "probability": 0.0015630722045898438
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 0.284423828125,
            "text": "sequences are degraded by chaperone mediated-autophagy",
            "probability": 0.0014629364013671875
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 0.284423828125,
            "text": "KFERQ-like sequences are degraded by chaperone mediated-autophagy",
            "probability": 0.0013637542724609375
        },
        {
            "start_logit": -7.546875,
            "end_logit": 0.284423828125,
            "text": "chaperone mediated-autophagy",
            "probability": 0.0012664794921875
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 0.284423828125,
            "text": "isolated lysosomes, only the annexins containing KFERQ-like sequences are degraded by chaperone mediated-autophagy",
            "probability": 0.0012216567993164062
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 0.284423828125,
            "text": "by chaperone mediated-autophagy",
            "probability": 0.0011396408081054688
        },
        {
            "start_logit": -7.6875,
            "end_logit": 0.284423828125,
            "text": "s containing KFERQ-like sequences are degraded by chaperone mediated-autophagy",
            "probability": 0.0010995864868164062
        },
        {
            "start_logit": -7.75,
            "end_logit": 0.284423828125,
            "text": "like sequences are degraded by chaperone mediated-autophagy",
            "probability": 0.0010328292846679688
        }
    ],
    "5540fbce234c5a7c75000001_11": [
        {
            "start_logit": 4.140625,
            "end_logit": 7.4453125,
            "text": "chaperone-mediated autophagy",
            "probability": 0.9951171875
        },
        {
            "start_logit": -2.11328125,
            "end_logit": 7.4453125,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 0.0019130706787109375
        },
        {
            "start_logit": -2.482421875,
            "end_logit": 7.4453125,
            "text": "autophagy",
            "probability": 0.00131988525390625
        },
        {
            "start_logit": -2.490234375,
            "end_logit": 7.4453125,
            "text": "mediated autophagy",
            "probability": 0.0013093948364257812
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 7.4453125,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 7.4453125,
            "text": "ophagy is followed by chaperone-mediated autophagy",
            "probability": 1.615285873413086e-05
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 7.4453125,
            "text": "-mediated autophagy",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -7.25,
            "end_logit": 7.4453125,
            "text": "by chaperone-mediated autophagy",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": 4.140625,
            "end_logit": -6.41015625,
            "text": "chaperone",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -7.65234375,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -7.66796875,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -7.671875,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -7.9765625,
            "text": "chaperone-mediated autophagy (CMA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -8.0546875,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -5.1328125,
            "text": "Macroautophagy",
            "probability": 0.0
        },
        {
            "start_logit": -2.482421875,
            "end_logit": -5.4375,
            "text": "autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes",
            "probability": 0.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -6.41015625,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -7.609375,
            "text": "Macroautophag",
            "probability": 0.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -7.65234375,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA),",
            "probability": 0.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -7.66796875,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA), in which Hsc",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_12": [
        {
            "start_logit": 4.140625,
            "end_logit": 7.4453125,
            "text": "chaperone-mediated autophagy",
            "probability": 0.9951171875
        },
        {
            "start_logit": -2.11328125,
            "end_logit": 7.4453125,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 0.0019130706787109375
        },
        {
            "start_logit": -2.482421875,
            "end_logit": 7.4453125,
            "text": "autophagy",
            "probability": 0.00131988525390625
        },
        {
            "start_logit": -2.490234375,
            "end_logit": 7.4453125,
            "text": "mediated autophagy",
            "probability": 0.0013093948364257812
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 7.4453125,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 7.4453125,
            "text": "ophagy is followed by chaperone-mediated autophagy",
            "probability": 1.615285873413086e-05
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 7.4453125,
            "text": "-mediated autophagy",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -7.25,
            "end_logit": 7.4453125,
            "text": "by chaperone-mediated autophagy",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": 4.140625,
            "end_logit": -6.41015625,
            "text": "chaperone",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -7.65234375,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -7.66796875,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -7.671875,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -7.9765625,
            "text": "chaperone-mediated autophagy (CMA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.140625,
            "end_logit": -8.0546875,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -5.1328125,
            "text": "Macroautophagy",
            "probability": 0.0
        },
        {
            "start_logit": -2.482421875,
            "end_logit": -5.4375,
            "text": "autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes",
            "probability": 0.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -6.41015625,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -7.609375,
            "text": "Macroautophag",
            "probability": 0.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -7.65234375,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA),",
            "probability": 0.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -7.66796875,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA), in which Hsc",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_13": [
        {
            "start_logit": 7.74609375,
            "end_logit": 7.76171875,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": 7.76171875,
            "text": "autophagy",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -2.55859375,
            "text": "Chaperone",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 7.76171875,
            "text": "mediated autophagy",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -6.79296875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 7.76171875,
            "text": "-mediated autophagy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.1328125,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.2890625,
            "text": "Chaperone-mediated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.37890625,
            "text": "Chaperone-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.76171875,
            "text": ": Chaperone-mediated autophagy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.48828125,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.7265625,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 7.76171875,
            "text": "AIMS: Chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.95703125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -8.0,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -8.03125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -8.0390625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -8.0703125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -8.1328125,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.287109375,
            "end_logit": -6.79296875,
            "text": "autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_14": [
        {
            "start_logit": 7.39453125,
            "end_logit": 7.6484375,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": 7.6484375,
            "text": "autophagy",
            "probability": 4.684925079345703e-05
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -3.18359375,
            "text": "chaperone",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -5.57421875,
            "end_logit": 7.6484375,
            "text": "mediated autophagy",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -6.02734375,
            "text": "chaperone-mediated autophagy, a lysosomal",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -6.50390625,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 7.6484375,
            "text": "-mediated autophagy",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -6.6484375,
            "text": "chaperone-mediated autophagy, a",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.0390625,
            "text": "chaperone-mediated autophagy,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.16015625,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.21484375,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of proteins containing a specific lysosomal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.21875,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.36328125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.46875,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.5390625,
            "text": "chaperone-mediated autophagy, a lysosomal import",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.734375,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.39453125,
            "end_logit": -7.76953125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -6.02734375,
            "text": "autophagy, a lysosomal",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -6.50390625,
            "text": "autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -6.6484375,
            "text": "autophagy, a",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_15": [
        {
            "start_logit": 4.953125,
            "end_logit": 7.8828125,
            "text": "chaperone-mediated autophagy",
            "probability": 0.998046875
        },
        {
            "start_logit": -1.6044921875,
            "end_logit": 7.8828125,
            "text": "autophagy",
            "probability": 0.001415252685546875
        },
        {
            "start_logit": -2.515625,
            "end_logit": 7.8828125,
            "text": "mediated autophagy",
            "probability": 0.0005698204040527344
        },
        {
            "start_logit": -5.453125,
            "end_logit": 7.8828125,
            "text": "lamp2a in the chaperone-mediated autophagy",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": -6.20703125,
            "end_logit": 7.8828125,
            "text": "-mediated autophagy",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.8828125,
            "text": "glycoprotein lamp2a in the chaperone-mediated autophagy",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.8828125,
            "text": "in the chaperone-mediated autophagy",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.8828125,
            "text": "2a in the chaperone-mediated autophagy",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 4.953125,
            "end_logit": -5.48828125,
            "text": "chaperone",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 4.953125,
            "end_logit": -8.015625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.953125,
            "end_logit": -8.0390625,
            "text": "chaperone-mediated autophagy of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.953125,
            "end_logit": -8.1015625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been described in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.953125,
            "end_logit": -8.109375,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has been described",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.953125,
            "end_logit": -8.1484375,
            "text": "chaperone-mediated autophagy of cytosolic proteins with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.953125,
            "end_logit": -8.1640625,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.953125,
            "end_logit": -8.171875,
            "text": "chaperone-mediated autophagy of cytosolic proteins with KFERQ motif has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6044921875,
            "end_logit": -7.98046875,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described in details as well as the chaperone protein Hsc73 and other chaperones involved in this process",
            "probability": 0.0
        },
        {
            "start_logit": -1.6044921875,
            "end_logit": -8.015625,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been",
            "probability": 0.0
        },
        {
            "start_logit": -1.6044921875,
            "end_logit": -8.0390625,
            "text": "autophagy of",
            "probability": 0.0
        },
        {
            "start_logit": -1.6044921875,
            "end_logit": -8.1015625,
            "text": "autophagy of cytosolic proteins with KFERQ motif has been described in",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_16": [
        {
            "start_logit": 6.2109375,
            "end_logit": 7.44921875,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": 7.44921875,
            "text": "autophagy",
            "probability": 0.00011867284774780273
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -4.87109375,
            "text": "Chaperone",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 7.44921875,
            "text": "mediated autophagy",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -5.19140625,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 7.44921875,
            "text": "-mediated autophagy",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -7.48828125,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -7.5,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -7.61328125,
            "text": "Chaperone-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -7.61328125,
            "text": "Chaperone-mediated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -8.0,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -8.03125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -8.0625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -8.09375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -8.1015625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -8.1328125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -8.2265625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -5.19140625,
            "text": "autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -7.48828125,
            "text": "autophagy (CMA) is",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -7.5,
            "text": "autophagy (CMA) is a",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_17": [
        {
            "start_logit": 5.78125,
            "end_logit": 7.66015625,
            "text": "chaperone-mediated autophagy",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.154296875,
            "end_logit": 7.66015625,
            "text": "autophagy",
            "probability": 0.0003597736358642578
        },
        {
            "start_logit": -3.58984375,
            "end_logit": 7.66015625,
            "text": "mediated autophagy",
            "probability": 8.541345596313477e-05
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 7.66015625,
            "text": "lysosomal pathway of chaperone-mediated autophagy",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 7.66015625,
            "text": "-mediated autophagy",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": 5.78125,
            "end_logit": -4.94140625,
            "text": "chaperone",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.66015625,
            "text": "suppress the lysosomal pathway of chaperone-mediated autophagy",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.66015625,
            "text": "pathway of chaperone-mediated autophagy",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 7.66015625,
            "text": ", growth factors suppress the lysosomal pathway of chaperone-mediated autophagy",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.66015625,
            "text": "the lysosomal pathway of chaperone-mediated autophagy",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 7.66015625,
            "text": "growth factors suppress the lysosomal pathway of chaperone-mediated autophagy",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 7.66015625,
            "text": "factors suppress the lysosomal pathway of chaperone-mediated autophagy",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 5.78125,
            "end_logit": -6.80078125,
            "text": "chaperone-mediated autophagy leading",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.78125,
            "end_logit": -7.35546875,
            "text": "chaperone-mediated autophagy leading to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.78125,
            "end_logit": -7.671875,
            "text": "chaperone-mediated autophagy leading to the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.78125,
            "end_logit": -7.99609375,
            "text": "chaperone-mediated autophagy leading to the accumulation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.78125,
            "end_logit": -8.125,
            "text": "chaperone-mediated autophagy leading to the accumulation of specific",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.78125,
            "end_logit": -8.171875,
            "text": "chaperone-mediated autophagy leading to the accumulation of specific cytoplasmic proteins containing KFERQ motifs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.154296875,
            "end_logit": -6.80078125,
            "text": "autophagy leading",
            "probability": 0.0
        },
        {
            "start_logit": -2.154296875,
            "end_logit": -7.35546875,
            "text": "autophagy leading to",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_18": [
        {
            "start_logit": 7.08203125,
            "end_logit": 7.578125,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -2.697265625,
            "end_logit": 7.578125,
            "text": "autophagy",
            "probability": 5.692243576049805e-05
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -3.65625,
            "text": "chaperone",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 7.578125,
            "text": "mediated autophagy",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -6.05078125,
            "text": "chaperone-mediated autophagy, a lysosomal",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 7.578125,
            "text": "-mediated autophagy",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -6.89453125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -6.97265625,
            "text": "chaperone-mediated autophagy, a",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.1640625,
            "text": "chaperone-mediated autophagy,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.2578125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.3359375,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.4921875,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of proteins containing a specific lysosomal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.55859375,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and allows the degradation of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.60546875,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.7109375,
            "text": "chaperone-mediated autophagy, a lysosomal import",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.73828125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.86328125,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.08203125,
            "end_logit": -7.875,
            "text": "chaperone-mediated autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.697265625,
            "end_logit": -6.05078125,
            "text": "autophagy, a lysosomal",
            "probability": 0.0
        },
        {
            "start_logit": -2.697265625,
            "end_logit": -6.89453125,
            "text": "autophagy, a lysosomal import pathway that depends on the 73-kDa heat shock cognate protein and",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_19": [
        {
            "start_logit": 1.57421875,
            "end_logit": 7.9140625,
            "text": "chaperone-mediated autophagy",
            "probability": 0.88330078125
        },
        {
            "start_logit": -0.8154296875,
            "end_logit": 7.9140625,
            "text": "mediated autophagy",
            "probability": 0.08123779296875
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": 7.9140625,
            "text": "autophagy",
            "probability": 0.034271240234375
        },
        {
            "start_logit": -6.09765625,
            "end_logit": 7.9140625,
            "text": "-mediated autophagy",
            "probability": 0.0004131793975830078
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.9140625,
            "text": "containing that chaperone-mediated autophagy",
            "probability": 9.47117805480957e-05
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.9140625,
            "text": "that chaperone-mediated autophagy",
            "probability": 9.399652481079102e-05
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.9140625,
            "text": "proteins containing that chaperone-mediated autophagy",
            "probability": 7.849931716918945e-05
        },
        {
            "start_logit": 1.57421875,
            "end_logit": -7.0234375,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38%",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.57421875,
            "end_logit": -7.28515625,
            "text": "chaperone",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.57421875,
            "end_logit": -7.546875,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.57421875,
            "end_logit": -7.7578125,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.57421875,
            "end_logit": -7.8203125,
            "text": "chaperone-mediated autophagy K",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.57421875,
            "end_logit": -7.859375,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38% and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.57421875,
            "end_logit": -7.88671875,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38% and individual KFERQ containing proteins [e.g.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.57421875,
            "end_logit": -7.9765625,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38% and individual KFERQ containing proteins [",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.57421875,
            "end_logit": -8.015625,
            "text": "chaperone-mediated autophagy KFERQ signal motif increased 38% and individual KFERQ containing proteins [e.g",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.8154296875,
            "end_logit": -7.0234375,
            "text": "mediated autophagy KFERQ signal motif increased 38%",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.8154296875,
            "end_logit": -7.546875,
            "text": "mediated autophagy KFERQ signal motif increased 38",
            "probability": 0.0
        },
        {
            "start_logit": -0.8154296875,
            "end_logit": -7.7578125,
            "text": "mediated autophagy KFERQ signal motif increased",
            "probability": 0.0
        },
        {
            "start_logit": -0.8154296875,
            "end_logit": -7.8203125,
            "text": "mediated autophagy K",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_20": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.875,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -1.9150390625,
            "end_logit": 7.875,
            "text": "autophagy",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.99609375,
            "text": "chaperone",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": -4.35546875,
            "end_logit": 7.875,
            "text": "mediated autophagy",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -6.0703125,
            "end_logit": 7.875,
            "text": "of chaperone-mediated autophagy",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 7.875,
            "text": "-mediated autophagy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.13671875,
            "text": "chaperone-mediated autophagy.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.875,
            "text": "the importance of KFERQ motifs in substrates of chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.875,
            "text": "substrates of chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 7.875,
            "text": "KFERQ motifs in substrates of chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.875,
            "text": "provide striking evidence for the importance of KFERQ motifs in substrates of chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 7.875,
            "text": "FERQ motifs in substrates of chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.875,
            "text": "evidence for the importance of KFERQ motifs in substrates of chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.84765625,
            "text": "chaperone-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 7.875,
            "text": "striking evidence for the importance of KFERQ motifs in substrates of chaperone-mediated autophagy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 7.875,
            "text": "These results provide striking evidence for the importance of KFERQ motifs in substrates of chaperone-mediated autophagy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -8.0234375,
            "text": "chaperone-mediated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.0703125,
            "end_logit": -1.99609375,
            "text": "of chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -1.9150390625,
            "end_logit": -7.13671875,
            "text": "autophagy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -1.99609375,
            "text": "the importance of KFERQ motifs in substrates of chaperone",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_21": [
        {
            "start_logit": 3.62109375,
            "end_logit": 7.328125,
            "text": "chaperone-mediated autophagy",
            "probability": 0.990234375
        },
        {
            "start_logit": -1.5458984375,
            "end_logit": 7.328125,
            "text": "mediated autophagy",
            "probability": 0.005619049072265625
        },
        {
            "start_logit": -2.59375,
            "end_logit": 7.328125,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 0.001972198486328125
        },
        {
            "start_logit": -2.634765625,
            "end_logit": 7.328125,
            "text": "autophagy",
            "probability": 0.0018968582153320312
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 7.328125,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 2.8789043426513672e-05
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 7.328125,
            "text": "-mediated autophagy",
            "probability": 2.8133392333984375e-05
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.328125,
            "text": "ophagy is followed by chaperone-mediated autophagy",
            "probability": 2.664327621459961e-05
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 7.328125,
            "text": "by chaperone-mediated autophagy",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": 3.62109375,
            "end_logit": -6.7109375,
            "text": "chaperone",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 3.62109375,
            "end_logit": -7.80859375,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.62109375,
            "end_logit": -7.859375,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.62109375,
            "end_logit": -7.91796875,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.62109375,
            "end_logit": -8.09375,
            "text": "chaperone-mediated autophagy (CMA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.62109375,
            "end_logit": -8.140625,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.59375,
            "end_logit": -5.765625,
            "text": "Macroautophagy",
            "probability": 0.0
        },
        {
            "start_logit": -2.634765625,
            "end_logit": -6.49609375,
            "text": "autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes",
            "probability": 0.0
        },
        {
            "start_logit": -2.59375,
            "end_logit": -6.7109375,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -1.5458984375,
            "end_logit": -7.80859375,
            "text": "mediated autophagy (CMA), in which Hsc",
            "probability": 0.0
        },
        {
            "start_logit": -1.5458984375,
            "end_logit": -7.859375,
            "text": "mediated autophagy (CMA), in which Hsc70",
            "probability": 0.0
        },
        {
            "start_logit": -1.5458984375,
            "end_logit": -7.91796875,
            "text": "mediated autophagy (CMA),",
            "probability": 0.0
        }
    ],
    "588f341594c1512c50000002_1": [
        {
            "start_logit": -0.031890869140625,
            "end_logit": 1.9091796875,
            "text": "learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.60986328125
        },
        {
            "start_logit": -0.031890869140625,
            "end_logit": 1.1015625,
            "text": "learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.27197265625
        },
        {
            "start_logit": -2.470703125,
            "end_logit": 1.9091796875,
            "text": "No Promoter Left Behind (NPLB): learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.053314208984375
        },
        {
            "start_logit": -2.470703125,
            "end_logit": 1.1015625,
            "text": "No Promoter Left Behind (NPLB): learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.02374267578125
        },
        {
            "start_logit": -4.0703125,
            "end_logit": 1.9091796875,
            "text": "from genome-wide transcription start sites.",
            "probability": 0.0107421875
        },
        {
            "start_logit": -4.65625,
            "end_logit": 1.9091796875,
            "text": "de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.005977630615234375
        },
        {
            "start_logit": -4.75,
            "end_logit": 1.9091796875,
            "text": ".",
            "probability": 0.005443572998046875
        },
        {
            "start_logit": -4.0703125,
            "end_logit": 1.1015625,
            "text": "from genome-wide transcription start sites",
            "probability": 0.0048065185546875
        },
        {
            "start_logit": -5.32421875,
            "end_logit": 1.9091796875,
            "text": "NPLB): learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.003078460693359375
        },
        {
            "start_logit": -4.65625,
            "end_logit": 1.1015625,
            "text": "de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.002674102783203125
        },
        {
            "start_logit": -5.32421875,
            "end_logit": 1.1015625,
            "text": "NPLB): learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.00136566162109375
        },
        {
            "start_logit": -6.28515625,
            "end_logit": 1.9091796875,
            "text": "novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.0011768341064453125
        },
        {
            "start_logit": -6.328125,
            "end_logit": 1.9091796875,
            "text": "promoter architectures from genome-wide transcription start sites.",
            "probability": 0.0011234283447265625
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 1.9091796875,
            "text": "LB): learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.0009760856628417969
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 1.9091796875,
            "text": "wide transcription start sites.",
            "probability": 0.0007781982421875
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 1.9091796875,
            "text": "start sites.",
            "probability": 0.0005965232849121094
        },
        {
            "start_logit": -6.96875,
            "end_logit": 1.9091796875,
            "text": "(NPLB): learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.0005922317504882812
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 1.9091796875,
            "text": "genome-wide transcription start sites.",
            "probability": 0.0005826950073242188
        },
        {
            "start_logit": -6.28515625,
            "end_logit": 1.1015625,
            "text": "novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.0005221366882324219
        },
        {
            "start_logit": -6.328125,
            "end_logit": 1.1015625,
            "text": "promoter architectures from genome-wide transcription start sites",
            "probability": 0.0005025863647460938
        }
    ],
    "588f341594c1512c50000002_2": [
        {
            "start_logit": -0.261474609375,
            "end_logit": 6.4453125,
            "text": "learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.89892578125
        },
        {
            "start_logit": -3.53515625,
            "end_logit": 6.4453125,
            "text": "from genome-wide transcription start sites",
            "probability": 0.0340576171875
        },
        {
            "start_logit": -4.3671875,
            "end_logit": 6.4453125,
            "text": "sites",
            "probability": 0.0148162841796875
        },
        {
            "start_logit": -4.46875,
            "end_logit": 6.4453125,
            "text": "No Promoter Left Behind (NPLB): learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.01338958740234375
        },
        {
            "start_logit": -4.60546875,
            "end_logit": 6.4453125,
            "text": "de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.0116729736328125
        },
        {
            "start_logit": -5.48828125,
            "end_logit": 6.4453125,
            "text": "NPLB): learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.00482940673828125
        },
        {
            "start_logit": -5.5625,
            "end_logit": 6.4453125,
            "text": "novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.004482269287109375
        },
        {
            "start_logit": -5.921875,
            "end_logit": 6.4453125,
            "text": "LB): learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.003131866455078125
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 6.4453125,
            "text": "promoter architectures from genome-wide transcription start sites",
            "probability": 0.0028839111328125
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 6.4453125,
            "text": "wide transcription start sites",
            "probability": 0.0023708343505859375
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 6.4453125,
            "text": "start sites",
            "probability": 0.001819610595703125
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 6.4453125,
            "text": "genome-wide transcription start sites",
            "probability": 0.001796722412109375
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 6.4453125,
            "text": "-wide transcription start sites",
            "probability": 0.001636505126953125
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 6.4453125,
            "text": "transcription start sites",
            "probability": 0.0015926361083984375
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 6.4453125,
            "text": "(NPLB): learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.0011034011840820312
        },
        {
            "start_logit": -7.03125,
            "end_logit": 6.4453125,
            "text": "architectures from genome-wide transcription start sites",
            "probability": 0.0010318756103515625
        },
        {
            "start_logit": -0.261474609375,
            "end_logit": -7.26171875,
            "text": "learn de novo promoter architectures",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -0.261474609375,
            "end_logit": -7.64453125,
            "text": "learn de novo promoter",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -4.46875,
            "end_logit": -6.21875,
            "text": "No Promoter Left Behind (NPLB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.48828125,
            "end_logit": -6.21875,
            "text": "NPLB",
            "probability": 0.0
        }
    ],
    "588f341594c1512c50000002_3": [
        {
            "start_logit": -0.031890869140625,
            "end_logit": 1.9091796875,
            "text": "learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.60986328125
        },
        {
            "start_logit": -0.031890869140625,
            "end_logit": 1.1015625,
            "text": "learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.27197265625
        },
        {
            "start_logit": -2.470703125,
            "end_logit": 1.9091796875,
            "text": "No Promoter Left Behind (NPLB): learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.053314208984375
        },
        {
            "start_logit": -2.470703125,
            "end_logit": 1.1015625,
            "text": "No Promoter Left Behind (NPLB): learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.02374267578125
        },
        {
            "start_logit": -4.0703125,
            "end_logit": 1.9091796875,
            "text": "from genome-wide transcription start sites.",
            "probability": 0.0107421875
        },
        {
            "start_logit": -4.65625,
            "end_logit": 1.9091796875,
            "text": "de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.005977630615234375
        },
        {
            "start_logit": -4.75,
            "end_logit": 1.9091796875,
            "text": ".",
            "probability": 0.005443572998046875
        },
        {
            "start_logit": -4.0703125,
            "end_logit": 1.1015625,
            "text": "from genome-wide transcription start sites",
            "probability": 0.0048065185546875
        },
        {
            "start_logit": -5.32421875,
            "end_logit": 1.9091796875,
            "text": "NPLB): learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.003078460693359375
        },
        {
            "start_logit": -4.65625,
            "end_logit": 1.1015625,
            "text": "de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.002674102783203125
        },
        {
            "start_logit": -5.32421875,
            "end_logit": 1.1015625,
            "text": "NPLB): learn de novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.00136566162109375
        },
        {
            "start_logit": -6.28515625,
            "end_logit": 1.9091796875,
            "text": "novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.0011768341064453125
        },
        {
            "start_logit": -6.328125,
            "end_logit": 1.9091796875,
            "text": "promoter architectures from genome-wide transcription start sites.",
            "probability": 0.0011234283447265625
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 1.9091796875,
            "text": "LB): learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.0009760856628417969
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 1.9091796875,
            "text": "wide transcription start sites.",
            "probability": 0.0007781982421875
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 1.9091796875,
            "text": "start sites.",
            "probability": 0.0005965232849121094
        },
        {
            "start_logit": -6.96875,
            "end_logit": 1.9091796875,
            "text": "(NPLB): learn de novo promoter architectures from genome-wide transcription start sites.",
            "probability": 0.0005922317504882812
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 1.9091796875,
            "text": "genome-wide transcription start sites.",
            "probability": 0.0005826950073242188
        },
        {
            "start_logit": -6.28515625,
            "end_logit": 1.1015625,
            "text": "novo promoter architectures from genome-wide transcription start sites",
            "probability": 0.0005221366882324219
        },
        {
            "start_logit": -6.328125,
            "end_logit": 1.1015625,
            "text": "promoter architectures from genome-wide transcription start sites",
            "probability": 0.0005025863647460938
        }
    ],
    "5ac138aa95d0062724000001_1": [
        {
            "start_logit": 7.1875,
            "end_logit": 7.6015625,
            "text": "N-arginine dibasic convertase",
            "probability": 1.0
        },
        {
            "start_logit": -2.65234375,
            "end_logit": 7.6015625,
            "text": "ase",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": 7.1875,
            "end_logit": -3.5,
            "text": "N",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": -4.46484375,
            "end_logit": 7.6015625,
            "text": "arginine dibasic convertase",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": 7.1875,
            "end_logit": -4.8046875,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -5.25,
            "end_logit": 7.6015625,
            "text": "-arginine dibasic convertase",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -5.32421875,
            "end_logit": 7.6015625,
            "text": "convertase",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -5.55078125,
            "end_logit": 7.6015625,
            "text": "Nardilysin (N-arginine dibasic convertase",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -5.5703125,
            "end_logit": 7.6015625,
            "text": "dibasic convertase",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 7.6015625,
            "text": "asic convertase",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.1875,
            "end_logit": -6.734375,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.1875,
            "end_logit": -6.94140625,
            "text": "N-arginine dibasic convert",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.13671875,
            "text": "N-arginine dibasic convertase;",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.1953125,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding of the precursor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.45703125,
            "text": "N-arginine dibasic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.47265625,
            "text": "N-arginine dib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.5,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1875,
            "end_logit": -7.75,
            "text": "N-arginine dibasic convertase; Nrdc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.107421875,
            "end_logit": 1.6708984375,
            "text": "of the precursor forms of various growth factors and cytokines by enhancing the protease activities of a disintegrin and metalloproteinase (ADAM) proteins.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.78125,
            "end_logit": 1.6708984375,
            "text": "odomain shedding of the precursor forms of various growth factors and cytokines by enhancing the protease activities of a disintegrin and metalloproteinase (ADAM) proteins.",
            "probability": 0.0
        }
    ],
    "5708a845cf1c32585100000f_1": [
        {
            "start_logit": 7.89453125,
            "end_logit": 7.66015625,
            "text": "Wnt signaling",
            "probability": 0.93115234375
        },
        {
            "start_logit": 6.25,
            "end_logit": 6.6328125,
            "text": "Wnt",
            "probability": 0.06439208984375
        },
        {
            "start_logit": 7.89453125,
            "end_logit": 2.306640625,
            "text": "Wnt",
            "probability": 0.004413604736328125
        },
        {
            "start_logit": -2.158203125,
            "end_logit": 7.66015625,
            "text": "signaling",
            "probability": 3.999471664428711e-05
        },
        {
            "start_logit": 6.25,
            "end_logit": -5.28515625,
            "text": "Wnt and involved in signal transduction",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.0390625,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be regulated by the proteins Dishevelled and Axin.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.5,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be regulated by the proteins Dishevelled and Axin. Although",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.6328125,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be regulated by the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.671875,
            "text": "Wnt signaling is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.68359375,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.25,
            "end_logit": -6.046875,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.7109375,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.71484375,
            "text": "Wnt signaling is known to be important",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 6.6328125,
            "text": "by Wnt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.25,
            "end_logit": -6.80859375,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 6.6328125,
            "text": ". Although Dishevelled is activated by Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.0390625,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned off.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.2890625,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.4609375,
            "text": "Wnt and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.4609375,
            "text": "Wnt and involved in signal transduction, it is not clear how Dish",
            "probability": 5.960464477539063e-08
        }
    ],
    "5708a845cf1c32585100000f_2": [
        {
            "start_logit": 7.265625,
            "end_logit": 7.625,
            "text": "canonical Wnt signaling",
            "probability": 1.0
        },
        {
            "start_logit": 7.265625,
            "end_logit": -0.81689453125,
            "text": "canonical Wnt",
            "probability": 0.00021660327911376953
        },
        {
            "start_logit": -2.376953125,
            "end_logit": 7.625,
            "text": "signaling",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": 7.265625,
            "end_logit": -3.4140625,
            "text": "canonical",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": -5.55078125,
            "end_logit": 7.625,
            "text": "Wnt signaling",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 7.625,
            "text": ". Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.265625,
            "end_logit": -7.07421875,
            "text": "canonical Wnt signaling,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.625,
            "text": "via canonical Wnt signaling",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.625,
            "text": "Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 7.625,
            "text": "Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 7.625,
            "text": "dsh) controls cell fate via canonical Wnt signaling",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 7.625,
            "text": "evelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 7.625,
            "text": "fate via canonical Wnt signaling",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 7.625,
            "text": "cell fate via canonical Wnt signaling",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.55078125,
            "end_logit": -0.81689453125,
            "text": "Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -0.81689453125,
            "text": ". Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -0.81689453125,
            "text": "via canonical Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -0.81689453125,
            "text": "Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -0.81689453125,
            "text": "Xdsh) controls cell fate via canonical Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -0.81689453125,
            "text": "dsh) controls cell fate via canonical Wnt",
            "probability": 0.0
        }
    ],
    "5708a845cf1c32585100000f_3": [
        {
            "start_logit": 6.6640625,
            "end_logit": 6.109375,
            "text": "Wnt",
            "probability": 1.0
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -2.556640625,
            "text": "Wnt signaling pathways",
            "probability": 0.00017273426055908203
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -6.08984375,
            "text": "Wnt signaling",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -6.9375,
            "end_logit": 6.109375,
            "text": "canonical and noncanonical Wnt",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 6.109375,
            "text": "noncanonical Wnt",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.56640625,
            "text": "Wnt signaling pathways.",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.203125,
            "end_logit": 6.109375,
            "text": "of canonical and noncanonical Wnt",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 6.109375,
            "text": "nical Wnt",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.109375,
            "text": "anonical Wnt",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 6.109375,
            "text": "components of canonical and noncanonical Wnt",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.109375,
            "text": "DVL) proteins, three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.109375,
            "text": "al Wnt",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": -2.556640625,
            "text": "canonical and noncanonical Wnt signaling pathways",
            "probability": 0.0
        },
        {
            "start_logit": -6.94140625,
            "end_logit": -2.556640625,
            "text": "noncanonical Wnt signaling pathways",
            "probability": 0.0
        },
        {
            "start_logit": -7.203125,
            "end_logit": -2.556640625,
            "text": "of canonical and noncanonical Wnt signaling pathways",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -2.556640625,
            "text": "nical Wnt signaling pathways",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -2.556640625,
            "text": "anonical Wnt signaling pathways",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -2.556640625,
            "text": "components of canonical and noncanonical Wnt signaling pathways",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -2.556640625,
            "text": "DVL) proteins, three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt signaling pathways",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": -2.556640625,
            "text": "al Wnt signaling pathways",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_1": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.96484375,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.603515625,
            "end_logit": 7.96484375,
            "text": "1",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.7060546875,
            "text": "ABC",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -5.89453125,
            "text": "ABCC1",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 7.96484375,
            "text": "C11",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.41796875,
            "text": "ABCC11 affects",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.4296875,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.45703125,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.48828125,
            "text": "ABCC11 affects the cerumen VOC profiles of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.5234375,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian descent",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.6953125,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.75390625,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.96484375,
            "text": "in ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.7890625,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.79296875,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.8515625,
            "text": "ABCC11 affects the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.96484375,
            "text": "single nucleotide polymorphism (SNP) in ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.9921875,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -8.046875,
            "text": "ABCC11 affects the cerumen VOC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.603515625,
            "end_logit": -7.41796875,
            "text": "1 affects",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_2": [
        {
            "start_logit": 7.95703125,
            "end_logit": 7.95703125,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -1.525390625,
            "text": "ABC",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": -1.59375,
            "end_logit": 7.95703125,
            "text": "1",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -5.98046875,
            "text": "ABCC1",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.265625,
            "end_logit": 7.95703125,
            "text": "C11",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.2421875,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.296875,
            "text": "ABCC11 genotype",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.546875,
            "text": "ABCC11 genotype alone does",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.60546875,
            "text": "ABCC11 genotype alone",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.62109375,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.63671875,
            "text": "ABCC11 genotype alone does not predict",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.67578125,
            "text": "ABCC11 genotype alone does not predict the type and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.71875,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.72265625,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.73828125,
            "text": "ABCC11 genotype alone does not predict the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.76953125,
            "text": "ABCC11 genotype alone does not predict the type and relative",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.78125,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.78125,
            "text": "ABCC11 genotype alone does not",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.8359375,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.95703125,
            "text": "that ABCC11",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5acf74460340b9f058000013_3": [
        {
            "start_logit": 7.8984375,
            "end_logit": 7.93359375,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.841796875,
            "end_logit": 7.93359375,
            "text": "1",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -1.9619140625,
            "text": "ABC",
            "probability": 5.066394805908203e-05
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -6.32421875,
            "text": "ABCC1",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.515625,
            "end_logit": 7.93359375,
            "text": "C11",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -6.953125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.20703125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.25390625,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.2578125,
            "text": "ABCC11 encodes an ATP-driven efflux pump",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.5078125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.52734375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.53515625,
            "text": "ABCC11 encodes an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.58203125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.5859375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.58984375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.6015625,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.6171875,
            "text": "ABCC11 encodes an ATP-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8984375,
            "end_logit": -7.62109375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of the auditory canal and the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.841796875,
            "end_logit": -6.953125,
            "text": "1 encodes an ATP-driven efflux pump protein that plays an important",
            "probability": 0.0
        },
        {
            "start_logit": -1.841796875,
            "end_logit": -7.20703125,
            "text": "1 encodes an ATP-driven efflux pump protein that plays an important function in",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_4": [
        {
            "start_logit": 7.80859375,
            "end_logit": 7.95703125,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.580078125,
            "end_logit": 7.95703125,
            "text": "1",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -2.2421875,
            "text": "ABC",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -5.65234375,
            "text": "ABCC1",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 7.95703125,
            "text": "C11",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 7.95703125,
            "text": "the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.95703125,
            "text": "11 gene (ABCC11",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.95703125,
            "text": "member 11 gene (ABCC11",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.23046875,
            "text": "ABCC11) to the production of different types of axillary odorants",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.95703125,
            "text": "cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 7.95703125,
            "text": ", member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 7.95703125,
            "text": "sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 7.95703125,
            "text": "family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.640625,
            "text": "ABCC11) to the production of different types of axillary odorants and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.95703125,
            "text": "(ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 7.95703125,
            "text": "in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.6875,
            "text": "ABCC11)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.95703125,
            "text": "adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.95703125,
            "text": "binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.95703125,
            "text": "triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        }
    ],
    "62265b4a3a8413c653000083_1": [
        {
            "start_logit": 7.67578125,
            "end_logit": 4.25,
            "text": "Runt-related transcription factor",
            "probability": 0.98095703125
        },
        {
            "start_logit": 7.67578125,
            "end_logit": 0.2027587890625,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 0.0172119140625
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -2.435546875,
            "text": "Run",
            "probability": 0.001232147216796875
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -4.6875,
            "text": "Runt-related transcription factor 1",
            "probability": 0.00012886524200439453
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -6.48046875,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in adipogenesis",
            "probability": 2.1517276763916016e-05
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -6.7421875,
            "text": "Runt-related transcription",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.03515625,
            "text": "Runt-related",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.12109375,
            "text": "Runt",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.37109375,
            "text": "Runt-",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.4921875,
            "text": "Runt-related transcription factor 1 (RUNX1",
            "probability": 7.808208465576172e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.5,
            "text": "Runt-related transcription factor 1 (RUNX1T1",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.7578125,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.796875,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.828125,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -8.078125,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -8.1328125,
            "text": "Runt-related transcription factor 1 (RUNX1T1)",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 4.25,
            "text": "factor",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 4.25,
            "text": "related transcription factor",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 4.25,
            "text": "transcription factor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 4.25,
            "text": "-related transcription factor",
            "probability": 5.960464477539062e-07
        }
    ],
    "54e8c7220fc566b149000002_1": [
        {
            "start_logit": -4.703125,
            "end_logit": 4.7734375,
            "text": "nucleus",
            "probability": 0.63232421875
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 4.7734375,
            "text": "p53 in the nucleus",
            "probability": 0.09149169921875
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 4.7734375,
            "text": "in the nucleus",
            "probability": 0.069580078125
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 4.7734375,
            "text": "the nucleus",
            "probability": 0.058380126953125
        },
        {
            "start_logit": -7.421875,
            "end_logit": 4.7734375,
            "text": "S100A4 interacts with p53 in the nucleus",
            "probability": 0.041717529296875
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 4.7734375,
            "text": "with p53 in the nucleus",
            "probability": 0.03814697265625
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 4.7734375,
            "text": "interacts with p53 in the nucleus",
            "probability": 0.0341796875
        },
        {
            "start_logit": -7.625,
            "end_logit": 4.7734375,
            "text": "4 interacts with p53 in the nucleus",
            "probability": 0.0340576171875
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -7.7578125,
            "text": "p53 in the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -8.0078125,
            "text": "p53",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.7578125,
            "text": "in the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": -7.7578125,
            "text": "the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.7578125,
            "text": "S100A4 interacts with p53 in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.7578125,
            "text": "with p53 in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.7578125,
            "text": "interacts with p53 in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.7578125,
            "text": "4 interacts with p53 in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": -8.0078125,
            "text": "S100A4 interacts with p53",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -8.0078125,
            "text": "with p53",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": -8.125,
            "text": "S100A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -8.0078125,
            "text": "interacts with p53",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54e8c7220fc566b149000002_2": [
        {
            "start_logit": 5.4296875,
            "end_logit": 7.0703125,
            "text": "nucleus",
            "probability": 1.0
        },
        {
            "start_logit": -4.63671875,
            "end_logit": 7.0703125,
            "text": "cell nucleus",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": -5.359375,
            "end_logit": 7.0703125,
            "text": "proximity ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": 5.4296875,
            "end_logit": -5.984375,
            "text": "nucleus.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.0703125,
            "text": "interaction takes place in the cell nucleus",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.0703125,
            "text": "in the cell nucleus",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.0703125,
            "text": "ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 7.0703125,
            "text": "that the interaction takes place in the cell nucleus",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 7.0703125,
            "text": "show that the interaction takes place in the cell nucleus",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 7.0703125,
            "text": "takes place in the cell nucleus",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 7.0703125,
            "text": "place in the cell nucleus",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -4.63671875,
            "end_logit": -5.984375,
            "text": "cell nucleus.",
            "probability": 0.0
        },
        {
            "start_logit": -5.359375,
            "end_logit": -5.984375,
            "text": "proximity ligation assay, we show that the interaction takes place in the cell nucleus.",
            "probability": 0.0
        },
        {
            "start_logit": -5.359375,
            "end_logit": -7.35546875,
            "text": "proximity ligation assay, we show that the interaction takes place in the",
            "probability": 0.0
        },
        {
            "start_logit": -5.359375,
            "end_logit": -7.3984375,
            "text": "proximity ligation assay, we",
            "probability": 0.0
        },
        {
            "start_logit": -5.359375,
            "end_logit": -7.52734375,
            "text": "proximity ligation assay",
            "probability": 0.0
        },
        {
            "start_logit": -5.359375,
            "end_logit": -7.609375,
            "text": "proximity ligation assay,",
            "probability": 0.0
        },
        {
            "start_logit": -5.359375,
            "end_logit": -7.7265625,
            "text": "proximity ligation assay, we show that the",
            "probability": 0.0
        },
        {
            "start_logit": -5.359375,
            "end_logit": -7.859375,
            "text": "proximity ligation",
            "probability": 0.0
        },
        {
            "start_logit": -5.359375,
            "end_logit": -7.8984375,
            "text": "proximity ligation assay, we show",
            "probability": 0.0
        }
    ],
    "58f0b0c070f9fc6f0f000006_1": [
        {
            "start_logit": 7.84765625,
            "end_logit": 7.90625,
            "text": "tardive dyskinesia",
            "probability": 1.0
        },
        {
            "start_logit": -1.8505859375,
            "end_logit": 7.90625,
            "text": "dyskinesia",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -2.189453125,
            "text": "tard",
            "probability": 4.1365623474121094e-05
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 7.90625,
            "text": "ive dyskinesia",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -6.84765625,
            "text": "tardive",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 7.90625,
            "text": "treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.90625,
            "text": "zine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.90625,
            "text": "drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.90625,
            "text": "ine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.90625,
            "text": "nazine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.90625,
            "text": "benazine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -2.189453125,
            "text": "treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -2.189453125,
            "text": "zine granted breakthrough drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -2.189453125,
            "text": "drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -2.189453125,
            "text": "ine granted breakthrough drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -2.189453125,
            "text": "nazine granted breakthrough drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -2.189453125,
            "text": "benazine granted breakthrough drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -6.73046875,
            "end_logit": -6.84765625,
            "text": "ive",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -6.84765625,
            "text": "treating tardive",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -6.84765625,
            "text": "zine granted breakthrough drug status for treating tardive",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_1": [
        {
            "start_logit": 7.4375,
            "end_logit": 3.982421875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.95947265625
        },
        {
            "start_logit": 7.4375,
            "end_logit": 0.7275390625,
            "text": "Borderline oxacillin-resistant",
            "probability": 0.03692626953125
        },
        {
            "start_logit": 7.4375,
            "end_logit": -2.20703125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 0.001964569091796875
        },
        {
            "start_logit": 7.4375,
            "end_logit": -2.61328125,
            "text": "Borderline",
            "probability": 0.001308441162109375
        },
        {
            "start_logit": 7.4375,
            "end_logit": -5.08203125,
            "text": "Borderline oxacillin",
            "probability": 0.0001112818717956543
        },
        {
            "start_logit": -2.041015625,
            "end_logit": 3.982421875,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 7.301568984985352e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -5.61328125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 6.538629531860352e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -6.09375,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 4.029273986816406e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -6.9765625,
            "text": "Borderline oxacillin-",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.43359375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.69921875,
            "text": "Borderline oxacil",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.7265625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 3.982421875,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -2.041015625,
            "end_logit": 0.7275390625,
            "text": "oxacillin-resistant",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -6.265625,
            "end_logit": 3.982421875,
            "text": "aureus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 3.982421875,
            "text": "resistant Staphylococcus aureus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 3.982421875,
            "text": "lin-resistant Staphylococcus aureus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 3.982421875,
            "text": "-resistant Staphylococcus aureus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.041015625,
            "end_logit": -2.20703125,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 0.7275390625,
            "text": "cillin-resistant",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5aae6499fcf456587200000c_2": [
        {
            "start_logit": 6.49609375,
            "end_logit": 6.7109375,
            "text": "MRSA",
            "probability": 1.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": 6.7109375,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -6.09765625,
            "text": "MRSA) in the clinical laboratory.",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 6.7109375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.765625,
            "end_logit": 6.7109375,
            "text": "cillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 6.7109375,
            "text": "resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.04296875,
            "text": "MRSA) in",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.7109375,
            "text": "lin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.7109375,
            "text": "misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.7109375,
            "text": "resistant Staphylococcus aureus (MRSA",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.71484375,
            "text": "MRSA)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.7265625,
            "text": "MRSA) in the",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.7109375,
            "text": "-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.7109375,
            "text": "may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.7109375,
            "text": "methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.7109375,
            "text": "identified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 6.7109375,
            "text": "be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.7109375,
            "text": "ified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -6.43359375,
            "text": "oxacillin-resistant",
            "probability": 0.0
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -7.04296875,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA) in",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_3": [
        {
            "start_logit": 6.16015625,
            "end_logit": 0.7197265625,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 0.9853515625
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -4.046875,
            "text": "oxa",
            "probability": 0.008392333984375
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -5.14453125,
            "text": "oxacillin-resistant",
            "probability": 0.00279998779296875
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -6.109375,
            "text": "oxacillin",
            "probability": 0.0010671615600585938
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -6.375,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin",
            "probability": 0.0008182525634765625
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -6.62890625,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg/L",
            "probability": 0.0006346702575683594
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -7.25390625,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654",
            "probability": 0.00033974647521972656
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -7.4453125,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 0.00028061866760253906
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -7.5,
            "text": "oxacil",
            "probability": 0.0002658367156982422
        },
        {
            "start_logit": -3.01953125,
            "end_logit": 0.7197265625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.00010162591934204102
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 0.7197265625,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": -6.40625,
            "end_logit": 0.7197265625,
            "text": "\u03b2-lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -6.734375,
            "end_logit": 0.7197265625,
            "text": "lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 0.7197265625,
            "text": "resistant Staphylococcus aureus",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.375,
            "end_logit": 0.7197265625,
            "text": "-resistant Staphylococcus aureus",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 0.7197265625,
            "text": "Staphylococcus aureus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -3.01953125,
            "end_logit": -4.046875,
            "text": "borderline oxa",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -4.25,
            "end_logit": -3.451171875,
            "text": "oxacillin against clinical BORSA isolates was evaluated.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -3.01953125,
            "end_logit": -5.14453125,
            "text": "borderline oxacillin-resistant",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.10546875,
            "end_logit": -3.451171875,
            "text": "oxacillin MICs \u22654 mg/L, the in vitro bactericidal activity and pharmacodynamic effect of oxacillin against clinical BORSA isolates was evaluated.",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5aae6499fcf456587200000c_4": [
        {
            "start_logit": 8.03125,
            "end_logit": 0.5546875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance.",
            "probability": 0.61962890625
        },
        {
            "start_logit": 8.03125,
            "end_logit": -0.49462890625,
            "text": "Borderline oxacillin-resistant",
            "probability": 0.2166748046875
        },
        {
            "start_logit": 8.03125,
            "end_logit": -1.3134765625,
            "text": "Borderline",
            "probability": 0.09576416015625
        },
        {
            "start_logit": 8.03125,
            "end_logit": -2.125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.042510986328125
        },
        {
            "start_logit": 8.03125,
            "end_logit": -2.8046875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance",
            "probability": 0.02154541015625
        },
        {
            "start_logit": 8.03125,
            "end_logit": -5.7421875,
            "text": "Borderline oxacillin",
            "probability": 0.0011425018310546875
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.87109375,
            "text": "Borderline oxacillin-",
            "probability": 0.00036907196044921875
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.9765625,
            "text": "Borderline oxacil",
            "probability": 0.00033211708068847656
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.09375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin",
            "probability": 0.0002956390380859375
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.34375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0002300739288330078
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.37890625,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 0.00022232532501220703
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.51953125,
            "text": "Borderline oxa",
            "probability": 0.00019228458404541016
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.5859375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and",
            "probability": 0.0001806020736694336
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.62890625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite",
            "probability": 0.0001723766326904297
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.68359375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequate",
            "probability": 0.00016450881958007812
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.73046875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 0.0001569986343383789
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.76171875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood",
            "probability": 0.00015211105346679688
        },
        {
            "start_logit": -5.265625,
            "end_logit": 0.5546875,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 0.5546875,
            "text": "methicillin resistance.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.265625,
            "end_logit": -0.49462890625,
            "text": "oxacillin-resistant",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5aae6499fcf456587200000c_5": [
        {
            "start_logit": 5.203125,
            "end_logit": -1.1162109375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.7802734375
        },
        {
            "start_logit": 5.203125,
            "end_logit": -3.857421875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin",
            "probability": 0.0504150390625
        },
        {
            "start_logit": 5.203125,
            "end_logit": -3.916015625,
            "text": "Borderline",
            "probability": 0.047515869140625
        },
        {
            "start_logit": -3.21484375,
            "end_logit": 3.892578125,
            "text": ".",
            "probability": 0.025848388671875
        },
        {
            "start_logit": 5.203125,
            "end_logit": -4.8671875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit",
            "probability": 0.0183563232421875
        },
        {
            "start_logit": 5.203125,
            "end_logit": -4.91796875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(-1)",
            "probability": 0.0174407958984375
        },
        {
            "start_logit": 5.203125,
            "end_logit": -5.2578125,
            "text": "Borderline oxacillin-resistant",
            "probability": 0.012420654296875
        },
        {
            "start_logit": -4.44140625,
            "end_logit": 3.892578125,
            "text": "mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 0.00759124755859375
        },
        {
            "start_logit": 5.203125,
            "end_logit": -5.7578125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 0.007534027099609375
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.10546875,
            "text": "Borderline oxacillin",
            "probability": 0.005321502685546875
        },
        {
            "start_logit": 0.1728515625,
            "end_logit": -1.1162109375,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 0.005096435546875
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.15625,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 0.00505828857421875
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.42578125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC",
            "probability": 0.0038623809814453125
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.6328125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0031414031982421875
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.8203125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(",
            "probability": 0.0026035308837890625
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.84375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacil",
            "probability": 0.0025424957275390625
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.9765625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(-1),",
            "probability": 0.002227783203125
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 3.892578125,
            "text": "penicillin-binding protein (PBP)2a.",
            "probability": 0.0008997917175292969
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 3.892578125,
            "text": "which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 0.0008449554443359375
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 3.892578125,
            "text": "the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 0.0006585121154785156
        }
    ],
    "5aae6499fcf456587200000c_6": [
        {
            "start_logit": 7.88671875,
            "end_logit": 4.953125,
            "text": "borderline oxacillin resistant Staphylococcus aureus",
            "probability": 0.7568359375
        },
        {
            "start_logit": 7.88671875,
            "end_logit": 3.814453125,
            "text": "borderline oxacillin resistant",
            "probability": 0.2418212890625
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -1.8046875,
            "text": "borderline",
            "probability": 0.0008754730224609375
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -4.0625,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BORSA)",
            "probability": 9.191036224365234e-05
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -4.5703125,
            "text": "borderline oxacillin",
            "probability": 5.4895877838134766e-05
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -6.48046875,
            "text": "borderline oxacillin resistant Staphylococcus aureus (",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -6.6171875,
            "text": "borderline oxacillin resistant Staphylococcus",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": -4.21484375,
            "end_logit": 4.953125,
            "text": "oxacillin resistant Staphylococcus aureus",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.390625,
            "text": "borderline oxacil",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.5390625,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BORSA",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.8125,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BOR",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -8.0078125,
            "text": "borderline oxa",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -4.21484375,
            "end_logit": 3.814453125,
            "text": "oxacillin resistant",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.63671875,
            "end_logit": 4.953125,
            "text": "aureus",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.828125,
            "end_logit": 4.953125,
            "text": "cillin resistant Staphylococcus aureus",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 4.953125,
            "text": "resistant Staphylococcus aureus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.828125,
            "end_logit": 3.814453125,
            "text": "cillin resistant",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 4.953125,
            "text": "lin resistant Staphylococcus aureus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 3.814453125,
            "text": "resistant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 4.953125,
            "text": "Staphylococcus aureus",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5aae6499fcf456587200000c_7": [
        {
            "start_logit": 7.4375,
            "end_logit": 3.982421875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.95947265625
        },
        {
            "start_logit": 7.4375,
            "end_logit": 0.7275390625,
            "text": "borderline oxacillin-resistant",
            "probability": 0.03692626953125
        },
        {
            "start_logit": 7.4375,
            "end_logit": -2.20703125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 0.001964569091796875
        },
        {
            "start_logit": 7.4375,
            "end_logit": -2.61328125,
            "text": "borderline",
            "probability": 0.001308441162109375
        },
        {
            "start_logit": 7.4375,
            "end_logit": -5.08203125,
            "text": "borderline oxacillin",
            "probability": 0.0001112818717956543
        },
        {
            "start_logit": -2.041015625,
            "end_logit": 3.982421875,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 7.301568984985352e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -5.61328125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 6.538629531860352e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -6.09375,
            "text": "borderline oxacillin-resistant Staphylococcus",
            "probability": 4.029273986816406e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -6.9765625,
            "text": "borderline oxacillin-",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.43359375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.69921875,
            "text": "borderline oxacil",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.7265625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 3.982421875,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -2.041015625,
            "end_logit": 0.7275390625,
            "text": "oxacillin-resistant",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -6.265625,
            "end_logit": 3.982421875,
            "text": "aureus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 3.982421875,
            "text": "resistant Staphylococcus aureus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 3.982421875,
            "text": "lin-resistant Staphylococcus aureus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 3.982421875,
            "text": "-resistant Staphylococcus aureus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.041015625,
            "end_logit": -2.20703125,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 0.7275390625,
            "text": "cillin-resistant",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5aae6499fcf456587200000c_8": [
        {
            "start_logit": 3.244140625,
            "end_logit": -2.1171875,
            "text": "oxacillin",
            "probability": 0.4052734375
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -2.412109375,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 0.3017578125
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -3.05859375,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA and ORSA",
            "probability": 0.158203125
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -3.58984375,
            "text": "oxacillin-resistant",
            "probability": 0.09295654296875
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -5.46875,
            "text": "oxa",
            "probability": 0.0142059326171875
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -5.50390625,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA and ORSA) s",
            "probability": 0.01371002197265625
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -7.01171875,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0030364990234375
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -7.1796875,
            "text": "oxacil",
            "probability": 0.0025653839111328125
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -7.30078125,
            "text": "oxacillin-resistant Staphylococcus",
            "probability": 0.0022830963134765625
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -7.4296875,
            "text": "oxacillin-",
            "probability": 0.0019989013671875
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -7.62890625,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA and ORSA)",
            "probability": 0.001644134521484375
        },
        {
            "start_logit": 3.244140625,
            "end_logit": -8.03125,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 0.001094818115234375
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -2.1171875,
            "text": "heterotypic oxacillin",
            "probability": 0.0001327991485595703
        },
        {
            "start_logit": -3.87890625,
            "end_logit": -3.05859375,
            "text": "ORSA",
            "probability": 0.0001277923583984375
        },
        {
            "start_logit": -4.8203125,
            "end_logit": -2.1171875,
            "text": "cillin",
            "probability": 0.0001277923583984375
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -2.412109375,
            "text": "heterotypic oxacillin-resistant Staphylococcus aureus",
            "probability": 9.948015213012695e-05
        },
        {
            "start_logit": -4.8203125,
            "end_logit": -2.412109375,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 9.495019912719727e-05
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -3.05859375,
            "text": "heterotypic oxacillin-resistant Staphylococcus aureus (BORSA and ORSA",
            "probability": 5.1975250244140625e-05
        },
        {
            "start_logit": -4.8203125,
            "end_logit": -3.05859375,
            "text": "cillin-resistant Staphylococcus aureus (BORSA and ORSA",
            "probability": 4.965066909790039e-05
        },
        {
            "start_logit": -5.890625,
            "end_logit": -2.1171875,
            "text": "typic oxacillin",
            "probability": 4.380941390991211e-05
        }
    ],
    "5aae6499fcf456587200000c_9": [
        {
            "start_logit": 6.49609375,
            "end_logit": 4.60546875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.9970703125
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -2.28125,
            "text": "borderline oxacillin-resistant",
            "probability": 0.001018524169921875
        },
        {
            "start_logit": -0.54248046875,
            "end_logit": 4.60546875,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 0.0008745193481445312
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -2.970703125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0005102157592773438
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -3.935546875,
            "text": "borderline",
            "probability": 0.00019502639770507812
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -5.33984375,
            "text": "borderline oxacillin",
            "probability": 4.780292510986328e-05
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -6.046875,
            "text": "borderline oxacillin-resistant Staphylococcus",
            "probability": 2.3484230041503906e-05
        },
        {
            "start_logit": -5.09765625,
            "end_logit": 4.60546875,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.1171875,
            "text": "borderline oxacillin-",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -5.62109375,
            "end_logit": 4.60546875,
            "text": "aureus",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.66796875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.828125,
            "text": "borderline oxacil",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 4.60546875,
            "text": "lin-resistant Staphylococcus aureus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -0.54248046875,
            "end_logit": -2.28125,
            "text": "oxacillin-resistant",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 4.60546875,
            "text": "-resistant Staphylococcus aureus",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 4.60546875,
            "text": "Staphylococcus aureus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 4.60546875,
            "text": "resistant Staphylococcus aureus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -0.54248046875,
            "end_logit": -2.970703125,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.54248046875,
            "end_logit": -5.33984375,
            "text": "oxacillin",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e46eb7a3f5415952900000d_1": [
        {
            "start_logit": 8.0234375,
            "end_logit": 7.98046875,
            "text": "Parkinson's Disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -1.0966796875,
            "text": "Parkinson",
            "probability": 0.00011414289474487305
        },
        {
            "start_logit": -1.576171875,
            "end_logit": 7.98046875,
            "text": "Disease",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -2.767578125,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 7.98046875,
            "text": "s Disease",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 7.98046875,
            "text": "'s Disease",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 7.98046875,
            "text": "Unified Parkinson's Disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 7.98046875,
            "text": "the Unified Parkinson's Disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.8046875,
            "text": "Parkinson's",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.09765625,
            "text": "Parkinson'",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 7.98046875,
            "text": ", the Unified Parkinson's Disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.46875,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with kinematic assessment of the treated limb",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.62109375,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with kinematic assessment of the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.75390625,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.76953125,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with kinematic assessment of the treated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.78125,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.79296875,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with kinematic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.576171875,
            "end_logit": -2.767578125,
            "text": "Disease Rating Scale, and the Quality of Life for Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -1.7041015625,
            "end_logit": -2.767578125,
            "text": "Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -1.0966796875,
            "text": "Unified Parkinson",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_2": [
        {
            "start_logit": 7.875,
            "end_logit": 7.8125,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 7.875,
            "end_logit": -1.4990234375,
            "text": "essential",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": 7.8125,
            "text": "tremor",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.89453125,
            "text": "essential tremor]",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.8125,
            "text": "hn-Tolosa-Marin scale for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.8125,
            "text": "Fahn-Tolosa-Marin scale for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.8125,
            "text": "Marin scale for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.8125,
            "text": "for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.8125,
            "text": "version of the Fahn-Tolosa-Marin scale for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.8125,
            "text": "Spanish version of the Fahn-Tolosa-Marin scale for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 7.8125,
            "text": "Tolosa-Marin scale for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.8125,
            "text": "osa-Marin scale for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.234375,
            "end_logit": 7.8125,
            "text": "scale for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": -1.4990234375,
            "text": "hn-Tolosa-Marin scale for essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -1.4990234375,
            "text": "Fahn-Tolosa-Marin scale for essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -1.4990234375,
            "text": "Marin scale for essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -1.4990234375,
            "text": "for essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -1.4990234375,
            "text": "version of the Fahn-Tolosa-Marin scale for essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -1.4990234375,
            "text": "Spanish version of the Fahn-Tolosa-Marin scale for essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -1.4990234375,
            "text": "Tolosa-Marin scale for essential",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_3": [
        {
            "start_logit": 7.890625,
            "end_logit": 7.796875,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.451171875,
            "text": "essential",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": -1.939453125,
            "end_logit": 7.796875,
            "text": "tremor",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -2.1640625,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -4.11328125,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low for patients with severe tremor",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 7.796875,
            "text": "Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.5234375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low for patients with severe tremor (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.73828125,
            "text": "essential tremor (ET",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.7421875,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.74609375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.76953125,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.7734375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.80859375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.796875,
            "text": "Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.88671875,
            "text": "essential tremor (ET),",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.90234375,
            "text": "essential tremor (ET), but",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 7.796875,
            "text": "Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 7.796875,
            "text": "Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 7.796875,
            "text": "Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.939453125,
            "end_logit": -2.1640625,
            "text": "tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_4": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.8984375,
            "text": "Essential Tremor",
            "probability": 0.1607666015625
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.8984375,
            "text": "Essential Tremor",
            "probability": 0.1607666015625
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.88671875,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.1583251953125
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.87890625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.1571044921875
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 7.88671875,
            "text": "Essential Tremor",
            "probability": 0.1571044921875
        },
        {
            "start_logit": 7.921875,
            "end_logit": 7.87890625,
            "text": "Essential Tremor",
            "probability": 0.1558837890625
        },
        {
            "start_logit": 6.48828125,
            "end_logit": 8.0078125,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0426025390625
        },
        {
            "start_logit": 6.48828125,
            "end_logit": 6.0859375,
            "text": "Tremor",
            "probability": 0.006237030029296875
        },
        {
            "start_logit": 2.1953125,
            "end_logit": 8.0078125,
            "text": "Clinical Tremor",
            "probability": 0.000579833984375
        },
        {
            "start_logit": 2.1953125,
            "end_logit": 7.8984375,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.0005197525024414062
        },
        {
            "start_logit": -0.0044097900390625,
            "end_logit": 8.0078125,
            "text": "Tremor",
            "probability": 6.407499313354492e-05
        },
        {
            "start_logit": -0.0044097900390625,
            "end_logit": 7.8984375,
            "text": "Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 5.7637691497802734e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.6171875,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -0.6171875,
            "text": "Essential",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.63671875,
            "text": "Essential",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.64111328125,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential",
            "probability": 3.123283386230469e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.64111328125,
            "text": "Essential",
            "probability": 3.123283386230469e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.71728515625,
            "text": "Essential",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -0.705078125,
            "end_logit": 7.87890625,
            "text": "Tremor Research Group Essential Tremor",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": -1.1865234375,
            "end_logit": 8.0078125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 1.9669532775878906e-05
        }
    ],
    "5e46eb7a3f5415952900000d_5": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.8984375,
            "text": "Essential Tremor",
            "probability": 0.1607666015625
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.8984375,
            "text": "Essential Tremor",
            "probability": 0.1607666015625
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.88671875,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.1583251953125
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.87890625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.1571044921875
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 7.88671875,
            "text": "Essential Tremor",
            "probability": 0.1571044921875
        },
        {
            "start_logit": 7.921875,
            "end_logit": 7.87890625,
            "text": "Essential Tremor",
            "probability": 0.1558837890625
        },
        {
            "start_logit": 6.48828125,
            "end_logit": 8.0078125,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0426025390625
        },
        {
            "start_logit": 6.48828125,
            "end_logit": 6.0859375,
            "text": "Tremor",
            "probability": 0.006237030029296875
        },
        {
            "start_logit": 2.1953125,
            "end_logit": 8.0078125,
            "text": "Clinical Tremor",
            "probability": 0.000579833984375
        },
        {
            "start_logit": 2.1953125,
            "end_logit": 7.8984375,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.0005197525024414062
        },
        {
            "start_logit": -0.0044097900390625,
            "end_logit": 8.0078125,
            "text": "Tremor",
            "probability": 6.407499313354492e-05
        },
        {
            "start_logit": -0.0044097900390625,
            "end_logit": 7.8984375,
            "text": "Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 5.7637691497802734e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.6171875,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -0.6171875,
            "text": "Essential",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.63671875,
            "text": "Essential",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.64111328125,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential",
            "probability": 3.123283386230469e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.64111328125,
            "text": "Essential",
            "probability": 3.123283386230469e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.71728515625,
            "text": "Essential",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -0.705078125,
            "end_logit": 7.87890625,
            "text": "Tremor Research Group Essential Tremor",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": -1.1865234375,
            "end_logit": 8.0078125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 1.9669532775878906e-05
        }
    ],
    "5e46eb7a3f5415952900000d_6": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.8984375,
            "text": "Essential Tremor",
            "probability": 0.1607666015625
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.8984375,
            "text": "Essential Tremor",
            "probability": 0.1607666015625
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.88671875,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.1583251953125
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.87890625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.1571044921875
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 7.88671875,
            "text": "Essential Tremor",
            "probability": 0.1571044921875
        },
        {
            "start_logit": 7.921875,
            "end_logit": 7.87890625,
            "text": "Essential Tremor",
            "probability": 0.1558837890625
        },
        {
            "start_logit": 6.48828125,
            "end_logit": 8.0078125,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0426025390625
        },
        {
            "start_logit": 6.48828125,
            "end_logit": 6.0859375,
            "text": "Tremor",
            "probability": 0.006237030029296875
        },
        {
            "start_logit": 2.1953125,
            "end_logit": 8.0078125,
            "text": "Clinical Tremor",
            "probability": 0.000579833984375
        },
        {
            "start_logit": 2.1953125,
            "end_logit": 7.8984375,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.0005197525024414062
        },
        {
            "start_logit": -0.0044097900390625,
            "end_logit": 8.0078125,
            "text": "Tremor",
            "probability": 6.407499313354492e-05
        },
        {
            "start_logit": -0.0044097900390625,
            "end_logit": 7.8984375,
            "text": "Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 5.7637691497802734e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.6171875,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -0.6171875,
            "text": "Essential",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.63671875,
            "text": "Essential",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.64111328125,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential",
            "probability": 3.123283386230469e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.64111328125,
            "text": "Essential",
            "probability": 3.123283386230469e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.71728515625,
            "text": "Essential",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -0.705078125,
            "end_logit": 7.87890625,
            "text": "Tremor Research Group Essential Tremor",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": -1.1865234375,
            "end_logit": 8.0078125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 1.9669532775878906e-05
        }
    ],
    "5e46eb7a3f5415952900000d_7": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.8984375,
            "text": "Essential Tremor",
            "probability": 0.1607666015625
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.8984375,
            "text": "Essential Tremor",
            "probability": 0.1607666015625
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.88671875,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.1583251953125
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 7.87890625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.1571044921875
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 7.88671875,
            "text": "Essential Tremor",
            "probability": 0.1571044921875
        },
        {
            "start_logit": 7.921875,
            "end_logit": 7.87890625,
            "text": "Essential Tremor",
            "probability": 0.1558837890625
        },
        {
            "start_logit": 6.48828125,
            "end_logit": 8.0078125,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0426025390625
        },
        {
            "start_logit": 6.48828125,
            "end_logit": 6.0859375,
            "text": "Tremor",
            "probability": 0.006237030029296875
        },
        {
            "start_logit": 2.1953125,
            "end_logit": 8.0078125,
            "text": "Clinical Tremor",
            "probability": 0.000579833984375
        },
        {
            "start_logit": 2.1953125,
            "end_logit": 7.8984375,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.0005197525024414062
        },
        {
            "start_logit": -0.0044097900390625,
            "end_logit": 8.0078125,
            "text": "Tremor",
            "probability": 6.407499313354492e-05
        },
        {
            "start_logit": -0.0044097900390625,
            "end_logit": 7.8984375,
            "text": "Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 5.7637691497802734e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.6171875,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -0.6171875,
            "text": "Essential",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.63671875,
            "text": "Essential",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.64111328125,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential",
            "probability": 3.123283386230469e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.64111328125,
            "text": "Essential",
            "probability": 3.123283386230469e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -0.71728515625,
            "text": "Essential",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -0.705078125,
            "end_logit": 7.87890625,
            "text": "Tremor Research Group Essential Tremor",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": -1.1865234375,
            "end_logit": 8.0078125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 1.9669532775878906e-05
        }
    ],
    "5e46eb7a3f5415952900000d_8": [
        {
            "start_logit": 7.88671875,
            "end_logit": 7.77734375,
            "text": "essential tremor",
            "probability": 0.88427734375
        },
        {
            "start_logit": 5.60546875,
            "end_logit": 7.77734375,
            "text": "Tremor Rating Scale (TRS) in essential tremor",
            "probability": 0.09033203125
        },
        {
            "start_logit": 5.60546875,
            "end_logit": 6.48828125,
            "text": "Tremor",
            "probability": 0.02490234375
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -1.337890625,
            "text": "essential",
            "probability": 9.709596633911133e-05
        },
        {
            "start_logit": -2.068359375,
            "end_logit": 7.77734375,
            "text": "tremor",
            "probability": 4.208087921142578e-05
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -1.337890625,
            "text": "Tremor Rating Scale (TRS) in essential",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.18359375,
            "text": "essential tremor (ET",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.5625,
            "text": "essential tremor (ET)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.77734375,
            "text": "n Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.77734375,
            "text": "rater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 7.77734375,
            "text": "S) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.77734375,
            "text": "Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.77734375,
            "text": "(TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.77734375,
            "text": "intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.77734375,
            "text": "interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.77734375,
            "text": "in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 6.48828125,
            "text": "n Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.48828125,
            "text": "rater reliability of the Fahn-Tolosa-Marin Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.48828125,
            "text": "Marin Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -7.18359375,
            "text": "Tremor Rating Scale (TRS) in essential tremor (ET",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e46eb7a3f5415952900000d_9": [
        {
            "start_logit": 7.8828125,
            "end_logit": 7.80078125,
            "text": "essential tremor",
            "probability": 0.994140625
        },
        {
            "start_logit": 2.642578125,
            "end_logit": 7.80078125,
            "text": "Tremor Rating Scale in essential tremor",
            "probability": 0.00525665283203125
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -1.57421875,
            "text": "essential",
            "probability": 8.434057235717773e-05
        },
        {
            "start_logit": 2.642578125,
            "end_logit": 3.150390625,
            "text": "Tremor",
            "probability": 5.036592483520508e-05
        },
        {
            "start_logit": -2.021484375,
            "end_logit": 7.80078125,
            "text": "tremor",
            "probability": 4.9591064453125e-05
        },
        {
            "start_logit": 2.642578125,
            "end_logit": -1.57421875,
            "text": "Tremor Rating Scale in essential",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 7.80078125,
            "text": "rater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 7.80078125,
            "text": "n Tremor Rating Scale in essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.80078125,
            "text": "Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 7.80078125,
            "text": "Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.80078125,
            "text": "in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.80078125,
            "text": "intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.80078125,
            "text": "interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.80078125,
            "text": "hn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.80078125,
            "text": "osa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.80078125,
            "text": "Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.80078125,
            "text": "the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.80078125,
            "text": "reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 3.150390625,
            "text": "rater reliability of the Fahn-Tolosa-Marin Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 3.150390625,
            "text": "n Tremor",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_10": [
        {
            "start_logit": 7.8828125,
            "end_logit": 7.8046875,
            "text": "Essential Tremor",
            "probability": 1.0
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -1.4404296875,
            "text": "Essential",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": -1.87109375,
            "end_logit": 7.8046875,
            "text": "Tremor",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.8046875,
            "text": "the Essential Tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 7.8046875,
            "text": "Clinical Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 7.8046875,
            "text": "and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -8.0859375,
            "text": "Essential Tremor Rating Assessment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -8.1015625,
            "text": "Essential Tremor Rating",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.8046875,
            "text": "Marin Clinical Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.8046875,
            "text": "Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.8046875,
            "text": "Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -1.4404296875,
            "text": "the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -1.4404296875,
            "text": "Clinical Rating Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -1.4404296875,
            "text": "and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -1.4404296875,
            "text": "Marin Clinical Rating Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -1.4404296875,
            "text": "Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -1.4404296875,
            "text": "Rating Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.87109375,
            "end_logit": -8.0859375,
            "text": "Tremor Rating Assessment",
            "probability": 0.0
        },
        {
            "start_logit": -1.87109375,
            "end_logit": -8.1015625,
            "text": "Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -7.7421875,
            "text": "Clinical",
            "probability": 0.0
        }
    ],
    "54e0ace81388e8454a000010_1": [
        {
            "start_logit": 6.4453125,
            "end_logit": 6.64453125,
            "text": "nuclear",
            "probability": 1.0
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -5.07421875,
            "text": "nuclear localization",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 6.64453125,
            "text": "A3B is the only family member with steady-state nuclear",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.64453125,
            "text": "member with steady-state nuclear",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.64453125,
            "text": "B is the only family member with steady-state nuclear",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 6.64453125,
            "text": "is the only family member with steady-state nuclear",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.64453125,
            "text": "state nuclear",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -5.07421875,
            "text": "A3B is the only family member with steady-state nuclear localization",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -5.07421875,
            "text": "member with steady-state nuclear localization",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -5.07421875,
            "text": "B is the only family member with steady-state nuclear localization",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -5.07421875,
            "text": "localization",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -5.07421875,
            "text": "is the only family member with steady-state nuclear localization",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -5.07421875,
            "text": "state nuclear localization",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.46875,
            "text": "A3B",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.546875,
            "text": "A3",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.65234375,
            "text": "A3B is the only family member with steady",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.68359375,
            "text": "A3B is the only family",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.7734375,
            "text": "A3B is the only",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.87890625,
            "text": "A3B is the only family member with steady-",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.95703125,
            "text": "A3B is the only family member with",
            "probability": 0.0
        }
    ],
    "54e0ace81388e8454a000010_2": [
        {
            "start_logit": 6.22265625,
            "end_logit": 6.37109375,
            "text": "nuclear",
            "probability": 0.7451171875
        },
        {
            "start_logit": 6.22265625,
            "end_logit": 4.734375,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear",
            "probability": 0.1444091796875
        },
        {
            "start_logit": 5.9453125,
            "end_logit": 4.734375,
            "text": "nuclear",
            "probability": 0.10992431640625
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -5.328125,
            "text": "nuclear import",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": 5.9453125,
            "end_logit": -5.53125,
            "text": "nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase)",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 6.37109375,
            "text": "A3B nuclear",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -6.11328125,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 5.9453125,
            "end_logit": -6.11328125,
            "text": "nuclear localization",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -6.4453125,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -6.62109375,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.875,
            "end_logit": 6.37109375,
            "text": "that A3B nuclear",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 6.37109375,
            "text": "show that A3B nuclear",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 5.9453125,
            "end_logit": -6.62109375,
            "text": "nuclear localization determinant",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.25390625,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 6.37109375,
            "text": "Here, we show that A3B nuclear",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 5.9453125,
            "end_logit": -7.20703125,
            "text": "nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.57421875,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.609375,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.6171875,
            "text": "nuclear import is an active process requiring at least one amino acid",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.640625,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal",
            "probability": 5.960464477539062e-07
        }
    ],
    "54e0ace81388e8454a000010_3": [
        {
            "start_logit": 6.22265625,
            "end_logit": 6.37109375,
            "text": "nuclear",
            "probability": 0.7451171875
        },
        {
            "start_logit": 6.22265625,
            "end_logit": 4.734375,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear",
            "probability": 0.1444091796875
        },
        {
            "start_logit": 5.9453125,
            "end_logit": 4.734375,
            "text": "nuclear",
            "probability": 0.10992431640625
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -5.328125,
            "text": "nuclear import",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": 5.9453125,
            "end_logit": -5.53125,
            "text": "nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase)",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 6.37109375,
            "text": "A3B nuclear",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -6.11328125,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 5.9453125,
            "end_logit": -6.11328125,
            "text": "nuclear localization",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -6.4453125,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -6.62109375,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.875,
            "end_logit": 6.37109375,
            "text": "that A3B nuclear",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 6.37109375,
            "text": "show that A3B nuclear",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 5.9453125,
            "end_logit": -6.62109375,
            "text": "nuclear localization determinant",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.25390625,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 6.37109375,
            "text": "Here, we show that A3B nuclear",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 5.9453125,
            "end_logit": -7.20703125,
            "text": "nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.57421875,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.609375,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.6171875,
            "text": "nuclear import is an active process requiring at least one amino acid",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.640625,
            "text": "nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal",
            "probability": 5.960464477539062e-07
        }
    ],
    "54e0ace81388e8454a000010_4": [
        {
            "start_logit": 6.5390625,
            "end_logit": 6.36328125,
            "text": "nuclear",
            "probability": 1.0
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -3.0234375,
            "text": "nuclear import",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -6.109375,
            "text": "nuclear import mechanism of an ancestral AID protein during the expansion of the APOBEC3 locus in primates",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.08984375,
            "text": "nuclear import mechanism",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.234375,
            "text": "nuclear import mechanism of an ancestral AID protein during the expansion of the APOBEC3",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.34375,
            "text": "nuclear import mechanism of",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 6.36328125,
            "text": "A3B enzyme retained the nuclear",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.40625,
            "text": "nuclear import mechanism of an",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.421875,
            "text": "nuclear import mechanism of an ancestral AID",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.6484375,
            "text": "nuclear import mechanism of an ancestral AID protein during the",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.6484375,
            "text": "nuclear import mechanism of an ancestral AID protein during",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.6640625,
            "text": "nuclear import mechanism of an ancestral AID protein during the expansion of the",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.69140625,
            "text": "nuclear import mechanism of an ancestral",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 6.36328125,
            "text": "retained the nuclear",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.76953125,
            "text": "nuclear import mechanism of an ancestral AID protein during the expansion of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.81640625,
            "text": "nuclear import mechanism of an ancestral AID protein during the expansion of the APOB",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.36328125,
            "text": "B enzyme retained the nuclear",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.36328125,
            "text": "suggest that the present-day A3B enzyme retained the nuclear",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.36328125,
            "text": "that the present-day A3B enzyme retained the nuclear",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.36328125,
            "text": "studies suggest that the present-day A3B enzyme retained the nuclear",
            "probability": 5.960464477539062e-07
        }
    ],
    "54e0ace81388e8454a000010_5": [
        {
            "start_logit": 6.3359375,
            "end_logit": 6.73828125,
            "text": "nuclear",
            "probability": 1.0
        },
        {
            "start_logit": 6.3359375,
            "end_logit": -6.65234375,
            "text": "nuclear A3B only",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.73828125,
            "text": "found that the predominantly nuclear",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 6.73828125,
            "text": ", we found that the predominantly nuclear",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.3359375,
            "end_logit": -7.1875,
            "text": "nuclear A3B only weakly restricted",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.73828125,
            "text": "predominantly nuclear",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.3359375,
            "end_logit": -7.26171875,
            "text": "nuclear A3B only weakly restricted infection by HIV",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.3359375,
            "end_logit": -7.296875,
            "text": "nuclear A3B only weakly restricted infection by HIV-1, HIV",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3359375,
            "end_logit": -7.34765625,
            "text": "nuclear A3B only weakly",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3359375,
            "end_logit": -7.5546875,
            "text": "nuclear A3B only weakly restricted infection by HIV-1, HIV-1\u0394vif, and human T-cell leukemia virus type 1 (HTLV",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.3359375,
            "end_logit": -7.79296875,
            "text": "nuclear A3B only weakly restricted infection by HIV-1, HIV-1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -6.65234375,
            "text": "found that the predominantly nuclear A3B only",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -6.65234375,
            "text": ", we found that the predominantly nuclear A3B only",
            "probability": 0.0
        },
        {
            "start_logit": -6.953125,
            "end_logit": -7.296875,
            "text": "), while significantly inhibiting LINE-1 retrotransp",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -6.65234375,
            "text": "predominantly nuclear A3B only",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -6.65234375,
            "text": "A3B only",
            "probability": 0.0
        },
        {
            "start_logit": -7.08203125,
            "end_logit": -7.296875,
            "text": "retrotransp",
            "probability": 0.0
        },
        {
            "start_logit": -7.19140625,
            "end_logit": -7.296875,
            "text": "while significantly inhibiting LINE-1 retrotransp",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": -7.296875,
            "text": "1 retrotransp",
            "probability": 0.0
        },
        {
            "start_logit": -6.953125,
            "end_logit": -7.59375,
            "text": "), while significantly",
            "probability": 0.0
        }
    ],
    "54e0ace81388e8454a000010_6": [
        {
            "start_logit": 6.12109375,
            "end_logit": 6.84375,
            "text": "nucleus",
            "probability": 0.89111328125
        },
        {
            "start_logit": 6.12109375,
            "end_logit": 4.67578125,
            "text": "nucleus. Further mutational analysis revealed that residues 18, 19, 22, and 24 in A3B were the major determinants for nuclear",
            "probability": 0.1015625
        },
        {
            "start_logit": 3.42578125,
            "end_logit": 4.67578125,
            "text": "nuclear",
            "probability": 0.00685882568359375
        },
        {
            "start_logit": 6.12109375,
            "end_logit": -2.275390625,
            "text": "nucleus. Further mutational analysis revealed that residues 18, 19, 22, and 24 in A3B were the major determinants for nuclear versus cytoplasmic localization",
            "probability": 9.703636169433594e-05
        },
        {
            "start_logit": -4.75390625,
            "end_logit": 6.84375,
            "text": "cytoplasm, was also present in the nucleus",
            "probability": 1.6868114471435547e-05
        },
        {
            "start_logit": -4.84765625,
            "end_logit": 6.84375,
            "text": "A3G/B protein, while localized mainly to the cytoplasm, was also present in the nucleus",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": 6.12109375,
            "end_logit": -4.80078125,
            "text": "nucleus. Further mutational analysis revealed that residues 18, 19, 22, and 24 in A3B were the major determinants for nuclear versus cytoplasmic",
            "probability": 7.808208465576172e-06
        },
        {
            "start_logit": -5.55859375,
            "end_logit": 6.84375,
            "text": "localized mainly to the cytoplasm, was also present in the nucleus",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 3.42578125,
            "end_logit": -2.275390625,
            "text": "nuclear versus cytoplasmic localization",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 6.84375,
            "text": "present in the nucleus",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 6.84375,
            "text": "in the nucleus",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -4.7734375,
            "end_logit": 4.67578125,
            "text": "revealed that residues 18, 19, 22, and 24 in A3B were the major determinants for nuclear",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 6.12109375,
            "end_logit": -6.234375,
            "text": "nucleus. Further mutational analysis revealed",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 6.84375,
            "text": "while localized mainly to the cytoplasm, was also present in the nucleus",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 6.84375,
            "text": "G/B protein, while localized mainly to the cytoplasm, was also present in the nucleus",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 6.84375,
            "text": "to the cytoplasm, was also present in the nucleus",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.12109375,
            "end_logit": -6.55078125,
            "text": "nucleus. Further mutational analysis revealed that residues 18, 19, 22, and 24 in A3B",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.12109375,
            "end_logit": -7.09765625,
            "text": "nucleus. Further mutational analysis revealed that residues 18, 19, 22, and 24 in A3",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.12109375,
            "end_logit": -7.12109375,
            "text": "nucleus.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 3.42578125,
            "end_logit": -4.80078125,
            "text": "nuclear versus cytoplasmic",
            "probability": 5.364418029785156e-07
        }
    ],
    "54e0ace81388e8454a000010_7": [
        {
            "start_logit": 5.375,
            "end_logit": 6.015625,
            "text": "nuclear",
            "probability": 0.9921875
        },
        {
            "start_logit": 5.375,
            "end_logit": 1.1337890625,
            "text": "nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic",
            "probability": 0.007518768310546875
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 6.015625,
            "text": "becomes nuclear",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 6.015625,
            "text": "APOBEC3B becomes nuclear",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 6.015625,
            "text": ", APOBEC3B becomes nuclear",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -6.65625,
            "text": "nuclear,",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 6.015625,
            "text": "EC3B becomes nuclear",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": 6.015625,
            "text": "3B becomes nuclear",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -7.76171875,
            "text": "nuclear, and",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -8.140625,
            "text": "nuclear, and APOBEC3",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -8.1875,
            "text": "nuclear, and APOBEC3D, APOBEC3",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -8.1875,
            "text": "nuclear, and APOBEC3D, APOBEC3F",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -8.203125,
            "text": "nuclear, and APOBEC3D, APOBEC",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -8.2734375,
            "text": "nuclear, and APOBEC3D",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -8.3203125,
            "text": "nuclear, and APOBEC",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.21875,
            "end_logit": 1.1337890625,
            "text": "cytoplasmic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 1.1337890625,
            "text": "become cytoplasmic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 1.1337890625,
            "text": "becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 1.1337890625,
            "text": "APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": 1.1337890625,
            "text": "EC3F and APOBEC3G become cytoplasmic",
            "probability": 0.0
        }
    ],
    "54e0ace81388e8454a000010_8": [
        {
            "start_logit": 6.01953125,
            "end_logit": 6.7890625,
            "text": "nuclear",
            "probability": 1.0
        },
        {
            "start_logit": -2.849609375,
            "end_logit": 6.7890625,
            "text": "cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.0001398324966430664
        },
        {
            "start_logit": -5.8359375,
            "end_logit": 6.7890625,
            "text": "APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -5.6328125,
            "text": "nuclear.",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -6.484375,
            "end_logit": 6.7890625,
            "text": "APOBEC3B, which is predominantly nuclear",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 6.7890625,
            "text": "EC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 6.7890625,
            "text": "localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 6.7890625,
            "text": "EC3B, which is predominantly nuclear",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.7890625,
            "text": "of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 6.7890625,
            "text": "which is predominantly nuclear",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 6.7890625,
            "text": "predominantly nuclear",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.7890625,
            "text": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.7890625,
            "text": "determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.7890625,
            "text": "with APOBEC3B, which is predominantly nuclear",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.7890625,
            "text": "define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.7890625,
            "text": "is predominantly nuclear",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.7890625,
            "text": "G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -2.849609375,
            "end_logit": -2.740234375,
            "text": "cytoplasmic",
            "probability": 0.0
        },
        {
            "start_logit": -2.849609375,
            "end_logit": -5.26171875,
            "text": "cytoplasmic localization",
            "probability": 0.0
        },
        {
            "start_logit": -2.849609375,
            "end_logit": -5.6328125,
            "text": "cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.",
            "probability": 0.0
        }
    ],
    "54e0ace81388e8454a000010_9": [
        {
            "start_logit": 1.66796875,
            "end_logit": 3.93359375,
            "text": "cytosolic",
            "probability": 0.986328125
        },
        {
            "start_logit": -3.0390625,
            "end_logit": 3.93359375,
            "text": "nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.0089111328125
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 3.93359375,
            "text": "APOBEC3F was mostly cytosolic",
            "probability": 0.000980377197265625
        },
        {
            "start_logit": -5.53125,
            "end_logit": 3.93359375,
            "text": "EC3F was mostly cytosolic",
            "probability": 0.0007371902465820312
        },
        {
            "start_logit": 1.66796875,
            "end_logit": -3.935546875,
            "text": "cytosolic.",
            "probability": 0.00037789344787597656
        },
        {
            "start_logit": -6.296875,
            "end_logit": 3.93359375,
            "text": "subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.0003426074981689453
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 3.93359375,
            "text": "mostly cytosolic",
            "probability": 0.0002701282501220703
        },
        {
            "start_logit": -6.546875,
            "end_logit": 3.93359375,
            "text": "L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.00026607513427734375
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 3.93359375,
            "text": "appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.0002384185791015625
        },
        {
            "start_logit": -6.71875,
            "end_logit": 3.93359375,
            "text": "distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.0002238750457763672
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 3.93359375,
            "text": "3F was mostly cytosolic",
            "probability": 0.0002104043960571289
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 3.93359375,
            "text": "and APOBEC3F was mostly cytosolic",
            "probability": 0.00016641616821289062
        },
        {
            "start_logit": -7.328125,
            "end_logit": 3.93359375,
            "text": "APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.00012171268463134766
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 3.93359375,
            "text": "predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 9.262561798095703e-05
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 3.93359375,
            "text": "F was mostly cytosolic",
            "probability": 8.910894393920898e-05
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 3.93359375,
            "text": "EC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 8.434057235717773e-05
        },
        {
            "start_logit": -3.0390625,
            "end_logit": -1.2333984375,
            "text": "nuclear",
            "probability": 5.072355270385742e-05
        },
        {
            "start_logit": -3.0390625,
            "end_logit": -3.935546875,
            "text": "nuclear and APOBEC3F was mostly cytosolic.",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -6.296875,
            "end_logit": -1.2333984375,
            "text": "subcellular protein distribution as APOBEC3B appeared predominantly nuclear",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.546875,
            "end_logit": -1.2333984375,
            "text": "L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear",
            "probability": 1.5497207641601562e-06
        }
    ],
    "54e0ace81388e8454a000010_10": [
        {
            "start_logit": 6.140625,
            "end_logit": 6.94140625,
            "text": "nuclear",
            "probability": 1.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 6.94140625,
            "text": "APOBEC3B protein is predominantly nuclear",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.94140625,
            "text": "predominantly nuclear",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.94140625,
            "text": "protein is predominantly nuclear",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.40625,
            "text": "nuclear and the only",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.52734375,
            "text": "nuclear and the only detectable source of DNA C-to-U editing activity in",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.625,
            "text": "nuclear and the",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.65234375,
            "text": "nuclear and the only detectable",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.65625,
            "text": "nuclear and the only detectable source of DNA C-to-U editing activity in breast",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.65625,
            "text": "nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.6875,
            "text": "nuclear and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.734375,
            "text": "nuclear and the only detectable source of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.765625,
            "text": "nuclear and the only detectable source",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.88671875,
            "text": "nuclear and the only detectable source of DNA C-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.91015625,
            "text": "nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.9453125,
            "text": "nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -7.9921875,
            "text": "nuclear and the only detectable source of DNA C-to-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.140625,
            "end_logit": -8.0078125,
            "text": "nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -7.40625,
            "text": "APOBEC3B protein is predominantly nuclear and the only",
            "probability": 0.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -7.52734375,
            "text": "APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in",
            "probability": 0.0
        }
    ],
    "54e0ace81388e8454a000010_11": [
        {
            "start_logit": -0.873046875,
            "end_logit": 0.97119140625,
            "text": "nuclear",
            "probability": 0.849609375
        },
        {
            "start_logit": -0.873046875,
            "end_logit": -0.9208984375,
            "text": "nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.1280517578125
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 0.97119140625,
            "text": "subcellular protein distribution as APOBEC3B appeared predominantly nuclear",
            "probability": 0.005191802978515625
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 0.97119140625,
            "text": "distribution as APOBEC3B appeared predominantly nuclear",
            "probability": 0.0026836395263671875
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 0.97119140625,
            "text": "L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear",
            "probability": 0.0026721954345703125
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 0.97119140625,
            "text": "appeared predominantly nuclear",
            "probability": 0.0019931793212890625
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 0.97119140625,
            "text": "APOBEC3B appeared predominantly nuclear",
            "probability": 0.0012531280517578125
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 0.97119140625,
            "text": "predominantly nuclear",
            "probability": 0.0011768341064453125
        },
        {
            "start_logit": -5.72265625,
            "end_logit": -0.9208984375,
            "text": "EC3F was mostly cytosolic",
            "probability": 0.0010023117065429688
        },
        {
            "start_logit": -7.640625,
            "end_logit": 0.97119140625,
            "text": "EC3B appeared predominantly nuclear",
            "probability": 0.0009794235229492188
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 0.97119140625,
            "text": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear",
            "probability": 0.0009241104125976562
        },
        {
            "start_logit": -5.921875,
            "end_logit": -0.9208984375,
            "text": "cytosolic",
            "probability": 0.0008215904235839844
        },
        {
            "start_logit": -5.97265625,
            "end_logit": -0.9208984375,
            "text": "subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.0007810592651367188
        },
        {
            "start_logit": -6.171875,
            "end_logit": -0.9208984375,
            "text": "APOBEC3F was mostly cytosolic",
            "probability": 0.0006399154663085938
        },
        {
            "start_logit": -0.873046875,
            "end_logit": -6.41796875,
            "text": "nuclear and",
            "probability": 0.00052642822265625
        },
        {
            "start_logit": -6.6328125,
            "end_logit": -0.9208984375,
            "text": "distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.0004036426544189453
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -0.9208984375,
            "text": "L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.0004019737243652344
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -0.9208984375,
            "text": "appeared predominantly nuclear and APOBEC3F was mostly cytosolic",
            "probability": 0.0002999305725097656
        },
        {
            "start_logit": -7.0078125,
            "end_logit": -0.9208984375,
            "text": "mostly cytosolic",
            "probability": 0.00027632713317871094
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -0.9208984375,
            "text": "3F was mostly cytosolic",
            "probability": 0.00027632713317871094
        }
    ],
    "54e0ace81388e8454a000010_12": [
        {
            "start_logit": -2.330078125,
            "end_logit": 4.921875,
            "text": "cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.80322265625
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 4.921875,
            "text": "nuclear",
            "probability": 0.08319091796875
        },
        {
            "start_logit": -5.70703125,
            "end_logit": 4.921875,
            "text": "localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.0274200439453125
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 4.921875,
            "text": "APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.0096435546875
        },
        {
            "start_logit": -6.8125,
            "end_logit": 4.921875,
            "text": "predominantly nuclear",
            "probability": 0.009063720703125
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 4.921875,
            "text": "EC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.0083160400390625
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 4.921875,
            "text": "which is predominantly nuclear",
            "probability": 0.007572174072265625
        },
        {
            "start_logit": -7.015625,
            "end_logit": 4.921875,
            "text": "is predominantly nuclear",
            "probability": 0.007396697998046875
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 4.921875,
            "text": "APOBEC3B, which is predominantly nuclear",
            "probability": 0.00695037841796875
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 4.921875,
            "text": "EC3B, which is predominantly nuclear",
            "probability": 0.00580596923828125
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 4.921875,
            "text": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.00496673583984375
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 4.921875,
            "text": "determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.0047760009765625
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 4.921875,
            "text": "with APOBEC3B, which is predominantly nuclear",
            "probability": 0.00463104248046875
        },
        {
            "start_logit": -7.515625,
            "end_logit": 4.921875,
            "text": "of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.004486083984375
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 4.921875,
            "text": "define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.004055023193359375
        },
        {
            "start_logit": -7.625,
            "end_logit": 4.921875,
            "text": "3B, which is predominantly nuclear",
            "probability": 0.004024505615234375
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 4.921875,
            "text": "3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear",
            "probability": 0.0037784576416015625
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -2.6171875,
            "text": "cytoplasmic",
            "probability": 0.00042700767517089844
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -6.62109375,
            "text": "cytoplasmic localization",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -6.98046875,
            "text": "cytoplasmic localization,",
            "probability": 5.424022674560547e-06
        }
    ],
    "58f4b1a170f9fc6f0f000010_1": [
        {
            "start_logit": -6.6875,
            "end_logit": -4.40234375,
            "text": "anita phalloides",
            "probability": 0.2127685546875
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -4.40234375,
            "text": "Amanita phalloides",
            "probability": 0.13525390625
        },
        {
            "start_logit": -7.21875,
            "end_logit": -4.40234375,
            "text": "in Amanita phalloides",
            "probability": 0.1251220703125
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -4.40234375,
            "text": "loides",
            "probability": 0.11126708984375
        },
        {
            "start_logit": -7.625,
            "end_logit": -4.40234375,
            "text": "ta phalloides",
            "probability": 0.08331298828125
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -4.40234375,
            "text": "phalloides",
            "probability": 0.07952880859375
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -4.40234375,
            "text": "liver transplantation improves patients' short-term post liver transplantation survival in Amanita phalloides",
            "probability": 0.07525634765625
        },
        {
            "start_logit": -7.890625,
            "end_logit": -4.40234375,
            "text": "liver transplantation survival in Amanita phalloides",
            "probability": 0.06390380859375
        },
        {
            "start_logit": -6.6875,
            "end_logit": -6.63671875,
            "text": "anita phalloides poisoning",
            "probability": 0.0227813720703125
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -6.63671875,
            "text": "Amanita phalloides poisoning",
            "probability": 0.0144805908203125
        },
        {
            "start_logit": -7.21875,
            "end_logit": -6.63671875,
            "text": "in Amanita phalloides poisoning",
            "probability": 0.01338958740234375
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -6.63671875,
            "text": "loides poisoning",
            "probability": 0.01190948486328125
        },
        {
            "start_logit": -7.625,
            "end_logit": -6.63671875,
            "text": "ta phalloides poisoning",
            "probability": 0.0089263916015625
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -6.63671875,
            "text": "phalloides poisoning",
            "probability": 0.008514404296875
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -6.63671875,
            "text": "liver transplantation improves patients' short-term post liver transplantation survival in Amanita phalloides poisoning",
            "probability": 0.008056640625
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -6.69140625,
            "text": "liver",
            "probability": 0.00762939453125
        },
        {
            "start_logit": -7.890625,
            "end_logit": -6.63671875,
            "text": "liver transplantation survival in Amanita phalloides poisoning",
            "probability": 0.006839752197265625
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -7.20703125,
            "text": "liver transplantation improves patients' short-term post liver",
            "probability": 0.00455474853515625
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.20703125,
            "text": "liver",
            "probability": 0.0038967132568359375
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -7.66015625,
            "text": "liver transplantation improves patients' short",
            "probability": 0.0028972625732421875
        }
    ],
    "58aa0c6f396a458e50000008_1": [
        {
            "start_logit": 6.625,
            "end_logit": 6.2890625,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 6.625,
            "end_logit": -6.84375,
            "text": "oxytocin (OXT)",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.625,
            "end_logit": -6.9453125,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors, including social recognition, pair",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.625,
            "end_logit": -6.94921875,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors, including social recognition",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.2578125,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors, including social recognition, pair bonding",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.3515625,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.3671875,
            "text": "oxytocin (OXT) and its receptor (OXTR",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.421875,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.45703125,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.203125,
            "end_logit": 6.2890625,
            "text": "ypophysial hormone oxytocin",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.5546875,
            "text": "oxytocin (OXT) and its",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.625,
            "end_logit": -7.5625,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.2890625,
            "text": "ophysial hormone oxytocin",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.2890625,
            "text": "neurohypophysial hormone oxytocin",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.2890625,
            "text": "hormone oxytocin",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.296875,
            "end_logit": -4.59765625,
            "text": "pair bonding, parental behavior, and stress-related responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -4.59765625,
            "text": "social recognition, pair bonding, parental behavior, and stress-related responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -4.59765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -4.59765625,
            "text": "stress-related responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -4.59765625,
            "text": "in the regulation of pro-social behaviors, including social recognition, pair bonding, parental behavior, and stress-related responses.",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_2": [
        {
            "start_logit": 6.59765625,
            "end_logit": 6.59765625,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -5.671875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.08984375,
            "text": "oxytocin has roles in social bonding,",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.12890625,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.234375,
            "text": "oxytocin has roles in",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.234375,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.28515625,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.3046875,
            "text": "oxytocin has roles",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.32421875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical,",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.3515625,
            "text": "oxytocin has roles in social bonding, energy metabolism, and",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.36328125,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.4296875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.453125,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.4765625,
            "text": "oxytocin has roles in social bonding, energy metabolism",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.51171875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.53125,
            "text": "oxytocin has roles in social bonding, energy metabolism,",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.54296875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.546875,
            "text": "oxytocin has roles in social bonding, energy",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.59765625,
            "text": "Neuropeptide hormone oxytocin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.59765625,
            "text": "hormone oxytocin",
            "probability": 3.5762786865234375e-07
        }
    ],
    "58aa0c6f396a458e50000008_3": [
        {
            "start_logit": 6.765625,
            "end_logit": 6.30859375,
            "text": "Oxytocin",
            "probability": 0.9912109375
        },
        {
            "start_logit": 6.765625,
            "end_logit": 1.5341796875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding.",
            "probability": 0.00830841064453125
        },
        {
            "start_logit": 6.765625,
            "end_logit": -6.60546875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -6.90234375,
            "text": "Oxytocin is known",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.125,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.12890625,
            "text": "Oxytocin is known as the 'lov",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.140625,
            "text": "Oxytocin is known as the 'love hormone'",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.1875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.25390625,
            "text": "Oxytocin is known as the 'love hormone",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.328125,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.37890625,
            "text": "Oxytocin is known as the",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.41015625,
            "text": "Oxytocin is known as the 'love hormone' due its role in",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.4609375,
            "text": "Oxytocin is known as the 'love hormone' due",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.46484375,
            "text": "Oxytocin is",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.5078125,
            "text": "Oxytocin is known as the 'love",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.5078125,
            "text": "Oxytocin is known as",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.51953125,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.765625,
            "end_logit": -7.53125,
            "text": "Oxytocin is known as the 'love hormone' due its role",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 1.5341796875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": 1.5341796875,
            "text": "mother-child and pair bonding.",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_4": [
        {
            "start_logit": 6.5703125,
            "end_logit": 5.41015625,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.2421875,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in pair",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.5546875,
            "text": "oxytocin (OT)",
            "probability": 1.722574234008789e-05
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.66015625,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OX",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.828125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one",
            "probability": 1.3113021850585938e-05
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.2109375,
            "text": "oxytocin (OT",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.4140625,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.171875,
            "text": "oxytocin (OT) hormone",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.27734375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.359375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in pair bonding",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.40234375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.44921875,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.46484375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in pair bonding behavior",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.48046875,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes,",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.55859375,
            "text": "oxytocin (OT) hormone pathway is involved in",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 5.41015625,
            "text": "The oxytocin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -3.271484375,
            "text": "pair bonding behavior in mammalian lineages.",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -3.271484375,
            "text": "been implicated in pair bonding behavior in mammalian lineages.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -3.271484375,
            "text": "OXTR) has been implicated in pair bonding behavior in mammalian lineages.",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -3.271484375,
            "text": "has been implicated in pair bonding behavior in mammalian lineages.",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_5": [
        {
            "start_logit": 6.67578125,
            "end_logit": 6.453125,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -6.98046875,
            "text": "oxytocin, a hormone involved in parent-offspring",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.25390625,
            "text": "oxytocin, a",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.6328125,
            "text": "oxytocin, a hormone involved in parent-offspring bonding",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.63671875,
            "text": "oxytocin, a hormone involved in",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.65234375,
            "text": "oxytocin, a hormone involved in parent",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.6796875,
            "text": "oxytocin,",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.86328125,
            "text": "oxytocin, a hormone",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.9375,
            "text": "oxytocin, a hormone involved",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.94140625,
            "text": "oxytocin, a hormone involved in parent-",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -6.98046875,
            "text": "parent-offspring",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -6.98046875,
            "text": "offspring",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -6.98046875,
            "text": "-offspring",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -7.6328125,
            "text": "parent-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -7.65234375,
            "text": "parent",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.6328125,
            "text": "offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -7.6328125,
            "text": "-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -7.94140625,
            "text": "parent-",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -7.94140625,
            "text": "-",
            "probability": 0.0
        }
    ],
    "58a5b1fe60087bc10a000024_1": [
        {
            "start_logit": 5.140625,
            "end_logit": 4.40234375,
            "text": ". SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.97802734375
        },
        {
            "start_logit": 1.3388671875,
            "end_logit": 4.40234375,
            "text": "SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.0217742919921875
        },
        {
            "start_logit": -3.57421875,
            "end_logit": 4.40234375,
            "text": ".",
            "probability": 0.00015985965728759766
        },
        {
            "start_logit": 5.140625,
            "end_logit": -5.25390625,
            "text": ". SUMO-conjugating enzyme (Ub",
            "probability": 6.258487701416016e-05
        },
        {
            "start_logit": 5.140625,
            "end_logit": -5.2890625,
            "text": ".",
            "probability": 6.020069122314453e-05
        },
        {
            "start_logit": 5.140625,
            "end_logit": -5.88671875,
            "text": ". SUMO-conjugating",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": 5.140625,
            "end_logit": -6.0234375,
            "text": ". SUMO-conjugating enzyme (Ubc9) is an important",
            "probability": 2.8908252716064453e-05
        },
        {
            "start_logit": 5.140625,
            "end_logit": -6.40234375,
            "text": ". SUMO-conjugating enzyme (Ubc9",
            "probability": 1.9729137420654297e-05
        },
        {
            "start_logit": 5.140625,
            "end_logit": -6.67578125,
            "text": ". SUMO-conjugating enzyme (Ubc",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": 5.140625,
            "end_logit": -6.74609375,
            "text": ". SUMO",
            "probability": 1.4007091522216797e-05
        },
        {
            "start_logit": -6.078125,
            "end_logit": 4.40234375,
            "text": "conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 1.3113021850585938e-05
        },
        {
            "start_logit": 5.140625,
            "end_logit": -7.078125,
            "text": ". SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": 5.140625,
            "end_logit": -7.171875,
            "text": ". SUMO-conjug",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 4.40234375,
            "text": "an important conjunction enzyme in the SUMO pathway.",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -6.859375,
            "end_logit": 4.40234375,
            "text": "-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 4.40234375,
            "text": "cellular processes, development and organelle biogenesis. SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -7.09375,
            "end_logit": 4.40234375,
            "text": "in the SUMO pathway.",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -7.203125,
            "end_logit": 4.40234375,
            "text": "is an important conjunction enzyme in the SUMO pathway.",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -7.3125,
            "end_logit": 4.40234375,
            "text": ") is an important conjunction enzyme in the SUMO pathway.",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 4.40234375,
            "text": "SUMO pathway.",
            "probability": 3.6954879760742188e-06
        }
    ],
    "58a5b1fe60087bc10a000024_2": [
        {
            "start_logit": -1.38671875,
            "end_logit": 5.375,
            "text": ".",
            "probability": 0.537109375
        },
        {
            "start_logit": -1.8583984375,
            "end_logit": 5.375,
            "text": "SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.3349609375
        },
        {
            "start_logit": -3.109375,
            "end_logit": 5.375,
            "text": "conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.095947265625
        },
        {
            "start_logit": -5.85546875,
            "end_logit": 5.375,
            "text": "RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.00615692138671875
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 5.375,
            "text": "sumoylation.",
            "probability": 0.0038242340087890625
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 5.375,
            "text": "80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.002628326416015625
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 5.375,
            "text": "target for sumoylation.",
            "probability": 0.0024585723876953125
        },
        {
            "start_logit": -6.78125,
            "end_logit": 5.375,
            "text": "a novel target for sumoylation.",
            "probability": 0.0024394989013671875
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 5.375,
            "text": "the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.002384185791015625
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 5.375,
            "text": "novel target for sumoylation.",
            "probability": 0.00237274169921875
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 5.375,
            "text": "with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.0021266937255859375
        },
        {
            "start_logit": -7.015625,
            "end_logit": 5.375,
            "text": "and is a novel target for sumoylation.",
            "probability": 0.00193023681640625
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 5.375,
            "text": "C9 and is a novel target for sumoylation.",
            "probability": 0.0018558502197265625
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 5.375,
            "text": "-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.0018482208251953125
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 5.375,
            "text": "for sumoylation.",
            "probability": 0.0017919540405273438
        },
        {
            "start_logit": -1.8583984375,
            "end_logit": -4.890625,
            "text": "SUMO-conjugating",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": -3.109375,
            "end_logit": -4.890625,
            "text": "conjugating",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -1.8583984375,
            "end_logit": -7.59765625,
            "text": "SUMO-conjugating enzyme",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.8583984375,
            "end_logit": -7.8671875,
            "text": "SUMO-conjugating enzyme UB",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.8583984375,
            "end_logit": -7.96875,
            "text": "SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation",
            "probability": 5.364418029785156e-07
        }
    ],
    "58a5b1fe60087bc10a000024_3": [
        {
            "start_logit": -0.1959228515625,
            "end_logit": -1.8671875,
            "text": "Ets-1 K15R/K227",
            "probability": 0.6015625
        },
        {
            "start_logit": -1.265625,
            "end_logit": -1.8671875,
            "text": "K15R/K227",
            "probability": 0.2064208984375
        },
        {
            "start_logit": -0.1959228515625,
            "end_logit": -4.25,
            "text": "Ets-1 K15R/K227R",
            "probability": 0.055511474609375
        },
        {
            "start_logit": -0.1959228515625,
            "end_logit": -5.22265625,
            "text": "Ets-1 K1",
            "probability": 0.0209808349609375
        },
        {
            "start_logit": -1.265625,
            "end_logit": -4.25,
            "text": "K15R/K227R",
            "probability": 0.01904296875
        },
        {
            "start_logit": -3.654296875,
            "end_logit": -1.8671875,
            "text": "K227",
            "probability": 0.018890380859375
        },
        {
            "start_logit": -4.140625,
            "end_logit": -1.8671875,
            "text": "Ets-1 wildtype (WT) or its sumoylation deficient version (Ets-1 K15R/K227",
            "probability": 0.0116424560546875
        },
        {
            "start_logit": -4.2578125,
            "end_logit": -1.8671875,
            "text": "1 K15R/K227",
            "probability": 0.01035308837890625
        },
        {
            "start_logit": -0.1959228515625,
            "end_logit": -6.140625,
            "text": "Ets-1",
            "probability": 0.00838470458984375
        },
        {
            "start_logit": -1.265625,
            "end_logit": -5.22265625,
            "text": "K1",
            "probability": 0.007198333740234375
        },
        {
            "start_logit": -1.1015625,
            "end_logit": -5.5390625,
            "text": "enhance Ets-1 sumoylation, while a SUMO protease, SENP1, can desumoylate Ets-1",
            "probability": 0.006183624267578125
        },
        {
            "start_logit": -0.1959228515625,
            "end_logit": -6.640625,
            "text": "Ets-1 K15R/K227R), as well as WT or mutant proteins of the SUMO pathway, we further demonstrated",
            "probability": 0.005084991455078125
        },
        {
            "start_logit": -0.1959228515625,
            "end_logit": -6.65625,
            "text": "Ets-1 K15",
            "probability": 0.005008697509765625
        },
        {
            "start_logit": -0.1959228515625,
            "end_logit": -6.91796875,
            "text": "Ets-1 K15R",
            "probability": 0.00385284423828125
        },
        {
            "start_logit": -5.25390625,
            "end_logit": -1.8671875,
            "text": "/K227",
            "probability": 0.0038242340087890625
        },
        {
            "start_logit": -5.40625,
            "end_logit": -1.8671875,
            "text": "sumoylation deficient version (Ets-1 K15R/K227",
            "probability": 0.0032825469970703125
        },
        {
            "start_logit": -0.1959228515625,
            "end_logit": -7.08984375,
            "text": "Ets-1 K15R/K227R)",
            "probability": 0.0032444000244140625
        },
        {
            "start_logit": -1.1015625,
            "end_logit": -6.19140625,
            "text": "enhance Ets-1",
            "probability": 0.0032196044921875
        },
        {
            "start_logit": -5.48046875,
            "end_logit": -1.8671875,
            "text": "5R/K227",
            "probability": 0.003047943115234375
        },
        {
            "start_logit": -0.1959228515625,
            "end_logit": -7.1796875,
            "text": "Ets-1 K15R/K227R), as well as WT or mutant proteins of the SUMO pathway, we",
            "probability": 0.0029659271240234375
        }
    ],
    "58a5b1fe60087bc10a000024_4": [
        {
            "start_logit": -2.16015625,
            "end_logit": -3.6640625,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB pathway",
            "probability": 0.488525390625
        },
        {
            "start_logit": -3.728515625,
            "end_logit": -3.6640625,
            "text": "SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB pathway",
            "probability": 0.10198974609375
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -3.6640625,
            "text": "conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB pathway",
            "probability": 0.045989990234375
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.06640625,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100",
            "probability": 0.044219970703125
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -3.6640625,
            "text": "activation of the alternative NF-kappaB pathway",
            "probability": 0.0418701171875
        },
        {
            "start_logit": -4.74609375,
            "end_logit": -3.6640625,
            "text": "NF-kappaB pathway",
            "probability": 0.036956787109375
        },
        {
            "start_logit": -4.89453125,
            "end_logit": -3.6640625,
            "text": "of the alternative NF-kappaB pathway",
            "probability": 0.0316162109375
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.43359375,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing",
            "probability": 0.0306243896484375
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.65625,
            "text": "E2",
            "probability": 0.0246124267578125
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.67578125,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB",
            "probability": 0.0240325927734375
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.80859375,
            "text": "E2 SUMO-conjugating",
            "probability": 0.02105712890625
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.8515625,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits",
            "probability": 0.02008056640625
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.91015625,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p1",
            "probability": 0.0190277099609375
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -7.22265625,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various",
            "probability": 0.01390838623046875
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -7.2421875,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological",
            "probability": 0.01358795166015625
        },
        {
            "start_logit": -6.09375,
            "end_logit": -3.6640625,
            "text": "the alternative NF-kappaB pathway",
            "probability": 0.0095672607421875
        },
        {
            "start_logit": -3.728515625,
            "end_logit": -6.06640625,
            "text": "SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100",
            "probability": 0.0092010498046875
        },
        {
            "start_logit": -6.25390625,
            "end_logit": -3.6640625,
            "text": "of E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB pathway",
            "probability": 0.00811767578125
        },
        {
            "start_logit": -6.296875,
            "end_logit": -3.6640625,
            "text": "p100 processing and ultimate activation of the alternative NF-kappaB pathway",
            "probability": 0.00780487060546875
        },
        {
            "start_logit": -6.32421875,
            "end_logit": -3.6640625,
            "text": "alternative NF-kappaB pathway",
            "probability": 0.00762176513671875
        }
    ],
    "58a5b1fe60087bc10a000024_5": [
        {
            "start_logit": 1.841796875,
            "end_logit": 6.359375,
            "text": "of white spot syndrome virus.",
            "probability": 0.71923828125
        },
        {
            "start_logit": 0.55078125,
            "end_logit": 6.359375,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.1973876953125
        },
        {
            "start_logit": -0.352294921875,
            "end_logit": 6.359375,
            "text": ".",
            "probability": 0.080078125
        },
        {
            "start_logit": -5.6484375,
            "end_logit": 6.359375,
            "text": "conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.00040078163146972656
        },
        {
            "start_logit": -5.7578125,
            "end_logit": 6.359375,
            "text": "in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.0003592967987060547
        },
        {
            "start_logit": -6.0,
            "end_logit": 6.359375,
            "text": "to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.00028204917907714844
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 6.359375,
            "text": "white spot syndrome virus.",
            "probability": 0.0002810955047607422
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 6.359375,
            "text": "crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.0002810955047607422
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 6.359375,
            "text": "facilitate reproduction of white spot syndrome virus.",
            "probability": 0.0002579689025878906
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 6.359375,
            "text": "reproduction of white spot syndrome virus.",
            "probability": 0.0002579689025878906
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 6.359375,
            "text": "mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.000244140625
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 6.359375,
            "text": "ayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.00020313262939453125
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 6.359375,
            "text": "SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.00019991397857666016
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 6.359375,
            "text": "early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.00016450881958007812
        },
        {
            "start_logit": -6.5625,
            "end_logit": 6.359375,
            "text": "immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.00016069412231445312
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 6.359375,
            "text": "ylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.00015211105346679688
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 6.359375,
            "text": "protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.00013017654418945312
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 6.359375,
            "text": "spot syndrome virus.",
            "probability": 0.0001270771026611328
        },
        {
            "start_logit": 1.841796875,
            "end_logit": -6.19921875,
            "text": "of white spot syndrome virus",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 0.55078125,
            "end_logit": -5.3671875,
            "text": "SUMO-conjugating enzyme E2",
            "probability": 1.6093254089355469e-06
        }
    ],
    "58a5b1fe60087bc10a000024_6": [
        {
            "start_logit": 0.395751953125,
            "end_logit": -1.0654296875,
            "text": "E2 SUMO-conjugating enzyme.",
            "probability": 0.9482421875
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -1.0654296875,
            "text": "SUMO-conjugating enzyme.",
            "probability": 0.016693115234375
        },
        {
            "start_logit": 0.395751953125,
            "end_logit": -5.51171875,
            "text": "E2 SUMO-conjugating",
            "probability": 0.0111236572265625
        },
        {
            "start_logit": 0.395751953125,
            "end_logit": -6.109375,
            "text": "E2",
            "probability": 0.00609588623046875
        },
        {
            "start_logit": 0.395751953125,
            "end_logit": -6.37890625,
            "text": "E2 SUMO-conjugating enzyme",
            "probability": 0.004673004150390625
        },
        {
            "start_logit": -5.42578125,
            "end_logit": -1.0654296875,
            "text": "conjugating enzyme.",
            "probability": 0.002811431884765625
        },
        {
            "start_logit": -5.72265625,
            "end_logit": -1.0654296875,
            "text": "revisited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0020904541015625
        },
        {
            "start_logit": 0.395751953125,
            "end_logit": -7.61328125,
            "text": "E2 SUMO-conjug",
            "probability": 0.0013599395751953125
        },
        {
            "start_logit": -6.15625,
            "end_logit": -1.0654296875,
            "text": ".",
            "probability": 0.00135040283203125
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -1.0654296875,
            "text": "unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0009279251098632812
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -1.0654296875,
            "text": "-conjugating enzyme.",
            "probability": 0.0009059906005859375
        },
        {
            "start_logit": -6.68359375,
            "end_logit": -1.0654296875,
            "text": "Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0007996559143066406
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -1.0654296875,
            "text": "SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0007004737854003906
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -1.0654296875,
            "text": "of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0007004737854003906
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -1.0654296875,
            "text": "on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0004737377166748047
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -1.0654296875,
            "text": "the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.00043129920959472656
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.0654296875,
            "text": "the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.00038361549377441406
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -5.51171875,
            "text": "SUMO-conjugating",
            "probability": 0.00019598007202148438
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -6.37890625,
            "text": "SUMO-conjugating enzyme",
            "probability": 8.231401443481445e-05
        },
        {
            "start_logit": -5.42578125,
            "end_logit": -5.51171875,
            "text": "conjugating",
            "probability": 3.3020973205566406e-05
        }
    ],
    "5c011057133db5eb78000025_1": [
        {
            "start_logit": 7.90234375,
            "end_logit": 7.84375,
            "text": "phase II",
            "probability": 1.0
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.4306640625,
            "text": "phase",
            "probability": 9.316205978393555e-05
        },
        {
            "start_logit": -1.65234375,
            "end_logit": 7.84375,
            "text": "II",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.53125,
            "text": "phase II clinical trials.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.84375,
            "text": "been evaluated in phase II",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.84375,
            "text": "have been evaluated in phase II",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 7.84375,
            "text": "in phase II",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.83984375,
            "text": "phase II clinical trials",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 7.84375,
            "text": "while several other novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase II",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 7.84375,
            "text": "evaluated in phase II",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.84375,
            "text": "novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase II",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": -1.4306640625,
            "text": "been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -1.4306640625,
            "text": "tuberculosis, while several other novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": -1.4306640625,
            "text": "have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -1.65234375,
            "end_logit": -7.53125,
            "text": "II clinical trials.",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -1.4306640625,
            "text": "in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -1.4306640625,
            "text": "while several other novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -1.4306640625,
            "text": "evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -1.4306640625,
            "text": "novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -1.65234375,
            "end_logit": -7.83984375,
            "text": "II clinical trials",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_1": [
        {
            "start_logit": 7.921875,
            "end_logit": 7.8203125,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": 7.921875,
            "end_logit": -1.0234375,
            "text": "primary microcephaly and define a novel laminopathy.",
            "probability": 0.0001442432403564453
        },
        {
            "start_logit": 7.921875,
            "end_logit": -1.7783203125,
            "text": "primary",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -2.23828125,
            "end_logit": 7.8203125,
            "text": "y",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -4.890625,
            "text": "primary microcephaly and",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 7.921875,
            "end_logit": -4.96875,
            "text": "primary microcephaly and define a novel laminopathy",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -5.32421875,
            "end_logit": 7.8203125,
            "text": "microcephaly",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.640625,
            "end_logit": 7.8203125,
            "text": "ephaly",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.8125,
            "end_logit": 7.8203125,
            "text": "Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.0703125,
            "text": "primary microcephaly and define a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.265625,
            "text": "primary microcephal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.50390625,
            "text": "primary microcephaly and define",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.5078125,
            "text": "primary microcephaly and define a novel",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.546875,
            "text": "primary microcephaly and define a novel lamin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.8203125,
            "text": "lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.8203125,
            "text": "cause primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.91015625,
            "text": "primary microc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 7.8203125,
            "text": "lamin B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.23828125,
            "end_logit": -1.0234375,
            "text": "y and define a novel laminopathy.",
            "probability": 0.0
        },
        {
            "start_logit": -3.11328125,
            "end_logit": -1.0234375,
            "text": "laminopathy.",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_2": [
        {
            "start_logit": 7.75,
            "end_logit": 7.91015625,
            "text": "primary microcephaly",
            "probability": 0.45556640625
        },
        {
            "start_logit": 7.484375,
            "end_logit": 7.8984375,
            "text": "primary microcephaly",
            "probability": 0.346435546875
        },
        {
            "start_logit": 7.75,
            "end_logit": 6.9296875,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 0.171630859375
        },
        {
            "start_logit": 5.87890625,
            "end_logit": 6.9296875,
            "text": "laminopathy",
            "probability": 0.0265045166015625
        },
        {
            "start_logit": -1.8125,
            "end_logit": 7.91015625,
            "text": "y",
            "probability": 3.2067298889160156e-05
        },
        {
            "start_logit": -1.859375,
            "end_logit": 7.8984375,
            "text": "y",
            "probability": 3.0338764190673828e-05
        },
        {
            "start_logit": 7.75,
            "end_logit": -1.73828125,
            "text": "primary",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -2.27734375,
            "end_logit": 7.8984375,
            "text": "microcephaly",
            "probability": 2.002716064453125e-05
        },
        {
            "start_logit": 7.484375,
            "end_logit": -2.2578125,
            "text": "primary",
            "probability": 1.3470649719238281e-05
        },
        {
            "start_logit": -1.8125,
            "end_logit": 6.9296875,
            "text": "y, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": -3.609375,
            "end_logit": 7.91015625,
            "text": "NB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -3.8515625,
            "end_logit": 7.91015625,
            "text": "microcephaly",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -3.150390625,
            "end_logit": 6.9296875,
            "text": "opathy",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -2.2578125,
            "text": "laminopathy. The distinct nature of this lamin B-associated phenotype highlights the strikingly different developmental requirements for lamin paralogs and suggests a novel mechanism for primary",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -3.498046875,
            "end_logit": 6.9296875,
            "text": "form of laminopathy",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -3.8515625,
            "end_logit": 6.9296875,
            "text": "microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.75,
            "end_logit": -4.765625,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of lamin",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -3.81640625,
            "text": "laminopathy. The distinct nature of this lamin B",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.484375,
            "end_logit": -5.59375,
            "text": "primary microcephaly warranting future investigation.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -4.765625,
            "text": "lamin",
            "probability": 2.384185791015625e-07
        }
    ],
    "601bfa531cb411341a000008_3": [
        {
            "start_logit": 7.75,
            "end_logit": 7.91015625,
            "text": "primary microcephaly",
            "probability": 0.45556640625
        },
        {
            "start_logit": 7.484375,
            "end_logit": 7.8984375,
            "text": "primary microcephaly",
            "probability": 0.346435546875
        },
        {
            "start_logit": 7.75,
            "end_logit": 6.9296875,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 0.171630859375
        },
        {
            "start_logit": 5.87890625,
            "end_logit": 6.9296875,
            "text": "laminopathy",
            "probability": 0.0265045166015625
        },
        {
            "start_logit": -1.8125,
            "end_logit": 7.91015625,
            "text": "y",
            "probability": 3.2067298889160156e-05
        },
        {
            "start_logit": -1.859375,
            "end_logit": 7.8984375,
            "text": "y",
            "probability": 3.0338764190673828e-05
        },
        {
            "start_logit": 7.75,
            "end_logit": -1.73828125,
            "text": "primary",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -2.27734375,
            "end_logit": 7.8984375,
            "text": "microcephaly",
            "probability": 2.002716064453125e-05
        },
        {
            "start_logit": 7.484375,
            "end_logit": -2.2578125,
            "text": "primary",
            "probability": 1.3470649719238281e-05
        },
        {
            "start_logit": -1.8125,
            "end_logit": 6.9296875,
            "text": "y, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": -3.609375,
            "end_logit": 7.91015625,
            "text": "NB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -3.8515625,
            "end_logit": 7.91015625,
            "text": "microcephaly",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -3.150390625,
            "end_logit": 6.9296875,
            "text": "opathy",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -2.2578125,
            "text": "laminopathy. The distinct nature of this lamin B-associated phenotype highlights the strikingly different developmental requirements for lamin paralogs and suggests a novel mechanism for primary",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -3.498046875,
            "end_logit": 6.9296875,
            "text": "form of laminopathy",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -3.8515625,
            "end_logit": 6.9296875,
            "text": "microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.75,
            "end_logit": -4.765625,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of lamin",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -3.81640625,
            "text": "laminopathy. The distinct nature of this lamin B",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.484375,
            "end_logit": -5.59375,
            "text": "primary microcephaly warranting future investigation.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.87890625,
            "end_logit": -4.765625,
            "text": "lamin",
            "probability": 2.384185791015625e-07
        }
    ],
    "601bfa531cb411341a000008_4": [
        {
            "start_logit": 7.8359375,
            "end_logit": 7.79296875,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -2.107421875,
            "text": "primary",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": -2.3125,
            "end_logit": 7.79296875,
            "text": "y",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -4.19921875,
            "text": "primary microcephaly and define a novel laminopathy",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -4.87890625,
            "text": "primary microcephaly and",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 7.79296875,
            "text": "microcephaly",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 7.79296875,
            "text": "ephaly",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 7.79296875,
            "text": "Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.07421875,
            "text": "primary microcephaly and define a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.37109375,
            "text": "primary microcephal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.421875,
            "text": "primary microcephaly and define a novel lamin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.50390625,
            "text": "primary microcephaly and define a novel",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.5625,
            "text": "primary microcephaly and define",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.79296875,
            "text": "cause primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.79296875,
            "text": "lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 7.79296875,
            "text": "lamin B2 variants cause primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 7.79296875,
            "text": "B2 variants cause primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -8.078125,
            "text": "primary microc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.3125,
            "end_logit": -4.19921875,
            "text": "y and define a novel laminopathy",
            "probability": 0.0
        },
        {
            "start_logit": -2.595703125,
            "end_logit": -4.19921875,
            "text": "laminopathy",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_5": [
        {
            "start_logit": 7.62890625,
            "end_logit": 6.73828125,
            "text": "primary microcephaly",
            "probability": 0.94384765625
        },
        {
            "start_logit": 7.62890625,
            "end_logit": 3.921875,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 0.056243896484375
        },
        {
            "start_logit": 7.62890625,
            "end_logit": -2.568359375,
            "text": "primary",
            "probability": 8.589029312133789e-05
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": 3.921875,
            "text": "laminopathy",
            "probability": 6.639957427978516e-05
        },
        {
            "start_logit": -4.09375,
            "end_logit": 6.73828125,
            "text": "y",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -5.484375,
            "end_logit": 6.73828125,
            "text": "NB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 6.73828125,
            "text": "microcephaly",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.62890625,
            "end_logit": -7.078125,
            "text": "primary microcephal",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.62890625,
            "end_logit": -7.2421875,
            "text": "primary microcephaly,",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.62890625,
            "end_logit": -7.5859375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 6.73828125,
            "text": "NB2 as a genetic cause of primary microcephaly",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -4.09375,
            "end_logit": 3.921875,
            "text": "y, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.62890625,
            "end_logit": -7.81640625,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.62890625,
            "end_logit": -7.87109375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of lamin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.62890625,
            "end_logit": -7.87890625,
            "text": "primary microcephaly, implicating a major structural component of the nuclear",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -4.18359375,
            "end_logit": 3.921875,
            "text": "of laminopathy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.62890625,
            "end_logit": -7.93359375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.2421875,
            "end_logit": 3.921875,
            "text": "form of laminopathy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 6.73828125,
            "text": "ephaly",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 6.73828125,
            "text": "LMNB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 3.5762786865234375e-07
        }
    ],
    "61f7d745882a024a10000038_1": [
        {
            "start_logit": 6.54296875,
            "end_logit": 6.66796875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -5.875,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.57421875,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as in the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.59375,
            "text": "malaria infection (CHMI) using homologous parasites (same P",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.640625,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as in the vaccine",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.6484375,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7109375,
            "text": "malaria infection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7421875,
            "text": "malaria infection (CHMI) using homologous parasites",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.66796875,
            "text": "Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.75,
            "text": "malaria infection (CHMI",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.66796875,
            "text": "human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7890625,
            "text": "malaria infection (CHMI) using homologous",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.80078125,
            "text": "malaria infection (CHMI) using homologous parasites (same",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 6.66796875,
            "text": "100% protection against controlled human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.8359375,
            "text": "malaria infection (CH",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": -5.875,
            "text": "falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -5.875,
            "text": "human malaria infection (CHMI) using homologous parasites (same P. falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -5.875,
            "text": "P. falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -5.875,
            "text": "100% protection against controlled human malaria infection (CHMI) using homologous parasites (same P. falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.0,
            "text": "Plasmodium falciparum",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_2": [
        {
            "start_logit": 6.484375,
            "end_logit": 6.7265625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -2.59765625,
            "end_logit": 6.7265625,
            "text": "human malaria",
            "probability": 0.00011414289474487305
        },
        {
            "start_logit": -7.0,
            "end_logit": 6.7265625,
            "text": "100% against homologous controlled human malaria",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 6.7265625,
            "text": "controlled human malaria",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.7265625,
            "text": "chloroquine chemoprophylaxis) have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.484375,
            "end_logit": -7.7578125,
            "text": "malaria infection",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.484375,
            "end_logit": -7.92578125,
            "text": "malaria infection (CHMI",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -2.59765625,
            "end_logit": -7.7578125,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -2.59765625,
            "end_logit": -7.8828125,
            "text": "human",
            "probability": 0.0
        },
        {
            "start_logit": -2.59765625,
            "end_logit": -7.92578125,
            "text": "human malaria infection (CHMI",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -5.62890625,
            "text": "Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -5.62890625,
            "text": "falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -7.5625,
            "text": "Plasmodium falciparum sporozoite (",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -7.74609375,
            "text": "Plasmodium falciparum sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -7.8515625,
            "text": "Plasmodium falciparum sporozoite (PfSPZ)",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -7.8671875,
            "text": "Plasmodium falciparum sporozoite (PfSPZ) Vaccine (radiation-attenuated, aseptic, purified, cryopreserved PfSPZ) and PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -7.265625,
            "text": "100%",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -7.94921875,
            "text": "Plasmodium falciparum sporozoite (PfSPZ) Vaccine (radiation-attenuated, aseptic, purified, cryopreserved PfSPZ)",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -7.94921875,
            "text": "Plasmodium falciparum spor",
            "probability": 0.0
        },
        {
            "start_logit": -6.359375,
            "end_logit": -7.95703125,
            "text": "Plasmodium falciparum sporozoite (PfSPZ) Vaccine (radiation-attenuated, aseptic, purified, cryopreserved PfSPZ) and",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_3": [
        {
            "start_logit": 7.86328125,
            "end_logit": 7.5390625,
            "text": "Plasmodium falciparum",
            "probability": 0.57763671875
        },
        {
            "start_logit": 7.86328125,
            "end_logit": 6.5625,
            "text": "Plasmodium falciparum sporozoite (PfSPZ) vaccine provides protection against P. falciparum infection in malaria",
            "probability": 0.2159423828125
        },
        {
            "start_logit": 7.86328125,
            "end_logit": 6.2109375,
            "text": "Plasmodium falciparum sporozoite (PfSPZ) vaccine provides protection against P. falciparum",
            "probability": 0.153076171875
        },
        {
            "start_logit": 6.453125,
            "end_logit": 6.5625,
            "text": "malaria",
            "probability": 0.05291748046875
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -1.5859375,
            "text": "Plasmodium falciparum sporozoite (PfSPZ) vaccine provides protection against P. falciparum infection",
            "probability": 6.29425048828125e-05
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -1.7138671875,
            "text": "Plasmodium",
            "probability": 5.513429641723633e-05
        },
        {
            "start_logit": -2.203125,
            "end_logit": 7.5390625,
            "text": "falciparum",
            "probability": 2.4437904357910156e-05
        },
        {
            "start_logit": -2.203125,
            "end_logit": 6.5625,
            "text": "falciparum sporozoite (PfSPZ) vaccine provides protection against P. falciparum infection in malaria",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": -2.203125,
            "end_logit": 6.2109375,
            "text": "falciparum sporozoite (PfSPZ) vaccine provides protection against P. falciparum",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": -2.6171875,
            "end_logit": 6.5625,
            "text": "P. falciparum infection in malaria",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -2.6171875,
            "end_logit": 6.2109375,
            "text": "P. falciparum",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -3.142578125,
            "end_logit": 6.5625,
            "text": "falciparum infection in malaria",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -3.142578125,
            "end_logit": 6.2109375,
            "text": "falciparum",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -5.08984375,
            "text": "Plasmodium falciparum sporozoite",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -5.3515625,
            "text": "Plasmodium falciparum sporozoite (PfSPZ) vaccine provides protection against P. falciparum infection in malaria-na\u00efve adults.",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.046875,
            "text": "Plasmodium falciparum sporozoite (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.453125,
            "end_logit": -5.3515625,
            "text": "malaria-na\u00efve adults.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 7.5390625,
            "text": "attenuated Plasmodium falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.09375,
            "text": "Plasmodium falciparum sporozoite (PfSPZ) vaccine provides protection against P. falciparum infection in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 7.5390625,
            "text": "The radiation-attenuated Plasmodium falciparum",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_4": [
        {
            "start_logit": 6.54296875,
            "end_logit": 6.66015625,
            "text": "malaria",
            "probability": 0.501953125
        },
        {
            "start_logit": 6.5390625,
            "end_logit": 6.65625,
            "text": "malaria",
            "probability": 0.498046875
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.66015625,
            "text": "human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.6328125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.66796875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7421875,
            "text": "malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.76171875,
            "text": "malaria infection (CH",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.78125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.80078125,
            "text": "malaria infection (CHMI",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.796875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.80859375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.80859375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.8125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.83203125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.84375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.84375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.8984375,
            "text": "malaria infection (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.8984375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.7421875,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.76171875,
            "text": "human malaria infection (CH",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_5": [
        {
            "start_logit": 6.54296875,
            "end_logit": 6.66015625,
            "text": "malaria",
            "probability": 0.501953125
        },
        {
            "start_logit": 6.5390625,
            "end_logit": 6.65625,
            "text": "malaria",
            "probability": 0.498046875
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.66015625,
            "text": "human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.6328125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.66796875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7421875,
            "text": "malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.76171875,
            "text": "malaria infection (CH",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.78125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.80078125,
            "text": "malaria infection (CHMI",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.796875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.80859375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.80859375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.8125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.83203125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.84375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.84375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.8984375,
            "text": "malaria infection (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.8984375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.7421875,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.76171875,
            "text": "human malaria infection (CH",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_6": [
        {
            "start_logit": 6.5625,
            "end_logit": 6.640625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.14453125,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.2421875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages of the parasite",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.96484375,
            "text": "malaria vaccines,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.984375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages of the parasite cycle",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.38671875,
            "end_logit": -7.30859375,
            "text": "Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -6.38671875,
            "end_logit": -7.9453125,
            "text": "Plasmodium",
            "probability": 0.0
        },
        {
            "start_logit": -6.38671875,
            "end_logit": -7.96875,
            "text": "Plasmodium vivax sexual erythrocytic and mosquito stages.",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": -7.30859375,
            "text": "vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -7.30859375,
            "text": "erythrocytic, but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.2421875,
            "text": "parasite",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -7.2421875,
            "text": "erythrocytic stages of the parasite",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -7.30859375,
            "text": "cytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -7.30859375,
            "text": "asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -7.8203125,
            "text": "PfSPZ-CVac",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -7.96875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -7.8203125,
            "text": "CVac",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -7.8203125,
            "text": "erythrocytic stages (PfSPZ Vaccine and PfSPZ-CVac",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -7.8203125,
            "text": "Z-CVac",
            "probability": 0.0
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -7.90234375,
            "text": "CVac), (3) prime boost vaccines that include recombinant DNA, viruses and bacteria, and protein with adjuvant aimed primarily at Pf",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_7": [
        {
            "start_logit": 6.5625,
            "end_logit": 6.640625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.14453125,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.2421875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages of the parasite",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.96484375,
            "text": "malaria vaccines,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.984375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages of the parasite cycle",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.38671875,
            "end_logit": -7.30859375,
            "text": "Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -6.38671875,
            "end_logit": -7.9453125,
            "text": "Plasmodium",
            "probability": 0.0
        },
        {
            "start_logit": -6.38671875,
            "end_logit": -7.96875,
            "text": "Plasmodium vivax sexual erythrocytic and mosquito stages.",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": -7.30859375,
            "text": "vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -7.30859375,
            "text": "erythrocytic, but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.2421875,
            "text": "parasite",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -7.2421875,
            "text": "erythrocytic stages of the parasite",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -7.30859375,
            "text": "cytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -7.30859375,
            "text": "asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -7.8203125,
            "text": "PfSPZ-CVac",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -7.96875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -7.8203125,
            "text": "CVac",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -7.8203125,
            "text": "erythrocytic stages (PfSPZ Vaccine and PfSPZ-CVac",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -7.8203125,
            "text": "Z-CVac",
            "probability": 0.0
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -7.90234375,
            "text": "CVac), (3) prime boost vaccines that include recombinant DNA, viruses and bacteria, and protein with adjuvant aimed primarily at Pf",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_8": [
        {
            "start_logit": 6.5703125,
            "end_logit": 6.62109375,
            "text": "malaria",
            "probability": 0.200927734375
        },
        {
            "start_logit": 6.5703125,
            "end_logit": 6.6171875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No injectable malaria",
            "probability": 0.200927734375
        },
        {
            "start_logit": 6.5546875,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.200927734375
        },
        {
            "start_logit": 6.5625,
            "end_logit": 6.6171875,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.5546875,
            "end_logit": 6.62109375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.19775390625
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 6.6171875,
            "text": ". No injectable malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.23828125,
            "text": "malaria vaccine has demonstrated long",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.54296875,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.61328125,
            "text": "malaria vaccine has demonstrated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.62890625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.62890625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.671875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.71484375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.75390625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.765625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No injectable",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.78125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.76953125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.79296875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.81640625,
            "text": "malaria infection (CH",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.82421875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_9": [
        {
            "start_logit": 6.5703125,
            "end_logit": 6.62109375,
            "text": "malaria",
            "probability": 0.200927734375
        },
        {
            "start_logit": 6.5703125,
            "end_logit": 6.6171875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No injectable malaria",
            "probability": 0.200927734375
        },
        {
            "start_logit": 6.5546875,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.200927734375
        },
        {
            "start_logit": 6.5625,
            "end_logit": 6.6171875,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.5546875,
            "end_logit": 6.62109375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.19775390625
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 6.6171875,
            "text": ". No injectable malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.23828125,
            "text": "malaria vaccine has demonstrated long",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.54296875,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.61328125,
            "text": "malaria vaccine has demonstrated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.62890625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.62890625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.671875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.71484375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.75390625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.765625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No injectable",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.78125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.76953125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.79296875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.81640625,
            "text": "malaria infection (CH",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.82421875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_10": [
        {
            "start_logit": 6.5703125,
            "end_logit": 6.62109375,
            "text": "malaria",
            "probability": 0.200927734375
        },
        {
            "start_logit": 6.5703125,
            "end_logit": 6.6171875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No injectable malaria",
            "probability": 0.200927734375
        },
        {
            "start_logit": 6.5546875,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.200927734375
        },
        {
            "start_logit": 6.5625,
            "end_logit": 6.6171875,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.5546875,
            "end_logit": 6.62109375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.19775390625
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 6.6171875,
            "text": ". No injectable malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.23828125,
            "text": "malaria vaccine has demonstrated long",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.54296875,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.61328125,
            "text": "malaria vaccine has demonstrated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.62890625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.62890625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.671875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.71484375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.75390625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.765625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No injectable",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.78125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.76953125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.79296875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.81640625,
            "text": "malaria infection (CH",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.82421875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_11": [
        {
            "start_logit": 6.5546875,
            "end_logit": 6.63671875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -3.34375,
            "end_logit": 6.63671875,
            "text": "P. falciparum sporozoite binding and invasion-inhibitory IgM antibodies are induced following immunization of malaria",
            "probability": 5.066394805908203e-05
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 6.63671875,
            "text": "falciparum sporozoite binding and invasion-inhibitory IgM antibodies are induced following immunization of malaria",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.6953125,
            "text": "malaria-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.7734375,
            "text": "malaria-preexpose",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.796875,
            "text": "malaria-preex",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.8203125,
            "text": "malaria-preexposed",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.84765625,
            "text": "malaria-preexpo",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.63671875,
            "text": ". falciparum sporozoite binding and invasion-inhibitory IgM antibodies are induced following immunization of malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.63671875,
            "text": "sporozoite binding and invasion-inhibitory IgM antibodies are induced following immunization of malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -3.34375,
            "end_logit": 0.97314453125,
            "text": "P. falciparum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 0.97314453125,
            "text": "falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": 0.97314453125,
            "text": ". falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -3.34375,
            "end_logit": -7.58203125,
            "text": "P",
            "probability": 0.0
        },
        {
            "start_logit": -3.34375,
            "end_logit": -7.6875,
            "text": "P. falciparum sporozoite binding",
            "probability": 0.0
        },
        {
            "start_logit": -3.34375,
            "end_logit": -7.6953125,
            "text": "P. falciparum sporozoite binding and invasion-inhibitory IgM antibodies are induced following immunization of malaria-",
            "probability": 0.0
        },
        {
            "start_logit": -3.34375,
            "end_logit": -7.734375,
            "text": "P. falciparum sporozoite binding and invasion-inhibitory IgM antibodies are induced following immunization of",
            "probability": 0.0
        },
        {
            "start_logit": -3.34375,
            "end_logit": -7.73828125,
            "text": "P. falciparum sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -3.34375,
            "end_logit": -7.76171875,
            "text": "P. falciparum sporozoite binding and invasion-inhibitory IgM antibodies",
            "probability": 0.0
        },
        {
            "start_logit": -3.34375,
            "end_logit": -7.7734375,
            "text": "P. falciparum sporozoite binding and invasion-inhibitory IgM antibodies are induced following immunization of malaria-preexpose",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_12": [
        {
            "start_logit": 6.5546875,
            "end_logit": 6.640625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.640625,
            "text": "Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.6328125,
            "text": "malaria, but the features of the antibody response",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.68359375,
            "text": "malaria, but the features of the antibody response induced",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.71875,
            "text": "malaria, but the features of the antibody",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.72265625,
            "text": "malaria, but the features of the antibody response induced by this",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.73828125,
            "text": "malaria, but the features of the antibody response induced by",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.74609375,
            "text": "malaria, but the features of the antibody response induced by this treatment",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.75,
            "text": "malaria, but the features of the antibody response induced by this treatment remain unclear",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.8046875,
            "text": "malaria,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.640625,
            "text": "falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.84375,
            "text": "malaria, but the features of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.875,
            "text": "malaria, but the",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 6.640625,
            "text": "shown to be protective against malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 6.640625,
            "text": "been shown to be protective against malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.640625,
            "text": "sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 6.640625,
            "text": "ozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.640625,
            "text": "Immunization with attenuated Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 6.640625,
            "text": "against malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 6.640625,
            "text": "has been shown to be protective against malaria",
            "probability": 3.5762786865234375e-07
        }
    ],
    "61f7d745882a024a10000038_13": [
        {
            "start_logit": 6.58203125,
            "end_logit": 6.6171875,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 0.2025146484375
        },
        {
            "start_logit": 6.58203125,
            "end_logit": 6.6171875,
            "text": "malaria",
            "probability": 0.2025146484375
        },
        {
            "start_logit": 6.58203125,
            "end_logit": 6.60546875,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.5625,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.5625,
            "end_logit": 6.60546875,
            "text": "malaria vaccines, which is based on human malaria",
            "probability": 0.1962890625
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.38671875,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria. PfS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.38671875,
            "text": "malaria. PfS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.6875,
            "text": "malaria sporozoites and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.6875,
            "text": "malaria vaccines, which is based on human malaria sporozoites and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.71875,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.7265625,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.734375,
            "text": "malaria sporozoites and called",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.71875,
            "text": "malaria vaccines",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.71875,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.72265625,
            "text": "malaria vaccines,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.7265625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.734375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.796875,
            "text": "malaria sporozoites",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.78515625,
            "text": "malaria vaccines, which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.8125,
            "text": "malaria sporozoites and called PfSPZ",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_14": [
        {
            "start_logit": 6.58203125,
            "end_logit": 6.6171875,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 0.2025146484375
        },
        {
            "start_logit": 6.58203125,
            "end_logit": 6.6171875,
            "text": "malaria",
            "probability": 0.2025146484375
        },
        {
            "start_logit": 6.58203125,
            "end_logit": 6.60546875,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.5625,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.5625,
            "end_logit": 6.60546875,
            "text": "malaria vaccines, which is based on human malaria",
            "probability": 0.1962890625
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.38671875,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria. PfS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.38671875,
            "text": "malaria. PfS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.6875,
            "text": "malaria sporozoites and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.6875,
            "text": "malaria vaccines, which is based on human malaria sporozoites and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.71875,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.7265625,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.734375,
            "text": "malaria sporozoites and called",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.71875,
            "text": "malaria vaccines",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.71875,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.72265625,
            "text": "malaria vaccines,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.7265625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.734375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.796875,
            "text": "malaria sporozoites",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.78515625,
            "text": "malaria vaccines, which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.8125,
            "text": "malaria sporozoites and called PfSPZ",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_15": [
        {
            "start_logit": 6.58203125,
            "end_logit": 6.6171875,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 0.2025146484375
        },
        {
            "start_logit": 6.58203125,
            "end_logit": 6.6171875,
            "text": "malaria",
            "probability": 0.2025146484375
        },
        {
            "start_logit": 6.58203125,
            "end_logit": 6.60546875,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.5625,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.5625,
            "end_logit": 6.60546875,
            "text": "malaria vaccines, which is based on human malaria",
            "probability": 0.1962890625
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.38671875,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria. PfS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.38671875,
            "text": "malaria. PfS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.6875,
            "text": "malaria sporozoites and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.6875,
            "text": "malaria vaccines, which is based on human malaria sporozoites and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.71875,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.7265625,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.734375,
            "text": "malaria sporozoites and called",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.71875,
            "text": "malaria vaccines",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.71875,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.72265625,
            "text": "malaria vaccines,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.7265625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.734375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.796875,
            "text": "malaria sporozoites",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.78515625,
            "text": "malaria vaccines, which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.8125,
            "text": "malaria sporozoites and called PfSPZ",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_16": [
        {
            "start_logit": 6.5546875,
            "end_logit": 6.6484375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -6.9140625,
            "text": "malaria infection (CHMI) using homologous parasites (sa",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.6484375,
            "text": "falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.6484375,
            "text": "100% protection against controlled human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.84765625,
            "text": "malaria infection (CHMI) using homologous parasites",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.6484375,
            "text": "Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.8515625,
            "text": "malaria infection",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.8515625,
            "text": "malaria infection (CHMI) using homologous parasites (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.6484375,
            "text": "human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.87109375,
            "text": "malaria infection (CHMI) using homologous",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.9375,
            "text": "malaria infection (CHMI",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.99609375,
            "text": "malaria infection (CH",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -6.9140625,
            "text": "100% protection against controlled human malaria infection (CHMI) using homologous parasites (sa",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -6.9140625,
            "text": "human malaria infection (CHMI) using homologous parasites (sa",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -6.9140625,
            "text": "parasites (sa",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -6.9140625,
            "text": "sa",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -7.04296875,
            "text": "falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -7.04296875,
            "text": "Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -7.04296875,
            "text": "BACKGROUND: A live-attenuated Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -7.04296875,
            "text": ": A live-attenuated Plasmodium falciparum",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_17": [
        {
            "start_logit": 6.53125,
            "end_logit": 6.67578125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.06640625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.765625,
            "text": "malaria infection (CHMI",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.76953125,
            "text": "malaria infection",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.76953125,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown. We",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.78125,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.84375,
            "text": "malaria infection (CH",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 6.67578125,
            "text": "human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.85546875,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.86328125,
            "text": "malaria infection (CHMI) 3 weeks after",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.86328125,
            "text": "malaria infection (CHMI) 3 weeks after immunization",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -7.06640625,
            "text": "human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -7.76953125,
            "text": ". We",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -7.765625,
            "text": "human malaria infection (CHMI",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -7.76953125,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -7.76953125,
            "text": "human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown. We",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -7.78125,
            "text": "human malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -7.84375,
            "text": "human malaria infection (CH",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -7.85546875,
            "text": "human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -7.86328125,
            "text": "human malaria infection (CHMI) 3 weeks after",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_18": [
        {
            "start_logit": 6.55078125,
            "end_logit": 6.65625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.54296875,
            "end_logit": 6.65625,
            "text": "malaria",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.55078125,
            "end_logit": 6.63671875,
            "text": "malaria",
            "probability": 0.329833984375
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -3.90625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -3.90625,
            "text": "malaria infection in malaria",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -5.7890625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -5.7890625,
            "text": "malaria infection in malaria-naive",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -6.2890625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive ind",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -6.2890625,
            "text": "malaria infection in malaria-naive ind",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.22265625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.63671875,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.4765625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.4765625,
            "text": "malaria infection in malaria-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.63671875,
            "text": "falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.66796875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.703125,
            "text": "malaria sporozoite",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.74609375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.75,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.74609375,
            "text": "malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.828125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_19": [
        {
            "start_logit": 6.55078125,
            "end_logit": 6.65625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.54296875,
            "end_logit": 6.65625,
            "text": "malaria",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.55078125,
            "end_logit": 6.63671875,
            "text": "malaria",
            "probability": 0.329833984375
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -3.90625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -3.90625,
            "text": "malaria infection in malaria",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -5.7890625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -5.7890625,
            "text": "malaria infection in malaria-naive",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -6.2890625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive ind",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -6.2890625,
            "text": "malaria infection in malaria-naive ind",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.22265625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.63671875,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.4765625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.4765625,
            "text": "malaria infection in malaria-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.63671875,
            "text": "falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.66796875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.703125,
            "text": "malaria sporozoite",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.74609375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.75,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.74609375,
            "text": "malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.828125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_20": [
        {
            "start_logit": 6.4921875,
            "end_logit": 6.70703125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.55078125,
            "text": "malaria by",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.70703125,
            "text": "human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.70703125,
            "text": "Sterile protection against human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.91015625,
            "text": "malaria by chemoattenuated",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.9921875,
            "text": "malaria by chemoat",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -8.046875,
            "text": "malaria by chemoattenuated PfSPZ vaccine",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -8.046875,
            "text": "malaria by chemoattenuated PfSPZ",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -8.125,
            "text": "malaria by chemoatten",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -8.15625,
            "text": "malaria by chemoattenuated PfSP",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -8.21875,
            "text": "malaria by chemoattenuated PfS",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.55078125,
            "text": "human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.55078125,
            "text": "Sterile protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.91015625,
            "text": "human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.9921875,
            "text": "human malaria by chemoat",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.8828125,
            "text": "Sterile protection",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.91015625,
            "text": "Sterile protection against human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -8.046875,
            "text": "human malaria by chemoattenuated PfSPZ vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -8.046875,
            "text": "human malaria by chemoattenuated PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.9921875,
            "text": "Sterile protection against human malaria by chemoat",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_21": [
        {
            "start_logit": 6.55078125,
            "end_logit": 6.6484375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 6.6484375,
            "text": "Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.38671875,
            "text": "malaria. A",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.6484375,
            "text": "falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.6484375,
            "text": "sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.6484375,
            "text": "(DVI) for maximal efficacy against malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.6484375,
            "text": "ozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.96875,
            "text": "malaria. A cri",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.6484375,
            "text": "against malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.6484375,
            "text": ", cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 6.6484375,
            "text": ", is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -7.11328125,
            "text": "Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.11328125,
            "text": "falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -7.38671875,
            "text": "Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria. A",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.38671875,
            "text": "falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria. A",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -7.11328125,
            "text": ", cryopreserved Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.38671875,
            "text": ". A",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -7.96875,
            "text": "Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria. A cri",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -8.0,
            "text": "Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DV",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -8.015625,
            "text": "Plasmodium",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_22": [
        {
            "start_logit": 6.55078125,
            "end_logit": 6.6484375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.765625,
            "text": "malaria vaccines because of its unparalleled",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.80078125,
            "text": "malaria vaccines because of its unp",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.8046875,
            "text": "malaria vaccines because of its unparall",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.82421875,
            "text": "malaria vaccines because of its unpara",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.87890625,
            "text": "malaria vaccines because of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.88671875,
            "text": "malaria vaccines",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.90625,
            "text": "malaria vaccines because",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.6484375,
            "text": "considered the gold standard for malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 6.6484375,
            "text": "been considered the gold standard for malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -7.765625,
            "text": "considered the gold standard for malaria vaccines because of its unparalleled",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -7.765625,
            "text": "been considered the gold standard for malaria vaccines because of its unparalleled",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -7.80078125,
            "text": "considered the gold standard for malaria vaccines because of its unp",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -7.8046875,
            "text": "considered the gold standard for malaria vaccines because of its unparall",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -7.80078125,
            "text": "been considered the gold standard for malaria vaccines because of its unp",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -7.8046875,
            "text": "been considered the gold standard for malaria vaccines because of its unparall",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -7.82421875,
            "text": "considered the gold standard for malaria vaccines because of its unpara",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -7.84375,
            "text": "considered the gold standard",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -7.82421875,
            "text": "been considered the gold standard for malaria vaccines because of its unpara",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -7.84375,
            "text": "been considered the gold standard",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_23": [
        {
            "start_logit": 6.55859375,
            "end_logit": 6.64453125,
            "text": "malaria",
            "probability": 0.50390625
        },
        {
            "start_logit": 6.55078125,
            "end_logit": 6.640625,
            "text": "malaria",
            "probability": 0.49609375
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 6.64453125,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.7578125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.80078125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.859375,
            "text": "malaria infection (CH",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.85546875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.8984375,
            "text": "malaria infection (CHMI",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.9140625,
            "text": "malaria infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.9140625,
            "text": "malaria infection (CHMI) 3 weeks after 5",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9140625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.921875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.94140625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9453125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9453125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9453125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 6.64453125,
            "text": "100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.95703125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9921875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 6.64453125,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_24": [
        {
            "start_logit": 6.55859375,
            "end_logit": 6.64453125,
            "text": "malaria",
            "probability": 0.50390625
        },
        {
            "start_logit": 6.55078125,
            "end_logit": 6.640625,
            "text": "malaria",
            "probability": 0.49609375
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 6.64453125,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.7578125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.80078125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.859375,
            "text": "malaria infection (CH",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.85546875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.8984375,
            "text": "malaria infection (CHMI",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.9140625,
            "text": "malaria infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.9140625,
            "text": "malaria infection (CHMI) 3 weeks after 5",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9140625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.921875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.94140625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9453125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9453125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9453125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 6.64453125,
            "text": "100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.95703125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9921875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 6.64453125,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_25": [
        {
            "start_logit": 6.5859375,
            "end_logit": 6.578125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -6.85546875,
            "text": "malaria-naive adult subjects.",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -7.55859375,
            "text": "malaria-naive",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.578125,
            "text": "demonstrated for the first time to our knowledge that PfSPZ Vaccine can protect against a 3-week heterologous CHMI in a limited group of malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -7.71484375,
            "text": "malaria-naive adult",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -7.7578125,
            "text": "malaria-naive adult subjects",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -7.78515625,
            "text": "malaria-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 6.578125,
            "text": "that PfSPZ Vaccine can protect against a 3-week heterologous CHMI in a limited group of malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 6.578125,
            "text": "CHMI in a limited group of malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.578125,
            "text": "heterologous CHMI in a limited group of malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.578125,
            "text": "MI in a limited group of malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 6.578125,
            "text": "time to our knowledge that PfSPZ Vaccine can protect against a 3-week heterologous CHMI in a limited group of malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -6.85546875,
            "text": "that PfSPZ Vaccine can protect against a 3-week heterologous CHMI in a limited group of malaria-naive adult subjects.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -6.85546875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -6.85546875,
            "text": "CHMI in a limited group of malaria-naive adult subjects.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -6.85546875,
            "text": "heterologous CHMI in a limited group of malaria-naive adult subjects.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -6.85546875,
            "text": "MI in a limited group of malaria-naive adult subjects.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -6.85546875,
            "text": "time to our knowledge that PfSPZ Vaccine can protect against a 3-week heterologous CHMI in a limited group of malaria-naive adult subjects.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.40625,
            "text": "demonstrated for the first time to our knowledge that PfSPZ Vaccine can protect against a",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.46875,
            "text": "demonstrated for the first time to our knowledge that PfSPZ Vaccine can protect against a 3-week heterologous CHMI in",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_26": [
        {
            "start_logit": 6.5625,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.6328125,
            "text": "malaria chemoprophylaxis. These advance",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.640625,
            "text": "malaria chemoprop",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.62890625,
            "text": "on malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.796875,
            "text": "malaria chemo",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.8203125,
            "text": "malaria chemoprophylax",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.83203125,
            "text": "malaria chemoprophylaxis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.859375,
            "text": "malaria chemoprophyla",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5625,
            "end_logit": -7.86328125,
            "text": "malaria chemoprophy",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.62890625,
            "text": "PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.62890625,
            "text": "while on malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 6.62890625,
            "text": "(IV) inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -7.6328125,
            "text": ". These advance",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.6328125,
            "text": "on malaria chemoprophylaxis. These advance",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.640625,
            "text": "on malaria chemoprop",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.6328125,
            "text": "PfSPZ or in those who were exposed to live PfSPZ while on malaria chemoprophylaxis. These advance",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.640625,
            "text": "PfSPZ or in those who were exposed to live PfSPZ while on malaria chemoprop",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.796875,
            "text": "on malaria chemo",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.6328125,
            "text": "while on malaria chemoprophylaxis. These advance",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.8203125,
            "text": "on malaria chemoprophylax",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_27": [
        {
            "start_logit": 6.58984375,
            "end_logit": 6.6015625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -5.5625,
            "text": "malaria (mAbs 580 and 663). RTS,S mA",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -6.984375,
            "end_logit": 6.6015625,
            "text": "to malaria",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 6.6015625,
            "text": "sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.6015625,
            "text": "whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.6015625,
            "text": "ozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.6015625,
            "text": "); or individuals exposed to malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.6015625,
            "text": "); an irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.92578125,
            "text": "malaria (mAbs 580 and 663",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.9453125,
            "text": "malaria (mAbs 580",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": -5.5625,
            "text": "to malaria (mAbs 580 and 663). RTS,S mA",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -5.5625,
            "text": "); or individuals exposed to malaria (mAbs 580 and 663). RTS,S mA",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -6.9609375,
            "text": "CSP",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -5.5625,
            "text": "mA",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -5.5625,
            "text": "). RTS,S mA",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -7.546875,
            "text": "CSP vaccine RTS,S/AS01 (mAbs 317 and 311); an irradiated whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -7.6875,
            "text": "CSP vaccine RTS,S/AS01",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -7.8984375,
            "text": "CSP vaccine RTS,S/AS",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -7.93359375,
            "text": "CSP vaccine RTS,S/",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -7.94140625,
            "text": "CSP vaccine",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_28": [
        {
            "start_logit": 6.54296875,
            "end_logit": 6.66796875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.58984375,
            "text": "malaria by",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.625,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.66015625,
            "text": "malaria by a simple chemoattenuated",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.72265625,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.75390625,
            "text": "malaria by a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7578125,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.77734375,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.828125,
            "text": "malaria by a simple chemoattenuated PfSPZ",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.875,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.8984375,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.9375,
            "text": "malaria by a simple chemoattenuated PfSP",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.9609375,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.98046875,
            "text": "malaria by a simple chemoat",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": -7.9609375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.625,
            "text": "tenuated PfSPZ vaccine regimen in",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.66015625,
            "text": "tenuated",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.72265625,
            "text": "tenuated PfSPZ vaccine regimen",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.7578125,
            "text": "tenuated PfSPZ vaccine regimen in a",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.77734375,
            "text": "tenuated PfSPZ vaccine regimen in a randomized trial",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_29": [
        {
            "start_logit": 6.55078125,
            "end_logit": 6.65625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.546875,
            "text": "malaria at",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.72265625,
            "text": "malaria at 1 year and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.84375,
            "text": "malaria at 1 year and immune correlates",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.87890625,
            "text": "malaria at 1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.8828125,
            "text": "malaria at 1 year and immune correlates following PfSPZ",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.890625,
            "text": "malaria at 1 year and immune",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.91015625,
            "text": "malaria at 1 year and immune correlates following",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9140625,
            "text": "malaria at 1 year and immune correlates following PfSPZ vaccination",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.9296875,
            "text": "malaria at 1 year",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.94140625,
            "text": "malaria at 1 year and immune correlates following PfSP",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -8.0078125,
            "text": "malaria at 1 year and immune correlates following PfSPZ vaccination.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -8.03125,
            "text": "malaria at 1 year and immune correlates following PfS",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -8.0078125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_30": [
        {
            "start_logit": 6.56640625,
            "end_logit": 6.625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.2734375,
            "text": "malaria infection",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 6.625,
            "text": "human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 6.625,
            "text": "controlled human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -8.0859375,
            "text": "malaria infection.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.2734375,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -7.2734375,
            "text": "controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -8.0859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.2734375,
            "text": "infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -8.0859375,
            "text": "human malaria infection.",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -8.0859375,
            "text": "controlled human malaria infection.",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -8.0859375,
            "text": "infection.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_31": [
        {
            "start_logit": 7.8203125,
            "end_logit": 8.03125,
            "text": "Plasmodium falciparum malaria",
            "probability": 1.0
        },
        {
            "start_logit": -0.9677734375,
            "end_logit": 8.03125,
            "text": "malaria",
            "probability": 0.00015234947204589844
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -2.333984375,
            "text": "Plasmodium",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -5.67578125,
            "text": "Plasmodium falciparum",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.890625,
            "end_logit": 8.03125,
            "text": "falciparum malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.03125,
            "text": "Protection against Plasmodium falciparum malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.3515625,
            "text": "Plasmodium falciparum malaria by",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.9375,
            "text": "Plasmodium falciparum malaria by PfSPZ Vaccine.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.0625,
            "text": "Plasmodium falciparum malaria by PfSPZ Vaccine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.0703125,
            "text": "Plasmodium falciparum malaria by PfSPZ",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.9677734375,
            "end_logit": -7.3515625,
            "text": "malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -0.9677734375,
            "end_logit": -7.9375,
            "text": "malaria by PfSPZ Vaccine.",
            "probability": 0.0
        },
        {
            "start_logit": -0.9677734375,
            "end_logit": -8.0625,
            "text": "malaria by PfSPZ Vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -0.9677734375,
            "end_logit": -8.0703125,
            "text": "malaria by PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -2.333984375,
            "text": "Protection against Plasmodium",
            "probability": 0.0
        },
        {
            "start_logit": -6.890625,
            "end_logit": -5.67578125,
            "text": "falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -5.67578125,
            "text": "Protection against Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -6.890625,
            "end_logit": -7.3515625,
            "text": "falciparum malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -6.890625,
            "end_logit": -7.9375,
            "text": "falciparum malaria by PfSPZ Vaccine.",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -7.3515625,
            "text": "Protection against Plasmodium falciparum malaria by",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_32": [
        {
            "start_logit": 6.4921875,
            "end_logit": 6.71484375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.44140625,
            "text": "malaria by",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.71484375,
            "text": "human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.734375,
            "text": "malaria by chemoattenuated",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.71484375,
            "text": "Sterile protection against human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.9453125,
            "text": "malaria by chemoattenuated PfSPZ",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.94921875,
            "text": "malaria by chemoat",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.96875,
            "text": "malaria by chemoattenuated PfSPZ vaccine",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -8.0078125,
            "text": "malaria by chemoatten",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -8.03125,
            "text": "malaria by chemoattenuated PfSPZ vaccine.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -8.1015625,
            "text": "malaria by chemoattenuated PfSP",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -8.1484375,
            "text": "malaria by chemoattenuated PfS",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": -8.03125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.44140625,
            "text": "human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -7.44140625,
            "text": "Sterile protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.734375,
            "text": "human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -7.734375,
            "text": "Sterile protection against human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.9453125,
            "text": "human malaria by chemoattenuated PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.94921875,
            "text": "human malaria by chemoat",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.96875,
            "text": "human malaria by chemoattenuated PfSPZ vaccine",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_33": [
        {
            "start_logit": 6.5390625,
            "end_logit": 6.66796875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.578125,
            "text": "malaria in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.66796875,
            "text": "malaria in infants in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.71484375,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.72265625,
            "text": "malaria in infants in western Kenya: a double-blind,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.75,
            "text": "malaria in infants in western Kenya",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.765625,
            "text": "malaria in infants",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.77734375,
            "text": "malaria in infants in western Kenya: a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.77734375,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.80859375,
            "text": "malaria in infants in western Kenya: a double-blind",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.8203125,
            "text": "malaria in infants in western",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.83203125,
            "text": "malaria in infants in western Kenya: a double-blind, randomized,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5390625,
            "end_logit": -7.83984375,
            "text": "malaria in infants in western Kenya: a double-",
            "probability": 4.76837158203125e-07
        }
    ],
    "61f7d745882a024a10000038_34": [
        {
            "start_logit": 6.5703125,
            "end_logit": 6.62109375,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.56640625,
            "end_logit": 6.625,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.07421875,
            "text": "malaria in Africa",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.38671875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.890625,
            "text": "malaria infection (CHMI) by direct venous inoculation (DV",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.90234375,
            "text": "malaria in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.91796875,
            "text": "malaria infection (CHMI",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.92578125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.9296875,
            "text": "malaria infection (CH",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.94140625,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.625,
            "text": "human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.953125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.96875,
            "text": "malaria infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.97265625,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.98046875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) spor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -8.0078125,
            "text": "malaria infection (CHMI) by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -8.0078125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -8.0078125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ) (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 6.62109375,
            "text": "PfSPZ Challenge) to try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 6.62109375,
            "text": "prevent malaria",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_35": [
        {
            "start_logit": 6.5703125,
            "end_logit": 6.62109375,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.56640625,
            "end_logit": 6.625,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.07421875,
            "text": "malaria in Africa",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.38671875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.890625,
            "text": "malaria infection (CHMI) by direct venous inoculation (DV",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.90234375,
            "text": "malaria in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.91796875,
            "text": "malaria infection (CHMI",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.92578125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.9296875,
            "text": "malaria infection (CH",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.94140625,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.625,
            "text": "human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.953125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.96875,
            "text": "malaria infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.97265625,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.98046875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) spor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -8.0078125,
            "text": "malaria infection (CHMI) by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -8.0078125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -8.0078125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ) (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 6.62109375,
            "text": "PfSPZ Challenge) to try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 6.62109375,
            "text": "prevent malaria",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_36": [
        {
            "start_logit": 6.53515625,
            "end_logit": 6.671875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.2109375,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.75,
            "text": "malaria infection (CHMI",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.7578125,
            "text": "malaria infection",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.671875,
            "text": "human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.78515625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.8125,
            "text": "malaria infection (CH",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.8359375,
            "text": "malaria infection (CHMI) 3",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.83984375,
            "text": "malaria infection (CHMI) 3 weeks after immunization",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.84765625,
            "text": "malaria infection (CHMI) 3 weeks after",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.671875,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 6.671875,
            "text": "sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 6.671875,
            "text": "highly protective against controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -7.2109375,
            "text": "human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.2109375,
            "text": "highly protective against controlled human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -7.75,
            "text": "human malaria infection (CHMI",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -7.7578125,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.52734375,
            "text": "Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -7.78515625,
            "text": "human malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -7.8125,
            "text": "human malaria infection (CH",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_37": [
        {
            "start_logit": 6.59375,
            "end_logit": 6.578125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.59375,
            "end_logit": -7.21484375,
            "text": "malaria-naive adult subjects.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.59375,
            "end_logit": -7.60546875,
            "text": "malaria-naive",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.578125,
            "text": "CHMI in a limited group of malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.59375,
            "end_logit": -7.74609375,
            "text": "malaria-naive adult",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.59375,
            "end_logit": -7.8046875,
            "text": "malaria-naive adult subjects",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.578125,
            "text": "demonstrated for the first time to our knowledge that PfSPZ Vaccine can protect against a 3-week heterologous CHMI in a limited group of malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 6.578125,
            "text": "MI in a limited group of malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.578125,
            "text": "that PfSPZ Vaccine can protect against a 3-week heterologous CHMI in a limited group of malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 6.578125,
            "text": "heterologous CHMI in a limited group of malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 6.578125,
            "text": "have demonstrated for the first time to our knowledge that PfSPZ Vaccine can protect against a 3-week heterologous CHMI in a limited group of malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.21484375,
            "text": "CHMI in a limited group of malaria-naive adult subjects.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.2265625,
            "text": "CHMI",
            "probability": 0.0
        },
        {
            "start_logit": -7.703125,
            "end_logit": -7.2265625,
            "text": ": We have demonstrated for the first time to our knowledge that PfSPZ Vaccine can protect against a 3-week heterologous CHMI",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": -7.2265625,
            "text": "CONCLUSIONS: We have demonstrated for the first time to our knowledge that PfSPZ Vaccine can protect against a 3-week heterologous CHMI",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -7.21484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.8125,
            "end_logit": -7.2265625,
            "text": "demonstrated for the first time to our knowledge that PfSPZ Vaccine can protect against a 3-week heterologous CHMI",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -7.21484375,
            "text": "MI in a limited group of malaria-naive adult subjects.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.5234375,
            "text": "CHMI in",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -7.2265625,
            "text": "MI",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_38": [
        {
            "start_logit": 6.57421875,
            "end_logit": 6.61328125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.4609375,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may further enhance protection",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.640625,
            "text": "malaria through long-lived tissue-resident T cells and",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.7265625,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may further enhance protection.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.8125,
            "text": "malaria through",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.91015625,
            "text": "malaria through long-lived tissue-resident T cells and that administration of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.9140625,
            "text": "malaria through long-lived tissue-resident T cells",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.9140625,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.9296875,
            "text": "malaria through long-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.94921875,
            "text": "malaria through long-lived tissue-resident",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.94921875,
            "text": "malaria through long-lived tissue-resident T cells and that",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -7.7265625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_39": [
        {
            "start_logit": 6.5703125,
            "end_logit": 6.62109375,
            "text": "malaria",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.55859375,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.55859375,
            "end_logit": 6.62109375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.359375,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.49609375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.49609375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.734375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.73828125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.73828125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.76171875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.77734375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.82421875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.83203125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.84375,
            "text": "malaria infection (CH",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.84765625,
            "text": "malaria infection (CHMI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.84765625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.84765625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.85546875,
            "text": "malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.84375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CH",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.84375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_40": [
        {
            "start_logit": 6.5703125,
            "end_logit": 6.62109375,
            "text": "malaria",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.55859375,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.55859375,
            "end_logit": 6.62109375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.359375,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.49609375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.49609375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.734375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.73828125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.73828125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.76171875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.77734375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.82421875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.83203125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.84375,
            "text": "malaria infection (CH",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.84765625,
            "text": "malaria infection (CHMI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.84765625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.84765625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -7.85546875,
            "text": "malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.84375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CH",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.84375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_41": [
        {
            "start_logit": 6.56640625,
            "end_logit": 6.6328125,
            "text": "malaria",
            "probability": 0.958984375
        },
        {
            "start_logit": 2.498046875,
            "end_logit": 7.0234375,
            "text": "P falciparum",
            "probability": 0.024200439453125
        },
        {
            "start_logit": 2.498046875,
            "end_logit": 6.6328125,
            "text": "P falciparum infection throughout an entire malaria",
            "probability": 0.0163726806640625
        },
        {
            "start_logit": -2.240234375,
            "end_logit": 7.0234375,
            "text": "falciparum",
            "probability": 0.0002110004425048828
        },
        {
            "start_logit": -2.240234375,
            "end_logit": 6.6328125,
            "text": "falciparum infection throughout an entire malaria",
            "probability": 0.00014281272888183594
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 7.0234375,
            "text": ". PfSPZ Vaccine showed significant protection in African adults against P falciparum",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 6.6328125,
            "text": ". PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -6.953125,
            "text": "malaria season.FUNDING: US National",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.44921875,
            "text": "malaria season.FUNDING: US National In",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.8203125,
            "text": "malaria season",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 2.498046875,
            "end_logit": -6.6640625,
            "text": "P",
            "probability": 0.0
        },
        {
            "start_logit": 2.498046875,
            "end_logit": -6.953125,
            "text": "P falciparum infection throughout an entire malaria season.FUNDING: US National",
            "probability": 0.0
        },
        {
            "start_logit": 2.498046875,
            "end_logit": -7.44921875,
            "text": "P falciparum infection throughout an entire malaria season.FUNDING: US National In",
            "probability": 0.0
        },
        {
            "start_logit": 2.498046875,
            "end_logit": -7.69921875,
            "text": "P falciparum infection",
            "probability": 0.0
        },
        {
            "start_logit": 2.498046875,
            "end_logit": -7.8203125,
            "text": "P falciparum infection throughout an entire malaria season",
            "probability": 0.0
        },
        {
            "start_logit": 2.498046875,
            "end_logit": -7.8671875,
            "text": "P falciparum infection throughout",
            "probability": 0.0
        },
        {
            "start_logit": 2.498046875,
            "end_logit": -7.95703125,
            "text": "P falciparum infection throughout an",
            "probability": 0.0
        },
        {
            "start_logit": -2.240234375,
            "end_logit": -6.953125,
            "text": "falciparum infection throughout an entire malaria season.FUNDING: US National",
            "probability": 0.0
        },
        {
            "start_logit": -2.240234375,
            "end_logit": -7.44921875,
            "text": "falciparum infection throughout an entire malaria season.FUNDING: US National In",
            "probability": 0.0
        },
        {
            "start_logit": -2.240234375,
            "end_logit": -7.69921875,
            "text": "falciparum infection",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_42": [
        {
            "start_logit": 6.546875,
            "end_logit": 6.65234375,
            "text": "malaria",
            "probability": 0.501953125
        },
        {
            "start_logit": 6.54296875,
            "end_logit": 6.65234375,
            "text": "malaria",
            "probability": 0.498046875
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.65234375,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.60546875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.66015625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.75,
            "text": "malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.75,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.7578125,
            "text": "malaria infection (CH",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7578125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.79296875,
            "text": "malaria infection (CHMI",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.796875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.8046875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.81640625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.82421875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.82421875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.828125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.890625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.89453125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.75,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.7578125,
            "text": "human malaria infection (CH",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_43": [
        {
            "start_logit": 6.546875,
            "end_logit": 6.65234375,
            "text": "malaria",
            "probability": 0.501953125
        },
        {
            "start_logit": 6.54296875,
            "end_logit": 6.65234375,
            "text": "malaria",
            "probability": 0.498046875
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.65234375,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.60546875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.66015625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.75,
            "text": "malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.75,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.7578125,
            "text": "malaria infection (CH",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.7578125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.79296875,
            "text": "malaria infection (CHMI",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.796875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.8046875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.81640625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.82421875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.82421875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.828125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.890625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.89453125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.75,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.7578125,
            "text": "human malaria infection (CH",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_44": [
        {
            "start_logit": 6.55859375,
            "end_logit": 6.6484375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.55078125,
            "end_logit": 6.6484375,
            "text": "malaria",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.55859375,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.329833984375
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -2.0234375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -2.0234375,
            "text": "malaria infection in malaria",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.03515625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.15234375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.15234375,
            "text": "malaria infection in malaria-naive",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 6.62890625,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.62890625,
            "text": "falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.56640625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.56640625,
            "text": "malaria infection in malaria-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.66796875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.66796875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.66796875,
            "text": "malaria infection in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.6796875,
            "text": "malaria sporozoite",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.703125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.703125,
            "text": "malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.76953125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.84765625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_45": [
        {
            "start_logit": 6.55859375,
            "end_logit": 6.6484375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.55078125,
            "end_logit": 6.6484375,
            "text": "malaria",
            "probability": 0.3349609375
        },
        {
            "start_logit": 6.55859375,
            "end_logit": 6.62890625,
            "text": "malaria",
            "probability": 0.329833984375
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -2.0234375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -2.0234375,
            "text": "malaria infection in malaria",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.03515625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.15234375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.15234375,
            "text": "malaria infection in malaria-naive",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 6.62890625,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.62890625,
            "text": "falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.56640625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.56640625,
            "text": "malaria infection in malaria-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.66796875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.66796875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.66796875,
            "text": "malaria infection in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.6796875,
            "text": "malaria sporozoite",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.703125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.703125,
            "text": "malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.76953125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.55859375,
            "end_logit": -7.84765625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_46": [
        {
            "start_logit": 6.57421875,
            "end_logit": 6.61328125,
            "text": "malaria",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -0.52783203125,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial",
            "probability": 0.0007910728454589844
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.3125,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprop",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.48046875,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.59375,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylax",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.61328125,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ-CVac",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.62890625,
            "text": "malaria-naive",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.66015625,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.68359375,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ-CVac).",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.68359375,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ-CV",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.61328125,
            "text": "to malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 6.61328125,
            "text": "PfSPZ Challenge') to malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.61328125,
            "text": "'PfSPZ Challenge') to malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.61328125,
            "text": "irradiated PfSPZ ('PfSPZ Challenge') to malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.61328125,
            "text": "Z Challenge') to malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.61328125,
            "text": "PfSPZ ('PfSPZ Challenge') to malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.90234375,
            "end_logit": -0.52783203125,
            "text": "antimalarial",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.61328125,
            "text": "cryopreserved, non-irradiated PfSPZ ('PfSPZ Challenge') to malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -0.90234375,
            "end_logit": -7.3125,
            "text": "antimalarial chemoprop",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -0.52783203125,
            "text": "for antimalarial",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_47": [
        {
            "start_logit": 6.57421875,
            "end_logit": 6.61328125,
            "text": "malaria",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -0.52783203125,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial",
            "probability": 0.0007910728454589844
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.3125,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprop",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.48046875,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.59375,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylax",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.61328125,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ-CVac",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.62890625,
            "text": "malaria-naive",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.66015625,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.68359375,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ-CVac).",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.57421875,
            "end_logit": -7.68359375,
            "text": "malaria-naive, healthy adult volunteers taking chloroquine for antimalarial chemoprophylaxis (vaccine approach denoted as PfSPZ-CV",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.61328125,
            "text": "to malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 6.61328125,
            "text": "PfSPZ Challenge') to malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.61328125,
            "text": "'PfSPZ Challenge') to malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.61328125,
            "text": "irradiated PfSPZ ('PfSPZ Challenge') to malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.61328125,
            "text": "Z Challenge') to malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.61328125,
            "text": "PfSPZ ('PfSPZ Challenge') to malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.90234375,
            "end_logit": -0.52783203125,
            "text": "antimalarial",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.61328125,
            "text": "cryopreserved, non-irradiated PfSPZ ('PfSPZ Challenge') to malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -0.90234375,
            "end_logit": -7.3125,
            "text": "antimalarial chemoprop",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -0.52783203125,
            "text": "for antimalarial",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_48": [
        {
            "start_logit": 4.98046875,
            "end_logit": 7.73046875,
            "text": "human malaria",
            "probability": 0.78662109375
        },
        {
            "start_logit": 3.67578125,
            "end_logit": 7.73046875,
            "text": "malaria",
            "probability": 0.21337890625
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.73046875,
            "text": "controlled human malaria",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 7.73046875,
            "text": "underwent controlled human malaria",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.73046875,
            "text": "100%) volunteers who underwent controlled human malaria",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.73046875,
            "text": "9 (100%) volunteers who underwent controlled human malaria",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.73046875,
            "text": "well tolerated and safe, and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 4.98046875,
            "end_logit": -5.3671875,
            "text": "human",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 4.98046875,
            "end_logit": -7.5703125,
            "text": "human malaria infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.98046875,
            "end_logit": -7.92578125,
            "text": "human malaria infection ten weeks after the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.98046875,
            "end_logit": -7.94140625,
            "text": "human malaria infection ten weeks after the last dose (group III",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.98046875,
            "end_logit": -7.9609375,
            "text": "human malaria infection ten",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.67578125,
            "end_logit": -7.5703125,
            "text": "malaria infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.67578125,
            "end_logit": -7.92578125,
            "text": "malaria infection ten weeks after the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.67578125,
            "end_logit": -7.94140625,
            "text": "malaria infection ten weeks after the last dose (group III",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.67578125,
            "end_logit": -7.9609375,
            "text": "malaria infection ten",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -5.3671875,
            "text": "controlled human",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -5.3671875,
            "text": "underwent controlled human",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -5.3671875,
            "text": "100%) volunteers who underwent controlled human",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -5.3671875,
            "text": "9 (100%) volunteers who underwent controlled human",
            "probability": 0.0
        }
    ],
    "5be48987133db5eb7800001c_1": [
        {
            "start_logit": 8.03125,
            "end_logit": 7.99609375,
            "text": "Kaposi's sarcoma",
            "probability": 1.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -1.0693359375,
            "text": "Kaposi",
            "probability": 0.0001150369644165039
        },
        {
            "start_logit": -1.54296875,
            "end_logit": 7.99609375,
            "text": "sarcoma",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.1484375,
            "text": "Kaposi'",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.40234375,
            "text": "Kaposi's",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 7.99609375,
            "text": ", Kaposi's sarcoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 7.99609375,
            "text": "s sarcoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.89453125,
            "text": "Kaposi's sarcoma, oral warts",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.328125,
            "text": "Kaposi's sarcoma, oral warts and other diseases.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 7.99609375,
            "text": "'s sarcoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.5,
            "text": "Kaposi's sarcoma, oral warts and other diseases",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.99609375,
            "text": ". In the immunosuppressed population, the spectrum of potential oral disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi's sarcoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.59375,
            "text": "Kaposi's sarcoma, oral",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.99609375,
            "text": "disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi's sarcoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -1.0693359375,
            "text": ", Kaposi",
            "probability": 0.0
        },
        {
            "start_logit": -1.54296875,
            "end_logit": -6.89453125,
            "text": "sarcoma, oral warts",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -1.0693359375,
            "text": ". In the immunosuppressed population, the spectrum of potential oral disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": -1.0693359375,
            "text": "disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -1.0693359375,
            "text": "infections. In the immunosuppressed population, the spectrum of potential oral disease is even broader, encompassing candidiasis, necrotizing gingivitis, parotid gland enlargement, Kaposi",
            "probability": 0.0
        },
        {
            "start_logit": -1.54296875,
            "end_logit": -7.328125,
            "text": "sarcoma, oral warts and other diseases.",
            "probability": 0.0
        }
    ],
    "622d1ed13a8413c6530000a3_1": [
        {
            "start_logit": 7.1796875,
            "end_logit": 0.044769287109375,
            "text": "The daughterless (da) gene in Drosophila",
            "probability": 0.76611328125
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -1.646484375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator",
            "probability": 0.14111328125
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -2.60546875,
            "text": "The",
            "probability": 0.054168701171875
        },
        {
            "start_logit": -1.1826171875,
            "end_logit": 4.9296875,
            "text": "daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and neurogenesis have been extensively examined.",
            "probability": 0.023681640625
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -5.5859375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination",
            "probability": 0.0027523040771484375
        },
        {
            "start_logit": -3.703125,
            "end_logit": 4.9296875,
            "text": ".",
            "probability": 0.0019063949584960938
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -6.06640625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly",
            "probability": 0.0017023086547851562
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -6.140625,
            "text": "The daughterless (da",
            "probability": 0.0015802383422851562
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -6.3671875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex",
            "probability": 0.0012598037719726562
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -6.6171875,
            "text": "The daughterless",
            "probability": 0.0009813308715820312
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -6.92578125,
            "text": "The daughterless (da) gene in Drosophila encodes a",
            "probability": 0.0007205009460449219
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -6.99609375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional",
            "probability": 0.00067138671875
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.01171875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and neurogenesis",
            "probability": 0.0006613731384277344
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.03515625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed",
            "probability": 0.0006461143493652344
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.32421875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose",
            "probability": 0.0004839897155761719
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.42578125,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific",
            "probability": 0.0004372596740722656
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.5390625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control",
            "probability": 0.0003902912139892578
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.5859375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and",
            "probability": 0.0003724098205566406
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.73828125,
            "text": "The daughterless (da)",
            "probability": 0.0003197193145751953
        },
        {
            "start_logit": -1.1826171875,
            "end_logit": 0.044769287109375,
            "text": "daughterless (da) gene in Drosophila",
            "probability": 0.00017940998077392578
        }
    ],
    "622668b13a8413c653000088_1": [
        {
            "start_logit": -1.048828125,
            "end_logit": 1.869140625,
            "text": "lncRNA prostate cancer-associated transcript 6",
            "probability": 0.65869140625
        },
        {
            "start_logit": -1.8486328125,
            "end_logit": 1.869140625,
            "text": "prostate cancer-associated transcript 6",
            "probability": 0.2958984375
        },
        {
            "start_logit": -4.046875,
            "end_logit": 1.869140625,
            "text": "cancer-associated transcript 6",
            "probability": 0.032867431640625
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 1.869140625,
            "text": "associated transcript 6",
            "probability": 0.004009246826171875
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 1.869140625,
            "text": "-associated transcript 6",
            "probability": 0.002956390380859375
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 1.869140625,
            "text": "transcript 6",
            "probability": 0.000873565673828125
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 1.869140625,
            "text": "of lncRNA prostate cancer-associated transcript 6",
            "probability": 0.0007767677307128906
        },
        {
            "start_logit": -7.8125,
            "end_logit": 1.869140625,
            "text": "6",
            "probability": 0.000759124755859375
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 1.869140625,
            "text": "the role and regulatory mechanism of lncRNA prostate cancer-associated transcript 6",
            "probability": 0.0007295608520507812
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 1.869140625,
            "text": ", we investigated the role and regulatory mechanism of lncRNA prostate cancer-associated transcript 6",
            "probability": 0.0007185935974121094
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 1.869140625,
            "text": "role and regulatory mechanism of lncRNA prostate cancer-associated transcript 6",
            "probability": 0.000675201416015625
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -5.17578125,
            "text": "lncRNA prostate cancer-associated transcript",
            "probability": 0.0005731582641601562
        },
        {
            "start_logit": -1.8486328125,
            "end_logit": -5.17578125,
            "text": "prostate cancer-associated transcript",
            "probability": 0.0002582073211669922
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -6.12109375,
            "text": "lncRNA prostate cancer-associated transcript 6 (PCAT6) in breast cancer progression.",
            "probability": 0.00022268295288085938
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -6.8125,
            "text": "lncRNA",
            "probability": 0.0001119375228881836
        },
        {
            "start_logit": -1.8486328125,
            "end_logit": -6.12109375,
            "text": "prostate cancer-associated transcript 6 (PCAT6) in breast cancer progression.",
            "probability": 0.00010031461715698242
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -7.62109375,
            "text": "lncRNA prostate cancer-associated transcript 6 (PCAT6) in breast cancer",
            "probability": 4.971027374267578e-05
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -7.875,
            "text": "lncRNA prostate cancer-associated transcript 6 (PCAT6",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -7.875,
            "text": "lncRNA prostate cancer-associated transcript 6 (PCAT6) in breast",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": -1.048828125,
            "end_logit": -7.91796875,
            "text": "lncRNA prostate cancer-associated transcript 6 (PCAT6) in breast cancer progression",
            "probability": 3.695487976074219e-05
        }
    ],
    "56bc9268ac7ad1001900001b_1": [
        {
            "start_logit": 7.79296875,
            "end_logit": 7.90234375,
            "text": "interleukin-17",
            "probability": 1.0
        },
        {
            "start_logit": -1.8310546875,
            "end_logit": 7.90234375,
            "text": "17",
            "probability": 6.604194641113281e-05
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -2.259765625,
            "text": "interleukin",
            "probability": 3.8504600524902344e-05
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -6.0078125,
            "text": "interleukin-17 receptor A",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -6.03515625,
            "text": "interleukin-",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -6.3046875,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.08203125,
            "text": "interleukin-17 receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.90234375,
            "text": "-17",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.4140625,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 7.90234375,
            "text": "-interleukin-17",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.78515625,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.83203125,
            "text": "interleukin-17 receptor A monoclonal antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.86328125,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 7.90234375,
            "text": ": Early clinical studies suggested that the anti-interleukin-17",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.8984375,
            "text": "interleukin-17 receptor A monoclonal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.9609375,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.96875,
            "text": "interleukin-17 receptor A monoclonal antibody brodaluma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.90234375,
            "text": "BACKGROUND: Early clinical studies suggested that the anti-interleukin-17",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -8.0,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.90234375,
            "text": "suggested that the anti-interleukin-17",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56bc9268ac7ad1001900001b_2": [
        {
            "start_logit": 7.91796875,
            "end_logit": 7.98046875,
            "text": "interleukin-17",
            "probability": 1.0
        },
        {
            "start_logit": -1.615234375,
            "end_logit": 7.98046875,
            "text": "17",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -1.7119140625,
            "text": "interleukin",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.6484375,
            "text": "interleukin-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 7.98046875,
            "text": "-17",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.125,
            "text": "interleukin-17-receptor antibody for psoriasis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.50390625,
            "text": "interleukin-17-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.56640625,
            "text": "interleukin-17-receptor antibody for psoriasis.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.59375,
            "text": "interleukin-17-receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 7.98046875,
            "text": "-interleukin-17",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.859375,
            "text": "interleukin-17-receptor antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.98046875,
            "text": "anti-interleukin-17",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -7.125,
            "text": "17-receptor antibody for psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -7.50390625,
            "text": "17-",
            "probability": 0.0
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -7.56640625,
            "text": "17-receptor antibody for psoriasis.",
            "probability": 0.0
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -7.59375,
            "text": "17-receptor",
            "probability": 0.0
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -7.859375,
            "text": "17-receptor antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": -1.7119140625,
            "text": "-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -1.7119140625,
            "text": "anti-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -6.93359375,
            "end_logit": -6.6484375,
            "text": "-",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_1": [
        {
            "start_logit": 4.1484375,
            "end_logit": 7.30859375,
            "text": "hypertension",
            "probability": 0.9892578125
        },
        {
            "start_logit": -0.392333984375,
            "end_logit": 7.30859375,
            "text": "essential hypertension",
            "probability": 0.01061248779296875
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 7.30859375,
            "text": "to patients with essential hypertension",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.30859375,
            "text": "with essential hypertension",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.30859375,
            "text": "patients with essential hypertension",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.30859375,
            "text": "dolol (1.16 +/- 0.12 mg once daily; n = 30) administered for 3 years to patients with essential hypertension",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.30859375,
            "text": "once daily; n = 30) administered for 3 years to patients with essential hypertension",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -3.171875,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.73046875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n = 11",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.7578125,
            "text": "antihypertensive treatment with isradipine as monotherapy",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.76953125,
            "text": "antihypertensive treatment with isradipine as",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.7734375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/-",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.82421875,
            "text": "antihypertensive treatment with isradipine as monotherapy (",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.85546875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n =",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.6171875,
            "text": "combination with bopindolol",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.65234375,
            "text": "combination with bopindolol (1.16 +/- 0.12",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.8046875,
            "text": "combination with bopindolol (1.16 +/- 0.12 mg once daily",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.8203125,
            "text": "combination with bopindolol (1.16 +/-",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.82421875,
            "text": "combination with bopindolol (1.16 +/- 0.12 mg once daily; n =",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.6171875,
            "text": "isradipine (7.5 +/- 0.63 mg twice daily) in combination with bopindolol",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_2": [
        {
            "start_logit": 4.3046875,
            "end_logit": 7.3359375,
            "text": "hypertension",
            "probability": 0.9970703125
        },
        {
            "start_logit": -1.7197265625,
            "end_logit": 7.3359375,
            "text": "essential hypertension",
            "probability": 0.0024127960205078125
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 7.3359375,
            "text": "antihypertensive drug in blacks with essential hypertension",
            "probability": 2.8789043426513672e-05
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 7.3359375,
            "text": "with essential hypertension",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 7.3359375,
            "text": "blacks with essential hypertension",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.2109375,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.26953125,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.6328125,
            "text": "hypertension, resulting in regression of left ventricular",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.65625,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.671875,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.765625,
            "text": "hypertension,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.77734375,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.8203125,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.8515625,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.87890625,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.90625,
            "text": "hypertension, resulting in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.90625,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.3046875,
            "end_logit": -7.92578125,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.7197265625,
            "end_logit": -7.2109375,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass.",
            "probability": 0.0
        },
        {
            "start_logit": -1.7197265625,
            "end_logit": -7.26953125,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_3": [
        {
            "start_logit": 4.1484375,
            "end_logit": 7.30859375,
            "text": "hypertension",
            "probability": 0.9892578125
        },
        {
            "start_logit": -0.392333984375,
            "end_logit": 7.30859375,
            "text": "essential hypertension",
            "probability": 0.01061248779296875
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 7.30859375,
            "text": "to patients with essential hypertension",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.30859375,
            "text": "with essential hypertension",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.30859375,
            "text": "patients with essential hypertension",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.30859375,
            "text": "dolol (1.16 +/- 0.12 mg once daily; n = 30) administered for 3 years to patients with essential hypertension",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.30859375,
            "text": "once daily; n = 30) administered for 3 years to patients with essential hypertension",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -3.171875,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.73046875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n = 11",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.7578125,
            "text": "antihypertensive treatment with isradipine as monotherapy",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.76953125,
            "text": "antihypertensive treatment with isradipine as",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.7734375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/-",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.82421875,
            "text": "antihypertensive treatment with isradipine as monotherapy (",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -7.85546875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n =",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.6171875,
            "text": "combination with bopindolol",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.65234375,
            "text": "combination with bopindolol (1.16 +/- 0.12",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.8046875,
            "text": "combination with bopindolol (1.16 +/- 0.12 mg once daily",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.8203125,
            "text": "combination with bopindolol (1.16 +/-",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.82421875,
            "text": "combination with bopindolol (1.16 +/- 0.12 mg once daily; n =",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.6171875,
            "text": "isradipine (7.5 +/- 0.63 mg twice daily) in combination with bopindolol",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_4": [
        {
            "start_logit": 6.38671875,
            "end_logit": 6.58984375,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -1.4228515625,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure",
            "probability": 0.00033020973205566406
        },
        {
            "start_logit": -7.0,
            "end_logit": 6.58984375,
            "text": "antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -6.94921875,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.22265625,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.3671875,
            "text": "hypertension (",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.52734375,
            "text": "hypertension (mean age 59 years) using",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.5703125,
            "text": "hypertension (mean age 59 years)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.62890625,
            "text": "hypertension (mean age 59",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.671875,
            "text": "hypertension (mean age 59 years",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.73828125,
            "end_logit": -1.4228515625,
            "text": "blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -1.4228515625,
            "text": "h blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -1.4228515625,
            "text": "pressure",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -1.4228515625,
            "text": "-h blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -1.4228515625,
            "text": "24-h blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -1.4228515625,
            "text": "ambulatory 24-h blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -1.4228515625,
            "text": "and ambulatory 24-h blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -5.18359375,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -5.73828125,
            "end_logit": -6.94921875,
            "text": "blood pressure measurement",
            "probability": 0.0
        },
        {
            "start_logit": -5.73828125,
            "end_logit": -7.22265625,
            "text": "blood pressure measurement.",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_5": [
        {
            "start_logit": -1.0400390625,
            "end_logit": 5.6015625,
            "text": "arterial hypertension",
            "probability": 0.79736328125
        },
        {
            "start_logit": -3.13671875,
            "end_logit": 5.6015625,
            "text": "coronary flow reserve in patients with arterial hypertension",
            "probability": 0.097900390625
        },
        {
            "start_logit": -3.638671875,
            "end_logit": 5.6015625,
            "text": "hypertension",
            "probability": 0.059234619140625
        },
        {
            "start_logit": -4.51171875,
            "end_logit": 5.6015625,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.024749755859375
        },
        {
            "start_logit": -6.22265625,
            "end_logit": 5.6015625,
            "text": "Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0044708251953125
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 5.6015625,
            "text": "term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0033092498779296875
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 5.6015625,
            "text": "in patients with arterial hypertension",
            "probability": 0.0022487640380859375
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 5.6015625,
            "text": "Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0020389556884765625
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 5.6015625,
            "text": "patients with arterial hypertension",
            "probability": 0.0014696121215820312
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 5.6015625,
            "text": "flow reserve in patients with arterial hypertension",
            "probability": 0.0013017654418945312
        },
        {
            "start_logit": -7.484375,
            "end_logit": 5.6015625,
            "text": "with arterial hypertension",
            "probability": 0.0012664794921875
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 5.6015625,
            "text": "[Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0008668899536132812
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 5.6015625,
            "text": ". Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0008602142333984375
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 5.6015625,
            "text": "isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0008502006530761719
        },
        {
            "start_logit": -7.921875,
            "end_logit": 5.6015625,
            "text": "of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0008177757263183594
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 5.6015625,
            "text": "-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0008015632629394531
        },
        {
            "start_logit": -1.0400390625,
            "end_logit": -3.4453125,
            "text": "arterial hypertension and microvascular angina].",
            "probability": 9.393692016601562e-05
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -3.4453125,
            "text": "coronary flow reserve in patients with arterial hypertension and microvascular angina].",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -2.314453125,
            "text": "antihypertensive",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -3.638671875,
            "end_logit": -3.4453125,
            "text": "hypertension and microvascular angina].",
            "probability": 6.973743438720703e-06
        }
    ],
    "56c3184050c68dd416000003_6": [
        {
            "start_logit": 3.25390625,
            "end_logit": 1.0390625,
            "text": "arterial hypertension",
            "probability": 0.8525390625
        },
        {
            "start_logit": 3.25390625,
            "end_logit": -0.736328125,
            "text": "arterial hypertension in motor vehicle drivers",
            "probability": 0.1444091796875
        },
        {
            "start_logit": 3.25390625,
            "end_logit": -6.06640625,
            "text": "arterial hypertension in motor vehicle",
            "probability": 0.0006995201110839844
        },
        {
            "start_logit": 3.25390625,
            "end_logit": -6.35546875,
            "text": "arterial hypertension in motor vehicle drivers].",
            "probability": 0.0005240440368652344
        },
        {
            "start_logit": 3.25390625,
            "end_logit": -6.6796875,
            "text": "arterial hypertension in motor vehicle drivers]",
            "probability": 0.0003788471221923828
        },
        {
            "start_logit": 3.25390625,
            "end_logit": -6.7421875,
            "text": "arterial hypertension in motor",
            "probability": 0.0003559589385986328
        },
        {
            "start_logit": 3.25390625,
            "end_logit": -6.97265625,
            "text": "arterial",
            "probability": 0.0002815723419189453
        },
        {
            "start_logit": -3.876953125,
            "end_logit": -0.736328125,
            "text": "in motor vehicle drivers",
            "probability": 0.00011557340621948242
        },
        {
            "start_logit": 3.25390625,
            "end_logit": -8.125,
            "text": "arterial hypertension in",
            "probability": 8.928775787353516e-05
        },
        {
            "start_logit": -6.96875,
            "end_logit": 1.0390625,
            "text": "hypertension",
            "probability": 3.1113624572753906e-05
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 1.0390625,
            "text": "Isradipine in arterial hypertension",
            "probability": 2.1398067474365234e-05
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 1.0390625,
            "text": "in arterial hypertension",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -7.75,
            "end_logit": 1.0390625,
            "text": "dipine in arterial hypertension",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 1.0390625,
            "text": "[Isradipine in arterial hypertension",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 1.0390625,
            "text": "pine in arterial hypertension",
            "probability": 1.2874603271484375e-05
        },
        {
            "start_logit": -6.96875,
            "end_logit": -0.736328125,
            "text": "hypertension in motor vehicle drivers",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -0.736328125,
            "text": "Isradipine in arterial hypertension in motor vehicle drivers",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -0.736328125,
            "text": "motor vehicle drivers",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -0.736328125,
            "text": "in arterial hypertension in motor vehicle drivers",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.75,
            "end_logit": -0.736328125,
            "text": "dipine in arterial hypertension in motor vehicle drivers",
            "probability": 2.384185791015625e-06
        }
    ],
    "56c3184050c68dd416000003_7": [
        {
            "start_logit": 3.650390625,
            "end_logit": 7.7578125,
            "text": "essential hypertension",
            "probability": 0.97607421875
        },
        {
            "start_logit": -0.0467529296875,
            "end_logit": 7.7578125,
            "text": "hypertension",
            "probability": 0.0242462158203125
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.7578125,
            "text": "elderly patients with essential hypertension",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.7578125,
            "text": "patients with essential hypertension",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 3.650390625,
            "end_logit": -6.83984375,
            "text": "essential",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 3.650390625,
            "end_logit": -7.69140625,
            "text": "essential hypertension.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.0467529296875,
            "end_logit": -7.69140625,
            "text": "hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -6.83984375,
            "text": "elderly patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -6.83984375,
            "text": "patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.69140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.69140625,
            "text": "elderly patients with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.69140625,
            "text": "patients with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.73828125,
            "text": "elderly",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.9375,
            "text": "elderly patients with",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.96484375,
            "text": "elderly patients",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.9375,
            "text": "patients with",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.96484375,
            "text": "patients",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_8": [
        {
            "start_logit": 5.96484375,
            "end_logit": 6.94921875,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": 6.94921875,
            "text": "treatment of hypertension",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.94921875,
            "text": "safety and efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.96484375,
            "end_logit": -7.859375,
            "text": "hypertension.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": -7.6171875,
            "text": "treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -7.859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -7.859375,
            "text": "treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.6171875,
            "text": "safety and efficacy of isradipine and atenolol in the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.7421875,
            "text": "safety and",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.75390625,
            "text": "safety and efficacy of isradipine and atenolol",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.859375,
            "text": "safety and efficacy of isradipine and atenolol in the treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.90625,
            "text": "safety and efficacy",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.92578125,
            "text": "safety and efficacy of",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.99609375,
            "text": "safety and efficacy of isradipine and",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_9": [
        {
            "start_logit": 6.33984375,
            "end_logit": 6.63671875,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.39453125,
            "text": "hypertension and other indications.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.484375,
            "text": "hypertension and other indications",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.609375,
            "text": "hypertension and other",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.67578125,
            "text": "hypertension and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.39453125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "56ffd08bcf1c325851000009_1": [
        {
            "start_logit": -2.458984375,
            "end_logit": -3.794921875,
            "text": "B1",
            "probability": 0.436767578125
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -4.91015625,
            "text": "B1 repeats, i.e., from a common 7SL RNA",
            "probability": 0.1434326171875
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -5.60546875,
            "text": "B1 repeats, i.e., from a",
            "probability": 0.07159423828125
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -5.96875,
            "text": "B1 repeats, i.e., from a common 7S",
            "probability": 0.049591064453125
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -6.00390625,
            "text": "B1 repeats, i.e., from a common",
            "probability": 0.048065185546875
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -6.46875,
            "text": "B1 repeats, i.e., from a common 7SL RNA-derived retroposing monomeric element",
            "probability": 0.0300750732421875
        },
        {
            "start_logit": -4.05859375,
            "end_logit": -4.91015625,
            "text": "a common 7SL RNA",
            "probability": 0.0289306640625
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -6.8046875,
            "text": "B1 repeats, i.e., from a common 7",
            "probability": 0.021484375
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -6.90234375,
            "text": "B1 repeats, i.e., from a common 7SL RNA-derived retroposing monomeric",
            "probability": 0.0195770263671875
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.05859375,
            "text": "B1 repeats, i.e., from a common 7SL RNA-",
            "probability": 0.0167388916015625
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.09375,
            "text": "B1 repeats, i.e., from a common 7SL",
            "probability": 0.0160980224609375
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.1015625,
            "text": "B1 repeats, i.e",
            "probability": 0.0159759521484375
        },
        {
            "start_logit": -5.84375,
            "end_logit": -3.794921875,
            "text": "Alu-like structural motifs supports the hypothesis of the monophyletic origin of Alu and B1",
            "probability": 0.0147705078125
        },
        {
            "start_logit": -4.05859375,
            "end_logit": -5.60546875,
            "text": "a",
            "probability": 0.014434814453125
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.2421875,
            "text": "B1 repeats, i.e., from a common 7SL RNA-derived",
            "probability": 0.01387786865234375
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.31640625,
            "text": "B1 repeats, i.e., from a common 7SL RNA-derived retroposing",
            "probability": 0.012939453125
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.40625,
            "text": "B1 repeats,",
            "probability": 0.01177978515625
        },
        {
            "start_logit": -4.9765625,
            "end_logit": -4.91015625,
            "text": "from a common 7SL RNA",
            "probability": 0.011505126953125
        },
        {
            "start_logit": -5.0078125,
            "end_logit": -4.91015625,
            "text": "7SL RNA",
            "probability": 0.0111541748046875
        },
        {
            "start_logit": -3.482421875,
            "end_logit": -6.46875,
            "text": "retroposing monomeric element",
            "probability": 0.01081085205078125
        }
    ],
    "56ffd08bcf1c325851000009_2": [
        {
            "start_logit": 5.3828125,
            "end_logit": 3.681640625,
            "text": "the 7SL RNA gene.",
            "probability": 0.9951171875
        },
        {
            "start_logit": 5.3828125,
            "end_logit": -1.9541015625,
            "text": "the 7SL RNA gene",
            "probability": 0.0035610198974609375
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -1.9541015625,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene",
            "probability": 0.0004973411560058594
        },
        {
            "start_logit": 5.3828125,
            "end_logit": -4.6640625,
            "text": "the",
            "probability": 0.00023663043975830078
        },
        {
            "start_logit": 5.3828125,
            "end_logit": -5.5859375,
            "text": "the 7SL RNA",
            "probability": 9.41157341003418e-05
        },
        {
            "start_logit": -3.89453125,
            "end_logit": 3.681640625,
            "text": ".",
            "probability": 9.340047836303711e-05
        },
        {
            "start_logit": 5.3828125,
            "end_logit": -6.18359375,
            "text": "the 7S",
            "probability": 5.2034854888916016e-05
        },
        {
            "start_logit": 5.3828125,
            "end_logit": -6.5703125,
            "text": "the 7",
            "probability": 3.516674041748047e-05
        },
        {
            "start_logit": 5.3828125,
            "end_logit": -6.58203125,
            "text": "the 7SL",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -4.6640625,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -4.6796875,
            "text": "Alu elements are each a",
            "probability": 3.254413604736328e-05
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -4.82421875,
            "text": "Alu",
            "probability": 2.8312206268310547e-05
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -5.25,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -5.484375,
            "text": "Alu elements are each a dimer",
            "probability": 1.4543533325195312e-05
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -5.5859375,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -5.6171875,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp",
            "probability": 1.2755393981933594e-05
        },
        {
            "start_logit": -5.90234375,
            "end_logit": 3.681640625,
            "text": "elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene.",
            "probability": 1.2576580047607422e-05
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 3.681640625,
            "text": "7SL RNA gene.",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -6.03125,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp,",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 3.4140625,
            "end_logit": -6.0625,
            "text": "Alu elements are each a dimer of similar",
            "probability": 8.165836334228516e-06
        }
    ],
    "58cf5c5a8acda34529000003_1": [
        {
            "start_logit": -6.15625,
            "end_logit": 1.9345703125,
            "text": "D-glucosyl-hydroxymethyluracil",
            "probability": 0.1510009765625
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 1.9345703125,
            "text": "uracil",
            "probability": 0.1407470703125
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 1.9345703125,
            "text": "hydroxymethyluracil",
            "probability": 0.1280517578125
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 1.9345703125,
            "text": "glucosyl-hydroxymethyluracil",
            "probability": 0.1082763671875
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 1.9345703125,
            "text": "Base J (\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.1025390625
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 1.9345703125,
            "text": "-hydroxymethyluracil",
            "probability": 0.07415771484375
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 1.9345703125,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.0511474609375
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 1.9345703125,
            "text": "cil",
            "probability": 0.050140380859375
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 1.9345703125,
            "text": "-D-glucosyl-hydroxymethyluracil",
            "probability": 0.049560546875
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 1.9345703125,
            "text": "(\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.047698974609375
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 1.9345703125,
            "text": "osyl-hydroxymethyluracil",
            "probability": 0.04730224609375
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 1.9345703125,
            "text": "-glucosyl-hydroxymethyluracil",
            "probability": 0.04241943359375
        },
        {
            "start_logit": -6.39453125,
            "end_logit": -2.015625,
            "text": "in telomeric repeats (99%) and in regions where transcription starts and stops.",
            "probability": 0.002300262451171875
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -2.015625,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and stops.",
            "probability": 0.0011568069458007812
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -2.015625,
            "text": "T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and stops.",
            "probability": 0.0011034011840820312
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -2.015625,
            "text": ".",
            "probability": 0.001087188720703125
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -2.015625,
            "text": "where transcription starts and stops.",
            "probability": 0.0007648468017578125
        },
        {
            "start_logit": -6.15625,
            "end_logit": -4.37890625,
            "text": "D-glucosyl-hydroxymethyluracil) replaces 1% of T",
            "probability": 0.00027489662170410156
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -4.37890625,
            "text": "uracil) replaces 1% of T",
            "probability": 0.0002541542053222656
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -4.37890625,
            "text": "hydroxymethyluracil) replaces 1% of T",
            "probability": 0.0002315044403076172
        }
    ],
    "58cf5c5a8acda34529000003_2": [
        {
            "start_logit": -6.17578125,
            "end_logit": 1.7705078125,
            "text": "uracil",
            "probability": 0.1549072265625
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 1.7705078125,
            "text": "D-glucosyl-hydroxymethyluracil",
            "probability": 0.152587890625
        },
        {
            "start_logit": -6.359375,
            "end_logit": 1.7705078125,
            "text": "hydroxymethyluracil",
            "probability": 0.12890625
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 1.7705078125,
            "text": "glucosyl-hydroxymethyluracil",
            "probability": 0.1060791015625
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 1.7705078125,
            "text": "-hydroxymethyluracil",
            "probability": 0.0816650390625
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 1.7705078125,
            "text": "Base J (\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.06768798828125
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 1.7705078125,
            "text": "osyl-hydroxymethyluracil",
            "probability": 0.054168701171875
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 1.7705078125,
            "text": "-D-glucosyl-hydroxymethyluracil",
            "probability": 0.053558349609375
        },
        {
            "start_logit": -7.25,
            "end_logit": 1.7705078125,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.05291748046875
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 1.7705078125,
            "text": "cil",
            "probability": 0.052337646484375
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 1.7705078125,
            "text": "(\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.04840087890625
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 1.7705078125,
            "text": "-glucosyl-hydroxymethyluracil",
            "probability": 0.045440673828125
        },
        {
            "start_logit": -6.17578125,
            "end_logit": -4.765625,
            "text": "uracil) replaces 1% of T",
            "probability": 0.0002257823944091797
        },
        {
            "start_logit": -6.19140625,
            "end_logit": -4.765625,
            "text": "D-glucosyl-hydroxymethyluracil) replaces 1% of T",
            "probability": 0.00022232532501220703
        },
        {
            "start_logit": -6.359375,
            "end_logit": -4.765625,
            "text": "hydroxymethyluracil) replaces 1% of T",
            "probability": 0.00018727779388427734
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -4.765625,
            "text": "glucosyl-hydroxymethyluracil) replaces 1% of T",
            "probability": 0.00015401840209960938
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -4.765625,
            "text": "-hydroxymethyluracil) replaces 1% of T",
            "probability": 0.00011897087097167969
        },
        {
            "start_logit": -6.17578125,
            "end_logit": -5.51953125,
            "text": "uracil) replaces 1%",
            "probability": 0.00010579824447631836
        },
        {
            "start_logit": -6.19140625,
            "end_logit": -5.51953125,
            "text": "D-glucosyl-hydroxymethyluracil) replaces 1%",
            "probability": 0.00010418891906738281
        },
        {
            "start_logit": -7.00390625,
            "end_logit": -4.765625,
            "text": "Base J (\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T",
            "probability": 9.864568710327148e-05
        }
    ],
    "61f86c03882a024a10000044_1": [
        {
            "start_logit": 0.43408203125,
            "end_logit": 7.734375,
            "text": "motor neuropathy",
            "probability": 0.82666015625
        },
        {
            "start_logit": -1.75390625,
            "end_logit": 7.734375,
            "text": "hereditary motor neuropathy",
            "probability": 0.09234619140625
        },
        {
            "start_logit": -2.369140625,
            "end_logit": 7.734375,
            "text": "neuropathy",
            "probability": 0.050018310546875
        },
        {
            "start_logit": -2.96484375,
            "end_logit": 7.734375,
            "text": "recessive hereditary motor neuropathy",
            "probability": 0.0275115966796875
        },
        {
            "start_logit": -5.8125,
            "end_logit": 7.734375,
            "text": "10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.0015954971313476562
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.734375,
            "text": "An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.00036025047302246094
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.734375,
            "text": "in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.0002446174621582031
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.734375,
            "text": "causes recessive hereditary motor neuropathy",
            "probability": 0.00023698806762695312
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.734375,
            "text": "bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.00022792816162109375
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 7.734375,
            "text": "VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.00021600723266601562
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 7.734375,
            "text": "expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.00021266937255859375
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 7.734375,
            "text": "repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.00020432472229003906
        },
        {
            "start_logit": -7.875,
            "end_logit": 7.734375,
            "text": "A1 causes recessive hereditary motor neuropathy",
            "probability": 0.0002027750015258789
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.734375,
            "text": "-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.0001996755599975586
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 7.734375,
            "text": "ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.00019359588623046875
        },
        {
            "start_logit": 0.43408203125,
            "end_logit": -6.47265625,
            "text": "motor neuropathy.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.75390625,
            "end_logit": -6.47265625,
            "text": "hereditary motor neuropathy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.369140625,
            "end_logit": -6.47265625,
            "text": "neuropathy.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.96484375,
            "end_logit": -6.47265625,
            "text": "recessive hereditary motor neuropathy.",
            "probability": 0.0
        },
        {
            "start_logit": -2.96484375,
            "end_logit": -7.61328125,
            "text": "recessive",
            "probability": 0.0
        }
    ],
    "61f86c03882a024a10000044_2": [
        {
            "start_logit": 7.703125,
            "end_logit": 7.890625,
            "text": "motor neuropathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.7705078125,
            "end_logit": 7.890625,
            "text": "neuropathy",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": 7.703125,
            "end_logit": -2.36328125,
            "text": "motor",
            "probability": 3.534555435180664e-05
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 7.890625,
            "text": "hereditary motor neuropathy",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.703125,
            "end_logit": -6.97265625,
            "text": "motor neuropathy cases in Europeans. The detailed clinical characterization provided here will facilitate targeted testing on suitable patient cohorts. This novel disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.703125,
            "end_logit": -7.203125,
            "text": "motor neuropathy cases",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.703125,
            "end_logit": -7.2265625,
            "text": "motor neuropathy cases in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.890625,
            "text": "biallelic variants in VWA1 may be responsible for up to 1% of unexplained hereditary motor neuropathy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.703125,
            "end_logit": -7.53515625,
            "text": "motor neuropathy cases in Europeans. The detailed clinical characterization provided here will facilitate targeted testing on suitable patient cohorts.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.703125,
            "end_logit": -7.53515625,
            "text": "motor neuropathy cases in Europeans.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.703125,
            "end_logit": -7.578125,
            "text": "motor neuropathy cases in European",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 7.890625,
            "text": "unexplained hereditary motor neuropathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.703125,
            "end_logit": -7.8046875,
            "text": "motor neuropathy cases in Europeans",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.7705078125,
            "end_logit": -6.97265625,
            "text": "neuropathy cases in Europeans. The detailed clinical characterization provided here will facilitate targeted testing on suitable patient cohorts. This novel disease",
            "probability": 0.0
        },
        {
            "start_logit": -6.4609375,
            "end_logit": -2.36328125,
            "text": "hereditary motor",
            "probability": 0.0
        },
        {
            "start_logit": -1.7705078125,
            "end_logit": -7.203125,
            "text": "neuropathy cases",
            "probability": 0.0
        },
        {
            "start_logit": -1.7705078125,
            "end_logit": -7.2265625,
            "text": "neuropathy cases in",
            "probability": 0.0
        },
        {
            "start_logit": -1.7705078125,
            "end_logit": -7.53515625,
            "text": "neuropathy cases in Europeans. The detailed clinical characterization provided here will facilitate targeted testing on suitable patient cohorts.",
            "probability": 0.0
        },
        {
            "start_logit": -1.7705078125,
            "end_logit": -7.53515625,
            "text": "neuropathy cases in Europeans.",
            "probability": 0.0
        },
        {
            "start_logit": -1.7705078125,
            "end_logit": -7.578125,
            "text": "neuropathy cases in European",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_1": [
        {
            "start_logit": 7.83203125,
            "end_logit": 7.82421875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -1.8984375,
            "text": "cystic",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -2.0078125,
            "end_logit": 7.82421875,
            "text": "fibrosis",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.45703125,
            "text": "cystic fibrosis (CF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.79296875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.8515625,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.8984375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.8984375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.9140625,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 7.82421875,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.9453125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 7.82421875,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.96484375,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.98046875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -8.0,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -8.0,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -8.0,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.82421875,
            "text": "testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.0078125,
            "end_logit": -7.45703125,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -2.0078125,
            "end_logit": -7.79296875,
            "text": "fibrosis (CF) involves sweat induction, collection and",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_2": [
        {
            "start_logit": 7.53515625,
            "end_logit": 5.71484375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -2.98046875,
            "text": "cystic",
            "probability": 0.00016736984252929688
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -4.3359375,
            "text": "cystic fibrosis transmembrane conductance regulator",
            "probability": 4.3332576751708984e-05
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -5.8515625,
            "text": "cystic fibrosis transmembrane conductance regulator)",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -6.13671875,
            "text": "cystic fibrosis transmembrane conductance",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -4.78125,
            "end_logit": 5.71484375,
            "text": "fibrosis",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.14453125,
            "text": "cystic fibrosis transmembrane",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.17578125,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.3203125,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subjects.",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.37109375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.4140625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subjects",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.453125,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.5859375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.62109375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.515625,
            "end_logit": 5.71484375,
            "text": "(cystic fibrosis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 5.71484375,
            "text": "CFTR (cystic fibrosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 5.71484375,
            "text": "results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 5.71484375,
            "text": "Objective: To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.78125,
            "end_logit": -4.3359375,
            "text": "fibrosis transmembrane conductance regulator",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -2.98046875,
            "text": "(cystic",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_3": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.89453125,
            "text": "cystic fibrosis",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.86328125,
            "end_logit": 7.90625,
            "text": "Cystic Fibrosis",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.86328125,
            "end_logit": 7.89453125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.4140625,
            "text": "cystic",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -1.4140625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -1.431640625,
            "text": "Cystic",
            "probability": 2.950429916381836e-05
        },
        {
            "start_logit": -1.6181640625,
            "end_logit": 7.90625,
            "text": "Fibrosis",
            "probability": 2.562999725341797e-05
        },
        {
            "start_logit": -1.6181640625,
            "end_logit": 7.89453125,
            "text": "Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 2.5391578674316406e-05
        },
        {
            "start_logit": -1.623046875,
            "end_logit": 7.89453125,
            "text": "fibrosis",
            "probability": 2.5212764739990234e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.4765625,
            "text": "cystic fibrosis (CF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.4765625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.82421875,
            "text": "Cystic Fibrosis Infants",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.03515625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.32421875,
            "text": "cystic fibrosis (CF) in support of universal newborn screening programs.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.32421875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.3359375,
            "text": "cystic fibrosis (CF) in support of universal newborn screening",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.89453125,
            "text": ".The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.5,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.53125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.5625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6e16eb7c78d6947100004e_4": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.89453125,
            "text": "cystic fibrosis",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.86328125,
            "end_logit": 7.90625,
            "text": "Cystic Fibrosis",
            "probability": 0.334228515625
        },
        {
            "start_logit": 7.86328125,
            "end_logit": 7.89453125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.4140625,
            "text": "cystic",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -1.4140625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -1.431640625,
            "text": "Cystic",
            "probability": 2.950429916381836e-05
        },
        {
            "start_logit": -1.6181640625,
            "end_logit": 7.90625,
            "text": "Fibrosis",
            "probability": 2.562999725341797e-05
        },
        {
            "start_logit": -1.6181640625,
            "end_logit": 7.89453125,
            "text": "Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 2.5391578674316406e-05
        },
        {
            "start_logit": -1.623046875,
            "end_logit": 7.89453125,
            "text": "fibrosis",
            "probability": 2.5212764739990234e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.4765625,
            "text": "cystic fibrosis (CF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.4765625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.82421875,
            "text": "Cystic Fibrosis Infants",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.03515625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.32421875,
            "text": "cystic fibrosis (CF) in support of universal newborn screening programs.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.32421875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.3359375,
            "text": "cystic fibrosis (CF) in support of universal newborn screening",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.89453125,
            "text": ".The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.5,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.53125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.5625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6e16eb7c78d6947100004e_5": [
        {
            "start_logit": 7.859375,
            "end_logit": 7.8515625,
            "text": "Cystic Fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.859375,
            "end_logit": -1.5478515625,
            "text": "Cystic",
            "probability": 8.285045623779297e-05
        },
        {
            "start_logit": -1.791015625,
            "end_logit": 7.8515625,
            "text": "Fibrosis",
            "probability": 6.455183029174805e-05
        },
        {
            "start_logit": 7.859375,
            "end_logit": -6.9140625,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.21875,
            "text": "Cystic Fibrosis Patients",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.33203125,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.421875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.44921875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.45703125,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time of diagnosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.48046875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time of diagnosis.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.48046875,
            "text": "Cystic Fibrosis Patients.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.48828125,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.49609375,
            "text": "Cystic Fibrosis Patients.The diagnosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.49609375,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.5,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.5390625,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.8515625,
            "text": "of Cystic Fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 7.8515625,
            "text": "Assessment of Correlation between Sweat Chloride Levels and Clinical Features of Cystic Fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.791015625,
            "end_logit": -6.9140625,
            "text": "Fibrosis Patients.The diagnosis is often delayed and the disease",
            "probability": 0.0
        },
        {
            "start_logit": -1.791015625,
            "end_logit": -7.21875,
            "text": "Fibrosis Patients",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_6": [
        {
            "start_logit": 7.82421875,
            "end_logit": 7.8359375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -1.8603515625,
            "text": "cystic",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": 7.8359375,
            "text": "fibrosis",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -5.7265625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate mutant CFTR",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.6953125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.8671875,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate mutant CFTR.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.87890625,
            "text": "cystic fibrosis (CF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.3046875,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.328125,
            "text": "cystic fibrosis (CF)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.3671875,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.51953125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate mutant",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.55859375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.5703125,
            "text": "cystic fibrosis (CF), sweat chloride concentration",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.609375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.62890625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.64453125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.6953125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.69921875,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -5.7265625,
            "text": "fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate mutant CFTR",
            "probability": 0.0
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -6.6953125,
            "text": "fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_7": [
        {
            "start_logit": 7.83984375,
            "end_logit": 7.82421875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -1.8515625,
            "text": "cystic",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": -1.9912109375,
            "end_logit": 7.82421875,
            "text": "fibrosis",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.44921875,
            "text": "cystic fibrosis (CF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.78515625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.8671875,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.87109375,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.82421875,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.9140625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.94921875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 7.82421875,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.9609375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.9765625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.984375,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.98828125,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -8.0078125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.82421875,
            "text": "testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.9912109375,
            "end_logit": -7.44921875,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -1.8515625,
            "text": "diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -1.9912109375,
            "end_logit": -7.78515625,
            "text": "fibrosis (CF) involves sweat induction, collection and",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_8": [
        {
            "start_logit": 7.83203125,
            "end_logit": 7.828125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -1.900390625,
            "text": "cystic",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": -1.998046875,
            "end_logit": 7.828125,
            "text": "fibrosis",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.40234375,
            "text": "cystic fibrosis (CF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.6171875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.87890625,
            "text": "cystic fibrosis (CF).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 7.828125,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.828125,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.828125,
            "text": "gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.828125,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.828125,
            "text": "testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.998046875,
            "end_logit": -7.40234375,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.998046875,
            "end_logit": -7.6171875,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -1.900390625,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -1.900390625,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -1.998046875,
            "end_logit": -7.87890625,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -1.900390625,
            "text": "gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -1.900390625,
            "text": "diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -1.900390625,
            "text": "testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -7.40234375,
            "text": "CF",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_9": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.84375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.7568359375,
            "text": "cystic",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": -1.9033203125,
            "end_logit": 7.84375,
            "text": "fibrosis",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.25390625,
            "text": "cystic fibrosis (CF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.515625,
            "text": "cystic fibrosis (CF) in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.578125,
            "text": "cystic fibrosis (CF) in support",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.64453125,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.65625,
            "text": "cystic fibrosis (CF) in support of universal newborn",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.72265625,
            "text": "cystic fibrosis (CF) in support of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.7421875,
            "text": "cystic fibrosis (CF) in support of universal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.78515625,
            "text": "cystic fibrosis (CF) in support of universal newborn screening",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.82421875,
            "text": "cystic fibrosis (CF) in support of universal newborn screening programs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.89453125,
            "text": "cystic fibrosis (CF) in support of universal newborn screening programs.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.84375,
            "text": "remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.84375,
            "text": "sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.84375,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.84375,
            "text": "the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.9033203125,
            "end_logit": -7.25390625,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.9033203125,
            "end_logit": -7.515625,
            "text": "fibrosis (CF) in",
            "probability": 0.0
        },
        {
            "start_logit": -1.9033203125,
            "end_logit": -7.578125,
            "text": "fibrosis (CF) in support",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_10": [
        {
            "start_logit": 7.828125,
            "end_logit": 7.8359375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.828125,
            "end_logit": -1.9619140625,
            "text": "cystic",
            "probability": 5.561113357543945e-05
        },
        {
            "start_logit": -1.982421875,
            "end_logit": 7.8359375,
            "text": "fibrosis",
            "probability": 5.4776668548583984e-05
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.59765625,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.67578125,
            "text": "cystic fibrosis,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.68359375,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.6875,
            "text": "cystic fibrosis, electrolyte metabolism",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.73046875,
            "text": "cystic fibrosis, electrolyte metabolism disorders",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.73828125,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.7421875,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte balance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.76171875,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.83984375,
            "text": "cystic fibrosis, electrolyte metabolism disorders,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.8515625,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.8515625,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.8359375,
            "text": "for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.8359375,
            "text": "Sweat chloride is of interest as a biomarker for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.982421875,
            "end_logit": -7.59765625,
            "text": "fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise.",
            "probability": 0.0
        },
        {
            "start_logit": -1.982421875,
            "end_logit": -7.67578125,
            "text": "fibrosis,",
            "probability": 0.0
        },
        {
            "start_logit": -1.982421875,
            "end_logit": -7.68359375,
            "text": "fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss",
            "probability": 0.0
        },
        {
            "start_logit": -1.982421875,
            "end_logit": -7.6875,
            "text": "fibrosis, electrolyte metabolism",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_11": [
        {
            "start_logit": 7.83203125,
            "end_logit": 7.828125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -1.900390625,
            "text": "cystic",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": -1.998046875,
            "end_logit": 7.828125,
            "text": "fibrosis",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.40234375,
            "text": "cystic fibrosis (CF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.6171875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83203125,
            "end_logit": -7.87890625,
            "text": "cystic fibrosis (CF).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 7.828125,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.828125,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.828125,
            "text": "gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.828125,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.828125,
            "text": "testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.998046875,
            "end_logit": -7.40234375,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.998046875,
            "end_logit": -7.6171875,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -1.900390625,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -1.900390625,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -1.998046875,
            "end_logit": -7.87890625,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -1.900390625,
            "text": "gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -1.900390625,
            "text": "diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -1.900390625,
            "text": "testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -7.40234375,
            "text": "CF",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_12": [
        {
            "start_logit": 7.83984375,
            "end_logit": 7.82421875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -1.8515625,
            "text": "cystic",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": -1.9912109375,
            "end_logit": 7.82421875,
            "text": "fibrosis",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.44921875,
            "text": "cystic fibrosis (CF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.78515625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.8671875,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.87109375,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.82421875,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.9140625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.94921875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 7.82421875,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.9609375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.9765625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.984375,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.98828125,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -8.0078125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.82421875,
            "text": "testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.9912109375,
            "end_logit": -7.44921875,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -1.8515625,
            "text": "diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -1.9912109375,
            "end_logit": -7.78515625,
            "text": "fibrosis (CF) involves sweat induction, collection and",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_13": [
        {
            "start_logit": 7.84765625,
            "end_logit": 7.83203125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -1.7646484375,
            "text": "cystic",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -1.9453125,
            "end_logit": 7.83203125,
            "text": "fibrosis",
            "probability": 5.561113357543945e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.359375,
            "text": "cystic fibrosis (CF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.74609375,
            "text": "cystic fibrosis (CF) diagnosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.7578125,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.83203125,
            "text": "Sweat chloride test is the gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.83203125,
            "text": "gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.83203125,
            "text": "test is the gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.9453125,
            "end_logit": -7.359375,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.9453125,
            "end_logit": -7.74609375,
            "text": "fibrosis (CF) diagnosis",
            "probability": 0.0
        },
        {
            "start_logit": -1.9453125,
            "end_logit": -7.7578125,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -1.7646484375,
            "text": "Sweat chloride test is the gold standard test for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -1.7646484375,
            "text": "gold standard test for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -1.7646484375,
            "text": "test is the gold standard test for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -7.359375,
            "text": "CF",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -7.74609375,
            "text": "CF) diagnosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -7.7578125,
            "text": "CF)",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.359375,
            "text": "Sweat chloride test is the gold standard test for cystic fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.359375,
            "text": "gold standard test for cystic fibrosis (CF",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_14": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.859375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.681640625,
            "text": "cystic",
            "probability": 7.200241088867188e-05
        },
        {
            "start_logit": -1.80078125,
            "end_logit": 7.859375,
            "text": "fibrosis",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.50390625,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are elevated in patients.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.53125,
            "text": "cystic fibrosis due to the fact that electrolyte",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.5390625,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.546875,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are elevated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.5546875,
            "text": "cystic fibrosis due",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.5625,
            "text": "cystic fibrosis due to the fact that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.6015625,
            "text": "cystic fibrosis due to the fact that electrolyte levels",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.625,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are elevated in patients",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.64453125,
            "text": "cystic fibrosis due to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.66015625,
            "text": "cystic fibrosis due to the fact that electrolyte levels in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.859375,
            "text": "Sweat chloride test is known to be a screening test for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.50390625,
            "text": "fibrosis due to the fact that electrolyte levels in sweat are elevated in patients.",
            "probability": 0.0
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.53125,
            "text": "fibrosis due to the fact that electrolyte",
            "probability": 0.0
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.5390625,
            "text": "fibrosis due to the fact that electrolyte levels in sweat are",
            "probability": 0.0
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.546875,
            "text": "fibrosis due to the fact that electrolyte levels in sweat are elevated",
            "probability": 0.0
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.5546875,
            "text": "fibrosis due",
            "probability": 0.0
        },
        {
            "start_logit": -1.80078125,
            "end_logit": -7.5625,
            "text": "fibrosis due to the fact that",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_15": [
        {
            "start_logit": 7.828125,
            "end_logit": 7.828125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.828125,
            "end_logit": -1.8955078125,
            "text": "cystic",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -1.986328125,
            "end_logit": 7.828125,
            "text": "fibrosis",
            "probability": 5.4776668548583984e-05
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.1484375,
            "text": "cystic fibrosis (CF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.5859375,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.6953125,
            "text": "cystic fibrosis (CF).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.828125,
            "text": "Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.986328125,
            "end_logit": -7.1484375,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.986328125,
            "end_logit": -7.5859375,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.986328125,
            "end_logit": -7.6953125,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -1.8955078125,
            "text": "Sweat chloride measurement is considered a standard diagnostic tool for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -7.1484375,
            "text": "CF",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.6953125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.1484375,
            "text": "Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -7.5859375,
            "text": "CF)",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -7.6953125,
            "text": "CF).",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.5859375,
            "text": "Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.6953125,
            "text": "Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.8515625,
            "text": "Sweat chloride measurement is considered a",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.87109375,
            "text": "Sweat chloride measurement is considered a standard",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_16": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.828125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.7978515625,
            "text": "cystic",
            "probability": 6.604194641113281e-05
        },
        {
            "start_logit": -1.962890625,
            "end_logit": 7.828125,
            "text": "fibrosis",
            "probability": 5.519390106201172e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.26171875,
            "text": "cystic fibrosis (CF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.78125,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.8046875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.828125,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.828125,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.90234375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.9140625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.9296875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.94140625,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.9609375,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.9609375,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.96875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.828125,
            "text": "testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.962890625,
            "end_logit": -7.26171875,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -1.7978515625,
            "text": "diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -1.7978515625,
            "text": "Sweat chloride testing for diagnosis of cystic",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_1": [
        {
            "start_logit": 7.58984375,
            "end_logit": 7.86328125,
            "text": "bladder cancer",
            "probability": 1.0
        },
        {
            "start_logit": -1.2041015625,
            "end_logit": 7.86328125,
            "text": "cancer",
            "probability": 0.00015115737915039062
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -2.27734375,
            "text": "bladder",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 7.86328125,
            "text": "Bacillus Calmette-Gu\u00e9rin immunotherapy for bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 7.86328125,
            "text": "Calmette-Gu\u00e9rin immunotherapy for bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.86328125,
            "text": "Gu\u00e9rin immunotherapy for bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.8359375,
            "text": "bladder cancer:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.89453125,
            "text": "bladder cancer: a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.9921875,
            "text": "bladder cancer: a review of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -8.0,
            "text": "bladder cancer: a review",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -8.0078125,
            "text": "bladder cancer: a review of immunological aspects,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -8.015625,
            "text": "bladder cancer: a review of immunological",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -8.0390625,
            "text": "bladder cancer: a review of immunological aspects",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -8.078125,
            "text": "bladder cancer: a review of immunological aspects, clinical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -8.0859375,
            "text": "bladder cancer: a review of immunological aspects, clinical effects and BCG infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -8.1484375,
            "text": "bladder cancer: a review of immunological aspects, clinical effects and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.2041015625,
            "end_logit": -7.8359375,
            "text": "cancer:",
            "probability": 0.0
        },
        {
            "start_logit": -1.2041015625,
            "end_logit": -7.89453125,
            "text": "cancer: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.2041015625,
            "end_logit": -7.9921875,
            "text": "cancer: a review of",
            "probability": 0.0
        },
        {
            "start_logit": -1.2041015625,
            "end_logit": -8.0,
            "text": "cancer: a review",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_2": [
        {
            "start_logit": 4.67578125,
            "end_logit": 7.80078125,
            "text": "bladder cancer",
            "probability": 0.89990234375
        },
        {
            "start_logit": 2.482421875,
            "end_logit": 7.80078125,
            "text": "cancer",
            "probability": 0.10015869140625
        },
        {
            "start_logit": -7.9375,
            "end_logit": 7.80078125,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy for bladder cancer",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.80078125,
            "text": "Gu\u00e9rin (BCG) immunotherapy for bladder cancer",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.80078125,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy for bladder cancer",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -5.484375,
            "text": "bladder",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.71875,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates was published.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.75,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.7578125,
            "text": "bladder cancer has been used since 1976",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.81640625,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.8203125,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.82421875,
            "text": "bladder cancer has been used since",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.83203125,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability to lower",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.8359375,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability to lower recurrence and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.83984375,
            "text": "bladder cancer has been used since 1976 when the first evidence of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.8515625,
            "text": "bladder cancer has been used",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.890625,
            "text": "bladder cancer has been used since 1976 when the first",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.890625,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates was published",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.67578125,
            "end_logit": -7.89453125,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.482421875,
            "end_logit": -7.71875,
            "text": "cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates was published.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_3": [
        {
            "start_logit": 6.4609375,
            "end_logit": 6.67578125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.5625,
            "end_logit": 6.67578125,
            "text": "bladder cancer",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 6.67578125,
            "text": "muscle invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 6.67578125,
            "text": "invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.953125,
            "text": "cancer (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.9921875,
            "text": "cancer (NMIBC) after transurethral resection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -8.03125,
            "text": "cancer (NMIBC) after",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -8.0703125,
            "text": "cancer (NMIBC) after transurethral",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -8.0703125,
            "text": "cancer (NMIBC) after transurethral resection.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -8.109375,
            "text": "cancer (NMIBC)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.5625,
            "end_logit": -7.953125,
            "text": "bladder cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -5.5625,
            "end_logit": -7.9921875,
            "text": "bladder cancer (NMIBC) after transurethral resection",
            "probability": 0.0
        },
        {
            "start_logit": -5.5625,
            "end_logit": -8.03125,
            "text": "bladder cancer (NMIBC) after",
            "probability": 0.0
        },
        {
            "start_logit": -5.5625,
            "end_logit": -8.0703125,
            "text": "bladder cancer (NMIBC) after transurethral",
            "probability": 0.0
        },
        {
            "start_logit": -5.5625,
            "end_logit": -8.0703125,
            "text": "bladder cancer (NMIBC) after transurethral resection.",
            "probability": 0.0
        },
        {
            "start_logit": -5.5625,
            "end_logit": -8.109375,
            "text": "bladder cancer (NMIBC)",
            "probability": 0.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": -8.0703125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -7.953125,
            "text": "muscle invasive bladder cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -7.9921875,
            "text": "muscle invasive bladder cancer (NMIBC) after transurethral resection",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -8.03125,
            "text": "muscle invasive bladder cancer (NMIBC) after",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_4": [
        {
            "start_logit": 6.50390625,
            "end_logit": 6.6484375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 0.360595703125
        },
        {
            "start_logit": 6.50390625,
            "end_logit": 6.6171875,
            "text": "Tuberculosis",
            "probability": 0.349365234375
        },
        {
            "start_logit": 6.29296875,
            "end_logit": 6.6484375,
            "text": "Cancer",
            "probability": 0.289794921875
        },
        {
            "start_logit": -3.87890625,
            "end_logit": 6.6484375,
            "text": "Bladder Cancer",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 6.6484375,
            "text": "Renal Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 6.6171875,
            "text": "Renal Tuberculosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.14453125,
            "text": "Tuberculosis Following",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.76953125,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.8125,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.6484375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.90625,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.921875,
            "text": "Tuberculosis Following Intravesical",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.9296875,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.94140625,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.95703125,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.97265625,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -7.76953125,
            "text": "Cancer.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.984375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -8.0234375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -8.0234375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (",
            "probability": 1.7881393432617188e-07
        }
    ],
    "60292d191cb411341a00010e_5": [
        {
            "start_logit": 6.90625,
            "end_logit": 7.93359375,
            "text": "bladder cancer",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.051544189453125,
            "end_logit": 7.93359375,
            "text": "cancer",
            "probability": 0.001049041748046875
        },
        {
            "start_logit": 6.90625,
            "end_logit": -3.388671875,
            "text": "bladder",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.93359375,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 7.93359375,
            "text": "superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 7.93359375,
            "text": "Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 7.93359375,
            "text": "years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.93359375,
            "text": "Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.93359375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.93359375,
            "text": "since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.90625,
            "end_logit": -7.828125,
            "text": "bladder cancer.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.051544189453125,
            "end_logit": -7.828125,
            "text": "cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -3.388671875,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -3.388671875,
            "text": "superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -3.388671875,
            "text": "Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -3.388671875,
            "text": "years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -3.388671875,
            "text": "Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -3.388671875,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -3.388671875,
            "text": "since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -7.828125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_6": [
        {
            "start_logit": 5.90625,
            "end_logit": 7.0,
            "text": "cancer",
            "probability": 0.9921875
        },
        {
            "start_logit": 1.0126953125,
            "end_logit": 7.0,
            "text": "bladder cancer",
            "probability": 0.007457733154296875
        },
        {
            "start_logit": 5.90625,
            "end_logit": -6.69921875,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.0,
            "text": "with bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.671875,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.71484375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.765625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.80859375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.828125,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.89453125,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease progression or",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.91015625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.9375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.9375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.9453125,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.90625,
            "end_logit": -7.9453125,
            "text": "cancer can",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.0126953125,
            "end_logit": -6.69921875,
            "text": "bladder cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor",
            "probability": 0.0
        },
        {
            "start_logit": 1.0126953125,
            "end_logit": -7.25,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 1.0126953125,
            "end_logit": -7.671875,
            "text": "bladder cancer can be effectively treated with BCG intravesical immunotherapy-",
            "probability": 0.0
        },
        {
            "start_logit": 1.0126953125,
            "end_logit": -7.71484375,
            "text": "bladder cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease",
            "probability": 0.0
        },
        {
            "start_logit": 1.0126953125,
            "end_logit": -7.765625,
            "text": "bladder cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_7": [
        {
            "start_logit": 6.2578125,
            "end_logit": 6.8359375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 6.8359375,
            "text": "bladder cancer",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 6.8359375,
            "text": "nonmuscle invasive bladder cancer",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 6.8359375,
            "text": "uscle invasive bladder cancer",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.8359375,
            "text": "invasive bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.8359375,
            "text": "le invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.2578125,
            "end_logit": -7.7421875,
            "text": "cancer.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -7.7421875,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -5.58984375,
            "end_logit": -7.7421875,
            "text": "nonmuscle invasive bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -7.7421875,
            "text": "uscle invasive bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -7.7421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -7.7421875,
            "text": "invasive bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.7421875,
            "text": "le invasive bladder cancer.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_8": [
        {
            "start_logit": 5.71484375,
            "end_logit": 7.078125,
            "text": "cancer",
            "probability": 0.97314453125
        },
        {
            "start_logit": 2.099609375,
            "end_logit": 7.078125,
            "text": "bladder cancer",
            "probability": 0.0261383056640625
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.078125,
            "text": "superficial bladder cancer",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.078125,
            "text": "advantage of BCG immunotherapy over intravesical chemotherapy in superficial bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.25,
            "text": "cancer has been most apparent in patients with carcinoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.5546875,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.6328125,
            "text": "cancer has been most apparent in patients with carcinoma in situ",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.734375,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.76953125,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.78515625,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.78515625,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than 70",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.79296875,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS),",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.80859375,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.81640625,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than 70%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -7.81640625,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 2.099609375,
            "end_logit": -6.390625,
            "text": "bladder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.099609375,
            "end_logit": -7.25,
            "text": "bladder cancer has been most apparent in patients with carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": 2.099609375,
            "end_logit": -7.5546875,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than",
            "probability": 0.0
        },
        {
            "start_logit": 2.099609375,
            "end_logit": -7.6328125,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ",
            "probability": 0.0
        },
        {
            "start_logit": 2.099609375,
            "end_logit": -7.734375,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_9": [
        {
            "start_logit": 6.53515625,
            "end_logit": 6.61328125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -6.33203125,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression. While most a",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 6.61328125,
            "text": "bladder cancer",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.6015625,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression. While",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.85546875,
            "text": "cancer (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.61328125,
            "text": "Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.86328125,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.87109375,
            "text": "cancer (NMIBC) and carcinoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.61328125,
            "text": "become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.61328125,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.91015625,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 6.61328125,
            "text": "muscle invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.91796875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.9296875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression. While most",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.94140625,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.9453125,
            "text": "cancer (NMIBC) and carcinoma in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.61328125,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.9609375,
            "text": "cancer (NMIBC) and carcinoma in-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.96484375,
            "text": "cancer (NMIB",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.96484375,
            "text": "cancer (NMIBC",
            "probability": 4.76837158203125e-07
        }
    ],
    "60292d191cb411341a00010e_10": [
        {
            "start_logit": 6.19921875,
            "end_logit": 6.88671875,
            "text": "cancer",
            "probability": 0.98828125
        },
        {
            "start_logit": 1.7744140625,
            "end_logit": 6.88671875,
            "text": "bladder cancer",
            "probability": 0.011871337890625
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 6.88671875,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy is regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 6.88671875,
            "text": ") bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 6.88671875,
            "text": "current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -7.828125,
            "text": "cancer (BC), though its efficacy is limited by high recurrence and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -7.875,
            "text": "cancer (BC), though its efficacy is limited by high",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -7.890625,
            "text": "cancer (BC), though its efficacy is limited by high recurrence and progression",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -7.9375,
            "text": "cancer (BC",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -8.0,
            "text": "cancer (BC), though its efficacy is limited",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -8.0234375,
            "text": "cancer (BC), though its efficacy is limited by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -8.0390625,
            "text": "cancer (BC), though its efficacy is limited by high recurrence",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -8.046875,
            "text": "cancer (BC), though its",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -8.09375,
            "text": "cancer (BC), though its efficacy is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -8.1015625,
            "text": "cancer (BC), though its efficacy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.7744140625,
            "end_logit": -6.60546875,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 1.7744140625,
            "end_logit": -7.828125,
            "text": "bladder cancer (BC), though its efficacy is limited by high recurrence and",
            "probability": 0.0
        },
        {
            "start_logit": 1.7744140625,
            "end_logit": -7.875,
            "text": "bladder cancer (BC), though its efficacy is limited by high",
            "probability": 0.0
        },
        {
            "start_logit": 1.7744140625,
            "end_logit": -7.890625,
            "text": "bladder cancer (BC), though its efficacy is limited by high recurrence and progression",
            "probability": 0.0
        },
        {
            "start_logit": 1.7744140625,
            "end_logit": -7.9375,
            "text": "bladder cancer (BC",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_11": [
        {
            "start_logit": 6.50390625,
            "end_logit": 6.6484375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.6484375,
            "text": "bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.67578125,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG), which activates the immune system to recognize and destroy malignant",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.6484375,
            "text": "muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.90234375,
            "text": "cancer (NMIBC) is immunotherapy with intravesical",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 6.6484375,
            "text": "standard of care for most patients with non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.9375,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG),",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 6.6484375,
            "text": "invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.94921875,
            "text": "cancer (NMIBC",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.95703125,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG), which activates the immune system",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.9609375,
            "text": "cancer (NMIBC) is",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.96875,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG), which activates",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.97265625,
            "text": "cancer (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.98046875,
            "text": "cancer (NMIBC) is immunotherapy with",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.98046875,
            "text": "cancer (NMIBC) is immunotherapy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.6484375,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.6484375,
            "text": "The standard of care for most patients with non-muscle-invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.9921875,
            "text": "cancer (NMIB",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.90234375,
            "text": "bladder cancer (NMIBC) is immunotherapy with intravesical",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.9375,
            "text": "bladder cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG),",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_12": [
        {
            "start_logit": 7.0625,
            "end_logit": 7.890625,
            "text": "bladder cancer",
            "probability": 0.9990234375
        },
        {
            "start_logit": -0.42431640625,
            "end_logit": 7.890625,
            "text": "cancer",
            "probability": 0.0005593299865722656
        },
        {
            "start_logit": 7.0625,
            "end_logit": -3.13671875,
            "text": "bladder",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 7.890625,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 7.890625,
            "text": "superficial bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.890625,
            "text": "years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.890625,
            "text": "Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.890625,
            "text": "Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.0625,
            "end_logit": -7.3203125,
            "text": "bladder cancer.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.0625,
            "end_logit": -7.7421875,
            "text": "bladder cancer. Des",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.42431640625,
            "end_logit": -7.3203125,
            "text": "cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -0.42431640625,
            "end_logit": -7.7421875,
            "text": "cancer. Des",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -3.13671875,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -3.13671875,
            "text": "superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -3.13671875,
            "text": "years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -3.13671875,
            "text": "Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -3.13671875,
            "text": "Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -7.3203125,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.3203125,
            "text": "superficial bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.3203125,
            "text": "years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_13": [
        {
            "start_logit": 6.51953125,
            "end_logit": 6.63671875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 6.63671875,
            "text": "bladder cancer",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.48828125,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC. However",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.734375,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.73828125,
            "text": "cancer (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.75390625,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.76953125,
            "text": "cancer (NMIBC), with proven effects on",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.78125,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.796875,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIB",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.796875,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.83984375,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.8515625,
            "text": "cancer (NMIBC",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.85546875,
            "text": "cancer (NMIBC)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.859375,
            "text": "cancer (NMIBC), with proven effects on reducing",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.890625,
            "text": "cancer (NMIBC),",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.63671875,
            "text": "bacille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 6.63671875,
            "text": "Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.63671875,
            "text": "Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -7.48828125,
            "text": "bladder cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC. However",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -7.734375,
            "text": "bladder cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_14": [
        {
            "start_logit": 7.625,
            "end_logit": 7.828125,
            "text": "bladder cancer",
            "probability": 1.0
        },
        {
            "start_logit": -1.029296875,
            "end_logit": 7.828125,
            "text": "cancer",
            "probability": 0.00017404556274414062
        },
        {
            "start_logit": 7.625,
            "end_logit": -2.01171875,
            "text": "bladder",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.69140625,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40%",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.7890625,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.81640625,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.8203125,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40% of patients",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.82421875,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.8359375,
            "text": "bladder cancer, its long-term efficacy is still argua",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.84765625,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40% of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.828125,
            "text": "Guerin (BCG) immunotherapy was approved many decades ago as a first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.86328125,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40% of patients will",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.87109375,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.87109375,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.8828125,
            "text": "bladder cancer, its long-term efficacy is still arguable",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.890625,
            "text": "bladder cancer,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.89453125,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40% of patients will develop recurrence or progression",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.828125,
            "text": "invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.828125,
            "text": "decades ago as a first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.828125,
            "text": "many decades ago as a first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60292d191cb411341a00010e_15": [
        {
            "start_logit": 6.51953125,
            "end_logit": 6.61328125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 6.61328125,
            "text": "bladder cancer",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.4375,
            "end_logit": 6.61328125,
            "text": "bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.41796875,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.61328125,
            "text": "Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.61328125,
            "text": "muscle-invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.671875,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.67578125,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.61328125,
            "text": "bladder tumour to reduce recurrences, bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.71484375,
            "text": "cancer and urothelial",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.74609375,
            "text": "cancer and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.61328125,
            "text": "ette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.61328125,
            "text": "invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.85546875,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy-related atypia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.8671875,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy-related",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.87890625,
            "text": "cancer and urothelial CIS and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.89453125,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.8984375,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.921875,
            "text": "cancer and urothelial CIS and platin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51953125,
            "end_logit": -7.93359375,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postc",
            "probability": 4.76837158203125e-07
        }
    ],
    "60292d191cb411341a00010e_16": [
        {
            "start_logit": 6.4453125,
            "end_logit": 6.6796875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -1.35546875,
            "end_logit": 6.6796875,
            "text": "bladder cancer",
            "probability": 0.0004093647003173828
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 6.6796875,
            "text": "muscle invasive bladder cancer",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.6796875,
            "text": "bladder tumor to reduce recurrences, BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.05078125,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.6796875,
            "text": "invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.6796875,
            "text": "high risk non-muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.6796875,
            "text": "tumor to reduce recurrences, BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.6796875,
            "text": "non-muscle invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.6796875,
            "text": "risk non-muscle invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 6.6796875,
            "text": "treat high risk non-muscle invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.6796875,
            "text": "resection of bladder tumor to reduce recurrences, BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.609375,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.6171875,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-specific survival some of the causes of therapy",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 6.6796875,
            "text": "intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.6796875,
            "text": "cancer and urothelial carcinoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.72265625,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-specific survival some of the causes of therapy related atypia",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.76171875,
            "text": "cancer and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.796875,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.80078125,
            "text": "cancer and urothelial carcinoma in situ, and",
            "probability": 5.364418029785156e-07
        }
    ],
    "60292d191cb411341a00010e_17": [
        {
            "start_logit": 6.3125,
            "end_logit": 7.63671875,
            "text": "bladder cancer",
            "probability": 0.9267578125
        },
        {
            "start_logit": 3.779296875,
            "end_logit": 7.63671875,
            "text": "cancer",
            "probability": 0.0731201171875
        },
        {
            "start_logit": 6.3125,
            "end_logit": -3.814453125,
            "text": "bladder",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 7.63671875,
            "text": "recent developments in intravesical therapy of bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.63671875,
            "text": "of bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 7.63671875,
            "text": "review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 7.63671875,
            "text": "highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.3125,
            "end_logit": -7.1015625,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3125,
            "end_logit": -7.4921875,
            "text": "bladder cancer and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3125,
            "end_logit": -7.83203125,
            "text": "bladder cancer and summarizes the mechanisms of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3125,
            "end_logit": -7.9921875,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3125,
            "end_logit": -7.99609375,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3125,
            "end_logit": -8.03125,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents in the therapy and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3125,
            "end_logit": -8.03125,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3125,
            "end_logit": -8.0390625,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3125,
            "end_logit": -8.046875,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents in the therapy and prophylaxis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.779296875,
            "end_logit": -7.1015625,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.779296875,
            "end_logit": -7.4921875,
            "text": "cancer and",
            "probability": 0.0
        },
        {
            "start_logit": 3.779296875,
            "end_logit": -7.83203125,
            "text": "cancer and summarizes the mechanisms of",
            "probability": 0.0
        },
        {
            "start_logit": 3.779296875,
            "end_logit": -7.96875,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents in the therapy and prophylaxis of",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_18": [
        {
            "start_logit": 6.51171875,
            "end_logit": 6.71875,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 0.348388671875
        },
        {
            "start_logit": 6.51171875,
            "end_logit": 6.6640625,
            "text": "cancer",
            "probability": 0.3271484375
        },
        {
            "start_logit": 6.4453125,
            "end_logit": 6.71875,
            "text": "cancer",
            "probability": 0.32470703125
        },
        {
            "start_logit": -4.703125,
            "end_logit": 6.71875,
            "text": "bladder cancer",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.16796875,
            "text": "cancer, discusses promising new therapies closely related to BCG, and briefly explores the possibility that BCG or related treatments may have an application in other urological malignancies",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.54296875,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.54296875,
            "text": "cancer,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.71875,
            "text": "summarises the history and development of BCG as a modern cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.6484375,
            "text": "cancer treatment,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.6640625,
            "text": "summarises the history and development of BCG as a modern cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.71875,
            "text": "modern cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.734375,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer, discusses promising new therapies closely related to BCG, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.6640625,
            "text": "modern cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.734375,
            "text": "cancer, discusses promising new therapies closely related to BCG, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.73828125,
            "text": "cancer, discusses promising new therapies closely related to BCG, and briefly explores the possibility that BCG or related treatments may have an application in other urological",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.71875,
            "text": "appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.8984375,
            "text": "cancer treatment, appraises current optimal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -7.87109375,
            "text": "cancer, discusses promising new therapies closely related to BCG, and briefly explores the possibility that BCG or related treatments may have an application in other urological malignancies.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.9921875,
            "text": "cancer treatment, appraises current",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.99609375,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer, discusses promising new therapies",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60292d191cb411341a00010e_19": [
        {
            "start_logit": 4.78125,
            "end_logit": 7.3125,
            "text": "cancer",
            "probability": 0.97265625
        },
        {
            "start_logit": 1.2265625,
            "end_logit": 7.3125,
            "text": "bladder cancer",
            "probability": 0.027801513671875
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.3125,
            "text": "Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.3125,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 7.3125,
            "text": "superficial bladder cancer",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 7.3125,
            "text": "Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 7.3125,
            "text": "recurrence of superficial bladder cancer",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 7.3125,
            "text": "ette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.3125,
            "text": "treat and prevent the recurrence of superficial bladder cancer",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.3125,
            "text": "(BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.3125,
            "text": "prevent the recurrence of superficial bladder cancer",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 4.78125,
            "end_logit": -7.94140625,
            "text": "cancer.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.2265625,
            "end_logit": -7.609375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 1.2265625,
            "end_logit": -7.94140625,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -7.609375,
            "text": "Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.609375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -7.94140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -7.94140625,
            "text": "Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": -7.609375,
            "text": "superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.609375,
            "text": "Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_20": [
        {
            "start_logit": 6.55078125,
            "end_logit": 6.61328125,
            "text": "cancer",
            "probability": 0.3369140625
        },
        {
            "start_logit": 6.5234375,
            "end_logit": 6.6328125,
            "text": "cancer",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.5234375,
            "end_logit": 6.61328125,
            "text": "cancer and one of the most successful applications of immunotherapy to the treatment of cancer",
            "probability": 0.3291015625
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.6328125,
            "text": "bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.61328125,
            "text": "bladder cancer and one of the most successful applications of immunotherapy to the treatment of cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -7.59765625,
            "text": "cancer and one of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -7.60546875,
            "text": "cancer and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -7.62109375,
            "text": "cancer and one",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.66015625,
            "text": "cancer.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -7.66015625,
            "text": "cancer and one of the most successful applications of immunotherapy to the treatment of cancer.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -7.71875,
            "text": "cancer and one of the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -7.72265625,
            "text": "cancer and one of the most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -7.8203125,
            "text": "cancer and one of the most successful",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 6.6328125,
            "text": "muscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 6.61328125,
            "text": "muscle invasive bladder cancer and one of the most successful applications of immunotherapy to the treatment of cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -7.66015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -7.59765625,
            "text": "bladder cancer and one of",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -7.60546875,
            "text": "bladder cancer and",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -7.62109375,
            "text": "bladder cancer and one",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -7.66015625,
            "text": "bladder cancer and one of the most successful applications of immunotherapy to the treatment of cancer.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_21": [
        {
            "start_logit": 6.53125,
            "end_logit": 6.61328125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 6.61328125,
            "text": "bladder cancer",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.76953125,
            "text": "cancer (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.61328125,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.61328125,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.7890625,
            "text": "cancer (NMIBC) and carcinoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.80078125,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.61328125,
            "text": "muscle invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.83984375,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 6.61328125,
            "text": "Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.86328125,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.61328125,
            "text": "become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.87890625,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.89453125,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.89453125,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.61328125,
            "text": ": The administration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.91015625,
            "text": "cancer (NMIBC) and carcinoma in-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.921875,
            "text": "cancer (NMIBC) and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.9296875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.9375,
            "text": "cancer (NMIBC",
            "probability": 4.76837158203125e-07
        }
    ],
    "60292d191cb411341a00010e_22": [
        {
            "start_logit": 6.01953125,
            "end_logit": 6.97265625,
            "text": "cancer",
            "probability": 0.986328125
        },
        {
            "start_logit": 1.763671875,
            "end_logit": 6.97265625,
            "text": "bladder cancer",
            "probability": 0.0139617919921875
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.97265625,
            "text": "invasive bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.97265625,
            "text": ": When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.97265625,
            "text": "SUMMARY: When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.97265625,
            "text": "muscle-invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -7.71875,
            "text": "cancer is",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -7.76953125,
            "text": "cancer is persistent or",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -7.87109375,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG) plus maintenance, further BCG is not likely",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -7.90625,
            "text": "cancer is persistent or recurs",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -7.91015625,
            "text": "cancer is persistent",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -7.9140625,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG) plus maintenance, further BCG is not",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -7.91796875,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG) plus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -7.93359375,
            "text": "cancer is persistent or recurs shortly after a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.01953125,
            "end_logit": -7.94140625,
            "text": "cancer is persistent or recurs shortly after a full",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 1.763671875,
            "end_logit": -6.77734375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 1.763671875,
            "end_logit": -7.71875,
            "text": "bladder cancer is",
            "probability": 0.0
        },
        {
            "start_logit": 1.763671875,
            "end_logit": -7.76953125,
            "text": "bladder cancer is persistent or",
            "probability": 0.0
        },
        {
            "start_logit": 1.763671875,
            "end_logit": -7.87109375,
            "text": "bladder cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG) plus maintenance, further BCG is not likely",
            "probability": 0.0
        },
        {
            "start_logit": 1.763671875,
            "end_logit": -7.90625,
            "text": "bladder cancer is persistent or recurs",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_23": [
        {
            "start_logit": 6.46484375,
            "end_logit": 6.68359375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.30078125,
            "end_logit": 6.68359375,
            "text": "bladder cancer",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 6.68359375,
            "text": "PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.77734375,
            "text": "cancer treated",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 6.68359375,
            "text": "muscle-invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.68359375,
            "text": "invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.90625,
            "text": "cancer treated with",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.46484375,
            "end_logit": -7.92578125,
            "text": "cancer treated with BCG immunotherapy",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.30078125,
            "end_logit": -7.40234375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -5.30078125,
            "end_logit": -7.77734375,
            "text": "bladder cancer treated",
            "probability": 0.0
        },
        {
            "start_logit": -5.30078125,
            "end_logit": -7.90625,
            "text": "bladder cancer treated with",
            "probability": 0.0
        },
        {
            "start_logit": -5.30078125,
            "end_logit": -7.92578125,
            "text": "bladder cancer treated with BCG immunotherapy",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -7.40234375,
            "text": "PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -7.40234375,
            "text": "muscle-invasive bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.40234375,
            "text": "invasive bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -7.77734375,
            "text": "PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -7.77734375,
            "text": "muscle-invasive bladder cancer treated",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -7.83984375,
            "text": "PD-L1 expression in patients with primary",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.77734375,
            "text": "invasive bladder cancer treated",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -7.8515625,
            "text": "PD-L1 expression in patients with primary high-",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_24": [
        {
            "start_logit": 6.5546875,
            "end_logit": 6.6171875,
            "text": "cancer",
            "probability": 0.487548828125
        },
        {
            "start_logit": 5.609375,
            "end_logit": 7.1328125,
            "text": "cancer",
            "probability": 0.3173828125
        },
        {
            "start_logit": 5.609375,
            "end_logit": 6.6171875,
            "text": "cancer and it still remains at the forefront of immunotherapy for cancer",
            "probability": 0.1895751953125
        },
        {
            "start_logit": 1.1064453125,
            "end_logit": 7.1328125,
            "text": "bladder cancer",
            "probability": 0.0035247802734375
        },
        {
            "start_logit": 1.1064453125,
            "end_logit": 6.6171875,
            "text": "bladder cancer and it still remains at the forefront of immunotherapy for cancer",
            "probability": 0.0020961761474609375
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.1328125,
            "text": "Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.80078125,
            "text": "cancer patients",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.91796875,
            "text": "cancer patients.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.6171875,
            "text": "Gu\u00e9rin (BCG) has been used for treating bladder cancer and it still remains at the forefront of immunotherapy for cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.6171875,
            "text": "remains at the forefront of immunotherapy for cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.64453125,
            "text": "cancer and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.80078125,
            "text": "cancer and it still remains at the forefront of immunotherapy for cancer patients",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.85546875,
            "text": "cancer and it still remains at the forefront",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.88671875,
            "text": "cancer and it",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.8984375,
            "text": "cancer and it still remains at the forefront of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.91796875,
            "text": "cancer and it still remains at the forefront of immunotherapy for cancer patients.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1064453125,
            "end_logit": -7.375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 1.1064453125,
            "end_logit": -7.64453125,
            "text": "bladder cancer and",
            "probability": 0.0
        },
        {
            "start_logit": 1.1064453125,
            "end_logit": -7.80078125,
            "text": "bladder cancer and it still remains at the forefront of immunotherapy for cancer patients",
            "probability": 0.0
        },
        {
            "start_logit": 1.1064453125,
            "end_logit": -7.85546875,
            "text": "bladder cancer and it still remains at the forefront",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_25": [
        {
            "start_logit": 7.81640625,
            "end_logit": 7.91015625,
            "text": "bladder cancer",
            "probability": 1.0
        },
        {
            "start_logit": -1.373046875,
            "end_logit": 7.91015625,
            "text": "cancer",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -1.591796875,
            "text": "bladder",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.265625,
            "text": "bladder cancer, BCG is ineffective in approximately 30-40 % of cases and disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.49609375,
            "text": "bladder cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up to 50 % of patients.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.91015625,
            "text": "muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.6640625,
            "text": "bladder cancer, BCG is ineffective in approximately 30-40 %",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.66796875,
            "text": "bladder cancer, BCG is ineffective",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.671875,
            "text": "bladder cancer, BCG is ineffective in approximately 30-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 7.91015625,
            "text": "tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.6953125,
            "text": "bladder cancer,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.7265625,
            "text": "bladder cancer, BCG is ineffective in approximately",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.73828125,
            "text": "bladder cancer, BCG is ineffective in approximately 30-40 % of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.91015625,
            "text": "invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.373046875,
            "end_logit": -7.265625,
            "text": "cancer, BCG is ineffective in approximately 30-40 % of cases and disease",
            "probability": 0.0
        },
        {
            "start_logit": -1.373046875,
            "end_logit": -7.49609375,
            "text": "cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up to 50 % of patients.",
            "probability": 0.0
        },
        {
            "start_logit": -1.373046875,
            "end_logit": -7.6640625,
            "text": "cancer, BCG is ineffective in approximately 30-40 %",
            "probability": 0.0
        },
        {
            "start_logit": -1.373046875,
            "end_logit": -7.66796875,
            "text": "cancer, BCG is ineffective",
            "probability": 0.0
        },
        {
            "start_logit": -1.373046875,
            "end_logit": -7.671875,
            "text": "cancer, BCG is ineffective in approximately 30-",
            "probability": 0.0
        },
        {
            "start_logit": -1.373046875,
            "end_logit": -7.6953125,
            "text": "cancer,",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_26": [
        {
            "start_logit": 4.69921875,
            "end_logit": 7.33203125,
            "text": "cancer",
            "probability": 0.947265625
        },
        {
            "start_logit": 1.806640625,
            "end_logit": 7.33203125,
            "text": "bladder cancer",
            "probability": 0.0526123046875
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.33203125,
            "text": "less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 4.69921875,
            "end_logit": -7.82421875,
            "text": "cancer immunotherapy.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.69921875,
            "end_logit": -7.84375,
            "text": "cancer immunotherapy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.806640625,
            "end_logit": -7.19140625,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 1.806640625,
            "end_logit": -7.82421875,
            "text": "bladder cancer immunotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": 1.806640625,
            "end_logit": -7.84375,
            "text": "bladder cancer immunotherapy",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.19140625,
            "text": "less toxic and more potent therapeutic agents for bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -7.82421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.82421875,
            "text": "less toxic and more potent therapeutic agents for bladder cancer immunotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.84375,
            "text": "less toxic and more potent therapeutic agents for bladder cancer immunotherapy",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_27": [
        {
            "start_logit": 6.3828125,
            "end_logit": 6.75,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": 6.75,
            "text": "bladder cancer",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -6.71875,
            "text": "cancer: inhibition of tumor",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.78125,
            "text": "cancer: inhibition of tumor recurrence",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.8359375,
            "text": "cancer: inhibition of tumor recurrence and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.85546875,
            "text": "cancer:",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.890625,
            "text": "cancer: inhibition of tumor recurrence and associated immune responses",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -8.03125,
            "text": "cancer: inhibition of tumor recurrence and associated immune",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -8.0390625,
            "text": "cancer: inhibition of tumor recurrence and associated immune responses.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -8.046875,
            "text": "cancer: inhibition of tumor recurrence and associated",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -8.078125,
            "text": "cancer: inhibition",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -8.1015625,
            "text": "cancer: inhibition of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -6.71875,
            "text": "bladder cancer: inhibition of tumor",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -7.78125,
            "text": "bladder cancer: inhibition of tumor recurrence",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -7.8359375,
            "text": "bladder cancer: inhibition of tumor recurrence and",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -7.85546875,
            "text": "bladder cancer:",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -7.890625,
            "text": "bladder cancer: inhibition of tumor recurrence and associated immune responses",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -6.71875,
            "text": "tumor",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -8.03125,
            "text": "bladder cancer: inhibition of tumor recurrence and associated immune",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -8.0390625,
            "text": "bladder cancer: inhibition of tumor recurrence and associated immune responses.",
            "probability": 0.0
        }
    ],
    "5e776db8835f4e4777000011_1": [
        {
            "start_logit": 7.89453125,
            "end_logit": 7.921875,
            "text": "MannKind Corporation",
            "probability": 1.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": 7.921875,
            "text": "tion",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -1.9853515625,
            "text": "Mann",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -5.61328125,
            "end_logit": 7.921875,
            "text": "Kind Corporation",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 7.921875,
            "text": "Corporation",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 7.921875,
            "text": "d Corporation",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -6.74609375,
            "text": "MannKind Corpora",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -6.97265625,
            "text": "MannKind",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.27734375,
            "text": "MannKind Corporation started",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.3203125,
            "text": "MannKin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.71875,
            "text": "MannKind Corporation started developing its ultra-rapid-acting insulin Afrezza in a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.7578125,
            "text": "MannKind Corporation started developing its ultra-rapid-acting insulin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.77734375,
            "text": "MannKind Corporation started developing its ultra-rapid-acting insulin Afrezza in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.796875,
            "text": "MannKind Corporation started developing its ultra-rapid-acting insulin Afrezza in a bold bid, probably",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.21875,
            "end_logit": -4.15234375,
            "text": "Sanofi",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.27734375,
            "text": "tion started",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.71875,
            "text": "tion started developing its ultra-rapid-acting insulin Afrezza in a",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.7578125,
            "text": "tion started developing its ultra-rapid-acting insulin",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.77734375,
            "text": "tion started developing its ultra-rapid-acting insulin Afrezza in",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.77734375,
            "text": "tion started developing its ultra-rapid-acting insulin Afrezza in a bold bid, probably by managing the issues in which Exubera",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_1": [
        {
            "start_logit": 7.58203125,
            "end_logit": 3.759765625,
            "text": "Nox1",
            "probability": 0.849609375
        },
        {
            "start_logit": 7.58203125,
            "end_logit": 1.826171875,
            "text": "Nox1 oxidase",
            "probability": 0.1224365234375
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -0.112060546875,
            "text": "Nox",
            "probability": 0.01763916015625
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -1.0625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1)",
            "probability": 0.00682830810546875
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -2.400390625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit",
            "probability": 0.0017881393432617188
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -3.84375,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox",
            "probability": 0.0004229545593261719
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -4.82421875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47",
            "probability": 0.00015866756439208984
        },
        {
            "start_logit": 3.673828125,
            "end_logit": -1.0625,
            "text": "Nox organizing subunit 1 (NoxO1)",
            "probability": 0.0001367330551147461
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -5.01171875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1",
            "probability": 0.00013148784637451172
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -5.0703125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox",
            "probability": 0.00012445449829101562
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -5.61328125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1",
            "probability": 7.206201553344727e-05
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -6.12890625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing",
            "probability": 4.303455352783203e-05
        },
        {
            "start_logit": 3.673828125,
            "end_logit": -2.400390625,
            "text": "Nox organizing subunit",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -6.48828125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox)",
            "probability": 3.0040740966796875e-05
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -6.6328125,
            "text": "Nox1 oxidase,",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -6.85546875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (Nox",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -6.875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox), respectively",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": 3.673828125,
            "end_logit": -3.84375,
            "text": "Nox",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": 3.673828125,
            "end_logit": -4.82421875,
            "text": "Nox organizing subunit 1 (NoxO1) or p47",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 3.673828125,
            "end_logit": -5.01171875,
            "text": "Nox organizing subunit 1",
            "probability": 2.6226043701171875e-06
        }
    ],
    "58a5a51060087bc10a000021_2": [
        {
            "start_logit": 7.05078125,
            "end_logit": 6.87890625,
            "text": "Noxa1",
            "probability": 0.669921875
        },
        {
            "start_logit": 7.05078125,
            "end_logit": 5.5,
            "text": "Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 0.1680908203125
        },
        {
            "start_logit": 7.00390625,
            "end_logit": 5.5,
            "text": "Nox1",
            "probability": 0.1602783203125
        },
        {
            "start_logit": 7.05078125,
            "end_logit": 0.071533203125,
            "text": "Noxa1 and the superoxide-producing activity of Nox",
            "probability": 0.0007395744323730469
        },
        {
            "start_logit": 7.00390625,
            "end_logit": 0.071533203125,
            "text": "Nox",
            "probability": 0.000705718994140625
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -0.5166015625,
            "text": "Nox",
            "probability": 0.00041174888610839844
        },
        {
            "start_logit": -2.12109375,
            "end_logit": 6.87890625,
            "text": "a1",
            "probability": 6.961822509765625e-05
        },
        {
            "start_logit": -2.431640625,
            "end_logit": 6.87890625,
            "text": "Noxo1 at threonine 341 regulates its interaction with Noxa1",
            "probability": 5.0961971282958984e-05
        },
        {
            "start_logit": -2.12109375,
            "end_logit": 5.5,
            "text": "a1 and the superoxide-producing activity of Nox1",
            "probability": 1.7583370208740234e-05
        },
        {
            "start_logit": -2.431640625,
            "end_logit": 5.5,
            "text": "Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 1.2874603271484375e-05
        },
        {
            "start_logit": -3.841796875,
            "end_logit": 5.5,
            "text": "1",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -5.8671875,
            "text": "Noxa1 and the superoxide-producing activity of Nox1.",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 7.00390625,
            "end_logit": -5.8671875,
            "text": "Nox1.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -6.9921875,
            "text": "Noxa1 and the superoxide",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.5,
            "end_logit": 5.5,
            "text": "superoxide-producing activity of Nox1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 6.87890625,
            "text": "of Noxo1 at threonine 341 regulates its interaction with Noxa1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 6.87890625,
            "text": "with Noxa1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 6.87890625,
            "text": "Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 6.87890625,
            "text": "interaction with Noxa1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 6.87890625,
            "text": "o1 at threonine 341 regulates its interaction with Noxa1",
            "probability": 3.5762786865234375e-07
        }
    ],
    "58a5a51060087bc10a000021_3": [
        {
            "start_logit": 6.41015625,
            "end_logit": 2.544921875,
            "text": "Nox1",
            "probability": 0.95947265625
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -1.384765625,
            "text": "Nox",
            "probability": 0.01885986328125
        },
        {
            "start_logit": 2.6328125,
            "end_logit": 2.267578125,
            "text": "Noxa1",
            "probability": 0.016632080078125
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -3.7265625,
            "text": "Nox1, a member of the Nox",
            "probability": 0.0018167495727539062
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -4.53125,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 0.000812530517578125
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -4.53125,
            "text": "Nox1, a member of the Nox family",
            "probability": 0.000812530517578125
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -5.21484375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1",
            "probability": 0.00041031837463378906
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -5.99609375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox",
            "probability": 0.00018775463104248047
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.08203125,
            "text": "Nox1, a",
            "probability": 0.0001722574234008789
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.140625,
            "text": "Nox1, a member of the Nox family NAPDH",
            "probability": 0.00016188621520996094
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.2265625,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 0.00014972686767578125
        },
        {
            "start_logit": -2.42578125,
            "end_logit": 2.544921875,
            "text": "Superoxide production by Nox1",
            "probability": 0.00013959407806396484
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.328125,
            "text": "Nox1, a member of the Nox family NAP",
            "probability": 0.0001342296600341797
        },
        {
            "start_logit": -2.474609375,
            "end_logit": 2.267578125,
            "text": "Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 0.00010132789611816406
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.67578125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 9.518861770629883e-05
        },
        {
            "start_logit": -3.09375,
            "end_logit": 2.267578125,
            "text": "Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 5.424022674560547e-05
        },
        {
            "start_logit": -3.4375,
            "end_logit": 2.267578125,
            "text": "NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 3.844499588012695e-05
        },
        {
            "start_logit": 2.6328125,
            "end_logit": -4.40625,
            "text": "Nox",
            "probability": 2.104043960571289e-05
        },
        {
            "start_logit": -4.66796875,
            "end_logit": 2.267578125,
            "text": "Nox organizer 1) and Noxa1",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": -5.12109375,
            "end_logit": 2.267578125,
            "text": "DH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 7.152557373046875e-06
        }
    ],
    "58a5a51060087bc10a000021_4": [
        {
            "start_logit": 7.46484375,
            "end_logit": 6.875,
            "text": "Nox1",
            "probability": 0.181396484375
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 6.80078125,
            "text": "Nox1",
            "probability": 0.1717529296875
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 6.72265625,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 0.1551513671875
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 6.80078125,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.1480712890625
        },
        {
            "start_logit": 7.39453125,
            "end_logit": 6.72265625,
            "text": "Nox1",
            "probability": 0.1446533203125
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 6.36328125,
            "text": "Nox1",
            "probability": 0.0955810546875
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 6.36328125,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 0.055328369140625
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 5.78515625,
            "text": "Noxa1",
            "probability": 0.0310211181640625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 3.888671875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1",
            "probability": 0.00931549072265625
        },
        {
            "start_logit": 3.630859375,
            "end_logit": 6.875,
            "text": "Noxo1 is phosphorylated in both resting and PMA-stimulated cells, and the phosphorylation probably participates in a PMA-independent constitutive activity of Nox1",
            "probability": 0.00391387939453125
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 1.1083984375,
            "text": "Nox",
            "probability": 0.0004978179931640625
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 0.9267578125,
            "text": "Nox",
            "probability": 0.00047135353088378906
        },
        {
            "start_logit": 1.4892578125,
            "end_logit": 6.80078125,
            "text": "Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.00042557716369628906
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 0.75390625,
            "text": "Nox",
            "probability": 0.0004062652587890625
        },
        {
            "start_logit": 4.22265625,
            "end_logit": 3.888671875,
            "text": "Nox1",
            "probability": 0.00035572052001953125
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 0.62646484375,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox",
            "probability": 0.0003502368927001953
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 0.75390625,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox",
            "probability": 0.0003502368927001953
        },
        {
            "start_logit": 7.39453125,
            "end_logit": 0.62646484375,
            "text": "Nox",
            "probability": 0.00032639503479003906
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 0.4638671875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1-catalyzed superoxide production. Furthermore, Ser154 in Noxo1",
            "probability": 0.0003044605255126953
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 1.1083984375,
            "text": "Noxa1, an interaction that participates in Nox",
            "probability": 0.0002892017364501953
        }
    ],
    "58a5a51060087bc10a000021_5": [
        {
            "start_logit": 7.46484375,
            "end_logit": 6.875,
            "text": "Nox1",
            "probability": 0.181396484375
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 6.80078125,
            "text": "Nox1",
            "probability": 0.1717529296875
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 6.72265625,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 0.1551513671875
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 6.80078125,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.1480712890625
        },
        {
            "start_logit": 7.39453125,
            "end_logit": 6.72265625,
            "text": "Nox1",
            "probability": 0.1446533203125
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 6.36328125,
            "text": "Nox1",
            "probability": 0.0955810546875
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 6.36328125,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 0.055328369140625
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 5.78515625,
            "text": "Noxa1",
            "probability": 0.0310211181640625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 3.888671875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1",
            "probability": 0.00931549072265625
        },
        {
            "start_logit": 3.630859375,
            "end_logit": 6.875,
            "text": "Noxo1 is phosphorylated in both resting and PMA-stimulated cells, and the phosphorylation probably participates in a PMA-independent constitutive activity of Nox1",
            "probability": 0.00391387939453125
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 1.1083984375,
            "text": "Nox",
            "probability": 0.0004978179931640625
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 0.9267578125,
            "text": "Nox",
            "probability": 0.00047135353088378906
        },
        {
            "start_logit": 1.4892578125,
            "end_logit": 6.80078125,
            "text": "Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.00042557716369628906
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 0.75390625,
            "text": "Nox",
            "probability": 0.0004062652587890625
        },
        {
            "start_logit": 4.22265625,
            "end_logit": 3.888671875,
            "text": "Nox1",
            "probability": 0.00035572052001953125
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 0.62646484375,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox",
            "probability": 0.0003502368927001953
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 0.75390625,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox",
            "probability": 0.0003502368927001953
        },
        {
            "start_logit": 7.39453125,
            "end_logit": 0.62646484375,
            "text": "Nox",
            "probability": 0.00032639503479003906
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 0.4638671875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1-catalyzed superoxide production. Furthermore, Ser154 in Noxo1",
            "probability": 0.0003044605255126953
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 1.1083984375,
            "text": "Noxa1, an interaction that participates in Nox",
            "probability": 0.0002892017364501953
        }
    ],
    "58a5a51060087bc10a000021_6": [
        {
            "start_logit": 7.46484375,
            "end_logit": 6.875,
            "text": "Nox1",
            "probability": 0.181396484375
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 6.80078125,
            "text": "Nox1",
            "probability": 0.1717529296875
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 6.72265625,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 0.1551513671875
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 6.80078125,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.1480712890625
        },
        {
            "start_logit": 7.39453125,
            "end_logit": 6.72265625,
            "text": "Nox1",
            "probability": 0.1446533203125
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 6.36328125,
            "text": "Nox1",
            "probability": 0.0955810546875
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 6.36328125,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 0.055328369140625
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 5.78515625,
            "text": "Noxa1",
            "probability": 0.0310211181640625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 3.888671875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1",
            "probability": 0.00931549072265625
        },
        {
            "start_logit": 3.630859375,
            "end_logit": 6.875,
            "text": "Noxo1 is phosphorylated in both resting and PMA-stimulated cells, and the phosphorylation probably participates in a PMA-independent constitutive activity of Nox1",
            "probability": 0.00391387939453125
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 1.1083984375,
            "text": "Nox",
            "probability": 0.0004978179931640625
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 0.9267578125,
            "text": "Nox",
            "probability": 0.00047135353088378906
        },
        {
            "start_logit": 1.4892578125,
            "end_logit": 6.80078125,
            "text": "Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.00042557716369628906
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 0.75390625,
            "text": "Nox",
            "probability": 0.0004062652587890625
        },
        {
            "start_logit": 4.22265625,
            "end_logit": 3.888671875,
            "text": "Nox1",
            "probability": 0.00035572052001953125
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 0.62646484375,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox",
            "probability": 0.0003502368927001953
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 0.75390625,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox",
            "probability": 0.0003502368927001953
        },
        {
            "start_logit": 7.39453125,
            "end_logit": 0.62646484375,
            "text": "Nox",
            "probability": 0.00032639503479003906
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 0.4638671875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1-catalyzed superoxide production. Furthermore, Ser154 in Noxo1",
            "probability": 0.0003044605255126953
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 1.1083984375,
            "text": "Noxa1, an interaction that participates in Nox",
            "probability": 0.0002892017364501953
        }
    ],
    "58a5a51060087bc10a000021_7": [
        {
            "start_logit": 7.46484375,
            "end_logit": 6.875,
            "text": "Nox1",
            "probability": 0.181396484375
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 6.80078125,
            "text": "Nox1",
            "probability": 0.1717529296875
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 6.72265625,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 0.1551513671875
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 6.80078125,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.1480712890625
        },
        {
            "start_logit": 7.39453125,
            "end_logit": 6.72265625,
            "text": "Nox1",
            "probability": 0.1446533203125
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 6.36328125,
            "text": "Nox1",
            "probability": 0.0955810546875
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 6.36328125,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 0.055328369140625
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 5.78515625,
            "text": "Noxa1",
            "probability": 0.0310211181640625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 3.888671875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1",
            "probability": 0.00931549072265625
        },
        {
            "start_logit": 3.630859375,
            "end_logit": 6.875,
            "text": "Noxo1 is phosphorylated in both resting and PMA-stimulated cells, and the phosphorylation probably participates in a PMA-independent constitutive activity of Nox1",
            "probability": 0.00391387939453125
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 1.1083984375,
            "text": "Nox",
            "probability": 0.0004978179931640625
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 0.9267578125,
            "text": "Nox",
            "probability": 0.00047135353088378906
        },
        {
            "start_logit": 1.4892578125,
            "end_logit": 6.80078125,
            "text": "Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.00042557716369628906
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 0.75390625,
            "text": "Nox",
            "probability": 0.0004062652587890625
        },
        {
            "start_logit": 4.22265625,
            "end_logit": 3.888671875,
            "text": "Nox1",
            "probability": 0.00035572052001953125
        },
        {
            "start_logit": 7.46484375,
            "end_logit": 0.62646484375,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox",
            "probability": 0.0003502368927001953
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 0.75390625,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox",
            "probability": 0.0003502368927001953
        },
        {
            "start_logit": 7.39453125,
            "end_logit": 0.62646484375,
            "text": "Nox",
            "probability": 0.00032639503479003906
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 0.4638671875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1-catalyzed superoxide production. Furthermore, Ser154 in Noxo1",
            "probability": 0.0003044605255126953
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 1.1083984375,
            "text": "Noxa1, an interaction that participates in Nox",
            "probability": 0.0002892017364501953
        }
    ],
    "58a5a51060087bc10a000021_8": [
        {
            "start_logit": 7.22265625,
            "end_logit": 6.8671875,
            "text": "Nox1",
            "probability": 0.9970703125
        },
        {
            "start_logit": 7.22265625,
            "end_logit": 0.95947265625,
            "text": "Nox",
            "probability": 0.00269317626953125
        },
        {
            "start_logit": -1.0927734375,
            "end_logit": 6.8671875,
            "text": "Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 0.0002428293228149414
        },
        {
            "start_logit": -2.08984375,
            "end_logit": 6.8671875,
            "text": "1",
            "probability": 9.006261825561523e-05
        },
        {
            "start_logit": -2.869140625,
            "end_logit": 6.8671875,
            "text": "154 appears to regulate Nox1",
            "probability": 4.124641418457031e-05
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -5.36328125,
            "text": "Nox1 activity in different manners.",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 6.8671875,
            "text": "of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -5.6796875,
            "end_logit": 6.8671875,
            "text": "Ser154 appears to regulate Nox1",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -5.75,
            "end_logit": 6.8671875,
            "text": "341 and at Ser154 appears to regulate Nox1",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -6.09765625,
            "end_logit": 6.8671875,
            "text": "phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 6.8671875,
            "text": "Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 6.8671875,
            "text": "regulate Nox1",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 6.8671875,
            "text": "Thus phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 6.8671875,
            "text": "appears to regulate Nox1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.27734375,
            "text": "Nox1 activity in different",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.0927734375,
            "end_logit": 0.95947265625,
            "text": "Noxo1 at Thr341 and at Ser154 appears to regulate Nox",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 6.8671875,
            "text": "o1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.22265625,
            "end_logit": -7.62890625,
            "text": "Nox1 activity in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 6.8671875,
            "text": "4 appears to regulate Nox1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -2.869140625,
            "end_logit": 0.95947265625,
            "text": "154 appears to regulate Nox",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58a5a51060087bc10a000021_9": [
        {
            "start_logit": 5.91796875,
            "end_logit": 3.650390625,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47",
            "probability": 0.47705078125
        },
        {
            "start_logit": 5.890625,
            "end_logit": 3.650390625,
            "text": "p47",
            "probability": 0.46240234375
        },
        {
            "start_logit": 5.91796875,
            "end_logit": 1.111328125,
            "text": "Nox1",
            "probability": 0.03765869140625
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -0.60791015625,
            "text": "Nox",
            "probability": 0.0067291259765625
        },
        {
            "start_logit": 1.3515625,
            "end_logit": 3.650390625,
            "text": "gp91(phox)/Nox2 and Nox1 is known to absolutely require both an organizer protein (p47",
            "probability": 0.004940032958984375
        },
        {
            "start_logit": 1.14453125,
            "end_logit": 3.650390625,
            "text": "Nox2 and Nox1 is known to absolutely require both an organizer protein (p47",
            "probability": 0.004032135009765625
        },
        {
            "start_logit": 5.890625,
            "end_logit": -1.69140625,
            "text": "p47(phox) or Noxo1) andanactivatorprotein (p67(phox) or Noxa1",
            "probability": 0.0022182464599609375
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -2.103515625,
            "text": "Nox1 is known to absolutely require both an organizer protein (p4",
            "probability": 0.001506805419921875
        },
        {
            "start_logit": 5.890625,
            "end_logit": -2.103515625,
            "text": "p4",
            "probability": 0.0014715194702148438
        },
        {
            "start_logit": 1.3515625,
            "end_logit": 1.111328125,
            "text": "gp91(phox)/Nox2 and Nox1",
            "probability": 0.00039005279541015625
        },
        {
            "start_logit": 1.14453125,
            "end_logit": 1.111328125,
            "text": "Nox2 and Nox1",
            "probability": 0.00031828880310058594
        },
        {
            "start_logit": -1.6640625,
            "end_logit": 3.650390625,
            "text": "Nox enzymes such as gp91(phox)/Nox2 and Nox1 is known to absolutely require both an organizer protein (p47",
            "probability": 0.00024211406707763672
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -4.39453125,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47(phox)",
            "probability": 0.00015282630920410156
        },
        {
            "start_logit": 5.890625,
            "end_logit": -4.39453125,
            "text": "p47(phox)",
            "probability": 0.0001480579376220703
        },
        {
            "start_logit": -2.431640625,
            "end_logit": 3.650390625,
            "text": "91(phox)/Nox2 and Nox1 is known to absolutely require both an organizer protein (p47",
            "probability": 0.00011265277862548828
        },
        {
            "start_logit": 5.890625,
            "end_logit": -4.72265625,
            "text": "p47(phox) or Noxo1) andanactivatorprotein (p67",
            "probability": 0.00010663270950317383
        },
        {
            "start_logit": 5.890625,
            "end_logit": -4.90234375,
            "text": "p47(phox) or Noxo1) andanactivatorprotein (p67(phox) or Nox",
            "probability": 8.982419967651367e-05
        },
        {
            "start_logit": 1.3515625,
            "end_logit": -0.60791015625,
            "text": "gp91(phox)/Nox2 and Nox",
            "probability": 6.99162483215332e-05
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -5.30078125,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47(phox",
            "probability": 6.16908073425293e-05
        },
        {
            "start_logit": 5.890625,
            "end_logit": -5.30078125,
            "text": "p47(phox",
            "probability": 5.984306335449219e-05
        }
    ],
    "58a5a51060087bc10a000021_10": [
        {
            "start_logit": 7.17578125,
            "end_logit": 7.0546875,
            "text": "NOXA1",
            "probability": 0.224609375
        },
        {
            "start_logit": 7.3203125,
            "end_logit": 6.88671875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1",
            "probability": 0.2176513671875
        },
        {
            "start_logit": 7.3203125,
            "end_logit": 6.78125,
            "text": "NOX1",
            "probability": 0.1966552734375
        },
        {
            "start_logit": 7.03125,
            "end_logit": 7.0546875,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 0.1934814453125
        },
        {
            "start_logit": 7.03125,
            "end_logit": 6.88671875,
            "text": "NOXA1",
            "probability": 0.164306640625
        },
        {
            "start_logit": 1.931640625,
            "end_logit": 7.0546875,
            "text": "NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 0.001178741455078125
        },
        {
            "start_logit": 1.931640625,
            "end_logit": 6.88671875,
            "text": "NOXO1 and NOXA1",
            "probability": 0.00099945068359375
        },
        {
            "start_logit": 7.3203125,
            "end_logit": 0.18603515625,
            "text": "NOX",
            "probability": 0.00026917457580566406
        },
        {
            "start_logit": 7.17578125,
            "end_logit": -0.139892578125,
            "text": "NOX",
            "probability": 0.0001678466796875
        },
        {
            "start_logit": 7.03125,
            "end_logit": -0.139892578125,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOX",
            "probability": 0.00014519691467285156
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -0.5712890625,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOX",
            "probability": 0.00012612342834472656
        },
        {
            "start_logit": 7.03125,
            "end_logit": -0.5712890625,
            "text": "NOX",
            "probability": 9.447336196899414e-05
        },
        {
            "start_logit": -1.4248046875,
            "end_logit": 7.0546875,
            "text": "A1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 4.094839096069336e-05
        },
        {
            "start_logit": -1.5517578125,
            "end_logit": 7.0546875,
            "text": "A1",
            "probability": 3.612041473388672e-05
        },
        {
            "start_logit": -1.4248046875,
            "end_logit": 6.88671875,
            "text": "A1",
            "probability": 3.4749507904052734e-05
        },
        {
            "start_logit": -2.1953125,
            "end_logit": 6.88671875,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": -2.1953125,
            "end_logit": 6.78125,
            "text": "1",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": 7.17578125,
            "end_logit": -3.560546875,
            "text": "NOXA1.",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 7.03125,
            "end_logit": -3.560546875,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1.",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -4.9453125,
            "text": "NOX1 was absolutely required for activation with NOXO1",
            "probability": 1.6093254089355469e-06
        }
    ],
    "58a5a51060087bc10a000021_11": [
        {
            "start_logit": 6.01171875,
            "end_logit": 1.0615234375,
            "text": "Nox1",
            "probability": 0.475830078125
        },
        {
            "start_logit": 5.84765625,
            "end_logit": 1.0615234375,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 0.40380859375
        },
        {
            "start_logit": 6.01171875,
            "end_logit": -1.5,
            "text": "Nox1.",
            "probability": 0.03668212890625
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -1.5,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1.",
            "probability": 0.0311279296875
        },
        {
            "start_logit": 6.01171875,
            "end_logit": -2.00390625,
            "text": "Nox",
            "probability": 0.0221710205078125
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -2.00390625,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox",
            "probability": 0.0188140869140625
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -2.919921875,
            "text": "NADPH oxidase Organizer 1",
            "probability": 0.00751495361328125
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -4.44140625,
            "text": "NADPH",
            "probability": 0.0016431808471679688
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -5.265625,
            "text": "NADPH oxidase",
            "probability": 0.000720977783203125
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -5.3046875,
            "text": "NADPH oxidase Organizer 1 (NoxO1",
            "probability": 0.0006933212280273438
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -5.875,
            "text": "NADPH oxidase Organize",
            "probability": 0.00039196014404296875
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -6.09765625,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH",
            "probability": 0.00031375885009765625
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -6.50390625,
            "text": "NADPH oxidase Organizer",
            "probability": 0.00020897388458251953
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.609375,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.70703125,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region",
            "probability": 6.252527236938477e-05
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.75390625,
            "text": "NADPH oxidase Organizer 1 (Nox",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.765625,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.87890625,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to",
            "probability": 5.263090133666992e-05
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -8.1171875,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the",
            "probability": 4.166364669799805e-05
        },
        {
            "start_logit": -3.453125,
            "end_logit": 1.0615234375,
            "text": "shown to interact with the NADPH-binding region of Nox1",
            "probability": 3.6776065826416016e-05
        }
    ],
    "58a5a51060087bc10a000021_12": [
        {
            "start_logit": 5.77734375,
            "end_logit": 5.84765625,
            "text": "Noxa1",
            "probability": 0.8134765625
        },
        {
            "start_logit": 4.25390625,
            "end_logit": 5.84765625,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 0.1773681640625
        },
        {
            "start_logit": 5.77734375,
            "end_logit": 0.79638671875,
            "text": "Noxa1.",
            "probability": 0.00521087646484375
        },
        {
            "start_logit": 4.25390625,
            "end_logit": 0.82421875,
            "text": "Nox1",
            "probability": 0.0011663436889648438
        },
        {
            "start_logit": 4.25390625,
            "end_logit": 0.79638671875,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1.",
            "probability": 0.0011358261108398438
        },
        {
            "start_logit": -0.80029296875,
            "end_logit": 5.84765625,
            "text": "Noxo1 and Noxa1",
            "probability": 0.0011310577392578125
        },
        {
            "start_logit": -2.126953125,
            "end_logit": 5.84765625,
            "text": "p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 0.00029969215393066406
        },
        {
            "start_logit": 5.77734375,
            "end_logit": -2.88671875,
            "text": "Nox",
            "probability": 0.0001308917999267578
        },
        {
            "start_logit": -3.111328125,
            "end_logit": 5.84765625,
            "text": "NADPH oxidase Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 0.00011199712753295898
        },
        {
            "start_logit": -3.400390625,
            "end_logit": 5.84765625,
            "text": "a1",
            "probability": 8.386373519897461e-05
        },
        {
            "start_logit": 4.25390625,
            "end_logit": -2.88671875,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Nox",
            "probability": 2.855062484741211e-05
        },
        {
            "start_logit": 4.25390625,
            "end_logit": -2.9609375,
            "text": "Nox",
            "probability": 2.664327621459961e-05
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 5.84765625,
            "text": "and Noxa1",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": -5.67578125,
            "end_logit": 5.84765625,
            "text": "superoxide-producing NADPH oxidase Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": -0.80029296875,
            "end_logit": 0.79638671875,
            "text": "Noxo1 and Noxa1.",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -6.1875,
            "end_logit": 5.84765625,
            "text": "proteins Noxo1 and Noxa1",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 4.25390625,
            "end_logit": -4.765625,
            "text": "Nox1,",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 5.84765625,
            "text": "1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -6.640625,
            "end_logit": 5.84765625,
            "text": "o1 and Noxa1",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 5.84765625,
            "text": "2(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 3.039836883544922e-06
        }
    ],
    "58a5a51060087bc10a000021_13": [
        {
            "start_logit": 7.5625,
            "end_logit": 5.32421875,
            "text": "NADPH oxidase 1",
            "probability": 0.9462890625
        },
        {
            "start_logit": 7.5625,
            "end_logit": 2.4375,
            "text": "NADPH oxidase",
            "probability": 0.05255126953125
        },
        {
            "start_logit": 7.5625,
            "end_logit": -2.458984375,
            "text": "NADPH",
            "probability": 0.00039196014404296875
        },
        {
            "start_logit": -0.634765625,
            "end_logit": 5.32421875,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 0.0002589225769042969
        },
        {
            "start_logit": 7.5625,
            "end_logit": -5.265625,
            "text": "NADPH oxidase 1 assembly and activation.",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": -0.634765625,
            "end_logit": 2.4375,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": -4.3203125,
            "end_logit": 5.32421875,
            "text": "1",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -7.86328125,
            "text": "NADPH oxidase 1 assembly and",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -7.8828125,
            "text": "NADPH oxidase 1 assembly and activation",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -5.9453125,
            "end_logit": 5.32421875,
            "text": "oxidase 1",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 5.32421875,
            "text": "on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.078125,
            "end_logit": 5.32421875,
            "text": "optimal NADPH oxidase 1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 5.32421875,
            "text": "O1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 5.32421875,
            "text": "phosphorylation on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 5.32421875,
            "text": "is critical for optimal NADPH oxidase 1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 5.32421875,
            "text": "serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.634765625,
            "end_logit": -2.458984375,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.9453125,
            "end_logit": 2.4375,
            "text": "oxidase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 2.4375,
            "text": "on serine 154 is critical for optimal NADPH oxidase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.078125,
            "end_logit": 2.4375,
            "text": "optimal NADPH oxidase",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_14": [
        {
            "start_logit": 5.5234375,
            "end_logit": 1.7138671875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1.",
            "probability": 0.452392578125
        },
        {
            "start_logit": 5.5234375,
            "end_logit": 1.4677734375,
            "text": "Nox1",
            "probability": 0.353515625
        },
        {
            "start_logit": 5.5234375,
            "end_logit": 0.8310546875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 0.18701171875
        },
        {
            "start_logit": 0.58544921875,
            "end_logit": 1.7138671875,
            "text": "Noxa1.",
            "probability": 0.0032444000244140625
        },
        {
            "start_logit": 5.5234375,
            "end_logit": -3.630859375,
            "text": "Nox",
            "probability": 0.0021610260009765625
        },
        {
            "start_logit": 0.58544921875,
            "end_logit": 0.8310546875,
            "text": "Noxa1",
            "probability": 0.0013418197631835938
        },
        {
            "start_logit": 5.5234375,
            "end_logit": -5.91796875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Nox",
            "probability": 0.00021898746490478516
        },
        {
            "start_logit": 5.5234375,
            "end_logit": -7.21484375,
            "text": "Nox1 requires both the organizer",
            "probability": 5.990266799926758e-05
        },
        {
            "start_logit": 5.5234375,
            "end_logit": -7.359375,
            "text": "Nox1 requires both the organizer protein Noxo1",
            "probability": 5.161762237548828e-05
        },
        {
            "start_logit": 5.5234375,
            "end_logit": -7.57421875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the",
            "probability": 4.184246063232422e-05
        },
        {
            "start_logit": -3.802734375,
            "end_logit": 1.7138671875,
            "text": ".",
            "probability": 4.017353057861328e-05
        },
        {
            "start_logit": 5.5234375,
            "end_logit": -7.6328125,
            "text": "Nox1 requires both the organizer protein",
            "probability": 3.9577484130859375e-05
        },
        {
            "start_logit": 5.5234375,
            "end_logit": -7.8515625,
            "text": "Nox1 requires",
            "probability": 3.1828880310058594e-05
        },
        {
            "start_logit": 5.5234375,
            "end_logit": -7.890625,
            "text": "Nox1 requires both the organize",
            "probability": 3.0338764190673828e-05
        },
        {
            "start_logit": 5.5234375,
            "end_logit": -7.92578125,
            "text": "Nox1 requires both the organizer protein Noxo1 and",
            "probability": 2.9385089874267578e-05
        },
        {
            "start_logit": -4.4609375,
            "end_logit": 1.7138671875,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1.",
            "probability": 2.086162567138672e-05
        },
        {
            "start_logit": -4.4609375,
            "end_logit": 1.4677734375,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -4.97265625,
            "end_logit": 1.7138671875,
            "text": "superoxide-producing NADPH oxidase Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1.",
            "probability": 1.245737075805664e-05
        },
        {
            "start_logit": -5.0078125,
            "end_logit": 1.7138671875,
            "text": "NADPH oxidase Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1.",
            "probability": 1.2099742889404297e-05
        },
        {
            "start_logit": -5.08203125,
            "end_logit": 1.7138671875,
            "text": "Noxo1 and the activator protein Noxa1.",
            "probability": 1.1146068572998047e-05
        }
    ],
    "58a5a51060087bc10a000021_15": [
        {
            "start_logit": 7.82421875,
            "end_logit": 6.95703125,
            "text": "NOX1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -0.033355712890625,
            "text": "NOX",
            "probability": 0.0009179115295410156
        },
        {
            "start_logit": -2.876953125,
            "end_logit": 6.95703125,
            "text": "1",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": 1.4794921875,
            "end_logit": 1.31640625,
            "text": "NOXA1",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -5.16015625,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -5.19921875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -5.9453125,
            "text": "NOX1, an NADPH oxidase",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.3515625,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.80859375,
            "text": "NOX1, an",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.04296875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.0546875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.1328125,
            "text": "NOX1, an NADPH oxidase homologue that is most",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.15625,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 1.4794921875,
            "end_logit": -2.12890625,
            "text": "NOXA1 (NOX activating protein 1), as well as the flavocytochrome component p22(phox) for maximal activity.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.69140625,
            "end_logit": 1.31640625,
            "text": "NOXO1 (NOX organizing protein 1) and NOXA1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.75,
            "end_logit": 1.31640625,
            "text": "NOX organizing protein 1) and NOXA1",
            "probability": 0.0
        },
        {
            "start_logit": -5.26171875,
            "end_logit": 1.31640625,
            "text": "and NOXA1",
            "probability": 0.0
        },
        {
            "start_logit": -5.7109375,
            "end_logit": 1.31640625,
            "text": "A1",
            "probability": 0.0
        },
        {
            "start_logit": 1.4794921875,
            "end_logit": -5.89453125,
            "text": "NOX",
            "probability": 0.0
        },
        {
            "start_logit": 1.4794921875,
            "end_logit": -6.19921875,
            "text": "NOXA1 (NOX activating protein 1), as well as the flavocytochrome",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_16": [
        {
            "start_logit": 5.578125,
            "end_logit": 4.0234375,
            "text": "Noxa1",
            "probability": 0.51708984375
        },
        {
            "start_logit": 6.8125,
            "end_logit": 2.55078125,
            "text": "Nox1",
            "probability": 0.405517578125
        },
        {
            "start_logit": 2.953125,
            "end_logit": 4.0234375,
            "text": "p47phox and p67phox, designated Noxo1 and Noxa1",
            "probability": 0.037445068359375
        },
        {
            "start_logit": 6.8125,
            "end_logit": -0.397216796875,
            "text": "Nox",
            "probability": 0.021331787109375
        },
        {
            "start_logit": 5.578125,
            "end_logit": 0.25,
            "text": "Noxa1, respectively.",
            "probability": 0.01187896728515625
        },
        {
            "start_logit": 6.8125,
            "end_logit": -2.533203125,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67",
            "probability": 0.0025272369384765625
        },
        {
            "start_logit": 2.953125,
            "end_logit": 0.25,
            "text": "p47phox and p67phox, designated Noxo1 and Noxa1, respectively.",
            "probability": 0.0008602142333984375
        },
        {
            "start_logit": 6.8125,
            "end_logit": -3.80078125,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox",
            "probability": 0.0007104873657226562
        },
        {
            "start_logit": 5.578125,
            "end_logit": -2.84765625,
            "text": "Nox",
            "probability": 0.0005364418029785156
        },
        {
            "start_logit": 6.8125,
            "end_logit": -4.25390625,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67phox",
            "probability": 0.0004515647888183594
        },
        {
            "start_logit": -1.6181640625,
            "end_logit": 4.0234375,
            "text": "Noxo1 and Noxa1",
            "probability": 0.0003876686096191406
        },
        {
            "start_logit": 6.8125,
            "end_logit": -4.62890625,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47",
            "probability": 0.0003104209899902344
        },
        {
            "start_logit": 6.8125,
            "end_logit": -4.7578125,
            "text": "Nox1, an oxidase that",
            "probability": 0.0002727508544921875
        },
        {
            "start_logit": 6.8125,
            "end_logit": -5.00390625,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p4",
            "probability": 0.00021338462829589844
        },
        {
            "start_logit": -2.52734375,
            "end_logit": 4.0234375,
            "text": "designated Noxo1 and Noxa1",
            "probability": 0.00015544891357421875
        },
        {
            "start_logit": 6.8125,
            "end_logit": -5.34375,
            "text": "Nox1, an",
            "probability": 0.0001518726348876953
        },
        {
            "start_logit": 6.8125,
            "end_logit": -5.390625,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47ph",
            "probability": 0.00014495849609375
        },
        {
            "start_logit": 6.8125,
            "end_logit": -5.43359375,
            "text": "Nox1, an oxidase",
            "probability": 0.00013935565948486328
        },
        {
            "start_logit": 6.8125,
            "end_logit": -5.61328125,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67ph",
            "probability": 0.00011551380157470703
        },
        {
            "start_logit": 6.8125,
            "end_logit": -6.3828125,
            "text": "Nox1, an oxidase that is likely involved in host defence",
            "probability": 5.370378494262695e-05
        }
    ],
    "58a5a51060087bc10a000021_17": [
        {
            "start_logit": 0.81982421875,
            "end_logit": -0.95556640625,
            "text": "NADPH oxidase",
            "probability": 0.52880859375
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -1.7958984375,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer 1.",
            "probability": 0.2281494140625
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -2.134765625,
            "text": "NADPH oxidase 1 with betaPix",
            "probability": 0.16259765625
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -3.5625,
            "text": "NADPH oxidase 1",
            "probability": 0.039031982421875
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -4.87890625,
            "text": "NADPH",
            "probability": 0.010467529296875
        },
        {
            "start_logit": -2.60546875,
            "end_logit": -1.7958984375,
            "text": ".",
            "probability": 0.00742340087890625
        },
        {
            "start_logit": -2.8828125,
            "end_logit": -1.7958984375,
            "text": "Nox Organizer 1.",
            "probability": 0.005626678466796875
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -5.7734375,
            "text": "NADPH oxidase 1 with betaPix and Nox",
            "probability": 0.00428009033203125
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -5.953125,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer 1",
            "probability": 0.0035762786865234375
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -6.1953125,
            "text": "NADPH oxidase 1 with beta",
            "probability": 0.0028076171875
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -6.6875,
            "text": "NADPH oxidase 1 with betaPi",
            "probability": 0.00171661376953125
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -6.83203125,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer",
            "probability": 0.0014848709106445312
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -7.2734375,
            "text": "NADPH oxidase 1 with betaPix and Nox Organize",
            "probability": 0.0009551048278808594
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -7.6015625,
            "text": "NADPH oxidase 1 with betaPix and",
            "probability": 0.0006875991821289062
        },
        {
            "start_logit": -6.0078125,
            "end_logit": -0.95556640625,
            "text": "Molecular interaction of NADPH oxidase",
            "probability": 0.00057220458984375
        },
        {
            "start_logit": 0.81982421875,
            "end_logit": -7.875,
            "text": "NADPH oxidase 1 with",
            "probability": 0.0005230903625488281
        },
        {
            "start_logit": -6.359375,
            "end_logit": -0.95556640625,
            "text": "of NADPH oxidase",
            "probability": 0.0004029273986816406
        },
        {
            "start_logit": -5.54296875,
            "end_logit": -1.7958984375,
            "text": "betaPix and Nox Organizer 1.",
            "probability": 0.0003933906555175781
        },
        {
            "start_logit": -6.515625,
            "end_logit": -0.95556640625,
            "text": "interaction of NADPH oxidase",
            "probability": 0.0003445148468017578
        },
        {
            "start_logit": -5.7265625,
            "end_logit": -1.7958984375,
            "text": "Organizer 1.",
            "probability": 0.0003273487091064453
        }
    ],
    "58a5a51060087bc10a000021_18": [
        {
            "start_logit": -1.029296875,
            "end_logit": 2.73828125,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1",
            "probability": 0.468505859375
        },
        {
            "start_logit": -1.1103515625,
            "end_logit": 2.73828125,
            "text": "NOXA1), and Rac1",
            "probability": 0.43212890625
        },
        {
            "start_logit": -3.158203125,
            "end_logit": 2.73828125,
            "text": "and Rac1",
            "probability": 0.05572509765625
        },
        {
            "start_logit": -4.625,
            "end_logit": 2.73828125,
            "text": "NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1",
            "probability": 0.012847900390625
        },
        {
            "start_logit": -5.48828125,
            "end_logit": 2.73828125,
            "text": "NOX activator 1 (NOXA1), and Rac1",
            "probability": 0.00540924072265625
        },
        {
            "start_logit": -5.57421875,
            "end_logit": 2.73828125,
            "text": "Rac1",
            "probability": 0.004962921142578125
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 2.73828125,
            "text": "NOXO1), NOX activator 1 (NOXA1), and Rac1",
            "probability": 0.0033855438232421875
        },
        {
            "start_logit": -6.05078125,
            "end_logit": 2.73828125,
            "text": "), and Rac1",
            "probability": 0.003082275390625
        },
        {
            "start_logit": -6.0546875,
            "end_logit": 2.73828125,
            "text": "component p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1",
            "probability": 0.003082275390625
        },
        {
            "start_logit": -6.078125,
            "end_logit": 2.73828125,
            "text": ", NOX activator 1 (NOXA1), and Rac1",
            "probability": 0.0030117034912109375
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 2.73828125,
            "text": "(NOXA1), and Rac1",
            "probability": 0.00267791748046875
        },
        {
            "start_logit": -6.34375,
            "end_logit": 2.73828125,
            "text": "A1), and Rac1",
            "probability": 0.002307891845703125
        },
        {
            "start_logit": -6.359375,
            "end_logit": 2.73828125,
            "text": "2(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1",
            "probability": 0.0022735595703125
        },
        {
            "start_logit": -1.029296875,
            "end_logit": -4.58984375,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1",
            "probability": 0.0003075599670410156
        },
        {
            "start_logit": -1.1103515625,
            "end_logit": -4.58984375,
            "text": "NOXA1",
            "probability": 0.0002846717834472656
        },
        {
            "start_logit": -1.029296875,
            "end_logit": -5.01171875,
            "text": "p22(PHOX)",
            "probability": 0.00020182132720947266
        },
        {
            "start_logit": -1.029296875,
            "end_logit": -5.328125,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX",
            "probability": 0.00014638900756835938
        },
        {
            "start_logit": -3.783203125,
            "end_logit": -3.099609375,
            "text": "NOX",
            "probability": 8.678436279296875e-05
        },
        {
            "start_logit": -1.029296875,
            "end_logit": -6.02734375,
            "text": "p22(PHOX",
            "probability": 7.30752944946289e-05
        },
        {
            "start_logit": -1.029296875,
            "end_logit": -6.265625,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOX",
            "probability": 5.733966827392578e-05
        }
    ],
    "58a5a51060087bc10a000021_19": [
        {
            "start_logit": 7.80078125,
            "end_logit": 6.76953125,
            "text": "NOX1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -0.054107666015625,
            "text": "NOX",
            "probability": 0.0010862350463867188
        },
        {
            "start_logit": -3.142578125,
            "end_logit": 6.76953125,
            "text": "1",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -5.41015625,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -5.69140625,
            "text": "NOX1, an NADPH oxidase",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -6.05078125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -6.46875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -6.90625,
            "text": "NOX1, an",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -6.93359375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.07421875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOX",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.19140625,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.203125,
            "text": "NOX1, an NADPH oxidase homologue that",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.23046875,
            "text": "NOX1,",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -0.2113037109375,
            "end_logit": 0.4765625,
            "text": "NOXA1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -4.328125,
            "end_logit": 0.4765625,
            "text": "NOXO1 (NOX organizing protein 1) and NOXA1",
            "probability": 0.0
        },
        {
            "start_logit": -5.0078125,
            "end_logit": 0.4765625,
            "text": "NOX organizing protein 1) and NOXA1",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": 0.4765625,
            "text": "and NOXA1",
            "probability": 0.0
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 0.4765625,
            "text": "A1",
            "probability": 0.0
        },
        {
            "start_logit": -6.046875,
            "end_logit": 0.4765625,
            "text": "subunits NOXO1 (NOX organizing protein 1) and NOXA1",
            "probability": 0.0
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 0.4765625,
            "text": "NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and NOXA1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_20": [
        {
            "start_logit": 4.8515625,
            "end_logit": 1.0126953125,
            "text": "Nox1",
            "probability": 0.5458984375
        },
        {
            "start_logit": 4.8515625,
            "end_logit": 0.80322265625,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 0.44384765625
        },
        {
            "start_logit": 0.32568359375,
            "end_logit": 0.80322265625,
            "text": "Noxa1",
            "probability": 0.00479888916015625
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -3.900390625,
            "text": "Nox",
            "probability": 0.004009246826171875
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -5.73046875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Nox",
            "probability": 0.0006437301635742188
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -7.4765625,
            "text": "Nox1 requires both the organizer protein Noxo1 and the",
            "probability": 0.00011283159255981445
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -7.55078125,
            "text": "Nox1 requires both the organizer",
            "probability": 0.0001043081283569336
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -7.6015625,
            "text": "Nox1 requires both the organizer protein Noxo1",
            "probability": 9.953975677490234e-05
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -7.82421875,
            "text": "Nox1 requires",
            "probability": 7.939338684082031e-05
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -7.89453125,
            "text": "Nox1 requires both the organizer protein",
            "probability": 7.396936416625977e-05
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -7.89453125,
            "text": "Nox1 requires both the organizer protein Noxo1 and",
            "probability": 7.396936416625977e-05
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -7.89453125,
            "text": "Nox1 requires both",
            "probability": 7.396936416625977e-05
        },
        {
            "start_logit": -4.12890625,
            "end_logit": 1.0126953125,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1",
            "probability": 6.842613220214844e-05
        },
        {
            "start_logit": 4.8515625,
            "end_logit": -8.03125,
            "text": "Nox1 requires both the organizer protein Nox",
            "probability": 6.431341171264648e-05
        },
        {
            "start_logit": -4.12890625,
            "end_logit": 0.80322265625,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 5.5849552154541016e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": 1.0126953125,
            "text": "superoxide-producing NADPH oxidase Nox1",
            "probability": 3.135204315185547e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": 0.80322265625,
            "text": "superoxide-producing NADPH oxidase Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 2.5391578674316406e-05
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 1.0126953125,
            "text": "NADPH oxidase Nox1",
            "probability": 2.4378299713134766e-05
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 0.80322265625,
            "text": "NADPH oxidase Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 1.990795135498047e-05
        },
        {
            "start_logit": -5.52734375,
            "end_logit": 0.80322265625,
            "text": "Noxo1 and the activator protein Noxa1",
            "probability": 1.3768672943115234e-05
        }
    ],
    "58a5a51060087bc10a000021_21": [
        {
            "start_logit": 3.712890625,
            "end_logit": 2.666015625,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 0.734375
        },
        {
            "start_logit": 3.712890625,
            "end_logit": 0.98974609375,
            "text": "Nox1",
            "probability": 0.137451171875
        },
        {
            "start_logit": 1.8388671875,
            "end_logit": 2.666015625,
            "text": "Noxa1",
            "probability": 0.11260986328125
        },
        {
            "start_logit": 3.712890625,
            "end_logit": -2.345703125,
            "text": "Nox",
            "probability": 0.004894256591796875
        },
        {
            "start_logit": -1.5693359375,
            "end_logit": 2.666015625,
            "text": "Noxo1 and Noxa1",
            "probability": 0.003734588623046875
        },
        {
            "start_logit": -1.7021484375,
            "end_logit": 2.666015625,
            "text": "p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 0.0032711029052734375
        },
        {
            "start_logit": -2.78125,
            "end_logit": 2.666015625,
            "text": "NADPH oxidase Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 0.0011129379272460938
        },
        {
            "start_logit": 3.712890625,
            "end_logit": -4.09375,
            "text": "Nox1,",
            "probability": 0.0008530616760253906
        },
        {
            "start_logit": 3.712890625,
            "end_logit": -4.359375,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Nox",
            "probability": 0.0006542205810546875
        },
        {
            "start_logit": -2.78125,
            "end_logit": 0.98974609375,
            "text": "NADPH oxidase Nox1",
            "probability": 0.00020754337310791016
        },
        {
            "start_logit": 3.712890625,
            "end_logit": -6.0546875,
            "text": "Nox1, complexed with p22(phox)",
            "probability": 0.00012004375457763672
        },
        {
            "start_logit": -5.15234375,
            "end_logit": 2.666015625,
            "text": "and Noxa1",
            "probability": 0.00010353326797485352
        },
        {
            "start_logit": 1.8388671875,
            "end_logit": -4.359375,
            "text": "Nox",
            "probability": 0.00010037422180175781
        },
        {
            "start_logit": -3.716796875,
            "end_logit": 0.98974609375,
            "text": "Activation of the non-phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 8.124113082885742e-05
        },
        {
            "start_logit": -5.453125,
            "end_logit": 2.666015625,
            "text": "proteins Noxo1 and Noxa1",
            "probability": 7.69495964050293e-05
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 2.666015625,
            "text": "superoxide-producing NADPH oxidase Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 7.05718994140625e-05
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 2.666015625,
            "text": "a1",
            "probability": 7.05718994140625e-05
        },
        {
            "start_logit": 3.712890625,
            "end_logit": -6.63671875,
            "text": "Nox1, complexed with p22(phox",
            "probability": 6.687641143798828e-05
        },
        {
            "start_logit": 3.712890625,
            "end_logit": -6.93359375,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1",
            "probability": 4.971027374267578e-05
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 2.666015625,
            "text": "o1 and Noxa1",
            "probability": 4.279613494873047e-05
        }
    ],
    "58a5a51060087bc10a000021_22": [
        {
            "start_logit": 1.638671875,
            "end_logit": 4.28515625,
            "text": "Nox1 activator 1, and Rac1",
            "probability": 0.87890625
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -1.0810546875,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 0.024261474609375
        },
        {
            "start_logit": 3.25,
            "end_logit": -1.0810546875,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 0.0205841064453125
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -1.357421875,
            "text": "Nox1",
            "probability": 0.0183868408203125
        },
        {
            "start_logit": 3.25,
            "end_logit": -1.357421875,
            "text": "NADPH oxidase 1 (Nox1",
            "probability": 0.015594482421875
        },
        {
            "start_logit": -3.0546875,
            "end_logit": 4.28515625,
            "text": "and Rac1",
            "probability": 0.00806427001953125
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -2.21484375,
            "text": "Nox",
            "probability": 0.007785797119140625
        },
        {
            "start_logit": 3.25,
            "end_logit": -2.21484375,
            "text": "NADPH oxidase 1 (Nox",
            "probability": 0.006633758544921875
        },
        {
            "start_logit": -3.49609375,
            "end_logit": 4.28515625,
            "text": "Nox organizer 1 (NOXO1), Nox1 activator 1, and Rac1",
            "probability": 0.00518798828125
        },
        {
            "start_logit": 1.638671875,
            "end_logit": -1.0810546875,
            "text": "Nox1",
            "probability": 0.004116058349609375
        },
        {
            "start_logit": -4.52734375,
            "end_logit": 4.28515625,
            "text": "p22(phox), Nox organizer 1 (NOXO1), Nox1 activator 1, and Rac1",
            "probability": 0.0018491744995117188
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 4.28515625,
            "text": "NOXO1), Nox1 activator 1, and Rac1",
            "probability": 0.0017232894897460938
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -3.818359375,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox",
            "probability": 0.0015687942504882812
        },
        {
            "start_logit": 3.25,
            "end_logit": -3.818359375,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox",
            "probability": 0.0013322830200195312
        },
        {
            "start_logit": -5.09375,
            "end_logit": 4.28515625,
            "text": "Rac1",
            "probability": 0.001049041748046875
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -4.69921875,
            "text": "Nox1)",
            "probability": 0.0006494522094726562
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -4.71484375,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox",
            "probability": 0.0006389617919921875
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 4.28515625,
            "text": ", Nox1 activator 1, and Rac1",
            "probability": 0.0005555152893066406
        },
        {
            "start_logit": 3.25,
            "end_logit": -4.69921875,
            "text": "NADPH oxidase 1 (Nox1)",
            "probability": 0.0005526542663574219
        },
        {
            "start_logit": 3.25,
            "end_logit": -4.71484375,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox",
            "probability": 0.0005445480346679688
        }
    ],
    "58a5a51060087bc10a000021_23": [
        {
            "start_logit": 1.638671875,
            "end_logit": 4.28515625,
            "text": "Nox1 activator 1, and Rac1",
            "probability": 0.87890625
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -1.0810546875,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 0.024261474609375
        },
        {
            "start_logit": 3.25,
            "end_logit": -1.0810546875,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 0.0205841064453125
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -1.357421875,
            "text": "Nox1",
            "probability": 0.0183868408203125
        },
        {
            "start_logit": 3.25,
            "end_logit": -1.357421875,
            "text": "NADPH oxidase 1 (Nox1",
            "probability": 0.015594482421875
        },
        {
            "start_logit": -3.0546875,
            "end_logit": 4.28515625,
            "text": "and Rac1",
            "probability": 0.00806427001953125
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -2.21484375,
            "text": "Nox",
            "probability": 0.007785797119140625
        },
        {
            "start_logit": 3.25,
            "end_logit": -2.21484375,
            "text": "NADPH oxidase 1 (Nox",
            "probability": 0.006633758544921875
        },
        {
            "start_logit": -3.49609375,
            "end_logit": 4.28515625,
            "text": "Nox organizer 1 (NOXO1), Nox1 activator 1, and Rac1",
            "probability": 0.00518798828125
        },
        {
            "start_logit": 1.638671875,
            "end_logit": -1.0810546875,
            "text": "Nox1",
            "probability": 0.004116058349609375
        },
        {
            "start_logit": -4.52734375,
            "end_logit": 4.28515625,
            "text": "p22(phox), Nox organizer 1 (NOXO1), Nox1 activator 1, and Rac1",
            "probability": 0.0018491744995117188
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 4.28515625,
            "text": "NOXO1), Nox1 activator 1, and Rac1",
            "probability": 0.0017232894897460938
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -3.818359375,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox",
            "probability": 0.0015687942504882812
        },
        {
            "start_logit": 3.25,
            "end_logit": -3.818359375,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox",
            "probability": 0.0013322830200195312
        },
        {
            "start_logit": -5.09375,
            "end_logit": 4.28515625,
            "text": "Rac1",
            "probability": 0.001049041748046875
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -4.69921875,
            "text": "Nox1)",
            "probability": 0.0006494522094726562
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -4.71484375,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox",
            "probability": 0.0006389617919921875
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 4.28515625,
            "text": ", Nox1 activator 1, and Rac1",
            "probability": 0.0005555152893066406
        },
        {
            "start_logit": 3.25,
            "end_logit": -4.69921875,
            "text": "NADPH oxidase 1 (Nox1)",
            "probability": 0.0005526542663574219
        },
        {
            "start_logit": 3.25,
            "end_logit": -4.71484375,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox",
            "probability": 0.0005445480346679688
        }
    ],
    "58a5a51060087bc10a000021_24": [
        {
            "start_logit": 6.64453125,
            "end_logit": 3.576171875,
            "text": "Nox1",
            "probability": 0.9873046875
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -1.75390625,
            "text": "Nox",
            "probability": 0.004791259765625
        },
        {
            "start_logit": 1.22265625,
            "end_logit": 3.576171875,
            "text": "Superoxide production by Nox1",
            "probability": 0.004360198974609375
        },
        {
            "start_logit": 1.5634765625,
            "end_logit": 2.1484375,
            "text": "Noxa1",
            "probability": 0.00147247314453125
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -3.6171875,
            "text": "Nox1, a member of the Nox",
            "probability": 0.0007433891296386719
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -4.828125,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 0.0002206563949584961
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -5.27734375,
            "text": "Nox1, a member of the Nox family",
            "probability": 0.00014138221740722656
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -5.72265625,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox",
            "probability": 9.059906005859375e-05
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -5.82421875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1",
            "probability": 8.183717727661133e-05
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -5.90234375,
            "text": "Nox1, a member of the Nox family NAPDH",
            "probability": 7.56978988647461e-05
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -6.22265625,
            "text": "Nox1, a member of the Nox family NAP",
            "probability": 5.4895877838134766e-05
        },
        {
            "start_logit": -1.77734375,
            "end_logit": 2.1484375,
            "text": "Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 5.239248275756836e-05
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -6.4296875,
            "text": "Nox1, a",
            "probability": 4.482269287109375e-05
        },
        {
            "start_logit": 6.64453125,
            "end_logit": -6.44921875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 4.380941390991211e-05
        },
        {
            "start_logit": -2.34375,
            "end_logit": 2.1484375,
            "text": "NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": 1.22265625,
            "end_logit": -1.75390625,
            "text": "Superoxide production by Nox",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": -3.546875,
            "end_logit": 2.1484375,
            "text": "Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 1.22265625,
            "end_logit": -3.6171875,
            "text": "Superoxide production by Nox1, a member of the Nox",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -6.01953125,
            "end_logit": 3.576171875,
            "text": "1",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -4.8515625,
            "end_logit": 2.1484375,
            "text": "Nox organizer 1) and Noxa1",
            "probability": 2.384185791015625e-06
        }
    ],
    "58a5a51060087bc10a000021_25": [
        {
            "start_logit": 4.2890625,
            "end_logit": 1.7080078125,
            "text": "NOX1",
            "probability": 0.66796875
        },
        {
            "start_logit": 4.2890625,
            "end_logit": 0.76123046875,
            "text": "NOX",
            "probability": 0.259521484375
        },
        {
            "start_logit": 1.5947265625,
            "end_logit": 1.7080078125,
            "text": "NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 0.045166015625
        },
        {
            "start_logit": 1.5947265625,
            "end_logit": 0.76123046875,
            "text": "NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX",
            "probability": 0.01751708984375
        },
        {
            "start_logit": -0.78662109375,
            "end_logit": 1.7080078125,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 0.004177093505859375
        },
        {
            "start_logit": 4.2890625,
            "end_logit": -4.2265625,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.",
            "probability": 0.00177001953125
        },
        {
            "start_logit": -0.78662109375,
            "end_logit": 0.76123046875,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 0.0016164779663085938
        },
        {
            "start_logit": 4.2890625,
            "end_logit": -5.23046875,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS",
            "probability": 0.00064849853515625
        },
        {
            "start_logit": 4.2890625,
            "end_logit": -6.03125,
            "text": "NOX1)",
            "probability": 0.0002911090850830078
        },
        {
            "start_logit": 1.5947265625,
            "end_logit": -3.568359375,
            "text": "NADPH oxidase organiser 1",
            "probability": 0.00023126602172851562
        },
        {
            "start_logit": 4.2890625,
            "end_logit": -6.34765625,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling",
            "probability": 0.00021207332611083984
        },
        {
            "start_logit": -3.892578125,
            "end_logit": 1.7080078125,
            "text": "p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 0.00018727779388427734
        },
        {
            "start_logit": -4.03515625,
            "end_logit": 1.7080078125,
            "text": "The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 0.0001614093780517578
        },
        {
            "start_logit": 4.2890625,
            "end_logit": -6.9765625,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS)",
            "probability": 0.00011265277862548828
        },
        {
            "start_logit": -3.892578125,
            "end_logit": 0.76123046875,
            "text": "p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX",
            "probability": 7.271766662597656e-05
        },
        {
            "start_logit": -4.95703125,
            "end_logit": 1.7080078125,
            "text": "of NADPH oxidase 1 (NOX1",
            "probability": 6.41942024230957e-05
        },
        {
            "start_logit": -4.03515625,
            "end_logit": 0.76123046875,
            "text": "The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX",
            "probability": 6.318092346191406e-05
        },
        {
            "start_logit": 1.5947265625,
            "end_logit": -5.23046875,
            "text": "NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS",
            "probability": 4.380941390991211e-05
        },
        {
            "start_logit": -5.59765625,
            "end_logit": 1.7080078125,
            "text": "activation of NADPH oxidase 1 (NOX1",
            "probability": 3.3855438232421875e-05
        },
        {
            "start_logit": 1.5947265625,
            "end_logit": -5.63671875,
            "text": "NADPH oxidase",
            "probability": 2.9206275939941406e-05
        }
    ],
    "58a5a51060087bc10a000021_26": [
        {
            "start_logit": 7.17578125,
            "end_logit": 7.0546875,
            "text": "NOXA1",
            "probability": 0.224609375
        },
        {
            "start_logit": 7.3203125,
            "end_logit": 6.88671875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1",
            "probability": 0.2176513671875
        },
        {
            "start_logit": 7.3203125,
            "end_logit": 6.78125,
            "text": "NOX1",
            "probability": 0.1966552734375
        },
        {
            "start_logit": 7.03125,
            "end_logit": 7.0546875,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 0.1934814453125
        },
        {
            "start_logit": 7.03125,
            "end_logit": 6.88671875,
            "text": "NOXA1",
            "probability": 0.164306640625
        },
        {
            "start_logit": 1.931640625,
            "end_logit": 7.0546875,
            "text": "NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 0.001178741455078125
        },
        {
            "start_logit": 1.931640625,
            "end_logit": 6.88671875,
            "text": "NOXO1 and NOXA1",
            "probability": 0.00099945068359375
        },
        {
            "start_logit": 7.3203125,
            "end_logit": 0.18603515625,
            "text": "NOX",
            "probability": 0.00026917457580566406
        },
        {
            "start_logit": 7.17578125,
            "end_logit": -0.139892578125,
            "text": "NOX",
            "probability": 0.0001678466796875
        },
        {
            "start_logit": 7.03125,
            "end_logit": -0.139892578125,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOX",
            "probability": 0.00014519691467285156
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -0.5712890625,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOX",
            "probability": 0.00012612342834472656
        },
        {
            "start_logit": 7.03125,
            "end_logit": -0.5712890625,
            "text": "NOX",
            "probability": 9.447336196899414e-05
        },
        {
            "start_logit": -1.4248046875,
            "end_logit": 7.0546875,
            "text": "A1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 4.094839096069336e-05
        },
        {
            "start_logit": -1.5517578125,
            "end_logit": 7.0546875,
            "text": "A1",
            "probability": 3.612041473388672e-05
        },
        {
            "start_logit": -1.4248046875,
            "end_logit": 6.88671875,
            "text": "A1",
            "probability": 3.4749507904052734e-05
        },
        {
            "start_logit": -2.1953125,
            "end_logit": 6.88671875,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": -2.1953125,
            "end_logit": 6.78125,
            "text": "1",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": 7.17578125,
            "end_logit": -3.560546875,
            "text": "NOXA1.",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 7.03125,
            "end_logit": -3.560546875,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1.",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -4.9453125,
            "text": "NOX1 was absolutely required for activation with NOXO1",
            "probability": 1.6093254089355469e-06
        }
    ],
    "58a5a51060087bc10a000021_27": [
        {
            "start_logit": 4.359375,
            "end_logit": 1.0419921875,
            "text": "Nox1",
            "probability": 0.5908203125
        },
        {
            "start_logit": 4.76953125,
            "end_logit": 0.0811767578125,
            "text": "p67(phox)",
            "probability": 0.3408203125
        },
        {
            "start_logit": 4.359375,
            "end_logit": -1.5732421875,
            "text": "Nox1.",
            "probability": 0.043121337890625
        },
        {
            "start_logit": 4.359375,
            "end_logit": -2.447265625,
            "text": "Nox",
            "probability": 0.0180206298828125
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -4.62890625,
            "text": "p67(phox",
            "probability": 0.0030651092529296875
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -5.32421875,
            "text": "p",
            "probability": 0.001529693603515625
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -6.51953125,
            "text": "p67(phox) that",
            "probability": 0.00046253204345703125
        },
        {
            "start_logit": -2.892578125,
            "end_logit": 1.0419921875,
            "text": "Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 0.0004181861877441406
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -7.05078125,
            "text": "p67(phox) that acts in conjunction with Nox",
            "probability": 0.0002720355987548828
        },
        {
            "start_logit": -3.515625,
            "end_logit": 1.0419921875,
            "text": "the NADPH oxidase Nox1",
            "probability": 0.00022459030151367188
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -7.26953125,
            "text": "p67(phox) that acts in conjunction with Nox organizer 1 (NoxO1",
            "probability": 0.00021851062774658203
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -7.33203125,
            "text": "p67",
            "probability": 0.0002052783966064453
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -7.44921875,
            "text": "p67(phox) that acts in conjunction with Nox organizer 1",
            "probability": 0.00018322467803955078
        },
        {
            "start_logit": -2.783203125,
            "end_logit": 0.0811767578125,
            "text": "NoxA1) is a homologue of p67(phox)",
            "probability": 0.00017905235290527344
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -7.48828125,
            "text": "p67(",
            "probability": 0.00017499923706054688
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -7.5546875,
            "text": "p67(phox) that acts in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS",
            "probability": 0.00016427040100097656
        },
        {
            "start_logit": -4.44140625,
            "end_logit": 1.0419921875,
            "text": "regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 8.928775787353516e-05
        },
        {
            "start_logit": -3.97265625,
            "end_logit": 0.0811767578125,
            "text": "Nox activator 1 (NoxA1) is a homologue of p67(phox)",
            "probability": 5.418062210083008e-05
        },
        {
            "start_logit": -4.95703125,
            "end_logit": 1.0419921875,
            "text": "NADPH oxidase Nox1",
            "probability": 5.334615707397461e-05
        },
        {
            "start_logit": -5.22265625,
            "end_logit": 1.0419921875,
            "text": "NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 4.088878631591797e-05
        }
    ],
    "58a5a51060087bc10a000021_28": [
        {
            "start_logit": 7.3984375,
            "end_logit": 5.28515625,
            "text": "Nox1",
            "probability": 0.640625
        },
        {
            "start_logit": 7.3984375,
            "end_logit": 4.59375,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 0.319580078125
        },
        {
            "start_logit": 5.26953125,
            "end_logit": 4.59375,
            "text": "NoxA1",
            "probability": 0.037841796875
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -0.544921875,
            "text": "Nox",
            "probability": 0.0018701553344726562
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -2.994140625,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit Nox",
            "probability": 0.0001621246337890625
        },
        {
            "start_logit": -2.28515625,
            "end_logit": 4.59375,
            "text": "NoxO1 and the activator subunit NoxA1",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -2.994140625,
            "text": "Nox",
            "probability": 1.919269561767578e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.78515625,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": 5.26953125,
            "end_logit": -3.75390625,
            "text": "NoxA1, as well as the binding of Rac1 GTPase, for its activity.",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -6.5859375,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -4.5390625,
            "end_logit": 5.28515625,
            "text": "1",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -6.71484375,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.03515625,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.10546875,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.12890625,
            "text": "Nox1 is highly expressed in the colon, and requires two",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.171875,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit Nox",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -4.515625,
            "end_logit": 4.59375,
            "text": "A1",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -4.5390625,
            "end_logit": 4.59375,
            "text": "1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.37890625,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organize",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.50390625,
            "text": "Nox1 is highly",
            "probability": 1.7285346984863281e-06
        }
    ],
    "58a5a51060087bc10a000021_29": [
        {
            "start_logit": 7.08984375,
            "end_logit": 6.67578125,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1",
            "probability": 0.5244140625
        },
        {
            "start_logit": 6.79296875,
            "end_logit": 6.67578125,
            "text": "NoxA1",
            "probability": 0.3896484375
        },
        {
            "start_logit": 7.08984375,
            "end_logit": 4.84765625,
            "text": "Nox1",
            "probability": 0.08428955078125
        },
        {
            "start_logit": 7.08984375,
            "end_logit": 0.16796875,
            "text": "Nox",
            "probability": 0.000782012939453125
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -0.75146484375,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and Nox",
            "probability": 0.0003123283386230469
        },
        {
            "start_logit": 6.79296875,
            "end_logit": -0.75146484375,
            "text": "Nox",
            "probability": 0.0002321004867553711
        },
        {
            "start_logit": -1.3515625,
            "end_logit": 6.67578125,
            "text": "NoxO1 and NoxA1",
            "probability": 0.00011354684829711914
        },
        {
            "start_logit": -1.84375,
            "end_logit": 6.67578125,
            "text": "A1",
            "probability": 6.890296936035156e-05
        },
        {
            "start_logit": 6.79296875,
            "end_logit": -4.55078125,
            "text": "NoxA1, as well as the binding of Rac1 GTPase, for its activity.",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -4.8671875,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -4.70703125,
            "end_logit": 6.67578125,
            "text": "1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -5.4765625,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1 GTPase",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -5.609375,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 6.79296875,
            "end_logit": -5.4765625,
            "text": "NoxA1, as well as the binding of Rac1 GTPase",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -5.890625,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.79296875,
            "end_logit": -5.609375,
            "text": "NoxA1, as well as the binding of Rac1",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -6.15234375,
            "text": "Nox1 is highly expressed in the colon, and it requires two",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.70703125,
            "end_logit": 4.84765625,
            "text": "1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -6.98046875,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, Nox",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -7.0234375,
            "text": "Nox1 is highly expressed in the colon",
            "probability": 5.960464477539062e-07
        }
    ],
    "58a5a51060087bc10a000021_30": [
        {
            "start_logit": 0.81005859375,
            "end_logit": -1.7431640625,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1.",
            "probability": 0.29736328125
        },
        {
            "start_logit": 0.57177734375,
            "end_logit": -1.7431640625,
            "text": "NOXA1), and Rac1.",
            "probability": 0.234130859375
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -2.1953125,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1",
            "probability": 0.1893310546875
        },
        {
            "start_logit": 0.57177734375,
            "end_logit": -2.1953125,
            "text": "NOXA1",
            "probability": 0.1490478515625
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -3.388671875,
            "text": "p22(PHOX)",
            "probability": 0.057403564453125
        },
        {
            "start_logit": -1.384765625,
            "end_logit": -2.19921875,
            "text": "NOX",
            "probability": 0.02099609375
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -5.390625,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOX",
            "probability": 0.007740020751953125
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -5.4609375,
            "text": "p22(PHOX",
            "probability": 0.007213592529296875
        },
        {
            "start_logit": -1.384765625,
            "end_logit": -3.388671875,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX)",
            "probability": 0.0063934326171875
        },
        {
            "start_logit": 0.57177734375,
            "end_logit": -5.390625,
            "text": "NOX",
            "probability": 0.00609588623046875
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -5.81640625,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX",
            "probability": 0.005054473876953125
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -6.37890625,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1",
            "probability": 0.002880096435546875
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -6.546875,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1",
            "probability": 0.0024356842041015625
        },
        {
            "start_logit": 0.57177734375,
            "end_logit": -6.37890625,
            "text": "NOXA1), and Rac1",
            "probability": 0.002269744873046875
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -6.65234375,
            "text": "p22(PHOX) and the cytosolic partners NOX",
            "probability": 0.0021915435791015625
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -6.6953125,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1)",
            "probability": 0.0020999908447265625
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -6.69921875,
            "text": "p22(PHOX) and the cytosolic",
            "probability": 0.0020923614501953125
        },
        {
            "start_logit": -1.384765625,
            "end_logit": -4.51171875,
            "text": "NOX1",
            "probability": 0.0020751953125
        },
        {
            "start_logit": -3.8828125,
            "end_logit": -2.19921875,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 0.0017271041870117188
        },
        {
            "start_logit": 0.81005859375,
            "end_logit": -6.921875,
            "text": "p2",
            "probability": 0.0016736984252929688
        }
    ],
    "58a5a51060087bc10a000021_31": [
        {
            "start_logit": 6.41015625,
            "end_logit": 2.544921875,
            "text": "Nox1",
            "probability": 0.95947265625
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -1.384765625,
            "text": "Nox",
            "probability": 0.01885986328125
        },
        {
            "start_logit": 2.6328125,
            "end_logit": 2.267578125,
            "text": "Noxa1",
            "probability": 0.016632080078125
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -3.7265625,
            "text": "Nox1, a member of the Nox",
            "probability": 0.0018167495727539062
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -4.53125,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 0.000812530517578125
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -4.53125,
            "text": "Nox1, a member of the Nox family",
            "probability": 0.000812530517578125
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -5.21484375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1",
            "probability": 0.00041031837463378906
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -5.99609375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox",
            "probability": 0.00018775463104248047
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.08203125,
            "text": "Nox1, a",
            "probability": 0.0001722574234008789
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.140625,
            "text": "Nox1, a member of the Nox family NAPDH",
            "probability": 0.00016188621520996094
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.2265625,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 0.00014972686767578125
        },
        {
            "start_logit": -2.42578125,
            "end_logit": 2.544921875,
            "text": "Superoxide production by Nox1",
            "probability": 0.00013959407806396484
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.328125,
            "text": "Nox1, a member of the Nox family NAP",
            "probability": 0.0001342296600341797
        },
        {
            "start_logit": -2.474609375,
            "end_logit": 2.267578125,
            "text": "Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 0.00010132789611816406
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.67578125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 9.518861770629883e-05
        },
        {
            "start_logit": -3.09375,
            "end_logit": 2.267578125,
            "text": "Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 5.424022674560547e-05
        },
        {
            "start_logit": -3.4375,
            "end_logit": 2.267578125,
            "text": "NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 3.844499588012695e-05
        },
        {
            "start_logit": 2.6328125,
            "end_logit": -4.40625,
            "text": "Nox",
            "probability": 2.104043960571289e-05
        },
        {
            "start_logit": -4.66796875,
            "end_logit": 2.267578125,
            "text": "Nox organizer 1) and Noxa1",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": -5.12109375,
            "end_logit": 2.267578125,
            "text": "DH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 7.152557373046875e-06
        }
    ],
    "58e7902b3e8b6dc87c000007_1": [
        {
            "start_logit": 7.890625,
            "end_logit": 7.92578125,
            "text": "IFN signature",
            "probability": 1.0
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.42578125,
            "text": "IFN",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -1.62109375,
            "end_logit": 7.92578125,
            "text": "signature",
            "probability": 7.426738739013672e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -5.4296875,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 7.92578125,
            "text": "five gene type I IFN signature",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.46875,
            "text": "IFN signature was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.6875,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.7578125,
            "text": "IFN signature was assessed in these subjects to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.765625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 7.92578125,
            "text": "type I IFN signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.78515625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.828125,
            "text": "IFN signature was assessed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.8359375,
            "text": "IFN signature was assessed in these subjects to identify",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.83984375,
            "text": "IFN signature was assessed in these",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 7.92578125,
            "text": "I IFN signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.62109375,
            "end_logit": -5.4296875,
            "text": "signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -1.42578125,
            "text": "five gene type I IFN",
            "probability": 0.0
        },
        {
            "start_logit": -1.62109375,
            "end_logit": -7.46875,
            "text": "signature was",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -1.42578125,
            "text": "type I IFN",
            "probability": 0.0
        },
        {
            "start_logit": -1.62109375,
            "end_logit": -7.6875,
            "text": "signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_2": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.9296875,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": -1.630859375,
            "end_logit": 7.9296875,
            "text": "signature",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.6474609375,
            "text": "interferon",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.65625,
            "text": "interferon signature similar to but",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.6953125,
            "text": "interferon signature similar",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.76171875,
            "text": "interferon signature similar to but less intense than that seen",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.77734375,
            "text": "interferon signature similar to but less intense than that seen in patients with lupus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.7890625,
            "text": "interferon signature similar to but less intense than that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 7.9296875,
            "text": "demonstrate an interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.828125,
            "text": "interferon signature similar to but less",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.86328125,
            "text": "interferon signature similar to but less intense than",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 7.9296875,
            "text": "Gene expression analysis of peripheral blood cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.90625,
            "text": "interferon signature similar to but less intense",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.91796875,
            "text": "interferon signature similar to but less intense than that seen in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.65625,
            "text": "signature similar to but",
            "probability": 0.0
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.6953125,
            "text": "signature similar",
            "probability": 0.0
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.76171875,
            "text": "signature similar to but less intense than that seen",
            "probability": 0.0
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.77734375,
            "text": "signature similar to but less intense than that seen in patients with lupus",
            "probability": 0.0
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.7890625,
            "text": "signature similar to but less intense than that",
            "probability": 0.0
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.828125,
            "text": "signature similar to but less",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_3": [
        {
            "start_logit": 7.890625,
            "end_logit": 7.92578125,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.5244140625,
            "text": "interferon",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -1.677734375,
            "end_logit": 7.92578125,
            "text": "signature",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 7.92578125,
            "text": "interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 7.92578125,
            "text": "termed the interferon signature",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.92578125,
            "text": "genes in their leukocytes, termed the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.92578125,
            "text": "the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.92578125,
            "text": "expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.92578125,
            "text": "arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 7.92578125,
            "text": "display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 7.92578125,
            "text": "rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.92578125,
            "text": "with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 7.92578125,
            "text": "of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 7.92578125,
            "text": "specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 7.92578125,
            "text": "a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.98828125,
            "text": "interferon signature.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -1.5244140625,
            "text": "interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -1.5244140625,
            "text": "termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -1.5244140625,
            "text": "genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -1.5244140625,
            "text": "the interferon",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_4": [
        {
            "start_logit": 7.671875,
            "end_logit": 7.8046875,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": -2.125,
            "end_logit": 7.8046875,
            "text": "signature",
            "probability": 5.561113357543945e-05
        },
        {
            "start_logit": 7.671875,
            "end_logit": -2.63671875,
            "text": "interferon",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": 7.671875,
            "end_logit": -6.87890625,
            "text": "interferon signature in lupus).",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 7.8046875,
            "text": "gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.8046875,
            "text": "the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.8046875,
            "text": "identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.59765625,
            "text": "interferon signature in lupus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.8046875,
            "text": "led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 7.8046875,
            "text": "have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.8046875,
            "text": ". interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 7.8046875,
            "text": "of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 7.8046875,
            "text": "e.g. interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.125,
            "end_logit": -6.87890625,
            "text": "signature in lupus).",
            "probability": 0.0
        },
        {
            "start_logit": -2.125,
            "end_logit": -7.59765625,
            "text": "signature in lupus",
            "probability": 0.0
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -2.63671875,
            "text": "gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -2.63671875,
            "text": "the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -2.63671875,
            "text": "identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": -2.63671875,
            "text": "led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": -2.63671875,
            "text": "have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_5": [
        {
            "start_logit": 7.859375,
            "end_logit": 7.92578125,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": -1.7060546875,
            "end_logit": 7.92578125,
            "text": "signature",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 7.859375,
            "end_logit": -1.75390625,
            "text": "interferon",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.3515625,
            "text": "interferon signature and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.68359375,
            "text": "interferon signature and the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.73046875,
            "text": "interferon signature and the response to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.75390625,
            "text": "interferon signature and the response to rituximab in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.76953125,
            "text": "interferon signature and the response to rituximab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.95703125,
            "text": "interferon signature and the response to rituximab in rheumatoid arthritis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.92578125,
            "text": "I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -8.0,
            "text": "interferon signature and the response to rituximab in rheumatoid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -8.0,
            "text": "interferon signature and the response",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -8.09375,
            "text": "interferon signature and the response to rituximab in rheumatoid arthritis patients",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -8.1015625,
            "text": "interferon signature and the response to rituximab in rheumatoid arthritis patients.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7060546875,
            "end_logit": -7.3515625,
            "text": "signature and",
            "probability": 0.0
        },
        {
            "start_logit": -1.7060546875,
            "end_logit": -7.68359375,
            "text": "signature and the",
            "probability": 0.0
        },
        {
            "start_logit": -1.7060546875,
            "end_logit": -7.73046875,
            "text": "signature and the response to",
            "probability": 0.0
        },
        {
            "start_logit": -1.7060546875,
            "end_logit": -7.75390625,
            "text": "signature and the response to rituximab in",
            "probability": 0.0
        },
        {
            "start_logit": -1.7060546875,
            "end_logit": -7.76953125,
            "text": "signature and the response to rituximab",
            "probability": 0.0
        },
        {
            "start_logit": -1.7060546875,
            "end_logit": -7.95703125,
            "text": "signature and the response to rituximab in rheumatoid arthritis",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_6": [
        {
            "start_logit": 7.88671875,
            "end_logit": 7.91796875,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -1.400390625,
            "text": "interferon",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": -1.6171875,
            "end_logit": 7.91796875,
            "text": "signature",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.8828125,
            "text": "interferon signature in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.91796875,
            "text": "type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.91796875,
            "text": "I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.91796875,
            "text": "gene expression levels: application to the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -8.1484375,
            "text": "interferon signature in rheumatoid arthritis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -1.400390625,
            "text": "type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -1.400390625,
            "text": "I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -1.400390625,
            "text": "gene expression levels: application to the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.6171875,
            "end_logit": -7.8828125,
            "text": "signature in",
            "probability": 0.0
        },
        {
            "start_logit": -1.6171875,
            "end_logit": -8.1484375,
            "text": "signature in rheumatoid arthritis.",
            "probability": 0.0
        },
        {
            "start_logit": -7.04296875,
            "end_logit": -8.1484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.8046875,
            "text": "gene expression levels:",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.8515625,
            "text": "gene expression levels",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.8828125,
            "text": "type I interferon signature in",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.8828125,
            "text": "I interferon signature in",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.86328125,
            "text": "gene expression",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.8828125,
            "text": "gene expression levels: application to the type I interferon signature in",
            "probability": 0.0
        }
    ],
    "517170c48ed59a060a00000d_1": [
        {
            "start_logit": 6.43359375,
            "end_logit": 6.6796875,
            "text": "25",
            "probability": 1.0
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -5.26171875,
            "text": "25 selenoproteins.",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -5.640625,
            "text": "25 selenoproteins",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 6.6796875,
            "text": "selenoproteome consists of 25",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.6796875,
            "text": "The human selenoproteome consists of 25",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.6796875,
            "text": "human selenoproteome consists of 25",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.6796875,
            "text": "ome consists of 25",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.6796875,
            "text": "of 25",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -5.26171875,
            "text": "selenoproteome consists of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -5.640625,
            "text": "selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -5.26171875,
            "text": "selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -5.640625,
            "text": "selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -5.26171875,
            "text": "oproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -5.26171875,
            "text": "The human selenoproteome consists of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -5.640625,
            "text": "oproteins",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -5.26171875,
            "text": "human selenoproteome consists of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -5.26171875,
            "text": "ome consists of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -5.26171875,
            "text": "of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -5.640625,
            "text": "The human selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -5.640625,
            "text": "human selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_1": [
        {
            "start_logit": 7.81640625,
            "end_logit": 7.8203125,
            "text": "XXY",
            "probability": 1.0
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -1.2001953125,
            "text": "XX",
            "probability": 0.00012058019638061523
        },
        {
            "start_logit": -1.70703125,
            "end_logit": 7.8203125,
            "text": "Y",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.8203125,
            "text": "(XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 7.8203125,
            "text": "Klinefelter syndrome (XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.8203125,
            "text": "syndrome (XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.8203125,
            "text": "inefelter syndrome (XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -1.2001953125,
            "text": "(XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -1.2001953125,
            "text": "Klinefelter syndrome (XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -1.2001953125,
            "text": "syndrome (XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -1.2001953125,
            "text": "inefelter syndrome (XX",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_2": [
        {
            "start_logit": 6.4921875,
            "end_logit": 6.7109375,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -2.849609375,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XX",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -4.9140625,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XXY",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -5.390625,
            "text": "X chromosome (47,XX",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -5.8984375,
            "text": "X chromosome (47,XXY",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 6.7109375,
            "text": "extra X",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.0390625,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.2734375,
            "text": "X chromosome (47",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.44921875,
            "text": "X chromosome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.6328125,
            "text": "X chromosome (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.7109375,
            "text": "an extra X",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.7109375,
            "text": "with an extra X",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.92578125,
            "text": "X chromosome (47,XXY or",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.94140625,
            "text": "X chromosome (47,XXY or Klinefe",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.9609375,
            "text": "X chromosome (47,XXY or Klinefelt",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.96875,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.5390625,
            "end_logit": -2.849609375,
            "text": "47,XXY or Klinefelter syndrome). 47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -5.47265625,
            "end_logit": -2.849609375,
            "text": "XXY or Klinefelter syndrome). 47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -5.6484375,
            "end_logit": -2.849609375,
            "text": "47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -2.849609375,
            "text": ". 47,XX",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_3": [
        {
            "start_logit": 6.4921875,
            "end_logit": 6.7109375,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -2.849609375,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XX",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -4.9140625,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XXY",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -5.390625,
            "text": "X chromosome (47,XX",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -5.8984375,
            "text": "X chromosome (47,XXY",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 6.7109375,
            "text": "extra X",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.0390625,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.2734375,
            "text": "X chromosome (47",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.44921875,
            "text": "X chromosome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.6328125,
            "text": "X chromosome (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.7109375,
            "text": "an extra X",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.7109375,
            "text": "with an extra X",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.92578125,
            "text": "X chromosome (47,XXY or",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.94140625,
            "text": "X chromosome (47,XXY or Klinefe",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.9609375,
            "text": "X chromosome (47,XXY or Klinefelt",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4921875,
            "end_logit": -7.96875,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.5390625,
            "end_logit": -2.849609375,
            "text": "47,XXY or Klinefelter syndrome). 47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -5.47265625,
            "end_logit": -2.849609375,
            "text": "XXY or Klinefelter syndrome). 47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -5.6484375,
            "end_logit": -2.849609375,
            "text": "47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -2.849609375,
            "text": ". 47,XX",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_4": [
        {
            "start_logit": 6.44921875,
            "end_logit": 6.7421875,
            "text": "X",
            "probability": 0.998046875
        },
        {
            "start_logit": 6.44921875,
            "end_logit": 0.4833984375,
            "text": "X chromosome in males (47,XXY",
            "probability": 0.001918792724609375
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -3.634765625,
            "text": "X chromosome in males (47,XX",
            "probability": 3.1113624572753906e-05
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 6.7421875,
            "text": "additional X",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -6.9140625,
            "text": "X chromosome",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -7.01171875,
            "text": "X chromosome in",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -7.40625,
            "text": "X chromosome in males (47,XXY)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -7.50390625,
            "text": "X chromosome in males (47,",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.7421875,
            "text": "an additional X",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -7.5234375,
            "text": "X chromosome in males (47,XXY),",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -7.546875,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity of external genitalia, testicular dysfunction.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.7421875,
            "text": "by an additional X",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -7.71484375,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -7.72265625,
            "text": "X chromosome in males (47,XXY), and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.7421875,
            "text": "caused by an additional X",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.7421875,
            "text": "the other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 6.7421875,
            "text": "chromosomal abnormality caused by an additional X",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.7421875,
            "text": "Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -7.82421875,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity of external genitalia, testicular",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.44921875,
            "end_logit": -7.83203125,
            "text": "X chromosome in males",
            "probability": 4.76837158203125e-07
        }
    ],
    "5e669e0e1af46fc130000019_5": [
        {
            "start_logit": 7.953125,
            "end_logit": 8.015625,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.6025390625,
            "end_logit": 8.015625,
            "text": "Y",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -1.890625,
            "text": "47",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -5.1328125,
            "text": "47, XX",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -5.94140625,
            "end_logit": 8.015625,
            "text": "XXY",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.453125,
            "text": "47, XXY; the extra sex",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.76171875,
            "text": "47,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.94140625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 8.015625,
            "text": ", XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.14453125,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.5234375,
            "text": "47, XXY; the extra sex chromosome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.015625,
            "text": "cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.6328125,
            "text": "47, XXY; the extra sex chromosome is due to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.015625,
            "text": "is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.015625,
            "text": "Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.875,
            "text": "47, XXY; the extra sex chromosome is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.99609375,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nond",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -8.015625,
            "text": "47, XXY;",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6025390625,
            "end_logit": -6.453125,
            "text": "Y; the extra sex",
            "probability": 0.0
        },
        {
            "start_logit": -1.6025390625,
            "end_logit": -6.94140625,
            "text": "Y; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_6": [
        {
            "start_logit": 6.54296875,
            "end_logit": 6.6640625,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -4.91015625,
            "text": "X chromosome in males leading to a karyotype of 47,XX",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -6.5546875,
            "text": "X chromosome in males leading to a karyotype of 47,XXY",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.6640625,
            "text": "additional X",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.62890625,
            "text": "X chromosome in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.67578125,
            "text": "X chromosome in males leading to a karyotype of 47,XXY.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.6640625,
            "text": "characterized by an additional X",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.8515625,
            "text": "X chromosome in males leading to a karyotype of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.86328125,
            "text": "X chromosome in males leading to a",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.87890625,
            "text": "X chromosome in males leading to a karyotype",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.91796875,
            "text": "X chromosome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.921875,
            "text": "X chromosome in males leading to a karyotype of 47",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.54296875,
            "end_logit": -7.95703125,
            "text": "X chromosome in males",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 6.6640625,
            "text": "an additional X",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 6.6640625,
            "text": "by an additional X",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.1484375,
            "end_logit": -4.91015625,
            "text": "XX",
            "probability": 0.0
        },
        {
            "start_logit": -6.37109375,
            "end_logit": -4.91015625,
            "text": "47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -5.1484375,
            "end_logit": -6.5546875,
            "text": "XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -4.91015625,
            "text": "karyotype of 47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -4.91015625,
            "text": ",XX",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_7": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.015625,
            "text": "47,XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": 8.015625,
            "text": "Y",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.947265625,
            "text": "47",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -4.86328125,
            "text": "47,XX",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -5.5703125,
            "end_logit": 8.015625,
            "text": "XXY",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.5546875,
            "text": "47,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 8.015625,
            "text": ",XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.20703125,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias to date.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.015625,
            "text": "a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.84765625,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.859375,
            "text": "47,XXY chromosomal abnormality, has been shown to be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 8.015625,
            "text": "Klinefelter syndrome (KS), a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.015625,
            "text": "KS), a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.9453125,
            "text": "47,XXY chromosomal abnormality,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.97265625,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 8.015625,
            "text": "inefelter syndrome (KS), a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 8.015625,
            "text": ", a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.99609375,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.015625,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -7.1640625,
            "text": "Y chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias to date. We",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_8": [
        {
            "start_logit": 7.9609375,
            "end_logit": 8.015625,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": 8.015625,
            "text": "Y",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -1.8466796875,
            "text": "47",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -5.34765625,
            "text": "47, XX",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.98828125,
            "end_logit": 8.015625,
            "text": "XXY",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -6.07421875,
            "text": "47, XXY; the extra sex",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -6.703125,
            "text": "47,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 8.015625,
            "text": ", XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.27734375,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.60546875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction. In",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.74609375,
            "text": "47, XXY; the extra sex chromosome is due to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.015625,
            "text": "Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.80078125,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nond",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.015625,
            "text": "cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 8.015625,
            "text": "is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.015625,
            "text": "syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.859375,
            "text": "47, XXY; the extra sex chromosome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 8.015625,
            "text": "inefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.98046875,
            "text": "47, XXY; the extra sex chromosome is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -7.9921875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e669e0e1af46fc130000019_9": [
        {
            "start_logit": 7.7890625,
            "end_logit": 7.8125,
            "text": "XXY",
            "probability": 1.0
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -1.283203125,
            "text": "XX",
            "probability": 0.00011235475540161133
        },
        {
            "start_logit": -1.662109375,
            "end_logit": 7.8125,
            "text": "Y",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.17578125,
            "text": "XXY chromosomal abnormality may",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.8125,
            "text": "the XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.4453125,
            "text": "XXY chromosomal abnormality may be more than",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.546875,
            "text": "XXY chromosomal abnormality may be more than coincidental",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.86328125,
            "text": "XXY chromosomal abnormality may be more than coincidental.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.87109375,
            "text": "XXY chromosomal abnormality may be more than coincident",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 7.8125,
            "text": "with the XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.8125,
            "text": "tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.8125,
            "text": "development of a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -1.283203125,
            "text": "the XX",
            "probability": 0.0
        },
        {
            "start_logit": -1.662109375,
            "end_logit": -7.17578125,
            "text": "Y chromosomal abnormality may",
            "probability": 0.0
        },
        {
            "start_logit": -1.662109375,
            "end_logit": -7.4453125,
            "text": "Y chromosomal abnormality may be more than",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -1.283203125,
            "text": "with the XX",
            "probability": 0.0
        },
        {
            "start_logit": -1.662109375,
            "end_logit": -7.546875,
            "text": "Y chromosomal abnormality may be more than coincidental",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -1.283203125,
            "text": "inefelter's syndrome with the development of a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XX",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -1.283203125,
            "text": "tumor with the XX",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -1.283203125,
            "text": "development of a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XX",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_10": [
        {
            "start_logit": 7.671875,
            "end_logit": 7.9453125,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": 7.671875,
            "end_logit": -1.4267578125,
            "text": "47, XXY karyotype",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -1.806640625,
            "end_logit": 7.9453125,
            "text": "Y",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": 7.671875,
            "end_logit": -2.677734375,
            "text": "47",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 7.671875,
            "end_logit": -4.5546875,
            "text": "47, XX",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -4.9609375,
            "end_logit": 7.9453125,
            "text": "XXY",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -5.17578125,
            "end_logit": 7.9453125,
            "text": "a 47, XXY",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.671875,
            "end_logit": -6.640625,
            "text": "47,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.9453125,
            "text": ", XXY",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.9453125,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.9453125,
            "text": "by a 47, XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.9453125,
            "text": "characterised by a 47, XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.9453125,
            "text": "KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.9453125,
            "text": "syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 7.9453125,
            "text": "chromosomal abnormality characterised by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 7.9453125,
            "text": "inefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 7.9453125,
            "text": "(KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 7.9453125,
            "text": ") is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.9453125,
            "text": "47, XXY karyotype associated with hypogonadism",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -8.0078125,
            "text": "47, XXY karyotype associated with",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e669e0e1af46fc130000019_11": [
        {
            "start_logit": 6.59765625,
            "end_logit": 6.47265625,
            "text": "Y",
            "probability": 0.95947265625
        },
        {
            "start_logit": 3.28125,
            "end_logit": 6.47265625,
            "text": "47,XXY) and Y",
            "probability": 0.03466796875
        },
        {
            "start_logit": 3.28125,
            "end_logit": 4.6953125,
            "text": "47,XXY",
            "probability": 0.005886077880859375
        },
        {
            "start_logit": -5.37890625,
            "end_logit": 6.47265625,
            "text": "XXY) and Y",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 6.47265625,
            "text": "Y) and Y",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -5.73046875,
            "text": "Y chromosome",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.28125,
            "text": "Y chromosome microdeletions.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.37890625,
            "end_logit": 4.6953125,
            "text": "XXY",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.47265625,
            "text": "(47,XXY) and Y",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 4.6953125,
            "text": "Y",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 6.47265625,
            "text": "and Y",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 6.47265625,
            "text": "nonobstructive azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY) and Y",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.47265625,
            "text": ",XXY) and Y",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 3.28125,
            "end_logit": -4.35546875,
            "text": "47,XX",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -7.6875,
            "text": "Y chromosome microdeletions",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.47265625,
            "text": "azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY) and Y",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.47265625,
            "text": "tructive azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY) and Y",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.47265625,
            "text": "ive azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY) and Y",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.47265625,
            "text": "including Klinefelter syndrome (47,XXY) and Y",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 3.28125,
            "end_logit": -5.73046875,
            "text": "47,XXY) and Y chromosome",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e669e0e1af46fc130000019_12": [
        {
            "start_logit": 6.3828125,
            "end_logit": 6.78125,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -0.97607421875,
            "text": "X chromosome in males (47,XXY",
            "probability": 0.00042748451232910156
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -3.74609375,
            "text": "X chromosome in males (47,XX",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -6.65625,
            "end_logit": 6.78125,
            "text": "additional X",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -6.48828125,
            "text": "X chromosome",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.05078125,
            "text": "X chromosome in",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.78125,
            "text": "an additional X",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.37890625,
            "text": "X chromosome in males (47,XXY)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.4375,
            "text": "X chromosome in males (47,",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 6.78125,
            "text": "hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.78125,
            "text": ", Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 6.78125,
            "text": "by an additional X",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.546875,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity of external genitalia, testicular dysfunction.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.78125,
            "text": "caused by an additional X",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.78125,
            "text": "other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 6.78125,
            "text": "Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.578125,
            "text": "X chromosome in males (47,XXY),",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.78125,
            "text": "chromosomal abnormality caused by an additional X",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.796875,
            "text": "X chromosome in males (47,XXY), and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.8125,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity",
            "probability": 4.76837158203125e-07
        }
    ],
    "5e669e0e1af46fc130000019_13": [
        {
            "start_logit": 7.90625,
            "end_logit": 7.97265625,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.6650390625,
            "end_logit": 7.97265625,
            "text": "Y",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -2.03515625,
            "text": "47",
            "probability": 4.5418739318847656e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -3.275390625,
            "text": "47, XX",
            "probability": 1.3113021850585938e-05
        },
        {
            "start_logit": -5.515625,
            "end_logit": 7.97265625,
            "text": "XXY",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.90625,
            "end_logit": -5.95703125,
            "text": "47,",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.83984375,
            "text": "47, XXY)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.9765625,
            "text": "47, XXY) was the most common",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 7.97265625,
            "text": "(47, XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.97265625,
            "text": "10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.97265625,
            "text": ", XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.97265625,
            "text": "which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.97265625,
            "text": "patients, 39(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.97265625,
            "text": "Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.61328125,
            "text": "47, XXY) was the most common chromosomal aberration. The incid",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.97265625,
            "text": "chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 7.97265625,
            "text": "inefelter's syndrome (47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6650390625,
            "end_logit": -6.83984375,
            "text": "Y)",
            "probability": 0.0
        },
        {
            "start_logit": -1.6650390625,
            "end_logit": -6.9765625,
            "text": "Y) was the most common",
            "probability": 0.0
        },
        {
            "start_logit": -5.515625,
            "end_logit": -3.275390625,
            "text": "XX",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_14": [
        {
            "start_logit": 7.78125,
            "end_logit": 7.92578125,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.8740234375,
            "end_logit": 7.92578125,
            "text": "Y",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": 7.78125,
            "end_logit": -2.369140625,
            "text": "47, XXY karyotype",
            "probability": 3.3974647521972656e-05
        },
        {
            "start_logit": 7.78125,
            "end_logit": -2.4140625,
            "text": "47",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": -3.818359375,
            "end_logit": 7.92578125,
            "text": "a 47, XXY",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": 7.78125,
            "end_logit": -4.12890625,
            "text": "47, XX",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -4.76953125,
            "end_logit": 7.92578125,
            "text": "XXY",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 7.78125,
            "end_logit": -6.453125,
            "text": "47, XXY karyotype associated with hypogonadism and infertility.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.78125,
            "end_logit": -6.5546875,
            "text": "47,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 7.92578125,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 7.92578125,
            "text": ", XXY",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.92578125,
            "text": "by a 47, XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.92578125,
            "text": "chromosome abnormality characterized by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.92578125,
            "text": "characterized by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.92578125,
            "text": "syndrome (KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 7.92578125,
            "text": "KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78125,
            "end_logit": -7.8203125,
            "text": "47, XXY karyotype associated with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 7.92578125,
            "text": "inefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 7.92578125,
            "text": "abnormality characterized by a 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.78125,
            "end_logit": -7.92578125,
            "text": "47, XXY karyotype associated with hypogonadism",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e669e0e1af46fc130000019_15": [
        {
            "start_logit": 5.1875,
            "end_logit": 6.51953125,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and XXXXY",
            "probability": 0.9716796875
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": 6.51953125,
            "text": "XXY, XXYY, XXXY and XXXXY",
            "probability": 0.0164031982421875
        },
        {
            "start_logit": 0.30419921875,
            "end_logit": 6.51953125,
            "text": "XXXXY",
            "probability": 0.007389068603515625
        },
        {
            "start_logit": -1.1083984375,
            "end_logit": 6.51953125,
            "text": "XXY",
            "probability": 0.001796722412109375
        },
        {
            "start_logit": -1.2470703125,
            "end_logit": 6.51953125,
            "text": "XXXY and XXXXY",
            "probability": 0.0015668869018554688
        },
        {
            "start_logit": -2.23046875,
            "end_logit": 6.51953125,
            "text": "XY",
            "probability": 0.0005855560302734375
        },
        {
            "start_logit": -2.66796875,
            "end_logit": 6.51953125,
            "text": "XXYY, XXXY and XXXXY",
            "probability": 0.0003781318664550781
        },
        {
            "start_logit": 5.1875,
            "end_logit": -1.6103515625,
            "text": "sex chromosome",
            "probability": 0.00028777122497558594
        },
        {
            "start_logit": 5.1875,
            "end_logit": -2.39453125,
            "text": "sex chromosome anomalies",
            "probability": 0.00013172626495361328
        },
        {
            "start_logit": 5.1875,
            "end_logit": -2.73046875,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY",
            "probability": 9.334087371826172e-05
        },
        {
            "start_logit": -4.4453125,
            "end_logit": 6.51953125,
            "text": "XY and XXXXY",
            "probability": 6.413459777832031e-05
        },
        {
            "start_logit": 5.1875,
            "end_logit": -3.5234375,
            "text": "sex",
            "probability": 4.2438507080078125e-05
        },
        {
            "start_logit": -5.046875,
            "end_logit": 6.51953125,
            "text": "YY, XXXY and XXXXY",
            "probability": 3.4928321838378906e-05
        },
        {
            "start_logit": 5.1875,
            "end_logit": -4.09765625,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and XXXXY.",
            "probability": 2.396106719970703e-05
        },
        {
            "start_logit": 5.1875,
            "end_logit": -4.34375,
            "text": "sex chromosome anomalies including XX",
            "probability": 1.8715858459472656e-05
        },
        {
            "start_logit": 5.1875,
            "end_logit": -5.421875,
            "text": "sex chromosome anomalies including XXY",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": -6.953125,
            "end_logit": 6.51953125,
            "text": "Y, XXXY and XXXXY",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -7.03125,
            "end_logit": 6.51953125,
            "text": "Y, XXYY, XXXY and XXXXY",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 6.51953125,
            "text": "and XXXXY",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 6.51953125,
            "text": ", XXXY and XXXXY",
            "probability": 3.993511199951172e-06
        }
    ],
    "5e669e0e1af46fc130000019_16": [
        {
            "start_logit": 7.9453125,
            "end_logit": 8.0234375,
            "text": "47,XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": 8.0234375,
            "text": "Y",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.8544921875,
            "text": "47",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -5.1796875,
            "text": "47,XX",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -5.54296875,
            "end_logit": 8.0234375,
            "text": "XXY",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 8.0234375,
            "text": ",XXY",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.83984375,
            "text": "47,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.890625,
            "text": "47,XXY chromosomal pattern, has largely been associated with physical abnormalities.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.0234375,
            "text": "characterised by a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.78125,
            "text": "47,XXY chromosomal pattern",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.0234375,
            "text": "a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 8.0234375,
            "text": "syndrome, characterised by a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 8.0234375,
            "text": "by a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.96484375,
            "text": "47,XXY chromosomal pattern, has largely been associated with physical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.9921875,
            "text": "47,XXY chromosomal pattern, has largely been associated with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 8.0234375,
            "text": "Klinefelter's syndrome, characterised by a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 8.0234375,
            "text": "inefelter's syndrome, characterised by a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -8.0234375,
            "text": "47,XXY chromosomal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 8.0234375,
            "text": "'s syndrome, characterised by a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -8.046875,
            "text": "47,XXY chromosomal pattern, has largely",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e669e0e1af46fc130000019_17": [
        {
            "start_logit": -0.038604736328125,
            "end_logit": 7.0234375,
            "text": "translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 0.63232421875
        },
        {
            "start_logit": -0.75830078125,
            "end_logit": 7.0234375,
            "text": "46,XXY,t(13q;14q)",
            "probability": 0.30810546875
        },
        {
            "start_logit": -3.27734375,
            "end_logit": 7.0234375,
            "text": ")",
            "probability": 0.024810791015625
        },
        {
            "start_logit": -4.22265625,
            "end_logit": 7.0234375,
            "text": "t(13q;14q)",
            "probability": 0.00963592529296875
        },
        {
            "start_logit": -4.67578125,
            "end_logit": 7.0234375,
            "text": "13/14 translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 0.00612640380859375
        },
        {
            "start_logit": -4.98828125,
            "end_logit": 7.0234375,
            "text": "14 translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 0.00447845458984375
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 7.0234375,
            "text": ",t(13q;14q)",
            "probability": 0.0038166046142578125
        },
        {
            "start_logit": -5.34765625,
            "end_logit": 7.0234375,
            "text": "13q;14q)",
            "probability": 0.0031280517578125
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 7.0234375,
            "text": "XXY,t(13q;14q)",
            "probability": 0.0014886856079101562
        },
        {
            "start_logit": -6.21875,
            "end_logit": 7.0234375,
            "text": "14q)",
            "probability": 0.0013093948364257812
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 7.0234375,
            "text": "q;14q)",
            "probability": 0.0010318756103515625
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 7.0234375,
            "text": ";14q)",
            "probability": 0.0009317398071289062
        },
        {
            "start_logit": -6.59375,
            "end_logit": 7.0234375,
            "text": "/14 translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 0.0008997917175292969
        },
        {
            "start_logit": -6.890625,
            "end_logit": 7.0234375,
            "text": "(13q;14q)",
            "probability": 0.0006685256958007812
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 7.0234375,
            "text": "Y,t(13q;14q)",
            "probability": 0.0005164146423339844
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.0234375,
            "text": ",XXY,t(13q;14q)",
            "probability": 0.00046324729919433594
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.0234375,
            "text": "abnormality 46,XXY,t(13q;14q)",
            "probability": 0.000457763671875
        },
        {
            "start_logit": -0.038604736328125,
            "end_logit": -4.2734375,
            "text": "translocation abnormality 46,XXY,t(13q;14",
            "probability": 7.808208465576172e-06
        },
        {
            "start_logit": -0.75830078125,
            "end_logit": -4.2734375,
            "text": "46,XXY,t(13q;14",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -0.038604736328125,
            "end_logit": -5.00390625,
            "text": "translocation",
            "probability": 3.7550926208496094e-06
        }
    ],
    "56c8f4615795f9a73e00001a_1": [
        {
            "start_logit": 7.921875,
            "end_logit": 7.90234375,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.921875,
            "end_logit": -1.732421875,
            "text": "GBs",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": -1.888671875,
            "end_logit": 7.90234375,
            "text": "e",
            "probability": 5.4776668548583984e-05
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 7.90234375,
            "text": "hape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.07421875,
            "text": "GBshap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.6640625,
            "text": "GBshape: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.94140625,
            "text": "GBshape:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.0,
            "text": "GBshape: a genome browser database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.0234375,
            "text": "GBshape: a genome browser database for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.125,
            "text": "GBshape: a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -8.1796875,
            "text": "GBshape: a genome browser database for DNA shape annotations.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.888671875,
            "end_logit": -7.6640625,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.888671875,
            "end_logit": -7.94140625,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -1.888671875,
            "end_logit": -8.0,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -1.888671875,
            "end_logit": -8.0234375,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -1.888671875,
            "end_logit": -8.125,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -1.888671875,
            "end_logit": -8.1796875,
            "text": "e: a genome browser database for DNA shape annotations.",
            "probability": 0.0
        },
        {
            "start_logit": -6.1328125,
            "end_logit": -7.07421875,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -6.1328125,
            "end_logit": -7.6640625,
            "text": "hape: a",
            "probability": 0.0
        },
        {
            "start_logit": -6.1328125,
            "end_logit": -7.94140625,
            "text": "hape:",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_2": [
        {
            "start_logit": 7.91796875,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.1727294921875
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.1700439453125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.1700439453125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.16748046875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 8.046875,
            "text": "GBshape framework. GBshape",
            "probability": 0.1610107421875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.158447265625
        },
        {
            "start_logit": -0.7236328125,
            "end_logit": 8.046875,
            "text": "e framework. GBshape",
            "probability": 3.0517578125e-05
        },
        {
            "start_logit": -0.7236328125,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 3.0040740966796875e-05
        },
        {
            "start_logit": -0.759765625,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.9385089874267578e-05
        },
        {
            "start_logit": -0.82958984375,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.7685546875,
            "text": "GBs",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.77197265625,
            "text": "GBs",
            "probability": 2.5331974029541016e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -0.7685546875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -0.912109375,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -0.912109375,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.491474151611328e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -0.77197265625,
            "text": "GBshape framework. GBs",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.099609375,
            "text": "GBs",
            "probability": 1.811981201171875e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.2490234375,
            "text": "GBs",
            "probability": 1.4781951904296875e-05
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 8.046875,
            "text": "hape framework. GBshape",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 8.03125,
            "text": "hape",
            "probability": 1.1324882507324219e-06
        }
    ],
    "56c8f4615795f9a73e00001a_3": [
        {
            "start_logit": 7.91796875,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.1727294921875
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.1700439453125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.1700439453125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.16748046875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 8.046875,
            "text": "GBshape framework. GBshape",
            "probability": 0.1610107421875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.158447265625
        },
        {
            "start_logit": -0.7236328125,
            "end_logit": 8.046875,
            "text": "e framework. GBshape",
            "probability": 3.0517578125e-05
        },
        {
            "start_logit": -0.7236328125,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 3.0040740966796875e-05
        },
        {
            "start_logit": -0.759765625,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.9385089874267578e-05
        },
        {
            "start_logit": -0.82958984375,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.7685546875,
            "text": "GBs",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.77197265625,
            "text": "GBs",
            "probability": 2.5331974029541016e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -0.7685546875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -0.912109375,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -0.912109375,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.491474151611328e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -0.77197265625,
            "text": "GBshape framework. GBs",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.099609375,
            "text": "GBs",
            "probability": 1.811981201171875e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.2490234375,
            "text": "GBs",
            "probability": 1.4781951904296875e-05
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 8.046875,
            "text": "hape framework. GBshape",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 8.03125,
            "text": "hape",
            "probability": 1.1324882507324219e-06
        }
    ],
    "56c8f4615795f9a73e00001a_4": [
        {
            "start_logit": 7.91796875,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.1727294921875
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.1700439453125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.1700439453125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.16748046875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 8.046875,
            "text": "GBshape framework. GBshape",
            "probability": 0.1610107421875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.158447265625
        },
        {
            "start_logit": -0.7236328125,
            "end_logit": 8.046875,
            "text": "e framework. GBshape",
            "probability": 3.0517578125e-05
        },
        {
            "start_logit": -0.7236328125,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 3.0040740966796875e-05
        },
        {
            "start_logit": -0.759765625,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.9385089874267578e-05
        },
        {
            "start_logit": -0.82958984375,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.7685546875,
            "text": "GBs",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.77197265625,
            "text": "GBs",
            "probability": 2.5331974029541016e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -0.7685546875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -0.912109375,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -0.912109375,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.491474151611328e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -0.77197265625,
            "text": "GBshape framework. GBs",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.099609375,
            "text": "GBs",
            "probability": 1.811981201171875e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.2490234375,
            "text": "GBs",
            "probability": 1.4781951904296875e-05
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 8.046875,
            "text": "hape framework. GBshape",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 8.03125,
            "text": "hape",
            "probability": 1.1324882507324219e-06
        }
    ],
    "56c8f4615795f9a73e00001a_5": [
        {
            "start_logit": 7.91796875,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.1727294921875
        },
        {
            "start_logit": 7.91796875,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.1700439453125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 8.046875,
            "text": "GBshape",
            "probability": 0.1700439453125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.16748046875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 8.046875,
            "text": "GBshape framework. GBshape",
            "probability": 0.1610107421875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.158447265625
        },
        {
            "start_logit": -0.7236328125,
            "end_logit": 8.046875,
            "text": "e framework. GBshape",
            "probability": 3.0517578125e-05
        },
        {
            "start_logit": -0.7236328125,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 3.0040740966796875e-05
        },
        {
            "start_logit": -0.759765625,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.9385089874267578e-05
        },
        {
            "start_logit": -0.82958984375,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.7685546875,
            "text": "GBs",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -0.77197265625,
            "text": "GBs",
            "probability": 2.5331974029541016e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -0.7685546875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -0.912109375,
            "end_logit": 8.046875,
            "text": "e",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -0.912109375,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.491474151611328e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -0.77197265625,
            "text": "GBshape framework. GBs",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -1.099609375,
            "text": "GBs",
            "probability": 1.811981201171875e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.2490234375,
            "text": "GBs",
            "probability": 1.4781951904296875e-05
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 8.046875,
            "text": "hape framework. GBshape",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 8.03125,
            "text": "hape",
            "probability": 1.1324882507324219e-06
        }
    ],
    "56c8f4615795f9a73e00001a_6": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.94140625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -1.572265625,
            "text": "GBs",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": 7.94140625,
            "text": "e",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -5.88671875,
            "end_logit": 7.94140625,
            "text": "hape",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.171875,
            "text": "GBshap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.0234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.0546875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.109375,
            "text": "GBshape can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.1171875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.1953125,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.203125,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.3125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.34375,
            "text": "GBshape can be used",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.0234375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.0546875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.109375,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.1171875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.1953125,
            "text": "e can be used to",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_7": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.0078125,
            "text": "GBshape",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0234375,
            "text": "GBshape",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0078125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.329833984375
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.857421875,
            "text": "GBs",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.857421875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": -1.1025390625,
            "end_logit": 8.0078125,
            "text": "e",
            "probability": 4.011392593383789e-05
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": 8.0234375,
            "text": "e",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": 8.0078125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.232421875,
            "text": "GBs",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 8.0234375,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 8.0078125,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 8.0234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 8.0078125,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 8.0078125,
            "text": "hape",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 8.0078125,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.0234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.3046875,
            "text": "GBshape;",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 8.0078125,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.66796875,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.66796875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c8f4615795f9a73e00001a_8": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.0078125,
            "text": "GBshape",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0234375,
            "text": "GBshape",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0078125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.329833984375
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.857421875,
            "text": "GBs",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.857421875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": -1.1025390625,
            "end_logit": 8.0078125,
            "text": "e",
            "probability": 4.011392593383789e-05
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": 8.0234375,
            "text": "e",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": 8.0078125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.232421875,
            "text": "GBs",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 8.0234375,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 8.0078125,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 8.0234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 8.0078125,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 8.0078125,
            "text": "hape",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 8.0078125,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.0234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.3046875,
            "text": "GBshape;",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 8.0078125,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.66796875,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.66796875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c8f4615795f9a73e00001a_9": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.94140625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -1.572265625,
            "text": "GBs",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": 7.94140625,
            "text": "e",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -5.88671875,
            "end_logit": 7.94140625,
            "text": "hape",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.171875,
            "text": "GBshap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.0234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.0546875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.109375,
            "text": "GBshape can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.1171875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.1953125,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.203125,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.3125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.34375,
            "text": "GBshape can be used",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.0234375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.0546875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.109375,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.1171875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.1953125,
            "text": "e can be used to",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_10": [
        {
            "start_logit": 7.9140625,
            "end_logit": 7.94921875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": 7.94921875,
            "text": "e",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.63671875,
            "text": "GBs",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -5.8203125,
            "end_logit": 7.94921875,
            "text": "hape",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.15625,
            "text": "GBshap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.90625,
            "text": "GBshape can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -7.98828125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.046875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.1015625,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -8.140625,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -7.90625,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -7.98828125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -8.046875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -8.1015625,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -1.6259765625,
            "end_logit": -8.140625,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -5.8203125,
            "end_logit": -7.15625,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -5.8203125,
            "end_logit": -7.90625,
            "text": "hape can",
            "probability": 0.0
        },
        {
            "start_logit": -5.8203125,
            "end_logit": -7.98828125,
            "text": "hape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -5.8203125,
            "end_logit": -8.046875,
            "text": "hape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        },
        {
            "start_logit": -5.8203125,
            "end_logit": -8.1015625,
            "text": "hape can be",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_11": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.98828125,
            "text": "GBshape",
            "probability": 0.345458984375
        },
        {
            "start_logit": 7.8671875,
            "end_logit": 8.0078125,
            "text": "GBshape",
            "probability": 0.32958984375
        },
        {
            "start_logit": 7.8671875,
            "end_logit": 7.98828125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.324462890625
        },
        {
            "start_logit": 0.38330078125,
            "end_logit": 8.0078125,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.00018513202667236328
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.66064453125,
            "text": "GBs",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -0.66064453125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 5.644559860229492e-05
        },
        {
            "start_logit": -1.060546875,
            "end_logit": 7.98828125,
            "text": "e",
            "probability": 4.297494888305664e-05
        },
        {
            "start_logit": -1.177734375,
            "end_logit": 8.0078125,
            "text": "e",
            "probability": 3.88026237487793e-05
        },
        {
            "start_logit": -1.177734375,
            "end_logit": 7.98828125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.4921875,
            "text": "GBs",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 8.0078125,
            "text": "hape",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 7.98828125,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -4.546875,
            "end_logit": 7.98828125,
            "text": "hape",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.44140625,
            "end_logit": 7.98828125,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -5.50390625,
            "text": "GBshape;",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 7.98828125,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -5.953125,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 8.0078125,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.34375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 7.98828125,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c8f4615795f9a73e00001a_12": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.98828125,
            "text": "GBshape",
            "probability": 0.345458984375
        },
        {
            "start_logit": 7.8671875,
            "end_logit": 8.0078125,
            "text": "GBshape",
            "probability": 0.32958984375
        },
        {
            "start_logit": 7.8671875,
            "end_logit": 7.98828125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.324462890625
        },
        {
            "start_logit": 0.38330078125,
            "end_logit": 8.0078125,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.00018513202667236328
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.66064453125,
            "text": "GBs",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -0.66064453125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 5.644559860229492e-05
        },
        {
            "start_logit": -1.060546875,
            "end_logit": 7.98828125,
            "text": "e",
            "probability": 4.297494888305664e-05
        },
        {
            "start_logit": -1.177734375,
            "end_logit": 8.0078125,
            "text": "e",
            "probability": 3.88026237487793e-05
        },
        {
            "start_logit": -1.177734375,
            "end_logit": 7.98828125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.4921875,
            "text": "GBs",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 8.0078125,
            "text": "hape",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 7.98828125,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -4.546875,
            "end_logit": 7.98828125,
            "text": "hape",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.44140625,
            "end_logit": 7.98828125,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -5.50390625,
            "text": "GBshape;",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 7.98828125,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -5.953125,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 8.0078125,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.34375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 7.98828125,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c8f4615795f9a73e00001a_13": [
        {
            "start_logit": 7.9375,
            "end_logit": 8.015625,
            "text": "GBshape",
            "probability": 0.340087890625
        },
        {
            "start_logit": 7.90625,
            "end_logit": 8.015625,
            "text": "GBshape",
            "probability": 0.329833984375
        },
        {
            "start_logit": 7.90625,
            "end_logit": 8.015625,
            "text": "GBshape framework. GBshape",
            "probability": 0.329833984375
        },
        {
            "start_logit": 7.9375,
            "end_logit": -1.140625,
            "text": "GBs",
            "probability": 3.5881996154785156e-05
        },
        {
            "start_logit": -1.2431640625,
            "end_logit": 8.015625,
            "text": "e",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": -1.2431640625,
            "end_logit": 8.015625,
            "text": "e framework. GBshape",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -1.140625,
            "text": "GBshape framework. GBs",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": -1.2607421875,
            "end_logit": 8.015625,
            "text": "e",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -1.37890625,
            "text": "GBs",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -4.94140625,
            "end_logit": 8.015625,
            "text": "hape",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -4.94140625,
            "end_logit": 8.015625,
            "text": "hape framework. GBshape",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 8.015625,
            "text": "hape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 8.015625,
            "text": ". GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 8.015625,
            "text": "the GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 8.015625,
            "text": "the GBshape framework. GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.71875,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.71875,
            "text": "GBshape framework. GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.015625,
            "text": "genomes can easily be added using the GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.015625,
            "text": "genomes can easily be added using the GBshape framework. GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.01953125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c8f4615795f9a73e00001a_14": [
        {
            "start_logit": 7.9375,
            "end_logit": 8.015625,
            "text": "GBshape",
            "probability": 0.340087890625
        },
        {
            "start_logit": 7.90625,
            "end_logit": 8.015625,
            "text": "GBshape",
            "probability": 0.329833984375
        },
        {
            "start_logit": 7.90625,
            "end_logit": 8.015625,
            "text": "GBshape framework. GBshape",
            "probability": 0.329833984375
        },
        {
            "start_logit": 7.9375,
            "end_logit": -1.140625,
            "text": "GBs",
            "probability": 3.5881996154785156e-05
        },
        {
            "start_logit": -1.2431640625,
            "end_logit": 8.015625,
            "text": "e",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": -1.2431640625,
            "end_logit": 8.015625,
            "text": "e framework. GBshape",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -1.140625,
            "text": "GBshape framework. GBs",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": -1.2607421875,
            "end_logit": 8.015625,
            "text": "e",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -1.37890625,
            "text": "GBs",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -4.94140625,
            "end_logit": 8.015625,
            "text": "hape",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -4.94140625,
            "end_logit": 8.015625,
            "text": "hape framework. GBshape",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 8.015625,
            "text": "hape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 8.015625,
            "text": ". GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 8.015625,
            "text": "the GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 8.015625,
            "text": "the GBshape framework. GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.71875,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -6.71875,
            "text": "GBshape framework. GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.015625,
            "text": "genomes can easily be added using the GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.015625,
            "text": "genomes can easily be added using the GBshape framework. GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.01953125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c8f4615795f9a73e00001a_15": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.259033203125
        },
        {
            "start_logit": 7.91015625,
            "end_logit": 8.0546875,
            "text": "GBshape",
            "probability": 0.259033203125
        },
        {
            "start_logit": 7.91015625,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.2548828125
        },
        {
            "start_logit": 7.8046875,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.2266845703125
        },
        {
            "start_logit": -0.79248046875,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 4.166364669799805e-05
        },
        {
            "start_logit": -0.86669921875,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.81787109375,
            "text": "GBs",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -0.81787109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.62396240234375e-05
        },
        {
            "start_logit": -0.98974609375,
            "end_logit": 8.0546875,
            "text": "e",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": -0.98974609375,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.457069396972656e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -1.2216796875,
            "text": "GBs",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -1.5400390625,
            "text": "GBs",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -4.5390625,
            "end_logit": 8.0546875,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 8.0546875,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 8.0390625,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.71484375,
            "end_logit": 8.03125,
            "text": "hape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 8.0390625,
            "text": "hape",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.01171875,
            "end_logit": 8.0390625,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 8.0546875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 8.03125,
            "text": "the GBshape",
            "probability": 3.5762786865234375e-07
        }
    ],
    "56c8f4615795f9a73e00001a_16": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.259033203125
        },
        {
            "start_logit": 7.91015625,
            "end_logit": 8.0546875,
            "text": "GBshape",
            "probability": 0.259033203125
        },
        {
            "start_logit": 7.91015625,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.2548828125
        },
        {
            "start_logit": 7.8046875,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.2266845703125
        },
        {
            "start_logit": -0.79248046875,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 4.166364669799805e-05
        },
        {
            "start_logit": -0.86669921875,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.81787109375,
            "text": "GBs",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -0.81787109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.62396240234375e-05
        },
        {
            "start_logit": -0.98974609375,
            "end_logit": 8.0546875,
            "text": "e",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": -0.98974609375,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.457069396972656e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -1.2216796875,
            "text": "GBs",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -1.5400390625,
            "text": "GBs",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -4.5390625,
            "end_logit": 8.0546875,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 8.0546875,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 8.0390625,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.71484375,
            "end_logit": 8.03125,
            "text": "hape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 8.0390625,
            "text": "hape",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.01171875,
            "end_logit": 8.0390625,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 8.0546875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 8.03125,
            "text": "the GBshape",
            "probability": 3.5762786865234375e-07
        }
    ],
    "56c8f4615795f9a73e00001a_17": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.0390625,
            "text": "GBshape",
            "probability": 0.259033203125
        },
        {
            "start_logit": 7.91015625,
            "end_logit": 8.0546875,
            "text": "GBshape",
            "probability": 0.259033203125
        },
        {
            "start_logit": 7.91015625,
            "end_logit": 8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.2548828125
        },
        {
            "start_logit": 7.8046875,
            "end_logit": 8.03125,
            "text": "GBshape",
            "probability": 0.2266845703125
        },
        {
            "start_logit": -0.79248046875,
            "end_logit": 8.03125,
            "text": "e",
            "probability": 4.166364669799805e-05
        },
        {
            "start_logit": -0.86669921875,
            "end_logit": 8.0390625,
            "text": "e",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.81787109375,
            "text": "GBs",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -0.81787109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.62396240234375e-05
        },
        {
            "start_logit": -0.98974609375,
            "end_logit": 8.0546875,
            "text": "e",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": -0.98974609375,
            "end_logit": 8.0390625,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.457069396972656e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -1.2216796875,
            "text": "GBs",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -1.5400390625,
            "text": "GBs",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -4.5390625,
            "end_logit": 8.0546875,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 8.0546875,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 8.0390625,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.71484375,
            "end_logit": 8.03125,
            "text": "hape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 8.0390625,
            "text": "hape",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.01171875,
            "end_logit": 8.0390625,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 8.0546875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 8.03125,
            "text": "the GBshape",
            "probability": 3.5762786865234375e-07
        }
    ],
    "56c8f4615795f9a73e00001a_18": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.94140625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -1.572265625,
            "text": "GBs",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": 7.94140625,
            "text": "e",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -5.88671875,
            "end_logit": 7.94140625,
            "text": "hape",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.171875,
            "text": "GBshap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.0234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.0546875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.109375,
            "text": "GBshape can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.1171875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.1953125,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.203125,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.3125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.34375,
            "text": "GBshape can be used",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.0234375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.0546875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.109375,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.1171875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.1953125,
            "text": "e can be used to",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_19": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.0078125,
            "text": "GBshape",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0234375,
            "text": "GBshape",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0078125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.329833984375
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.857421875,
            "text": "GBs",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.857421875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": -1.1025390625,
            "end_logit": 8.0078125,
            "text": "e",
            "probability": 4.011392593383789e-05
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": 8.0234375,
            "text": "e",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": 8.0078125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.232421875,
            "text": "GBs",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 8.0234375,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 8.0078125,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 8.0234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 8.0078125,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 8.0078125,
            "text": "hape",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 8.0078125,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.0234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.3046875,
            "text": "GBshape;",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 8.0078125,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.66796875,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.66796875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c8f4615795f9a73e00001a_20": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.0078125,
            "text": "GBshape",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0234375,
            "text": "GBshape",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9140625,
            "end_logit": 8.0078125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.329833984375
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.857421875,
            "text": "GBs",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -0.857421875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": -1.1025390625,
            "end_logit": 8.0078125,
            "text": "e",
            "probability": 4.011392593383789e-05
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": 8.0234375,
            "text": "e",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": -1.1982421875,
            "end_logit": 8.0078125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -1.232421875,
            "text": "GBs",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 8.0234375,
            "text": "hape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 8.0078125,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 8.0234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 8.0078125,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 8.0078125,
            "text": "hape",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 8.0078125,
            "text": "freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.0234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.3046875,
            "text": "GBshape;",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 8.0078125,
            "text": "rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.66796875,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9140625,
            "end_logit": -6.66796875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e36cf8eb5b409ea53000007_1": [
        {
            "start_logit": 7.51953125,
            "end_logit": 7.40234375,
            "text": "melanocyte",
            "probability": 0.4775390625
        },
        {
            "start_logit": 7.51953125,
            "end_logit": 6.375,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 0.1702880859375
        },
        {
            "start_logit": 6.66796875,
            "end_logit": 6.40234375,
            "text": "melanocytes",
            "probability": 0.074951171875
        },
        {
            "start_logit": 6.6484375,
            "end_logit": 6.40234375,
            "text": "melanocytes",
            "probability": 0.0732421875
        },
        {
            "start_logit": 6.6328125,
            "end_logit": 6.41796875,
            "text": "melanocytes",
            "probability": 0.0732421875
        },
        {
            "start_logit": 6.53515625,
            "end_logit": 6.41796875,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 0.06671142578125
        },
        {
            "start_logit": 6.53515625,
            "end_logit": 6.375,
            "text": "melanocytes",
            "probability": 0.0635986328125
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -1.263671875,
            "text": "melan",
            "probability": 8.249282836914062e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 7.40234375,
            "text": "ocyte",
            "probability": 3.1054019927978516e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 6.375,
            "text": "ocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -5.078125,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -5.48828125,
            "text": "melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -5.7578125,
            "text": "melanocytes above the stem cell niche protect HSPCs against ultraviolet-light-induced DNA damage. Indeed",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -6.67578125,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes have normal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 6.40234375,
            "text": "that melanocytes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.703125,
            "end_logit": 6.41796875,
            "text": "that melanocytes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 7.40234375,
            "text": "kidney marrow in teleost fish. Here we show that a melanocyte",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 6.40234375,
            "text": "reveal that melanocytes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -6.64453125,
            "text": "melanocytes above the stem cell niche protect HSPCs against ultraviolet-light-induced DNA damage. Indeed, after ultraviolet-light irradiation, unpigmented larvae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 6.41796875,
            "text": "zebrafish. Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e36cf8eb5b409ea53000007_2": [
        {
            "start_logit": 7.51953125,
            "end_logit": 7.40234375,
            "text": "melanocyte",
            "probability": 0.4775390625
        },
        {
            "start_logit": 7.51953125,
            "end_logit": 6.375,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 0.1702880859375
        },
        {
            "start_logit": 6.66796875,
            "end_logit": 6.40234375,
            "text": "melanocytes",
            "probability": 0.074951171875
        },
        {
            "start_logit": 6.6484375,
            "end_logit": 6.40234375,
            "text": "melanocytes",
            "probability": 0.0732421875
        },
        {
            "start_logit": 6.6328125,
            "end_logit": 6.41796875,
            "text": "melanocytes",
            "probability": 0.0732421875
        },
        {
            "start_logit": 6.53515625,
            "end_logit": 6.41796875,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 0.06671142578125
        },
        {
            "start_logit": 6.53515625,
            "end_logit": 6.375,
            "text": "melanocytes",
            "probability": 0.0635986328125
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -1.263671875,
            "text": "melan",
            "probability": 8.249282836914062e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 7.40234375,
            "text": "ocyte",
            "probability": 3.1054019927978516e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 6.375,
            "text": "ocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -5.078125,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -5.48828125,
            "text": "melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -5.7578125,
            "text": "melanocytes above the stem cell niche protect HSPCs against ultraviolet-light-induced DNA damage. Indeed",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -6.67578125,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes have normal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 6.40234375,
            "text": "that melanocytes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.703125,
            "end_logit": 6.41796875,
            "text": "that melanocytes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 7.40234375,
            "text": "kidney marrow in teleost fish. Here we show that a melanocyte",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 6.40234375,
            "text": "reveal that melanocytes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -6.64453125,
            "text": "melanocytes above the stem cell niche protect HSPCs against ultraviolet-light-induced DNA damage. Indeed, after ultraviolet-light irradiation, unpigmented larvae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 6.41796875,
            "text": "zebrafish. Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e36cf8eb5b409ea53000007_3": [
        {
            "start_logit": 7.51953125,
            "end_logit": 7.40234375,
            "text": "melanocyte",
            "probability": 0.4775390625
        },
        {
            "start_logit": 7.51953125,
            "end_logit": 6.375,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 0.1702880859375
        },
        {
            "start_logit": 6.66796875,
            "end_logit": 6.40234375,
            "text": "melanocytes",
            "probability": 0.074951171875
        },
        {
            "start_logit": 6.6484375,
            "end_logit": 6.40234375,
            "text": "melanocytes",
            "probability": 0.0732421875
        },
        {
            "start_logit": 6.6328125,
            "end_logit": 6.41796875,
            "text": "melanocytes",
            "probability": 0.0732421875
        },
        {
            "start_logit": 6.53515625,
            "end_logit": 6.41796875,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 0.06671142578125
        },
        {
            "start_logit": 6.53515625,
            "end_logit": 6.375,
            "text": "melanocytes",
            "probability": 0.0635986328125
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -1.263671875,
            "text": "melan",
            "probability": 8.249282836914062e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 7.40234375,
            "text": "ocyte",
            "probability": 3.1054019927978516e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 6.375,
            "text": "ocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -5.078125,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -5.48828125,
            "text": "melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -5.7578125,
            "text": "melanocytes above the stem cell niche protect HSPCs against ultraviolet-light-induced DNA damage. Indeed",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -6.67578125,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes have normal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 6.40234375,
            "text": "that melanocytes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.703125,
            "end_logit": 6.41796875,
            "text": "that melanocytes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 7.40234375,
            "text": "kidney marrow in teleost fish. Here we show that a melanocyte",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 6.40234375,
            "text": "reveal that melanocytes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -6.64453125,
            "text": "melanocytes above the stem cell niche protect HSPCs against ultraviolet-light-induced DNA damage. Indeed, after ultraviolet-light irradiation, unpigmented larvae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 6.41796875,
            "text": "zebrafish. Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e36cf8eb5b409ea53000007_4": [
        {
            "start_logit": 7.51953125,
            "end_logit": 7.40234375,
            "text": "melanocyte",
            "probability": 0.4775390625
        },
        {
            "start_logit": 7.51953125,
            "end_logit": 6.375,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 0.1702880859375
        },
        {
            "start_logit": 6.66796875,
            "end_logit": 6.40234375,
            "text": "melanocytes",
            "probability": 0.074951171875
        },
        {
            "start_logit": 6.6484375,
            "end_logit": 6.40234375,
            "text": "melanocytes",
            "probability": 0.0732421875
        },
        {
            "start_logit": 6.6328125,
            "end_logit": 6.41796875,
            "text": "melanocytes",
            "probability": 0.0732421875
        },
        {
            "start_logit": 6.53515625,
            "end_logit": 6.41796875,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 0.06671142578125
        },
        {
            "start_logit": 6.53515625,
            "end_logit": 6.375,
            "text": "melanocytes",
            "probability": 0.0635986328125
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -1.263671875,
            "text": "melan",
            "probability": 8.249282836914062e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 7.40234375,
            "text": "ocyte",
            "probability": 3.1054019927978516e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 6.375,
            "text": "ocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -5.078125,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -5.48828125,
            "text": "melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -5.7578125,
            "text": "melanocytes above the stem cell niche protect HSPCs against ultraviolet-light-induced DNA damage. Indeed",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.51953125,
            "end_logit": -6.67578125,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes have normal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 6.40234375,
            "text": "that melanocytes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.703125,
            "end_logit": 6.41796875,
            "text": "that melanocytes",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 7.40234375,
            "text": "kidney marrow in teleost fish. Here we show that a melanocyte",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 6.40234375,
            "text": "reveal that melanocytes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -6.64453125,
            "text": "melanocytes above the stem cell niche protect HSPCs against ultraviolet-light-induced DNA damage. Indeed, after ultraviolet-light irradiation, unpigmented larvae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 6.41796875,
            "text": "zebrafish. Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54ff45966ad7dcbc12000010_1": [
        {
            "start_logit": 7.33984375,
            "end_logit": 7.28515625,
            "text": "serine protease inhibitor",
            "probability": 0.96240234375
        },
        {
            "start_logit": 7.33984375,
            "end_logit": 4.046875,
            "text": "serine protease inhibitor Kazal-type 5",
            "probability": 0.03790283203125
        },
        {
            "start_logit": -2.80859375,
            "end_logit": 7.28515625,
            "text": "inhibitor",
            "probability": 3.7670135498046875e-05
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -3.32421875,
            "text": "serine",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -4.25,
            "text": "serine protease inhibitor Kazal-type 5 gene",
            "probability": 9.47713851928711e-06
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -5.19921875,
            "text": "serine protease inhibitor Kazal-type 5 gene, which encodes the lympho-epithelial Kazal-type-related inhibitor.",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -5.484375,
            "text": "serine protease inhibitor Kazal-type 5 gene, which encodes the",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -5.8359375,
            "end_logit": 7.28515625,
            "text": "protease inhibitor",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.02734375,
            "text": "serine protease inhibitor Kazal-type 5 gene, which encodes the lympho-epithelial Kazal-type",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -2.80859375,
            "end_logit": 4.046875,
            "text": "inhibitor Kazal-type 5",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.20703125,
            "text": "serine protease inhibitor Kazal-type 5 gene, which encodes the lympho-epithelial Kazal-type-related inhibitor",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 7.28515625,
            "text": "the serine protease inhibitor",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.765625,
            "text": "serine protease",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.81640625,
            "text": "serine protease inhibitor Kazal-type 5 gene, which encodes the lympho-epithelial Kazal-type-",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.87890625,
            "text": "serine protease inhibitor Kazal-type",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.953125,
            "text": "serine protease inhibitor Kazal-type 5 gene, which encodes the lympho",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.0390625,
            "text": "serine protease inhibitor Kazal-type 5 gene, which encodes the lympho-epithelial Kazal-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.09375,
            "text": "serine protease inhibitor Kazal-type 5 gene, which encodes the lympho-epithelial",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.109375,
            "text": "serine protease inhibitor Kazal-type 5 gene, which",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.26171875,
            "text": "serine protease inhibitor Kazal-type 5 gene, which encodes the lympho-epithelial Ka",
            "probability": 4.76837158203125e-07
        }
    ],
    "54ff45966ad7dcbc12000010_2": [
        {
            "start_logit": 6.6640625,
            "end_logit": 6.98046875,
            "text": "SPINK5",
            "probability": 1.0
        },
        {
            "start_logit": -3.484375,
            "end_logit": 6.98046875,
            "text": "5",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -4.203125,
            "text": "SPIN",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 6.98046875,
            "text": "K5",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 6.98046875,
            "text": "Netherton syndrome is caused by loss-of-function mutations in SPINK5",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -6.87109375,
            "text": "SPINK5 encoding the Kazal-type inhibitor",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -6.890625,
            "text": "SPINK5 encoding the Kazal-type inhibitor LEKTI-1",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -6.984375,
            "text": "SPINK",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.08984375,
            "text": "SPINK5 encoding the Kazal-type",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.98046875,
            "text": "syndrome is caused by loss-of-function mutations in SPINK5",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.453125,
            "text": "SPINK5 encoding the Ka",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.51953125,
            "text": "SPINK5 encoding the Kazal",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.65625,
            "text": "SPINK5 encoding the Kazal-type inhibitor LEKTI",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.7421875,
            "text": "SPINK5 encoding the Kaz",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.75390625,
            "text": "SPINK5 encoding the Kazal-type inhibitor LEKT",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.77734375,
            "text": "SPINK5 encoding the Kazal-type inhibitor LEKTI-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -8.015625,
            "text": "SPINK5 encoding the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -8.1015625,
            "text": "SPINK5 encoding the Kazal-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.0859375,
            "end_logit": -6.87109375,
            "text": "the Kazal-type inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -3.0859375,
            "end_logit": -6.890625,
            "text": "the Kazal-type inhibitor LEKTI-1",
            "probability": 0.0
        }
    ],
    "54ff45966ad7dcbc12000010_3": [
        {
            "start_logit": 6.203125,
            "end_logit": 6.94140625,
            "text": "serine protease inhibitor",
            "probability": 0.79150390625
        },
        {
            "start_logit": 4.86328125,
            "end_logit": 6.94140625,
            "text": "serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor",
            "probability": 0.2081298828125
        },
        {
            "start_logit": 4.86328125,
            "end_logit": -0.455322265625,
            "text": "serine protease inhibitor",
            "probability": 0.00012731552124023438
        },
        {
            "start_logit": -3.265625,
            "end_logit": 6.94140625,
            "text": "inhibitor",
            "probability": 6.115436553955078e-05
        },
        {
            "start_logit": -3.328125,
            "end_logit": 6.94140625,
            "text": "a serine protease inhibitor",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": -4.69921875,
            "end_logit": 6.94140625,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor",
            "probability": 1.4603137969970703e-05
        },
        {
            "start_logit": 6.203125,
            "end_logit": -4.47265625,
            "text": "serine protease inhibitor LEKTI",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 6.203125,
            "end_logit": -4.47265625,
            "text": "serine",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 6.203125,
            "end_logit": -5.0,
            "text": "serine protease",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -5.84765625,
            "end_logit": 6.94140625,
            "text": "K5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 6.94140625,
            "text": "protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 6.94140625,
            "text": "protease inhibitor",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 4.86328125,
            "end_logit": -4.47265625,
            "text": "serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 4.86328125,
            "end_logit": -4.47265625,
            "text": "serine protease inhibitor Kazal type 5) which encodes for a serine",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 4.86328125,
            "end_logit": -5.0,
            "text": "serine protease inhibitor Kazal type 5) which encodes for a serine protease",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 6.94140625,
            "text": "(serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 6.94140625,
            "text": "5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.28125,
            "end_logit": 6.94140625,
            "text": "gene SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 4.86328125,
            "end_logit": -5.4453125,
            "text": "serine",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.94140625,
            "text": "the gene SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor",
            "probability": 7.748603820800781e-07
        }
    ],
    "54ff45966ad7dcbc12000010_4": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.81640625,
            "text": "serine protease inhibitor",
            "probability": 1.0
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.818359375,
            "text": "serine",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": -1.900390625,
            "end_logit": 7.81640625,
            "text": "inhibitor",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -5.875,
            "text": "serine protease inhibitor Kazal type 5",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.078125,
            "text": "serine protease",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.1875,
            "end_logit": 7.81640625,
            "text": "protease inhibitor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.71484375,
            "text": "serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.875,
            "text": "serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.05078125,
            "text": "serine protease inhibitor Ka",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.0546875,
            "text": "serine protease inhibitor Kazal type 5 (SPINK5",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.12109375,
            "text": "serine protease inhibitor Kazal type 5 (SPINK",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.1484375,
            "text": "serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.20703125,
            "text": "serine protease inhibitor Kazal type 5 (SPINK5)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.375,
            "text": "serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.5078125,
            "text": "serine protease inhibitor Kazal type 5 (SPIN",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.65234375,
            "text": "serine protease inhibitor Kazal type",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.7421875,
            "text": "serine protease inhibitor Kazal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -7.7578125,
            "text": "serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.81640625,
            "text": "Mutations in the serine protease inhibitor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -5.875,
            "text": "inhibitor Kazal type 5",
            "probability": 0.0
        }
    ],
    "54ff45966ad7dcbc12000010_5": [
        {
            "start_logit": 7.890625,
            "end_logit": 7.9453125,
            "text": "SPINK5",
            "probability": 1.0
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.4375,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": -1.6435546875,
            "end_logit": 7.9453125,
            "text": "5",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -1.970703125,
            "text": "SPIN",
            "probability": 4.947185516357422e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -5.46875,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the skin and all stratified epithelial tissues.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.890625,
            "end_logit": -5.75,
            "text": "SPINK",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.578125,
            "end_logit": 7.9453125,
            "text": "K5",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.1640625,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the skin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.23828125,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.40234375,
            "text": "SPINK5 gene and to the consequent lack of expression of its",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.44921875,
            "text": "SPINK5 gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.45703125,
            "text": "SPINK5 gene and to the consequent lack of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.47265625,
            "text": "SPINK5 gene and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.51171875,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the skin and all",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.9453125,
            "text": "NS is due to loss-of-function mutations in the SPINK5",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.53125,
            "text": "SPINK5 gene and to the consequent lack of expression",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.62109375,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.63671875,
            "text": "SPINK5 gene and to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.6640625,
            "text": "SPINK5 gene and to the consequent lack of expression of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.69140625,
            "text": "SPINK5 gene and to the consequent",
            "probability": 1.7881393432617188e-07
        }
    ],
    "54ff45966ad7dcbc12000010_6": [
        {
            "start_logit": 4.12109375,
            "end_logit": 3.873046875,
            "text": "serine protease inhibitor of kazal type 5)",
            "probability": 0.9931640625
        },
        {
            "start_logit": -1.2958984375,
            "end_logit": 3.873046875,
            "text": "SPINK5 (serine protease inhibitor of kazal type 5)",
            "probability": 0.004421234130859375
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -2.826171875,
            "text": "serine protease inhibitor of kazal type 5) encoding LEKTI-1 (lympho-epithelial kazal type related inhibitor type 5)",
            "probability": 0.00122833251953125
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -4.58984375,
            "text": "serine protease inhibitor",
            "probability": 0.00021016597747802734
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -5.8203125,
            "text": "serine",
            "probability": 6.16312026977539e-05
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -5.828125,
            "text": "serine protease inhibitor of kazal type 5",
            "probability": 6.0677528381347656e-05
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -5.90625,
            "text": "serine protease inhibitor of kazal type 5) encoding LEKTI-1",
            "probability": 5.614757537841797e-05
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -5.98046875,
            "text": "serine protease",
            "probability": 5.233287811279297e-05
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -6.19921875,
            "text": "serine protease inhibitor of kazal type 5) encoding LEKTI-1 (",
            "probability": 4.202127456665039e-05
        },
        {
            "start_logit": -6.03125,
            "end_logit": 3.873046875,
            "text": ")",
            "probability": 3.892183303833008e-05
        },
        {
            "start_logit": -6.10546875,
            "end_logit": 3.873046875,
            "text": "K5 (serine protease inhibitor of kazal type 5)",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -6.375,
            "text": "serine protease inhibitor of kazal type 5) encoding LEKTI-1 (lympho-epithelial kazal type related inhibitor type 5",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": -6.12890625,
            "end_logit": 3.873046875,
            "text": "protease inhibitor of kazal type 5)",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -6.8828125,
            "text": "serine protease inhibitor of kazal type 5) encoding LEKTI-1 (lympho-epithelial kazal type related inhibitor type 5) expressed",
            "probability": 2.1338462829589844e-05
        },
        {
            "start_logit": -0.0457763671875,
            "end_logit": -2.826171875,
            "text": "LEKTI-1 (lympho-epithelial kazal type related inhibitor type 5)",
            "probability": 1.913309097290039e-05
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -7.125,
            "text": "serine protease inhibitor of kazal type 5) encoding LEKTI",
            "probability": 1.6570091247558594e-05
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -7.171875,
            "text": "serine protease inhibitor of kazal type 5) encoding LEKTI-",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -0.0457763671875,
            "end_logit": -3.0625,
            "text": "LEKTI-1 (lympho-epithelial kazal type related inhibitor type 5) expressed in stratified epithelia.",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -7.0625,
            "end_logit": 3.873046875,
            "text": "NS is caused by loss-of-function mutations in SPINK5 (serine protease inhibitor of kazal type 5)",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 4.12109375,
            "end_logit": -7.41796875,
            "text": "serine protease inhibitor of kazal type 5) encoding LEKTI-1 (lympho-epithelial kazal type related inhibitor",
            "probability": 1.245737075805664e-05
        }
    ],
    "54ff45966ad7dcbc12000010_7": [
        {
            "start_logit": 7.54296875,
            "end_logit": 1.7021484375,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKTI)",
            "probability": 0.93359375
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -1.17578125,
            "text": "Lympho-epithelial Kazal-type-related inhibitor",
            "probability": 0.05267333984375
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -2.798828125,
            "text": "Lympho",
            "probability": 0.01036834716796875
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -5.578125,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.0006451606750488281
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -5.70703125,
            "text": "Lympho-epithelial Kazal-type",
            "probability": 0.0005669593811035156
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -6.1796875,
            "text": "Lympho-epithelial Ka",
            "probability": 0.0003533363342285156
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -6.43359375,
            "text": "Lympho-epithelial Kazal-type-related",
            "probability": 0.0002741813659667969
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -6.640625,
            "text": "Lympho-epithelial Kazal-type-",
            "probability": 0.0002219676971435547
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -6.69140625,
            "text": "Lympho-epithelial",
            "probability": 0.00021183490753173828
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -6.734375,
            "text": "Lympho-epithelial Kazal",
            "probability": 0.000202178955078125
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -6.8203125,
            "text": "Lympho-",
            "probability": 0.000186920166015625
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.1484375,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKT",
            "probability": 0.00013458728790283203
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.20703125,
            "text": "Lympho-epithelial Kaz",
            "probability": 0.0001264810562133789
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.29296875,
            "text": "Lympho-epithelial Kazal-",
            "probability": 0.00011605024337768555
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.3203125,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKTI) is the defective protein of",
            "probability": 0.00011336803436279297
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.609375,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKTI) is the defective protein",
            "probability": 8.428096771240234e-05
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.68359375,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKTI) is the defective",
            "probability": 7.855892181396484e-05
        },
        {
            "start_logit": -5.09765625,
            "end_logit": 1.7021484375,
            "text": "LEKTI)",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 1.7021484375,
            "text": "related inhibitor (LEKTI)",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 1.7021484375,
            "text": "KTI)",
            "probability": 5.960464477539062e-07
        }
    ],
    "54ff45966ad7dcbc12000010_8": [
        {
            "start_logit": 6.66796875,
            "end_logit": 6.9453125,
            "text": "serine protease inhibitor",
            "probability": 0.98193359375
        },
        {
            "start_logit": 6.66796875,
            "end_logit": 2.94921875,
            "text": "serine protease inhibitor LEKTI",
            "probability": 0.01812744140625
        },
        {
            "start_logit": -3.466796875,
            "end_logit": 6.9453125,
            "text": "inhibitor",
            "probability": 3.904104232788086e-05
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -4.19921875,
            "text": "serine",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 6.9453125,
            "text": "Deficiency in the serine protease inhibitor",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -5.88671875,
            "text": "serine protease",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 6.9453125,
            "text": "protease inhibitor",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -2.724609375,
            "end_logit": 2.94921875,
            "text": "LEKTI",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -6.46484375,
            "text": "serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -3.466796875,
            "end_logit": 2.94921875,
            "text": "inhibitor LEKTI",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.44140625,
            "text": "serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.5078125,
            "text": "serine protease inhibitor LEKTI is the etiological",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.55078125,
            "text": "serine protease inhibitor LEKTI is the etiological origin",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.75390625,
            "text": "serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.8203125,
            "text": "serine protease inhibitor LEKTI is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.890625,
            "text": "serine protease inhibitor LEKTI is the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.90234375,
            "text": "serine protease inhibitor LEKTI is the etiological origin of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.91796875,
            "text": "serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.9296875,
            "text": "serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.94921875,
            "text": "serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which",
            "probability": 3.5762786865234375e-07
        }
    ],
    "53175e9fb166e2b80600000a_1": [
        {
            "start_logit": 2.09765625,
            "end_logit": 5.90625,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.9716796875
        },
        {
            "start_logit": -2.29296875,
            "end_logit": 5.90625,
            "text": "the Wnt-signaling pathway",
            "probability": 0.01209259033203125
        },
        {
            "start_logit": -2.3203125,
            "end_logit": 5.90625,
            "text": "Wnt-signaling pathway",
            "probability": 0.0117645263671875
        },
        {
            "start_logit": -4.41015625,
            "end_logit": 5.90625,
            "text": "controlling the Wnt-signaling pathway",
            "probability": 0.0014543533325195312
        },
        {
            "start_logit": -4.734375,
            "end_logit": 5.90625,
            "text": "pathway",
            "probability": 0.0010519027709960938
        },
        {
            "start_logit": -5.04296875,
            "end_logit": 5.90625,
            "text": "signaling pathway",
            "probability": 0.0007729530334472656
        },
        {
            "start_logit": -5.87890625,
            "end_logit": 5.90625,
            "text": "studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.0003349781036376953
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 5.90625,
            "text": "-signaling pathway",
            "probability": 0.00027251243591308594
        },
        {
            "start_logit": -6.22265625,
            "end_logit": 5.90625,
            "text": "LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.00023829936981201172
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 5.90625,
            "text": "that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.00021719932556152344
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 5.90625,
            "text": "B1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.00021719932556152344
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 5.90625,
            "text": "have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.0001900196075439453
        },
        {
            "start_logit": -4.21484375,
            "end_logit": 1.671875,
            "text": ".",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": 2.09765625,
            "end_logit": -4.78515625,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway and",
            "probability": 2.2172927856445312e-05
        },
        {
            "start_logit": 2.09765625,
            "end_logit": -6.21875,
            "text": "Recent",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 1.671875,
            "text": "activation of the pathway as a consequence of LKB1 haploinsufficiency might be responsible for the development of harmatomatous polyps.",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -6.125,
            "end_logit": 1.671875,
            "text": "development of harmatomatous polyps.",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -6.2734375,
            "end_logit": 1.671875,
            "text": "harmatomatous polyps.",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 2.09765625,
            "end_logit": -6.72265625,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway and activation of the pathway",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -6.375,
            "end_logit": 1.671875,
            "text": "LKB1 haploinsufficiency might be responsible for the development of harmatomatous polyps.",
            "probability": 2.9802322387695312e-06
        }
    ],
    "5c65901c7c78d69471000008_1": [
        {
            "start_logit": 7.03515625,
            "end_logit": 6.17578125,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV",
            "probability": 0.455810546875
        },
        {
            "start_logit": 6.69921875,
            "end_logit": 6.17578125,
            "text": "HIV",
            "probability": 0.325927734375
        },
        {
            "start_logit": 7.03515625,
            "end_logit": 5.4375,
            "text": "HIV",
            "probability": 0.217041015625
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -0.521484375,
            "text": "HIV-1",
            "probability": 0.0005640983581542969
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -1.62890625,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-1",
            "probability": 0.00018596649169921875
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -1.62890625,
            "text": "HIV-1",
            "probability": 0.0001327991485595703
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -3.005859375,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-1-infected",
            "probability": 4.70280647277832e-05
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -3.005859375,
            "text": "HIV-1-infected",
            "probability": 3.361701965332031e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -4.64453125,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-",
            "probability": 9.119510650634766e-06
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -4.64453125,
            "text": "HIV-",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -5.0390625,
            "text": "HIV-",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -5.3203125,
            "text": "HIV-1-infected bone marrow-liver-thymus (BLT) humanized mice",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -6.578125,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.3515625,
            "text": "HIV-1-specific bNAb PGT121 in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.38671875,
            "text": "HIV-1-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.5234375,
            "text": "HIV-1-specific bNAb",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.59375,
            "text": "HIV-1-specific bN",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.65234375,
            "text": "HIV-1-specific bNAb PGT1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -7.60546875,
            "text": "HIV-1-infected bone marrow-liver-thymus (BLT) humanized mice.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.17578125,
            "text": "in HIV",
            "probability": 2.384185791015625e-07
        }
    ],
    "5c65901c7c78d69471000008_2": [
        {
            "start_logit": 7.03515625,
            "end_logit": 6.17578125,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV",
            "probability": 0.455810546875
        },
        {
            "start_logit": 6.69921875,
            "end_logit": 6.17578125,
            "text": "HIV",
            "probability": 0.325927734375
        },
        {
            "start_logit": 7.03515625,
            "end_logit": 5.4375,
            "text": "HIV",
            "probability": 0.217041015625
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -0.521484375,
            "text": "HIV-1",
            "probability": 0.0005640983581542969
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -1.62890625,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-1",
            "probability": 0.00018596649169921875
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -1.62890625,
            "text": "HIV-1",
            "probability": 0.0001327991485595703
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -3.005859375,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-1-infected",
            "probability": 4.70280647277832e-05
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -3.005859375,
            "text": "HIV-1-infected",
            "probability": 3.361701965332031e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -4.64453125,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-",
            "probability": 9.119510650634766e-06
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -4.64453125,
            "text": "HIV-",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -5.0390625,
            "text": "HIV-",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -5.3203125,
            "text": "HIV-1-infected bone marrow-liver-thymus (BLT) humanized mice",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -6.578125,
            "text": "HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.3515625,
            "text": "HIV-1-specific bNAb PGT121 in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.38671875,
            "text": "HIV-1-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.5234375,
            "text": "HIV-1-specific bNAb",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.59375,
            "text": "HIV-1-specific bN",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.65234375,
            "text": "HIV-1-specific bNAb PGT1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.69921875,
            "end_logit": -7.60546875,
            "text": "HIV-1-infected bone marrow-liver-thymus (BLT) humanized mice.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.17578125,
            "text": "in HIV",
            "probability": 2.384185791015625e-07
        }
    ],
    "5c65901c7c78d69471000008_3": [
        {
            "start_logit": 6.56640625,
            "end_logit": 6.421875,
            "text": "HIV",
            "probability": 0.4306640625
        },
        {
            "start_logit": 6.58984375,
            "end_logit": 6.37890625,
            "text": "HIV",
            "probability": 0.423828125
        },
        {
            "start_logit": 6.56640625,
            "end_logit": 5.3046875,
            "text": "HIV-1-infected",
            "probability": 0.14208984375
        },
        {
            "start_logit": 6.58984375,
            "end_logit": 1.5732421875,
            "text": "HIV-1-infected",
            "probability": 0.0034732818603515625
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -3.046875,
            "text": "HIV-1",
            "probability": 3.325939178466797e-05
        },
        {
            "start_logit": -2.6171875,
            "end_logit": 5.3046875,
            "text": "infected",
            "probability": 1.4543533325195312e-05
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -4.53125,
            "text": "HIV-1",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -5.05859375,
            "text": "HIV-1-infected BLT humanized mice, Ad5",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -5.7578125,
            "end_logit": 6.421875,
            "text": "antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.140625,
            "end_logit": 6.37890625,
            "text": "In HIV",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 5.3046875,
            "text": "1-infected",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -6.46875,
            "text": "HIV-",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.515625,
            "text": "HIV-1-infected BLT humanized mice, Ad",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -6.49609375,
            "text": "HIV-1-infected humanized mice",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.609375,
            "text": "HIV-1-infected BLT humanized mice, Ad5.PGT121 resulted in a greater reduction of viral",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.7421875,
            "text": "HIV-1-infected BLT humanized mice",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 6.421875,
            "text": "5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.8359375,
            "text": "HIV-1-infected BLT humanized mice, Ad5.PGT121 resulted in a greater reduction of viral loads than did AAV",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.703125,
            "end_logit": 6.421875,
            "text": "in HIV",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.7578125,
            "end_logit": 5.3046875,
            "text": "antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV-1-infected",
            "probability": 5.960464477539062e-07
        }
    ],
    "5c65901c7c78d69471000008_4": [
        {
            "start_logit": 6.56640625,
            "end_logit": 6.421875,
            "text": "HIV",
            "probability": 0.4306640625
        },
        {
            "start_logit": 6.58984375,
            "end_logit": 6.37890625,
            "text": "HIV",
            "probability": 0.423828125
        },
        {
            "start_logit": 6.56640625,
            "end_logit": 5.3046875,
            "text": "HIV-1-infected",
            "probability": 0.14208984375
        },
        {
            "start_logit": 6.58984375,
            "end_logit": 1.5732421875,
            "text": "HIV-1-infected",
            "probability": 0.0034732818603515625
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -3.046875,
            "text": "HIV-1",
            "probability": 3.325939178466797e-05
        },
        {
            "start_logit": -2.6171875,
            "end_logit": 5.3046875,
            "text": "infected",
            "probability": 1.4543533325195312e-05
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -4.53125,
            "text": "HIV-1",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -5.05859375,
            "text": "HIV-1-infected BLT humanized mice, Ad5",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -5.7578125,
            "end_logit": 6.421875,
            "text": "antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.140625,
            "end_logit": 6.37890625,
            "text": "In HIV",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 5.3046875,
            "text": "1-infected",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -6.46875,
            "text": "HIV-",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.515625,
            "text": "HIV-1-infected BLT humanized mice, Ad",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -6.49609375,
            "text": "HIV-1-infected humanized mice",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.609375,
            "text": "HIV-1-infected BLT humanized mice, Ad5.PGT121 resulted in a greater reduction of viral",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.7421875,
            "text": "HIV-1-infected BLT humanized mice",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 6.421875,
            "text": "5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.8359375,
            "text": "HIV-1-infected BLT humanized mice, Ad5.PGT121 resulted in a greater reduction of viral loads than did AAV",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.703125,
            "end_logit": 6.421875,
            "text": "in HIV",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.7578125,
            "end_logit": 5.3046875,
            "text": "antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV-1-infected",
            "probability": 5.960464477539062e-07
        }
    ],
    "5c65901c7c78d69471000008_5": [
        {
            "start_logit": 6.421875,
            "end_logit": 6.58984375,
            "text": "HIV",
            "probability": 0.501953125
        },
        {
            "start_logit": 6.4375,
            "end_logit": 6.5703125,
            "text": "HIV",
            "probability": 0.497802734375
        },
        {
            "start_logit": 6.4375,
            "end_logit": -0.96923828125,
            "text": "HIV-1-infected",
            "probability": 0.00026488304138183594
        },
        {
            "start_logit": 6.4375,
            "end_logit": -5.953125,
            "text": "HIV-1",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.421875,
            "end_logit": -5.9921875,
            "text": "HIV-1",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.421875,
            "end_logit": -6.84375,
            "text": "HIV-1-specific bNAb PGT121. Ad5",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -6.875,
            "text": "HIV-1-infected humanized mice",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -6.96875,
            "text": "HIV-1-specific bNAb PGT121. Ad5.PGT121 afforded more rapid, robust, and durable antiviral",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.0234375,
            "text": "HIV-1-specific bNAb PGT121. Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.05078125,
            "text": "HIV-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.2109375,
            "text": "HIV-1-specific bNAb PGT121. Ad",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.26171875,
            "text": "HIV-1-specific bNAb PGT121. Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 6.5703125,
            "text": "in HIV",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.5703125,
            "text": "AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.58984375,
            "text": "AAV1) vectors to deliver the HIV",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 6.5703125,
            "text": "5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.4921875,
            "text": "HIV-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.55859375,
            "text": "HIV-1-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.5703125,
            "text": "antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.58984375,
            "text": "adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5c65901c7c78d69471000008_6": [
        {
            "start_logit": 6.421875,
            "end_logit": 6.58984375,
            "text": "HIV",
            "probability": 0.501953125
        },
        {
            "start_logit": 6.4375,
            "end_logit": 6.5703125,
            "text": "HIV",
            "probability": 0.497802734375
        },
        {
            "start_logit": 6.4375,
            "end_logit": -0.96923828125,
            "text": "HIV-1-infected",
            "probability": 0.00026488304138183594
        },
        {
            "start_logit": 6.4375,
            "end_logit": -5.953125,
            "text": "HIV-1",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.421875,
            "end_logit": -5.9921875,
            "text": "HIV-1",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.421875,
            "end_logit": -6.84375,
            "text": "HIV-1-specific bNAb PGT121. Ad5",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -6.875,
            "text": "HIV-1-infected humanized mice",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -6.96875,
            "text": "HIV-1-specific bNAb PGT121. Ad5.PGT121 afforded more rapid, robust, and durable antiviral",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.0234375,
            "text": "HIV-1-specific bNAb PGT121. Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.05078125,
            "text": "HIV-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.2109375,
            "text": "HIV-1-specific bNAb PGT121. Ad",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.26171875,
            "text": "HIV-1-specific bNAb PGT121. Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 6.5703125,
            "text": "in HIV",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.5703125,
            "text": "AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.58984375,
            "text": "AAV1) vectors to deliver the HIV",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 6.5703125,
            "text": "5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.4921875,
            "text": "HIV-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.55859375,
            "text": "HIV-1-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.5703125,
            "text": "antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.58984375,
            "text": "adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5a9d31711d1251d03b00001c_1": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.90625,
            "text": "100 nm",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.5244140625,
            "text": "100",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": -1.748046875,
            "end_logit": 7.90625,
            "text": "nm",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": -5.32421875,
            "end_logit": 7.90625,
            "text": "diamtere of 100 nm",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.828125,
            "end_logit": 7.90625,
            "text": "tere of 100 nm",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.51171875,
            "text": "100 nm.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.90625,
            "text": "attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 7.90625,
            "text": "e of 100 nm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 7.90625,
            "text": "maximum diamtere of 100 nm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.90625,
            "text": "of 100 nm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.90625,
            "text": "vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.90625,
            "text": "relatively constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.90625,
            "text": "their maximum diamtere of 100 nm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.32421875,
            "end_logit": -1.5244140625,
            "text": "diamtere of 100",
            "probability": 0.0
        },
        {
            "start_logit": -6.828125,
            "end_logit": -1.5244140625,
            "text": "tere of 100",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -1.5244140625,
            "text": "attained their maximum diamtere of 100",
            "probability": 0.0
        },
        {
            "start_logit": -1.748046875,
            "end_logit": -7.51171875,
            "text": "nm.",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -1.5244140625,
            "text": "e of 100",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -1.5244140625,
            "text": "maximum diamtere of 100",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -1.5244140625,
            "text": "of 100",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_1": [
        {
            "start_logit": 6.19140625,
            "end_logit": 7.59765625,
            "text": "Intravenous drug addiction",
            "probability": 1.0
        },
        {
            "start_logit": -2.603515625,
            "end_logit": 7.59765625,
            "text": "addiction",
            "probability": 0.00015115737915039062
        },
        {
            "start_logit": -2.669921875,
            "end_logit": 7.59765625,
            "text": "drug addiction",
            "probability": 0.00014209747314453125
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -4.3046875,
            "text": "Intravenous",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -6.57421875,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -6.984375,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious. There is a syndrome, rarely observed in rheumatology",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.05078125,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious. There is a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.46484375,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious. There is a syndrome, rarely observed in rheumatology, resulting in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.5234375,
            "text": "Intravenous drug addiction is responsible for",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.54296875,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious. There is a syndrome, rarely",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.625,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious. There is a syndrome, rarely observed in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.71875,
            "text": "Intravenous drug addiction is responsible for many",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.73828125,
            "text": "Intravenous drug",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.76953125,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious. There is a syndrome, rarely observed in rheumatology,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.76953125,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious. There is a syndrome, rarely observed",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.79296875,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.19140625,
            "end_logit": -7.80078125,
            "text": "Intravenous drug addiction is responsible for many complications, especially cutaneous and infectious",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.603515625,
            "end_logit": -6.57421875,
            "text": "addiction is responsible for many complications, especially cutaneous and infectious.",
            "probability": 0.0
        },
        {
            "start_logit": -2.669921875,
            "end_logit": -6.57421875,
            "text": "drug addiction is responsible for many complications, especially cutaneous and infectious.",
            "probability": 0.0
        },
        {
            "start_logit": -2.603515625,
            "end_logit": -6.984375,
            "text": "addiction is responsible for many complications, especially cutaneous and infectious. There is a syndrome, rarely observed in rheumatology",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_2": [
        {
            "start_logit": 0.51220703125,
            "end_logit": 5.55859375,
            "text": "Puffy hand syndrome develops after long-term intravenous drug addiction",
            "probability": 0.98388671875
        },
        {
            "start_logit": -5.18359375,
            "end_logit": 5.55859375,
            "text": "drug addiction",
            "probability": 0.0033054351806640625
        },
        {
            "start_logit": -5.28125,
            "end_logit": 5.55859375,
            "text": "long-term intravenous drug addiction",
            "probability": 0.0030002593994140625
        },
        {
            "start_logit": -5.30859375,
            "end_logit": 5.55859375,
            "text": "addiction",
            "probability": 0.002918243408203125
        },
        {
            "start_logit": -5.7890625,
            "end_logit": 5.55859375,
            "text": "y hand syndrome develops after long-term intravenous drug addiction",
            "probability": 0.0018053054809570312
        },
        {
            "start_logit": 0.51220703125,
            "end_logit": -1.123046875,
            "text": "Puffy hand syndrome develops after long-term intravenous drug addiction.",
            "probability": 0.0012350082397460938
        },
        {
            "start_logit": -6.32421875,
            "end_logit": 5.55859375,
            "text": "intravenous drug addiction",
            "probability": 0.0010576248168945312
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 5.55859375,
            "text": "term intravenous drug addiction",
            "probability": 0.0008134841918945312
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 5.55859375,
            "text": "after long-term intravenous drug addiction",
            "probability": 0.0007495880126953125
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 5.55859375,
            "text": "syndrome develops after long-term intravenous drug addiction",
            "probability": 0.00029349327087402344
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 5.55859375,
            "text": "-term intravenous drug addiction",
            "probability": 0.0002529621124267578
        },
        {
            "start_logit": -7.796875,
            "end_logit": 5.55859375,
            "text": "hand syndrome develops after long-term intravenous drug addiction",
            "probability": 0.00024127960205078125
        },
        {
            "start_logit": -8.03125,
            "end_logit": 5.55859375,
            "text": "develops after long-term intravenous drug addiction",
            "probability": 0.00019097328186035156
        },
        {
            "start_logit": -5.18359375,
            "end_logit": -1.123046875,
            "text": "drug addiction.",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -5.28125,
            "end_logit": -1.123046875,
            "text": "long-term intravenous drug addiction.",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -5.30859375,
            "end_logit": -1.123046875,
            "text": "addiction.",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 0.51220703125,
            "end_logit": -7.234375,
            "text": "Puffy hand syndrome develops after long-term",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 0.51220703125,
            "end_logit": -7.32421875,
            "text": "Puffy hand syndrome develops after long-term intravenous drug",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 0.51220703125,
            "end_logit": -7.36328125,
            "text": "Puffy hand syndrome develops after long-term intravenous",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -5.7890625,
            "end_logit": -1.123046875,
            "text": "y hand syndrome develops after long-term intravenous drug addiction.",
            "probability": 2.2649765014648438e-06
        }
    ],
    "5a7346662dc08e987e00001a_3": [
        {
            "start_logit": 2.896484375,
            "end_logit": 7.765625,
            "text": "intravenous drug abuse",
            "probability": 0.9931640625
        },
        {
            "start_logit": -2.388671875,
            "end_logit": 7.765625,
            "text": "abuse",
            "probability": 0.00501251220703125
        },
        {
            "start_logit": -3.52734375,
            "end_logit": 7.765625,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 0.0016078948974609375
        },
        {
            "start_logit": -5.48828125,
            "end_logit": 7.765625,
            "text": "drug abuse",
            "probability": 0.00022542476654052734
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 7.765625,
            "text": "of intravenous drug abuse",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 7.765625,
            "text": "complication of intravenous drug abuse",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.765625,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 4.202127456665039e-05
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 7.765625,
            "text": "an unrecognized complication of intravenous drug abuse",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.765625,
            "text": "unrecognized complication of intravenous drug abuse",
            "probability": 1.913309097290039e-05
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.765625,
            "text": "syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.765625,
            "text": "hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 2.896484375,
            "end_logit": -5.37109375,
            "text": "intravenous drug abuse.",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 2.896484375,
            "end_logit": -6.65234375,
            "text": "intravenous drug",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 2.896484375,
            "end_logit": -7.375,
            "text": "intravenous",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -5.37109375,
            "text": "abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -3.52734375,
            "end_logit": -5.37109375,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -3.52734375,
            "end_logit": -6.65234375,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -5.48828125,
            "end_logit": -5.37109375,
            "text": "drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -3.52734375,
            "end_logit": -7.375,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -3.52734375,
            "end_logit": -7.80078125,
            "text": "Puffy hand syndrome is an unrecognized",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_4": [
        {
            "start_logit": -1.615234375,
            "end_logit": 0.5986328125,
            "text": "intravenous drug use",
            "probability": 0.97607421875
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -4.32421875,
            "text": "intravenous drug",
            "probability": 0.007110595703125
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 0.5986328125,
            "text": "drug use",
            "probability": 0.004085540771484375
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 0.5986328125,
            "text": ": We studied the pathogenesis of puffy hand syndrome of intravenous drug use",
            "probability": 0.0018768310546875
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 0.5986328125,
            "text": "puffy hand syndrome of intravenous drug use",
            "probability": 0.0017633438110351562
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 0.5986328125,
            "text": "pathogenesis of puffy hand syndrome of intravenous drug use",
            "probability": 0.0015325546264648438
        },
        {
            "start_logit": -8.078125,
            "end_logit": 0.5986328125,
            "text": "hand syndrome of intravenous drug use",
            "probability": 0.0015201568603515625
        },
        {
            "start_logit": -8.125,
            "end_logit": 0.5986328125,
            "text": "y hand syndrome of intravenous drug use",
            "probability": 0.0014505386352539062
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 0.5986328125,
            "text": "AIM: We studied the pathogenesis of puffy hand syndrome of intravenous drug use",
            "probability": 0.0014171600341796875
        },
        {
            "start_logit": -8.171875,
            "end_logit": 0.5986328125,
            "text": "syndrome of intravenous drug use",
            "probability": 0.001384735107421875
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 0.5986328125,
            "text": "studied the pathogenesis of puffy hand syndrome of intravenous drug use",
            "probability": 0.0013103485107421875
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -6.87890625,
            "text": "intravenous drug use.",
            "probability": 0.0005526542663574219
        },
        {
            "start_logit": -1.615234375,
            "end_logit": -8.0625,
            "text": "intravenous",
            "probability": 0.0001685619354248047
        },
        {
            "start_logit": -7.08984375,
            "end_logit": -4.32421875,
            "text": "drug",
            "probability": 2.9742717742919922e-05
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -4.32421875,
            "text": ": We studied the pathogenesis of puffy hand syndrome of intravenous drug",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -4.32421875,
            "text": "puffy hand syndrome of intravenous drug",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -4.32421875,
            "text": "pathogenesis of puffy hand syndrome of intravenous drug",
            "probability": 1.1205673217773438e-05
        },
        {
            "start_logit": -8.078125,
            "end_logit": -4.32421875,
            "text": "hand syndrome of intravenous drug",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": -8.125,
            "end_logit": -4.32421875,
            "text": "y hand syndrome of intravenous drug",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -4.32421875,
            "text": "AIM: We studied the pathogenesis of puffy hand syndrome of intravenous drug",
            "probability": 1.0371208190917969e-05
        }
    ],
    "5a7346662dc08e987e00001a_5": [
        {
            "start_logit": 5.05859375,
            "end_logit": 7.7734375,
            "text": "intravenous drug abuse",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.310546875,
            "end_logit": 7.7734375,
            "text": "abuse",
            "probability": 0.0006313323974609375
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 7.7734375,
            "text": "drug abuse",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": -6.65625,
            "end_logit": 7.7734375,
            "text": "Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": -6.75,
            "end_logit": 7.7734375,
            "text": "complication of intravenous drug abuse",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": -7.328125,
            "end_logit": 7.7734375,
            "text": "of intravenous drug abuse",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 7.7734375,
            "text": ": Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 7.7734375,
            "text": "y hand syndrome is a complication of intravenous drug abuse",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.7734375,
            "text": "syndrome is a complication of intravenous drug abuse",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.7734375,
            "text": "hand syndrome is a complication of intravenous drug abuse",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.7734375,
            "text": "is a complication of intravenous drug abuse",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.7734375,
            "text": "a complication of intravenous drug abuse",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -8.1875,
            "end_logit": 7.7734375,
            "text": "BACKGROUND: Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 5.05859375,
            "end_logit": -5.625,
            "text": "intravenous drug abuse, which has no current available treatment.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 5.05859375,
            "end_logit": -5.8671875,
            "text": "intravenous",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 5.05859375,
            "end_logit": -6.234375,
            "text": "intravenous drug",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 5.05859375,
            "end_logit": -7.68359375,
            "text": "intravenous drug abuse, which has no",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.05859375,
            "end_logit": -7.7109375,
            "text": "intravenous drug abuse,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.05859375,
            "end_logit": -7.7109375,
            "text": "intravenous drug abuse, which has no current available",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.05859375,
            "end_logit": -7.75,
            "text": "intravenous drug abuse, which has no current",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5a7346662dc08e987e00001a_6": [
        {
            "start_logit": 4.73828125,
            "end_logit": 7.67578125,
            "text": "intravenous drug abuse",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.58203125,
            "end_logit": 7.67578125,
            "text": "abuse",
            "probability": 0.0006613731384277344
        },
        {
            "start_logit": -4.15234375,
            "end_logit": 7.67578125,
            "text": "Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 0.00013756752014160156
        },
        {
            "start_logit": -6.0625,
            "end_logit": 7.67578125,
            "text": "drug abuse",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 7.67578125,
            "text": "y hand syndrome is a complication of intravenous drug abuse",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 7.67578125,
            "text": "of intravenous drug abuse",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.67578125,
            "text": "complication of intravenous drug abuse",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -4.87109375,
            "text": "intravenous drug abuse, which has no current available treatment.",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.67578125,
            "text": "syndrome is a complication of intravenous drug abuse",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.67578125,
            "text": "is a complication of intravenous drug abuse",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.67578125,
            "text": "hand syndrome is a complication of intravenous drug abuse",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.67578125,
            "text": "a complication of intravenous drug abuse",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -6.125,
            "text": "intravenous drug",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -6.2421875,
            "text": "intravenous",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.40234375,
            "text": "intravenous drug abuse,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.5546875,
            "text": "intravenous drug abuse, which has no current available",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.5625,
            "text": "intravenous drug abuse, which has no",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.58203125,
            "text": "intravenous drug abuse, which has no current",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.76171875,
            "text": "intravenous drug abuse, which has no current available treatment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.73828125,
            "end_logit": -7.8984375,
            "text": "intravenous drug abuse, which has",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5a7346662dc08e987e00001a_7": [
        {
            "start_logit": 2.896484375,
            "end_logit": 7.765625,
            "text": "intravenous drug abuse",
            "probability": 0.9931640625
        },
        {
            "start_logit": -2.388671875,
            "end_logit": 7.765625,
            "text": "abuse",
            "probability": 0.00501251220703125
        },
        {
            "start_logit": -3.52734375,
            "end_logit": 7.765625,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 0.0016078948974609375
        },
        {
            "start_logit": -5.48828125,
            "end_logit": 7.765625,
            "text": "drug abuse",
            "probability": 0.00022542476654052734
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 7.765625,
            "text": "of intravenous drug abuse",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 7.765625,
            "text": "complication of intravenous drug abuse",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.765625,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 4.202127456665039e-05
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 7.765625,
            "text": "an unrecognized complication of intravenous drug abuse",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.765625,
            "text": "unrecognized complication of intravenous drug abuse",
            "probability": 1.913309097290039e-05
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.765625,
            "text": "syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.765625,
            "text": "hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 2.896484375,
            "end_logit": -5.37109375,
            "text": "intravenous drug abuse.",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 2.896484375,
            "end_logit": -6.65234375,
            "text": "intravenous drug",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 2.896484375,
            "end_logit": -7.375,
            "text": "intravenous",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -5.37109375,
            "text": "abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -3.52734375,
            "end_logit": -5.37109375,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -3.52734375,
            "end_logit": -6.65234375,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -5.48828125,
            "end_logit": -5.37109375,
            "text": "drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -3.52734375,
            "end_logit": -7.375,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -3.52734375,
            "end_logit": -7.80078125,
            "text": "Puffy hand syndrome is an unrecognized",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_8": [
        {
            "start_logit": -3.515625,
            "end_logit": -0.433349609375,
            "text": "drug use",
            "probability": 0.49658203125
        },
        {
            "start_logit": -3.6171875,
            "end_logit": -0.433349609375,
            "text": "intravenous drug use",
            "probability": 0.448486328125
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -0.433349609375,
            "text": "<b>AIM</b>: We studied the pathogenesis of puffy hand syndrome of intravenous drug use",
            "probability": 0.00850677490234375
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -0.433349609375,
            "text": "puffy hand syndrome of intravenous drug use",
            "probability": 0.006946563720703125
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -0.433349609375,
            "text": "hand syndrome of intravenous drug use",
            "probability": 0.00585174560546875
        },
        {
            "start_logit": -7.98828125,
            "end_logit": -0.433349609375,
            "text": "y hand syndrome of intravenous drug use",
            "probability": 0.00566864013671875
        },
        {
            "start_logit": -8.0,
            "end_logit": -0.433349609375,
            "text": "studied the pathogenesis of puffy hand syndrome of intravenous drug use",
            "probability": 0.005626678466796875
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -0.433349609375,
            "text": ": We studied the pathogenesis of puffy hand syndrome of intravenous drug use",
            "probability": 0.005580902099609375
        },
        {
            "start_logit": -8.03125,
            "end_logit": -0.433349609375,
            "text": "syndrome of intravenous drug use",
            "probability": 0.005451202392578125
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -0.433349609375,
            "text": "b>AIM</b>: We studied the pathogenesis of puffy hand syndrome of intravenous drug use",
            "probability": 0.005245208740234375
        },
        {
            "start_logit": -3.515625,
            "end_logit": -5.70703125,
            "text": "drug",
            "probability": 0.00255584716796875
        },
        {
            "start_logit": -3.6171875,
            "end_logit": -5.70703125,
            "text": "intravenous drug",
            "probability": 0.0022907257080078125
        },
        {
            "start_logit": -3.515625,
            "end_logit": -7.23828125,
            "text": "drug use.",
            "probability": 0.0005526542663574219
        },
        {
            "start_logit": -3.6171875,
            "end_logit": -7.23828125,
            "text": "intravenous drug use.",
            "probability": 0.0004954338073730469
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -5.70703125,
            "text": "<b>AIM</b>: We studied the pathogenesis of puffy hand syndrome of intravenous drug",
            "probability": 4.3451786041259766e-05
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -5.70703125,
            "text": "puffy hand syndrome of intravenous drug",
            "probability": 3.546476364135742e-05
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -5.70703125,
            "text": "hand syndrome of intravenous drug",
            "probability": 2.9861927032470703e-05
        },
        {
            "start_logit": -7.98828125,
            "end_logit": -5.70703125,
            "text": "y hand syndrome of intravenous drug",
            "probability": 2.8967857360839844e-05
        },
        {
            "start_logit": -8.0,
            "end_logit": -5.70703125,
            "text": "studied the pathogenesis of puffy hand syndrome of intravenous drug",
            "probability": 2.8967857360839844e-05
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -5.70703125,
            "text": ": We studied the pathogenesis of puffy hand syndrome of intravenous drug",
            "probability": 2.849102020263672e-05
        }
    ],
    "5a7346662dc08e987e00001a_9": [
        {
            "start_logit": -4.6328125,
            "end_logit": 4.796875,
            "text": "drug abuse",
            "probability": 0.40576171875
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 4.796875,
            "text": "intravenous drug abuse",
            "probability": 0.2197265625
        },
        {
            "start_logit": -5.6875,
            "end_logit": 4.796875,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 0.141357421875
        },
        {
            "start_logit": -5.75,
            "end_logit": 4.796875,
            "text": "abuse",
            "probability": 0.1326904296875
        },
        {
            "start_logit": -6.96875,
            "end_logit": 4.796875,
            "text": "of intravenous drug abuse",
            "probability": 0.03924560546875
        },
        {
            "start_logit": -7.109375,
            "end_logit": 4.796875,
            "text": "complication of intravenous drug abuse",
            "probability": 0.034088134765625
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 4.796875,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 0.02728271484375
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -4.30078125,
            "text": "drug abuse this painless syndrome appears during or after a long period of drug addiction",
            "probability": 4.5239925384521484e-05
        },
        {
            "start_logit": -5.2265625,
            "end_logit": -4.30078125,
            "text": "drug addiction",
            "probability": 2.4974346160888672e-05
        },
        {
            "start_logit": -5.24609375,
            "end_logit": -4.30078125,
            "text": "intravenous drug abuse this painless syndrome appears during or after a long period of drug addiction",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": -5.6875,
            "end_logit": -4.30078125,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse this painless syndrome appears during or after a long period of drug addiction",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -5.75,
            "end_logit": -4.30078125,
            "text": "abuse this painless syndrome appears during or after a long period of drug addiction",
            "probability": 1.4901161193847656e-05
        },
        {
            "start_logit": -4.625,
            "end_logit": -5.87109375,
            "text": "hand",
            "probability": 9.47713851928711e-06
        },
        {
            "start_logit": -4.625,
            "end_logit": -5.89453125,
            "text": "hand volume is important physiopathological mechanisms of the puffy hand syndrome are unclear and include venous and lymphatic insufficiencies infectious complications and direct toxicity of injected drugs",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": -6.6171875,
            "end_logit": -4.171875,
            "text": "drugs and their adulterants",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -6.16015625,
            "text": "drug",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -6.80859375,
            "end_logit": -4.171875,
            "text": "toxicity of injected drugs and their adulterants",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -6.4453125,
            "text": "drug abuse this painless syndrome appears during or after a long period of drug",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -5.2265625,
            "end_logit": -5.87109375,
            "text": "drug addiction it involves the hands and sometimes the forearms and may cause functional aesthetic and social disturbances when the hand",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -6.96875,
            "end_logit": -4.30078125,
            "text": "of intravenous drug abuse this painless syndrome appears during or after a long period of drug addiction",
            "probability": 4.410743713378906e-06
        }
    ],
    "5a7346662dc08e987e00001a_10": [
        {
            "start_logit": 1.6259765625,
            "end_logit": 2.779296875,
            "text": "buprenorphine",
            "probability": 0.9208984375
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -0.57080078125,
            "text": "buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 0.032257080078125
        },
        {
            "start_logit": -1.736328125,
            "end_logit": 2.74609375,
            "text": "buprenorphine",
            "probability": 0.03082275390625
        },
        {
            "start_logit": -3.39453125,
            "end_logit": 2.74609375,
            "text": "sublingual buprenorphine",
            "probability": 0.0058746337890625
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -2.455078125,
            "text": "buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine misuse",
            "probability": 0.00490570068359375
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -0.57080078125,
            "text": "buprenorphine",
            "probability": 0.0029315948486328125
        },
        {
            "start_logit": -4.79296875,
            "end_logit": 2.779296875,
            "text": "sublingual buprenorphine",
            "probability": 0.0014972686767578125
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -2.455078125,
            "text": "buprenorphine misuse",
            "probability": 0.0004458427429199219
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -1.4921875,
            "text": "heroin",
            "probability": 0.00027680397033691406
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -5.984375,
            "text": "buprenorphine misuse",
            "probability": 0.0001436471939086914
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -0.57080078125,
            "text": "sublingual buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 5.2869319915771484e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -1.4921875,
            "text": "buprenorphine misuse and injection practices we included 33 cases and 33 controls mean age of 34 years they were past heroin",
            "probability": 1.8537044525146484e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -1.53125,
            "text": "buprenorphine",
            "probability": 1.7702579498291016e-05
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -0.57080078125,
            "text": "likely to cause puffy hands syndrome but buprenorphine",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -5.86328125,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users must still be warned of local and systemic complications of intravenous drug misuse",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -0.57080078125,
            "text": "injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -4.5,
            "text": "heroin users mainly methadone substituted in multivariate analysis sex women",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -5.94140625,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users must still be warned of local and systemic complications of intravenous drug",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -4.79296875,
            "text": "heroin users",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -6.4609375,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users",
            "probability": 8.106231689453125e-06
        }
    ],
    "5a7346662dc08e987e00001a_11": [
        {
            "start_logit": 1.6259765625,
            "end_logit": 2.779296875,
            "text": "buprenorphine",
            "probability": 0.9208984375
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -0.57080078125,
            "text": "buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 0.032257080078125
        },
        {
            "start_logit": -1.736328125,
            "end_logit": 2.74609375,
            "text": "buprenorphine",
            "probability": 0.03082275390625
        },
        {
            "start_logit": -3.39453125,
            "end_logit": 2.74609375,
            "text": "sublingual buprenorphine",
            "probability": 0.0058746337890625
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -2.455078125,
            "text": "buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine misuse",
            "probability": 0.00490570068359375
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -0.57080078125,
            "text": "buprenorphine",
            "probability": 0.0029315948486328125
        },
        {
            "start_logit": -4.79296875,
            "end_logit": 2.779296875,
            "text": "sublingual buprenorphine",
            "probability": 0.0014972686767578125
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -2.455078125,
            "text": "buprenorphine misuse",
            "probability": 0.0004458427429199219
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -1.4921875,
            "text": "heroin",
            "probability": 0.00027680397033691406
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -5.984375,
            "text": "buprenorphine misuse",
            "probability": 0.0001436471939086914
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -0.57080078125,
            "text": "sublingual buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 5.2869319915771484e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -1.4921875,
            "text": "buprenorphine misuse and injection practices we included 33 cases and 33 controls mean age of 34 years they were past heroin",
            "probability": 1.8537044525146484e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -1.53125,
            "text": "buprenorphine",
            "probability": 1.7702579498291016e-05
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -0.57080078125,
            "text": "likely to cause puffy hands syndrome but buprenorphine",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -5.86328125,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users must still be warned of local and systemic complications of intravenous drug misuse",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -0.57080078125,
            "text": "injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -4.5,
            "text": "heroin users mainly methadone substituted in multivariate analysis sex women",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -5.94140625,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users must still be warned of local and systemic complications of intravenous drug",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -4.79296875,
            "text": "heroin users",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -6.4609375,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users",
            "probability": 8.106231689453125e-06
        }
    ],
    "5a7346662dc08e987e00001a_12": [
        {
            "start_logit": 1.6259765625,
            "end_logit": 2.779296875,
            "text": "buprenorphine",
            "probability": 0.9208984375
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -0.57080078125,
            "text": "buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 0.032257080078125
        },
        {
            "start_logit": -1.736328125,
            "end_logit": 2.74609375,
            "text": "buprenorphine",
            "probability": 0.03082275390625
        },
        {
            "start_logit": -3.39453125,
            "end_logit": 2.74609375,
            "text": "sublingual buprenorphine",
            "probability": 0.0058746337890625
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -2.455078125,
            "text": "buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine misuse",
            "probability": 0.00490570068359375
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -0.57080078125,
            "text": "buprenorphine",
            "probability": 0.0029315948486328125
        },
        {
            "start_logit": -4.79296875,
            "end_logit": 2.779296875,
            "text": "sublingual buprenorphine",
            "probability": 0.0014972686767578125
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -2.455078125,
            "text": "buprenorphine misuse",
            "probability": 0.0004458427429199219
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -1.4921875,
            "text": "heroin",
            "probability": 0.00027680397033691406
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -5.984375,
            "text": "buprenorphine misuse",
            "probability": 0.0001436471939086914
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -0.57080078125,
            "text": "sublingual buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 5.2869319915771484e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -1.4921875,
            "text": "buprenorphine misuse and injection practices we included 33 cases and 33 controls mean age of 34 years they were past heroin",
            "probability": 1.8537044525146484e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -1.53125,
            "text": "buprenorphine",
            "probability": 1.7702579498291016e-05
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -0.57080078125,
            "text": "likely to cause puffy hands syndrome but buprenorphine",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -5.86328125,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users must still be warned of local and systemic complications of intravenous drug misuse",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -0.57080078125,
            "text": "injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -4.5,
            "text": "heroin users mainly methadone substituted in multivariate analysis sex women",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -5.94140625,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users must still be warned of local and systemic complications of intravenous drug",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -4.79296875,
            "text": "heroin users",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -6.4609375,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users",
            "probability": 8.106231689453125e-06
        }
    ],
    "5a7346662dc08e987e00001a_13": [
        {
            "start_logit": 1.6259765625,
            "end_logit": 2.779296875,
            "text": "buprenorphine",
            "probability": 0.9208984375
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -0.57080078125,
            "text": "buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 0.032257080078125
        },
        {
            "start_logit": -1.736328125,
            "end_logit": 2.74609375,
            "text": "buprenorphine",
            "probability": 0.03082275390625
        },
        {
            "start_logit": -3.39453125,
            "end_logit": 2.74609375,
            "text": "sublingual buprenorphine",
            "probability": 0.0058746337890625
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -2.455078125,
            "text": "buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine misuse",
            "probability": 0.00490570068359375
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -0.57080078125,
            "text": "buprenorphine",
            "probability": 0.0029315948486328125
        },
        {
            "start_logit": -4.79296875,
            "end_logit": 2.779296875,
            "text": "sublingual buprenorphine",
            "probability": 0.0014972686767578125
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -2.455078125,
            "text": "buprenorphine misuse",
            "probability": 0.0004458427429199219
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -1.4921875,
            "text": "heroin",
            "probability": 0.00027680397033691406
        },
        {
            "start_logit": 1.6259765625,
            "end_logit": -5.984375,
            "text": "buprenorphine misuse",
            "probability": 0.0001436471939086914
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -0.57080078125,
            "text": "sublingual buprenorphine misuse although it appeared not to be a significant risk factor for puffy hand syndrome injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 5.2869319915771484e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -1.4921875,
            "text": "buprenorphine misuse and injection practices we included 33 cases and 33 controls mean age of 34 years they were past heroin",
            "probability": 1.8537044525146484e-05
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -1.53125,
            "text": "buprenorphine",
            "probability": 1.7702579498291016e-05
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -0.57080078125,
            "text": "likely to cause puffy hands syndrome but buprenorphine",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -5.86328125,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users must still be warned of local and systemic complications of intravenous drug misuse",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -0.57080078125,
            "text": "injection practices are likely to cause puffy hands syndrome but buprenorphine",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -4.5,
            "text": "heroin users mainly methadone substituted in multivariate analysis sex women",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -5.94140625,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users must still be warned of local and systemic complications of intravenous drug",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -4.79296875,
            "text": "heroin users",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": -0.77197265625,
            "end_logit": -6.4609375,
            "text": "buprenorphine misuse should not be considered as a significant risk factor however intravenous drug users",
            "probability": 8.106231689453125e-06
        }
    ],
    "5a7346662dc08e987e00001a_14": [
        {
            "start_logit": -2.8828125,
            "end_logit": 6.93359375,
            "text": "drug users",
            "probability": 0.435791015625
        },
        {
            "start_logit": -3.21484375,
            "end_logit": 6.93359375,
            "text": "intravenous drug users",
            "probability": 0.3125
        },
        {
            "start_logit": -3.63671875,
            "end_logit": 6.93359375,
            "text": "users",
            "probability": 0.2049560546875
        },
        {
            "start_logit": -5.86328125,
            "end_logit": 6.93359375,
            "text": "puffy hand in long term intravenous drug users",
            "probability": 0.022125244140625
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 6.93359375,
            "text": "hand in long term intravenous drug users",
            "probability": 0.006961822509765625
        },
        {
            "start_logit": -7.078125,
            "end_logit": 6.93359375,
            "text": "term intravenous drug users",
            "probability": 0.006565093994140625
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.93359375,
            "text": "long term intravenous drug users",
            "probability": 0.003757476806640625
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.93359375,
            "text": "y hand in long term intravenous drug users",
            "probability": 0.003627777099609375
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.93359375,
            "text": "in long term intravenous drug users",
            "probability": 0.0034999847412109375
        },
        {
            "start_logit": -2.8828125,
            "end_logit": -6.765625,
            "text": "drug",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -3.21484375,
            "end_logit": -6.765625,
            "text": "intravenous drug",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.21484375,
            "end_logit": -8.1796875,
            "text": "intravenous",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -6.765625,
            "text": "puffy hand in long term intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -7.56640625,
            "text": "puffy hand in",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -6.765625,
            "text": "hand in long term intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -6.765625,
            "text": "term intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -8.078125,
            "text": "puffy hand in long term",
            "probability": 0.0
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -8.1015625,
            "text": "puffy hand in long",
            "probability": 0.0
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -8.1484375,
            "text": "puffy hand",
            "probability": 0.0
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -8.1796875,
            "text": "puffy",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_15": [
        {
            "start_logit": -0.1014404296875,
            "end_logit": -2.341796875,
            "text": "narcotic",
            "probability": 0.53369140625
        },
        {
            "start_logit": -0.1014404296875,
            "end_logit": -2.521484375,
            "text": "narcotic addiction",
            "probability": 0.44580078125
        },
        {
            "start_logit": -2.14453125,
            "end_logit": -4.65234375,
            "text": "hands",
            "probability": 0.006877899169921875
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -3.44921875,
            "text": "drug addicts for four to twelve years mean duration 7 3 years and had stopped heroin",
            "probability": 0.003173828125
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -2.99609375,
            "text": "buprenorphine",
            "probability": 0.0025310516357421875
        },
        {
            "start_logit": -4.8046875,
            "end_logit": -3.44921875,
            "text": "heroin",
            "probability": 0.0016078948974609375
        },
        {
            "start_logit": -3.904296875,
            "end_logit": -4.65234375,
            "text": "hands swollen from the proximal segments of the fingers to the wrist in one patient the edema was localized both in the hands",
            "probability": 0.0011854171752929688
        },
        {
            "start_logit": -3.904296875,
            "end_logit": -4.9375,
            "text": "hands",
            "probability": 0.0008878707885742188
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -4.7734375,
            "text": "drug",
            "probability": 0.0008473396301269531
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -4.91796875,
            "text": "drug addicts",
            "probability": 0.000736236572265625
        },
        {
            "start_logit": -4.8203125,
            "end_logit": -4.65234375,
            "text": "fingers to the wrist in one patient the edema was localized both in the hands",
            "probability": 0.0004754066467285156
        },
        {
            "start_logit": -4.1171875,
            "end_logit": -5.36328125,
            "text": "drug addicts for four to twelve years mean duration 7 3 years and had stopped heroin injections for 3 5 years mean 4 6 participating in a buprenorphine",
            "probability": 0.0004680156707763672
        },
        {
            "start_logit": -3.904296875,
            "end_logit": -5.75390625,
            "text": "hands swollen from the proximal segments of the fingers",
            "probability": 0.0003941059112548828
        },
        {
            "start_logit": -5.65625,
            "end_logit": -4.484375,
            "text": "edema was not pitting and unaffected by elevation duplex ultrasound examination of the extremities was normal lymphangiography performed in one patient was consistent with deep lymphatic destruction",
            "probability": 0.00024271011352539062
        },
        {
            "start_logit": -4.8046875,
            "end_logit": -5.36328125,
            "text": "heroin injections for 3 5 years mean 4 6 participating in a buprenorphine",
            "probability": 0.0002353191375732422
        },
        {
            "start_logit": -5.78125,
            "end_logit": -4.4609375,
            "text": "drug users two males one female mean age 30 6 years 26 37",
            "probability": 0.0002193450927734375
        },
        {
            "start_logit": -5.828125,
            "end_logit": -4.484375,
            "text": "deep lymphatic destruction",
            "probability": 0.00020444393157958984
        },
        {
            "start_logit": -5.83984375,
            "end_logit": -4.484375,
            "text": "extremities was normal lymphangiography performed in one patient was consistent with deep lymphatic destruction",
            "probability": 0.00020122528076171875
        },
        {
            "start_logit": -5.80078125,
            "end_logit": -4.65234375,
            "text": "edema was localized both in the hands",
            "probability": 0.00017762184143066406
        },
        {
            "start_logit": -6.08203125,
            "end_logit": -4.4609375,
            "text": "hard core injection addicts three long term intravenous drug users two males one female mean age 30 6 years 26 37",
            "probability": 0.00016164779663085938
        }
    ],
    "5a7346662dc08e987e00001a_16": [
        {
            "start_logit": -2.263671875,
            "end_logit": -4.15625,
            "text": "hand",
            "probability": 0.5478515625
        },
        {
            "start_logit": -3.876953125,
            "end_logit": -3.662109375,
            "text": "multilayer bandaging",
            "probability": 0.17919921875
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -4.17578125,
            "text": "lymphedema",
            "probability": 0.07830810546875
        },
        {
            "start_logit": -3.876953125,
            "end_logit": -5.0078125,
            "text": "multilayer bandaging lymphedema",
            "probability": 0.0467529296875
        },
        {
            "start_logit": -2.263671875,
            "end_logit": -7.1015625,
            "text": "hand circumference decreased 4 3 cm on the left side and 3 2 cm on the right side in case 1",
            "probability": 0.02880859375
        },
        {
            "start_logit": -2.263671875,
            "end_logit": -7.1796875,
            "text": "hand circumference",
            "probability": 0.0266571044921875
        },
        {
            "start_logit": -6.1015625,
            "end_logit": -3.662109375,
            "text": "bandaging",
            "probability": 0.01934814453125
        },
        {
            "start_logit": -4.19140625,
            "end_logit": -6.0078125,
            "text": "lymphedema volume remained stable after 18 months in one",
            "probability": 0.01248931884765625
        },
        {
            "start_logit": -5.53515625,
            "end_logit": -4.703125,
            "text": "puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 0.01210784912109375
        },
        {
            "start_logit": -3.876953125,
            "end_logit": -6.65625,
            "text": "multilayer bandaging lymphedema volumes calculated by utilizing the formula for a truncated cone decreased by 16 on the left side and 12 on the right side for the first",
            "probability": 0.00899505615234375
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -4.15625,
            "text": "patient and 31 and 17 for the second hand",
            "probability": 0.007755279541015625
        },
        {
            "start_logit": -3.876953125,
            "end_logit": -6.8515625,
            "text": "multilayer",
            "probability": 0.0074005126953125
        },
        {
            "start_logit": -3.876953125,
            "end_logit": -6.875,
            "text": "multilayer bandaging lymphedema volumes calculated by utilizing the formula for a truncated cone",
            "probability": 0.007228851318359375
        },
        {
            "start_logit": -6.1015625,
            "end_logit": -5.0078125,
            "text": "bandaging lymphedema",
            "probability": 0.005046844482421875
        },
        {
            "start_logit": -6.1484375,
            "end_logit": -5.0078125,
            "text": "lymphedema",
            "probability": 0.00481414794921875
        },
        {
            "start_logit": -5.80859375,
            "end_logit": -6.2109375,
            "text": "venous lymphatic insufficiency and the direct toxicity of injected drugs lymphedema",
            "probability": 0.0020389556884765625
        },
        {
            "start_logit": -5.80859375,
            "end_logit": -6.52734375,
            "text": "venous lymphatic insufficiency and the direct toxicity of injected drugs",
            "probability": 0.0014801025390625
        },
        {
            "start_logit": -5.80859375,
            "end_logit": -6.58984375,
            "text": "venous lymphatic insufficiency",
            "probability": 0.0013895034790039062
        },
        {
            "start_logit": -6.43359375,
            "end_logit": -6.2109375,
            "text": "lymphatic insufficiency and the direct toxicity of injected drugs lymphedema",
            "probability": 0.00109100341796875
        },
        {
            "start_logit": -6.4453125,
            "end_logit": -6.2109375,
            "text": "the pathogenesis of this edema is probably multifactorial venous lymphatic insufficiency and the direct toxicity of injected drugs lymphedema",
            "probability": 0.0010738372802734375
        }
    ],
    "5a7346662dc08e987e00001a_17": [
        {
            "start_logit": 1.7294921875,
            "end_logit": 2.154296875,
            "text": "cocaine",
            "probability": 0.62451171875
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": 4.59375,
            "text": "better knowledge of vascular complications due to drug abuse",
            "probability": 0.30908203125
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": 2.833984375,
            "text": "drug abuse",
            "probability": 0.0300140380859375
        },
        {
            "start_logit": -4.57421875,
            "end_logit": 4.59375,
            "text": "abuse",
            "probability": 0.0131072998046875
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 4.59375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.007297515869140625
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 4.59375,
            "text": "drug abuse",
            "probability": 0.006801605224609375
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 4.59375,
            "text": "complications due to drug abuse",
            "probability": 0.0065155029296875
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -0.54931640625,
            "text": "drug abuse is at present increasing due to new types of drugs and to the different ways of intake of such substances the vascular complications related to drug abuse",
            "probability": 0.001018524169921875
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 2.833984375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.0008215904235839844
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -1.8349609375,
            "text": "heroin",
            "probability": 0.00019991397857666016
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 0.79638671875,
            "text": "vascular pathologies due to drug abuse",
            "probability": 0.00017905235290527344
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 0.79638671875,
            "text": "four patients affected by vascular pathologies due to drug abuse",
            "probability": 0.00010693073272705078
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -4.16796875,
            "text": "better",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -5.5,
            "end_logit": -0.54931640625,
            "text": "drug abuse",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -1.8349609375,
            "text": "vascular pathologies due to drug abuse in one case a heroin",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -5.03515625,
            "text": "drug",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -1.8349609375,
            "text": "four patients affected by vascular pathologies due to drug abuse in one case a heroin",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -6.1171875,
            "text": "better knowledge of vascular complications due to drug abuse should improve",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -5.875,
            "text": "heroin addict has undergone multiple fasciotomies for compartimental syndrome arising because the patient",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -6.12109375,
            "text": "heroin addic",
            "probability": 2.7418136596679688e-06
        }
    ],
    "5a7346662dc08e987e00001a_18": [
        {
            "start_logit": 1.7294921875,
            "end_logit": 2.154296875,
            "text": "cocaine",
            "probability": 0.62451171875
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": 4.59375,
            "text": "better knowledge of vascular complications due to drug abuse",
            "probability": 0.30908203125
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": 2.833984375,
            "text": "drug abuse",
            "probability": 0.0300140380859375
        },
        {
            "start_logit": -4.57421875,
            "end_logit": 4.59375,
            "text": "abuse",
            "probability": 0.0131072998046875
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 4.59375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.007297515869140625
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 4.59375,
            "text": "drug abuse",
            "probability": 0.006801605224609375
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 4.59375,
            "text": "complications due to drug abuse",
            "probability": 0.0065155029296875
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -0.54931640625,
            "text": "drug abuse is at present increasing due to new types of drugs and to the different ways of intake of such substances the vascular complications related to drug abuse",
            "probability": 0.001018524169921875
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 2.833984375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.0008215904235839844
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -1.8349609375,
            "text": "heroin",
            "probability": 0.00019991397857666016
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 0.79638671875,
            "text": "vascular pathologies due to drug abuse",
            "probability": 0.00017905235290527344
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 0.79638671875,
            "text": "four patients affected by vascular pathologies due to drug abuse",
            "probability": 0.00010693073272705078
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -4.16796875,
            "text": "better",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -5.5,
            "end_logit": -0.54931640625,
            "text": "drug abuse",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -1.8349609375,
            "text": "vascular pathologies due to drug abuse in one case a heroin",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -5.03515625,
            "text": "drug",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -1.8349609375,
            "text": "four patients affected by vascular pathologies due to drug abuse in one case a heroin",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -6.1171875,
            "text": "better knowledge of vascular complications due to drug abuse should improve",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -5.875,
            "text": "heroin addict has undergone multiple fasciotomies for compartimental syndrome arising because the patient",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -6.12109375,
            "text": "heroin addic",
            "probability": 2.7418136596679688e-06
        }
    ],
    "5a7346662dc08e987e00001a_19": [
        {
            "start_logit": 1.7294921875,
            "end_logit": 2.154296875,
            "text": "cocaine",
            "probability": 0.62451171875
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": 4.59375,
            "text": "better knowledge of vascular complications due to drug abuse",
            "probability": 0.30908203125
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": 2.833984375,
            "text": "drug abuse",
            "probability": 0.0300140380859375
        },
        {
            "start_logit": -4.57421875,
            "end_logit": 4.59375,
            "text": "abuse",
            "probability": 0.0131072998046875
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 4.59375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.007297515869140625
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 4.59375,
            "text": "drug abuse",
            "probability": 0.006801605224609375
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 4.59375,
            "text": "complications due to drug abuse",
            "probability": 0.0065155029296875
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -0.54931640625,
            "text": "drug abuse is at present increasing due to new types of drugs and to the different ways of intake of such substances the vascular complications related to drug abuse",
            "probability": 0.001018524169921875
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 2.833984375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.0008215904235839844
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -1.8349609375,
            "text": "heroin",
            "probability": 0.00019991397857666016
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 0.79638671875,
            "text": "vascular pathologies due to drug abuse",
            "probability": 0.00017905235290527344
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 0.79638671875,
            "text": "four patients affected by vascular pathologies due to drug abuse",
            "probability": 0.00010693073272705078
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -4.16796875,
            "text": "better",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -5.5,
            "end_logit": -0.54931640625,
            "text": "drug abuse",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -1.8349609375,
            "text": "vascular pathologies due to drug abuse in one case a heroin",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -5.03515625,
            "text": "drug",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -1.8349609375,
            "text": "four patients affected by vascular pathologies due to drug abuse in one case a heroin",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -6.1171875,
            "text": "better knowledge of vascular complications due to drug abuse should improve",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -5.875,
            "text": "heroin addict has undergone multiple fasciotomies for compartimental syndrome arising because the patient",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -6.12109375,
            "text": "heroin addic",
            "probability": 2.7418136596679688e-06
        }
    ],
    "5a7346662dc08e987e00001a_20": [
        {
            "start_logit": 1.7294921875,
            "end_logit": 2.154296875,
            "text": "cocaine",
            "probability": 0.62451171875
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": 4.59375,
            "text": "better knowledge of vascular complications due to drug abuse",
            "probability": 0.30908203125
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": 2.833984375,
            "text": "drug abuse",
            "probability": 0.0300140380859375
        },
        {
            "start_logit": -4.57421875,
            "end_logit": 4.59375,
            "text": "abuse",
            "probability": 0.0131072998046875
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 4.59375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.007297515869140625
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 4.59375,
            "text": "drug abuse",
            "probability": 0.006801605224609375
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 4.59375,
            "text": "complications due to drug abuse",
            "probability": 0.0065155029296875
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -0.54931640625,
            "text": "drug abuse is at present increasing due to new types of drugs and to the different ways of intake of such substances the vascular complications related to drug abuse",
            "probability": 0.001018524169921875
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 2.833984375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.0008215904235839844
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -1.8349609375,
            "text": "heroin",
            "probability": 0.00019991397857666016
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 0.79638671875,
            "text": "vascular pathologies due to drug abuse",
            "probability": 0.00017905235290527344
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 0.79638671875,
            "text": "four patients affected by vascular pathologies due to drug abuse",
            "probability": 0.00010693073272705078
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -4.16796875,
            "text": "better",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -5.5,
            "end_logit": -0.54931640625,
            "text": "drug abuse",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -1.8349609375,
            "text": "vascular pathologies due to drug abuse in one case a heroin",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -5.03515625,
            "text": "drug",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -1.8349609375,
            "text": "four patients affected by vascular pathologies due to drug abuse in one case a heroin",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -6.1171875,
            "text": "better knowledge of vascular complications due to drug abuse should improve",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -5.875,
            "text": "heroin addict has undergone multiple fasciotomies for compartimental syndrome arising because the patient",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -6.12109375,
            "text": "heroin addic",
            "probability": 2.7418136596679688e-06
        }
    ],
    "5a7346662dc08e987e00001a_21": [
        {
            "start_logit": 1.7294921875,
            "end_logit": 2.154296875,
            "text": "cocaine",
            "probability": 0.62451171875
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": 4.59375,
            "text": "better knowledge of vascular complications due to drug abuse",
            "probability": 0.30908203125
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": 2.833984375,
            "text": "drug abuse",
            "probability": 0.0300140380859375
        },
        {
            "start_logit": -4.57421875,
            "end_logit": 4.59375,
            "text": "abuse",
            "probability": 0.0131072998046875
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 4.59375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.007297515869140625
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 4.59375,
            "text": "drug abuse",
            "probability": 0.006801605224609375
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 4.59375,
            "text": "complications due to drug abuse",
            "probability": 0.0065155029296875
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -0.54931640625,
            "text": "drug abuse is at present increasing due to new types of drugs and to the different ways of intake of such substances the vascular complications related to drug abuse",
            "probability": 0.001018524169921875
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 2.833984375,
            "text": "vascular complications due to drug abuse",
            "probability": 0.0008215904235839844
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -1.8349609375,
            "text": "heroin",
            "probability": 0.00019991397857666016
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 0.79638671875,
            "text": "vascular pathologies due to drug abuse",
            "probability": 0.00017905235290527344
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 0.79638671875,
            "text": "four patients affected by vascular pathologies due to drug abuse",
            "probability": 0.00010693073272705078
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -4.16796875,
            "text": "better",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -5.5,
            "end_logit": -0.54931640625,
            "text": "drug abuse",
            "probability": 3.0159950256347656e-05
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -1.8349609375,
            "text": "vascular pathologies due to drug abuse in one case a heroin",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -1.9853515625,
            "end_logit": -5.03515625,
            "text": "drug",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": -5.58203125,
            "end_logit": -1.8349609375,
            "text": "four patients affected by vascular pathologies due to drug abuse in one case a heroin",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": -6.1171875,
            "text": "better knowledge of vascular complications due to drug abuse should improve",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -5.875,
            "text": "heroin addict has undergone multiple fasciotomies for compartimental syndrome arising because the patient",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -2.330078125,
            "end_logit": -6.12109375,
            "text": "heroin addic",
            "probability": 2.7418136596679688e-06
        }
    ],
    "5a7346662dc08e987e00001a_22": [
        {
            "start_logit": 7.484375,
            "end_logit": 5.55078125,
            "text": "heroin intoxication",
            "probability": 0.927734375
        },
        {
            "start_logit": 3.015625,
            "end_logit": 7.17578125,
            "text": "intravenous drug addiction",
            "probability": 0.053985595703125
        },
        {
            "start_logit": 7.484375,
            "end_logit": 1.494140625,
            "text": "heroin",
            "probability": 0.016082763671875
        },
        {
            "start_logit": -1.11328125,
            "end_logit": 7.69140625,
            "text": "intravenous drug addiction",
            "probability": 0.001461029052734375
        },
        {
            "start_logit": -2.044921875,
            "end_logit": 7.69140625,
            "text": "addiction",
            "probability": 0.0005769729614257812
        },
        {
            "start_logit": -1.11328125,
            "end_logit": 5.55078125,
            "text": "intravenous drug addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 0.00017178058624267578
        },
        {
            "start_logit": -2.8203125,
            "end_logit": 7.17578125,
            "text": "addiction",
            "probability": 0.0001589059829711914
        },
        {
            "start_logit": -3.419921875,
            "end_logit": 7.69140625,
            "text": "drug addiction",
            "probability": 0.00014579296112060547
        },
        {
            "start_logit": -2.044921875,
            "end_logit": 5.55078125,
            "text": "addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 6.783008575439453e-05
        },
        {
            "start_logit": -4.1015625,
            "end_logit": 7.17578125,
            "text": "drug addiction",
            "probability": 4.410743713378906e-05
        },
        {
            "start_logit": -3.419921875,
            "end_logit": 5.55078125,
            "text": "drug addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": -4.6796875,
            "end_logit": 5.55078125,
            "text": "intoxication",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.69140625,
            "text": "patients had intravenous drug addiction",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -1.11328125,
            "end_logit": 1.494140625,
            "text": "intravenous drug addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.69140625,
            "text": "hands the puffy hand syndrome we report two cases of this condition from our rheumatologic consultation our two patients had intravenous drug addiction",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 7.484375,
            "end_logit": -7.53515625,
            "text": "heroin intoxication and in the other 2 years after stopping injections in our two patients",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.75390625,
            "end_logit": 5.55078125,
            "text": "hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -2.044921875,
            "end_logit": 1.494140625,
            "text": "addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 5.55078125,
            "text": "during heroin intoxication",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 5.55078125,
            "text": "patients had intravenous drug addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 4.172325134277344e-07
        }
    ],
    "5a7346662dc08e987e00001a_23": [
        {
            "start_logit": 7.484375,
            "end_logit": 5.55078125,
            "text": "heroin intoxication",
            "probability": 0.927734375
        },
        {
            "start_logit": 3.015625,
            "end_logit": 7.17578125,
            "text": "intravenous drug addiction",
            "probability": 0.053985595703125
        },
        {
            "start_logit": 7.484375,
            "end_logit": 1.494140625,
            "text": "heroin",
            "probability": 0.016082763671875
        },
        {
            "start_logit": -1.11328125,
            "end_logit": 7.69140625,
            "text": "intravenous drug addiction",
            "probability": 0.001461029052734375
        },
        {
            "start_logit": -2.044921875,
            "end_logit": 7.69140625,
            "text": "addiction",
            "probability": 0.0005769729614257812
        },
        {
            "start_logit": -1.11328125,
            "end_logit": 5.55078125,
            "text": "intravenous drug addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 0.00017178058624267578
        },
        {
            "start_logit": -2.8203125,
            "end_logit": 7.17578125,
            "text": "addiction",
            "probability": 0.0001589059829711914
        },
        {
            "start_logit": -3.419921875,
            "end_logit": 7.69140625,
            "text": "drug addiction",
            "probability": 0.00014579296112060547
        },
        {
            "start_logit": -2.044921875,
            "end_logit": 5.55078125,
            "text": "addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 6.783008575439453e-05
        },
        {
            "start_logit": -4.1015625,
            "end_logit": 7.17578125,
            "text": "drug addiction",
            "probability": 4.410743713378906e-05
        },
        {
            "start_logit": -3.419921875,
            "end_logit": 5.55078125,
            "text": "drug addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": -4.6796875,
            "end_logit": 5.55078125,
            "text": "intoxication",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.69140625,
            "text": "patients had intravenous drug addiction",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -1.11328125,
            "end_logit": 1.494140625,
            "text": "intravenous drug addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.69140625,
            "text": "hands the puffy hand syndrome we report two cases of this condition from our rheumatologic consultation our two patients had intravenous drug addiction",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 7.484375,
            "end_logit": -7.53515625,
            "text": "heroin intoxication and in the other 2 years after stopping injections in our two patients",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.75390625,
            "end_logit": 5.55078125,
            "text": "hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -2.044921875,
            "end_logit": 1.494140625,
            "text": "addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 5.55078125,
            "text": "during heroin intoxication",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 5.55078125,
            "text": "patients had intravenous drug addiction they presented with an edema of the hands bilateral painless no pitting occurring in one of our patient during heroin intoxication",
            "probability": 4.172325134277344e-07
        }
    ],
    "5a7346662dc08e987e00001a_24": [
        {
            "start_logit": 3.107421875,
            "end_logit": 5.9375,
            "text": "heroin addiction",
            "probability": 0.8974609375
        },
        {
            "start_logit": -0.9140625,
            "end_logit": 7.15625,
            "text": "drug addiction",
            "probability": 0.0543212890625
        },
        {
            "start_logit": -1.2392578125,
            "end_logit": 7.15625,
            "text": "intravenous drug addiction",
            "probability": 0.039276123046875
        },
        {
            "start_logit": -2.908203125,
            "end_logit": 7.15625,
            "text": "addiction",
            "probability": 0.00740814208984375
        },
        {
            "start_logit": -3.615234375,
            "end_logit": 5.9375,
            "text": "intravenous heroin addiction",
            "probability": 0.00107574462890625
        },
        {
            "start_logit": -4.734375,
            "end_logit": 5.9375,
            "text": "addiction",
            "probability": 0.00035190582275390625
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 7.15625,
            "text": "term intravenous drug addiction",
            "probability": 0.00017976760864257812
        },
        {
            "start_logit": 3.107421875,
            "end_logit": -2.654296875,
            "text": "heroin",
            "probability": 0.00016629695892333984
        },
        {
            "start_logit": 3.107421875,
            "end_logit": -3.380859375,
            "text": "heroin addiction we retained the diagnosis of puffy hand syndrome revealed by a severe staphylococcal infection with toxic involvement mimicking a four limbs cellulitis",
            "probability": 8.040666580200195e-05
        },
        {
            "start_logit": 3.107421875,
            "end_logit": -6.390625,
            "text": "heroin addiction we retained the diagnosis of puffy hand syndrome revealed by a severe staphylococcal",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 3.107421875,
            "end_logit": -6.5703125,
            "text": "heroin addiction we retained the diagnosis of puffy hand syndrome revealed by a severe staphylococcal infection",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 3.107421875,
            "end_logit": -7.00390625,
            "text": "heroin addiction we",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 3.107421875,
            "end_logit": -7.6015625,
            "text": "heroin addiction we retained the diagnosis of puffy hand syndrome revealed by a severe staphylococcal infection with toxic involvement mimicking a four limbs cellulitis puffy hand syndrome apart",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -2.2734375,
            "end_logit": -3.380859375,
            "text": "staphylococcal infection with toxic involvement mimicking a four limbs cellulitis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.615234375,
            "end_logit": -2.654296875,
            "text": "intravenous heroin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.615234375,
            "end_logit": -3.380859375,
            "text": "intravenous heroin addiction we retained the diagnosis of puffy hand syndrome revealed by a severe staphylococcal infection with toxic involvement mimicking a four limbs cellulitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.9140625,
            "end_logit": -6.94921875,
            "text": "drug",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.9140625,
            "end_logit": -6.98828125,
            "text": "drug addiction it is characterized by a nonpitting edema affecting the dorsal side of fingers and hands with puffy aspect",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.734375,
            "end_logit": -3.380859375,
            "text": "addiction we retained the diagnosis of puffy hand syndrome revealed by a severe staphylococcal infection with toxic involvement mimicking a four limbs cellulitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.9140625,
            "end_logit": -7.2734375,
            "text": "drug addiction it is characterized by a nonpitting edema affecting the dorsal side of fingers",
            "probability": 5.960464477539063e-08
        }
    ],
    "56cf236f3975bb303a000002_1": [
        {
            "start_logit": 8.0546875,
            "end_logit": 7.484375,
            "text": "T-type calcium channels",
            "probability": 0.998046875
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 0.85546875,
            "text": "T-type calcium channels, we examined if more selective T-type",
            "probability": 0.0013132095336914062
        },
        {
            "start_logit": 7.02734375,
            "end_logit": 0.85546875,
            "text": "T-type",
            "probability": 0.00047206878662109375
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -1.353515625,
            "text": "T",
            "probability": 0.00014519691467285156
        },
        {
            "start_logit": -2.666015625,
            "end_logit": 7.484375,
            "text": "channels",
            "probability": 2.205371856689453e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -3.609375,
            "text": "T-type calcium channels, we examined if more selective T",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -3.630859375,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -4.37890625,
            "text": "T-type",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": 7.02734375,
            "end_logit": -3.609375,
            "text": "T",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 7.02734375,
            "end_logit": -3.630859375,
            "text": "T-type calcium channel",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -4.7421875,
            "end_logit": 7.484375,
            "text": "block T-type calcium channels",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -5.828125,
            "end_logit": 7.484375,
            "text": "type calcium channels",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.8203125,
            "text": "T-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.9765625,
            "text": "T-type calcium channels, we examined if more selective T-",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.15234375,
            "text": "T-type calcium channels,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 7.484375,
            "text": "calcium channels",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.328125,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-\u03b3-lyase (CSE",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.44921875,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-\u03b3-lyase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.5234375,
            "text": "T-type calcium channels, we",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.625,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-\u03b3-",
            "probability": 2.980232238769531e-07
        }
    ],
    "56cf236f3975bb303a000002_2": [
        {
            "start_logit": 8.0,
            "end_logit": 8.0234375,
            "text": "T-type channels",
            "probability": 1.0
        },
        {
            "start_logit": -1.591796875,
            "end_logit": 8.0234375,
            "text": "channels",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": 8.0,
            "end_logit": -1.720703125,
            "text": "T",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": 8.0,
            "end_logit": -2.818359375,
            "text": "T-type channels in a state-dependent manner, with higher affinity for inactivated channels",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -4.9609375,
            "end_logit": 8.0234375,
            "text": "block human T-type channels",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 8.0234375,
            "text": "methyl-alpha-phenylsuccinimide (MPS), block human T-type channels",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 8.0234375,
            "text": "human T-type channels",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.58203125,
            "end_logit": 8.0234375,
            "text": "type channels",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 8.0234375,
            "text": "-type channels",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 8.0234375,
            "text": "alpha-methyl-alpha-phenylsuccinimide (MPS), block human T-type channels",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -6.58984375,
            "text": "T-type",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 8.0234375,
            "text": "alpha-phenylsuccinimide (MPS), block human T-type channels",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 8.0234375,
            "text": "methsuximide, alpha-methyl-alpha-phenylsuccinimide (MPS), block human T-type channels",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.0234375,
            "text": "suximide, alpha-methyl-alpha-phenylsuccinimide (MPS), block human T-type channels",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.390625,
            "text": "T-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 8.0234375,
            "text": "phenylsuccinimide (MPS), block human T-type channels",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.0234375,
            "text": "), block human T-type channels",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.46484375,
            "text": "T-type channels in a state-dependent manner, with higher",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.5,
            "text": "T-type channels in a state-dependent manner, with higher affinity for inactivated channels.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0,
            "end_logit": -7.578125,
            "text": "T-type channels in",
            "probability": 1.7881393432617188e-07
        }
    ],
    "56cf236f3975bb303a000002_3": [
        {
            "start_logit": 7.91796875,
            "end_logit": 7.98046875,
            "text": "T-type channels",
            "probability": 1.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": 7.98046875,
            "text": "channels",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -1.953125,
            "text": "T",
            "probability": 4.83393669128418e-05
        },
        {
            "start_logit": -5.921875,
            "end_logit": 7.98046875,
            "text": "type channels",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.25390625,
            "text": "T-type",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.98046875,
            "text": "-type channels",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.8984375,
            "text": "T-type channels display",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.109375,
            "text": "T-type channels display current at the end of long pulses (persistent current), and this current was especially",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.3359375,
            "text": "T-type channels display current at the end of long pulses (persistent current), and this current was especially sensitive to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.34375,
            "text": "T-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.44140625,
            "text": "T-type channels display current at the end of long pulses (persistent current), and this current was especially sensitive to block",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.4453125,
            "text": "T-type channels display current at the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.4765625,
            "text": "T-type channels display current at the end of long pulses (persistent current), and this current was especially sensitive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.58984375,
            "text": "T-type channels display current at the end of long pulses (persistent current), and this current was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -6.8984375,
            "text": "channels display",
            "probability": 0.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -7.109375,
            "text": "channels display current at the end of long pulses (persistent current), and this current was especially",
            "probability": 0.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -7.3359375,
            "text": "channels display current at the end of long pulses (persistent current), and this current was especially sensitive to",
            "probability": 0.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -7.44140625,
            "text": "channels display current at the end of long pulses (persistent current), and this current was especially sensitive to block",
            "probability": 0.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -7.4453125,
            "text": "channels display current at the",
            "probability": 0.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -7.4765625,
            "text": "channels display current at the end of long pulses (persistent current), and this current was especially sensitive",
            "probability": 0.0
        }
    ],
    "56cf236f3975bb303a000002_4": [
        {
            "start_logit": 7.8046875,
            "end_logit": 5.55078125,
            "text": "T-type",
            "probability": 1.0
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -2.427734375,
            "text": "T",
            "probability": 0.0003407001495361328
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -5.01171875,
            "text": "T-type calcium channel",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -4.5546875,
            "end_logit": 5.55078125,
            "text": "type",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -6.89453125,
            "text": "T-",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.70703125,
            "text": "T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.70703125,
            "text": "T-type calcium channel blockers, including",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.7265625,
            "text": "T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomer",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.80078125,
            "text": "T-type calcium channel blockers,",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.8125,
            "text": "T-type calcium channel blockers, including zonisamide (ZNS",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.828125,
            "text": "T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomerizine, amiloride",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 5.55078125,
            "text": "-type",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -5.01171875,
            "text": "type calcium channel",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -5.01171875,
            "text": "calcium channel",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.70703125,
            "text": "type calcium channel blockers, including zonisamide (ZNS), ethosuximide",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.70703125,
            "text": "type calcium channel blockers, including",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.7265625,
            "text": "type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomer",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.80078125,
            "text": "type calcium channel blockers,",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.8125,
            "text": "type calcium channel blockers, including zonisamide (ZNS",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.828125,
            "text": "type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomerizine, amiloride",
            "probability": 0.0
        }
    ],
    "56cf236f3975bb303a000002_5": [
        {
            "start_logit": 7.96875,
            "end_logit": 5.3046875,
            "text": "T-type",
            "probability": 0.99609375
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.61865234375,
            "text": "T-type calcium channel",
            "probability": 0.0026702880859375
        },
        {
            "start_logit": 7.96875,
            "end_logit": -1.8134765625,
            "text": "T",
            "probability": 0.0008077621459960938
        },
        {
            "start_logit": 7.96875,
            "end_logit": -6.74609375,
            "text": "T-",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -4.20703125,
            "end_logit": 5.3046875,
            "text": "type",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.37890625,
            "text": "T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil.",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.4140625,
            "text": "T-type calcium channel blockers",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.625,
            "text": "T-type calcium channel blockers ethosuximide, trimethadione",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.63671875,
            "text": "T-type calcium channel blockers ethosuximide, trimethadi",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.7265625,
            "text": "T-type calcium channel blockers ethosuximide",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.75390625,
            "text": "T-type calcium channel blockers ethosuximide, trimethadione, and mibefradi",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.76953125,
            "text": "T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.77734375,
            "text": "T-type calcium channel blockers ethosuximide,",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.83203125,
            "text": "T-type calcium",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 5.3046875,
            "text": "-type",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 5.3046875,
            "text": "yperalgesic effects of the T-type",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.20703125,
            "end_logit": -0.61865234375,
            "text": "type calcium channel",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -0.61865234375,
            "text": "-type calcium channel",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -0.61865234375,
            "text": "calcium channel",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -0.61865234375,
            "text": "yperalgesic effects of the T-type calcium channel",
            "probability": 0.0
        }
    ],
    "56cf236f3975bb303a000002_6": [
        {
            "start_logit": 7.8046875,
            "end_logit": 5.55078125,
            "text": "T-type",
            "probability": 1.0
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -2.427734375,
            "text": "T",
            "probability": 0.0003407001495361328
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -5.01171875,
            "text": "T-type calcium channel",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -4.5546875,
            "end_logit": 5.55078125,
            "text": "type",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -6.89453125,
            "text": "T-",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.70703125,
            "text": "T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.70703125,
            "text": "T-type calcium channel blockers, including",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.7265625,
            "text": "T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomer",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.80078125,
            "text": "T-type calcium channel blockers,",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.8125,
            "text": "T-type calcium channel blockers, including zonisamide (ZNS",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.828125,
            "text": "T-type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomerizine, amiloride",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 5.55078125,
            "text": "-type",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -5.01171875,
            "text": "type calcium channel",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -5.01171875,
            "text": "calcium channel",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.70703125,
            "text": "type calcium channel blockers, including zonisamide (ZNS), ethosuximide",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.70703125,
            "text": "type calcium channel blockers, including",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.7265625,
            "text": "type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomer",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.80078125,
            "text": "type calcium channel blockers,",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.8125,
            "text": "type calcium channel blockers, including zonisamide (ZNS",
            "probability": 0.0
        },
        {
            "start_logit": -4.5546875,
            "end_logit": -7.828125,
            "text": "type calcium channel blockers, including zonisamide (ZNS), ethosuximide, lomerizine, amiloride",
            "probability": 0.0
        }
    ],
    "56cf236f3975bb303a000002_7": [
        {
            "start_logit": 7.81640625,
            "end_logit": 7.3984375,
            "text": "T-type",
            "probability": 1.0
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -2.310546875,
            "text": "T",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": -2.634765625,
            "end_logit": 7.3984375,
            "text": "type",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -6.28125,
            "text": "T-type calcium",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -6.48828125,
            "text": "T-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.2734375,
            "text": "T-type calcium blockers, trimethadione and ethosuximide, which are anti-epileptic",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.6015625,
            "text": "T-type calcium blockers,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.6015625,
            "text": "T-type calcium blockers",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.62890625,
            "text": "T-type calcium blockers, trimethadione and ethosuximide",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.66015625,
            "text": "T-type calcium blockers, trimethadione and ethosuximide, which are anti-epileptics approved by the Food and Drug Administration.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.74609375,
            "text": "T-type calcium blockers, trimethadione",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.796875,
            "text": "T-type calcium blockers, trimethadione and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.859375,
            "text": "T-type calcium blockers, trimethadione and ethos",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.9140625,
            "text": "T-type calcium blockers, trimethadione and eth",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.3984375,
            "text": "-type",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.95703125,
            "text": "T-type calcium blockers, trimethadi",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.81640625,
            "end_logit": -7.95703125,
            "text": "T-type calcium blockers, trimethadione and ethosux",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.634765625,
            "end_logit": -6.28125,
            "text": "type calcium",
            "probability": 0.0
        },
        {
            "start_logit": -2.634765625,
            "end_logit": -7.2734375,
            "text": "type calcium blockers, trimethadione and ethosuximide, which are anti-epileptic",
            "probability": 0.0
        },
        {
            "start_logit": -2.634765625,
            "end_logit": -7.6015625,
            "text": "type calcium blockers,",
            "probability": 0.0
        }
    ],
    "6026ed981cb411341a0000d2_1": [
        {
            "start_logit": -4.375,
            "end_logit": -4.7421875,
            "text": "canezumab) and TEV48125",
            "probability": 0.227294921875
        },
        {
            "start_logit": -4.76953125,
            "end_logit": -4.7421875,
            "text": "TEV48125",
            "probability": 0.152587890625
        },
        {
            "start_logit": -5.4765625,
            "end_logit": -4.7421875,
            "text": "ezumab) and TEV48125",
            "probability": 0.0755615234375
        },
        {
            "start_logit": -4.375,
            "end_logit": -5.96875,
            "text": "canezumab",
            "probability": 0.066650390625
        },
        {
            "start_logit": -5.75390625,
            "end_logit": -4.7421875,
            "text": "galcanezumab) and TEV48125",
            "probability": 0.05706787109375
        },
        {
            "start_logit": -5.890625,
            "end_logit": -4.7421875,
            "text": "erenumab), LY2951742 (galcanezumab) and TEV48125",
            "probability": 0.049957275390625
        },
        {
            "start_logit": -6.1015625,
            "end_logit": -4.7421875,
            "text": "LY2951742 (galcanezumab) and TEV48125",
            "probability": 0.040435791015625
        },
        {
            "start_logit": -4.375,
            "end_logit": -6.546875,
            "text": "canezumab) and TEV48125 (fremanezumab",
            "probability": 0.03741455078125
        },
        {
            "start_logit": -6.1875,
            "end_logit": -4.7421875,
            "text": "inezumab), AMG334 (erenumab), LY2951742 (galcanezumab) and TEV48125",
            "probability": 0.037109375
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -4.7421875,
            "text": "V48125",
            "probability": 0.032501220703125
        },
        {
            "start_logit": -4.375,
            "end_logit": -6.71484375,
            "text": "canezumab) and TEV48125 (fremanezumab)] have been published recently, and phase 3 trials are in process.",
            "probability": 0.031494140625
        },
        {
            "start_logit": -6.48828125,
            "end_logit": -4.7421875,
            "text": "48125",
            "probability": 0.0273590087890625
        },
        {
            "start_logit": -4.76953125,
            "end_logit": -6.546875,
            "text": "TEV48125 (fremanezumab",
            "probability": 0.0253143310546875
        },
        {
            "start_logit": -5.44921875,
            "end_logit": -5.96875,
            "text": "eptinezumab), AMG334 (erenumab), LY2951742 (galcanezumab",
            "probability": 0.0226898193359375
        },
        {
            "start_logit": -5.4765625,
            "end_logit": -5.96875,
            "text": "ezumab",
            "probability": 0.02215576171875
        },
        {
            "start_logit": -4.76953125,
            "end_logit": -6.71484375,
            "text": "TEV48125 (fremanezumab)] have been published recently, and phase 3 trials are in process.",
            "probability": 0.0213165283203125
        },
        {
            "start_logit": -6.765625,
            "end_logit": -4.7421875,
            "text": "and TEV48125",
            "probability": 0.02081298828125
        },
        {
            "start_logit": -6.8828125,
            "end_logit": -4.7421875,
            "text": "enumab), LY2951742 (galcanezumab) and TEV48125",
            "probability": 0.0185089111328125
        },
        {
            "start_logit": -5.171875,
            "end_logit": -6.546875,
            "text": "fremanezumab",
            "probability": 0.0168609619140625
        },
        {
            "start_logit": -5.75390625,
            "end_logit": -5.96875,
            "text": "galcanezumab",
            "probability": 0.0168609619140625
        }
    ],
    "587e0116ae05ffb474000002_1": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.9375,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.517578125,
            "text": "Cis",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": 7.9375,
            "text": "per",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -6.328125,
            "end_logit": 7.9375,
            "text": "Mapper",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.890625,
            "text": "CisMap",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.8828125,
            "text": "CisMapper:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.0859375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.1484375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.1953125,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.203125,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.2265625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.2578125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.265625,
            "text": "CisMapper: predicting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -8.3359375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -7.8828125,
            "text": "per:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.0859375,
            "text": "per: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.1484375,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.1953125,
            "text": "per: predicting regulatory interactions from",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.203125,
            "text": "per: predicting regulatory interactions from transcription",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -8.2265625,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_2": [
        {
            "start_logit": 7.90625,
            "end_logit": 7.9296875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -1.7275390625,
            "end_logit": 7.9296875,
            "text": "per",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": 7.90625,
            "end_logit": -1.7177734375,
            "text": "Cis",
            "probability": 6.455183029174805e-05
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 7.9296875,
            "text": "Mapper",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.02734375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.03125,
            "text": "CisMap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.56640625,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF'",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.578125,
            "text": "CisMapper,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.59765625,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.65625,
            "text": "CisMapper, which",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.68359375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.68359375,
            "text": "CisMapper, which predicts the regulatory targets of a TF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.72265625,
            "text": "CisMapper, which predicts the regulatory targets of a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.765625,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.76953125,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's bound sites and the expression of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.78125,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's bound sites and the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.79296875,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.90625,
            "end_logit": -7.8125,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7275390625,
            "end_logit": -7.02734375,
            "text": "per, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF",
            "probability": 0.0
        },
        {
            "start_logit": -1.7275390625,
            "end_logit": -7.56640625,
            "text": "per, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF'",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_3": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.9296875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.478515625,
            "text": "Cis",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": -1.6396484375,
            "end_logit": 7.9296875,
            "text": "per",
            "probability": 6.979703903198242e-05
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 7.9296875,
            "text": "Mapper",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.76171875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.76953125,
            "text": "CisMap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.31640625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.65625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.9296875,
            "text": "that CisMapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.6875,
            "text": "CisMapper is more accurate at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.703125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.8046875,
            "text": "CisMapper is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.8046875,
            "text": "CisMapper is more accurate at predicting the target genes of a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.8203125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.8203125,
            "text": "CisMapper is more accurate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.82421875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly advantageous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.828125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.89453125,
            "text": "CisMapper is more",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.9140625,
            "text": "CisMapper is more accurate at predicting the target genes of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6396484375,
            "end_logit": -6.76171875,
            "text": "per is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_4": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.96484375,
            "text": "CisMapper",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9453125,
            "end_logit": 7.96484375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 0.33251953125
        },
        {
            "start_logit": 7.9453125,
            "end_logit": 7.96484375,
            "text": "CisMapper",
            "probability": 0.33251953125
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.1435546875,
            "text": "Cis",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.1435546875,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, Cis",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.173828125,
            "text": "Cis",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": 7.96484375,
            "text": "per",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -1.421875,
            "end_logit": 7.96484375,
            "text": "per also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.421875,
            "end_logit": 7.96484375,
            "text": "per",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 7.96484375,
            "text": "Mapper",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -5.84375,
            "text": "CisMap",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -5.84375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMap",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 7.96484375,
            "text": "Mapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 7.96484375,
            "text": "Mapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.92578125,
            "end_logit": 7.96484375,
            "text": ", CisMapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.2578125,
            "text": "CisMap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.96484375,
            "text": ". Unlike distance-based methods, CisMapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.5859375,
            "text": "CisMapper can predict which transcription start site of a gene is regulated by a particular binding site of the TF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.390625,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.4453125,
            "text": "CisMapper can predict which transcription start site of a gene is regulated by a particular binding site of the",
            "probability": 5.960464477539063e-08
        }
    ],
    "587e0116ae05ffb474000002_5": [
        {
            "start_logit": 7.94921875,
            "end_logit": 7.96484375,
            "text": "CisMapper",
            "probability": 0.3349609375
        },
        {
            "start_logit": 7.9453125,
            "end_logit": 7.96484375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 0.33251953125
        },
        {
            "start_logit": 7.9453125,
            "end_logit": 7.96484375,
            "text": "CisMapper",
            "probability": 0.33251953125
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.1435546875,
            "text": "Cis",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.1435546875,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, Cis",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -1.173828125,
            "text": "Cis",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -1.4130859375,
            "end_logit": 7.96484375,
            "text": "per",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -1.421875,
            "end_logit": 7.96484375,
            "text": "per also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.421875,
            "end_logit": 7.96484375,
            "text": "per",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 7.96484375,
            "text": "Mapper",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -5.84375,
            "text": "CisMap",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -5.84375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMap",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 7.96484375,
            "text": "Mapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 7.96484375,
            "text": "Mapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.92578125,
            "end_logit": 7.96484375,
            "text": ", CisMapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.2578125,
            "text": "CisMap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.96484375,
            "text": ". Unlike distance-based methods, CisMapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -6.5859375,
            "text": "CisMapper can predict which transcription start site of a gene is regulated by a particular binding site of the TF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.390625,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -7.4453125,
            "text": "CisMapper can predict which transcription start site of a gene is regulated by a particular binding site of the",
            "probability": 5.960464477539063e-08
        }
    ],
    "587e0116ae05ffb474000002_6": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.9375,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -1.513671875,
            "text": "Cis",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": 7.9375,
            "text": "per",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 7.9375,
            "text": "Mapper",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -6.84375,
            "text": "CisMap",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.82421875,
            "text": "CisMapper:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.0703125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.078125,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.1875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.2109375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.2109375,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.21875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.2265625,
            "text": "CisMapper: predicting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.28125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.3125,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -7.82421875,
            "text": "per:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -8.0703125,
            "text": "per: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -8.078125,
            "text": "per: predicting regulatory interactions from",
            "probability": 0.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -8.1875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -8.2109375,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_7": [
        {
            "start_logit": 7.93359375,
            "end_logit": 7.9375,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -1.513671875,
            "text": "Cis",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": 7.9375,
            "text": "per",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 7.9375,
            "text": "Mapper",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -6.84375,
            "text": "CisMap",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -7.82421875,
            "text": "CisMapper:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.0703125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.078125,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.1875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.2109375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.2109375,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.21875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.2265625,
            "text": "CisMapper: predicting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.28125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.93359375,
            "end_logit": -8.3125,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -7.82421875,
            "text": "per:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -8.0703125,
            "text": "per: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -8.078125,
            "text": "per: predicting regulatory interactions from",
            "probability": 0.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -8.1875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -8.2109375,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_8": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.9296875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -1.4619140625,
            "text": "Cis",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": -1.6484375,
            "end_logit": 7.9296875,
            "text": "per",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 7.9296875,
            "text": "Mapper",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.5078125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.703125,
            "text": "CisMap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.19140625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.51171875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.51953125,
            "text": "CisMapper is more accurate at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.5234375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.9296875,
            "text": "that CisMapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.62890625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.65625,
            "text": "CisMapper is more accurate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.67578125,
            "text": "CisMapper is more accurate at predicting the target genes of a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.6953125,
            "text": "CisMapper is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.71484375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.7421875,
            "text": "CisMapper is more",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.75,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly advantageous",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.79296875,
            "text": "CisMapper is more accurate at predicting the target genes of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -7.8125,
            "text": "CisMapper is more accurate at predicting the",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60314c361cb411341a00012e_1": [
        {
            "start_logit": 6.36328125,
            "end_logit": 7.1015625,
            "text": "inflammation of the aorta",
            "probability": 0.9970703125
        },
        {
            "start_logit": 6.36328125,
            "end_logit": 1.3486328125,
            "text": "inflammation of the aorta due to various causes.",
            "probability": 0.0031490325927734375
        },
        {
            "start_logit": -2.92578125,
            "end_logit": 7.1015625,
            "text": "aorta",
            "probability": 9.149312973022461e-05
        },
        {
            "start_logit": -3.08203125,
            "end_logit": 7.1015625,
            "text": "Aortitis is the inflammation of the aorta",
            "probability": 7.82012939453125e-05
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -2.728515625,
            "text": "inflammation of the aorta due to various causes",
            "probability": 5.328655242919922e-05
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -4.4140625,
            "text": "inflammation",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 7.1015625,
            "text": "the aorta",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -5.77734375,
            "end_logit": 7.1015625,
            "text": "the inflammation of the aorta",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 7.1015625,
            "text": "of the aorta",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -6.5234375,
            "text": "inflammation of",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -6.83203125,
            "text": "inflammation of the aorta due to various",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -6.8671875,
            "text": "inflammation of the aorta due to",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -6.9765625,
            "text": "inflammation of the",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 7.1015625,
            "text": "itis is the inflammation of the aorta",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 7.1015625,
            "text": "is the inflammation of the aorta",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.859375,
            "text": "inflammation of the aorta due",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.92578125,
            "end_logit": 1.3486328125,
            "text": "aorta due to various causes.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.08203125,
            "end_logit": 1.3486328125,
            "text": "Aortitis is the inflammation of the aorta due to various causes.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 1.3486328125,
            "text": "the aorta due to various causes.",
            "probability": 0.0
        },
        {
            "start_logit": -5.77734375,
            "end_logit": 1.3486328125,
            "text": "the inflammation of the aorta due to various causes.",
            "probability": 0.0
        }
    ],
    "60314c361cb411341a00012e_2": [
        {
            "start_logit": -1.5087890625,
            "end_logit": 7.6171875,
            "text": "inflammatory diseases of the aorta",
            "probability": 0.50439453125
        },
        {
            "start_logit": -1.755859375,
            "end_logit": 7.6171875,
            "text": "aorta",
            "probability": 0.392822265625
        },
        {
            "start_logit": -3.861328125,
            "end_logit": 7.6171875,
            "text": "Aortitis and periaortitis are inflammatory diseases of the aorta",
            "probability": 0.047943115234375
        },
        {
            "start_logit": -4.54296875,
            "end_logit": 7.6171875,
            "text": "the aorta",
            "probability": 0.0242462158203125
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 7.6171875,
            "text": "periaortitis are inflammatory diseases of the aorta",
            "probability": 0.00624847412109375
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 7.6171875,
            "text": "rtitis are inflammatory diseases of the aorta",
            "probability": 0.0056915283203125
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 7.6171875,
            "text": "aortitis are inflammatory diseases of the aorta",
            "probability": 0.005161285400390625
        },
        {
            "start_logit": -6.12890625,
            "end_logit": 7.6171875,
            "text": "itis are inflammatory diseases of the aorta",
            "probability": 0.004962921142578125
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 7.6171875,
            "text": "diseases of the aorta",
            "probability": 0.00494384765625
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 7.6171875,
            "text": "of the aorta",
            "probability": 0.003307342529296875
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -1.8505859375,
            "text": "inflammatory diseases of the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 3.898143768310547e-05
        },
        {
            "start_logit": -1.755859375,
            "end_logit": -1.8505859375,
            "text": "aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 3.0338764190673828e-05
        },
        {
            "start_logit": -4.54296875,
            "end_logit": -1.8505859375,
            "text": "the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -1.5087890625,
            "end_logit": -6.0,
            "text": "inflammatory diseases of the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.8984375,
            "end_logit": -1.8505859375,
            "text": "periaortitis are inflammatory diseases of the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.755859375,
            "end_logit": -6.0,
            "text": "aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -1.8505859375,
            "text": "rtitis are inflammatory diseases of the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.08984375,
            "end_logit": -1.8505859375,
            "text": "aortitis are inflammatory diseases of the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.12890625,
            "end_logit": -1.8505859375,
            "text": "itis are inflammatory diseases of the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.1328125,
            "end_logit": -1.8505859375,
            "text": "diseases of the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 4.172325134277344e-07
        }
    ],
    "60314c361cb411341a00012e_3": [
        {
            "start_logit": 2.05859375,
            "end_logit": 7.828125,
            "text": "\"Aortitis\" is a pathologic term that refers to an abnormal inflammation of the aortic wall",
            "probability": 0.87451171875
        },
        {
            "start_logit": 2.05859375,
            "end_logit": 5.63671875,
            "text": "\"Aortitis\" is a pathologic term that refers to an abnormal inflammation of the aortic wall.",
            "probability": 0.09735107421875
        },
        {
            "start_logit": -2.275390625,
            "end_logit": 7.828125,
            "text": "wall",
            "probability": 0.01145172119140625
        },
        {
            "start_logit": -3.146484375,
            "end_logit": 7.828125,
            "text": "inflammation of the aortic wall",
            "probability": 0.00476837158203125
        },
        {
            "start_logit": -3.544921875,
            "end_logit": 7.828125,
            "text": "Aortitis\" is a pathologic term that refers to an abnormal inflammation of the aortic wall",
            "probability": 0.003204345703125
        },
        {
            "start_logit": -3.806640625,
            "end_logit": 7.828125,
            "text": "term that refers to an abnormal inflammation of the aortic wall",
            "probability": 0.002475738525390625
        },
        {
            "start_logit": -2.275390625,
            "end_logit": 5.63671875,
            "text": "wall.",
            "probability": 0.00127410888671875
        },
        {
            "start_logit": -4.875,
            "end_logit": 7.828125,
            "text": "abnormal inflammation of the aortic wall",
            "probability": 0.0008487701416015625
        },
        {
            "start_logit": -2.720703125,
            "end_logit": 5.63671875,
            "text": ".",
            "probability": 0.00081634521484375
        },
        {
            "start_logit": -5.23828125,
            "end_logit": 7.828125,
            "text": "aortic wall",
            "probability": 0.0005903244018554688
        },
        {
            "start_logit": -3.146484375,
            "end_logit": 5.63671875,
            "text": "inflammation of the aortic wall.",
            "probability": 0.0005354881286621094
        },
        {
            "start_logit": -5.390625,
            "end_logit": 7.828125,
            "text": "the aortic wall",
            "probability": 0.0005068778991699219
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 7.828125,
            "text": "of the aortic wall",
            "probability": 0.00042510032653808594
        },
        {
            "start_logit": -3.544921875,
            "end_logit": 5.63671875,
            "text": "Aortitis\" is a pathologic term that refers to an abnormal inflammation of the aortic wall.",
            "probability": 0.00035953521728515625
        },
        {
            "start_logit": -3.806640625,
            "end_logit": 5.63671875,
            "text": "term that refers to an abnormal inflammation of the aortic wall.",
            "probability": 0.00027561187744140625
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 7.828125,
            "text": "pathologic term that refers to an abnormal inflammation of the aortic wall",
            "probability": 0.00024700164794921875
        },
        {
            "start_logit": -6.34375,
            "end_logit": 7.828125,
            "text": "a pathologic term that refers to an abnormal inflammation of the aortic wall",
            "probability": 0.00019550323486328125
        },
        {
            "start_logit": -6.609375,
            "end_logit": 7.828125,
            "text": "refers to an abnormal inflammation of the aortic wall",
            "probability": 0.00014984607696533203
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 7.828125,
            "text": "\" is a pathologic term that refers to an abnormal inflammation of the aortic wall",
            "probability": 0.0001251697540283203
        },
        {
            "start_logit": -6.84375,
            "end_logit": 7.828125,
            "text": "to an abnormal inflammation of the aortic wall",
            "probability": 0.00011855363845825195
        }
    ],
    "60314c361cb411341a00012e_4": [
        {
            "start_logit": 6.1796875,
            "end_logit": 7.38671875,
            "text": "Inflammation of the aortic wall",
            "probability": 1.0
        },
        {
            "start_logit": 3.484375,
            "end_logit": 1.9013671875,
            "text": "aortic aneurysm or dissection",
            "probability": 0.00028252601623535156
        },
        {
            "start_logit": -3.123046875,
            "end_logit": 7.38671875,
            "text": "wall",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -3.154296875,
            "text": "Inflammation of the",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": 3.484375,
            "end_logit": -1.30859375,
            "text": "aortic aneurysm or dissection.",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -4.01953125,
            "text": "Inflammation of the aortic wall, known as aortitis, is a rare clinical entity which is frequently asymptomatic, or identified when the patient presents with an aortic",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 3.484375,
            "end_logit": -1.5517578125,
            "text": "aortic aneurysm",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -4.3984375,
            "text": "Inflammation",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 7.38671875,
            "text": "aortic wall",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -5.1171875,
            "text": "Inflammation of",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 7.38671875,
            "text": "the aortic wall",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -5.47265625,
            "text": "Inflammation of the aortic",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 7.38671875,
            "text": "of the aortic wall",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -6.54296875,
            "text": "Inflammation of the aortic wall, known",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -6.55078125,
            "text": "Inflammation of the aortic wall,",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 3.484375,
            "end_logit": -4.01953125,
            "text": "aortic",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -7.28515625,
            "text": "Inflammation of the aortic wall, known as aortitis, is a rare clinical entity which is frequently asymptomatic, or identified when the patient",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -3.123046875,
            "end_logit": 1.9013671875,
            "text": "wall, known as aortitis, is a rare clinical entity which is frequently asymptomatic, or identified when the patient presents with an aortic aneurysm or dissection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -7.43359375,
            "text": "Inflammation of the aortic wall, known as aortitis, is a rare clinical entity which",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -7.49609375,
            "text": "Inflammation of the aortic wall, known as aortitis, is a rare",
            "probability": 3.5762786865234375e-07
        }
    ],
    "60314c361cb411341a00012e_5": [
        {
            "start_logit": -1.974609375,
            "end_logit": 7.25,
            "text": "Aortitis and periaortitis are inflammatory diseases of the aorta",
            "probability": 0.40673828125
        },
        {
            "start_logit": -2.265625,
            "end_logit": 7.25,
            "text": "aorta",
            "probability": 0.3046875
        },
        {
            "start_logit": -2.9921875,
            "end_logit": 7.25,
            "text": "periaortitis are inflammatory diseases of the aorta",
            "probability": 0.147216796875
        },
        {
            "start_logit": -3.51953125,
            "end_logit": 7.25,
            "text": "inflammatory diseases of the aorta",
            "probability": 0.0869140625
        },
        {
            "start_logit": -4.703125,
            "end_logit": 7.25,
            "text": "the aorta",
            "probability": 0.026611328125
        },
        {
            "start_logit": -5.83984375,
            "end_logit": 7.25,
            "text": "aortitis are inflammatory diseases of the aorta",
            "probability": 0.00853729248046875
        },
        {
            "start_logit": -5.9296875,
            "end_logit": 7.25,
            "text": "diseases of the aorta",
            "probability": 0.00780487060546875
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 7.25,
            "text": "rtitis are inflammatory diseases of the aorta",
            "probability": 0.007335662841796875
        },
        {
            "start_logit": -6.625,
            "end_logit": 7.25,
            "text": "of the aorta",
            "probability": 0.0038928985595703125
        },
        {
            "start_logit": -2.265625,
            "end_logit": -1.798828125,
            "text": "aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 3.5881996154785156e-05
        },
        {
            "start_logit": -2.9921875,
            "end_logit": -1.798828125,
            "text": "periaortitis are inflammatory diseases of the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": -4.75,
            "end_logit": -0.180419921875,
            "text": ".",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": -3.51953125,
            "end_logit": -1.798828125,
            "text": "inflammatory diseases of the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": -5.4921875,
            "end_logit": -0.180419921875,
            "text": "periaortitis.",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -6.18359375,
            "end_logit": -0.180419921875,
            "text": "in periaortitis.",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -4.703125,
            "end_logit": -1.798828125,
            "text": "the aorta and its main branches; they differ in the extension of inflammation, which is confined to the aortic wall",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -1.974609375,
            "end_logit": -4.54296875,
            "text": "Aortitis and periaortitis",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -6.578125,
            "end_logit": -0.180419921875,
            "text": "aortitis.",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -6.58203125,
            "end_logit": -0.180419921875,
            "text": "aortitis, and spreads to the periaortic space in periaortitis.",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -6.67578125,
            "end_logit": -0.180419921875,
            "text": "rtitis.",
            "probability": 2.205371856689453e-06
        }
    ],
    "60314c361cb411341a00012e_6": [
        {
            "start_logit": 2.611328125,
            "end_logit": 7.72265625,
            "text": "Aortitis is a general term denoting inflammation of the aortic wall",
            "probability": 0.56982421875
        },
        {
            "start_logit": 1.9873046875,
            "end_logit": 7.72265625,
            "text": "inflammation of the aortic wall",
            "probability": 0.304931640625
        },
        {
            "start_logit": 2.611328125,
            "end_logit": 5.734375,
            "text": "Aortitis is a general term denoting inflammation of the aortic wall.",
            "probability": 0.07769775390625
        },
        {
            "start_logit": 1.9873046875,
            "end_logit": 5.734375,
            "text": "inflammation of the aortic wall.",
            "probability": 0.041778564453125
        },
        {
            "start_logit": -2.525390625,
            "end_logit": 7.72265625,
            "text": "wall",
            "probability": 0.0033359527587890625
        },
        {
            "start_logit": -2.166015625,
            "end_logit": 5.734375,
            "text": ".",
            "probability": 0.0006570816040039062
        },
        {
            "start_logit": -2.525390625,
            "end_logit": 5.734375,
            "text": "wall.",
            "probability": 0.00045871734619140625
        },
        {
            "start_logit": -4.546875,
            "end_logit": 7.72265625,
            "text": "term denoting inflammation of the aortic wall",
            "probability": 0.00044274330139160156
        },
        {
            "start_logit": -4.6953125,
            "end_logit": 7.72265625,
            "text": "aortic wall",
            "probability": 0.00038170814514160156
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 7.72265625,
            "text": "the aortic wall",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 7.72265625,
            "text": "denoting inflammation of the aortic wall",
            "probability": 6.258487701416016e-05
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 7.72265625,
            "text": "oting inflammation of the aortic wall",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": -4.546875,
            "end_logit": 5.734375,
            "text": "term denoting inflammation of the aortic wall.",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": -4.6953125,
            "end_logit": 5.734375,
            "text": "aortic wall.",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 7.72265625,
            "text": "of the aortic wall",
            "probability": 4.9054622650146484e-05
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 7.72265625,
            "text": "general term denoting inflammation of the aortic wall",
            "probability": 3.5881996154785156e-05
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 7.72265625,
            "text": "a general term denoting inflammation of the aortic wall",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 7.72265625,
            "text": "itis is a general term denoting inflammation of the aortic wall",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.72265625,
            "text": "is a general term denoting inflammation of the aortic wall",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 5.734375,
            "text": "the aortic wall.",
            "probability": 1.150369644165039e-05
        }
    ],
    "60314c361cb411341a00012e_7": [
        {
            "start_logit": 0.53466796875,
            "end_logit": 7.57421875,
            "text": "inflammation of the aorta",
            "probability": 0.931640625
        },
        {
            "start_logit": -2.185546875,
            "end_logit": 7.57421875,
            "text": "aorta",
            "probability": 0.06146240234375
        },
        {
            "start_logit": -5.27734375,
            "end_logit": 7.57421875,
            "text": "Aortitis is the inflammation of the aorta",
            "probability": 0.0027866363525390625
        },
        {
            "start_logit": -5.66015625,
            "end_logit": 7.57421875,
            "text": "the aorta",
            "probability": 0.00189971923828125
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 7.57421875,
            "text": "of the aorta",
            "probability": 0.0006961822509765625
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.57421875,
            "text": "the inflammation of the aorta",
            "probability": 0.00027370452880859375
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.57421875,
            "text": ": Aortitis is the inflammation of the aorta",
            "probability": 0.0002397298812866211
        },
        {
            "start_logit": -7.828125,
            "end_logit": 7.57421875,
            "text": "REVIEW: Aortitis is the inflammation of the aorta",
            "probability": 0.00021827220916748047
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.57421875,
            "text": "itis is the inflammation of the aorta",
            "probability": 0.00021314620971679688
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.57421875,
            "text": "PURPOSE OF REVIEW: Aortitis is the inflammation of the aorta",
            "probability": 0.00016999244689941406
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.57421875,
            "text": "is the inflammation of the aorta",
            "probability": 0.0001596212387084961
        },
        {
            "start_logit": 0.53466796875,
            "end_logit": -5.1953125,
            "text": "inflammation of the aorta due",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 0.53466796875,
            "end_logit": -7.3125,
            "text": "inflammation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 0.53466796875,
            "end_logit": -7.35546875,
            "text": "inflammation of the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.185546875,
            "end_logit": -5.1953125,
            "text": "aorta due",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.53466796875,
            "end_logit": -7.94140625,
            "text": "inflammation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.27734375,
            "end_logit": -5.1953125,
            "text": "Aortitis is the inflammation of the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -5.66015625,
            "end_logit": -5.1953125,
            "text": "the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -6.6640625,
            "end_logit": -5.1953125,
            "text": "of the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -5.27734375,
            "end_logit": -7.3125,
            "text": "Aortitis is the inflammation",
            "probability": 0.0
        }
    ],
    "60314c361cb411341a00012e_8": [
        {
            "start_logit": -0.92431640625,
            "end_logit": 7.86328125,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.5927734375
        },
        {
            "start_logit": -1.88671875,
            "end_logit": 7.86328125,
            "text": "aorta",
            "probability": 0.2266845703125
        },
        {
            "start_logit": -2.451171875,
            "end_logit": 7.86328125,
            "text": "inflammation of the aorta",
            "probability": 0.129150390625
        },
        {
            "start_logit": -4.1875,
            "end_logit": 7.86328125,
            "text": "term ascribed to inflammation of the aorta",
            "probability": 0.0227203369140625
        },
        {
            "start_logit": -5.328125,
            "end_logit": 7.86328125,
            "text": "the aorta",
            "probability": 0.00725555419921875
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 7.86328125,
            "text": "to inflammation of the aorta",
            "probability": 0.0037364959716796875
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 7.86328125,
            "text": "of the aorta",
            "probability": 0.003284454345703125
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 7.86328125,
            "text": "pathological term ascribed to inflammation of the aorta",
            "probability": 0.0028324127197265625
        },
        {
            "start_logit": -0.92431640625,
            "end_logit": 2.49609375,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the aorta.",
            "probability": 0.0027637481689453125
        },
        {
            "start_logit": -6.59375,
            "end_logit": 7.86328125,
            "text": "ascribed to inflammation of the aorta",
            "probability": 0.0020465850830078125
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 7.86328125,
            "text": "the all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.00197601318359375
        },
        {
            "start_logit": -1.88671875,
            "end_logit": 2.49609375,
            "text": "aorta.",
            "probability": 0.0010576248168945312
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.86328125,
            "text": "encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.0009708404541015625
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.86328125,
            "text": "-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.000667572021484375
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.86328125,
            "text": "all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.0006341934204101562
        },
        {
            "start_logit": -2.451171875,
            "end_logit": 2.49609375,
            "text": "inflammation of the aorta.",
            "probability": 0.0006031990051269531
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 7.86328125,
            "text": "is the all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.0005888938903808594
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 7.86328125,
            "text": "itis is the all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.0005154609680175781
        },
        {
            "start_logit": -4.1875,
            "end_logit": 2.49609375,
            "text": "term ascribed to inflammation of the aorta.",
            "probability": 0.00010639429092407227
        },
        {
            "start_logit": -5.3125,
            "end_logit": 2.49609375,
            "text": ".",
            "probability": 3.457069396972656e-05
        }
    ],
    "60314c361cb411341a00012e_9": [
        {
            "start_logit": 6.1640625,
            "end_logit": 7.75390625,
            "text": "inflammation of the aortic wall",
            "probability": 0.94921875
        },
        {
            "start_logit": 6.1640625,
            "end_logit": 4.765625,
            "text": "inflammation of the aortic wall, regardless of its cause.",
            "probability": 0.047607421875
        },
        {
            "start_logit": 0.406494140625,
            "end_logit": 7.75390625,
            "text": "Aortitis is a pathological term designating inflammation of the aortic wall",
            "probability": 0.00299835205078125
        },
        {
            "start_logit": -2.466796875,
            "end_logit": 7.75390625,
            "text": "wall",
            "probability": 0.0001691579818725586
        },
        {
            "start_logit": 0.406494140625,
            "end_logit": 4.765625,
            "text": "Aortitis is a pathological term designating inflammation of the aortic wall, regardless of its cause.",
            "probability": 0.00015032291412353516
        },
        {
            "start_logit": -4.66796875,
            "end_logit": 7.75390625,
            "text": "aortic wall",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 6.1640625,
            "end_logit": -3.6015625,
            "text": "inflammation of",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": -2.466796875,
            "end_logit": 4.765625,
            "text": "wall, regardless of its cause.",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": -5.80078125,
            "end_logit": 7.75390625,
            "text": "term designating inflammation of the aortic wall",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 6.1640625,
            "end_logit": -4.234375,
            "text": "inflammation of the",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": 6.1640625,
            "end_logit": -4.41015625,
            "text": "inflammation",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 7.75390625,
            "text": "the aortic wall",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 7.75390625,
            "text": "pathological term designating inflammation of the aortic wall",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -3.595703125,
            "end_logit": 4.765625,
            "text": ".",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -6.6875,
            "end_logit": 7.75390625,
            "text": "of the aortic wall",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 7.75390625,
            "text": "a pathological term designating inflammation of the aortic wall",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.1640625,
            "end_logit": -5.59765625,
            "text": "inflammation of the aortic wall,",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.75390625,
            "text": "ating inflammation of the aortic wall",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.75390625,
            "text": "designating inflammation of the aortic wall",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.75390625,
            "text": "is a pathological term designating inflammation of the aortic wall",
            "probability": 1.1920928955078125e-06
        }
    ],
    "60314c361cb411341a00012e_10": [
        {
            "start_logit": 2.689453125,
            "end_logit": 6.3203125,
            "text": "Aortitis is a general term that refers to a broad category of infectious or noninfectious conditions in which there is abnormal inflammation of the aortic wall",
            "probability": 0.98828125
        },
        {
            "start_logit": -2.01953125,
            "end_logit": 6.13671875,
            "text": ".",
            "probability": 0.007427215576171875
        },
        {
            "start_logit": -4.46484375,
            "end_logit": 6.3203125,
            "text": "wall",
            "probability": 0.0007739067077636719
        },
        {
            "start_logit": -4.46484375,
            "end_logit": 6.13671875,
            "text": "wall.",
            "probability": 0.0006442070007324219
        },
        {
            "start_logit": -5.3203125,
            "end_logit": 6.3203125,
            "text": "term that refers to a broad category of infectious or noninfectious conditions in which there is abnormal inflammation of the aortic wall",
            "probability": 0.00032901763916015625
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 6.3203125,
            "text": "infectious or noninfectious conditions in which there is abnormal inflammation of the aortic wall",
            "probability": 0.0003066062927246094
        },
        {
            "start_logit": -5.3203125,
            "end_logit": 6.13671875,
            "text": "term that refers to a broad category of infectious or noninfectious conditions in which there is abnormal inflammation of the aortic wall.",
            "probability": 0.000274658203125
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 6.3203125,
            "text": "inflammation of the aortic wall",
            "probability": 0.0002684593200683594
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 6.13671875,
            "text": "infectious or noninfectious conditions in which there is abnormal inflammation of the aortic wall.",
            "probability": 0.0002560615539550781
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 6.13671875,
            "text": "inflammation of the aortic wall.",
            "probability": 0.0002243518829345703
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 6.3203125,
            "text": "which there is abnormal inflammation of the aortic wall",
            "probability": 0.00012195110321044922
        },
        {
            "start_logit": -6.3125,
            "end_logit": 6.3203125,
            "text": "abnormal inflammation of the aortic wall",
            "probability": 0.00012195110321044922
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 6.3203125,
            "text": "the aortic wall",
            "probability": 0.00011283159255981445
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 6.3203125,
            "text": "of the aortic wall",
            "probability": 0.00010854005813598633
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 6.13671875,
            "text": "which there is abnormal inflammation of the aortic wall.",
            "probability": 0.00010192394256591797
        },
        {
            "start_logit": -6.3125,
            "end_logit": 6.13671875,
            "text": "abnormal inflammation of the aortic wall.",
            "probability": 0.0001010894775390625
        },
        {
            "start_logit": -6.5,
            "end_logit": 6.3203125,
            "text": "conditions in which there is abnormal inflammation of the aortic wall",
            "probability": 0.0001010894775390625
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 6.3203125,
            "text": "aortic wall",
            "probability": 9.804964065551758e-05
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 6.13671875,
            "text": "the aortic wall.",
            "probability": 9.351968765258789e-05
        },
        {
            "start_logit": -6.59375,
            "end_logit": 6.3203125,
            "text": "of infectious or noninfectious conditions in which there is abnormal inflammation of the aortic wall",
            "probability": 9.208917617797852e-05
        }
    ],
    "5891c90949702f2e01000001_1": [
        {
            "start_logit": 7.84765625,
            "end_logit": 7.80078125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -1.4501953125,
            "text": "INC",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": -1.828125,
            "end_logit": 7.80078125,
            "text": "A",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.76171875,
            "text": "INCA:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.85546875,
            "text": "INCA: synonymous codon usage analysis and clustering by means of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.89453125,
            "text": "INCA: synonymous codon usage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.9296875,
            "text": "INCA: synonymous codon usage analysis and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.0,
            "text": "INCA: synonymous codon usage analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.109375,
            "text": "INCA: synonymous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.1171875,
            "text": "INCA: synonymous codon",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.2109375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.828125,
            "end_logit": -7.76171875,
            "text": "A:",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -7.85546875,
            "text": "A: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -7.89453125,
            "text": "A: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -7.9296875,
            "text": "A: synonymous codon usage analysis and",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -8.0,
            "text": "A: synonymous codon usage analysis",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -8.109375,
            "text": "A: synonymous",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -8.1171875,
            "text": "A: synonymous codon",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -8.2109375,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map.",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -8.2109375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_2": [
        {
            "start_logit": 7.7734375,
            "end_logit": 7.8125,
            "text": "INCA",
            "probability": 0.25146484375
        },
        {
            "start_logit": 7.76171875,
            "end_logit": 7.8125,
            "text": "INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.76171875,
            "end_logit": 7.8125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.75390625,
            "end_logit": 7.8125,
            "text": "INCA",
            "probability": 0.2457275390625
        },
        {
            "start_logit": 3.45703125,
            "end_logit": 7.8125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0033435821533203125
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -0.923828125,
            "text": "INC",
            "probability": 4.0471553802490234e-05
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -0.923828125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.981590270996094e-05
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -1.0,
            "text": "INC",
            "probability": 3.6835670471191406e-05
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -1.2109375,
            "text": "INC",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -1.357421875,
            "end_logit": 7.8125,
            "text": "A",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": -1.357421875,
            "end_logit": 7.8125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": 7.8125,
            "text": "A",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": -1.4541015625,
            "end_logit": 7.8125,
            "text": "A",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -4.02734375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map,",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -4.90625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 3.45703125,
            "end_logit": -1.2109375,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.625,
            "end_logit": 7.8125,
            "text": ", INCA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -5.80078125,
            "text": "INCA)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.921875,
            "end_logit": 7.8125,
            "text": ". Finally, INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 7.8125,
            "text": "display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.384185791015625e-07
        }
    ],
    "5891c90949702f2e01000001_3": [
        {
            "start_logit": 7.7734375,
            "end_logit": 7.8125,
            "text": "INCA",
            "probability": 0.25146484375
        },
        {
            "start_logit": 7.76171875,
            "end_logit": 7.8125,
            "text": "INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.76171875,
            "end_logit": 7.8125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.75390625,
            "end_logit": 7.8125,
            "text": "INCA",
            "probability": 0.2457275390625
        },
        {
            "start_logit": 3.45703125,
            "end_logit": 7.8125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0033435821533203125
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -0.923828125,
            "text": "INC",
            "probability": 4.0471553802490234e-05
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -0.923828125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.981590270996094e-05
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -1.0,
            "text": "INC",
            "probability": 3.6835670471191406e-05
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -1.2109375,
            "text": "INC",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -1.357421875,
            "end_logit": 7.8125,
            "text": "A",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": -1.357421875,
            "end_logit": 7.8125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": 7.8125,
            "text": "A",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": -1.4541015625,
            "end_logit": 7.8125,
            "text": "A",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -4.02734375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map,",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -4.90625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 3.45703125,
            "end_logit": -1.2109375,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.625,
            "end_logit": 7.8125,
            "text": ", INCA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -5.80078125,
            "text": "INCA)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.921875,
            "end_logit": 7.8125,
            "text": ". Finally, INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 7.8125,
            "text": "display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.384185791015625e-07
        }
    ],
    "5891c90949702f2e01000001_4": [
        {
            "start_logit": 7.7734375,
            "end_logit": 7.8125,
            "text": "INCA",
            "probability": 0.25146484375
        },
        {
            "start_logit": 7.76171875,
            "end_logit": 7.8125,
            "text": "INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.76171875,
            "end_logit": 7.8125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.75390625,
            "end_logit": 7.8125,
            "text": "INCA",
            "probability": 0.2457275390625
        },
        {
            "start_logit": 3.45703125,
            "end_logit": 7.8125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0033435821533203125
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -0.923828125,
            "text": "INC",
            "probability": 4.0471553802490234e-05
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -0.923828125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.981590270996094e-05
        },
        {
            "start_logit": 7.76171875,
            "end_logit": -1.0,
            "text": "INC",
            "probability": 3.6835670471191406e-05
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -1.2109375,
            "text": "INC",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -1.357421875,
            "end_logit": 7.8125,
            "text": "A",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": -1.357421875,
            "end_logit": 7.8125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": 7.8125,
            "text": "A",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": -1.4541015625,
            "end_logit": 7.8125,
            "text": "A",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -4.02734375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map,",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -4.90625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 3.45703125,
            "end_logit": -1.2109375,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.625,
            "end_logit": 7.8125,
            "text": ", INCA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75390625,
            "end_logit": -5.80078125,
            "text": "INCA)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.921875,
            "end_logit": 7.8125,
            "text": ". Finally, INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 7.8125,
            "text": "display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.384185791015625e-07
        }
    ],
    "5891c90949702f2e01000001_5": [
        {
            "start_logit": 1.5068359375,
            "end_logit": 0.78076171875,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.9697265625
        },
        {
            "start_logit": -2.328125,
            "end_logit": 0.78076171875,
            "text": "INCA",
            "probability": 0.020965576171875
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -4.546875,
            "text": "INteractive Codon usage Analysis (INCA)",
            "probability": 0.004703521728515625
        },
        {
            "start_logit": -5.6640625,
            "end_logit": 0.78076171875,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 0.0007443428039550781
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -6.76171875,
            "text": "INteractive",
            "probability": 0.0005154609680175781
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 0.78076171875,
            "text": "Analysis (INCA",
            "probability": 0.000499725341796875
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -7.171875,
            "text": "INteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0003409385681152344
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 0.78076171875,
            "text": "Codon usage Analysis (INCA",
            "probability": 0.00026154518127441406
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 0.78076171875,
            "text": "usage Analysis (INCA",
            "probability": 0.00020515918731689453
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 0.78076171875,
            "text": ": INteractive Codon usage Analysis (INCA",
            "probability": 0.00019884109497070312
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 0.78076171875,
            "text": "A",
            "probability": 0.00018525123596191406
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 0.78076171875,
            "text": "(INCA",
            "probability": 0.0001825094223022461
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -7.96875,
            "text": "INteractive Codon usage Analysis",
            "probability": 0.00015366077423095703
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -8.1015625,
            "text": "INteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 0.00013458728790283203
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -8.109375,
            "text": "INteractive Codon usage Analysis (INCA) provides an array",
            "probability": 0.000133514404296875
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -8.140625,
            "text": "INteractive Codon usage",
            "probability": 0.00012934207916259766
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -8.140625,
            "text": "INteractive Codon usage Analysis (INCA) provides",
            "probability": 0.00012934207916259766
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -8.2109375,
            "text": "INteractive Codon usage Analysis (INCA) provides an array of features useful in",
            "probability": 0.00012058019638061523
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -8.21875,
            "text": "INteractive Codon",
            "probability": 0.00011962652206420898
        },
        {
            "start_logit": 1.5068359375,
            "end_logit": -8.28125,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.00011241436004638672
        }
    ],
    "5891c90949702f2e01000001_6": [
        {
            "start_logit": 7.84765625,
            "end_logit": 7.796875,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -1.443359375,
            "text": "INC",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": 7.796875,
            "text": "A",
            "probability": 6.35385513305664e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.82421875,
            "text": "INCA:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.8671875,
            "text": "INCA: synonymous codon usage analysis and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.87890625,
            "text": "INCA: synonymous codon usage analysis and clustering by means of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.953125,
            "text": "INCA: synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.015625,
            "text": "INCA: synonymous codon usage analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.078125,
            "text": "INCA: synonymous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.1328125,
            "text": "INCA: synonymous codon",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.1796875,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.2734375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": -7.82421875,
            "text": "A:",
            "probability": 0.0
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": -7.8671875,
            "text": "A: synonymous codon usage analysis and",
            "probability": 0.0
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": -7.87890625,
            "text": "A: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": -7.953125,
            "text": "A: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": -8.015625,
            "text": "A: synonymous codon usage analysis",
            "probability": 0.0
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": -8.078125,
            "text": "A: synonymous",
            "probability": 0.0
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": -8.1328125,
            "text": "A: synonymous codon",
            "probability": 0.0
        },
        {
            "start_logit": -1.8212890625,
            "end_logit": -8.1796875,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_7": [
        {
            "start_logit": 7.765625,
            "end_logit": 7.61328125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 7.765625,
            "end_logit": -1.9267578125,
            "text": "INC",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -2.341796875,
            "end_logit": 7.61328125,
            "text": "A",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": -4.08203125,
            "end_logit": 7.61328125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": 7.765625,
            "end_logit": -5.41015625,
            "text": "INCA)",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -6.890625,
            "end_logit": 7.61328125,
            "text": "(INCA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 7.61328125,
            "text": "Codon usage Analysis (INCA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 7.61328125,
            "text": "Analysis (INCA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 7.61328125,
            "text": "usage Analysis (INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -8.109375,
            "text": "INCA) provides",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -8.234375,
            "text": "INCA) provides an array of features useful in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -8.2890625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -8.359375,
            "text": "INCA) provides an array",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -8.359375,
            "text": "INCA) provides an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.765625,
            "end_logit": -8.3671875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.08203125,
            "end_logit": -1.9267578125,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -2.341796875,
            "end_logit": -5.41015625,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -6.890625,
            "end_logit": -1.9267578125,
            "text": "(INC",
            "probability": 0.0
        },
        {
            "start_logit": -6.89453125,
            "end_logit": -1.9267578125,
            "text": "Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -7.1171875,
            "end_logit": -1.9267578125,
            "text": "Analysis (INC",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_8": [
        {
            "start_logit": 7.8046875,
            "end_logit": 7.69140625,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -1.7578125,
            "text": "INC",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -2.18359375,
            "end_logit": 7.69140625,
            "text": "A",
            "probability": 4.57763671875e-05
        },
        {
            "start_logit": -4.03515625,
            "end_logit": 7.69140625,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -6.91796875,
            "text": "INCA)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 7.69140625,
            "text": "Codon usage Analysis (INCA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.69140625,
            "text": "Analysis (INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.69140625,
            "text": "usage Analysis (INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.69140625,
            "text": "(INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.71484375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -8.1015625,
            "text": "INCA) provides an array of features useful in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -8.1171875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -8.140625,
            "text": "INCA) provides",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -8.1953125,
            "text": "INCA) provides an array",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -8.21875,
            "text": "INCA) provides an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -8.21875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -8.3046875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.03515625,
            "end_logit": -1.7578125,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -6.9609375,
            "end_logit": -1.7578125,
            "text": "Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -1.7578125,
            "text": "Analysis (INC",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_9": [
        {
            "start_logit": 7.7265625,
            "end_logit": 7.70703125,
            "text": "INCA",
            "probability": 0.2337646484375
        },
        {
            "start_logit": 7.6796875,
            "end_logit": 7.65625,
            "text": "INCA",
            "probability": 0.211181640625
        },
        {
            "start_logit": 7.7109375,
            "end_logit": 7.61328125,
            "text": "INCA",
            "probability": 0.2095947265625
        },
        {
            "start_logit": 7.62109375,
            "end_logit": 7.61328125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.19091796875
        },
        {
            "start_logit": 7.62109375,
            "end_logit": 7.3984375,
            "text": "INCA",
            "probability": 0.1533203125
        },
        {
            "start_logit": 2.384765625,
            "end_logit": 7.65625,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0010576248168945312
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -0.89404296875,
            "text": "INC",
            "probability": 4.26173210144043e-05
        },
        {
            "start_logit": 7.7109375,
            "end_logit": -0.9404296875,
            "text": "INC",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -0.9404296875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -1.1669921875,
            "text": "INC",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -1.392578125,
            "text": "INC",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -1.654296875,
            "end_logit": 7.70703125,
            "text": "A",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -1.615234375,
            "end_logit": 7.65625,
            "text": "A",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -1.654296875,
            "end_logit": 7.61328125,
            "text": "A",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 7.61328125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 7.3984375,
            "text": "A",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -4.87890625,
            "end_logit": 7.65625,
            "text": "Analysis (INCA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.74609375,
            "end_logit": 7.65625,
            "text": "usage Analysis (INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 7.61328125,
            "text": ". Finally, INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.96875,
            "end_logit": 7.65625,
            "text": "Codon usage Analysis (INCA",
            "probability": 2.384185791015625e-07
        }
    ],
    "5891c90949702f2e01000001_10": [
        {
            "start_logit": 7.7265625,
            "end_logit": 7.70703125,
            "text": "INCA",
            "probability": 0.2337646484375
        },
        {
            "start_logit": 7.6796875,
            "end_logit": 7.65625,
            "text": "INCA",
            "probability": 0.211181640625
        },
        {
            "start_logit": 7.7109375,
            "end_logit": 7.61328125,
            "text": "INCA",
            "probability": 0.2095947265625
        },
        {
            "start_logit": 7.62109375,
            "end_logit": 7.61328125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.19091796875
        },
        {
            "start_logit": 7.62109375,
            "end_logit": 7.3984375,
            "text": "INCA",
            "probability": 0.1533203125
        },
        {
            "start_logit": 2.384765625,
            "end_logit": 7.65625,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0010576248168945312
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -0.89404296875,
            "text": "INC",
            "probability": 4.26173210144043e-05
        },
        {
            "start_logit": 7.7109375,
            "end_logit": -0.9404296875,
            "text": "INC",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -0.9404296875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -1.1669921875,
            "text": "INC",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -1.392578125,
            "text": "INC",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -1.654296875,
            "end_logit": 7.70703125,
            "text": "A",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -1.615234375,
            "end_logit": 7.65625,
            "text": "A",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -1.654296875,
            "end_logit": 7.61328125,
            "text": "A",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 7.61328125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 7.3984375,
            "text": "A",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -4.87890625,
            "end_logit": 7.65625,
            "text": "Analysis (INCA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.74609375,
            "end_logit": 7.65625,
            "text": "usage Analysis (INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 7.61328125,
            "text": ". Finally, INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.96875,
            "end_logit": 7.65625,
            "text": "Codon usage Analysis (INCA",
            "probability": 2.384185791015625e-07
        }
    ],
    "5891c90949702f2e01000001_11": [
        {
            "start_logit": 7.7265625,
            "end_logit": 7.70703125,
            "text": "INCA",
            "probability": 0.2337646484375
        },
        {
            "start_logit": 7.6796875,
            "end_logit": 7.65625,
            "text": "INCA",
            "probability": 0.211181640625
        },
        {
            "start_logit": 7.7109375,
            "end_logit": 7.61328125,
            "text": "INCA",
            "probability": 0.2095947265625
        },
        {
            "start_logit": 7.62109375,
            "end_logit": 7.61328125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.19091796875
        },
        {
            "start_logit": 7.62109375,
            "end_logit": 7.3984375,
            "text": "INCA",
            "probability": 0.1533203125
        },
        {
            "start_logit": 2.384765625,
            "end_logit": 7.65625,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0010576248168945312
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -0.89404296875,
            "text": "INC",
            "probability": 4.26173210144043e-05
        },
        {
            "start_logit": 7.7109375,
            "end_logit": -0.9404296875,
            "text": "INC",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -0.9404296875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -1.1669921875,
            "text": "INC",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -1.392578125,
            "text": "INC",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -1.654296875,
            "end_logit": 7.70703125,
            "text": "A",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -1.615234375,
            "end_logit": 7.65625,
            "text": "A",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -1.654296875,
            "end_logit": 7.61328125,
            "text": "A",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 7.61328125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 7.3984375,
            "text": "A",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -4.87890625,
            "end_logit": 7.65625,
            "text": "Analysis (INCA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.74609375,
            "end_logit": 7.65625,
            "text": "usage Analysis (INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 7.61328125,
            "text": ". Finally, INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.96875,
            "end_logit": 7.65625,
            "text": "Codon usage Analysis (INCA",
            "probability": 2.384185791015625e-07
        }
    ],
    "5891c90949702f2e01000001_12": [
        {
            "start_logit": 7.7265625,
            "end_logit": 7.70703125,
            "text": "INCA",
            "probability": 0.2337646484375
        },
        {
            "start_logit": 7.6796875,
            "end_logit": 7.65625,
            "text": "INCA",
            "probability": 0.211181640625
        },
        {
            "start_logit": 7.7109375,
            "end_logit": 7.61328125,
            "text": "INCA",
            "probability": 0.2095947265625
        },
        {
            "start_logit": 7.62109375,
            "end_logit": 7.61328125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.19091796875
        },
        {
            "start_logit": 7.62109375,
            "end_logit": 7.3984375,
            "text": "INCA",
            "probability": 0.1533203125
        },
        {
            "start_logit": 2.384765625,
            "end_logit": 7.65625,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0010576248168945312
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -0.89404296875,
            "text": "INC",
            "probability": 4.26173210144043e-05
        },
        {
            "start_logit": 7.7109375,
            "end_logit": -0.9404296875,
            "text": "INC",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -0.9404296875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -1.1669921875,
            "text": "INC",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 7.62109375,
            "end_logit": -1.392578125,
            "text": "INC",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -1.654296875,
            "end_logit": 7.70703125,
            "text": "A",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -1.615234375,
            "end_logit": 7.65625,
            "text": "A",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -1.654296875,
            "end_logit": 7.61328125,
            "text": "A",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 7.61328125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": -1.8134765625,
            "end_logit": 7.3984375,
            "text": "A",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -4.87890625,
            "end_logit": 7.65625,
            "text": "Analysis (INCA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.74609375,
            "end_logit": 7.65625,
            "text": "usage Analysis (INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 7.61328125,
            "text": ". Finally, INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.96875,
            "end_logit": 7.65625,
            "text": "Codon usage Analysis (INCA",
            "probability": 2.384185791015625e-07
        }
    ],
    "5891c90949702f2e01000001_13": [
        {
            "start_logit": 7.59765625,
            "end_logit": 7.3828125,
            "text": "INCA",
            "probability": 0.52685546875
        },
        {
            "start_logit": 7.44921875,
            "end_logit": 7.4296875,
            "text": "INCA",
            "probability": 0.472412109375
        },
        {
            "start_logit": 0.282470703125,
            "end_logit": 7.4296875,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0003657341003417969
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -1.349609375,
            "text": "INC",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 7.44921875,
            "end_logit": -1.7802734375,
            "text": "INC",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": -1.87890625,
            "end_logit": 7.4296875,
            "text": "A",
            "probability": 4.202127456665039e-05
        },
        {
            "start_logit": -1.8623046875,
            "end_logit": 7.3828125,
            "text": "A",
            "probability": 4.07099723815918e-05
        },
        {
            "start_logit": -3.77734375,
            "end_logit": 7.4296875,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": -5.0703125,
            "end_logit": 7.4296875,
            "text": "Analysis (INCA",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.44921875,
            "end_logit": -5.21484375,
            "text": "INCA)",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.8828125,
            "end_logit": 7.4296875,
            "text": "Codon usage Analysis (INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.1015625,
            "end_logit": 7.3828125,
            "text": "of INCA",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 7.4296875,
            "text": "usage Analysis (INCA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.27734375,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 7.4296875,
            "text": "(INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 7.3828125,
            "text": "codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.375,
            "text": "INCA has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.44921875,
            "end_logit": -7.27734375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.67578125,
            "text": "INCA has numerous options for the interactive graphical",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.44921875,
            "end_logit": -7.890625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes. In addition to computing codon frequencies and several usage",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5891c90949702f2e01000001_14": [
        {
            "start_logit": 7.59765625,
            "end_logit": 7.3828125,
            "text": "INCA",
            "probability": 0.52685546875
        },
        {
            "start_logit": 7.44921875,
            "end_logit": 7.4296875,
            "text": "INCA",
            "probability": 0.472412109375
        },
        {
            "start_logit": 0.282470703125,
            "end_logit": 7.4296875,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0003657341003417969
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -1.349609375,
            "text": "INC",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 7.44921875,
            "end_logit": -1.7802734375,
            "text": "INC",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": -1.87890625,
            "end_logit": 7.4296875,
            "text": "A",
            "probability": 4.202127456665039e-05
        },
        {
            "start_logit": -1.8623046875,
            "end_logit": 7.3828125,
            "text": "A",
            "probability": 4.07099723815918e-05
        },
        {
            "start_logit": -3.77734375,
            "end_logit": 7.4296875,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": -5.0703125,
            "end_logit": 7.4296875,
            "text": "Analysis (INCA",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.44921875,
            "end_logit": -5.21484375,
            "text": "INCA)",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.8828125,
            "end_logit": 7.4296875,
            "text": "Codon usage Analysis (INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.1015625,
            "end_logit": 7.3828125,
            "text": "of INCA",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 7.4296875,
            "text": "usage Analysis (INCA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.27734375,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 7.4296875,
            "text": "(INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 7.3828125,
            "text": "codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.375,
            "text": "INCA has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.44921875,
            "end_logit": -7.27734375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.59765625,
            "end_logit": -7.67578125,
            "text": "INCA has numerous options for the interactive graphical",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.44921875,
            "end_logit": -7.890625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes. In addition to computing codon frequencies and several usage",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5891c90949702f2e01000001_15": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.8515625,
            "text": "INCA",
            "probability": 0.25146484375
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 7.84375,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 7.84375,
            "text": "INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.84765625,
            "end_logit": 7.84765625,
            "text": "INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.0400390625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.0400390625,
            "text": "INC",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.0810546875,
            "text": "INC",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -1.091796875,
            "text": "INC",
            "probability": 3.2782554626464844e-05
        },
        {
            "start_logit": -1.3974609375,
            "end_logit": 7.8515625,
            "text": "A",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -1.3974609375,
            "end_logit": 7.84375,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.396106719970703e-05
        },
        {
            "start_logit": -1.3984375,
            "end_logit": 7.84375,
            "text": "A",
            "probability": 2.396106719970703e-05
        },
        {
            "start_logit": -1.431640625,
            "end_logit": 7.84765625,
            "text": "A",
            "probability": 2.3245811462402344e-05
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 7.84375,
            "text": ". Finally, INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.53125,
            "end_logit": 7.84375,
            "text": "display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 7.84375,
            "text": ", INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 7.84765625,
            "text": "neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.AVAILABILITY: INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.8515625,
            "text": "of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.84375,
            "text": "graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.84375,
            "text": "of INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.1484375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_16": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.8515625,
            "text": "INCA",
            "probability": 0.25146484375
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 7.84375,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 7.84375,
            "text": "INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.84765625,
            "end_logit": 7.84765625,
            "text": "INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.0400390625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.0400390625,
            "text": "INC",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.0810546875,
            "text": "INC",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -1.091796875,
            "text": "INC",
            "probability": 3.2782554626464844e-05
        },
        {
            "start_logit": -1.3974609375,
            "end_logit": 7.8515625,
            "text": "A",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -1.3974609375,
            "end_logit": 7.84375,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.396106719970703e-05
        },
        {
            "start_logit": -1.3984375,
            "end_logit": 7.84375,
            "text": "A",
            "probability": 2.396106719970703e-05
        },
        {
            "start_logit": -1.431640625,
            "end_logit": 7.84765625,
            "text": "A",
            "probability": 2.3245811462402344e-05
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 7.84375,
            "text": ". Finally, INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.53125,
            "end_logit": 7.84375,
            "text": "display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 7.84375,
            "text": ", INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 7.84765625,
            "text": "neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.AVAILABILITY: INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.8515625,
            "text": "of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.84375,
            "text": "graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.84375,
            "text": "of INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.1484375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_17": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.8515625,
            "text": "INCA",
            "probability": 0.25146484375
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 7.84375,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": 7.84375,
            "text": "INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.84765625,
            "end_logit": 7.84765625,
            "text": "INCA",
            "probability": 0.24951171875
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.0400390625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.0400390625,
            "text": "INC",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.0810546875,
            "text": "INC",
            "probability": 3.3020973205566406e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -1.091796875,
            "text": "INC",
            "probability": 3.2782554626464844e-05
        },
        {
            "start_logit": -1.3974609375,
            "end_logit": 7.8515625,
            "text": "A",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -1.3974609375,
            "end_logit": 7.84375,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.396106719970703e-05
        },
        {
            "start_logit": -1.3984375,
            "end_logit": 7.84375,
            "text": "A",
            "probability": 2.396106719970703e-05
        },
        {
            "start_logit": -1.431640625,
            "end_logit": 7.84765625,
            "text": "A",
            "probability": 2.3245811462402344e-05
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 7.84375,
            "text": ". Finally, INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.53125,
            "end_logit": 7.84375,
            "text": "display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 7.84375,
            "text": ", INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 7.84765625,
            "text": "neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.AVAILABILITY: INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.8515625,
            "text": "of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.84375,
            "text": "graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.84375,
            "text": "of INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.1484375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_18": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.83984375,
            "text": "INCA",
            "probability": 0.501953125
        },
        {
            "start_logit": 7.84375,
            "end_logit": 7.8359375,
            "text": "INCA",
            "probability": 0.498046875
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.15625,
            "text": "INC",
            "probability": 6.192922592163086e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.2255859375,
            "text": "INC",
            "probability": 5.7756900787353516e-05
        },
        {
            "start_logit": -1.5048828125,
            "end_logit": 7.83984375,
            "text": "A",
            "probability": 4.357099533081055e-05
        },
        {
            "start_logit": -1.5078125,
            "end_logit": 7.8359375,
            "text": "A",
            "probability": 4.32133674621582e-05
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 7.83984375,
            "text": "neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.AVAILABILITY: INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.40625,
            "text": "INCA includes a specific unsupervised neural network",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.546875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.5625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.5859375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.83984375,
            "text": ".AVAILABILITY: INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.8359375,
            "text": ", INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.71484375,
            "text": "INCA is available for the Win32 platform and is free of charge for academic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.76953125,
            "text": "INCA includes a specific unsupervised neural network algorithm,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.78125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.8125,
            "text": "INCA includes a specific unsupervised",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.84765625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.84765625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.859375,
            "text": "INCA is available for the Win32 platform and",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5891c90949702f2e01000001_19": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.83984375,
            "text": "INCA",
            "probability": 0.501953125
        },
        {
            "start_logit": 7.84375,
            "end_logit": 7.8359375,
            "text": "INCA",
            "probability": 0.498046875
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.15625,
            "text": "INC",
            "probability": 6.192922592163086e-05
        },
        {
            "start_logit": 7.84375,
            "end_logit": -1.2255859375,
            "text": "INC",
            "probability": 5.7756900787353516e-05
        },
        {
            "start_logit": -1.5048828125,
            "end_logit": 7.83984375,
            "text": "A",
            "probability": 4.357099533081055e-05
        },
        {
            "start_logit": -1.5078125,
            "end_logit": 7.8359375,
            "text": "A",
            "probability": 4.32133674621582e-05
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 7.83984375,
            "text": "neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.AVAILABILITY: INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.40625,
            "text": "INCA includes a specific unsupervised neural network",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.546875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.5625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.5859375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.83984375,
            "text": ".AVAILABILITY: INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.8359375,
            "text": ", INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.71484375,
            "text": "INCA is available for the Win32 platform and is free of charge for academic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.76953125,
            "text": "INCA includes a specific unsupervised neural network algorithm,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.78125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.8125,
            "text": "INCA includes a specific unsupervised",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.84765625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.84765625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.859375,
            "text": "INCA is available for the Win32 platform and",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5891c90949702f2e01000001_20": [
        {
            "start_logit": 7.84765625,
            "end_logit": 7.80078125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -1.4501953125,
            "text": "INC",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": -1.828125,
            "end_logit": 7.80078125,
            "text": "A",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.76171875,
            "text": "INCA:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.85546875,
            "text": "INCA: synonymous codon usage analysis and clustering by means of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.89453125,
            "text": "INCA: synonymous codon usage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -7.9296875,
            "text": "INCA: synonymous codon usage analysis and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.0,
            "text": "INCA: synonymous codon usage analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.109375,
            "text": "INCA: synonymous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.1171875,
            "text": "INCA: synonymous codon",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.2109375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.828125,
            "end_logit": -7.76171875,
            "text": "A:",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -7.85546875,
            "text": "A: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -7.89453125,
            "text": "A: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -7.9296875,
            "text": "A: synonymous codon usage analysis and",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -8.0,
            "text": "A: synonymous codon usage analysis",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -8.109375,
            "text": "A: synonymous",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -8.1171875,
            "text": "A: synonymous codon",
            "probability": 0.0
        },
        {
            "start_logit": -1.828125,
            "end_logit": -8.2109375,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map.",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -8.2109375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_1": [
        {
            "start_logit": -3.595703125,
            "end_logit": -3.6484375,
            "text": "NSAIDs",
            "probability": 0.427734375
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -3.904296875,
            "text": "NSAIDs",
            "probability": 0.3154296875
        },
        {
            "start_logit": -5.03125,
            "end_logit": -3.6484375,
            "text": "acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 0.10162353515625
        },
        {
            "start_logit": -5.03125,
            "end_logit": -4.40625,
            "text": "acetaminophen",
            "probability": 0.047607421875
        },
        {
            "start_logit": -3.595703125,
            "end_logit": -7.125,
            "text": "NSAIDs in management of COVID-19 patients until there are enough evidence.",
            "probability": 0.01322174072265625
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -7.2578125,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus",
            "probability": 0.01104736328125
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -7.3359375,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus, since there is no",
            "probability": 0.010223388671875
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -7.4375,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus, since there is no clinical trial on COVID-19 and",
            "probability": 0.0092315673828125
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -7.4765625,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhin",
            "probability": 0.00887298583984375
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -7.48046875,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza",
            "probability": 0.00881195068359375
        },
        {
            "start_logit": -3.642578125,
            "end_logit": -7.484375,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus,",
            "probability": 0.00881195068359375
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -3.6484375,
            "text": "COVID-19, it is recommended to use substitutes such as acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 0.00867462158203125
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -3.6484375,
            "text": "patients with COVID-19, it is recommended to use substitutes such as acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 0.007415771484375
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -3.6484375,
            "text": "substitutes such as acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 0.006755828857421875
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -4.40625,
            "text": "COVID-19, it is recommended to use substitutes such as acetaminophen",
            "probability": 0.004062652587890625
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -4.40625,
            "text": "patients with COVID-19, it is recommended to use substitutes such as acetaminophen",
            "probability": 0.003448486328125
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -4.40625,
            "text": "substitutes such as acetaminophen",
            "probability": 0.0031890869140625
        },
        {
            "start_logit": -5.03125,
            "end_logit": -7.125,
            "text": "acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs in management of COVID-19 patients until there are enough evidence.",
            "probability": 0.0031414031982421875
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -7.125,
            "text": "COVID-19 patients until there are enough evidence.",
            "probability": 0.00033092498779296875
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.125,
            "text": ".",
            "probability": 0.0002536773681640625
        }
    ],
    "6277e4ee56bf9aee6f000008_2": [
        {
            "start_logit": -1.9892578125,
            "end_logit": 0.6884765625,
            "text": "ibuprofen",
            "probability": 0.849609375
        },
        {
            "start_logit": -1.9892578125,
            "end_logit": -2.5625,
            "text": "ibuprofen can be safely administered for pain",
            "probability": 0.032958984375
        },
        {
            "start_logit": -5.62109375,
            "end_logit": 0.6884765625,
            "text": "acetaminophen and ibuprofen",
            "probability": 0.0224761962890625
        },
        {
            "start_logit": -5.65625,
            "end_logit": 0.6884765625,
            "text": "NSAIDS, spasmolytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.021697998046875
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 0.6884765625,
            "text": "current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.01605224609375
        },
        {
            "start_logit": -5.96875,
            "end_logit": 0.6884765625,
            "text": ", acetaminophen and ibuprofen",
            "probability": 0.015869140625
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 0.6884765625,
            "text": "spasmolytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.0071258544921875
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 0.6884765625,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.006664276123046875
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 0.6884765625,
            "text": "olytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.0062408447265625
        },
        {
            "start_logit": -3.7421875,
            "end_logit": -2.5625,
            "text": "pain",
            "probability": 0.005702972412109375
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 0.6884765625,
            "text": "strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.00362396240234375
        },
        {
            "start_logit": -7.484375,
            "end_logit": 0.6884765625,
            "text": "pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.0034885406494140625
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 0.6884765625,
            "text": "the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.0032634735107421875
        },
        {
            "start_logit": -1.9892578125,
            "end_logit": -5.45703125,
            "text": "ibuprofen can be safely administered for pain management in children with COVID-19.",
            "probability": 0.00182342529296875
        },
        {
            "start_logit": -5.62109375,
            "end_logit": -2.5625,
            "text": "acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0008678436279296875
        },
        {
            "start_logit": -1.9892578125,
            "end_logit": -6.3984375,
            "text": "ibuprofen can be safely administered for pain management in children",
            "probability": 0.0007081031799316406
        },
        {
            "start_logit": -5.95703125,
            "end_logit": -2.5625,
            "text": "current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0006251335144042969
        },
        {
            "start_logit": -5.96875,
            "end_logit": -2.5625,
            "text": ", acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0006155967712402344
        },
        {
            "start_logit": -3.7421875,
            "end_logit": -5.45703125,
            "text": "pain management in children with COVID-19.",
            "probability": 0.0003142356872558594
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -2.5625,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.00025963783264160156
        }
    ],
    "6277e4ee56bf9aee6f000008_3": [
        {
            "start_logit": -1.9892578125,
            "end_logit": 0.6884765625,
            "text": "ibuprofen",
            "probability": 0.849609375
        },
        {
            "start_logit": -1.9892578125,
            "end_logit": -2.5625,
            "text": "ibuprofen can be safely administered for pain",
            "probability": 0.032958984375
        },
        {
            "start_logit": -5.62109375,
            "end_logit": 0.6884765625,
            "text": "acetaminophen and ibuprofen",
            "probability": 0.0224761962890625
        },
        {
            "start_logit": -5.65625,
            "end_logit": 0.6884765625,
            "text": "NSAIDS, spasmolytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.021697998046875
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 0.6884765625,
            "text": "current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.01605224609375
        },
        {
            "start_logit": -5.96875,
            "end_logit": 0.6884765625,
            "text": ", acetaminophen and ibuprofen",
            "probability": 0.015869140625
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 0.6884765625,
            "text": "spasmolytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.0071258544921875
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 0.6884765625,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.006664276123046875
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 0.6884765625,
            "text": "olytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.0062408447265625
        },
        {
            "start_logit": -3.7421875,
            "end_logit": -2.5625,
            "text": "pain",
            "probability": 0.005702972412109375
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 0.6884765625,
            "text": "strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.00362396240234375
        },
        {
            "start_logit": -7.484375,
            "end_logit": 0.6884765625,
            "text": "pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.0034885406494140625
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 0.6884765625,
            "text": "the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.0032634735107421875
        },
        {
            "start_logit": -1.9892578125,
            "end_logit": -5.45703125,
            "text": "ibuprofen can be safely administered for pain management in children with COVID-19.",
            "probability": 0.00182342529296875
        },
        {
            "start_logit": -5.62109375,
            "end_logit": -2.5625,
            "text": "acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0008678436279296875
        },
        {
            "start_logit": -1.9892578125,
            "end_logit": -6.3984375,
            "text": "ibuprofen can be safely administered for pain management in children",
            "probability": 0.0007081031799316406
        },
        {
            "start_logit": -5.95703125,
            "end_logit": -2.5625,
            "text": "current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0006251335144042969
        },
        {
            "start_logit": -5.96875,
            "end_logit": -2.5625,
            "text": ", acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0006155967712402344
        },
        {
            "start_logit": -3.7421875,
            "end_logit": -5.45703125,
            "text": "pain management in children with COVID-19.",
            "probability": 0.0003142356872558594
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -2.5625,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.00025963783264160156
        }
    ],
    "6277e4ee56bf9aee6f000008_4": [
        {
            "start_logit": 2.66015625,
            "end_logit": 2.4609375,
            "text": "NSAIDs",
            "probability": 0.98291015625
        },
        {
            "start_logit": 2.66015625,
            "end_logit": -1.9658203125,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs",
            "probability": 0.01175689697265625
        },
        {
            "start_logit": -2.744140625,
            "end_logit": 2.4609375,
            "text": "NSAIDs but there are issues with liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs",
            "probability": 0.004413604736328125
        },
        {
            "start_logit": -2.1015625,
            "end_logit": -1.0625,
            "text": "Paracetamol",
            "probability": 0.00024890899658203125
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 2.4609375,
            "text": "liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs",
            "probability": 0.00010538101196289062
        },
        {
            "start_logit": -2.1015625,
            "end_logit": -2.3515625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs",
            "probability": 6.80088996887207e-05
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 2.4609375,
            "text": "where NSAIDs",
            "probability": 6.80088996887207e-05
        },
        {
            "start_logit": 2.66015625,
            "end_logit": -7.234375,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs must be avoided",
            "probability": 6.0498714447021484e-05
        },
        {
            "start_logit": 2.66015625,
            "end_logit": -7.3359375,
            "text": "NSAIDs should not",
            "probability": 5.46574592590332e-05
        },
        {
            "start_logit": -2.931640625,
            "end_logit": -1.9658203125,
            "text": "NSAIDs",
            "probability": 4.392862319946289e-05
        },
        {
            "start_logit": -7.453125,
            "end_logit": 2.4609375,
            "text": ". There are clearly COVID-19 cases where NSAIDs",
            "probability": 3.999471664428711e-05
        },
        {
            "start_logit": 2.66015625,
            "end_logit": -7.6875,
            "text": "NSAIDs should",
            "probability": 3.8504600524902344e-05
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 2.4609375,
            "text": "COVID-19 cases where NSAIDs",
            "probability": 3.8504600524902344e-05
        },
        {
            "start_logit": 2.66015625,
            "end_logit": -7.7109375,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs must",
            "probability": 3.7550926208496094e-05
        },
        {
            "start_logit": 2.66015625,
            "end_logit": -7.734375,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs must be avoided in all",
            "probability": 3.6716461181640625e-05
        },
        {
            "start_logit": -2.744140625,
            "end_logit": -2.3515625,
            "text": "NSAIDs",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 2.4609375,
            "text": "has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs",
            "probability": 3.421306610107422e-05
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 2.4609375,
            "text": "been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs",
            "probability": 3.36766242980957e-05
        },
        {
            "start_logit": -6.48046875,
            "end_logit": -1.9658203125,
            "text": "liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs should not be used, but there is no strong evidence that NSAIDs",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -2.1015625,
            "end_logit": -6.4296875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high doses.",
            "probability": 1.1920928955078125e-06
        }
    ],
    "6277e4ee56bf9aee6f000008_5": [
        {
            "start_logit": 3.802734375,
            "end_logit": 4.45703125,
            "text": "paracetamol",
            "probability": 1.0
        },
        {
            "start_logit": 3.802734375,
            "end_logit": -3.517578125,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain",
            "probability": 0.0003447532653808594
        },
        {
            "start_logit": 3.802734375,
            "end_logit": -5.44921875,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 4.45703125,
            "text": "analgesia, paracetamol",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 4.45703125,
            "text": ", paracetamol",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": 3.802734375,
            "end_logit": -7.82421875,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 3.802734375,
            "end_logit": -7.82421875,
            "text": "paracetamol can",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 3.802734375,
            "end_logit": -7.92578125,
            "text": "paracetamol can be listed as the first option",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 3.802734375,
            "end_logit": -7.95703125,
            "text": "paracetamol can be listed",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 3.802734375,
            "end_logit": -7.97265625,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 3.802734375,
            "end_logit": -7.9765625,
            "text": "paracetamol can be listed as the first option in these patients, and",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -4.0625,
            "end_logit": -3.517578125,
            "text": "pain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.61328125,
            "end_logit": -3.517578125,
            "text": "NSAIDs can also be reliably used for pain",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -3.517578125,
            "text": "analgesia, paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain",
            "probability": 0.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": -3.517578125,
            "text": "then NSAIDs can also be reliably used for pain",
            "probability": 0.0
        },
        {
            "start_logit": -4.0625,
            "end_logit": -6.7890625,
            "text": "pain management in patients with COVID-19 if there are no absolute contraindications such as kidney failure or gastric bleeding.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3671875,
            "end_logit": -3.517578125,
            "text": "patients, and then NSAIDs can also be reliably used for pain",
            "probability": 0.0
        },
        {
            "start_logit": -5.61328125,
            "end_logit": -5.44921875,
            "text": "NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -3.517578125,
            "text": "in these patients, and then NSAIDs can also be reliably used for pain",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": -3.517578125,
            "text": ", paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_6": [
        {
            "start_logit": 6.4609375,
            "end_logit": 6.51953125,
            "text": "Paracetamol",
            "probability": 1.0
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -5.4609375,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -6.296875,
            "text": "Paracetamol (acetaminophen",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -6.78515625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.3203125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.6328125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.78125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.88671875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.8984375,
            "text": "Paracetamol (acetaminophen) has been proposed as an",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.90625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.94140625,
            "text": "Paracetamol (acetaminophen) has been proposed",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.94140625,
            "text": "Paracetamol (acetaminophen)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": -5.4609375,
            "text": "acetaminophen) has been proposed as an alternative to NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -5.4609375,
            "text": "NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -5.4609375,
            "text": "has been proposed as an alternative to NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -5.4609375,
            "text": "been proposed as an alternative to NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -5.4609375,
            "text": "to NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -5.4609375,
            "text": "proposed as an alternative to NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.1328125,
            "end_logit": -6.296875,
            "text": "acetaminophen",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -5.4609375,
            "text": "alternative to NSAIDs",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_1": [
        {
            "start_logit": 6.359375,
            "end_logit": 6.8203125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.8203125,
            "text": "ialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -7.796875,
            "text": "ialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.796875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.82421875,
            "text": "Unituxin\u2122; ch14.18",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -7.86328125,
            "text": "ialogangli",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.86328125,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialogangli",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.86328125,
            "text": "Unituxin\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -7.8984375,
            "text": "ialoganglioside, improved survival as",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.87890625,
            "text": "Unituxin",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.8984375,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival as",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -7.9296875,
            "text": "ialoganglioside, improved survival as part of",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -7.9296875,
            "text": "ialoganglioside, improved survival",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -7.9375,
            "text": "ialoganglioside, improved survival as part of post-consolidation therapy for high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.9140625,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -7.9453125,
            "text": "ialoganglioside, improved",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -7.9453125,
            "text": "ialog",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.9296875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival as part of",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.9296875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.9296875,
            "text": "Unituxin\u2122; ch14.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_2": [
        {
            "start_logit": 6.3046875,
            "end_logit": 6.87109375,
            "text": "Neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.87109375,
            "text": "Risk Neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.87109375,
            "text": "High-Risk Neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 6.87109375,
            "text": "Dinutuximab: A Review in High-Risk Neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.87109375,
            "text": "in High-Risk Neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.87109375,
            "text": "uximab: A Review in High-Risk Neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 6.87109375,
            "text": "utuximab: A Review in High-Risk Neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": -7.93359375,
            "text": "Dinutuximab: A",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -7.96484375,
            "text": "Dinutuximab: A Review",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -7.93359375,
            "text": "uximab: A",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -8.078125,
            "text": "Dinutuximab:",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -7.96484375,
            "text": "uximab: A Review",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.93359375,
            "text": "utuximab: A",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.96484375,
            "text": "utuximab: A Review",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -8.078125,
            "text": "uximab:",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -8.078125,
            "text": "utuximab:",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_3": [
        {
            "start_logit": 6.375,
            "end_logit": 6.78515625,
            "text": "neuroblastoma",
            "probability": 0.5
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 6.78515625,
            "text": "neuroblastoma",
            "probability": 0.5
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.78515625,
            "text": "for the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.78515625,
            "text": "to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.78515625,
            "text": "treatment of patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.78515625,
            "text": "dation treatment of patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.78515625,
            "text": "glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.78515625,
            "text": "patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.78515625,
            "text": "postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.78515625,
            "text": "ialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.78515625,
            "text": "risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.78515625,
            "text": "is highly expressed on the surface of neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.89453125,
            "text": "neuroblastoma.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.89453125,
            "text": "neuroblastoma cells.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.92578125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.94140625,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.89453125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.89453125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.92578125,
            "text": ". This intravenous drug is approved in the EU and USA as combination therapy",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.94140625,
            "text": ". This intravenous drug is approved in the EU",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_4": [
        {
            "start_logit": 6.375,
            "end_logit": 6.78515625,
            "text": "neuroblastoma",
            "probability": 0.5
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 6.78515625,
            "text": "neuroblastoma",
            "probability": 0.5
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.78515625,
            "text": "for the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.78515625,
            "text": "to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.78515625,
            "text": "treatment of patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.78515625,
            "text": "dation treatment of patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.78515625,
            "text": "glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.78515625,
            "text": "patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.78515625,
            "text": "postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.78515625,
            "text": "ialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.78515625,
            "text": "risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.78515625,
            "text": "is highly expressed on the surface of neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.89453125,
            "text": "neuroblastoma.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.89453125,
            "text": "neuroblastoma cells.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.92578125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.94140625,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.89453125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.89453125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.92578125,
            "text": ". This intravenous drug is approved in the EU and USA as combination therapy",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.94140625,
            "text": ". This intravenous drug is approved in the EU",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_5": [
        {
            "start_logit": 6.359375,
            "end_logit": 6.8046875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.515625,
            "text": "neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis and limited therapeutic options.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.65234375,
            "text": "neuroblastoma, with its benefits outweighing its risks in a patient population",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.6875,
            "text": "neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 6.8046875,
            "text": "lidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.7421875,
            "text": "neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.8046875,
            "text": "GM-CSF, IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 6.8046875,
            "text": "postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.7734375,
            "text": "neuroblastoma, with its benefits outweigh",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 6.8046875,
            "text": "solidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.7890625,
            "text": "neuroblastoma, with its benefits outweighing its risks",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.796875,
            "text": "neuroblastoma, with its benefits outweighing its risks in a patient population with a poor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.25,
            "end_logit": 6.8046875,
            "text": "risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.8125,
            "text": "neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis and limited therapeutic",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 6.8046875,
            "text": "dation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 6.8046875,
            "text": "in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.515625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -7.515625,
            "text": "risk neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis and limited therapeutic options.",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -7.65234375,
            "text": "lidation treatment of patients with high-risk neuroblastoma, with its benefits outweighing its risks in a patient population",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -7.6875,
            "text": "lidation treatment of patients with high-risk neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_6": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.81640625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 6.81640625,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 6.81640625,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.81640625,
            "text": "risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 6.81640625,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.828125,
            "text": "treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.828125,
            "text": "Dinutuximab for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.87109375,
            "text": "treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.87109375,
            "text": "pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.87109375,
            "text": "Dinutuximab for the treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.91015625,
            "text": "treatment of pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.91015625,
            "text": "pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.9375,
            "text": "treatment of pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.94140625,
            "text": "treatment of pediatric",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.9375,
            "text": "pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.94140625,
            "text": "pediatric",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.91015625,
            "text": "Dinutuximab for the treatment of pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.91796875,
            "text": "Dinutuximab for",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.96484375,
            "text": "treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.96484375,
            "text": "pediatric patients with high",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_7": [
        {
            "start_logit": 6.26953125,
            "end_logit": 6.8671875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 6.8671875,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.8671875,
            "text": "high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 6.8671875,
            "text": "risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.61328125,
            "text": "neuroblastoma who",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.6484375,
            "text": "neuroblastoma who achieve at",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.69921875,
            "text": "neuroblastoma who achieve at least a partial",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.71484375,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.73828125,
            "text": "neuroblastoma who achieve at least a",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.74609375,
            "text": "neuroblastoma who achieve at least",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.76171875,
            "text": "neuroblastoma who achieve",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.76953125,
            "text": "neuroblastoma who achieve at least a partial response to first",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.40234375,
            "end_logit": -7.61328125,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -6.40234375,
            "end_logit": -7.73046875,
            "text": "GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -6.40234375,
            "end_logit": -7.73046875,
            "text": "GD2 monoclonal antibody approved",
            "probability": 0.0
        },
        {
            "start_logit": -6.40234375,
            "end_logit": -7.74609375,
            "text": "GD2",
            "probability": 0.0
        },
        {
            "start_logit": -6.40234375,
            "end_logit": -7.79296875,
            "text": "GD",
            "probability": 0.0
        },
        {
            "start_logit": -6.40234375,
            "end_logit": -7.8046875,
            "text": "GD2 monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.35546875,
            "text": "<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.40625,
            "text": "<br><b>",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_8": [
        {
            "start_logit": 6.35546875,
            "end_logit": 6.8046875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 6.8046875,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 6.8046875,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.7109375,
            "text": "neuroblastoma who",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.8046875,
            "text": "(13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.8046875,
            "text": "cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.7734375,
            "text": "neuroblastoma who achieve at",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.8359375,
            "text": "neuroblastoma who achieve at least a partial",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.84375,
            "text": "neuroblastoma who achieve at least",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.84765625,
            "text": "neuroblastoma who achieve at least a partial response to first",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.859375,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.8828125,
            "text": "neuroblastoma who achieve at least a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.8828125,
            "text": "neuroblastoma who achieve",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.59375,
            "text": "GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.59375,
            "text": "esleukin (interleukin-2 [",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.59375,
            "text": "stimulating factor (GM-CSF), aldesleukin (interleukin-2 [",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.59375,
            "text": "(GM-CSF), aldesleukin (interleukin-2 [",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.75390625,
            "text": "esleukin (interleukin-2 [IL-2]",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -7.7109375,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.7109375,
            "text": "treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_9": [
        {
            "start_logit": 6.26953125,
            "end_logit": 6.87109375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.87109375,
            "text": "/b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.87109375,
            "text": "</b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.87109375,
            "text": "CONCLUSION</b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.87109375,
            "text": ": Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.87109375,
            "text": "b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.87109375,
            "text": "novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.87109375,
            "text": "risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -7.67578125,
            "text": "neuroblastoma.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.26953125,
            "end_logit": -8.0546875,
            "text": "neuroblastoma.<br>",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.35546875,
            "text": "5 mg/m<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.50390625,
            "text": "5 mg/m<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -7.35546875,
            "text": "<b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.35546875,
            "text": "b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.67578125,
            "text": "/b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.35546875,
            "text": "br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.67578125,
            "text": "</b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.35546875,
            "text": "The recommended dosage of dinutuximab is 17.5 mg/m<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -7.35546875,
            "text": "<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.50390625,
            "text": "br>",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_10": [
        {
            "start_logit": 6.359375,
            "end_logit": 6.796875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.796875,
            "text": "GD2 monoclonal antibody ch14.18, or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.66796875,
            "text": "neuroblastoma and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.69921875,
            "text": "neuroblastoma and is now considered part of standard of care in this patient population.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.7265625,
            "text": "neuroblastoma and is now considered part of standard of care in this patient population",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.796875,
            "text": "represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.8671875,
            "text": "neuroblastoma and is now considered part of standard of care",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.89453125,
            "text": "neuroblastoma and is now considered part of standard of care in this",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.69921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.66796875,
            "text": "GD2 monoclonal antibody ch14.18, or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma and",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.7265625,
            "text": "GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.765625,
            "text": "GD2 monoclonal antibody ch14.",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.7734375,
            "text": "GD2 monoclonal antibody ch14.18",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.78515625,
            "text": "GD2 monoclonal antibody ch14.18, or dinutuximab, represents an important therapeutic advance in the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.80078125,
            "text": "GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.8203125,
            "text": "GD2 monoclonal antibody ch14.18, or",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.82421875,
            "text": "GD2 monoclonal antibody ch14.18, or dinut",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.828125,
            "text": "GD2 monoclonal antibody ch14.18,",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.83984375,
            "text": "GD2 monoclonal antibody ch14.18, or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.859375,
            "text": "GD2 monoclonal antibody ch14",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_11": [
        {
            "start_logit": 6.3671875,
            "end_logit": 6.80078125,
            "text": "neuroblastoma",
            "probability": 0.5
        },
        {
            "start_logit": 6.359375,
            "end_logit": 6.80859375,
            "text": "neuroblastoma",
            "probability": 0.5
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.1484375,
            "text": "neuroblastoma are reviewed.<br>",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.19140625,
            "text": "neuroblastoma are reviewed.<br><b>",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.58984375,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.7890625,
            "text": "neuroblastoma are reviewed.<br",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.80078125,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinutuximab (Unituxin, United Therapeutics",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.84375,
            "text": "neuroblastoma are",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.89453125,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinut",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.9140625,
            "text": "neuroblastoma.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.1484375,
            "text": "<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.1484375,
            "text": ".<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.19140625,
            "text": "<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.19140625,
            "text": ".<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.5625,
            "text": "<b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -7.1484375,
            "text": "br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -7.19140625,
            "text": "b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -7.19140625,
            "text": "br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.9140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.58984375,
            "text": "<br><b>SUMMARY</b>",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_12": [
        {
            "start_logit": 6.3671875,
            "end_logit": 6.80078125,
            "text": "neuroblastoma",
            "probability": 0.5
        },
        {
            "start_logit": 6.359375,
            "end_logit": 6.80859375,
            "text": "neuroblastoma",
            "probability": 0.5
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.1484375,
            "text": "neuroblastoma are reviewed.<br>",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.19140625,
            "text": "neuroblastoma are reviewed.<br><b>",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.58984375,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.7890625,
            "text": "neuroblastoma are reviewed.<br",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.80078125,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinutuximab (Unituxin, United Therapeutics",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.84375,
            "text": "neuroblastoma are",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.89453125,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinut",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.9140625,
            "text": "neuroblastoma.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.1484375,
            "text": "<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.1484375,
            "text": ".<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.19140625,
            "text": "<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.19140625,
            "text": ".<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.5625,
            "text": "<b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -7.1484375,
            "text": "br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -7.19140625,
            "text": "b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -7.19140625,
            "text": "br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.9140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.58984375,
            "text": "<br><b>SUMMARY</b>",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_13": [
        {
            "start_logit": 6.30859375,
            "end_logit": 6.8515625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 6.8515625,
            "text": "treatment of paediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.75390625,
            "text": "neuroblastoma who achieve at",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.7578125,
            "text": "neuroblastoma who achieve at least",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.765625,
            "text": "neuroblastoma who achieve at least partial",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.79296875,
            "text": "neuroblastoma who",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.8125,
            "text": "neuroblastoma who achieve",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.81640625,
            "text": "neuroblastoma who achieve at least partial response to",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.84375,
            "text": "neuroblastoma who achieve at least partial response to prior",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.875,
            "text": "neuroblastoma who achieve at least partial response to prior first-line multiagent, multimodality therapy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.875,
            "text": "neuroblastoma who achieve at least partial response to prior first",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.78125,
            "text": "summarizes the milestones in the development of dinutuximab leading",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -7.78125,
            "text": "This article summarizes the milestones in the development of dinutuximab leading",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.8359375,
            "text": "summarizes the milestones in the development of dinutuximab leading to this first",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.84375,
            "text": "summarizes the milestones in the development of dinutuximab leading to this first approval for",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.8515625,
            "text": "summarizes the milestones in the development",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.8515625,
            "text": "summarizes the milestones in the development of dinutuximab leading to",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.8671875,
            "text": "summarizes the milestones",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -7.8359375,
            "text": "This article summarizes the milestones in the development of dinutuximab leading to this first",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.875,
            "text": "summarizes the milestones in the development of dinutuximab leading to this",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_14": [
        {
            "start_logit": 6.39453125,
            "end_logit": 6.78515625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.78515625,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.78515625,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.78515625,
            "text": "risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.78515625,
            "text": "FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 6.78515625,
            "text": "dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.98046875,
            "text": "neuroblastoma in paediatric",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.984375,
            "text": "neuroblastoma in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -8.046875,
            "text": "neuroblastoma in paediatric patients",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.94921875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.98046875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in paediatric",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.984375,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.98828125,
            "text": "recently approved the use of",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0,
            "text": "recently approved the use of dinutuximab combination therapy",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0234375,
            "text": "recently approved the use of dinutuximab combination",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0390625,
            "text": "recently approved",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0390625,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0390625,
            "text": "recently approved the use of dinutuximab combination therapy for the",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.046875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in paediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.046875,
            "text": "recently approved the use of dinutuximab combination therapy for",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_15": [
        {
            "start_logit": 6.26171875,
            "end_logit": 6.87890625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.87890625,
            "text": "GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 6.87890625,
            "text": "targeting GD2, for the treatment of neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.87890625,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.87890625,
            "text": "uxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.96875,
            "text": "neuroblastoma.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -2.71875,
            "text": "Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.07421875,
            "text": "Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -2.71875,
            "text": "National Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.73046875,
            "text": "Cancer Institute are",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.86328125,
            "text": "Cancer Institute are developing",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.87109375,
            "text": "Cancer Institute are developing dinut",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.89453125,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.97265625,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122;",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.9765625,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -8.0,
            "text": "Cancer Institute are developing dinutuximab (Unituxin",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -8.0078125,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -2.71875,
            "text": "the National Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -2.71875,
            "text": "and the National Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -2.71875,
            "text": "United Therapeutics Corporation and the National Cancer",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_16": [
        {
            "start_logit": 6.22265625,
            "end_logit": 6.83203125,
            "text": "Neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 6.83203125,
            "text": "TGF\u03b2R1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -6.97265625,
            "text": "Neuroblastoma Activity of the Anti-GD",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.83203125,
            "text": "-Neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 6.83203125,
            "text": "Anti-Neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.5078125,
            "text": "Neuroblastoma Activity of the Anti-GD2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.66796875,
            "text": "Neuroblastoma Activity of the Anti-GD2 Antibody",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.68359375,
            "text": "Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.69140625,
            "text": "Neuroblastoma Activity",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.72265625,
            "text": "Neuroblastoma Activity of the Anti-GD2 Antibody Dinut",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.80078125,
            "text": "Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.8515625,
            "text": "Neuroblastoma Activity of the Anti-GD2 Antibody Din",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.85546875,
            "text": "Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.85546875,
            "text": "Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.8828125,
            "text": "Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.89453125,
            "text": "Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.73046875,
            "end_logit": -6.97265625,
            "text": "GD",
            "probability": 0.0
        },
        {
            "start_logit": -5.73046875,
            "end_logit": -7.5078125,
            "text": "GD2",
            "probability": 0.0
        },
        {
            "start_logit": -5.73046875,
            "end_logit": -7.66796875,
            "text": "GD2 Antibody",
            "probability": 0.0
        },
        {
            "start_logit": -5.73046875,
            "end_logit": -7.68359375,
            "text": "GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_17": [
        {
            "start_logit": 6.31640625,
            "end_logit": 6.85546875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.85546875,
            "text": "high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.625,
            "text": "neuroblastoma using the anti-GD",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.69140625,
            "text": "neuroblastoma using the anti-GD2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.7734375,
            "text": "neuroblastoma using the anti-GD2 antibody",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.8203125,
            "text": "neuroblastoma using",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.84375,
            "text": "neuroblastoma using the anti-GD2 antibody dinut",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.87109375,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.890625,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.93359375,
            "text": "neuroblastoma using the anti-GD2 antibody din",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.93359375,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADC",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.9375,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.95703125,
            "text": "neuroblastoma using the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.96484375,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.96484375,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC).",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -7.96484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.625,
            "text": "GD",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.69140625,
            "text": "GD2",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.625,
            "text": "high-risk neuroblastoma using the anti-GD",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.7734375,
            "text": "GD2 antibody",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_18": [
        {
            "start_logit": 6.35546875,
            "end_logit": 6.8046875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 6.8046875,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 6.8046875,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.7109375,
            "text": "neuroblastoma who",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.8046875,
            "text": "(13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.8046875,
            "text": "cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.7734375,
            "text": "neuroblastoma who achieve at",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.8359375,
            "text": "neuroblastoma who achieve at least a partial",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.84375,
            "text": "neuroblastoma who achieve at least",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.84765625,
            "text": "neuroblastoma who achieve at least a partial response to first",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.859375,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.8828125,
            "text": "neuroblastoma who achieve at least a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.8828125,
            "text": "neuroblastoma who achieve",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.59375,
            "text": "GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.59375,
            "text": "esleukin (interleukin-2 [",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.59375,
            "text": "stimulating factor (GM-CSF), aldesleukin (interleukin-2 [",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.59375,
            "text": "(GM-CSF), aldesleukin (interleukin-2 [",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.75390625,
            "text": "esleukin (interleukin-2 [IL-2]",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -7.7109375,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.7109375,
            "text": "treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_19": [
        {
            "start_logit": 6.36328125,
            "end_logit": 6.8046875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": 6.8046875,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.73828125,
            "text": "neuroblastoma who achieve at",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.75390625,
            "text": "neuroblastoma who",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.7578125,
            "text": "neuroblastoma who achieve at least a partial",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.8046875,
            "text": "high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 6.8046875,
            "text": "patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 6.8046875,
            "text": "GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.7734375,
            "text": "neuroblastoma who achieve at least a",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.78515625,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.80078125,
            "text": "neuroblastoma who achieve at least",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.83203125,
            "text": "neuroblastoma who achieve",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.8359375,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.83984375,
            "text": "neuroblastoma who achieve at least a partial response to first",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": -7.75390625,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -7.7734375,
            "text": "GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -7.79296875,
            "text": "GD2 monoclonal antibody approved",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -7.796875,
            "text": "GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -7.81640625,
            "text": "GD2 monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -7.83203125,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_20": [
        {
            "start_logit": 6.26171875,
            "end_logit": 6.87890625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.87890625,
            "text": "GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 6.87890625,
            "text": "targeting GD2, for the treatment of neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.87890625,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.87890625,
            "text": "uxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.96875,
            "text": "neuroblastoma.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -2.71875,
            "text": "Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.07421875,
            "text": "Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -6.54296875,
            "end_logit": -2.71875,
            "text": "National Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.73046875,
            "text": "Cancer Institute are",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.86328125,
            "text": "Cancer Institute are developing",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.87109375,
            "text": "Cancer Institute are developing dinut",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.89453125,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.97265625,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122;",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -7.9765625,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -8.0,
            "text": "Cancer Institute are developing dinutuximab (Unituxin",
            "probability": 0.0
        },
        {
            "start_logit": -1.98046875,
            "end_logit": -8.0078125,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -2.71875,
            "text": "the National Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -2.71875,
            "text": "and the National Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -2.71875,
            "text": "United Therapeutics Corporation and the National Cancer",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_21": [
        {
            "start_logit": 6.328125,
            "end_logit": 6.8359375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.8359375,
            "text": "stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 6.8359375,
            "text": "high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 6.8359375,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 6.8359375,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 6.8359375,
            "text": "granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.8359375,
            "text": "-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 6.8359375,
            "text": "colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 6.8359375,
            "text": "- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.94921875,
            "text": "neuroblastoma.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -7.94921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.859375,
            "text": "Unituxin, United Therapeutics) is a novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.93359375,
            "text": "Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved for",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.87109375,
            "text": "recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0,
            "text": "Unituxin, United Therapeutics",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.015625,
            "text": "Unituxin, United Therapeutics) is a novel monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.015625,
            "text": "Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -7.859375,
            "text": "uxin, United Therapeutics) is a novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -7.859375,
            "text": "novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -7.859375,
            "text": "SUMMARY Dinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_22": [
        {
            "start_logit": 6.38671875,
            "end_logit": 6.79296875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.79296875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 6.79296875,
            "text": "novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.77734375,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.80078125,
            "text": "CONCLUSION Dinut",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.8125,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.828125,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.83203125,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.86328125,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.8671875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.87890625,
            "text": "CONCLUSION Dinutuximab",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.88671875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.8984375,
            "text": "CONCLUSION Dinutuximab is a",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.90625,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.91796875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.9375,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.94921875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.953125,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_23": [
        {
            "start_logit": 6.35546875,
            "end_logit": 6.80859375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.80859375,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.48828125,
            "text": "neuroblastoma.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 6.80859375,
            "text": "disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 6.80859375,
            "text": "been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 6.80859375,
            "text": "anglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.48828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.48828125,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.54296875,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival rates",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.5625,
            "text": "ialoganglioside GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.6015625,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.671875,
            "text": "ialoganglioside GD2, has been shown to",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.6796875,
            "text": "ialoganglioside GD2, has been shown to significantly",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.6796875,
            "text": "ialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.6875,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival rates in patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.734375,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.7578125,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.48828125,
            "text": "disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.54296875,
            "text": "disialoganglioside GD2, has been shown to significantly improve survival rates",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -7.48828125,
            "text": "been shown to significantly improve survival rates in patients with high-risk neuroblastoma.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_24": [
        {
            "start_logit": 6.30859375,
            "end_logit": 6.8125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.09375,
            "text": "neuroblastoma cells.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.8125,
            "text": "human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.8125,
            "text": "to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.8125,
            "text": "glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.8125,
            "text": "ialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 6.8125,
            "text": "mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 6.8125,
            "text": "on the surface of neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.8125,
            "text": "surface of neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.69140625,
            "text": "neuroblastoma cells",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.09375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -7.09375,
            "text": "human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells.",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -7.09375,
            "text": "to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -7.09375,
            "text": "glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells.",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -7.09375,
            "text": "ialoganglioside, which is highly expressed on the surface of neuroblastoma cells.",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -7.09375,
            "text": "mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells.",
            "probability": 0.0
        },
        {
            "start_logit": -7.98828125,
            "end_logit": -7.09375,
            "text": "on the surface of neuroblastoma cells.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.09375,
            "text": "surface of neuroblastoma cells.",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -7.625,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -7.625,
            "text": "human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_25": [
        {
            "start_logit": 6.39453125,
            "end_logit": 6.78515625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.78515625,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.78515625,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.78515625,
            "text": "risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.78515625,
            "text": "FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 6.78515625,
            "text": "dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.98046875,
            "text": "neuroblastoma in paediatric",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.984375,
            "text": "neuroblastoma in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -8.046875,
            "text": "neuroblastoma in paediatric patients",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.94921875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.98046875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in paediatric",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.984375,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.98828125,
            "text": "recently approved the use of",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0,
            "text": "recently approved the use of dinutuximab combination therapy",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0234375,
            "text": "recently approved the use of dinutuximab combination",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0390625,
            "text": "recently approved",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0390625,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.0390625,
            "text": "recently approved the use of dinutuximab combination therapy for the",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.046875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in paediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -8.046875,
            "text": "recently approved the use of dinutuximab combination therapy for",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_26": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.81640625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 6.81640625,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 6.81640625,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.81640625,
            "text": "risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 6.81640625,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.828125,
            "text": "treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.828125,
            "text": "Dinutuximab for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.87109375,
            "text": "treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.87109375,
            "text": "pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.87109375,
            "text": "Dinutuximab for the treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.91015625,
            "text": "treatment of pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.91015625,
            "text": "pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.9375,
            "text": "treatment of pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.94140625,
            "text": "treatment of pediatric",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.9375,
            "text": "pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.94140625,
            "text": "pediatric",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.91015625,
            "text": "Dinutuximab for the treatment of pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.91796875,
            "text": "Dinutuximab for",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.96484375,
            "text": "treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -7.96484375,
            "text": "pediatric patients with high",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_27": [
        {
            "start_logit": 6.390625,
            "end_logit": 6.7890625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.578125,
            "text": "neuroblastoma: A case series",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.64453125,
            "text": "neuroblastoma: A",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.7421875,
            "text": "neuroblastoma: A case",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.80078125,
            "text": "neuroblastoma:",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 6.7890625,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 6.7890625,
            "text": "patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 6.7890625,
            "text": "risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 6.7890625,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.578125,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma: A case series",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.62109375,
            "text": "myelitis as",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.64453125,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma: A",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -7.578125,
            "text": "patients with high-risk neuroblastoma: A case series",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -7.578125,
            "text": "risk neuroblastoma: A case series",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -7.578125,
            "text": "pediatric patients with high-risk neuroblastoma: A case series",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.7109375,
            "text": "myelitis",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.7421875,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma: A case",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.7421875,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -7.64453125,
            "text": "patients with high-risk neuroblastoma: A",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.74609375,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_28": [
        {
            "start_logit": 6.40234375,
            "end_logit": 6.7734375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 6.7734375,
            "text": "led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 6.7734375,
            "text": "to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.234375,
            "end_logit": 6.7734375,
            "text": "phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.234375,
            "end_logit": 6.7734375,
            "text": "children with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.40234375,
            "end_logit": -7.8671875,
            "text": "neuroblastoma.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -7.8671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.6484375,
            "text": "Findings of the randomized phase III",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.70703125,
            "text": "Findings of",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.72265625,
            "text": "Findings of the randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.75,
            "text": "Findings of the randomized phase III study (ANBL0032",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.72265625,
            "text": "led to the approval of dinutuximab for the treatment of children with high-",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.7578125,
            "text": "Findings of the randomized",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.765625,
            "text": "Findings of the randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -7.6484375,
            "text": "phase III",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.77734375,
            "text": "Findings of the randomized phase III study (ANBL0032) led to the approval of",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.79296875,
            "text": "Findings",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -7.765625,
            "text": "led to the approval of dinutuximab for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.8046875,
            "text": "Findings of the randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.81640625,
            "text": "Findings of the randomized phase III study (ANBL0032) led to the approval",
            "probability": 0.0
        }
    ],
    "5c8cd26a0101eac870000003_1": [
        {
            "start_logit": 5.31640625,
            "end_logit": 4.46875,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 0.9990234375
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -2.966796875,
            "text": "secreted protein content",
            "probability": 0.0005927085876464844
        },
        {
            "start_logit": -3.345703125,
            "end_logit": 4.46875,
            "text": ".",
            "probability": 0.00017392635345458984
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -5.13671875,
            "text": "secreted",
            "probability": 6.759166717529297e-05
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -5.421875,
            "text": "secreted protein",
            "probability": 5.060434341430664e-05
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -5.86328125,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate",
            "probability": 3.266334533691406e-05
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -6.09765625,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -6.26953125,
            "text": "secreted protein content (",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -6.53125,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 4.46875,
            "text": "many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 1.531839370727539e-05
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -6.828125,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -6.84765625,
            "text": "secreted protein content (exoproteome) revealed",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -6.9140625,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec2",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": -6.1171875,
            "end_logit": 4.46875,
            "text": "VdSec22 or VdSso1.",
            "probability": 1.0848045349121094e-05
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 4.46875,
            "text": "revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -7.046875,
            "text": "secreted protein content (exoproteome) revealed that many enzymes",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 4.46875,
            "text": "that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -7.23046875,
            "text": "secreted protein content (exoproteome) revealed that many",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": 5.31640625,
            "end_logit": -7.41015625,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -6.5625,
            "end_logit": 4.46875,
            "text": "enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 6.973743438720703e-06
        }
    ],
    "5cb0e4a6ecadf2e73f00005b_1": [
        {
            "start_logit": 4.94921875,
            "end_logit": 2.076171875,
            "text": "surfaceome predictor SURFY, based on machine learning",
            "probability": 0.56103515625
        },
        {
            "start_logit": 4.94921875,
            "end_logit": 1.806640625,
            "text": "surfaceome",
            "probability": 0.43017578125
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": 3.779296875,
            "text": "surfaceome",
            "probability": 0.004283905029296875
        },
        {
            "start_logit": 4.94921875,
            "end_logit": -3.505859375,
            "text": "surfaceome predictor SURFY, based on machine learning.",
            "probability": 0.0021209716796875
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": 2.076171875,
            "text": "surfaceome, we developed the surfaceome predictor SURFY, based on machine learning",
            "probability": 0.0007801055908203125
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": 1.806640625,
            "text": "surfaceome, we developed the surfaceome",
            "probability": 0.0005960464477539062
        },
        {
            "start_logit": 4.94921875,
            "end_logit": -5.296875,
            "text": "surface",
            "probability": 0.0003528594970703125
        },
        {
            "start_logit": 4.94921875,
            "end_logit": -6.78125,
            "text": "surfaceome predictor",
            "probability": 7.975101470947266e-05
        },
        {
            "start_logit": -4.5546875,
            "end_logit": 2.076171875,
            "text": "machine learning",
            "probability": 4.202127456665039e-05
        },
        {
            "start_logit": 4.94921875,
            "end_logit": -7.4765625,
            "text": "surfaceome predictor SURFY,",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": -6.359375,
            "end_logit": 3.779296875,
            "text": "ome",
            "probability": 3.796815872192383e-05
        },
        {
            "start_logit": 4.94921875,
            "end_logit": -7.5703125,
            "text": "surfaceome predictor SURFY",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": -6.40625,
            "end_logit": 3.779296875,
            "text": "human surfaceome",
            "probability": 3.62396240234375e-05
        },
        {
            "start_logit": 4.94921875,
            "end_logit": -7.5859375,
            "text": "surfaceome predictor SURF",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": 4.94921875,
            "end_logit": -8.0546875,
            "text": "surfaceome predictor SURFY, based on",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -6.90625,
            "end_logit": 3.779296875,
            "text": "the human surfaceome",
            "probability": 2.199411392211914e-05
        },
        {
            "start_logit": -7.203125,
            "end_logit": 3.779296875,
            "text": "of the human surfaceome",
            "probability": 1.633167266845703e-05
        },
        {
            "start_logit": -7.375,
            "end_logit": 3.779296875,
            "text": "analysis of the human surfaceome",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 3.779296875,
            "text": "enable analysis of the human surfaceome",
            "probability": 1.138448715209961e-05
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 3.779296875,
            "text": "o enable analysis of the human surfaceome",
            "probability": 8.64267349243164e-06
        }
    ],
    "550618f58e1671127b000007_1": [
        {
            "start_logit": 4.87109375,
            "end_logit": 0.68017578125,
            "text": ", protein phosphatase inhibitor-1 (PPI",
            "probability": 0.9091796875
        },
        {
            "start_logit": 4.87109375,
            "end_logit": -2.044921875,
            "text": ", protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 0.059600830078125
        },
        {
            "start_logit": 4.87109375,
            "end_logit": -2.90234375,
            "text": ", protein phosphatase inhibitor-1 (PPI-1",
            "probability": 0.025299072265625
        },
        {
            "start_logit": 4.87109375,
            "end_logit": -5.29296875,
            "text": ",",
            "probability": 0.0023174285888671875
        },
        {
            "start_logit": 4.87109375,
            "end_logit": -5.578125,
            "text": ", protein phosphatase inhibitor",
            "probability": 0.0017414093017578125
        },
        {
            "start_logit": -1.9794921875,
            "end_logit": 0.68017578125,
            "text": "protein phosphatase inhibitor-1 (PPI",
            "probability": 0.0009617805480957031
        },
        {
            "start_logit": 4.87109375,
            "end_logit": -7.265625,
            "text": ", protein phosphatase inhibitor-1 (PPI-",
            "probability": 0.00032210350036621094
        },
        {
            "start_logit": -1.9794921875,
            "end_logit": -2.044921875,
            "text": "protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 6.29425048828125e-05
        },
        {
            "start_logit": -1.9794921875,
            "end_logit": -2.90234375,
            "text": "protein phosphatase inhibitor-1 (PPI-1",
            "probability": 2.664327621459961e-05
        },
        {
            "start_logit": -5.8828125,
            "end_logit": 0.68017578125,
            "text": "Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI",
            "probability": 1.9490718841552734e-05
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 0.68017578125,
            "text": "phosphatase-1 activities, are hallmarks of heart failure. Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 0.68017578125,
            "text": "(PPI",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 0.68017578125,
            "text": ". Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI",
            "probability": 8.106231689453125e-06
        },
        {
            "start_logit": -6.8125,
            "end_logit": 0.68017578125,
            "text": "1 (PPI",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 0.68017578125,
            "text": "PPI",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 0.68017578125,
            "text": "inhibitor, protein phosphatase inhibitor-1 (PPI",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -7.546875,
            "end_logit": 0.68017578125,
            "text": "-1 (PPI",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -7.546875,
            "end_logit": 0.68017578125,
            "text": "phosphatase inhibitor-1 (PPI",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 0.68017578125,
            "text": "1 activities, are hallmarks of heart failure. Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -7.609375,
            "end_logit": 0.68017578125,
            "text": "by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI",
            "probability": 3.4570693969726562e-06
        }
    ],
    "550618f58e1671127b000007_2": [
        {
            "start_logit": 4.703125,
            "end_logit": -2.4140625,
            "text": "constitutively active inhibitor-1,",
            "probability": 0.7216796875
        },
        {
            "start_logit": 4.703125,
            "end_logit": -4.55078125,
            "text": "constitutively active inhibitor",
            "probability": 0.085205078125
        },
        {
            "start_logit": 4.703125,
            "end_logit": -4.59375,
            "text": "constitutively active inhibitor-1, significantly increases cardiac contractility and calcium handling.",
            "probability": 0.08160400390625
        },
        {
            "start_logit": 4.703125,
            "end_logit": -5.07421875,
            "text": "constitutively",
            "probability": 0.05047607421875
        },
        {
            "start_logit": 4.703125,
            "end_logit": -5.7421875,
            "text": "constitutively active inhibitor-1",
            "probability": 0.02587890625
        },
        {
            "start_logit": 4.703125,
            "end_logit": -6.375,
            "text": "constitutively active",
            "probability": 0.01374053955078125
        },
        {
            "start_logit": 4.703125,
            "end_logit": -6.78125,
            "text": "constitutively active inhibitor-",
            "probability": 0.0091552734375
        },
        {
            "start_logit": 4.703125,
            "end_logit": -6.98828125,
            "text": "constitutively active inhibitor-1, significantly",
            "probability": 0.007442474365234375
        },
        {
            "start_logit": 4.703125,
            "end_logit": -7.47265625,
            "text": "constitutively active inhibitor-1, significantly increases cardiac",
            "probability": 0.00458526611328125
        },
        {
            "start_logit": -4.953125,
            "end_logit": -2.4140625,
            "text": "active inhibitor-1,",
            "probability": 4.6193599700927734e-05
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -2.4140625,
            "text": "1,",
            "probability": 4.1425228118896484e-05
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -2.4140625,
            "text": "protein phosphatase 1, by its constitutively active inhibitor-1,",
            "probability": 2.5331974029541016e-05
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -2.4140625,
            "text": "inhibitor-1,",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -6.0,
            "end_logit": -2.4140625,
            "text": "its constitutively active inhibitor-1,",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -4.953125,
            "end_logit": -4.55078125,
            "text": "active inhibitor",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -4.953125,
            "end_logit": -4.59375,
            "text": "active inhibitor-1, significantly increases cardiac contractility and calcium handling.",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -4.59375,
            "text": "1, significantly increases cardiac contractility and calcium handling.",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -7.28125,
            "end_logit": -2.4140625,
            "text": "-1,",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -4.55078125,
            "text": "protein phosphatase 1, by its constitutively active inhibitor",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.71875,
            "end_logit": -2.4140625,
            "text": "showed that inhibition of the protein phosphatase 1, by its constitutively active inhibitor-1,",
            "probability": 2.9206275939941406e-06
        }
    ],
    "550618f58e1671127b000007_3": [
        {
            "start_logit": -4.7421875,
            "end_logit": -5.97265625,
            "text": "protein phosphatase 1 inhibitor-1",
            "probability": 0.190673828125
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -5.97265625,
            "text": "the protein phosphatase 1 inhibitor-1",
            "probability": 0.1405029296875
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -6.96875,
            "text": "protein phosphatase 1 inhibitor-",
            "probability": 0.0706787109375
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -6.96875,
            "text": "the protein phosphatase 1 inhibitor-",
            "probability": 0.0521240234375
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -7.36328125,
            "text": "protein phosphatase 1 inhibitor-1 and",
            "probability": 0.047454833984375
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -7.3671875,
            "text": "protein phosphatase 1 inhibitor",
            "probability": 0.047454833984375
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -7.5234375,
            "text": "protein phosphatase 1 inhibitor-1 and the associated increases in cardiac",
            "probability": 0.04058837890625
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -7.58203125,
            "text": "protein phosphatase 1 inhibitor-1 and the associated increases in cardiac contractility appear to herald changes in a rather",
            "probability": 0.03814697265625
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -7.609375,
            "text": "protein phosphatase 1 inhibitor-1 and the associated increases in cardiac contractility appear to herald changes in a rather small",
            "probability": 0.037261962890625
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -7.62109375,
            "text": "protein phosphatase 1 inhibitor-1 and the associated increases in cardiac contractility appear to herald changes in a rather small number of proteins, which may reflect important",
            "probability": 0.036956787109375
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -7.671875,
            "text": "protein phosphatase 1 inhibitor-1 and the",
            "probability": 0.035003662109375
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -7.36328125,
            "text": "the protein phosphatase 1 inhibitor-1 and",
            "probability": 0.035003662109375
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -7.3671875,
            "text": "the protein phosphatase 1 inhibitor",
            "probability": 0.03472900390625
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -7.78515625,
            "text": "protein phosphatase 1 inhibitor-1 and the associated increases in cardiac contractility appear to herald changes in a",
            "probability": 0.0311126708984375
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -7.5234375,
            "text": "the protein phosphatase 1 inhibitor-1 and the associated increases in cardiac",
            "probability": 0.029693603515625
        },
        {
            "start_logit": -4.7421875,
            "end_logit": -7.890625,
            "text": "protein phosphatase 1 inhibitor-1 and the associated increases in cardiac contractility appear to",
            "probability": 0.028106689453125
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -7.58203125,
            "text": "the protein phosphatase 1 inhibitor-1 and the associated increases in cardiac contractility appear to herald changes in a rather",
            "probability": 0.028106689453125
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -7.609375,
            "text": "the protein phosphatase 1 inhibitor-1 and the associated increases in cardiac contractility appear to herald changes in a rather small",
            "probability": 0.0274505615234375
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -7.671875,
            "text": "the protein phosphatase 1 inhibitor-1 and the",
            "probability": 0.0258026123046875
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -7.78515625,
            "text": "the protein phosphatase 1 inhibitor-1 and the associated increases in cardiac contractility appear to herald changes in a",
            "probability": 0.02294921875
        }
    ],
    "550618f58e1671127b000007_4": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.53125,
            "text": "Inhibitor-1",
            "probability": 0.54052734375
        },
        {
            "start_logit": 7.9375,
            "end_logit": 7.3671875,
            "text": "inhibitor-1",
            "probability": 0.458740234375
        },
        {
            "start_logit": 7.9375,
            "end_logit": -0.256103515625,
            "text": "inhibitor",
            "probability": 0.0002238750457763672
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -0.39208984375,
            "text": "Inhibitor",
            "probability": 0.00019681453704833984
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -0.9296875,
            "text": "Inhibitor-1 becomes a potent inhibitor of protein phosphatase 1 when phosphorylated by cAMP-dependent protein kinase",
            "probability": 0.00011527538299560547
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -1.5361328125,
            "text": "Inhibitor-1 becomes a potent inhibitor of protein phosphatase 1 when phosphorylated by cAMP-dependent protein kinase at Thr(35).",
            "probability": 6.270408630371094e-05
        },
        {
            "start_logit": 7.9375,
            "end_logit": -1.53515625,
            "text": "inhibitor-1 serves as a substrate for cyclin-dependent kinase 5 in the brain.",
            "probability": 6.270408630371094e-05
        },
        {
            "start_logit": -1.984375,
            "end_logit": 7.53125,
            "text": "1",
            "probability": 2.6524066925048828e-05
        },
        {
            "start_logit": -1.93359375,
            "end_logit": 7.3671875,
            "text": "1",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": -1.96484375,
            "end_logit": 7.3671875,
            "text": "cAMP-dependent protein kinase at Thr(35). Moreover, Ser(67) of inhibitor-1",
            "probability": 2.3066997528076172e-05
        },
        {
            "start_logit": -4.13671875,
            "end_logit": 7.3671875,
            "text": "of inhibitor-1",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -4.6171875,
            "end_logit": 7.3671875,
            "text": ". Moreover, Ser(67) of inhibitor-1",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 7.9375,
            "end_logit": -5.390625,
            "text": "inhibitor-",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -5.5390625,
            "text": "Inhibitor-1 becomes a potent inhibitor of protein phosphatase 1 when phosphorylated by cAMP-dependent protein",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -5.56640625,
            "text": "Inhibitor-1 becomes",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.203125,
            "end_logit": 7.3671875,
            "text": "by cAMP-dependent protein kinase at Thr(35). Moreover, Ser(67) of inhibitor-1",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.3359375,
            "end_logit": 7.3671875,
            "text": "protein phosphatase 1 when phosphorylated by cAMP-dependent protein kinase at Thr(35). Moreover, Ser(67) of inhibitor-1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.015625,
            "text": "Inhibitor-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.0703125,
            "text": "inhibitor-1 serves as a substrate for cyclin-dependent kinase 5 in the brain",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.3828125,
            "text": "Inhibitor-1 becomes a potent inhibitor of protein phosphatase 1 when",
            "probability": 4.76837158203125e-07
        }
    ],
    "550618f58e1671127b000007_5": [
        {
            "start_logit": 7.73828125,
            "end_logit": 5.41796875,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.9970703125
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -0.607421875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 0.0024127960205078125
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -2.478515625,
            "text": "Inhibitor",
            "probability": 0.000370025634765625
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -4.18359375,
            "text": "Inhibitor 1",
            "probability": 6.747245788574219e-05
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -5.0703125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase",
            "probability": 2.7894973754882812e-05
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -5.453125,
            "text": "Inhibitor 1 (I-1",
            "probability": 1.8894672393798828e-05
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -6.16015625,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -6.84375,
            "text": "Inhibitor 1 (I-",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -6.890625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -5.17578125,
            "end_logit": 5.41796875,
            "text": ")",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -5.62109375,
            "end_logit": 5.41796875,
            "text": "I-1)",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -0.2274169921875,
            "end_logit": -0.607421875,
            "text": "protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 5.41796875,
            "text": "(I-1)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -0.2274169921875,
            "end_logit": -5.0703125,
            "text": "protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase",
            "probability": 0.0
        },
        {
            "start_logit": -0.2274169921875,
            "end_logit": -5.078125,
            "text": "protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase. Nonphosphorylated I-1",
            "probability": 0.0
        },
        {
            "start_logit": -4.90234375,
            "end_logit": -0.60888671875,
            "text": "whereas phosphorylated I-1 is a potent PP1 inhibitor.",
            "probability": 0.0
        },
        {
            "start_logit": -5.17578125,
            "end_logit": -0.607421875,
            "text": ") is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 0.0
        },
        {
            "start_logit": -5.2734375,
            "end_logit": -0.607421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.2734375,
            "end_logit": -0.60888671875,
            "text": ". Nonphosphorylated I-1 is inactive, whereas phosphorylated I-1 is a potent PP1 inhibitor.",
            "probability": 0.0
        },
        {
            "start_logit": -5.27734375,
            "end_logit": -0.60888671875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "550618f58e1671127b000007_6": [
        {
            "start_logit": -0.298095703125,
            "end_logit": 0.004119873046875,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 0.6044921875
        },
        {
            "start_logit": -0.298095703125,
            "end_logit": -0.5712890625,
            "text": "Ser67-phosphorylated inhibitor 1",
            "probability": 0.340087890625
        },
        {
            "start_logit": -4.26953125,
            "end_logit": 0.004119873046875,
            "text": ".",
            "probability": 0.011383056640625
        },
        {
            "start_logit": -4.375,
            "end_logit": 0.004119873046875,
            "text": "phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 0.0102386474609375
        },
        {
            "start_logit": -4.64453125,
            "end_logit": 0.004119873046875,
            "text": "67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 0.00782012939453125
        },
        {
            "start_logit": -4.375,
            "end_logit": -0.5712890625,
            "text": "phosphorylated inhibitor 1",
            "probability": 0.005764007568359375
        },
        {
            "start_logit": -5.1640625,
            "end_logit": 0.004119873046875,
            "text": "protein phosphatase 1 inhibitor.",
            "probability": 0.004650115966796875
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -0.5712890625,
            "text": "67-phosphorylated inhibitor 1",
            "probability": 0.004405975341796875
        },
        {
            "start_logit": -5.8203125,
            "end_logit": 0.004119873046875,
            "text": "inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 0.002414703369140625
        },
        {
            "start_logit": -5.8203125,
            "end_logit": -0.5712890625,
            "text": "inhibitor 1",
            "probability": 0.0013589859008789062
        },
        {
            "start_logit": -0.298095703125,
            "end_logit": -6.11328125,
            "text": "Ser67",
            "probability": 0.0013332366943359375
        },
        {
            "start_logit": -6.5625,
            "end_logit": 0.004119873046875,
            "text": "-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 0.0011491775512695312
        },
        {
            "start_logit": -0.298095703125,
            "end_logit": -6.50390625,
            "text": "Ser67-phosphorylated",
            "probability": 0.0009016990661621094
        },
        {
            "start_logit": -0.298095703125,
            "end_logit": -6.60546875,
            "text": "Ser67-phosphorylated inhibitor",
            "probability": 0.0008144378662109375
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 0.004119873046875,
            "text": "potent protein phosphatase 1 inhibitor.",
            "probability": 0.000774383544921875
        },
        {
            "start_logit": -6.5625,
            "end_logit": -0.5712890625,
            "text": "-phosphorylated inhibitor 1",
            "probability": 0.0006465911865234375
        },
        {
            "start_logit": -0.298095703125,
            "end_logit": -6.9609375,
            "text": "Ser67-phosphorylated inhibitor 1 is",
            "probability": 0.0005707740783691406
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 0.004119873046875,
            "text": "a potent protein phosphatase 1 inhibitor.",
            "probability": 0.00047326087951660156
        },
        {
            "start_logit": -0.298095703125,
            "end_logit": -7.23828125,
            "text": "Ser",
            "probability": 0.00043272972106933594
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 0.004119873046875,
            "text": "inhibitor.",
            "probability": 0.0003819465637207031
        }
    ],
    "550618f58e1671127b000007_7": [
        {
            "start_logit": 2.517578125,
            "end_logit": -0.354248046875,
            "text": "type-1 protein serine/threonine",
            "probability": 0.55224609375
        },
        {
            "start_logit": 2.517578125,
            "end_logit": -1.7822265625,
            "text": "type",
            "probability": 0.13232421875
        },
        {
            "start_logit": 0.390869140625,
            "end_logit": -0.354248046875,
            "text": "the type-1 protein serine/threonine",
            "probability": 0.06585693359375
        },
        {
            "start_logit": 2.517578125,
            "end_logit": -2.484375,
            "text": "type-1 protein serine/threonine phosphatase (PP1). N-Terminal phosphopeptides of I-1",
            "probability": 0.0655517578125
        },
        {
            "start_logit": 2.517578125,
            "end_logit": -2.806640625,
            "text": "type-1 protein serine/threonine phosphatase (PP1).",
            "probability": 0.0474853515625
        },
        {
            "start_logit": 2.517578125,
            "end_logit": -2.85546875,
            "text": "type-1 protein serine/threonine phosphatase",
            "probability": 0.04522705078125
        },
        {
            "start_logit": 0.390869140625,
            "end_logit": -1.7822265625,
            "text": "the type",
            "probability": 0.0157928466796875
        },
        {
            "start_logit": -1.5419921875,
            "end_logit": 0.10595703125,
            "text": "protein phosphatase inhibitor-1 (I-1) was expressed in Escherichia coli. Following PKA",
            "probability": 0.0150909423828125
        },
        {
            "start_logit": -1.6767578125,
            "end_logit": 0.10595703125,
            "text": "PKA",
            "probability": 0.0131988525390625
        },
        {
            "start_logit": 2.517578125,
            "end_logit": -4.296875,
            "text": "type-1",
            "probability": 0.01070404052734375
        },
        {
            "start_logit": 0.390869140625,
            "end_logit": -2.484375,
            "text": "the type-1 protein serine/threonine phosphatase (PP1). N-Terminal phosphopeptides of I-1",
            "probability": 0.00782012939453125
        },
        {
            "start_logit": 0.390869140625,
            "end_logit": -2.806640625,
            "text": "the type-1 protein serine/threonine phosphatase (PP1).",
            "probability": 0.00567626953125
        },
        {
            "start_logit": 0.390869140625,
            "end_logit": -2.85546875,
            "text": "the type-1 protein serine/threonine phosphatase",
            "probability": 0.00539398193359375
        },
        {
            "start_logit": -2.455078125,
            "end_logit": -0.354248046875,
            "text": "protein serine/threonine",
            "probability": 0.0038242340087890625
        },
        {
            "start_logit": 2.517578125,
            "end_logit": -5.42578125,
            "text": "type-1 protein serine/threonine phosphatase (PP1). N-Terminal phosphopeptides of I-1 that",
            "probability": 0.003467559814453125
        },
        {
            "start_logit": -2.66015625,
            "end_logit": -0.354248046875,
            "text": "1 protein serine/threonine",
            "probability": 0.003108978271484375
        },
        {
            "start_logit": -1.6767578125,
            "end_logit": -1.7822265625,
            "text": "PKA phosphorylation at a threonine, recombinant human I-1 was indistinguishable from rabbit skeletal muscle I-1 as a potent and specific inhibitor of the type",
            "probability": 0.00199127197265625
        },
        {
            "start_logit": -3.123046875,
            "end_logit": -0.354248046875,
            "text": "I-1 was indistinguishable from rabbit skeletal muscle I-1 as a potent and specific inhibitor of the type-1 protein serine/threonine",
            "probability": 0.00196075439453125
        },
        {
            "start_logit": -3.60546875,
            "end_logit": 0.10595703125,
            "text": "I-1) was expressed in Escherichia coli. Following PKA",
            "probability": 0.00191497802734375
        },
        {
            "start_logit": -3.486328125,
            "end_logit": -0.354248046875,
            "text": "I-1 as a potent and specific inhibitor of the type-1 protein serine/threonine",
            "probability": 0.0013647079467773438
        }
    ],
    "550618f58e1671127b000007_8": [
        {
            "start_logit": 1.3388671875,
            "end_logit": 0.693359375,
            "text": "Protein phosphatase inhibitor-1 was purified from bovine adipose tissue.",
            "probability": 0.96337890625
        },
        {
            "start_logit": -3.884765625,
            "end_logit": 0.69287109375,
            "text": "cAMP-dependent protein kinase on a threonyl residue; this phosphorylation was necessary for inhibition of protein phosphatase-1.",
            "probability": 0.00519561767578125
        },
        {
            "start_logit": -4.0390625,
            "end_logit": 0.69287109375,
            "text": "inhibition of protein phosphatase-1.",
            "probability": 0.004459381103515625
        },
        {
            "start_logit": 1.3388671875,
            "end_logit": -4.85546875,
            "text": "Protein phosphatase inhibitor-1 was",
            "probability": 0.003757476806640625
        },
        {
            "start_logit": 1.3388671875,
            "end_logit": -5.375,
            "text": "Protein phosphatase inhibitor-1 was purified from bovine adipose tissue",
            "probability": 0.0022335052490234375
        },
        {
            "start_logit": -4.7578125,
            "end_logit": 0.693359375,
            "text": ".",
            "probability": 0.00217437744140625
        },
        {
            "start_logit": -4.7578125,
            "end_logit": 0.69287109375,
            "text": ". The protein had an apparent molecular mass of 32 kDa by SDS/PAGE and a Stokes' radius of 3.4 nm.",
            "probability": 0.002166748046875
        },
        {
            "start_logit": -4.7578125,
            "end_logit": 0.69287109375,
            "text": ".",
            "probability": 0.002166748046875
        },
        {
            "start_logit": -4.7578125,
            "end_logit": 0.69287109375,
            "text": ". It was phosphorylated by cAMP-dependent protein kinase on a threonyl residue; this phosphorylation was necessary for inhibition of protein phosphatase-1.",
            "probability": 0.002166748046875
        },
        {
            "start_logit": -4.7578125,
            "end_logit": 0.69287109375,
            "text": ".",
            "probability": 0.002166748046875
        },
        {
            "start_logit": -3.884765625,
            "end_logit": -0.273681640625,
            "text": "cAMP-dependent protein kinase",
            "probability": 0.001972198486328125
        },
        {
            "start_logit": -4.97265625,
            "end_logit": 0.69287109375,
            "text": "by cAMP-dependent protein kinase on a threonyl residue; this phosphorylation was necessary for inhibition of protein phosphatase-1.",
            "probability": 0.00174713134765625
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 0.69287109375,
            "text": "protein phosphatase-1.",
            "probability": 0.001560211181640625
        },
        {
            "start_logit": 1.3388671875,
            "end_logit": -6.2890625,
            "text": "Protein phosphatase inhibitor-1 was purified from bovine adipose tissue. The protein",
            "probability": 0.0008955001831054688
        },
        {
            "start_logit": -4.7578125,
            "end_logit": -0.273681640625,
            "text": ". It was phosphorylated by cAMP-dependent protein kinase",
            "probability": 0.0008249282836914062
        },
        {
            "start_logit": 1.3388671875,
            "end_logit": -6.5078125,
            "text": "Protein phosphatase inhibitor",
            "probability": 0.0007200241088867188
        },
        {
            "start_logit": 1.3388671875,
            "end_logit": -6.56640625,
            "text": "Protein phosphatase inhibitor-1 was purified from bovine adipose",
            "probability": 0.00067901611328125
        },
        {
            "start_logit": -4.97265625,
            "end_logit": -0.273681640625,
            "text": "by cAMP-dependent protein kinase",
            "probability": 0.0006656646728515625
        },
        {
            "start_logit": 1.3388671875,
            "end_logit": -6.6875,
            "text": "Protein phosphatase inhibitor-1 was purified from bovine adipose tissue. The protein had an apparent molecular mass of 32 kDa",
            "probability": 0.0006012916564941406
        },
        {
            "start_logit": 1.3388671875,
            "end_logit": -6.73828125,
            "text": "Protein phosphatase inhibitor-1",
            "probability": 0.0005712509155273438
        }
    ],
    "550618f58e1671127b000007_9": [
        {
            "start_logit": 6.8359375,
            "end_logit": 3.890625,
            "text": "Protein inhibitor-1 (I-1)",
            "probability": 0.9970703125
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -2.615234375,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant PLB phosphatase in heart.",
            "probability": 0.0014867782592773438
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -3.47265625,
            "text": "Protein",
            "probability": 0.0006322860717773438
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -5.1953125,
            "text": "Protein inhibitor",
            "probability": 0.00011289119720458984
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -5.47265625,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant PLB phosphatase in heart",
            "probability": 8.589029312133789e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -6.23046875,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant PLB phosphatase",
            "probability": 3.993511199951172e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.05078125,
            "text": "Protein inhibitor-",
            "probability": 1.7702579498291016e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.06640625,
            "text": "Protein inhibitor-1 (I-1",
            "probability": 1.7464160919189453e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.15625,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant",
            "probability": 1.5854835510253906e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.171875,
            "text": "Protein inhibitor-1 (I-1) specifically",
            "probability": 1.5616416931152344e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.24609375,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.27734375,
            "text": "Protein inhibitor-1 (I-",
            "probability": 1.4007091522216797e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.4375,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant PLB",
            "probability": 1.1980533599853516e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.45703125,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant PLB phosphatase in",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.4609375,
            "text": "Protein inhibitor-1",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.52734375,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1",
            "probability": 1.0907649993896484e-05
        },
        {
            "start_logit": 6.8359375,
            "end_logit": -7.609375,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1),",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": -6.3046875,
            "end_logit": 3.890625,
            "text": ")",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.9375,
            "end_logit": 3.890625,
            "text": "(I-1)",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 3.890625,
            "text": "1 (I-1)",
            "probability": 8.344650268554688e-07
        }
    ],
    "550618f58e1671127b000007_10": [
        {
            "start_logit": 7.58984375,
            "end_logit": 7.49609375,
            "text": "Inhibitor 1 (I-1)",
            "probability": 1.0
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -2.82421875,
            "text": "Inhibitor",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": -2.763671875,
            "end_logit": 7.49609375,
            "text": ")",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -5.3203125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -5.91015625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -5.953125,
            "end_logit": 7.49609375,
            "text": "(I-1)",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -6.08203125,
            "text": "Inhibitor 1",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -6.109375,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 7.49609375,
            "text": "I-1)",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -6.5859375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 7.49609375,
            "text": "1)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -6.76171875,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -6.96875,
            "text": "Inhibitor 1 (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.25390625,
            "text": "Inhibitor 1 (I-1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 7.49609375,
            "text": "1 (I-1)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predom",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.49609375,
            "text": "-1)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.4453125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.44921875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.58984375,
            "end_logit": -7.46484375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the",
            "probability": 2.980232238769531e-07
        }
    ],
    "550618f58e1671127b000007_11": [
        {
            "start_logit": 7.8046875,
            "end_logit": 7.3671875,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.8046875,
            "end_logit": 0.054351806640625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 0.0006666183471679688
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -2.298828125,
            "text": "Inhibitor",
            "probability": 6.347894668579102e-05
        },
        {
            "start_logit": -2.98828125,
            "end_logit": 7.3671875,
            "text": ")",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -4.953125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -6.1484375,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -6.3203125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 7.3671875,
            "text": "(I-1)",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -6.46875,
            "text": "Inhibitor 1",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.0703125,
            "end_logit": 7.3671875,
            "text": "I-1)",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -6.63671875,
            "text": "Inhibitor 1 (",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -6.71484375,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.4375,
            "end_logit": 7.3671875,
            "text": "1)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.29296875,
            "text": "Inhibitor 1 (I-1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 7.3671875,
            "text": "1 (I-1)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.515625,
            "text": "Inhibitor 1 (I-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 7.3671875,
            "text": "-1)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.61328125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.65625,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.66015625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 2.980232238769531e-07
        }
    ],
    "550618f58e1671127b000007_12": [
        {
            "start_logit": 6.87890625,
            "end_logit": 7.21875,
            "text": "Inhibitor 1 (I-1)",
            "probability": 1.0
        },
        {
            "start_logit": -3.11328125,
            "end_logit": 7.21875,
            "text": ")",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -3.62890625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -3.84375,
            "text": "Inhibitor",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": -5.45703125,
            "end_logit": 7.21875,
            "text": "(I-1)",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -5.67578125,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -5.69921875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -6.11328125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.546875,
            "end_logit": 7.21875,
            "text": "I-1)",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 7.21875,
            "text": "1)",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -6.37109375,
            "text": "Inhibitor 1",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -6.671875,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 7.21875,
            "text": "1 (I-1)",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 7.21875,
            "text": "-1)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -7.2421875,
            "text": "Inhibitor 1 (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -7.2421875,
            "text": "Inhibitor 1 (I-1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -7.328125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -7.4921875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -7.56640625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.87890625,
            "end_logit": -7.5703125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predom",
            "probability": 3.5762786865234375e-07
        }
    ],
    "550618f58e1671127b000007_13": [
        {
            "start_logit": 6.66796875,
            "end_logit": 4.28125,
            "text": "Protein inhibitor-1 (I-1)",
            "probability": 0.998046875
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -2.61328125,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant PLB phosphatase in heart",
            "probability": 0.001007080078125
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -3.48828125,
            "text": "Protein",
            "probability": 0.0004200935363769531
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -5.37109375,
            "text": "Protein inhibitor",
            "probability": 6.389617919921875e-05
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -5.5234375,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant PLB phosphatase",
            "probability": 5.46574592590332e-05
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -6.046875,
            "text": "Protein inhibitor-1 (I-1) specifically",
            "probability": 3.266334533691406e-05
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -6.8828125,
            "text": "Protein inhibitor-1 (I-1",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.0703125,
            "text": "Protein inhibitor-",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.26171875,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.421875,
            "text": "Protein inhibitor-1 (I-",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.43359375,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.4453125,
            "text": "Protein inhibitor-1",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.578125,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.609375,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant PL",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.640625,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1),",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.6484375,
            "text": "Protein inhibitor-1 (I-1) specifically inhibits protein phosphatase 1 (PP1), the predominant PLB",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 6.66796875,
            "end_logit": -7.66796875,
            "text": "Protein inhibitor-1 (",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -5.859375,
            "end_logit": 4.28125,
            "text": ")",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 4.28125,
            "text": "(I-1)",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 4.28125,
            "text": "1 (I-1)",
            "probability": 1.0132789611816406e-06
        }
    ],
    "5881f9b65bf093691f000001_1": [
        {
            "start_logit": 7.79296875,
            "end_logit": 7.19140625,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -1.947265625,
            "text": "Parasympathetic",
            "probability": 0.00010722875595092773
        },
        {
            "start_logit": -3.1015625,
            "end_logit": 7.19140625,
            "text": "neurons",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -5.7265625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -6.91796875,
            "text": "Parasympathetic neurons originate",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.23828125,
            "text": "Parasympathetic neurons originate from",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.79296875,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.98046875,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -8.0390625,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -8.078125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -8.09375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.1015625,
            "end_logit": -5.7265625,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -3.1015625,
            "end_logit": -6.91796875,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -3.1015625,
            "end_logit": -7.23828125,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -3.1015625,
            "end_logit": -7.79296875,
            "text": "neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -3.1015625,
            "end_logit": -7.98046875,
            "text": "neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -3.1015625,
            "end_logit": -8.0390625,
            "text": "neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": -3.1015625,
            "end_logit": -8.078125,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -3.1015625,
            "end_logit": -8.09375,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -5.7265625,
            "text": "progenitors.",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_2": [
        {
            "start_logit": 3.875,
            "end_logit": 4.0390625,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -5.34375,
            "end_logit": 4.0390625,
            "text": "neurons",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -5.58984375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 6.604194641113281e-05
        },
        {
            "start_logit": -5.90625,
            "end_logit": 4.0390625,
            "text": ". Parasympathetic neurons",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -6.4921875,
            "text": "Parasympathetic",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -6.56640625,
            "text": "Parasympathetic neurons originate",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 4.0390625,
            "text": "Neurodevelopment. Parasympathetic neurons",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -6.671875,
            "text": "Parasympathetic neurons originate from",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -7.9765625,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 3.875,
            "end_logit": -8.171875,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -5.34375,
            "end_logit": -5.58984375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -5.58984375,
            "text": ". Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -5.34375,
            "end_logit": -6.56640625,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -5.34375,
            "end_logit": -6.671875,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -5.58984375,
            "text": "Neurodevelopment. Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -6.4921875,
            "text": ". Parasympathetic",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -6.56640625,
            "text": ". Parasympathetic neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -6.671875,
            "text": ". Parasympathetic neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -6.4921875,
            "text": "Neurodevelopment. Parasympathetic",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -5.58984375,
            "text": "progenitors.",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_3": [
        {
            "start_logit": 6.83984375,
            "end_logit": 5.68359375,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -3.583984375,
            "text": "Parasympathetic",
            "probability": 9.459257125854492e-05
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -5.14453125,
            "text": "Parasympathetic neurons originate",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -4.65234375,
            "end_logit": 5.68359375,
            "text": "neurons",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -6.54296875,
            "text": "Parasympathetic neurons originate from",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -6.87890625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.1328125,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.140625,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.1484375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.3046875,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -5.14453125,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -6.54296875,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -6.87890625,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -8.1328125,
            "text": "neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -8.140625,
            "text": "neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -8.1484375,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": -8.3046875,
            "text": "neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -6.54296875,
            "text": "from",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -6.87890625,
            "text": "from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -6.87890625,
            "text": "peripheral glial progenitors",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_4": [
        {
            "start_logit": 3.875,
            "end_logit": 4.0390625,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -5.34375,
            "end_logit": 4.0390625,
            "text": "neurons",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -5.58984375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 6.604194641113281e-05
        },
        {
            "start_logit": -5.90625,
            "end_logit": 4.0390625,
            "text": ". Parasympathetic neurons",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -6.4921875,
            "text": "Parasympathetic",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -6.56640625,
            "text": "Parasympathetic neurons originate",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 4.0390625,
            "text": "Neurodevelopment. Parasympathetic neurons",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -6.671875,
            "text": "Parasympathetic neurons originate from",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": 3.875,
            "end_logit": -7.9765625,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 3.875,
            "end_logit": -8.171875,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -5.34375,
            "end_logit": -5.58984375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -5.58984375,
            "text": ". Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -5.34375,
            "end_logit": -6.56640625,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -5.34375,
            "end_logit": -6.671875,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -5.58984375,
            "text": "Neurodevelopment. Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -6.4921875,
            "text": ". Parasympathetic",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -6.56640625,
            "text": ". Parasympathetic neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -6.671875,
            "text": ". Parasympathetic neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -6.4921875,
            "text": "Neurodevelopment. Parasympathetic",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -5.58984375,
            "text": "progenitors.",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_1": [
        {
            "start_logit": 7.859375,
            "end_logit": 7.79296875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.859375,
            "end_logit": -1.7509765625,
            "text": "Clostridium",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -1.9814453125,
            "end_logit": 7.79296875,
            "text": "difficile",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.79296875,
            "text": "microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.609375,
            "text": "Clostridium difficile,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.640625,
            "text": "Clostridium difficile, a common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.671875,
            "text": "Clostridium difficile, a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.703125,
            "text": "Clostridium difficile, a common hospital",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.703125,
            "text": "Clostridium difficile, a common hospital-acquired",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.80078125,
            "text": "Clostridium difficile, a common hospital-acquired infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.859375,
            "end_logit": -7.85546875,
            "text": "Clostridium difficile, a common hospital-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.79296875,
            "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": -1.7509765625,
            "text": "microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.9814453125,
            "end_logit": -7.609375,
            "text": "difficile,",
            "probability": 0.0
        },
        {
            "start_logit": -1.9814453125,
            "end_logit": -7.640625,
            "text": "difficile, a common",
            "probability": 0.0
        },
        {
            "start_logit": -1.9814453125,
            "end_logit": -7.671875,
            "text": "difficile, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.9814453125,
            "end_logit": -7.703125,
            "text": "difficile, a common hospital",
            "probability": 0.0
        },
        {
            "start_logit": -1.9814453125,
            "end_logit": -7.703125,
            "text": "difficile, a common hospital-acquired",
            "probability": 0.0
        },
        {
            "start_logit": -1.9814453125,
            "end_logit": -7.80078125,
            "text": "difficile, a common hospital-acquired infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -1.7509765625,
            "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_2": [
        {
            "start_logit": 7.875,
            "end_logit": 7.796875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.875,
            "end_logit": -1.703125,
            "text": "Clostridium",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": 7.796875,
            "text": "difficile",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.6875,
            "text": "Clostridium difficile Proctitis Following",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.796875,
            "text": "Fecal Microbiota Transplantation for Treatment of Clostridium difficile",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.75390625,
            "text": "Clostridium difficile Proctitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.76953125,
            "text": "Clostridium difficile Proctitis Following Total Colectomy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.79296875,
            "text": "Clostridium difficile Proct",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.87109375,
            "text": "Clostridium difficile Proctitis Following Total",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.796875,
            "text": "Microbiota Transplantation for Treatment of Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -1.703125,
            "text": "Fecal Microbiota Transplantation for Treatment of Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.6875,
            "text": "difficile Proctitis Following",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.75390625,
            "text": "difficile Proctitis",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.76953125,
            "text": "difficile Proctitis Following Total Colectomy",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.79296875,
            "text": "difficile Proct",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -1.703125,
            "text": "Microbiota Transplantation for Treatment of Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.87109375,
            "text": "difficile Proctitis Following Total",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -6.69921875,
            "text": "Fecal Microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -6.69921875,
            "text": "Microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.6875,
            "text": "Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis Following",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_3": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.78125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.6728515625,
            "text": "Clostridium",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -1.9755859375,
            "end_logit": 7.78125,
            "text": "difficile",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.08984375,
            "text": "Clostridium difficile carriage rates following fecal microbiota",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.375,
            "text": "Clostridium difficile carriage",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.57421875,
            "text": "Clostridium difficile carriage rates",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.68359375,
            "text": "Clostridium difficile carriage rates following",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.69140625,
            "text": "Clostridium difficile carriage rates following fecal microbiota transplantation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.9755859375,
            "end_logit": -7.08984375,
            "text": "difficile carriage rates following fecal microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -1.9755859375,
            "end_logit": -7.375,
            "text": "difficile carriage",
            "probability": 0.0
        },
        {
            "start_logit": -1.9755859375,
            "end_logit": -7.57421875,
            "text": "difficile carriage rates",
            "probability": 0.0
        },
        {
            "start_logit": -1.9755859375,
            "end_logit": -7.68359375,
            "text": "difficile carriage rates following",
            "probability": 0.0
        },
        {
            "start_logit": -1.9755859375,
            "end_logit": -7.69140625,
            "text": "difficile carriage rates following fecal microbiota transplantation",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_4": [
        {
            "start_logit": 7.875,
            "end_logit": 7.8125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.875,
            "end_logit": -1.5634765625,
            "text": "Clostridium",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -1.8662109375,
            "end_logit": 7.8125,
            "text": "difficile",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.75,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.78125,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.83203125,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.859375,
            "text": "Clostridium difficile infection, and case reports",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.86328125,
            "text": "Clostridium difficile infection, and case reports document its use in the successful",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.86328125,
            "text": "Clostridium difficile infection, and case reports document its use in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.87109375,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.87890625,
            "text": "Clostridium difficile infection, and case",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.8125,
            "text": "feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.8125,
            "text": "been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.8125,
            "text": "into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.8125,
            "text": "decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8662109375,
            "end_logit": -7.75,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -1.5634765625,
            "text": "feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.8662109375,
            "end_logit": -7.78125,
            "text": "difficile infection, and case reports document its use in the successful treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -1.8662109375,
            "end_logit": -7.83203125,
            "text": "difficile infection, and case reports document its use in the successful treatment",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -1.5634765625,
            "text": "been used for decades to treat recurrent Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_5": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.83203125,
            "text": "Clostridium difficile",
            "probability": 0.501953125
        },
        {
            "start_logit": 7.921875,
            "end_logit": 7.828125,
            "text": "Clostridium difficile",
            "probability": 0.498046875
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.162109375,
            "text": "Clostridium",
            "probability": 6.240606307983398e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -1.1552734375,
            "text": "Clostridium",
            "probability": 6.240606307983398e-05
        },
        {
            "start_logit": -1.7109375,
            "end_logit": 7.83203125,
            "text": "difficile",
            "probability": 3.266334533691406e-05
        },
        {
            "start_logit": -1.732421875,
            "end_logit": 7.828125,
            "text": "difficile",
            "probability": 3.1888484954833984e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -5.546875,
            "text": "Clostridium difficile infection (CDI",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.484375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 7.828125,
            "text": "Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.2578125,
            "text": "Clostridium difficile Infection in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.37109375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 7.83203125,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.83203125,
            "text": "Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.83203125,
            "text": ".Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.53125,
            "text": "Clostridium difficile Infection in Two English",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.5546875,
            "text": "Clostridium difficile Infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.5859375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.83203125,
            "text": "microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.6484375,
            "text": "Clostridium difficile Infection in Two",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.74609375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c71d6d27c78d6947100006a_6": [
        {
            "start_logit": 7.92578125,
            "end_logit": 7.83203125,
            "text": "Clostridium difficile",
            "probability": 0.501953125
        },
        {
            "start_logit": 7.921875,
            "end_logit": 7.828125,
            "text": "Clostridium difficile",
            "probability": 0.498046875
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.162109375,
            "text": "Clostridium",
            "probability": 6.240606307983398e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -1.1552734375,
            "text": "Clostridium",
            "probability": 6.240606307983398e-05
        },
        {
            "start_logit": -1.7109375,
            "end_logit": 7.83203125,
            "text": "difficile",
            "probability": 3.266334533691406e-05
        },
        {
            "start_logit": -1.732421875,
            "end_logit": 7.828125,
            "text": "difficile",
            "probability": 3.1888484954833984e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -5.546875,
            "text": "Clostridium difficile infection (CDI",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.484375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 7.828125,
            "text": "Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.2578125,
            "text": "Clostridium difficile Infection in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.37109375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 7.83203125,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.83203125,
            "text": "Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.83203125,
            "text": ".Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.53125,
            "text": "Clostridium difficile Infection in Two English",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.5546875,
            "text": "Clostridium difficile Infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.5859375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.83203125,
            "text": "microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.6484375,
            "text": "Clostridium difficile Infection in Two",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.74609375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c71d6d27c78d6947100006a_7": [
        {
            "start_logit": 7.87890625,
            "end_logit": 7.8125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -1.53515625,
            "text": "Clostridium",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": 7.8125,
            "text": "difficile",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -6.0859375,
            "text": "Clostridium difficile Infection following Fecal Microbiota",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.6953125,
            "text": "Clostridium difficile Infection following Fecal Microbiota Transplantation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.73046875,
            "text": "Clostridium difficile Infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.76171875,
            "text": "Clostridium difficile Infection following",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.91015625,
            "text": "Clostridium difficile Infection following Fecal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 7.8125,
            "text": "Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.8125,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -6.0859375,
            "text": "difficile Infection following Fecal Microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -1.53515625,
            "text": "Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.6953125,
            "text": "difficile Infection following Fecal Microbiota Transplantation",
            "probability": 0.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.73046875,
            "text": "difficile Infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -1.53515625,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.76171875,
            "text": "difficile Infection following",
            "probability": 0.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.91015625,
            "text": "difficile Infection following Fecal",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -6.0859375,
            "text": "Microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -6.0859375,
            "text": "Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -6.0859375,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_8": [
        {
            "start_logit": 7.875,
            "end_logit": 7.8125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.875,
            "end_logit": -1.5634765625,
            "text": "Clostridium",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -1.8662109375,
            "end_logit": 7.8125,
            "text": "difficile",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.75,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.78125,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.83203125,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.859375,
            "text": "Clostridium difficile infection, and case reports",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.86328125,
            "text": "Clostridium difficile infection, and case reports document its use in the successful",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.86328125,
            "text": "Clostridium difficile infection, and case reports document its use in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.87109375,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.87890625,
            "text": "Clostridium difficile infection, and case",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.8125,
            "text": "feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.8125,
            "text": "been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.8125,
            "text": "into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.8125,
            "text": "decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8662109375,
            "end_logit": -7.75,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -1.5634765625,
            "text": "feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.8662109375,
            "end_logit": -7.78125,
            "text": "difficile infection, and case reports document its use in the successful treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -1.8662109375,
            "end_logit": -7.83203125,
            "text": "difficile infection, and case reports document its use in the successful treatment",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -1.5634765625,
            "text": "been used for decades to treat recurrent Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_9": [
        {
            "start_logit": 7.875,
            "end_logit": 7.796875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.875,
            "end_logit": -1.6669921875,
            "text": "Clostridium",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": 7.796875,
            "text": "difficile",
            "probability": 5.435943603515625e-05
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.3671875,
            "text": "Clostridium difficile infection, with near 90%",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.796875,
            "text": "microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.625,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.6328125,
            "text": "Clostridium difficile infection, with near 90",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.6796875,
            "text": "Clostridium difficile infection, with near 90% of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.7578125,
            "text": "Clostridium difficile infection, with near 90% of success",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.7578125,
            "text": "Clostridium difficile infection, with near",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.78515625,
            "text": "Clostridium difficile infection,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.80078125,
            "text": "Clostridium difficile infection, with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 7.796875,
            "text": "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -1.6669921875,
            "text": "microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": -7.3671875,
            "text": "difficile infection, with near 90%",
            "probability": 0.0
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": -7.625,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -1.6669921875,
            "text": "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": -7.6328125,
            "text": "difficile infection, with near 90",
            "probability": 0.0
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": -7.6796875,
            "text": "difficile infection, with near 90% of",
            "probability": 0.0
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": -7.7578125,
            "text": "difficile infection, with near 90% of success",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_10": [
        {
            "start_logit": 7.87109375,
            "end_logit": 7.80859375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -1.71875,
            "text": "Clostridium",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": 7.80859375,
            "text": "difficile",
            "probability": 5.435943603515625e-05
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.421875,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.48046875,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.53125,
            "text": "Clostridium difficile infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.578125,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.62890625,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.64453125,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.6484375,
            "text": "Clostridium difficile infection, has emerged as a promising",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.6640625,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolon",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.671875,
            "text": "Clostridium difficile infection, has emerged as a promising therapy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.80859375,
            "text": "microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.421875,
            "text": "difficile infection, has emerged as a promising therapy for intestinal MDR bacterial",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.48046875,
            "text": "difficile infection, has emerged as a promising therapy for intestinal MDR",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.53125,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.578125,
            "text": "difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.62890625,
            "text": "difficile infection, has emerged as a promising therapy for intestinal",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.64453125,
            "text": "difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization.",
            "probability": 0.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": -7.6484375,
            "text": "difficile infection, has emerged as a promising",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_11": [
        {
            "start_logit": 7.88671875,
            "end_logit": 7.80859375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -1.505859375,
            "text": "Clostridium",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": -1.861328125,
            "end_logit": 7.80859375,
            "text": "difficile",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.02734375,
            "text": "Clostridium difficile infection (R-CDI",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.3203125,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.3671875,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.50390625,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.59375,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.65234375,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.69921875,
            "text": "Clostridium difficile infection (R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.703125,
            "text": "Clostridium difficile infection (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.765625,
            "text": "Clostridium difficile infection (R-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.80859375,
            "text": "microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.80859375,
            "text": "Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 7.80859375,
            "text": "OBJECTIVES Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.861328125,
            "end_logit": -7.02734375,
            "text": "difficile infection (R-CDI",
            "probability": 0.0
        },
        {
            "start_logit": -1.861328125,
            "end_logit": -7.3203125,
            "text": "difficile infection (R-CDI) that cannot be cured with antibiotics",
            "probability": 0.0
        },
        {
            "start_logit": -1.861328125,
            "end_logit": -7.3671875,
            "text": "difficile infection (R-CDI) that cannot be cured with antibiotics alone",
            "probability": 0.0
        },
        {
            "start_logit": -1.861328125,
            "end_logit": -7.50390625,
            "text": "difficile infection (R-CDI) that cannot be cured with antibiotics alone.",
            "probability": 0.0
        },
        {
            "start_logit": -1.861328125,
            "end_logit": -7.59375,
            "text": "difficile infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_12": [
        {
            "start_logit": 7.88671875,
            "end_logit": 7.8125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -1.4541015625,
            "text": "Clostridium",
            "probability": 9.459257125854492e-05
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": 7.8125,
            "text": "difficile",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -6.91796875,
            "text": "Clostridium difficile infection (CDI",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.8125,
            "text": "microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.66796875,
            "text": "Clostridium difficile infection (CDI).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.88671875,
            "end_logit": -7.70703125,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.8125,
            "text": "Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.8125,
            "text": "FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.8125,
            "text": "to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -1.4541015625,
            "text": "microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -6.91796875,
            "text": "difficile infection (CDI",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -1.4541015625,
            "text": "Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -7.66796875,
            "text": "difficile infection (CDI).",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -7.70703125,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -1.4541015625,
            "text": "FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -1.4541015625,
            "text": "to the gastrointestinal tract and may effectively treat patients with Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -4.8203125,
            "text": "microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -4.8203125,
            "text": "Fecal microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -6.91796875,
            "text": "microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile infection (CDI",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_13": [
        {
            "start_logit": 7.85546875,
            "end_logit": 7.80859375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -1.7431640625,
            "text": "Clostridium",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -1.92578125,
            "end_logit": 7.80859375,
            "text": "difficile",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -4.66796875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -6.98828125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.47265625,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.57421875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.58203125,
            "text": "Clostridium difficile infection (rC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.58984375,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.60546875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FM",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.61328125,
            "text": "Clostridium difficile infection (rCDI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.63671875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.66015625,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.67578125,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.85546875,
            "end_logit": -7.67578125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.92578125,
            "end_logit": -4.66796875,
            "text": "difficile infection (rCDI) by fecal microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -1.92578125,
            "end_logit": -6.98828125,
            "text": "difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool",
            "probability": 0.0
        },
        {
            "start_logit": -1.92578125,
            "end_logit": -7.47265625,
            "text": "difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor",
            "probability": 0.0
        },
        {
            "start_logit": -1.92578125,
            "end_logit": -7.57421875,
            "text": "difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool",
            "probability": 0.0
        },
        {
            "start_logit": -1.92578125,
            "end_logit": -7.58203125,
            "text": "difficile infection (rC",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_14": [
        {
            "start_logit": 7.875,
            "end_logit": 7.8125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.875,
            "end_logit": -1.607421875,
            "text": "Clostridium",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": -1.8720703125,
            "end_logit": 7.8125,
            "text": "difficile",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": 7.875,
            "end_logit": -5.74609375,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.078125,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.48046875,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.6171875,
            "text": "Clostridium difficile infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.70703125,
            "text": "Clostridium difficile infections, with potential",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.71875,
            "text": "Clostridium difficile infections, with potential applications against",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.78125,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.78515625,
            "text": "Clostridium difficile infections,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 7.8125,
            "text": "microbiota transplantation is a compelling treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8720703125,
            "end_logit": -5.74609375,
            "text": "difficile infections, with potential applications against other diseases associated with changes in gut microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -1.8720703125,
            "end_logit": -7.078125,
            "text": "difficile infections, with potential applications against other diseases associated with changes in gut",
            "probability": 0.0
        },
        {
            "start_logit": -1.8720703125,
            "end_logit": -7.48046875,
            "text": "difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8720703125,
            "end_logit": -7.6171875,
            "text": "difficile infections",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -1.607421875,
            "text": "microbiota transplantation is a compelling treatment for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.8720703125,
            "end_logit": -7.70703125,
            "text": "difficile infections, with potential",
            "probability": 0.0
        },
        {
            "start_logit": -1.8720703125,
            "end_logit": -7.71875,
            "text": "difficile infections, with potential applications against",
            "probability": 0.0
        },
        {
            "start_logit": -1.8720703125,
            "end_logit": -7.78125,
            "text": "difficile infections, with potential applications against other diseases associated with changes",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_15": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.8046875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.7490234375,
            "text": "Clostridium",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": -1.9609375,
            "end_logit": 7.8046875,
            "text": "difficile",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.52734375,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.8046875,
            "text": "microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.65234375,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.66015625,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.71484375,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.71875,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.76953125,
            "text": "Clostridium difficile infection, but well-designed,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.78125,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.81640625,
            "text": "Clostridium difficile infection,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.8046875,
            "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.8046875,
            "text": "T) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.8046875,
            "text": "FMT) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -1.7490234375,
            "text": "microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -7.52734375,
            "text": "difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -1.7490234375,
            "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -7.65234375,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -7.66015625,
            "text": "difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required.",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_16": [
        {
            "start_logit": 7.87890625,
            "end_logit": 7.83203125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -1.615234375,
            "text": "Clostridium",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -1.84765625,
            "end_logit": 7.83203125,
            "text": "difficile",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.2265625,
            "text": "Clostridium difficile infection (CDI",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.484375,
            "text": "Clostridium difficile infection (CDI) and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.63671875,
            "text": "Clostridium difficile infection (CDI) and is considered as a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.83203125,
            "text": "microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.69921875,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.7109375,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI) diseases.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.73828125,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.74609375,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI) diseases",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.78515625,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.796875,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 7.83203125,
            "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.84765625,
            "end_logit": -7.2265625,
            "text": "difficile infection (CDI",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -1.615234375,
            "text": "microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.84765625,
            "end_logit": -7.484375,
            "text": "difficile infection (CDI) and",
            "probability": 0.0
        },
        {
            "start_logit": -1.84765625,
            "end_logit": -7.63671875,
            "text": "difficile infection (CDI) and is considered as a",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -1.615234375,
            "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.84765625,
            "end_logit": -7.69921875,
            "text": "difficile infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_17": [
        {
            "start_logit": 7.875,
            "end_logit": 7.80859375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.875,
            "end_logit": -1.5712890625,
            "text": "Clostridium",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": 7.80859375,
            "text": "difficile",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.64453125,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.6875,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.6953125,
            "text": "Clostridium difficile infection with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.74609375,
            "text": "Clostridium difficile infection with ulcerative pancolitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.74609375,
            "text": "Clostridium difficile infection with ulcerative",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.80078125,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.8203125,
            "text": "Clostridium difficile infection with ulcerative pancoli",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.83203125,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.875,
            "end_logit": -7.83203125,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.80859375,
            "text": "microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.64453125,
            "text": "difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy",
            "probability": 0.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.6875,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.6953125,
            "text": "difficile infection with",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -1.5712890625,
            "text": "microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.74609375,
            "text": "difficile infection with ulcerative pancolitis",
            "probability": 0.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.74609375,
            "text": "difficile infection with ulcerative",
            "probability": 0.0
        },
        {
            "start_logit": -1.8369140625,
            "end_logit": -7.80078125,
            "text": "difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_18": [
        {
            "start_logit": 7.87109375,
            "end_logit": 7.8046875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -1.6904296875,
            "text": "Clostridium",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": -1.927734375,
            "end_logit": 7.8046875,
            "text": "difficile",
            "probability": 5.561113357543945e-05
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.5546875,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.6875,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.70703125,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.7265625,
            "text": "Clostridium difficile infection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.73828125,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.78125,
            "text": "Clostridium difficile infection and coexistent",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.78125,
            "text": "Clostridium difficile infection and coexist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.83203125,
            "text": "Clostridium difficile infection and coexistent inflammatory",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -7.9921875,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease remains",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.8046875,
            "text": "microbiota transplantation in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.8046875,
            "text": "fecal microbiota transplantation in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.927734375,
            "end_logit": -7.5546875,
            "text": "difficile infection and coexistent inflammatory bowel",
            "probability": 0.0
        },
        {
            "start_logit": -1.927734375,
            "end_logit": -7.6875,
            "text": "difficile infection and coexistent inflammatory bowel disease remains unclear",
            "probability": 0.0
        },
        {
            "start_logit": -1.927734375,
            "end_logit": -7.70703125,
            "text": "difficile infection and coexistent inflammatory bowel disease",
            "probability": 0.0
        },
        {
            "start_logit": -1.927734375,
            "end_logit": -7.7265625,
            "text": "difficile infection and",
            "probability": 0.0
        },
        {
            "start_logit": -1.927734375,
            "end_logit": -7.73828125,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.927734375,
            "end_logit": -7.78125,
            "text": "difficile infection and coexistent",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_1": [
        {
            "start_logit": -1.8779296875,
            "end_logit": 0.310302734375,
            "text": "histone deacetylase",
            "probability": 0.7568359375
        },
        {
            "start_logit": -3.84765625,
            "end_logit": 0.310302734375,
            "text": "filzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 0.1055908203125
        },
        {
            "start_logit": -4.859375,
            "end_logit": 0.310302734375,
            "text": "proteasome inhibitors (bortezomib, carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 0.03826904296875
        },
        {
            "start_logit": -5.09765625,
            "end_logit": 0.310302734375,
            "text": "deacetylase",
            "probability": 0.0301666259765625
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 0.310302734375,
            "text": "carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 0.016265869140625
        },
        {
            "start_logit": -3.84765625,
            "end_logit": -2.21484375,
            "text": "filzomib",
            "probability": 0.0084381103515625
        },
        {
            "start_logit": -6.38671875,
            "end_logit": 0.310302734375,
            "text": "zomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 0.00830841064453125
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 0.310302734375,
            "text": "bortezomib, carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 0.008209228515625
        },
        {
            "start_logit": -6.46875,
            "end_logit": 0.310302734375,
            "text": "), histone deacetylase",
            "probability": 0.007656097412109375
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 0.310302734375,
            "text": ", histone deacetylase",
            "probability": 0.004962921142578125
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 0.310302734375,
            "text": "), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 0.004825592041015625
        },
        {
            "start_logit": -7.359375,
            "end_logit": 0.310302734375,
            "text": ", carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 0.0031414031982421875
        },
        {
            "start_logit": -4.859375,
            "end_logit": -2.21484375,
            "text": "proteasome inhibitors (bortezomib, carfilzomib",
            "probability": 0.0030689239501953125
        },
        {
            "start_logit": -5.71484375,
            "end_logit": -2.21484375,
            "text": "carfilzomib",
            "probability": 0.00130462646484375
        },
        {
            "start_logit": -6.38671875,
            "end_logit": -2.21484375,
            "text": "zomib",
            "probability": 0.0006661415100097656
        },
        {
            "start_logit": -6.3984375,
            "end_logit": -2.21484375,
            "text": "bortezomib, carfilzomib",
            "probability": 0.0006613731384277344
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.15234375,
            "text": "histone deacetylase (HDAC) inhibitors (Panobinostat).",
            "probability": 0.0004334449768066406
        },
        {
            "start_logit": -6.85546875,
            "end_logit": -2.21484375,
            "text": "), proteasome inhibitors (bortezomib, carfilzomib",
            "probability": 0.00041675567626953125
        },
        {
            "start_logit": -1.8779296875,
            "end_logit": -7.26171875,
            "text": "histone deacetylase (HDAC",
            "probability": 0.0003886222839355469
        },
        {
            "start_logit": -7.359375,
            "end_logit": -2.21484375,
            "text": ", carfilzomib",
            "probability": 0.00025200843811035156
        }
    ],
    "589630f378275d0c4a000007_2": [
        {
            "start_logit": 6.43359375,
            "end_logit": 6.671875,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -6.32421875,
            "end_logit": 6.671875,
            "text": "generation proteasome",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -6.609375,
            "text": "proteasome inhibitor",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.0390625,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.671875,
            "text": "second-generation proteasome",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.671875,
            "text": "Ixazomib (MLN9708-MLN2238), the second-generation proteasome",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.765625,
            "text": "proteasome inhibitor,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.83203125,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently being investigated in phase I studies.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.99609375,
            "text": "proteasome inhibitor, selectivity and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.32421875,
            "end_logit": -6.609375,
            "text": "generation proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -6.32421875,
            "end_logit": -7.0390625,
            "text": "generation proteasome inhibitor, selectivity and potency were similar to that of bortezomib",
            "probability": 0.0
        },
        {
            "start_logit": -6.32421875,
            "end_logit": -7.765625,
            "text": "generation proteasome inhibitor,",
            "probability": 0.0
        },
        {
            "start_logit": -6.32421875,
            "end_logit": -7.83203125,
            "text": "generation proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently being investigated in phase I studies.",
            "probability": 0.0
        },
        {
            "start_logit": -6.32421875,
            "end_logit": -7.99609375,
            "text": "generation proteasome inhibitor, selectivity and",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -6.609375,
            "text": "second-generation proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -6.609375,
            "text": "Ixazomib (MLN9708-MLN2238), the second-generation proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.0390625,
            "text": "bortezomib",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -7.0390625,
            "text": "to that of bortezomib",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -7.0390625,
            "text": "second-generation proteasome inhibitor, selectivity and potency were similar to that of bortezomib",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -7.0390625,
            "text": "of bortezomib",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_3": [
        {
            "start_logit": 6.640625,
            "end_logit": 6.44921875,
            "text": "CD38",
            "probability": 1.0
        },
        {
            "start_logit": -1.0341796875,
            "end_logit": 6.44921875,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 0.0004620552062988281
        },
        {
            "start_logit": 6.640625,
            "end_logit": -6.87890625,
            "text": "CD38 and SLAMF7",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 6.44921875,
            "text": "target CD38",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.109375,
            "end_logit": 6.44921875,
            "text": "oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.32421875,
            "text": "CD38 and SLAMF7, respectively.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.44921875,
            "text": "atumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.44921875,
            "text": "first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.44921875,
            "text": "multiple myeloma: ixazomib, the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.44921875,
            "text": "that target CD38",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -8.0,
            "text": "CD38 and SLAMF7, respectively",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.44921875,
            "text": "daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.0341796875,
            "end_logit": -0.5615234375,
            "text": "proteasome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -1.0341796875,
            "end_logit": -5.9609375,
            "text": "proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -7.109375,
            "end_logit": -0.5615234375,
            "text": "oral proteasome",
            "probability": 0.0
        },
        {
            "start_logit": -1.0341796875,
            "end_logit": -6.87890625,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and SLAMF7",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -0.5615234375,
            "text": "first oral proteasome",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -0.5615234375,
            "text": "multiple myeloma: ixazomib, the first oral proteasome",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -0.5615234375,
            "text": "FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome",
            "probability": 0.0
        },
        {
            "start_logit": -1.0341796875,
            "end_logit": -7.2265625,
            "text": "proteasome inhibitor;",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_4": [
        {
            "start_logit": 6.546875,
            "end_logit": 6.62890625,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.65234375,
            "text": "proteasome inhibitor to",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.671875,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.6875,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.6953125,
            "text": "proteasome inhibitor to be",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.73046875,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.74609375,
            "text": "proteasome inhibitor to be evaluated in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.77734375,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.7890625,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.80078125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.62890625,
            "text": "first oral proteasome",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.81640625,
            "text": "proteasome inhibitor to be evaluated",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.84375,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.8515625,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 6.62890625,
            "text": "oral proteasome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -7.69140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.65234375,
            "text": "first oral proteasome inhibitor to",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.671875,
            "text": "first oral proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.6875,
            "text": "first oral proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.6953125,
            "text": "first oral proteasome inhibitor to be",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_5": [
        {
            "start_logit": 6.42578125,
            "end_logit": 6.41796875,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -3.728515625,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -4.91796875,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib, and delanzomib",
            "probability": 1.1920928955078125e-05
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -5.515625,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -5.72265625,
            "text": "proteasome inhibitors",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 6.41796875,
            "text": "generation proteasome",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -6.77734375,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib, and delanzomib.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.06640625,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomi",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.078125,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oproz",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.09375,
            "text": "proteasome inhibitors have also been used clinically, including carfil",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.19921875,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.41796875,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazo",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.55859375,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib, and delanz",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.640625,
            "text": "proteasome inhibitors have also been used clinically, including car",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.41796875,
            "text": "bortezomib in 2003, several next-generation proteasome",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.41796875,
            "text": "introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.8828125,
            "text": "proteasome inhibitors have also",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.95703125,
            "text": "proteasome inhibitors have also been used",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": -3.728515625,
            "text": "generation proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib",
            "probability": 0.0
        },
        {
            "start_logit": -6.52734375,
            "end_logit": -3.728515625,
            "text": "rozomib",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_6": [
        {
            "start_logit": 6.56640625,
            "end_logit": 6.59375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -6.01171875,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.7265625,
            "text": "proteasome inhibitor, ixazomib, in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.82421875,
            "text": "proteasome inhibitor,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.86328125,
            "text": "proteasome inhibitor, ixazomi",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.921875,
            "text": "proteasome inhibitor, ixazomib, in patients with",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.96875,
            "text": "proteasome inhibitor, ixazomib, in patients",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.97265625,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic impairment, to provide posology",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.56640625,
            "end_logit": -7.98046875,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.59375,
            "text": "AIM: The aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.59375,
            "text": ": The aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.01171875,
            "text": "hepatic",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -7.97265625,
            "text": "hepatic impairment, to provide posology",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.97265625,
            "text": "posology",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.7265625,
            "text": "AIM: The aim of the present study was to characterize the pharmacokinetics of the oral proteasome inhibitor, ixazomib, in",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.7265625,
            "text": ": The aim of the present study was to characterize the pharmacokinetics of the oral proteasome inhibitor, ixazomib, in",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.75390625,
            "text": "AIM: The aim of the present study was to characterize the pharmacokinetics of",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.75390625,
            "text": "AIM: The aim of the present study was to characterize the pharmacokinetics",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.75390625,
            "text": ": The aim of the present study was to characterize the pharmacokinetics of",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.75390625,
            "text": ": The aim of the present study was to characterize the pharmacokinetics",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_7": [
        {
            "start_logit": 6.6171875,
            "end_logit": 6.40625,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -3.1484375,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.14453125,
            "text": "proteasome inhibitor, in",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.46875,
            "text": "proteasome inhibitor",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 6.40625,
            "text": "oral proteasome",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.609375,
            "text": "proteasome inhibitor, in solid tumour patients with moderate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.6328125,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.6796875,
            "text": "proteasome inhibitor, in solid tumour",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.69921875,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.73046875,
            "text": "proteasome inhibitor, in solid tumour patients with",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.7578125,
            "text": "proteasome inhibitor, in solid",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.83984375,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.84765625,
            "text": "proteasome inhibitor, in solid tumour patients",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -8.0,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 6.40625,
            "text": "an oral proteasome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.859375,
            "end_logit": -3.1484375,
            "text": "hepatic",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -3.1484375,
            "text": "oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -3.1484375,
            "text": "an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic",
            "probability": 0.0
        },
        {
            "start_logit": -5.859375,
            "end_logit": -7.6328125,
            "text": "hepatic impairment",
            "probability": 0.0
        },
        {
            "start_logit": -5.859375,
            "end_logit": -8.0,
            "text": "hepatic impairment.",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_8": [
        {
            "start_logit": 6.09765625,
            "end_logit": 6.31640625,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -7.2109375,
            "text": "proteasome inhibitor",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.31640625,
            "text": ", proteasome",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -7.4140625,
            "text": "proteasome inhibitor to reach phase III trials.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -7.77734375,
            "text": "proteasome inhibitor to",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.31640625,
            "text": "first oral, proteasome",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.31640625,
            "text": "oral, proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.31640625,
            "text": "Ixazomib is the first oral, proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -7.9453125,
            "text": "proteasome inhibitor to reach phase III",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -7.9921875,
            "text": "proteasome inhibitor to reach phase III trials",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -8.0390625,
            "text": "proteasome inhibitor to reach",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -8.125,
            "text": "proteasome inhibitor to reach phase",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.2109375,
            "text": ", proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -7.4140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.4140625,
            "text": ", proteasome inhibitor to reach phase III trials.",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.2109375,
            "text": "first oral, proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.2109375,
            "text": "oral, proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -7.2109375,
            "text": "Ixazomib is the first oral, proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.77734375,
            "text": ", proteasome inhibitor to",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.4140625,
            "text": "first oral, proteasome inhibitor to reach phase III trials.",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_9": [
        {
            "start_logit": 6.53125,
            "end_logit": 6.40625,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.53125,
            "end_logit": -6.984375,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.10546875,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.21875,
            "end_logit": 6.40625,
            "text": "MLN2238 (ixazomib), an oral proteasome",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.453125,
            "end_logit": 6.40625,
            "text": "oral proteasome",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -7.65625,
            "text": "proteasome inhibitor",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -8.015625,
            "text": "proteasome inhibitor, has improved pharmac",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -8.0234375,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.40625,
            "text": "ixazomib), an oral proteasome",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.40625,
            "text": "an oral proteasome",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -8.1015625,
            "text": "proteasome inhibitor,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.40625,
            "text": ", an oral proteasome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -8.15625,
            "text": "proteasome inhibitor, has",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -8.171875,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53125,
            "end_logit": -8.1796875,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": -6.984375,
            "text": "MLN2238 (ixazomib), an oral proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -7.10546875,
            "text": "MLN2238 (ixazomib), an oral proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib.",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -6.984375,
            "text": "oral proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -7.10546875,
            "text": "oral proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib.",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -7.48046875,
            "text": "MLN223",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_10": [
        {
            "start_logit": 6.53515625,
            "end_logit": 6.62109375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.60546875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to fixed dosing, and the impact of",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.6953125,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.7109375,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to fixed dosing, and the impact of baseline covariates",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.7421875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.76171875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.765625,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.80078125,
            "text": "proteasome inhibitor ixazomi",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.84765625,
            "text": "proteasome inhibitor ixazomib",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.84765625,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to fixed dosing,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.87890625,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to fixed",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.53515625,
            "end_logit": -7.88671875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.62109375,
            "text": "population pharmacokinetic analysis of the investigational oral proteasome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": -7.01171875,
            "text": "ixazomib pharmacokinetics",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.40234375,
            "text": "population pharmacokinetic",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -7.4296875,
            "text": "ixazomib",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.6953125,
            "text": "population pharmacokinetic analysis of the investigational oral proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.7421875,
            "text": "population pharmacokinetic analysis of the investigational oral proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.76171875,
            "text": "population pharmacokinetic analysis of the investigational oral proteasome inhibitor ixazomib assessed the feasibility of",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.765625,
            "text": "population pharmacokinetic analysis of the investigational oral proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)",
            "probability": 0.0
        }
    ],
    "55201a316b348bb82c000019_1": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.65234375,
            "text": "55 S",
            "probability": 1.0
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -1.244140625,
            "text": "55",
            "probability": 0.00013768672943115234
        },
        {
            "start_logit": -2.36328125,
            "end_logit": 7.65234375,
            "text": "S",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -4.21875,
            "text": "55 S, consisting of 39 S large and 28 S",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -4.75390625,
            "text": "55 S, consisting of 39 S large and 28 S small subunits.",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -4.77734375,
            "text": "55 S, consisting of 39 S",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 7.65234375,
            "text": "mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.5078125,
            "text": "55 S,",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.95703125,
            "text": "55 S, consisting of 39 S large and 28 S small subunits",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.125,
            "text": "55 S, consisting of 39 S large and 28 S small",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.65234375,
            "text": "ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.65234375,
            "text": "small sedimentation coefficient of 55 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.65234375,
            "text": "sedimentation coefficient of 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 7.65234375,
            "text": "a small sedimentation coefficient of 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 7.65234375,
            "text": "The mammalian mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.65234375,
            "text": "of 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.36328125,
            "end_logit": -4.21875,
            "text": "S, consisting of 39 S large and 28 S",
            "probability": 0.0
        },
        {
            "start_logit": -2.36328125,
            "end_logit": -4.75390625,
            "text": "S, consisting of 39 S large and 28 S small subunits.",
            "probability": 0.0
        },
        {
            "start_logit": -2.36328125,
            "end_logit": -4.77734375,
            "text": "S, consisting of 39 S",
            "probability": 0.0
        },
        {
            "start_logit": -6.13671875,
            "end_logit": -1.244140625,
            "text": "mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55",
            "probability": 0.0
        }
    ],
    "55201a316b348bb82c000019_2": [
        {
            "start_logit": 7.96875,
            "end_logit": 6.8046875,
            "text": "55 S",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.96875,
            "end_logit": 0.1162109375,
            "text": "55",
            "probability": 0.0012454986572265625
        },
        {
            "start_logit": -3.78515625,
            "end_logit": 6.8046875,
            "text": "S",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -6.3125,
            "text": "55 S mammalian mitochondrial ribosome (",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -6.96875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.01953125,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich,",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.28515625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.31640625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.375,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.38671875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice as",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.42578125,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.47265625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice as much protein",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.51953125,
            "text": "55 S mammalian mitochondrial ribosome (referred to",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.5625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribos",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.578125,
            "text": "55 S mammalian mitochondrial ribosome",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -7.58984375,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice as much",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 6.8046875,
            "text": "The 55 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 0.1162109375,
            "text": "The 55",
            "probability": 0.0
        },
        {
            "start_logit": -3.78515625,
            "end_logit": -6.3125,
            "text": "S mammalian mitochondrial ribosome (",
            "probability": 0.0
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -2.9140625,
            "text": "nearly twice as much protein as the Escherichia coli ribosome.",
            "probability": 0.0
        }
    ],
    "55201a316b348bb82c000019_3": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.77734375,
            "text": "55 S",
            "probability": 1.0
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -1.6708984375,
            "text": "55",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -2.123046875,
            "end_logit": 7.77734375,
            "text": "S",
            "probability": 4.684925079345703e-05
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.140625,
            "text": "55 S.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 7.77734375,
            "text": "about 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.77734375,
            "text": "intact monosome was about 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.77734375,
            "text": "ome was about 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.123046875,
            "end_logit": -7.140625,
            "text": "S.",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -1.6708984375,
            "text": "about 55",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -1.6708984375,
            "text": "intact monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -1.6708984375,
            "text": "ome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -7.140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.140625,
            "text": "about 55 S.",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.140625,
            "text": "intact monosome was about 55 S.",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.140625,
            "text": "ome was about 55 S.",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.47265625,
            "text": "intact monosome was",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.47265625,
            "text": "ome was",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.60546875,
            "text": "intact monos",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.96484375,
            "text": "about",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.91015625,
            "text": "intact",
            "probability": 0.0
        }
    ],
    "5e2a1096aa19d7443100000e_1": [
        {
            "start_logit": 7.92578125,
            "end_logit": 5.94140625,
            "text": "vascular endothelial growth factor A",
            "probability": 0.8505859375
        },
        {
            "start_logit": 7.92578125,
            "end_logit": 4.1953125,
            "text": "vascular endothelial growth factor",
            "probability": 0.14892578125
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -1.91015625,
            "text": "vascular",
            "probability": 0.00033092498779296875
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -5.62109375,
            "text": "vascular endothelial growth",
            "probability": 8.106231689453125e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -5.921875,
            "text": "vascular endothelial growth factor A (VEGF-A)",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.4765625,
            "text": "vascular endothelial",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -4.79296875,
            "end_logit": 5.94140625,
            "text": "A",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -4.8671875,
            "end_logit": 5.94140625,
            "text": "modified mRNA encoding vascular endothelial growth factor A",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.0078125,
            "text": "vascular endothelial growth factor A (VEGF-A), in vivo.",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -5.0390625,
            "end_logit": 5.94140625,
            "text": "factor A",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.21875,
            "text": "vascular endothelial growth factor A (VEGF-A",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.58984375,
            "text": "vascular endothelial growth factor A (VEGF-A), in vivo",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.609375,
            "text": "vascular endothelial growth factor A (VEGF",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -7.87890625,
            "text": "vascular endothelial growth factor A (VEGF-",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 5.94140625,
            "text": "endothelial growth factor A",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.5,
            "end_logit": 5.94140625,
            "text": "encoding vascular endothelial growth factor A",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 5.94140625,
            "text": "mRNA encoding vascular endothelial growth factor A",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.8671875,
            "end_logit": 4.1953125,
            "text": "modified mRNA encoding vascular endothelial growth factor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.0390625,
            "end_logit": 4.1953125,
            "text": "factor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 5.94140625,
            "text": "growth factor A",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5caa0247ecadf2e73f000055_1": [
        {
            "start_logit": 7.65625,
            "end_logit": 7.453125,
            "text": "moesin",
            "probability": 1.0
        },
        {
            "start_logit": 7.65625,
            "end_logit": -2.662109375,
            "text": "mo",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": -2.654296875,
            "end_logit": 7.453125,
            "text": "esin",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": 7.65625,
            "end_logit": -6.5546875,
            "text": "moesin (Moe).",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.53125,
            "end_logit": 7.453125,
            "text": "Crb recruitment of moesin",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 7.453125,
            "text": "b recruitment of moesin",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.453125,
            "text": "of moesin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.453125,
            "text": "recruitment of moesin",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 7.453125,
            "text": "propose is mediated by Crb recruitment of moesin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.453125,
            "text": "cell apical constriction and for organising an actomyosin complex, which we propose is mediated by Crb recruitment of moesin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.453125,
            "text": "actomyosin complex, which we propose is mediated by Crb recruitment of moesin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.453125,
            "text": "is required for tracheal cell apical constriction and for organising an actomyosin complex, which we propose is mediated by Crb recruitment of moesin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.65625,
            "end_logit": -7.78515625,
            "text": "moesin (Mo",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.65625,
            "end_logit": -8.0859375,
            "text": "moesin (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.53125,
            "end_logit": -2.662109375,
            "text": "Crb recruitment of mo",
            "probability": 0.0
        },
        {
            "start_logit": -2.654296875,
            "end_logit": -6.5546875,
            "text": "esin (Moe).",
            "probability": 0.0
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -2.662109375,
            "text": "b recruitment of mo",
            "probability": 0.0
        },
        {
            "start_logit": -6.92578125,
            "end_logit": -2.662109375,
            "text": "of mo",
            "probability": 0.0
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -2.662109375,
            "text": "recruitment of mo",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -2.662109375,
            "text": "propose is mediated by Crb recruitment of mo",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_1": [
        {
            "start_logit": 7.953125,
            "end_logit": 8.0234375,
            "text": "Cervical Artery Dissection in Stroke",
            "probability": 1.0
        },
        {
            "start_logit": -1.4970703125,
            "end_logit": 8.0234375,
            "text": "Stroke",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -1.7001953125,
            "text": "Cervical",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -4.03515625,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 7.953125,
            "end_logit": -4.6328125,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.953125,
            "end_logit": -5.734375,
            "text": "Cervical Artery Dissection",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.953125,
            "end_logit": -5.765625,
            "text": "Cervical Artery Dissection in",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.125,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 8.0234375,
            "text": "Artery Dissection in Stroke",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 8.0234375,
            "text": "Dissection in Stroke",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.765625,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.87890625,
            "text": "Cervical Artery",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 8.0234375,
            "text": "in Stroke",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.41015625,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.0234375,
            "text": "the Cervical Artery Dissection in Stroke",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.0234375,
            "text": "nonrandomized arm of the Cervical Artery Dissection in Stroke",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.6484375,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.66015625,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.7421875,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 8.0234375,
            "text": "OBJECTIVE: To present the results of the nonrandomized arm of the Cervical Artery Dissection in Stroke",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e4604d83f54159529000003_2": [
        {
            "start_logit": 5.1875,
            "end_logit": 7.7421875,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.318359375,
            "end_logit": 7.7421875,
            "text": "dissection",
            "probability": 0.0005483627319335938
        },
        {
            "start_logit": -3.419921875,
            "end_logit": 7.7421875,
            "text": "artery dissection",
            "probability": 0.00018227100372314453
        },
        {
            "start_logit": -4.98046875,
            "end_logit": 7.7421875,
            "text": "vertebral artery dissection",
            "probability": 3.814697265625e-05
        },
        {
            "start_logit": -6.484375,
            "end_logit": 7.7421875,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 7.7421875,
            "text": ") carotid and vertebral artery dissection",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 5.1875,
            "end_logit": -5.1484375,
            "text": "carotid",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 7.7421875,
            "text": ": CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 7.7421875,
            "text": "AIMS: CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 5.1875,
            "end_logit": -7.2890625,
            "text": "carotid and vertebral artery dissection.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.1875,
            "end_logit": -7.84765625,
            "text": "carotid and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.318359375,
            "end_logit": -7.2890625,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -3.419921875,
            "end_logit": -7.2890625,
            "text": "artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -5.1484375,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -4.98046875,
            "end_logit": -7.2890625,
            "text": "vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -5.1484375,
            "text": ") carotid",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -5.1484375,
            "text": ": CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -5.1484375,
            "text": "AIMS: CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -7.2890625,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -7.7109375,
            "text": "acute (within 7 days of",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_3": [
        {
            "start_logit": 5.7578125,
            "end_logit": 7.7109375,
            "text": "carotid and vertebral artery dissection",
            "probability": 1.0
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 7.7109375,
            "text": "dissection",
            "probability": 0.0002961158752441406
        },
        {
            "start_logit": -3.498046875,
            "end_logit": 7.7109375,
            "text": "artery dissection",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": -4.62109375,
            "end_logit": 7.7109375,
            "text": "vertebral artery dissection",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 7.7109375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -4.76953125,
            "text": "carotid",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.7109375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.7109375,
            "text": "AIMS  CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.18359375,
            "text": "carotid and vertebral artery dissection.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.94921875,
            "text": "carotid and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.37109375,
            "end_logit": -7.18359375,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -3.498046875,
            "end_logit": -7.18359375,
            "text": "artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -4.76953125,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -7.18359375,
            "text": "vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -4.76953125,
            "text": ") carotid",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -4.76953125,
            "text": "AIMS  CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.18359375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.67578125,
            "text": "acute (within 7 days of",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.81640625,
            "text": "acute (",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.87109375,
            "text": "acute (within",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_4": [
        {
            "start_logit": 5.7578125,
            "end_logit": 7.7109375,
            "text": "carotid and vertebral artery dissection",
            "probability": 1.0
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 7.7109375,
            "text": "dissection",
            "probability": 0.0002961158752441406
        },
        {
            "start_logit": -3.498046875,
            "end_logit": 7.7109375,
            "text": "artery dissection",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": -4.62109375,
            "end_logit": 7.7109375,
            "text": "vertebral artery dissection",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 7.7109375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -4.76953125,
            "text": "carotid",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.7109375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.7109375,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.18359375,
            "text": "carotid and vertebral artery dissection.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.94921875,
            "text": "carotid and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.37109375,
            "end_logit": -7.18359375,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -3.498046875,
            "end_logit": -7.18359375,
            "text": "artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -4.76953125,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -7.18359375,
            "text": "vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -4.76953125,
            "text": ") carotid",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -4.76953125,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.18359375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.67578125,
            "text": "acute (within 7 days of",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.81640625,
            "text": "acute (",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.87109375,
            "text": "acute (within",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_5": [
        {
            "start_logit": 7.953125,
            "end_logit": 8.046875,
            "text": "Cervical Artery Dissection in Stroke",
            "probability": 1.0
        },
        {
            "start_logit": -1.400390625,
            "end_logit": 8.046875,
            "text": "Stroke",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -1.685546875,
            "text": "Cervical",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -3.23046875,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": 7.953125,
            "end_logit": -4.8203125,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 7.953125,
            "end_logit": -5.390625,
            "text": "Cervical Artery Dissection",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 7.953125,
            "end_logit": -5.68359375,
            "text": "Cervical Artery Dissection in",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 8.046875,
            "text": "Artery Dissection in Stroke",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.546875,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 8.046875,
            "text": "Dissection in Stroke",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.7734375,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -6.78125,
            "text": "Cervical Artery",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 8.046875,
            "text": "in Stroke",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 8.046875,
            "text": "nonrandomized arm of the Cervical Artery Dissection in Stroke",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.31640625,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.046875,
            "text": "the Cervical Artery Dissection in Stroke",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.59375,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.64453125,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.64453125,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.67578125,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e4604d83f54159529000003_6": [
        {
            "start_logit": 5.7578125,
            "end_logit": 7.7109375,
            "text": "carotid and vertebral artery dissection",
            "probability": 1.0
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 7.7109375,
            "text": "dissection",
            "probability": 0.0002961158752441406
        },
        {
            "start_logit": -3.498046875,
            "end_logit": 7.7109375,
            "text": "artery dissection",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": -4.62109375,
            "end_logit": 7.7109375,
            "text": "vertebral artery dissection",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 7.7109375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -4.76953125,
            "text": "carotid",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.7109375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.7109375,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.18359375,
            "text": "carotid and vertebral artery dissection.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.94921875,
            "text": "carotid and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.37109375,
            "end_logit": -7.18359375,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -3.498046875,
            "end_logit": -7.18359375,
            "text": "artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -4.76953125,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -7.18359375,
            "text": "vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -4.76953125,
            "text": ") carotid",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -4.76953125,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.18359375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.67578125,
            "text": "acute (within 7 days of",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.81640625,
            "text": "acute (",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -7.87109375,
            "text": "acute (within",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_7": [
        {
            "start_logit": 5.59375,
            "end_logit": 7.6953125,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.37890625,
            "end_logit": 7.6953125,
            "text": "dissection",
            "probability": 0.0003445148468017578
        },
        {
            "start_logit": -3.3203125,
            "end_logit": 7.6953125,
            "text": "artery dissection",
            "probability": 0.00013434886932373047
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 7.6953125,
            "text": "vertebral artery dissection",
            "probability": 3.063678741455078e-05
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 7.6953125,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": 5.59375,
            "end_logit": -4.9453125,
            "text": "carotid",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.6953125,
            "text": ") carotid and vertebral artery dissection",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 5.59375,
            "end_logit": -7.14453125,
            "text": "carotid and vertebral artery dissection.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.59375,
            "end_logit": -7.890625,
            "text": "carotid and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.37890625,
            "end_logit": -7.14453125,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -3.3203125,
            "end_logit": -7.14453125,
            "text": "artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -4.9453125,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -7.14453125,
            "text": "vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -4.9453125,
            "text": ") carotid",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -7.14453125,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -7.69921875,
            "text": "acute (within 7 days of",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -7.890625,
            "text": "acute (within 7 days of onset) carotid and",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -7.90625,
            "text": "acute (",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -7.9453125,
            "text": "acute (within",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -7.95703125,
            "text": "acute (within 7",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_8": [
        {
            "start_logit": 7.95703125,
            "end_logit": 8.046875,
            "text": "Cervical Artery Dissection in Stroke",
            "probability": 1.0
        },
        {
            "start_logit": -1.404296875,
            "end_logit": 8.046875,
            "text": "Stroke",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -1.6767578125,
            "text": "Cervical",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -3.51953125,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -4.765625,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -5.375,
            "text": "Cervical Artery Dissection",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -5.70703125,
            "text": "Cervical Artery Dissection in",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 8.046875,
            "text": "Artery Dissection in Stroke",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.55859375,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 8.046875,
            "text": "Dissection in Stroke",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.75390625,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.80859375,
            "text": "Cervical Artery",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 8.046875,
            "text": "in Stroke",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.27734375,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.046875,
            "text": "nonrandomized arm of the Cervical Artery Dissection in Stroke",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.046875,
            "text": "the Cervical Artery Dissection in Stroke",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.67578125,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.6796875,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.74609375,
            "text": "Cervical Artery Dissection in Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.404296875,
            "end_logit": -3.51953125,
            "text": "Stroke Study (CADISS-NR) trial, comparing anticoagulation and antiplatelets for prevention of recurrent stroke after carotid and vertebral dissection",
            "probability": 0.0
        }
    ],
    "56c073fcef6e394741000020_1": [
        {
            "start_logit": 5.2734375,
            "end_logit": 4.30859375,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity.",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.279296875,
            "end_logit": 4.30859375,
            "text": ".",
            "probability": 0.0005273818969726562
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -4.984375,
            "text": "Spermidine",
            "probability": 9.232759475708008e-05
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -5.23046875,
            "text": "Spermidine protects against",
            "probability": 7.2479248046875e-05
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -6.703125,
            "text": "Spermidine protects",
            "probability": 1.6570091247558594e-05
        },
        {
            "start_logit": -5.77734375,
            "end_logit": 4.30859375,
            "text": "protects against \u03b1-synuclein neurotoxicity.",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 4.30859375,
            "text": "\u03b1-synuclein neurotoxicity.",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 4.30859375,
            "text": "synuclein neurotoxicity.",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -8.046875,
            "text": "Spermidine protects against \u03b1-",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -8.0546875,
            "text": "Spermidine protects against \u03b1-synuclein",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 5.2734375,
            "end_logit": -8.140625,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -7.1875,
            "end_logit": 4.30859375,
            "text": "neurotoxicity.",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 4.30859375,
            "text": "against \u03b1-synuclein neurotoxicity.",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.375,
            "end_logit": 4.30859375,
            "text": "-synuclein neurotoxicity.",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -5.77734375,
            "end_logit": -5.23046875,
            "text": "protects against",
            "probability": 0.0
        },
        {
            "start_logit": -5.77734375,
            "end_logit": -6.703125,
            "text": "protects",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -5.23046875,
            "text": "against",
            "probability": 0.0
        },
        {
            "start_logit": -5.77734375,
            "end_logit": -8.046875,
            "text": "protects against \u03b1-",
            "probability": 0.0
        },
        {
            "start_logit": -5.77734375,
            "end_logit": -8.0546875,
            "text": "protects against \u03b1-synuclein",
            "probability": 0.0
        },
        {
            "start_logit": -5.77734375,
            "end_logit": -8.140625,
            "text": "protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.0
        }
    ],
    "56c073fcef6e394741000020_2": [
        {
            "start_logit": 0.2086181640625,
            "end_logit": -3.955078125,
            "text": "Spermidine protects against",
            "probability": 0.64501953125
        },
        {
            "start_logit": 0.2086181640625,
            "end_logit": -5.12890625,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.1990966796875
        },
        {
            "start_logit": 0.2086181640625,
            "end_logit": -5.875,
            "text": "Spermidine protects",
            "probability": 0.09442138671875
        },
        {
            "start_logit": 0.2086181640625,
            "end_logit": -7.1875,
            "text": "Spermidine",
            "probability": 0.025421142578125
        },
        {
            "start_logit": 0.2086181640625,
            "end_logit": -8.125,
            "text": "Spermidine protects against \u03b1-",
            "probability": 0.00995635986328125
        },
        {
            "start_logit": 0.2086181640625,
            "end_logit": -8.1328125,
            "text": "Spermidine protects against \u03b1-synuclein",
            "probability": 0.0098724365234375
        },
        {
            "start_logit": 0.2086181640625,
            "end_logit": -8.1796875,
            "text": "Spermidine protects against \u03b1",
            "probability": 0.00942230224609375
        },
        {
            "start_logit": -5.03125,
            "end_logit": -3.955078125,
            "text": "protects against",
            "probability": 0.00342559814453125
        },
        {
            "start_logit": -5.03125,
            "end_logit": -5.12890625,
            "text": "protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.0010614395141601562
        },
        {
            "start_logit": -5.03125,
            "end_logit": -5.875,
            "text": "protects",
            "probability": 0.0005011558532714844
        },
        {
            "start_logit": -7.28125,
            "end_logit": -3.955078125,
            "text": "against",
            "probability": 0.0003612041473388672
        },
        {
            "start_logit": -6.5078125,
            "end_logit": -5.12890625,
            "text": "synuclein neurotoxicity",
            "probability": 0.00024056434631347656
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -5.12890625,
            "text": "\u03b1-synuclein neurotoxicity",
            "probability": 0.00024056434631347656
        },
        {
            "start_logit": -7.1171875,
            "end_logit": -5.12890625,
            "text": "-synuclein neurotoxicity",
            "probability": 0.00013124942779541016
        },
        {
            "start_logit": -7.28125,
            "end_logit": -5.12890625,
            "text": "against \u03b1-synuclein neurotoxicity",
            "probability": 0.00011229515075683594
        },
        {
            "start_logit": -5.03125,
            "end_logit": -8.125,
            "text": "protects against \u03b1-",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": -5.03125,
            "end_logit": -8.1328125,
            "text": "protects against \u03b1-synuclein",
            "probability": 5.221366882324219e-05
        },
        {
            "start_logit": -5.03125,
            "end_logit": -8.1796875,
            "text": "protects against \u03b1",
            "probability": 4.982948303222656e-05
        },
        {
            "start_logit": -6.5078125,
            "end_logit": -8.1328125,
            "text": "synuclein",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -8.125,
            "text": "\u03b1-",
            "probability": 1.2040138244628906e-05
        }
    ],
    "606074ab94d57fd87900003e_1": [
        {
            "start_logit": 7.953125,
            "end_logit": 7.9375,
            "text": "Rtpca",
            "probability": 1.0
        },
        {
            "start_logit": 7.953125,
            "end_logit": -1.505859375,
            "text": "Rt",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -1.6787109375,
            "end_logit": 7.9375,
            "text": "a",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": -5.78515625,
            "end_logit": 7.9375,
            "text": "pca",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.07421875,
            "text": "Rtpc",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.66796875,
            "text": "Rtpca:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.74609375,
            "text": "Rtpca: an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -7.91796875,
            "text": "Rtpca: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -8.0390625,
            "text": "Rtpca: an R package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -8.1328125,
            "text": "Rtpca: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -8.171875,
            "text": "Rtpca: an R package for differential",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -8.1796875,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -8.21875,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -8.2265625,
            "text": "Rtpca: an R package for differential thermal proximity coaggreg",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -8.234375,
            "text": "Rtpca: an R package for differential thermal proximity coaggr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.953125,
            "end_logit": -8.3046875,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation analysis.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6787109375,
            "end_logit": -7.66796875,
            "text": "a:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6787109375,
            "end_logit": -7.74609375,
            "text": "a: an",
            "probability": 0.0
        },
        {
            "start_logit": -1.6787109375,
            "end_logit": -7.91796875,
            "text": "a: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": -1.6787109375,
            "end_logit": -8.0390625,
            "text": "a: an R package",
            "probability": 0.0
        }
    ],
    "606074ab94d57fd87900003e_2": [
        {
            "start_logit": 7.984375,
            "end_logit": 7.98046875,
            "text": "Rtpca",
            "probability": 0.255859375
        },
        {
            "start_logit": 7.96875,
            "end_logit": 7.96484375,
            "text": "Rtpca",
            "probability": 0.248046875
        },
        {
            "start_logit": 7.96875,
            "end_logit": 7.97265625,
            "text": "Rtpca",
            "probability": 0.248046875
        },
        {
            "start_logit": 7.96875,
            "end_logit": 7.96484375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 0.248046875
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.7099609375,
            "text": "Rt",
            "probability": 4.214048385620117e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.7099609375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rt",
            "probability": 4.214048385620117e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.72021484375,
            "text": "Rt",
            "probability": 4.184246063232422e-05
        },
        {
            "start_logit": 7.984375,
            "end_logit": -0.791015625,
            "text": "Rt",
            "probability": 3.9577484130859375e-05
        },
        {
            "start_logit": -1.1171875,
            "end_logit": 7.97265625,
            "text": "a",
            "probability": 2.8312206268310547e-05
        },
        {
            "start_logit": -1.1171875,
            "end_logit": 7.96484375,
            "text": "a is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": -1.140625,
            "end_logit": 7.96484375,
            "text": "a",
            "probability": 2.7418136596679688e-05
        },
        {
            "start_logit": -1.1552734375,
            "end_logit": 7.98046875,
            "text": "a",
            "probability": 2.7418136596679688e-05
        },
        {
            "start_logit": -4.9453125,
            "end_logit": 7.96484375,
            "text": "pca",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.125,
            "end_logit": 7.97265625,
            "text": "pca",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.125,
            "end_logit": 7.96484375,
            "text": "pca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.30078125,
            "end_logit": 7.98046875,
            "text": "pca",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.5078125,
            "text": "Rtpc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.5078125,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.70703125,
            "text": "Rtpc",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.921875,
            "end_logit": 7.97265625,
            "text": "packages.AVAILABILITY: Rtpca",
            "probability": 2.384185791015625e-07
        }
    ],
    "606074ab94d57fd87900003e_3": [
        {
            "start_logit": 7.984375,
            "end_logit": 7.98046875,
            "text": "Rtpca",
            "probability": 0.255859375
        },
        {
            "start_logit": 7.96875,
            "end_logit": 7.96484375,
            "text": "Rtpca",
            "probability": 0.248046875
        },
        {
            "start_logit": 7.96875,
            "end_logit": 7.97265625,
            "text": "Rtpca",
            "probability": 0.248046875
        },
        {
            "start_logit": 7.96875,
            "end_logit": 7.96484375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 0.248046875
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.7099609375,
            "text": "Rt",
            "probability": 4.214048385620117e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.7099609375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rt",
            "probability": 4.214048385620117e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.72021484375,
            "text": "Rt",
            "probability": 4.184246063232422e-05
        },
        {
            "start_logit": 7.984375,
            "end_logit": -0.791015625,
            "text": "Rt",
            "probability": 3.9577484130859375e-05
        },
        {
            "start_logit": -1.1171875,
            "end_logit": 7.97265625,
            "text": "a",
            "probability": 2.8312206268310547e-05
        },
        {
            "start_logit": -1.1171875,
            "end_logit": 7.96484375,
            "text": "a is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": -1.140625,
            "end_logit": 7.96484375,
            "text": "a",
            "probability": 2.7418136596679688e-05
        },
        {
            "start_logit": -1.1552734375,
            "end_logit": 7.98046875,
            "text": "a",
            "probability": 2.7418136596679688e-05
        },
        {
            "start_logit": -4.9453125,
            "end_logit": 7.96484375,
            "text": "pca",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.125,
            "end_logit": 7.97265625,
            "text": "pca",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.125,
            "end_logit": 7.96484375,
            "text": "pca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.30078125,
            "end_logit": 7.98046875,
            "text": "pca",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.5078125,
            "text": "Rtpc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.5078125,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.70703125,
            "text": "Rtpc",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.921875,
            "end_logit": 7.97265625,
            "text": "packages.AVAILABILITY: Rtpca",
            "probability": 2.384185791015625e-07
        }
    ],
    "606074ab94d57fd87900003e_4": [
        {
            "start_logit": 7.984375,
            "end_logit": 7.98046875,
            "text": "Rtpca",
            "probability": 0.255859375
        },
        {
            "start_logit": 7.96875,
            "end_logit": 7.96484375,
            "text": "Rtpca",
            "probability": 0.248046875
        },
        {
            "start_logit": 7.96875,
            "end_logit": 7.97265625,
            "text": "Rtpca",
            "probability": 0.248046875
        },
        {
            "start_logit": 7.96875,
            "end_logit": 7.96484375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 0.248046875
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.7099609375,
            "text": "Rt",
            "probability": 4.214048385620117e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.7099609375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rt",
            "probability": 4.214048385620117e-05
        },
        {
            "start_logit": 7.96875,
            "end_logit": -0.72021484375,
            "text": "Rt",
            "probability": 4.184246063232422e-05
        },
        {
            "start_logit": 7.984375,
            "end_logit": -0.791015625,
            "text": "Rt",
            "probability": 3.9577484130859375e-05
        },
        {
            "start_logit": -1.1171875,
            "end_logit": 7.97265625,
            "text": "a",
            "probability": 2.8312206268310547e-05
        },
        {
            "start_logit": -1.1171875,
            "end_logit": 7.96484375,
            "text": "a is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": -1.140625,
            "end_logit": 7.96484375,
            "text": "a",
            "probability": 2.7418136596679688e-05
        },
        {
            "start_logit": -1.1552734375,
            "end_logit": 7.98046875,
            "text": "a",
            "probability": 2.7418136596679688e-05
        },
        {
            "start_logit": -4.9453125,
            "end_logit": 7.96484375,
            "text": "pca",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.125,
            "end_logit": 7.97265625,
            "text": "pca",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.125,
            "end_logit": 7.96484375,
            "text": "pca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.30078125,
            "end_logit": 7.98046875,
            "text": "pca",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.5078125,
            "text": "Rtpc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.5078125,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96875,
            "end_logit": -5.70703125,
            "text": "Rtpc",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.921875,
            "end_logit": 7.97265625,
            "text": "packages.AVAILABILITY: Rtpca",
            "probability": 2.384185791015625e-07
        }
    ],
    "602598301cb411341a0000b0_1": [
        {
            "start_logit": 7.9765625,
            "end_logit": 7.875,
            "text": "disease-modifying antirheumatic drugs",
            "probability": 1.0
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -1.7724609375,
            "text": "disease",
            "probability": 6.455183029174805e-05
        },
        {
            "start_logit": -2.0390625,
            "end_logit": 7.875,
            "text": "drugs",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": -5.1171875,
            "end_logit": 7.875,
            "text": "conventional synthetic disease-modifying antirheumatic drugs",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.02734375,
            "end_logit": 7.875,
            "text": "matic drugs",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.125,
            "end_logit": 7.875,
            "text": "modifying antirheumatic drugs",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.1796875,
            "end_logit": 7.875,
            "text": "-modifying antirheumatic drugs",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 7.875,
            "text": "eumatic drugs",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 7.875,
            "text": "rheumatic drugs",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 7.875,
            "text": "antirheumatic drugs",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.8515625,
            "text": "disease-modifying antirheumatic",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.04296875,
            "text": "disease-modifying",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.10546875,
            "text": "disease-modifying anti",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 7.875,
            "text": "synthetic disease-modifying antirheumatic drugs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.390625,
            "text": "disease-modifying antirheumatic drugs (csDMARDS) achieve similar clinical benefits more cheaply than high-cost biologics",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 7.875,
            "text": "combinations of conventional synthetic disease-modifying antirheumatic drugs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.703125,
            "text": "disease-modifying antirheumatic drugs (csDMARDS) achieve similar",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -7.71875,
            "text": "disease-modifying antirheumatic drugs (csDMARDS) achieve similar clinical benefits more cheaply than high",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.1171875,
            "end_logit": -1.7724609375,
            "text": "conventional synthetic disease",
            "probability": 0.0
        },
        {
            "start_logit": -2.0390625,
            "end_logit": -6.12890625,
            "text": "drugs (csDMARDS) achieve similar clinical benefits more cheaply than high-cost biologics such as tumor necrosis factor inhibitors (TNF",
            "probability": 0.0
        }
    ],
    "513ce494bee46bd34c000009_1": [
        {
            "start_logit": 7.796875,
            "end_logit": 7.8125,
            "text": "autosomal dominant polycystic kidney disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": 7.8125,
            "text": "disease",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": 7.796875,
            "end_logit": -2.427734375,
            "text": "autosomal",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": -4.83984375,
            "end_logit": 7.8125,
            "text": "polycystic kidney disease",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 7.796875,
            "end_logit": -5.734375,
            "text": "autosomal dominant",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.796875,
            "end_logit": -5.83984375,
            "text": "autosomal dominant polycystic kidney",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 7.8125,
            "text": "kidney disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.796875,
            "end_logit": -6.87109375,
            "text": "autosomal dominant polycystic",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 7.8125,
            "text": "dominant polycystic kidney disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.83984375,
            "end_logit": -5.83984375,
            "text": "polycystic kidney",
            "probability": 0.0
        },
        {
            "start_logit": -4.83984375,
            "end_logit": -6.87109375,
            "text": "polycystic",
            "probability": 0.0
        },
        {
            "start_logit": -6.8671875,
            "end_logit": -5.83984375,
            "text": "kidney",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -5.734375,
            "text": "dominant",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -5.83984375,
            "text": "dominant polycystic kidney",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -6.87109375,
            "text": "dominant polycystic",
            "probability": 0.0
        }
    ],
    "513ce494bee46bd34c000009_2": [
        {
            "start_logit": 6.65625,
            "end_logit": 7.7109375,
            "text": "polycystic kidney disease",
            "probability": 0.998046875
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": 7.7109375,
            "text": "autosomal recessive polycystic kidney disease",
            "probability": 0.0022182464599609375
        },
        {
            "start_logit": -2.18359375,
            "end_logit": 7.7109375,
            "text": "disease",
            "probability": 0.00014400482177734375
        },
        {
            "start_logit": 6.65625,
            "end_logit": -4.40625,
            "text": "polycystic",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -6.03125,
            "end_logit": 7.7109375,
            "text": "kidney disease",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 6.65625,
            "end_logit": -6.34375,
            "text": "polycystic kidney disease (PKD",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.7109375,
            "text": "of autosomal recessive polycystic kidney disease",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.65625,
            "end_logit": -6.4453125,
            "text": "polycystic kidney disease (PK",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.7109375,
            "text": "recessive polycystic kidney disease",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.7109375,
            "text": "development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.7109375,
            "text": "kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.65625,
            "end_logit": -6.921875,
            "text": "polycystic kidney",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.7109375,
            "text": "cilia, and in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.65625,
            "end_logit": -7.23828125,
            "text": "polycystic kidney disease (PKD)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -4.40625,
            "text": "autosomal recessive polycystic",
            "probability": 0.0
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -6.25,
            "text": "autosomal recessive",
            "probability": 0.0
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -6.34375,
            "text": "autosomal recessive polycystic kidney disease (PKD",
            "probability": 0.0
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -6.4453125,
            "text": "autosomal recessive polycystic kidney disease (PK",
            "probability": 0.0
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -6.921875,
            "text": "autosomal recessive polycystic kidney",
            "probability": 0.0
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -7.23828125,
            "text": "autosomal recessive polycystic kidney disease (PKD)",
            "probability": 0.0
        }
    ],
    "513ce494bee46bd34c000009_3": [
        {
            "start_logit": 4.15625,
            "end_logit": 7.74609375,
            "text": "polycystic kidney disease",
            "probability": 0.99609375
        },
        {
            "start_logit": -2.08203125,
            "end_logit": 7.74609375,
            "text": "diabetes and polycystic kidney disease",
            "probability": 0.0019378662109375
        },
        {
            "start_logit": -2.12109375,
            "end_logit": 7.74609375,
            "text": "disease",
            "probability": 0.0018634796142578125
        },
        {
            "start_logit": -4.85546875,
            "end_logit": 7.74609375,
            "text": "diabetes and hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 0.00012099742889404297
        },
        {
            "start_logit": -5.80078125,
            "end_logit": 7.74609375,
            "text": "kidney disease",
            "probability": 4.70280647277832e-05
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 7.74609375,
            "text": "neonatal diabetes and hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 3.439188003540039e-05
        },
        {
            "start_logit": -6.75,
            "end_logit": 7.74609375,
            "text": "and polycystic kidney disease",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 7.74609375,
            "text": "hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 1.800060272216797e-05
        },
        {
            "start_logit": -6.90625,
            "end_logit": 7.74609375,
            "text": "abnormalities very similar to those of patients with neonatal diabetes and hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 1.5616416931152344e-05
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.74609375,
            "text": "and hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 1.52587890625e-05
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 7.74609375,
            "text": "of diabetes and polycystic kidney disease",
            "probability": 1.245737075805664e-05
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 7.74609375,
            "text": "mice display abnormalities very similar to those of patients with neonatal diabetes and hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 1.1622905731201172e-05
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.74609375,
            "text": "development of diabetes and polycystic kidney disease",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.74609375,
            "text": "display abnormalities very similar to those of patients with neonatal diabetes and hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.74609375,
            "text": "with neonatal diabetes and hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.74609375,
            "text": "patients with neonatal diabetes and hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 7.74609375,
            "text": "similar to those of patients with neonatal diabetes and hypothyroidism syndrome, including the development of diabetes and polycystic kidney disease",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 4.15625,
            "end_logit": -6.49609375,
            "text": "polycystic",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 4.15625,
            "end_logit": -7.23046875,
            "text": "polycystic kidney",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.08203125,
            "end_logit": -6.203125,
            "text": "diabetes",
            "probability": 0.0
        }
    ],
    "513ce494bee46bd34c000009_4": [
        {
            "start_logit": 6.65625,
            "end_logit": 7.875,
            "text": "autosomal recessive polycystic kidney disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.912109375,
            "end_logit": 7.875,
            "text": "disease",
            "probability": 0.00018966197967529297
        },
        {
            "start_logit": -3.04296875,
            "end_logit": 7.875,
            "text": "polycystic kidney disease",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": 6.65625,
            "end_logit": -4.3203125,
            "text": "autosomal",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 7.875,
            "text": "kidney disease",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.65625,
            "end_logit": -5.97265625,
            "text": "autosomal recessive",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 7.875,
            "text": "recessive polycystic kidney disease",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.65625,
            "end_logit": -6.37109375,
            "text": "autosomal recessive polycystic kidney",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.875,
            "text": "The autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.65625,
            "end_logit": -7.765625,
            "text": "autosomal recessive polycystic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.65625,
            "end_logit": -8.0234375,
            "text": "autosomal recessive polycystic kidney disease protein is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.65625,
            "end_logit": -8.09375,
            "text": "autosomal recessive polycystic kidney disease protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.04296875,
            "end_logit": -6.37109375,
            "text": "polycystic kidney",
            "probability": 0.0
        },
        {
            "start_logit": -1.912109375,
            "end_logit": -8.0234375,
            "text": "disease protein is",
            "probability": 0.0
        },
        {
            "start_logit": -1.912109375,
            "end_logit": -8.09375,
            "text": "disease protein",
            "probability": 0.0
        },
        {
            "start_logit": -3.04296875,
            "end_logit": -7.765625,
            "text": "polycystic",
            "probability": 0.0
        },
        {
            "start_logit": -3.04296875,
            "end_logit": -8.0234375,
            "text": "polycystic kidney disease protein is",
            "probability": 0.0
        },
        {
            "start_logit": -3.04296875,
            "end_logit": -8.09375,
            "text": "polycystic kidney disease protein",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -4.3203125,
            "text": "The autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -6.6484375,
            "end_logit": -6.37109375,
            "text": "kidney",
            "probability": 0.0
        }
    ],
    "513ce494bee46bd34c000009_5": [
        {
            "start_logit": 7.91796875,
            "end_logit": 7.87890625,
            "text": "autosomal recessive polycystic kidney disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.955078125,
            "end_logit": 7.87890625,
            "text": "disease",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -2.05859375,
            "text": "autosomal",
            "probability": 4.83393669128418e-05
        },
        {
            "start_logit": -5.1640625,
            "end_logit": 7.87890625,
            "text": "polycystic kidney disease",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -5.390625,
            "text": "autosomal recessive",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.19140625,
            "text": "autosomal recessive polycystic kidney",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.671875,
            "text": "autosomal recessive polycystic",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 7.87890625,
            "text": "kidney disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 7.87890625,
            "text": "recessive polycystic kidney disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.7421875,
            "text": "autosomal recessive polycystic kidney disease is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.91796875,
            "text": "autosomal recessive polycystic kidney disease is linked to the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 7.87890625,
            "text": "pathogenesis of autosomal recessive polycystic kidney disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.87890625,
            "text": "It is proposed that the pathogenesis of autosomal recessive polycystic kidney disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.955078125,
            "end_logit": -7.7421875,
            "text": "disease is",
            "probability": 0.0
        },
        {
            "start_logit": -1.955078125,
            "end_logit": -7.91796875,
            "text": "disease is linked to the",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -2.05859375,
            "text": "pathogenesis of autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -2.05859375,
            "text": "It is proposed that the pathogenesis of autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -5.1640625,
            "end_logit": -6.19140625,
            "text": "polycystic kidney",
            "probability": 0.0
        },
        {
            "start_logit": -5.1640625,
            "end_logit": -6.671875,
            "text": "polycystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -5.390625,
            "text": "recessive",
            "probability": 0.0
        }
    ],
    "5a885daa61bb38fb24000018_1": [
        {
            "start_logit": 2.9375,
            "end_logit": 5.328125,
            "text": "eight",
            "probability": 0.53369140625
        },
        {
            "start_logit": 4.46875,
            "end_logit": 2.84765625,
            "text": "DEAD box proteins are putative RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing.",
            "probability": 0.20654296875
        },
        {
            "start_logit": 4.46875,
            "end_logit": 2.771484375,
            "text": "DEAD box proteins are putative RNA helicase",
            "probability": 0.1917724609375
        },
        {
            "start_logit": 0.69873046875,
            "end_logit": 5.328125,
            "text": "RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing. These proteins share eight",
            "probability": 0.056884765625
        },
        {
            "start_logit": 0.69873046875,
            "end_logit": 2.84765625,
            "text": "RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing.",
            "probability": 0.004764556884765625
        },
        {
            "start_logit": 0.69873046875,
            "end_logit": 2.771484375,
            "text": "RNA helicase",
            "probability": 0.004405975341796875
        },
        {
            "start_logit": 4.46875,
            "end_logit": -2.421875,
            "text": "DEAD box proteins are putative RNA helicases",
            "probability": 0.0010623931884765625
        },
        {
            "start_logit": -4.1640625,
            "end_logit": 5.328125,
            "text": ". These proteins share eight",
            "probability": 0.00043964385986328125
        },
        {
            "start_logit": -4.3359375,
            "end_logit": 5.328125,
            "text": "share eight",
            "probability": 0.00037026405334472656
        },
        {
            "start_logit": 4.46875,
            "end_logit": -4.76171875,
            "text": "DEAD",
            "probability": 0.00010198354721069336
        },
        {
            "start_logit": -6.01171875,
            "end_logit": 5.328125,
            "text": "helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing. These proteins share eight",
            "probability": 6.902217864990234e-05
        },
        {
            "start_logit": 2.9375,
            "end_logit": -3.958984375,
            "text": "eight conserved amino acid motifs, including Asp(D)-Glu-(E)-Ala(A)-Asp",
            "probability": 4.935264587402344e-05
        },
        {
            "start_logit": -4.1640625,
            "end_logit": 2.84765625,
            "text": ".",
            "probability": 3.695487976074219e-05
        },
        {
            "start_logit": -4.1640625,
            "end_logit": 2.84765625,
            "text": ".",
            "probability": 3.695487976074219e-05
        },
        {
            "start_logit": -6.78125,
            "end_logit": 5.328125,
            "text": "proteins share eight",
            "probability": 3.2067298889160156e-05
        },
        {
            "start_logit": -4.33984375,
            "end_logit": 2.84765625,
            "text": "including Asp(D)-Glu-(E)-Ala(A)-Asp(D) which is part of a more extended motif.",
            "probability": 3.0875205993652344e-05
        },
        {
            "start_logit": 0.69873046875,
            "end_logit": -2.421875,
            "text": "RNA helicases",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": 4.46875,
            "end_logit": -6.23828125,
            "text": "DEAD box proteins are putative RNA helicases that",
            "probability": 2.3484230041503906e-05
        },
        {
            "start_logit": 2.9375,
            "end_logit": -4.71875,
            "text": "eight conserved amino acid motifs, including Asp(D)-Glu-(E)-Ala(A)-Asp(D)",
            "probability": 2.3126602172851562e-05
        },
        {
            "start_logit": 4.46875,
            "end_logit": -6.64453125,
            "text": "DEAD box proteins are putative RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary",
            "probability": 1.5676021575927734e-05
        }
    ],
    "52b2e409f828ad283c00000e_1": [
        {
            "start_logit": 6.5,
            "end_logit": 6.65625,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.52734375,
            "text": "schizophrenia in",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.7421875,
            "text": "schizophrenia in Canada",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.796875,
            "text": "schizophrenia in Canada from",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.99609375,
            "text": "schizophrenia in Canada from 2005",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.99609375,
            "text": "schizophrenia in Canada from 2005 to 2009",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -8.0,
            "text": "schizophrenia in Canada from 2005 to",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -7.99609375,
            "text": "2009",
            "probability": 0.0
        }
    ],
    "52b2e409f828ad283c00000e_2": [
        {
            "start_logit": 6.515625,
            "end_logit": 6.66015625,
            "text": "schizophrenia",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.5078125,
            "end_logit": 6.66015625,
            "text": "schizophrenia",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.5078125,
            "end_logit": 6.66015625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.515625,
            "end_logit": -6.8046875,
            "text": "schizophrenia increased by 38% between 2005 and 2009",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -6.8046875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38% between 2005 and 2009",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 6.66015625,
            "text": ". RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.49609375,
            "text": "schizophrenia increased by 38%",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.49609375,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38%",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.52734375,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380 to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.5546875,
            "text": "schizophrenia increased by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.546875,
            "text": "schizophrenia was listed as the indication",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.5546875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.62890625,
            "text": "schizophrenia increased",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.62890625,
            "text": "schizophrenia increased by 38",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.66015625,
            "text": ": First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.62890625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.62890625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.640625,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380 to 454 960",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.671875,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.66015625,
            "text": "RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 1.7881393432617188e-07
        }
    ],
    "52b2e409f828ad283c00000e_3": [
        {
            "start_logit": 6.515625,
            "end_logit": 6.66015625,
            "text": "schizophrenia",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.5078125,
            "end_logit": 6.66015625,
            "text": "schizophrenia",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.5078125,
            "end_logit": 6.66015625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.515625,
            "end_logit": -6.8046875,
            "text": "schizophrenia increased by 38% between 2005 and 2009",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -6.8046875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38% between 2005 and 2009",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 6.66015625,
            "text": ". RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.49609375,
            "text": "schizophrenia increased by 38%",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.49609375,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38%",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.52734375,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380 to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.5546875,
            "text": "schizophrenia increased by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.546875,
            "text": "schizophrenia was listed as the indication",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.5546875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.62890625,
            "text": "schizophrenia increased",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.62890625,
            "text": "schizophrenia increased by 38",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.66015625,
            "text": ": First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.62890625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5078125,
            "end_logit": -7.62890625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.640625,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380 to 454 960",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.671875,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.66015625,
            "text": "RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 1.7881393432617188e-07
        }
    ],
    "52b2e409f828ad283c00000e_4": [
        {
            "start_logit": 5.64453125,
            "end_logit": 7.140625,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": -2.86328125,
            "end_logit": 7.140625,
            "text": "paranoid schizophrenia",
            "probability": 0.0002034902572631836
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.140625,
            "text": "oid schizophrenia",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.140625,
            "text": ". Its best indication seems to be paranoid schizophrenia",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.140625,
            "text": "seems to be paranoid schizophrenia",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 7.140625,
            "text": "to be paranoid schizophrenia",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.140625,
            "text": "indication seems to be paranoid schizophrenia",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.140625,
            "text": "best indication seems to be paranoid schizophrenia",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 5.64453125,
            "end_logit": -7.6953125,
            "text": "schizophrenia, although some data suggest bipolar action.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.86328125,
            "end_logit": -7.3203125,
            "text": "paranoid",
            "probability": 0.0
        },
        {
            "start_logit": -2.86328125,
            "end_logit": -7.6953125,
            "text": "paranoid schizophrenia, although some data suggest bipolar action.",
            "probability": 0.0
        },
        {
            "start_logit": -2.86328125,
            "end_logit": -7.859375,
            "text": "paran",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -6.76953125,
            "text": ". Its pharmacological profile is close to that of clozapine",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -6.76953125,
            "text": "clozapine",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -6.76953125,
            "text": "1980. Its pharmacological profile is close to that of clozapine",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.3203125,
            "text": "oid",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -6.76953125,
            "text": "been prescribed in France since 1980. Its pharmacological profile is close to that of clozapine",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -6.76953125,
            "text": "has been prescribed in France since 1980. Its pharmacological profile is close to that of clozapine",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.3203125,
            "text": ". Its best indication seems to be paranoid",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -6.76953125,
            "text": "France since 1980. Its pharmacological profile is close to that of clozapine",
            "probability": 0.0
        }
    ],
    "6252f496e764a53204000020_1": [
        {
            "start_logit": 7.4453125,
            "end_logit": 6.94921875,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 0.955078125
        },
        {
            "start_logit": 7.4453125,
            "end_logit": 3.869140625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter",
            "probability": 0.043975830078125
        },
        {
            "start_logit": -0.96630859375,
            "end_logit": 6.94921875,
            "text": ".",
            "probability": 0.00021350383758544922
        },
        {
            "start_logit": 7.4453125,
            "end_logit": -1.830078125,
            "text": "ABCG1 is an ATP binding cassette (",
            "probability": 0.00014781951904296875
        },
        {
            "start_logit": 7.4453125,
            "end_logit": -2.88671875,
            "text": "ABC",
            "probability": 5.14984130859375e-05
        },
        {
            "start_logit": -2.80859375,
            "end_logit": 6.94921875,
            "text": "G1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -3.267578125,
            "end_logit": 6.94921875,
            "text": "an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": -4.70703125,
            "end_logit": 6.94921875,
            "text": "transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 7.4453125,
            "end_logit": -5.23828125,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -5.11328125,
            "end_logit": 6.94921875,
            "text": "ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 7.4453125,
            "end_logit": -5.8203125,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 6.94921875,
            "text": ") transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 7.4453125,
            "end_logit": -6.265625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -5.8671875,
            "end_logit": 6.94921875,
            "text": "removes excess cholesterol from peripheral tissues.",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -2.80859375,
            "end_logit": 3.869140625,
            "text": "G1 is an ATP binding cassette (ABC) transporter",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.4453125,
            "end_logit": -6.60546875,
            "text": "ABCG1 is an ATP binding cassette",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -3.267578125,
            "end_logit": 3.869140625,
            "text": "an ATP binding cassette (ABC) transporter",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.4453125,
            "end_logit": -6.8515625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 6.94921875,
            "text": "binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.4453125,
            "end_logit": -7.12109375,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess",
            "probability": 7.152557373046875e-07
        }
    ],
    "601ee4c61cb411341a000066_1": [
        {
            "start_logit": 7.50390625,
            "end_logit": 7.65234375,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.19921875,
            "end_logit": 7.65234375,
            "text": "7",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -2.708984375,
            "text": "196",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.42578125,
            "text": "1967 was performed using a deceased donor heart,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.70703125,
            "text": "1967 was performed using a deceased donor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.71875,
            "text": "1967 was",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.65234375,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.74609375,
            "text": "1967 was performed using a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.65234375,
            "text": "first human heart transplant in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.921875,
            "text": "1967 was performed using a deceased donor heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -8.0,
            "text": "1967 was performed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -8.0,
            "text": "1967 was performed using a deceased",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.65234375,
            "text": "transplant in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.65234375,
            "text": "heart transplant in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -8.0390625,
            "text": "1967 was performed using",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 7.65234375,
            "text": "human heart transplant in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.19921875,
            "end_logit": -7.42578125,
            "text": "7 was performed using a deceased donor heart,",
            "probability": 0.0
        },
        {
            "start_logit": -2.19921875,
            "end_logit": -7.70703125,
            "text": "7 was performed using a deceased donor",
            "probability": 0.0
        },
        {
            "start_logit": -2.19921875,
            "end_logit": -7.71875,
            "text": "7 was",
            "probability": 0.0
        },
        {
            "start_logit": -2.19921875,
            "end_logit": -7.74609375,
            "text": "7 was performed using a",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_2": [
        {
            "start_logit": 0.1756591796875,
            "end_logit": 7.79296875,
            "text": "In 1967",
            "probability": 0.62646484375
        },
        {
            "start_logit": -0.5458984375,
            "end_logit": 7.79296875,
            "text": "1967",
            "probability": 0.30419921875
        },
        {
            "start_logit": -2.02734375,
            "end_logit": 7.79296875,
            "text": "7",
            "probability": 0.0692138671875
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -6.9765625,
            "text": "In 1967, Christian Barnard performed the first successful human-to-human heart transplant.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.42578125,
            "text": "In 1967, Christian Barnard performed the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.5458984375,
            "end_logit": -6.9765625,
            "text": "1967, Christian Barnard performed the first successful human-to-human heart transplant.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.74609375,
            "text": "In 1967, Christian Barnard performed the first successful human-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.7578125,
            "text": "In 1967, Christian Barnard performed the first successful human-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.76953125,
            "text": "In 1967, Christian Barnard",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.7734375,
            "text": "In 1967, Christian Barnard performed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.828125,
            "text": "In 1967, Christian Barnard performed the first successful human-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.90234375,
            "text": "In 1967, Christian Barnard performed the first successful human",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.9375,
            "text": "In 1967, Christian Barnard performed the first successful human-to-human",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.953125,
            "text": "In 1967, Christian Barnar",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.98046875,
            "text": "In 1967, Christian",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.9921875,
            "text": "In 1967,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -7.99609375,
            "text": "In 1967, Christian Barnard performed the first successful human-to-human heart",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -8.0078125,
            "text": "In 1967, Christian Barnard performed the first successful human-to-human heart transplant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.1756591796875,
            "end_logit": -8.015625,
            "text": "In 1967, Christian Barnard performed the first",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.5458984375,
            "end_logit": -7.42578125,
            "text": "1967, Christian Barnard performed the",
            "probability": 5.960464477539063e-08
        }
    ],
    "601ee4c61cb411341a000066_3": [
        {
            "start_logit": 7.45703125,
            "end_logit": 7.70703125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.978515625,
            "end_logit": 7.70703125,
            "text": "7",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -2.615234375,
            "text": "196",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -6.4453125,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 7.70703125,
            "text": "Christiaan Barnard in 1967",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.22265625,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.70703125,
            "text": "in 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.35546875,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.390625,
            "text": "1967, there has been substantial progress in the field of heart transplantation,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.41015625,
            "text": "1967,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 7.70703125,
            "text": "Since the first successful human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.70703125,
            "text": "n Barnard in 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.70703125,
            "text": "Barnard in 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.70703125,
            "text": "d in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.7265625,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.70703125,
            "text": "istiaan Barnard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.70703125,
            "text": "nard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.8359375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.8828125,
            "text": "1967, there has been substantial progress",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.978515625,
            "end_logit": -6.4453125,
            "text": "7, there has been substantial progress in the field of heart transplantation, especially over the last several decades.",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_4": [
        {
            "start_logit": 4.97265625,
            "end_logit": 7.20703125,
            "text": "1967",
            "probability": 0.9931640625
        },
        {
            "start_logit": 6.83984375,
            "end_logit": 0.072998046875,
            "text": "50th anniversary",
            "probability": 0.005130767822265625
        },
        {
            "start_logit": -2.35546875,
            "end_logit": 7.20703125,
            "text": "7",
            "probability": 0.000652313232421875
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -2.486328125,
            "text": "50th",
            "probability": 0.00039577484130859375
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -3.244140625,
            "text": "50",
            "probability": 0.00018537044525146484
        },
        {
            "start_logit": -4.83984375,
            "end_logit": 7.20703125,
            "text": "December 3rd, 1967",
            "probability": 5.441904067993164e-05
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -4.5859375,
            "text": "196",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 7.20703125,
            "text": "on December 3rd, 1967",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.20703125,
            "text": ", 1967",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.20703125,
            "text": "Christiaan ('Chris') Barnard at Groote Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.20703125,
            "text": "Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.20703125,
            "text": "Chris') Barnard at Groote Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.20703125,
            "text": "Barnard at Groote Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.20703125,
            "text": ", Christiaan ('Chris') Barnard at Groote Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 7.20703125,
            "text": "at Groote Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.5390625,
            "text": "50th anniversary of the first human heart transplant that had been",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.65625,
            "text": "50th anniversary of",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.7109375,
            "text": "50th anniversary of the first human heart transplant that had",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.734375,
            "text": "50th anniversary of the first human heart transplant that had been carried out by the South African surgeon, Christiaa",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.73828125,
            "text": "50th anniversary of the first human heart transplant that had been carried out by the South African surgeon, Christiaan",
            "probability": 2.086162567138672e-06
        }
    ],
    "601ee4c61cb411341a000066_5": [
        {
            "start_logit": 1.8310546875,
            "end_logit": 7.640625,
            "text": "December 1967",
            "probability": 0.96435546875
        },
        {
            "start_logit": -2.11328125,
            "end_logit": 7.640625,
            "text": "1967",
            "probability": 0.0187225341796875
        },
        {
            "start_logit": -2.244140625,
            "end_logit": 7.640625,
            "text": "7",
            "probability": 0.0164642333984375
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.640625,
            "text": "40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 7.277727127075195e-05
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.640625,
            "text": "has been 40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 6.783008575439453e-05
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 7.640625,
            "text": "Christiaan Barnard in December 1967",
            "probability": 6.270408630371094e-05
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.640625,
            "text": "years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 5.888938903808594e-05
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 7.640625,
            "text": "d in December 1967",
            "probability": 5.239248275756836e-05
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.640625,
            "text": "in December 1967",
            "probability": 5.1140785217285156e-05
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.640625,
            "text": "human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 4.9173831939697266e-05
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.640625,
            "text": "istiaan Barnard in December 1967",
            "probability": 4.845857620239258e-05
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.640625,
            "text": "first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 4.8100948333740234e-05
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.640625,
            "text": "human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 4.583597183227539e-05
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.640625,
            "text": "been 40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 4.553794860839844e-05
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.640625,
            "text": "since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 4.553794860839844e-05
        },
        {
            "start_logit": 1.8310546875,
            "end_logit": -7.44921875,
            "text": "December",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.8310546875,
            "end_logit": -7.58203125,
            "text": "December 196",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.11328125,
            "end_logit": -7.58203125,
            "text": "196",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -7.44921875,
            "text": "40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.44921875,
            "text": "has been 40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_6": [
        {
            "start_logit": 7.57421875,
            "end_logit": 7.734375,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.009765625,
            "end_logit": 7.734375,
            "text": "7",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -2.484375,
            "text": "196",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 7.734375,
            "text": "Christiaan Barnard in 1967",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.43359375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.734375,
            "text": "in 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.47265625,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades. With",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.546875,
            "text": "1967, there has been substantial progress in the field of heart transplantation,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.58203125,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.7109375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.75,
            "text": "1967,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.76953125,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 7.734375,
            "text": "n Barnard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.734375,
            "text": "istiaan Barnard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.734375,
            "text": "Barnard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.734375,
            "text": "by Christiaan Barnard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.734375,
            "text": "successful human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.734375,
            "text": "nard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.95703125,
            "text": "1967, there",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.96484375,
            "text": "1967, there has been substantial progress",
            "probability": 1.7881393432617188e-07
        }
    ],
    "601ee4c61cb411341a000066_7": [
        {
            "start_logit": 7.41015625,
            "end_logit": 7.72265625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.9921875,
            "end_logit": 7.72265625,
            "text": "7",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -2.685546875,
            "text": "196",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.07421875,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable quality of life are commonplace.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.72265625,
            "text": "Since the first human heart transplantation was performed in 1967",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.72265625,
            "text": "in 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.59765625,
            "text": "1967,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.75390625,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable quality of life are commonplace",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.72265625,
            "text": "first human heart transplantation was performed in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.80078125,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable quality of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.80078125,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.83203125,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.84765625,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable quality of life are common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.87890625,
            "text": "1967, the field of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.8984375,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable quality of life",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.9296875,
            "text": "1967, the field of heart transplantation has advanced to the point where survival",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.93359375,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable quality of life are",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.41015625,
            "end_logit": -7.94921875,
            "text": "1967, the field of heart transplantation has advanced to the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.9921875,
            "end_logit": -7.07421875,
            "text": "7, the field of heart transplantation has advanced to the point where survival and acceptable quality of life are commonplace.",
            "probability": 0.0
        },
        {
            "start_logit": -1.9921875,
            "end_logit": -7.59765625,
            "text": "7,",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_8": [
        {
            "start_logit": 7.50390625,
            "end_logit": 7.578125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.5625,
            "end_logit": 7.578125,
            "text": "7",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -2.884765625,
            "text": "196",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.578125,
            "text": "50 years ago in 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 7.578125,
            "text": "first human-to-human heart transplant was performed 50 years ago in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.578125,
            "text": "years ago in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.578125,
            "text": "human heart transplant was performed 50 years ago in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.578125,
            "text": "The first human-to-human heart transplant was performed 50 years ago in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.578125,
            "text": "heart transplant was performed 50 years ago in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.25,
            "end_logit": 7.578125,
            "text": "transplant was performed 50 years ago in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -2.884765625,
            "text": "50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -2.884765625,
            "text": "first human-to-human heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -2.884765625,
            "text": "years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -2.884765625,
            "text": "human heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -2.884765625,
            "text": "The first human-to-human heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -2.884765625,
            "text": "heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -2.884765625,
            "text": "transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.23046875,
            "text": "50 years ago",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.23046875,
            "text": "first human-to-human heart transplant was performed 50 years ago",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.23046875,
            "text": "years ago",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_9": [
        {
            "start_logit": 7.66796875,
            "end_logit": 7.7421875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.9521484375,
            "end_logit": 7.7421875,
            "text": "7",
            "probability": 6.657838821411133e-05
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -2.2265625,
            "text": "196",
            "probability": 4.684925079345703e-05
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.75390625,
            "text": "1967,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.8359375,
            "text": "1967, advances in organ donation, surgical",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.84375,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation, perioperative",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.84765625,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.8515625,
            "text": "1967, advances in organ donation, surgical techniques,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.85546875,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.859375,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 7.7421875,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.7421875,
            "text": "Since the first human-to-human heart transplantation, performed in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.7421875,
            "text": "performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.234375,
            "end_logit": 7.7421875,
            "text": "human heart transplantation, performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.9521484375,
            "end_logit": -7.75390625,
            "text": "7,",
            "probability": 0.0
        },
        {
            "start_logit": -1.9521484375,
            "end_logit": -7.8359375,
            "text": "7, advances in organ donation, surgical",
            "probability": 0.0
        },
        {
            "start_logit": -1.9521484375,
            "end_logit": -7.84375,
            "text": "7, advances in organ donation, surgical techniques, organ preservation, perioperative",
            "probability": 0.0
        },
        {
            "start_logit": -1.9521484375,
            "end_logit": -7.84765625,
            "text": "7, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft function and surveillance of",
            "probability": 0.0
        },
        {
            "start_logit": -1.9521484375,
            "end_logit": -7.84765625,
            "text": "7, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft",
            "probability": 0.0
        },
        {
            "start_logit": -1.9521484375,
            "end_logit": -7.8515625,
            "text": "7, advances in organ donation, surgical techniques,",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_10": [
        {
            "start_logit": 7.48828125,
            "end_logit": 7.72265625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": 7.72265625,
            "text": "7",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -2.734375,
            "text": "196",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.3203125,
            "text": "1967 was performed using a deceased donor heart,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.4921875,
            "text": "1967 was",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.5625,
            "text": "1967 was performed using a deceased donor heart, the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.6171875,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.625,
            "text": "1967 was performed using a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.66796875,
            "text": "1967 was performed using a deceased donor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.6796875,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac death",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.68359375,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.7265625,
            "text": "1967 was performed using a deceased donor heart, the advent of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 7.72265625,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.72265625,
            "text": "first human heart transplant in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -7.3203125,
            "text": "7 was performed using a deceased donor heart,",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -7.4921875,
            "text": "7 was",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -7.5625,
            "text": "7 was performed using a deceased donor heart, the",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -7.6171875,
            "text": "7 was performed using a deceased donor heart, the advent of brain death",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -7.625,
            "text": "7 was performed using a",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -7.66796875,
            "text": "7 was performed using a deceased donor",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_11": [
        {
            "start_logit": 2.169921875,
            "end_logit": 7.61328125,
            "text": "December 1967",
            "probability": 0.9873046875
        },
        {
            "start_logit": -2.421875,
            "end_logit": 7.61328125,
            "text": "7",
            "probability": 0.0100250244140625
        },
        {
            "start_logit": -4.171875,
            "end_logit": 7.61328125,
            "text": "1967",
            "probability": 0.0017423629760742188
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.61328125,
            "text": "first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 4.2438507080078125e-05
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 7.61328125,
            "text": "1983 had its origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 4.214048385620117e-05
        },
        {
            "start_logit": -7.90625,
            "end_logit": 7.61328125,
            "text": "successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 4.1425228118896484e-05
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 7.61328125,
            "text": "Professor Christiaan Barnard and his team in December 1967",
            "probability": 4.1425228118896484e-05
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.61328125,
            "text": "heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 3.927946090698242e-05
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.61328125,
            "text": "origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 3.6597251892089844e-05
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.61328125,
            "text": "or Christiaan Barnard and his team in December 1967",
            "probability": 3.600120544433594e-05
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.61328125,
            "text": "Christiaan Barnard and his team in December 1967",
            "probability": 3.600120544433594e-05
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.61328125,
            "text": "team in December 1967",
            "probability": 3.546476364135742e-05
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.61328125,
            "text": "in December 1967",
            "probability": 3.3855438232421875e-05
        },
        {
            "start_logit": 2.169921875,
            "end_logit": -7.39453125,
            "text": "December",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 2.169921875,
            "end_logit": -7.4140625,
            "text": "December 196",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.171875,
            "end_logit": -7.4140625,
            "text": "196",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -7.39453125,
            "text": "first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -7.4140625,
            "text": "first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -7.39453125,
            "text": "1983 had its origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -7.39453125,
            "text": "successful heart transplant operation performed by Professor Christiaan Barnard and his team in December",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_12": [
        {
            "start_logit": 7.3359375,
            "end_logit": 7.8203125,
            "text": "December 1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.796875,
            "end_logit": 7.8203125,
            "text": "7",
            "probability": 0.0001080632209777832
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -2.865234375,
            "text": "December",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -4.38671875,
            "end_logit": 7.8203125,
            "text": "1967",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -6.734375,
            "text": "December 196",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.8203125,
            "text": "Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 7.8203125,
            "text": "has been 50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 7.8203125,
            "text": "Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 7.8203125,
            "text": "istiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.8203125,
            "text": "years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.8203125,
            "text": "iaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.8203125,
            "text": "n Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.8203125,
            "text": "human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.8203125,
            "text": "Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.8203125,
            "text": ". Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.8203125,
            "text": "performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.8203125,
            "text": "first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -7.671875,
            "text": "December 1967 in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.8203125,
            "text": "human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -7.77734375,
            "text": "December 1967 in South Africa",
            "probability": 1.7881393432617188e-07
        }
    ],
    "601ee4c61cb411341a000066_13": [
        {
            "start_logit": 6.37890625,
            "end_logit": 7.7421875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": 7.7421875,
            "text": "7",
            "probability": 0.00026535987854003906
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -3.962890625,
            "text": "196",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 7.7421875,
            "text": "3 December 1967",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.7421875,
            "text": "December 1967",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.7421875,
            "text": "The first successful human heart transplantation was reported on 3 December 1967",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.7421875,
            "text": "first successful human heart transplantation was reported on 3 December 1967",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 7.7421875,
            "text": "human heart transplantation was reported on 3 December 1967",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 7.7421875,
            "text": "successful human heart transplantation was reported on 3 December 1967",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 7.7421875,
            "text": "transplantation was reported on 3 December 1967",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.7421875,
            "text": "heart transplantation was reported on 3 December 1967",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.50390625,
            "text": "1967, by Christiaan Barnard in South Africa.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.8203125,
            "text": "1967,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -8.09375,
            "text": "1967, by Christiaan Barnard",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -8.1015625,
            "text": "1967, by Christiaa",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -8.1015625,
            "text": "1967, by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -8.109375,
            "text": "1967, by Christiaan Barnard in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -8.125,
            "text": "1967, by Christiaan Barnar",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -7.50390625,
            "text": "7, by Christiaan Barnard in South Africa.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -7.8203125,
            "text": "7,",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_14": [
        {
            "start_logit": 7.68359375,
            "end_logit": 7.61328125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 7.68359375,
            "end_logit": -1.4921875,
            "text": "196",
            "probability": 0.000110626220703125
        },
        {
            "start_logit": -1.771484375,
            "end_logit": 7.61328125,
            "text": "7",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 7.61328125,
            "text": "December 1967",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.68359375,
            "end_logit": -6.9765625,
            "text": "1967.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 7.61328125,
            "text": "The world's first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.61328125,
            "text": "human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.61328125,
            "text": "first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 7.61328125,
            "text": "human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.61328125,
            "text": "ote Schuur Hospital on the 2nd December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.61328125,
            "text": "2nd December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.61328125,
            "text": "Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.61328125,
            "text": "uur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.61328125,
            "text": "heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.61328125,
            "text": "to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.61328125,
            "text": "transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.33203125,
            "end_logit": -1.4921875,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.771484375,
            "end_logit": -6.9765625,
            "text": "7.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -1.4921875,
            "text": "The world's first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -1.4921875,
            "text": "human heart transplant was performed at Groote Schuur Hospital on the 2nd December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_15": [
        {
            "start_logit": 7.4140625,
            "end_logit": 7.54296875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.7802734375,
            "end_logit": 7.54296875,
            "text": "7",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 7.4140625,
            "end_logit": -1.8095703125,
            "text": "196",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -4.8984375,
            "end_logit": 7.54296875,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 7.54296875,
            "text": "December 3rd 1967",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 7.54296875,
            "text": "Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.4140625,
            "end_logit": -7.4453125,
            "text": "1967.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.54296875,
            "text": "passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.54296875,
            "text": "istiaan Barnard in Cape Town December 3rd 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.54296875,
            "text": "3rd 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 7.54296875,
            "text": "n Barnard in Cape Town December 3rd 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 7.54296875,
            "text": "human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 7.54296875,
            "text": "Town December 3rd 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 7.54296875,
            "text": "have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 7.54296875,
            "text": "by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 7.54296875,
            "text": "first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 7.54296875,
            "text": "Barnard in Cape Town December 3rd 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.8984375,
            "end_logit": -1.8095703125,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 196",
            "probability": 0.0
        },
        {
            "start_logit": -5.38671875,
            "end_logit": -1.8095703125,
            "text": "December 3rd 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -1.8095703125,
            "text": "Christiaan Barnard in Cape Town December 3rd 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_16": [
        {
            "start_logit": 5.828125,
            "end_logit": 7.7421875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.068359375,
            "end_logit": 7.7421875,
            "text": "7",
            "probability": 0.0003712177276611328
        },
        {
            "start_logit": -5.53125,
            "end_logit": 7.7421875,
            "text": "In 1967",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 5.828125,
            "end_logit": -4.765625,
            "text": "196",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 5.828125,
            "end_logit": -6.8046875,
            "text": "1967, he led the team that performed the world's first human-to-human heart transplant.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.07421875,
            "text": "1967, he led the team that performed the world",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.18359375,
            "text": "1967, he led the team that performed the world's",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.3984375,
            "text": "1967, he led the team that performed the world'",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.65234375,
            "text": "1967, he led the team that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.73046875,
            "text": "1967, he led the team that performed the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.7578125,
            "text": "1967, he led the team that performed the world's first human-to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.80078125,
            "text": "1967, he led the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.83984375,
            "text": "1967, he led the team that performed the world's first human-to-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.84375,
            "text": "1967, he led the team that performed the world's first human-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.85546875,
            "text": "1967, he led the team",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.94140625,
            "text": "1967, he",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.9453125,
            "text": "1967, he led the team that performed the world's first human",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.96484375,
            "text": "1967, he led the team that performed the world's first human-to-human heart transplant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.828125,
            "end_logit": -7.97265625,
            "text": "1967, he led the team that performed the world's first",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.068359375,
            "end_logit": -6.8046875,
            "text": "7, he led the team that performed the world's first human-to-human heart transplant.",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_17": [
        {
            "start_logit": 7.4375,
            "end_logit": 7.70703125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": 7.70703125,
            "text": "7",
            "probability": 0.00010073184967041016
        },
        {
            "start_logit": 7.4375,
            "end_logit": -2.322265625,
            "text": "196",
            "probability": 4.4345855712890625e-05
        },
        {
            "start_logit": -4.4921875,
            "end_logit": 7.70703125,
            "text": "1953, followed by the first successful heart transplant in 1967",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 7.4375,
            "end_logit": -5.55859375,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been made in h",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 7.4375,
            "end_logit": -6.94921875,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.0703125,
            "text": "1967,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.70703125,
            "text": "3, followed by the first successful heart transplant in 1967",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.234375,
            "text": "1967, and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.70703125,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.4921875,
            "end_logit": -2.322265625,
            "text": "1953, followed by the first successful heart transplant in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -5.55859375,
            "text": "7, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been made in h",
            "probability": 0.0
        },
        {
            "start_logit": -4.4921875,
            "end_logit": -2.951171875,
            "text": "1953",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -6.94921875,
            "text": "7, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -7.0703125,
            "text": "7,",
            "probability": 0.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": -7.234375,
            "text": "7, and",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -2.322265625,
            "text": "3, followed by the first successful heart transplant in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -2.951171875,
            "text": "3",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -2.322265625,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -4.4921875,
            "end_logit": -6.89453125,
            "text": "195",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_18": [
        {
            "start_logit": 7.44140625,
            "end_logit": 7.62890625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.6396484375,
            "end_logit": 7.62890625,
            "text": "7",
            "probability": 0.00011414289474487305
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -1.9384765625,
            "text": "196",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 7.62890625,
            "text": "3 December 1967",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.62890625,
            "text": "December 1967",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.62890625,
            "text": "Article on the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 7.62890625,
            "text": "first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 7.62890625,
            "text": "on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.62890625,
            "text": "performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.44140625,
            "end_logit": -7.91015625,
            "text": "1967.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.62890625,
            "text": "Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -1.9384765625,
            "text": "3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -6.92578125,
            "end_logit": -1.9384765625,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.6396484375,
            "end_logit": -7.91015625,
            "text": "7.",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -1.9384765625,
            "text": "Article on the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -1.9384765625,
            "text": "first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -1.9384765625,
            "text": "on 3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -1.9384765625,
            "text": "performed at Groote Schuur Hospital, Cape Town, on 3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -1.9384765625,
            "text": "Schuur Hospital, Cape Town, on 3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -7.77734375,
            "text": "3 December",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_19": [
        {
            "start_logit": 6.63671875,
            "end_logit": 7.6015625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.087890625,
            "end_logit": 7.6015625,
            "text": "7",
            "probability": 0.0001634359359741211
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -3.59375,
            "text": "196",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 7.6015625,
            "text": "On December 3, 1967",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 7.6015625,
            "text": "December 3, 1967",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -7.04296875,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the first successful human heart transplant.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -7.25,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -7.3984375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -7.5234375,
            "text": "1967, in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -7.5859375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -8.0234375,
            "text": "1967, in Cape Town,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -8.03125,
            "text": "1967, in Cape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -8.0546875,
            "text": "1967,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -8.0625,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolution",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.63671875,
            "end_logit": -8.0703125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the first successful human heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.087890625,
            "end_logit": -7.04296875,
            "text": "7, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the first successful human heart transplant.",
            "probability": 0.0
        },
        {
            "start_logit": -2.087890625,
            "end_logit": -7.25,
            "text": "7, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with",
            "probability": 0.0
        },
        {
            "start_logit": -2.087890625,
            "end_logit": -7.3984375,
            "text": "7, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation",
            "probability": 0.0
        },
        {
            "start_logit": -2.087890625,
            "end_logit": -7.5234375,
            "text": "7, in",
            "probability": 0.0
        },
        {
            "start_logit": -2.087890625,
            "end_logit": -7.5859375,
            "text": "7, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_20": [
        {
            "start_logit": 7.46875,
            "end_logit": 7.6875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.9013671875,
            "end_logit": 7.6875,
            "text": "7",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 7.46875,
            "end_logit": -2.38671875,
            "text": "196",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": 7.46875,
            "end_logit": -3.583984375,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in 1974",
            "probability": 1.2695789337158203e-05
        },
        {
            "start_logit": 7.46875,
            "end_logit": -6.95703125,
            "text": "1967 and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.6875,
            "text": "Barnard performed the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.2890625,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in 1974.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.5234375,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.58203125,
            "text": "1967 and followed this by introducing the technique of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.63671875,
            "text": "1967 and followed this",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.6875,
            "text": "nard performed the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 7.6875,
            "text": "d performed the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.74609375,
            "text": "1967 and followed this by",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.79296875,
            "text": "1967 and followed this by introducing the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.8125,
            "text": "1967 and followed this by introducing the technique of heterotopic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.6875,
            "text": "orthotopic heart transplantation in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.8671875,
            "text": "1967 and followed this by introducing the technique of heterotopic heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.87109375,
            "text": "1967 and followed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.6875,
            "text": "performed the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.9013671875,
            "end_logit": -3.583984375,
            "text": "7 and followed this by introducing the technique of heterotopic heart transplantation in 1974",
            "probability": 0.0
        }
    ],
    "5fdb2e23a43ad3127800000a_1": [
        {
            "start_logit": 3.41015625,
            "end_logit": 1.9150390625,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.82958984375
        },
        {
            "start_logit": 3.41015625,
            "end_logit": 0.28271484375,
            "text": "cis-regulatory elements",
            "probability": 0.1624755859375
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -3.666015625,
            "text": "cis-regulatory elements is central to understanding gene transcription",
            "probability": 0.0031375885009765625
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -4.84375,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements",
            "probability": 0.0009636878967285156
        },
        {
            "start_logit": -3.484375,
            "end_logit": 1.9150390625,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0008411407470703125
        },
        {
            "start_logit": -3.611328125,
            "end_logit": 1.9150390625,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0007419586181640625
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -5.50390625,
            "text": "cis",
            "probability": 0.0004982948303222656
        },
        {
            "start_logit": -4.953125,
            "end_logit": 1.9150390625,
            "text": ".",
            "probability": 0.00019443035125732422
        },
        {
            "start_logit": -4.953125,
            "end_logit": 1.9150390625,
            "text": ". Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.00019443035125732422
        },
        {
            "start_logit": -4.953125,
            "end_logit": 1.9150390625,
            "text": ".",
            "probability": 0.00019443035125732422
        },
        {
            "start_logit": -3.484375,
            "end_logit": 0.28271484375,
            "text": "The identification of cis-regulatory elements",
            "probability": 0.00016486644744873047
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 1.9150390625,
            "text": "regulatory elements is central to understanding gene transcription.",
            "probability": 0.00011605024337768555
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.1328125,
            "text": "cis-regulatory",
            "probability": 9.775161743164062e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.140625,
            "text": "cis-regulatory elements is central to understanding gene",
            "probability": 9.691715240478516e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.14453125,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard",
            "probability": 9.620189666748047e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.21875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI",
            "probability": 8.96453857421875e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.2421875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold",
            "probability": 8.761882781982422e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.2421875,
            "text": "cis-regulatory elements is central",
            "probability": 8.761882781982422e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.34765625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-",
            "probability": 7.849931716918945e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.34765625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to",
            "probability": 7.849931716918945e-05
        }
    ],
    "5fdb2e23a43ad3127800000a_2": [
        {
            "start_logit": 3.41015625,
            "end_logit": 1.9150390625,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.82958984375
        },
        {
            "start_logit": 3.41015625,
            "end_logit": 0.28271484375,
            "text": "cis-regulatory elements",
            "probability": 0.1624755859375
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -3.666015625,
            "text": "cis-regulatory elements is central to understanding gene transcription",
            "probability": 0.0031375885009765625
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -4.84375,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements",
            "probability": 0.0009636878967285156
        },
        {
            "start_logit": -3.484375,
            "end_logit": 1.9150390625,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0008411407470703125
        },
        {
            "start_logit": -3.611328125,
            "end_logit": 1.9150390625,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0007419586181640625
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -5.50390625,
            "text": "cis",
            "probability": 0.0004982948303222656
        },
        {
            "start_logit": -4.953125,
            "end_logit": 1.9150390625,
            "text": ".",
            "probability": 0.00019443035125732422
        },
        {
            "start_logit": -4.953125,
            "end_logit": 1.9150390625,
            "text": ". Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.00019443035125732422
        },
        {
            "start_logit": -4.953125,
            "end_logit": 1.9150390625,
            "text": ".",
            "probability": 0.00019443035125732422
        },
        {
            "start_logit": -3.484375,
            "end_logit": 0.28271484375,
            "text": "The identification of cis-regulatory elements",
            "probability": 0.00016486644744873047
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 1.9150390625,
            "text": "regulatory elements is central to understanding gene transcription.",
            "probability": 0.00011605024337768555
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.1328125,
            "text": "cis-regulatory",
            "probability": 9.775161743164062e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.140625,
            "text": "cis-regulatory elements is central to understanding gene",
            "probability": 9.691715240478516e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.14453125,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard",
            "probability": 9.620189666748047e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.21875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI",
            "probability": 8.96453857421875e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.2421875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold",
            "probability": 8.761882781982422e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.2421875,
            "text": "cis-regulatory elements is central",
            "probability": 8.761882781982422e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.34765625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-",
            "probability": 7.849931716918945e-05
        },
        {
            "start_logit": 3.41015625,
            "end_logit": -7.34765625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to",
            "probability": 7.849931716918945e-05
        }
    ],
    "5fdb2e23a43ad3127800000a_3": [
        {
            "start_logit": -0.0821533203125,
            "end_logit": 0.48974609375,
            "text": "gene regulatory elements",
            "probability": 0.98388671875
        },
        {
            "start_logit": -4.98828125,
            "end_logit": 0.48974609375,
            "text": "Identifying gene regulatory elements",
            "probability": 0.0072784423828125
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -5.2890625,
            "text": "gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites.",
            "probability": 0.0030460357666015625
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -6.2578125,
            "text": "gene regulatory",
            "probability": 0.0011568069458007812
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -6.2578125,
            "text": "gene regulatory elements by genomic microarray mapping of",
            "probability": 0.0011568069458007812
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 0.48974609375,
            "text": "regulatory elements",
            "probability": 0.0006237030029296875
        },
        {
            "start_logit": -7.59375,
            "end_logit": 0.48974609375,
            "text": "elements",
            "probability": 0.0005373954772949219
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -7.07421875,
            "text": "gene regulatory elements by",
            "probability": 0.00051116943359375
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -7.34765625,
            "text": "gene regulatory elements by genomic microarray",
            "probability": 0.00038886070251464844
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -7.53515625,
            "text": "gene regulatory elements by genomic microarray mapping of DNaseI",
            "probability": 0.0003223419189453125
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -7.53515625,
            "text": "gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites",
            "probability": 0.0003223419189453125
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -7.60546875,
            "text": "gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive",
            "probability": 0.00030040740966796875
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -7.71875,
            "text": "gene regulatory elements by genomic",
            "probability": 0.00026702880859375
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -7.84375,
            "text": "gene regulatory elements by genomic microarray mapping",
            "probability": 0.0002357959747314453
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -7.98828125,
            "text": "gene regulatory elements by genomic microarray mapping of DNase",
            "probability": 0.0002048015594482422
        },
        {
            "start_logit": -0.0821533203125,
            "end_logit": -8.1015625,
            "text": "gene",
            "probability": 0.00018227100372314453
        },
        {
            "start_logit": -4.98828125,
            "end_logit": -5.2890625,
            "text": "Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites.",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -4.98828125,
            "end_logit": -6.2578125,
            "text": "Identifying gene regulatory",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -4.98828125,
            "end_logit": -6.2578125,
            "text": "Identifying gene regulatory elements by genomic microarray mapping of",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -4.98828125,
            "end_logit": -7.07421875,
            "text": "Identifying gene regulatory elements by",
            "probability": 3.814697265625e-06
        }
    ],
    "5fdb2e23a43ad3127800000a_4": [
        {
            "start_logit": 4.63671875,
            "end_logit": 6.2578125,
            "text": "cis-regulatory elements",
            "probability": 0.98291015625
        },
        {
            "start_logit": 4.63671875,
            "end_logit": 2.146484375,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0161285400390625
        },
        {
            "start_logit": -2.7265625,
            "end_logit": 6.2578125,
            "text": "Hypersensitivity of cis-regulatory elements",
            "probability": 0.0006256103515625
        },
        {
            "start_logit": -3.3203125,
            "end_logit": 6.2578125,
            "text": "elements",
            "probability": 0.0003457069396972656
        },
        {
            "start_logit": -4.22265625,
            "end_logit": 6.2578125,
            "text": "regulatory elements",
            "probability": 0.00013959407806396484
        },
        {
            "start_logit": -5.39453125,
            "end_logit": 6.2578125,
            "text": "of cis-regulatory elements",
            "probability": 4.32133674621582e-05
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 6.2578125,
            "text": "-regulatory elements",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": -2.7265625,
            "end_logit": 2.146484375,
            "text": "Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -5.53125,
            "text": "cis",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -3.3203125,
            "end_logit": 2.146484375,
            "text": "elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -5.84765625,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": -4.22265625,
            "end_logit": 2.146484375,
            "text": "regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -6.875,
            "text": "cis-regulatory elements to",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -6.9296875,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -4.515625,
            "end_logit": 2.146484375,
            "text": ".",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.34375,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.5234375,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.62890625,
            "text": "cis-regulatory elements to digestion with DNaseI",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.67578125,
            "text": "cis-regulatory",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.6875,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach",
            "probability": 8.940696716308594e-07
        }
    ],
    "5fdb2e23a43ad3127800000a_5": [
        {
            "start_logit": -1.345703125,
            "end_logit": 2.880859375,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.82568359375
        },
        {
            "start_logit": -3.560546875,
            "end_logit": 2.880859375,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.09014892578125
        },
        {
            "start_logit": -4.55859375,
            "end_logit": 2.880859375,
            "text": ".",
            "probability": 0.033233642578125
        },
        {
            "start_logit": -5.15234375,
            "end_logit": 2.880859375,
            "text": "of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.018341064453125
        },
        {
            "start_logit": -5.984375,
            "end_logit": 2.880859375,
            "text": "understanding gene transcription.",
            "probability": 0.00797271728515625
        },
        {
            "start_logit": -6.01171875,
            "end_logit": 2.880859375,
            "text": "regulatory elements is central to understanding gene transcription.",
            "probability": 0.007785797119140625
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 2.880859375,
            "text": "identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.004169464111328125
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 2.880859375,
            "text": "gene transcription.",
            "probability": 0.00397491455078125
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 2.880859375,
            "text": "elements is central to understanding gene transcription.",
            "probability": 0.0020389556884765625
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 2.880859375,
            "text": "to understanding gene transcription.",
            "probability": 0.0015878677368164062
        },
        {
            "start_logit": -7.765625,
            "end_logit": 2.880859375,
            "text": "-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0013475418090820312
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 2.880859375,
            "text": "is central to understanding gene transcription.",
            "probability": 0.0011987686157226562
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 2.880859375,
            "text": "central to understanding gene transcription.",
            "probability": 0.0011615753173828125
        },
        {
            "start_logit": -1.345703125,
            "end_logit": -3.974609375,
            "text": "The identification of cis-regulatory elements",
            "probability": 0.0008702278137207031
        },
        {
            "start_logit": -1.345703125,
            "end_logit": -4.8203125,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription",
            "probability": 0.0003743171691894531
        },
        {
            "start_logit": -3.560546875,
            "end_logit": -3.974609375,
            "text": "cis-regulatory elements",
            "probability": 9.500980377197266e-05
        },
        {
            "start_logit": -1.345703125,
            "end_logit": -6.41796875,
            "text": "The",
            "probability": 7.575750350952148e-05
        },
        {
            "start_logit": -1.345703125,
            "end_logit": -7.00390625,
            "text": "The identification of cis-regulatory elements is central to understanding gene",
            "probability": 4.184246063232422e-05
        },
        {
            "start_logit": -3.560546875,
            "end_logit": -4.8203125,
            "text": "cis-regulatory elements is central to understanding gene transcription",
            "probability": 4.0531158447265625e-05
        },
        {
            "start_logit": -1.345703125,
            "end_logit": -7.27734375,
            "text": "The identification of cis-regulatory elements is central",
            "probability": 3.2067298889160156e-05
        }
    ],
    "5fdb2e23a43ad3127800000a_6": [
        {
            "start_logit": -1.23046875,
            "end_logit": 4.7734375,
            "text": "gene regulatory elements",
            "probability": 0.93701171875
        },
        {
            "start_logit": -5.25,
            "end_logit": 4.7734375,
            "text": "of active gene regulatory elements",
            "probability": 0.0168304443359375
        },
        {
            "start_logit": -5.28125,
            "end_logit": 4.7734375,
            "text": "elements",
            "probability": 0.0163116455078125
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 4.7734375,
            "text": "which mark all types of active gene regulatory elements",
            "probability": 0.0068511962890625
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 4.7734375,
            "text": "all types of active gene regulatory elements",
            "probability": 0.006824493408203125
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 4.7734375,
            "text": "active gene regulatory elements",
            "probability": 0.004169464111328125
        },
        {
            "start_logit": -7.125,
            "end_logit": 4.7734375,
            "text": "regulatory elements",
            "probability": 0.0025806427001953125
        },
        {
            "start_logit": -7.234375,
            "end_logit": 4.7734375,
            "text": "mark all types of active gene regulatory elements",
            "probability": 0.0023136138916015625
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 4.7734375,
            "text": "types of active gene regulatory elements",
            "probability": 0.002033233642578125
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 4.7734375,
            "text": "DHS) sites, which mark all types of active gene regulatory elements",
            "probability": 0.001895904541015625
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 4.7734375,
            "text": "mapped DNaseI hypersensitive (DHS) sites, which mark all types of active gene regulatory elements",
            "probability": 0.0013761520385742188
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 4.7734375,
            "text": "To identify the genetic source of regulatory differences, we mapped DNaseI hypersensitive (DHS) sites, which mark all types of active gene regulatory elements",
            "probability": 0.001354217529296875
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -2.75,
            "text": "gene regulatory elements,",
            "probability": 0.0005059242248535156
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -5.03515625,
            "text": "gene regulatory elements, genome-wide",
            "probability": 5.131959915161133e-05
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -5.43359375,
            "text": "gene regulatory elements, genome-wide in",
            "probability": 3.4749507904052734e-05
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -5.88671875,
            "text": "gene regulatory elements, genome-wide in the same cell type isolated from human, chimpanzee, and macaque.",
            "probability": 2.205371856689453e-05
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -6.1875,
            "text": "gene regulatory elements, genome-wide in the same cell type",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -6.42578125,
            "text": "gene regulatory",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": -5.25,
            "end_logit": -2.75,
            "text": "of active gene regulatory elements,",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -5.28125,
            "end_logit": -2.75,
            "text": "elements,",
            "probability": 8.761882781982422e-06
        }
    ],
    "53318685d6d3ac6a3400003d_1": [
        {
            "start_logit": 7.91015625,
            "end_logit": 7.84765625,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -1.51171875,
            "text": "autosomal",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": 7.84765625,
            "text": "dominant",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.55859375,
            "text": "autosomal dominant mode of inheritance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.91015625,
            "text": "autosomal dominant mode of inheritance,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.9375,
            "text": "autosomal dominant mode of inheritance, distinct",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.953125,
            "text": "autosomal dominant mode of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.9609375,
            "text": "autosomal dominant mode of inheritance, distinct facial and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.96484375,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.98046875,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.98828125,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.55859375,
            "text": "dominant mode of inheritance",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.91015625,
            "text": "dominant mode of inheritance,",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.9375,
            "text": "dominant mode of inheritance, distinct",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.953125,
            "text": "dominant mode of",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.9609375,
            "text": "dominant mode of inheritance, distinct facial and",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.96484375,
            "text": "dominant mode of inheritance, distinct facial and skeleton",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.98046875,
            "text": "dominant mode of inheritance, distinct facial and skeleton features (a",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.98828125,
            "text": "dominant mode of inheritance, distinct facial and skeleton features (a hoarse",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.55859375,
            "text": "mode of inheritance",
            "probability": 0.0
        }
    ],
    "53318685d6d3ac6a3400003d_2": [
        {
            "start_logit": 7.9765625,
            "end_logit": 7.95703125,
            "text": "autosomal dominant",
            "probability": 0.3369140625
        },
        {
            "start_logit": 7.9765625,
            "end_logit": 7.94921875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.9765625,
            "end_logit": 7.94921875,
            "text": "autosomal dominant",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -0.6953125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive",
            "probability": 5.8650970458984375e-05
        },
        {
            "start_logit": -0.99755859375,
            "end_logit": 7.94921875,
            "text": "autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 4.225969314575195e-05
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -1.2568359375,
            "text": "autosomal",
            "probability": 3.343820571899414e-05
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -1.2880859375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal",
            "probability": 3.236532211303711e-05
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -1.2880859375,
            "text": "autosomal",
            "probability": 3.236532211303711e-05
        },
        {
            "start_logit": -1.541015625,
            "end_logit": 7.95703125,
            "text": "dominant",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": -1.541015625,
            "end_logit": 7.94921875,
            "text": "dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 2.4437904357910156e-05
        },
        {
            "start_logit": -1.5693359375,
            "end_logit": 7.94921875,
            "text": "dominant",
            "probability": 2.3663043975830078e-05
        },
        {
            "start_logit": -1.833984375,
            "end_logit": 7.94921875,
            "text": "autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -3.275390625,
            "text": "autosomal dominant or an autosomal recessive",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.140625,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.140625,
            "text": "autosomal dominant mode of inheritance",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.55859375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.77734375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.88671875,
            "text": "autosomal dominant or an autosomal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 7.94921875,
            "text": "mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 7.94921875,
            "text": "inheritance and AD by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        }
    ],
    "53318685d6d3ac6a3400003d_3": [
        {
            "start_logit": 7.9765625,
            "end_logit": 7.95703125,
            "text": "autosomal dominant",
            "probability": 0.3369140625
        },
        {
            "start_logit": 7.9765625,
            "end_logit": 7.94921875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.9765625,
            "end_logit": 7.94921875,
            "text": "autosomal dominant",
            "probability": 0.33154296875
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -0.6953125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive",
            "probability": 5.8650970458984375e-05
        },
        {
            "start_logit": -0.99755859375,
            "end_logit": 7.94921875,
            "text": "autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 4.225969314575195e-05
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -1.2568359375,
            "text": "autosomal",
            "probability": 3.343820571899414e-05
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -1.2880859375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal",
            "probability": 3.236532211303711e-05
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -1.2880859375,
            "text": "autosomal",
            "probability": 3.236532211303711e-05
        },
        {
            "start_logit": -1.541015625,
            "end_logit": 7.95703125,
            "text": "dominant",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": -1.541015625,
            "end_logit": 7.94921875,
            "text": "dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 2.4437904357910156e-05
        },
        {
            "start_logit": -1.5693359375,
            "end_logit": 7.94921875,
            "text": "dominant",
            "probability": 2.3663043975830078e-05
        },
        {
            "start_logit": -1.833984375,
            "end_logit": 7.94921875,
            "text": "autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -3.275390625,
            "text": "autosomal dominant or an autosomal recessive",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.140625,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.140625,
            "text": "autosomal dominant mode of inheritance",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.55859375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.77734375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9765625,
            "end_logit": -6.88671875,
            "text": "autosomal dominant or an autosomal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 7.94921875,
            "text": "mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 7.94921875,
            "text": "inheritance and AD by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        }
    ],
    "53318685d6d3ac6a3400003d_4": [
        {
            "start_logit": 7.91015625,
            "end_logit": 7.88671875,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -1.4296875,
            "text": "autosomal",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": -1.5986328125,
            "end_logit": 7.88671875,
            "text": "dominant",
            "probability": 7.426738739013672e-05
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.6640625,
            "text": "autosomal dominant mode of inheritance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.88671875,
            "text": "consistent with an autosomal dominant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.88671875,
            "text": "families was consistent with an autosomal dominant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.73828125,
            "text": "autosomal dominant mode of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.88671875,
            "text": "an autosomal dominant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.88671875,
            "text": "with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.91015625,
            "end_logit": -7.90234375,
            "text": "autosomal dominant mode of inheritance.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 7.88671875,
            "text": "transmission in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 7.88671875,
            "text": "condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 7.88671875,
            "text": "vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -1.4296875,
            "text": "consistent with an autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -1.4296875,
            "text": "families was consistent with an autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": -1.4296875,
            "text": "an autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -1.5986328125,
            "end_logit": -7.6640625,
            "text": "dominant mode of inheritance",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -1.4296875,
            "text": "with an autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -1.5986328125,
            "end_logit": -7.73828125,
            "text": "dominant mode of",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -1.4296875,
            "text": "transmission in three families was consistent with an autosomal",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_1": [
        {
            "start_logit": 7.60546875,
            "end_logit": 7.73046875,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": -2.23046875,
            "end_logit": 7.73046875,
            "text": "io",
            "probability": 5.346536636352539e-05
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -2.740234375,
            "text": "Oh",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -7.5078125,
            "text": "Ohio,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.73046875,
            "text": "in Ohio",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 7.73046875,
            "text": "Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 7.73046875,
            "text": "measles outbreak in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 7.73046875,
            "text": "communities include a 2014 measles outbreak in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.73046875,
            "text": "outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.73046875,
            "text": "sh communities include a 2014 measles outbreak in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 7.73046875,
            "text": "in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.73046875,
            "text": "outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.23046875,
            "end_logit": -7.5078125,
            "text": "io,",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -2.740234375,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -2.740234375,
            "text": "Amish communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": -2.740234375,
            "text": "measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -2.740234375,
            "text": "communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -2.740234375,
            "text": "outbreaks in Amish communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -2.740234375,
            "text": "sh communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -2.740234375,
            "text": "in Amish communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_2": [
        {
            "start_logit": 7.296875,
            "end_logit": 7.609375,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": -2.478515625,
            "end_logit": 7.609375,
            "text": "io",
            "probability": 5.692243576049805e-05
        },
        {
            "start_logit": 7.296875,
            "end_logit": -3.337890625,
            "text": "Oh",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": -7.0625,
            "end_logit": 7.609375,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.609375,
            "text": "in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.609375,
            "text": "United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 7.609375,
            "text": "in Ohio",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 7.609375,
            "text": "outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.609375,
            "text": "continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.609375,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 7.609375,
            "text": "Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 7.609375,
            "text": "undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": -3.337890625,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -3.337890625,
            "text": "Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -3.337890625,
            "text": "in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -3.337890625,
            "text": "United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -3.337890625,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": -4.25,
            "text": "the United States",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -3.337890625,
            "text": "outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -3.337890625,
            "text": "continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_3": [
        {
            "start_logit": 7.8046875,
            "end_logit": 7.796875,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -1.748046875,
            "text": "Oh",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -1.8955078125,
            "end_logit": 7.796875,
            "text": "io",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.34765625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.3671875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.40625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.48828125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.53515625,
            "text": "Ohio were transmission primarily within households, the small",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.55078125,
            "text": "Ohio were",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.578125,
            "text": "Ohio were transmission primarily within households, the small proportion of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.58203125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.66015625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.6640625,
            "text": "Ohio were transmission",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.703125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.70703125,
            "text": "Ohio were transmission primarily within households, the small proportion",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.74609375,
            "text": "Ohio were transmission primarily within households",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.74609375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who sought",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.74609375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.76953125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.80078125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected,",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5c5312097e3cb0e231000011_4": [
        {
            "start_logit": 7.74609375,
            "end_logit": 7.72265625,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -2.119140625,
            "text": "Oh",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": -2.166015625,
            "end_logit": 7.72265625,
            "text": "io",
            "probability": 4.947185516357422e-05
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 7.72265625,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.01171875,
            "text": "Ohio pushing the annual cases to the highest national",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.17578125,
            "text": "Ohio pushing the annual cases to the highest",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.390625,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last 20 years.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.42578125,
            "text": "Ohio push",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.51171875,
            "text": "Ohio pushing the annual cases to the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.5234375,
            "text": "Ohio pushing the annual cases to the highest national number",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.56640625,
            "text": "Ohio pushing the annual cases to the highest national number reported",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.62890625,
            "text": "Ohio pushing the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.72265625,
            "text": "United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.66796875,
            "text": "Ohio pushing the annual",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.72265625,
            "text": "in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.72265625,
            "text": "in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 7.72265625,
            "text": "outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 7.72265625,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 7.72265625,
            "text": "Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.72265625,
            "text": "continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c5312097e3cb0e231000011_5": [
        {
            "start_logit": 7.78125,
            "end_logit": 7.78515625,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": -1.9921875,
            "end_logit": 7.78515625,
            "text": "io",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 7.78125,
            "end_logit": -2.015625,
            "text": "Oh",
            "probability": 5.561113357543945e-05
        },
        {
            "start_logit": 7.78125,
            "end_logit": -7.60546875,
            "text": "Ohio,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.78515625,
            "text": "in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78125,
            "end_logit": -7.7109375,
            "text": "Ohio, resulting in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78125,
            "end_logit": -7.7265625,
            "text": "Ohio, resulting in 368",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78125,
            "end_logit": -7.8046875,
            "text": "Ohio, resulting in 36",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78125,
            "end_logit": -7.84765625,
            "text": "Ohio, resulting in 368 cases reported",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.78125,
            "end_logit": -7.95703125,
            "text": "Ohio, resulting in 368 cases",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.78515625,
            "text": "measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.78125,
            "end_logit": -7.98828125,
            "text": "Ohio, resulting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 7.78515625,
            "text": "Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.78515625,
            "text": "communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.78515625,
            "text": "outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.78515625,
            "text": "sh communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 7.78515625,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.78515625,
            "text": "outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.78515625,
            "text": "in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.9921875,
            "end_logit": -7.60546875,
            "text": "io,",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_6": [
        {
            "start_logit": 7.8046875,
            "end_logit": 7.796875,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -1.748046875,
            "text": "Oh",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -1.8955078125,
            "end_logit": 7.796875,
            "text": "io",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.34765625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.3671875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.40625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.48828125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.53515625,
            "text": "Ohio were transmission primarily within households, the small",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.55078125,
            "text": "Ohio were",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.578125,
            "text": "Ohio were transmission primarily within households, the small proportion of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.58203125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.66015625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.6640625,
            "text": "Ohio were transmission",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.703125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.70703125,
            "text": "Ohio were transmission primarily within households, the small proportion",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.74609375,
            "text": "Ohio were transmission primarily within households",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.74609375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who sought",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.74609375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.76953125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8046875,
            "end_logit": -7.80078125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected,",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5c5312097e3cb0e231000011_7": [
        {
            "start_logit": 7.6953125,
            "end_logit": 7.6875,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": -2.25,
            "end_logit": 7.6875,
            "text": "io",
            "probability": 4.792213439941406e-05
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -2.345703125,
            "text": "Oh",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": -6.453125,
            "end_logit": 7.6875,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.11328125,
            "text": "Ohio pushing the annual cases to the highest national",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.22265625,
            "text": "Ohio push",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.328125,
            "text": "Ohio pushing the annual cases to the highest",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.3671875,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last 20 years.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.6875,
            "text": "in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.6875,
            "text": "in Ohio",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.56640625,
            "text": "Ohio pushing the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.6875,
            "text": "United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.6875,
            "text": "Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 7.6875,
            "text": "undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 7.6875,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 7.6875,
            "text": "continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.453125,
            "end_logit": -2.345703125,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.11328125,
            "text": "io pushing the annual cases to the highest national",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.22265625,
            "text": "io push",
            "probability": 0.0
        },
        {
            "start_logit": -7.1328125,
            "end_logit": -2.345703125,
            "text": "Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        }
    ],
    "61f95f9f882a024a1000004e_1": [
        {
            "start_logit": 7.57421875,
            "end_logit": 7.80078125,
            "text": "Oguchi disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.25390625,
            "end_logit": 7.80078125,
            "text": "disease",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -2.939453125,
            "text": "Og",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -5.32421875,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -6.6953125,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB).",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 7.80078125,
            "text": "i disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -6.8984375,
            "text": "Oguchi disease,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -6.94921875,
            "text": "Oguchi disease, a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -6.97265625,
            "text": "Oguch",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.0078125,
            "text": "Oguchi",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.80078125,
            "text": "uchi disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.11328125,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.80078125,
            "text": "cause Oguchi disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.31640625,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.80078125,
            "text": "allelic mutations in G-Protein coupled receptor kinase 1 (GRK1) cause Oguchi disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 7.80078125,
            "text": "Biallelic mutations in G-Protein coupled receptor kinase 1 (GRK1) cause Oguchi disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.80078125,
            "text": "in G-Protein coupled receptor kinase 1 (GRK1) cause Oguchi disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.77734375,
            "text": "Oguchi disease, a rare subtype of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.83203125,
            "text": "Oguchi disease, a rare",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -8.125,
            "text": "Oguchi disease, a rare subtype of congenital stationary",
            "probability": 1.1920928955078125e-07
        }
    ]
}
